{
    "data": [
        {
            "product_ndc": "59148-007",
            "generic_name": "ARIPIPRAZOLE",
            "labeler_name": "Otsuka America Pharmaceutical, Inc.",
            "brand_name": "ABILIFY",
            "active_ingredients": [
                {
                    "name": "ARIPIPRAZOLE",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59148-007-13",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (59148-007-13)",
                    "marketing_start_date": "20021115",
                    "sample": false
                },
                {
                    "package_ndc": "59148-007-35",
                    "description": "100 TABLET in 1 BLISTER PACK (59148-007-35)",
                    "marketing_start_date": "20021115",
                    "sample": false
                },
                {
                    "package_ndc": "59148-007-94",
                    "description": "7 TABLET in 1 BLISTER PACK (59148-007-94)",
                    "marketing_start_date": "20021115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Otsuka America Pharmaceutical, Inc."
                ],
                "rxcui": [
                    "349490",
                    "349545",
                    "349547",
                    "349553",
                    "352307",
                    "352308",
                    "352309",
                    "352310",
                    "402131",
                    "404602",
                    "485496",
                    "544412",
                    "602964",
                    "615172",
                    "643019",
                    "643021",
                    "643022",
                    "643023",
                    "672356",
                    "672540"
                ],
                "spl_set_id": [
                    "c040bd1d-45b7-49f2-93ea-aed7220b30ac"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "82VFR53I78"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "54fce3dd-d985-44ac-a5d8-d44be28fb2fa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20021115",
            "product_id": "59148-007_54fce3dd-d985-44ac-a5d8-d44be28fb2fa",
            "application_number": "NDA021436",
            "brand_name_base": "ABILIFY",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "59148-007",
            "generic_name": "ARIPIPRAZOLE",
            "labeler_name": "Otsuka America Pharmaceutical, Inc.",
            "brand_name": "ABILIFY",
            "active_ingredients": [
                {
                    "name": "ARIPIPRAZOLE",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59148-007-13",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (59148-007-13)",
                    "marketing_start_date": "20021115",
                    "sample": false
                },
                {
                    "package_ndc": "59148-007-35",
                    "description": "100 TABLET in 1 BLISTER PACK (59148-007-35)",
                    "marketing_start_date": "20021115",
                    "sample": false
                },
                {
                    "package_ndc": "59148-007-94",
                    "description": "7 TABLET in 1 BLISTER PACK (59148-007-94)",
                    "marketing_start_date": "20021115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Otsuka America Pharmaceutical, Inc."
                ],
                "rxcui": [
                    "349490",
                    "349545",
                    "349547",
                    "349553",
                    "352307",
                    "352308",
                    "352309",
                    "352310",
                    "402131",
                    "404602",
                    "485496",
                    "544412",
                    "602964",
                    "615172",
                    "643019",
                    "643021",
                    "643022",
                    "643023",
                    "672356",
                    "672540"
                ],
                "spl_set_id": [
                    "c040bd1d-45b7-49f2-93ea-aed7220b30ac"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "82VFR53I78"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "54fce3dd-d985-44ac-a5d8-d44be28fb2fa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20021115",
            "product_id": "59148-007_54fce3dd-d985-44ac-a5d8-d44be28fb2fa",
            "application_number": "NDA021436",
            "brand_name_base": "ABILIFY",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "68817-134",
            "generic_name": "Paclitaxel",
            "labeler_name": "Abraxis BioScience, LLC",
            "brand_name": "ABRAXANE",
            "active_ingredients": [
                {
                    "name": "PACLITAXEL",
                    "strength": "100 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68817-134-50",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50)  / 20 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20050210",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Abraxis BioScience, LLC"
                ],
                "rxcui": [
                    "583214",
                    "583218"
                ],
                "spl_set_id": [
                    "24d10449-2936-4cd3-b7db-a7683db721e4"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0368817134500"
                ],
                "nui": [
                    "N0000175085",
                    "N0000175592"
                ],
                "pharm_class_pe": [
                    "Microtubule Inhibition [PE]"
                ],
                "pharm_class_epc": [
                    "Microtubule Inhibitor [EPC]"
                ],
                "unii": [
                    "P88XT4IS4D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",
            "spl_id": "25a98542-1909-490d-b162-6e36d3997d8a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20050210",
            "product_id": "68817-134_25a98542-1909-490d-b162-6e36d3997d8a",
            "application_number": "NDA021660",
            "brand_name_base": "ABRAXANE",
            "pharm_class": [
                "Microtubule Inhibition [PE]",
                "Microtubule Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "0069-0325",
            "generic_name": "adalimumab-afzb",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "ABRILADA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0325-01",
                    "description": "1 KIT in 1 CARTON (0069-0325-01)  / 1 KIT in 1 KIT *  .8 mL in 1 SYRINGE (0069-0318-01)  *  1 mL in 1 PACKET (0069-1111-01)",
                    "marketing_start_date": "20231018",
                    "sample": false
                },
                {
                    "package_ndc": "0069-0325-02",
                    "description": "2 KIT in 1 CARTON (0069-0325-02)  / 1 KIT in 1 KIT *  .8 mL in 1 SYRINGE (0069-0318-01)  *  1 mL in 1 PACKET (0069-1111-01)",
                    "marketing_start_date": "20231018",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "797544",
                    "2668064",
                    "2668071",
                    "2668074",
                    "2668078",
                    "2668095",
                    "2668096",
                    "2668105",
                    "2668106",
                    "2668109",
                    "2668113"
                ],
                "spl_set_id": [
                    "81a33cfa-262f-4432-a05d-7dd260928437"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "4c5ed4e2-012a-436f-993d-896ab3d12ac6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20231018",
            "product_id": "0069-0325_4c5ed4e2-012a-436f-993d-896ab3d12ac6",
            "application_number": "BLA761118",
            "brand_name_base": "ABRILADA"
        },
        {
            "product_ndc": "0069-0344",
            "generic_name": "Respiratory Syncytial Virus Vaccine",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Abrysvo",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0344-01",
                    "description": "1 TRAY in 1 CARTON (0069-0344-01)  / 1 KIT in 1 TRAY (0069-0344-21)  *  .5 mL in 1 VIAL, GLASS (0069-0207-01)  *  .69 mL in 1 SYRINGE, GLASS (0069-0250-01)",
                    "marketing_start_date": "20230712",
                    "sample": false
                },
                {
                    "package_ndc": "0069-0344-05",
                    "description": "5 TRAY in 1 CARTON (0069-0344-05)  / 1 KIT in 1 TRAY (0069-0344-21)  *  .5 mL in 1 VIAL, GLASS (0069-0207-01)  *  .69 mL in 1 SYRINGE, GLASS (0069-0250-01)",
                    "marketing_start_date": "20230712",
                    "sample": false
                },
                {
                    "package_ndc": "0069-0344-10",
                    "description": "10 TRAY in 1 CARTON (0069-0344-10)  / 1 KIT in 1 TRAY (0069-0344-21)  *  .5 mL in 1 VIAL, GLASS (0069-0207-01)  *  .69 mL in 1 SYRINGE, GLASS (0069-0250-01)",
                    "marketing_start_date": "20230712",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "54fac5a9-853a-4908-aee8-86d466476556",
            "product_type": "VACCINE",
            "marketing_start_date": "20230712",
            "product_id": "0069-0344_54fac5a9-853a-4908-aee8-86d466476556",
            "application_number": "BLA125769",
            "brand_name_base": "Abrysvo"
        },
        {
            "product_ndc": "13548-132",
            "generic_name": "Clindamycin Phosphate and Benzoyl Peroxide",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Acanya",
            "active_ingredients": [
                {
                    "name": "BENZOYL PEROXIDE",
                    "strength": "25 mg/g"
                },
                {
                    "name": "CLINDAMYCIN PHOSPHATE",
                    "strength": "10 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "13548-132-50",
                    "description": "1 BOTTLE, PUMP in 1 CARTON (13548-132-50)  / 50 g in 1 BOTTLE, PUMP",
                    "marketing_start_date": "20100726",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "spl_set_id": [
                    "3dcd2c96-72b1-4a9f-b65c-08198d63b7df"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "W9WZN9A0GM",
                    "EH6D7113I8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GEL",
            "spl_id": "110dde63-b7d7-49af-aa96-9daefccb84ff",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20100726",
            "product_id": "13548-132_110dde63-b7d7-49af-aa96-9daefccb84ff",
            "application_number": "NDA050819",
            "brand_name_base": "Acanya",
            "pharm_class": [
                "Decreased Sebaceous Gland Activity [PE]",
                "Lincosamide Antibacterial [EPC]",
                "Lincosamides [CS]"
            ]
        },
        {
            "product_ndc": "50242-135",
            "generic_name": "tocilizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "ACTEMRA",
            "active_ingredients": [
                {
                    "name": "TOCILIZUMAB",
                    "strength": "80 mg/4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-135-01",
                    "description": "1 VIAL, SINGLE-USE in 1 BOX (50242-135-01)  / 4 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20100108",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1441527",
                    "1441530",
                    "1657974",
                    "1657976",
                    "1657979",
                    "1657980",
                    "1657981",
                    "1657982",
                    "2106073",
                    "2106075"
                ],
                "spl_set_id": [
                    "2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190478",
                    "N0000190480"
                ],
                "pharm_class_moa": [
                    "Interleukin 6 Receptor Antagonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Interleukin-6 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "I031V2H011"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "dcb66364-6d57-4088-b445-5043bd97116c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20100108",
            "product_id": "50242-135_dcb66364-6d57-4088-b445-5043bd97116c",
            "application_number": "BLA125276",
            "brand_name_base": "ACTEMRA",
            "pharm_class": [
                "Interleukin 6 Receptor Antagonists [MoA]",
                "Interleukin-6 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "75987-111",
            "generic_name": "Interferon gamma-1b",
            "labeler_name": "Horizon Therapeutics USA, Inc.",
            "brand_name": "ACTIMMUNE",
            "active_ingredients": [
                {
                    "name": "INTERFERON GAMMA-1B",
                    "strength": "100 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75987-111-11",
                    "description": "12 VIAL, SINGLE-DOSE in 1 CARTON (75987-111-11)  / .5 mL in 1 VIAL, SINGLE-DOSE (75987-111-10)",
                    "marketing_start_date": "20131201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Horizon Therapeutics USA, Inc."
                ],
                "rxcui": [
                    "240448",
                    "751970"
                ],
                "spl_set_id": [
                    "5d0b1256-1981-4519-94f4-a4a2f98bd8a3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175541",
                    "M0011490"
                ],
                "pharm_class_epc": [
                    "Interferon gamma [EPC]"
                ],
                "pharm_class_cs": [
                    "Interferon-gamma [CS]"
                ],
                "unii": [
                    "21K6M2I7AG"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7d221d93-6904-47ec-95ef-89eed9521368",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20131201",
            "product_id": "75987-111_7d221d93-6904-47ec-95ef-89eed9521368",
            "application_number": "BLA103836",
            "brand_name_base": "ACTIMMUNE",
            "pharm_class": [
                "Interferon gamma [EPC]",
                "Interferon-gamma [CS]"
            ]
        },
        {
            "product_ndc": "50242-044",
            "generic_name": "Alteplase",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Activase",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-044-13",
                    "description": "1 KIT in 1 CARTON (50242-044-13)  *  50 mL in 1 VIAL, SINGLE-USE *  50 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "19871113",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1804799",
                    "1804802",
                    "1804804",
                    "1804806"
                ],
                "spl_set_id": [
                    "c669f77c-fa48-478b-a14b-80b20a0139c2"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "d156776e-911a-4db0-945b-9d952f4ece42",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "19871113",
            "product_id": "50242-044_d156776e-911a-4db0-945b-9d952f4ece42",
            "application_number": "BLA103172",
            "brand_name_base": "Activase"
        },
        {
            "product_ndc": "49281-400",
            "generic_name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN",
            "labeler_name": "Sanofi Pasteur Inc.",
            "brand_name": "Adacel TDaP",
            "brand_name_suffix": "TDaP",
            "active_ingredients": [
                {
                    "name": "BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "5 ug/.5mL"
                },
                {
                    "name": "BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN",
                    "strength": "5 ug/.5mL"
                },
                {
                    "name": "BORDETELLA PERTUSSIS PERTACTIN ANTIGEN",
                    "strength": "3 ug/.5mL"
                },
                {
                    "name": "BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)",
                    "strength": "2.5 ug/.5mL"
                },
                {
                    "name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "5 [Lf]/.5mL"
                },
                {
                    "name": "CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "2 [Lf]/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49281-400-05",
                    "description": "5 VIAL in 1 PACKAGE (49281-400-05)  / .5 mL in 1 VIAL (49281-400-58)",
                    "marketing_start_date": "20050610",
                    "sample": false
                },
                {
                    "package_ndc": "49281-400-10",
                    "description": "10 VIAL in 1 PACKAGE (49281-400-10)  / .5 mL in 1 VIAL (49281-400-58)",
                    "marketing_start_date": "20050610",
                    "sample": false
                },
                {
                    "package_ndc": "49281-400-20",
                    "description": "5 SYRINGE in 1 PACKAGE (49281-400-20)  / .5 mL in 1 SYRINGE (49281-400-89)",
                    "marketing_start_date": "20050610",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "54c1ecd8-c9cc-4c58-b42d-345d03eb5e5b",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20050610",
            "product_id": "49281-400_54c1ecd8-c9cc-4c58-b42d-345d03eb5e5b",
            "application_number": "BLA125111",
            "brand_name_base": "Adacel",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Diphtheria Toxoid [CS]",
                "Inactivated Bordetella Pertussis Vaccine [EPC]",
                "Inactivated Bordetella Pertussis Vaccine [EPC]",
                "Inactivated Bordetella Pertussis Vaccine [EPC]",
                "Inactivated Clostridium Tetani Vaccine [EPC]",
                "Inactivated Corynebacterium Diphtheriae Vaccine [EPC]",
                "Pertussis Vaccine [CS]",
                "Pertussis Vaccine [CS]",
                "Pertussis Vaccine [CS]",
                "Tetanus Toxoid [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]"
            ]
        },
        {
            "product_ndc": "0078-0883",
            "generic_name": "crizanlizumab",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "ADAKVEO",
            "active_ingredients": [
                {
                    "name": "CRIZANLIZUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0883-61",
                    "description": "10 mL in 1 VIAL, GLASS (0078-0883-61)",
                    "marketing_start_date": "20191115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2262425",
                    "2262430"
                ],
                "spl_set_id": [
                    "b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194032",
                    "N0000194031"
                ],
                "pharm_class_epc": [
                    "Selectin Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "P-Selectin Blockers [MoA]"
                ],
                "unii": [
                    "L7451S9126"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "9f1b7498-2769-40fb-8e5c-0fd7ac9ff177",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20191115",
            "product_id": "0078-0883_9f1b7498-2769-40fb-8e5c-0fd7ac9ff177",
            "application_number": "BLA761128",
            "brand_name_base": "ADAKVEO"
        },
        {
            "product_ndc": "50222-346",
            "generic_name": "tralokinumab-ldrm",
            "labeler_name": "LEO Pharma Inc.",
            "brand_name": "Adbry",
            "active_ingredients": [
                {
                    "name": "TRALOKINUMAB",
                    "strength": "150 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50222-346-02",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (50222-346-02)  / 1 mL in 1 SYRINGE, GLASS (50222-346-01)",
                    "marketing_start_date": "20220102",
                    "sample": false
                },
                {
                    "package_ndc": "50222-346-04",
                    "description": "2 CARTON in 1 CARTON (50222-346-04)  / 2 SYRINGE, GLASS in 1 CARTON (50222-346-22)  / 1 mL in 1 SYRINGE, GLASS (50222-346-01)",
                    "marketing_start_date": "20220102",
                    "sample": false
                },
                {
                    "package_ndc": "50222-346-92",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (50222-346-92)  / 1 mL in 1 SYRINGE, GLASS (50222-346-91)",
                    "marketing_start_date": "20220102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "28cb6865-63bf-4254-9eb1-5b54f5f74a54",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220102",
            "product_id": "50222-346_28cb6865-63bf-4254-9eb1-5b54f5f74a54",
            "application_number": "BLA761180",
            "brand_name_base": "Adbry",
            "pharm_class": [
                "Interleukin-13 Antagonist [EPC]",
                "Interleukin-13 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "51144-050",
            "generic_name": "brentuximab vedotin",
            "labeler_name": "SEAGEN INC.",
            "brand_name": "ADCETRIS",
            "active_ingredients": [
                {
                    "name": "BRENTUXIMAB VEDOTIN",
                    "strength": "50 mg/10.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51144-050-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01)  / 10.5 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20110825",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "SEAGEN INC."
                ],
                "rxcui": [
                    "1147323",
                    "1147327"
                ],
                "spl_set_id": [
                    "3904f8dd-1aef-3490-e48f-bd55f32ed67f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000182966",
                    "N0000182967",
                    "M0028142",
                    "N0000175085"
                ],
                "pharm_class_moa": [
                    "CD30-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD30-directed Immunoconjugate [EPC]"
                ],
                "pharm_class_cs": [
                    "Immunoconjugates [CS]"
                ],
                "pharm_class_pe": [
                    "Microtubule Inhibition [PE]"
                ],
                "unii": [
                    "7XL5ISS668"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "06e66dfb-7f66-4fd2-930f-876324ce1ac5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20110825",
            "product_id": "51144-050_06e66dfb-7f66-4fd2-930f-876324ce1ac5",
            "application_number": "BLA125388",
            "brand_name_base": "ADCETRIS",
            "pharm_class": [
                "CD30-directed Antibody Interactions [MoA]",
                "CD30-directed Immunoconjugate [EPC]",
                "Immunoconjugates [CS]",
                "Microtubule Inhibition [PE]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0024-5925",
            "generic_name": "insulin lispro",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "ADMELOG",
            "active_ingredients": [
                {
                    "name": "INSULIN LISPRO",
                    "strength": "100 U/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5925-00",
                    "description": "1 SYRINGE in 1 CARTON (0024-5925-00)  / 3 mL in 1 SYRINGE",
                    "marketing_start_date": "20171211",
                    "sample": true
                },
                {
                    "package_ndc": "0024-5925-05",
                    "description": "5 SYRINGE in 1 CARTON (0024-5925-05)  / 3 mL in 1 SYRINGE (0024-5925-01)",
                    "marketing_start_date": "20171211",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "242120",
                    "1652639",
                    "1992169",
                    "1992171"
                ],
                "spl_set_id": [
                    "0691def8-4a7b-4de3-866f-a280989f47f1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000004931",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [Chemical/Ingredient]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "GFX7QIS1II"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "5c8efb5f-4957-428e-ad2a-a2a9a28ca2fd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20171211",
            "product_id": "0024-5925_5c8efb5f-4957-428e-ad2a-a2a9a28ca2fd",
            "application_number": "BLA209196",
            "brand_name_base": "ADMELOG",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [Chemical/Ingredient]"
            ]
        },
        {
            "product_ndc": "64406-101",
            "generic_name": "Aducanumab",
            "labeler_name": "Biogen Inc.",
            "brand_name": "Aduhelm",
            "active_ingredients": [
                {
                    "name": "ADUCANUMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64406-101-01",
                    "description": "1 VIAL in 1 CARTON (64406-101-01)  / 1.7 mL in 1 VIAL",
                    "marketing_start_date": "20210607",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Biogen Inc."
                ],
                "rxcui": [
                    "2557224",
                    "2557229",
                    "2557232",
                    "2557233"
                ],
                "spl_set_id": [
                    "41706573-546f-6774-6872-5374726f6e67"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193951",
                    "N0000193950"
                ],
                "pharm_class_epc": [
                    "Amyloid Beta-directed Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Amyloid Beta-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "105J35OE21"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "bdbcb712-6e43-45e4-9404-452239d0daa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210607",
            "product_id": "64406-101_bdbcb712-6e43-45e4-9404-452239d0daa0",
            "application_number": "BLA761178",
            "brand_name_base": "Aduhelm",
            "pharm_class": [
                "Amyloid Beta-directed Antibody Interactions [MoA]",
                "Amyloid Beta-directed Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "0944-3045",
            "generic_name": "Antihemophilic Factor (Recombinant)",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "ADVATE",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0944-3045-10",
                    "description": "1 BLISTER PACK in 1 CONTAINER (0944-3045-10)  / 1 CONTAINER in 1 BLISTER PACK (0944-3045-12)  / 1 KIT in 1 CONTAINER (0944-3045-11)  *  5 mL in 1 VIAL, GLASS (0944-2945-01)  *  5 mL in 1 VIAL, GLASS (64764-515-50)",
                    "marketing_start_date": "20060412",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "e3808f08-3c70-4d96-81a9-519f9d384951",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20060412",
            "product_id": "0944-3045_e3808f08-3c70-4d96-81a9-519f9d384951",
            "application_number": "BLA125063",
            "brand_name_base": "ADVATE"
        },
        {
            "product_ndc": "0944-4622",
            "generic_name": "Antihemophilic Factor (Recombinant) PEGylated",
            "labeler_name": "Takeda Pharmaceuticals Amercia, Inc.",
            "brand_name": "ADYNOVATE",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0944-4622-01",
                    "description": "1 KIT in 1 CARTON (0944-4622-01)  / 1 CONTAINER in 1 KIT (0944-4622-02)  / 1 KIT in 1 CONTAINER (0944-4622-03)  *  5 mL in 1 VIAL, GLASS (0944-4137-01)  *  2 mL in 1 VIAL, GLASS (64764-514-02)",
                    "marketing_start_date": "20160728",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "215d2368-3d55-4bf5-adce-cc4d43c566f6",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20160728",
            "product_id": "0944-4622_215d2368-3d55-4bf5-adce-cc4d43c566f6",
            "application_number": "BLA125566",
            "brand_name_base": "ADYNOVATE"
        },
        {
            "product_ndc": "64764-145",
            "generic_name": "Apadamtase Alfa",
            "labeler_name": "TAKEDA PHARMACEUTICALS AMERICA, INC.",
            "brand_name": "ADZYNMA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-145-05",
                    "description": "1 KIT in 1 CARTON (64764-145-05)  *  1500 [iU] in 1 VIAL, SINGLE-DOSE (64764-135-01)  *  5 mL in 1 VIAL, GLASS (64764-515-50)",
                    "marketing_start_date": "20231109",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TAKEDA PHARMACEUTICALS AMERICA, INC."
                ],
                "rxcui": [
                    "2670293",
                    "2670300",
                    "2670311",
                    "2670313"
                ],
                "spl_set_id": [
                    "22728e96-efa0-46c1-bdd1-ad89a796d5e3"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "325b9c3f-c547-44ed-b8c1-c5abe8b3da53",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20231109",
            "product_id": "64764-145_325b9c3f-c547-44ed-b8c1-c5abe8b3da53",
            "application_number": "BLA125795",
            "brand_name_base": "ADZYNMA"
        },
        {
            "product_ndc": "0078-0620",
            "generic_name": "everolimus",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Afinitor",
            "active_ingredients": [
                {
                    "name": "EVEROLIMUS",
                    "strength": "7.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0620-51",
                    "description": "28 BLISTER PACK in 1 CARTON (0078-0620-51)  / 1 TABLET in 1 BLISTER PACK (0078-0620-61)",
                    "marketing_start_date": "20110729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "845507",
                    "845512",
                    "845515",
                    "845518",
                    "998189",
                    "998191",
                    "1119400",
                    "1119402",
                    "1308428",
                    "1308430",
                    "1308432",
                    "1310138",
                    "1310144",
                    "1310147"
                ],
                "spl_set_id": [
                    "2150f73a-179b-4afc-b8ce-67c85cc72f04"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076",
                    "N0000182141",
                    "N0000182137",
                    "N0000175625",
                    "N0000175624",
                    "N0000175550"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]",
                    "mTOR Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "mTOR Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased Immunologic Activity [PE]"
                ],
                "unii": [
                    "9HW64Q8G6G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110729",
            "product_id": "0078-0620_fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "application_number": "NDA022334",
            "brand_name_base": "Afinitor",
            "pharm_class": [
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Decreased Immunologic Activity [PE]",
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]",
                "mTOR Inhibitor Immunosuppressant [EPC]",
                "mTOR Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0620",
            "generic_name": "everolimus",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Afinitor",
            "active_ingredients": [
                {
                    "name": "EVEROLIMUS",
                    "strength": "7.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0620-51",
                    "description": "28 BLISTER PACK in 1 CARTON (0078-0620-51)  / 1 TABLET in 1 BLISTER PACK (0078-0620-61)",
                    "marketing_start_date": "20110729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "845507",
                    "845512",
                    "845515",
                    "845518",
                    "998189",
                    "998191",
                    "1119400",
                    "1119402",
                    "1308428",
                    "1308430",
                    "1308432",
                    "1310138",
                    "1310144",
                    "1310147"
                ],
                "spl_set_id": [
                    "2150f73a-179b-4afc-b8ce-67c85cc72f04"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076",
                    "N0000182141",
                    "N0000182137",
                    "N0000175625",
                    "N0000175624",
                    "N0000175550"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]",
                    "mTOR Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "mTOR Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased Immunologic Activity [PE]"
                ],
                "unii": [
                    "9HW64Q8G6G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110729",
            "product_id": "0078-0620_fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "application_number": "NDA022334",
            "brand_name_base": "Afinitor",
            "pharm_class": [
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Decreased Immunologic Activity [PE]",
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]",
                "mTOR Inhibitor Immunosuppressant [EPC]",
                "mTOR Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "69911-477",
            "generic_name": "ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT",
            "labeler_name": "CSL Behring Lengnau AG",
            "brand_name": "AFSTYLA Antihemophilic Factor (Recombinant), Single Chain",
            "brand_name_suffix": "Antihemophilic Factor (Recombinant), Single Chain",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69911-477-02",
                    "description": "1 KIT in 1 CARTON (69911-477-02)  *  5 mL in 1 VIAL, SINGLE-USE (69911-487-01)  *  5 mL in 1 VIAL, SINGLE-USE (69911-765-84)",
                    "marketing_start_date": "20160525",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "757ccd2f-85b7-440f-905f-b999e2d1dd4b",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20160525",
            "product_id": "69911-477_757ccd2f-85b7-440f-905f-b999e2d1dd4b",
            "application_number": "BLA125591",
            "brand_name_base": "AFSTYLA"
        },
        {
            "product_ndc": "69616-264",
            "generic_name": "VAMOROLONE",
            "labeler_name": "Catalyst Pharmaceuticals, Inc.",
            "brand_name": "AGAMREE",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69616-264-38",
                    "description": "1 KIT in 1 CARTON (69616-264-38)  *  100 mL in 1 BOTTLE, GLASS (69616-265-38)",
                    "marketing_start_date": "20240201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Catalyst Pharmaceuticals, Inc."
                ],
                "spl_set_id": [
                    "fb376f09-cf9c-42b5-b4dd-02d5bcd73211"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0369616265389"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "94a0ca8d-bf91-40e4-ae4b-e834c824b1e2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240201",
            "product_id": "69616-264_94a0ca8d-bf91-40e4-ae4b-e834c824b1e2",
            "application_number": "NDA215239",
            "brand_name_base": "AGAMREE"
        },
        {
            "product_ndc": "54092-063",
            "generic_name": "anagrelide hydrochloride",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Agrylin",
            "active_ingredients": [
                {
                    "name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS",
                    "strength": ".5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54092-063-01",
                    "description": "100 CAPSULE in 1 BOTTLE (54092-063-01)",
                    "marketing_start_date": "19970314",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "597850",
                    "597857"
                ],
                "spl_set_id": [
                    "cb960074-99c1-4a73-941f-f0644a7ec219"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0354092063017"
                ],
                "unii": [
                    "VNS4435G39"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "40de069d-9fb0-4ad2-946d-babdbe02bf18",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19970314",
            "product_id": "54092-063_40de069d-9fb0-4ad2-946d-babdbe02bf18",
            "application_number": "NDA020333",
            "brand_name_base": "Agrylin",
            "pharm_class": [
                "Decreased Platelet Production [PE]",
                "Phosphodiesterase 3 Inhibitors [MoA]",
                "Platelet-reducing Agent [EPC]"
            ]
        },
        {
            "product_ndc": "55513-843",
            "generic_name": "erenumab-aooe",
            "labeler_name": "Amgen Inc",
            "brand_name": "AIMOVIG",
            "active_ingredients": [
                {
                    "name": "ERENUMAB",
                    "strength": "140 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-843-00",
                    "description": "1 SYRINGE in 1 CARTON (55513-843-00)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20190315",
                    "sample": true
                },
                {
                    "package_ndc": "55513-843-01",
                    "description": "1 SYRINGE in 1 CARTON (55513-843-01)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20190315",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "2045627",
                    "2045632",
                    "2045636",
                    "2045638",
                    "2056669",
                    "2056670",
                    "2056680",
                    "2056681",
                    "2120193",
                    "2120195",
                    "2120198",
                    "2120199"
                ],
                "spl_set_id": [
                    "b998ed05-94b0-47fd-b28f-cddd1e128fd8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "I5I8VB78VT"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "9e3343fd-826c-41a4-a655-c71b4a651a16",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190315",
            "product_id": "55513-843_9e3343fd-826c-41a4-a655-c71b4a651a16",
            "application_number": "BLA761077",
            "brand_name_base": "AIMOVIG"
        },
        {
            "product_ndc": "0310-9080",
            "generic_name": "Albuterol sulfate and budesonide",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "AIRSUPRA",
            "active_ingredients": [
                {
                    "name": "ALBUTEROL SULFATE",
                    "strength": "90 ug/1"
                },
                {
                    "name": "BUDESONIDE",
                    "strength": "80 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-9080-12",
                    "description": "1 INHALER in 1 CARTON (0310-9080-12)  / 120 AEROSOL, METERED in 1 INHALER",
                    "marketing_start_date": "20231002",
                    "sample": false
                },
                {
                    "package_ndc": "0310-9080-28",
                    "description": "1 INHALER in 1 CARTON (0310-9080-28)  / 28 AEROSOL, METERED in 1 INHALER",
                    "marketing_start_date": "20231002",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2665906",
                    "2665912",
                    "2678391",
                    "2678392"
                ],
                "spl_set_id": [
                    "e60aa9f9-5139-44df-b886-ebddc3c7eb13"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "021SEF3731",
                    "Q3OKS62Q6X"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "AEROSOL, METERED",
            "spl_id": "7b62395d-40cb-4098-842f-5b6b4289e3c4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20231002",
            "product_id": "0310-9080_7b62395d-40cb-4098-842f-5b6b4289e3c4",
            "application_number": "NDA214070",
            "brand_name_base": "AIRSUPRA",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "51759-204",
            "generic_name": "fremanezumab-vfrm",
            "labeler_name": "Teva Pharmaceuticals USA, Inc.",
            "brand_name": "AJOVY",
            "active_ingredients": [
                {
                    "name": "FREMANEZUMAB",
                    "strength": "225 mg/1.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51759-204-10",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (51759-204-10)  / 1.5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20180915",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Teva Pharmaceuticals USA, Inc."
                ],
                "rxcui": [
                    "2056695",
                    "2056700",
                    "2287903",
                    "2287905"
                ],
                "spl_set_id": [
                    "98e344ea-5916-4947-b6f2-4a76ccc04b6b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "PF8K38CG54"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "0ca1b7ee-c1d4-40cc-b545-34d9acf767ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20180915",
            "product_id": "51759-204_0ca1b7ee-c1d4-40cc-b545-34d9acf767ad",
            "application_number": "BLA761089",
            "brand_name_base": "AJOVY"
        },
        {
            "product_ndc": "57894-050",
            "generic_name": "NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "AKEEGA",
            "active_ingredients": [
                {
                    "name": "ABIRATERONE ACETATE",
                    "strength": "500 mg/1"
                },
                {
                    "name": "NIRAPARIB TOSYLATE MONOHYDRATE",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-050-60",
                    "description": "1 BOTTLE in 1 CARTON (57894-050-60)  / 60 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20230811",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "2645244",
                    "2645250",
                    "2645251",
                    "2645253"
                ],
                "spl_set_id": [
                    "8245a990-3268-4613-b5c5-9537858a1eb9"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "195Q483UZD",
                    "EM5OCB9YJ6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "03865989-303a-10fc-e063-6394a90ac80b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230811",
            "product_id": "57894-050_03865989-303a-10fc-e063-6394a90ac80b",
            "application_number": "NDA216793",
            "brand_name_base": "AKEEGA",
            "pharm_class": [
                "Cytochrome P450 17A1 Inhibitor [EPC]",
                "Cytochrome P450 17A1 Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Poly(ADP-Ribose) Polymerase Inhibitor [EPC]",
                "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "99207-260",
            "generic_name": "imiquimod",
            "labeler_name": "Bausch Health US LLC",
            "brand_name": "Aldara",
            "active_ingredients": [
                {
                    "name": "IMIQUIMOD",
                    "strength": "50 mg/g"
                }
            ],
            "finished": true,
            "packaging": [],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US LLC"
                ],
                "rxcui": [
                    "226734",
                    "310982"
                ],
                "spl_set_id": [
                    "0c3aed27-7b3f-442e-9f60-f2f5c672c85d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000009267",
                    "N0000009269",
                    "N0000000157"
                ],
                "pharm_class_pe": [
                    "Increased Cytokine Activity [PE]",
                    "Increased Cytokine Production [PE]"
                ],
                "pharm_class_moa": [
                    "Interferon Inducers [MoA]"
                ],
                "unii": [
                    "P1QW714R7M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "06f8e9e9-eba2-176e-e063-6394a90ab88e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "19970227",
            "product_id": "99207-260_06f8e9e9-eba2-176e-e063-6394a90ab88e",
            "application_number": "NDA020723",
            "brand_name_base": "Aldara",
            "pharm_class": [
                "Increased Cytokine Activity [PE]",
                "Increased Cytokine Production [PE]",
                "Interferon Inducers [MoA]"
            ]
        },
        {
            "product_ndc": "50242-130",
            "generic_name": "ALECTINIB HYDROCHLORIDE",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "ALECENSA",
            "active_ingredients": [
                {
                    "name": "ALECTINIB HYDROCHLORIDE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-130-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-130-01)  / 240 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20151211",
                    "sample": false
                },
                {
                    "package_ndc": "50242-130-86",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-130-86)  / 240 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20171010",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1727479",
                    "1727485"
                ],
                "spl_set_id": [
                    "42c49deb-713b-427a-9670-08af08adcffb"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "P9YY73LO6J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "695be40e-969f-42d9-a851-9b3c78869d77",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151211",
            "product_id": "50242-130_695be40e-969f-42d9-a851-9b3c78869d77",
            "application_number": "NDA208434",
            "brand_name_base": "ALECENSA",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0002-7623",
            "generic_name": "Pemetrexed disodium",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Alimta",
            "active_ingredients": [
                {
                    "name": "PEMETREXED DISODIUM HEPTAHYDRATE",
                    "strength": "500 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-7623-01",
                    "description": "1 VIAL in 1 CARTON (0002-7623-01)  / 20 mL in 1 VIAL",
                    "marketing_start_date": "20040213",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "1728072",
                    "1728075",
                    "1728077",
                    "1728079"
                ],
                "spl_set_id": [
                    "f5a860f3-37ec-429c-ae04-9c88d7c55c08"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9T47E4OM16"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "3af0bc84-13d6-46aa-a4c0-c62410b73bc6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20040204",
            "product_id": "0002-7623_3af0bc84-13d6-46aa-a4c0-c62410b73bc6",
            "application_number": "NDA021462",
            "brand_name_base": "Alimta",
            "pharm_class": [
                "Folate Analog Metabolic Inhibitor [EPC]",
                "Folic Acid Metabolism Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "71104-933",
            "generic_name": "Coagulation Factor IX (Recombinant), Fc Fusion Protein",
            "labeler_name": "Bioverativ Therapeutics Inc.",
            "brand_name": "ALPROLIX",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71104-933-01",
                    "description": "1 KIT in 1 KIT (71104-933-01)  *  5 mL in 1 VIAL (71104-955-09)  *  5 mL in 1 VIAL (71104-045-01)",
                    "marketing_start_date": "20140505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "24887518-9870-451a-9db5-b03dc5571c19",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20140505",
            "product_id": "71104-933_24887518-9870-451a-9db5-b03dc5571c19",
            "application_number": "BLA125444",
            "brand_name_base": "ALPROLIX"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "71104-978",
            "generic_name": "Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl",
            "labeler_name": "Bioverativ Therapeutics Inc.",
            "brand_name": "ALTUVIIIO",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71104-978-01",
                    "description": "1 KIT in 1 KIT (71104-978-01)  *  3 mL in 1 VIAL (71104-985-08)  *  3 mL in 1 SYRINGE (71104-035-01)",
                    "marketing_start_date": "20230222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bioverativ Therapeutics Inc."
                ],
                "rxcui": [
                    "2631088",
                    "2631093"
                ],
                "spl_set_id": [
                    "01411972-df40-4ccf-88f0-d3220e5abda9"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "c97ac954-b5c8-4169-8202-8e76415d5edf",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20230222",
            "product_id": "71104-978_c97ac954-b5c8-4169-8202-8e76415d5edf",
            "application_number": "BLA125771",
            "brand_name_base": "ALTUVIIIO"
        },
        {
            "product_ndc": "63020-113",
            "generic_name": "brigatinib",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Alunbrig",
            "active_ingredients": [
                {
                    "name": "BRIGATINIB",
                    "strength": "30 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63020-113-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (63020-113-30)",
                    "marketing_start_date": "20171002",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1921222",
                    "1921228",
                    "1925494",
                    "1988768",
                    "1988770",
                    "1988772",
                    "1988785",
                    "1988786"
                ],
                "spl_set_id": [
                    "0fe9ff20-d402-41f3-bc1e-7002ea7007db"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020001",
                    "N0000190118"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tyrosine Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]"
                ],
                "unii": [
                    "HYW8DB273J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "046cf609-69fd-47b9-9e48-dd2ceec3be64",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170428",
            "product_id": "63020-113_046cf609-69fd-47b9-9e48-dd2ceec3be64",
            "application_number": "NDA208772",
            "brand_name_base": "Alunbrig",
            "pharm_class": [
                "Cytochrome P450 3A Inducers [MoA]",
                "Kinase Inhibitor [EPC]",
                "Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70121-1755",
            "generic_name": "bevacizumab-maly",
            "labeler_name": "Amneal Pharmaceuticals LLC",
            "brand_name": "ALYMSYS",
            "active_ingredients": [
                {
                    "name": "BEVACIZUMAB",
                    "strength": "400 mg/16mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70121-1755-1",
                    "description": "1 VIAL in 1 CARTON (70121-1755-1)  / 16 mL in 1 VIAL",
                    "marketing_start_date": "20220415",
                    "sample": false
                },
                {
                    "package_ndc": "70121-1755-7",
                    "description": "10 VIAL in 1 CARTON (70121-1755-7)  / 16 mL in 1 VIAL",
                    "marketing_start_date": "20220415",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amneal Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "2599043",
                    "2599049",
                    "2599051",
                    "2599052"
                ],
                "spl_set_id": [
                    "6b4040a2-a5c5-4ff0-ab45-935d7e49cf78"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370121175513",
                    "0370121175414"
                ],
                "nui": [
                    "N0000193543",
                    "N0000178291",
                    "N0000193542"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "unii": [
                    "2S9ZZM9Q9V"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "eef75c43-bea4-4772-a341-c33ab0c5216a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220415",
            "product_id": "70121-1755_eef75c43-bea4-4772-a341-c33ab0c5216a",
            "application_number": "BLA761231",
            "brand_name_base": "ALYMSYS",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]",
                "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "64764-080",
            "marketing_end_date": "20270331",
            "generic_name": "lubiprostone",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Amitiza",
            "active_ingredients": [
                {
                    "name": "LUBIPROSTONE",
                    "strength": "8 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-080-60",
                    "description": "60 CAPSULE, GELATIN COATED in 1 BOTTLE (64764-080-60)",
                    "marketing_start_date": "20080429",
                    "marketing_end_date": "20250930",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "616578",
                    "617768",
                    "794639",
                    "794641"
                ],
                "spl_set_id": [
                    "d474ac6a-444d-4aa6-9986-24be6fcf811d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175573",
                    "N0000175456"
                ],
                "pharm_class_epc": [
                    "Chloride Channel Activator [EPC]"
                ],
                "pharm_class_moa": [
                    "Chloride Channel Activators [MoA]"
                ],
                "unii": [
                    "7662KG2R6K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "c2ca8178-4da1-42d1-a8b9-ff66dca82649",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20060131",
            "product_id": "64764-080_c2ca8178-4da1-42d1-a8b9-ff66dca82649",
            "application_number": "NDA021908",
            "brand_name_base": "Amitiza",
            "pharm_class": [
                "Chloride Channel Activator [EPC]",
                "Chloride Channel Activators [MoA]"
            ]
        },
        {
            "product_ndc": "55513-411",
            "generic_name": "adalimumab-atto",
            "labeler_name": "Amgen Inc",
            "brand_name": "AMJEVITA",
            "active_ingredients": [
                {
                    "name": "ADALIMUMAB",
                    "strength": "20 mg/.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-411-01",
                    "description": "1 SYRINGE in 1 CARTON (55513-411-01)  / .4 mL in 1 SYRINGE",
                    "marketing_start_date": "20230131",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "2627711",
                    "2627717",
                    "2627719",
                    "2627722",
                    "2627724",
                    "2627725",
                    "2634478",
                    "2634479",
                    "2663901",
                    "2663904",
                    "2663906",
                    "2663907",
                    "2663908",
                    "2663910",
                    "2663912",
                    "2663913",
                    "2663914",
                    "2663915"
                ],
                "spl_set_id": [
                    "9c44bd5b-4464-40a4-8933-8680950f00f2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "6377113400015"
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "FYS6T7F842"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "33c4c071-0502-4a4f-a8eb-333ee94091a9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230131",
            "product_id": "55513-411_33c4c071-0502-4a4f-a8eb-333ee94091a9",
            "application_number": "BLA761024",
            "brand_name_base": "AMJEVITA",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "0591-3875",
            "marketing_end_date": "20280229",
            "generic_name": "memantine hydrochloride",
            "labeler_name": "Actavis Pharma, Inc.",
            "brand_name": "memantine hydrochloride",
            "active_ingredients": [
                {
                    "name": "MEMANTINE HYDROCHLORIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0591-3875-44",
                    "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (0591-3875-44)  / 10 TABLET in 1 BLISTER PACK (0591-3875-45)",
                    "marketing_start_date": "20150401",
                    "marketing_end_date": "20270731",
                    "sample": false
                },
                {
                    "package_ndc": "0591-3875-60",
                    "description": "60 TABLET in 1 BOTTLE (0591-3875-60)",
                    "marketing_start_date": "20150401",
                    "marketing_end_date": "20280229",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Actavis Pharma, Inc."
                ],
                "rxcui": [
                    "996561",
                    "996571",
                    "996572"
                ],
                "spl_set_id": [
                    "72973b46-f307-4a9e-8fb1-ad2cbccfd736"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "JY0WD0UA60"
                ]
            },
            "marketing_category": "NDA AUTHORIZED GENERIC",
            "dosage_form": "TABLET",
            "spl_id": "985e1190-b8a0-4775-9a20-ad1924b14fb2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150401",
            "product_id": "0591-3875_985e1190-b8a0-4775-9a20-ad1924b14fb2",
            "application_number": "NDA021487",
            "brand_name_base": "memantine hydrochloride",
            "pharm_class": [
                "N-methyl-D-aspartate Receptor Antagonist [EPC]",
                "NMDA Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "71336-1003",
            "generic_name": "VUTRISIRAN",
            "labeler_name": "Alnylam Pharmaceuticals, Inc.",
            "brand_name": "AMVUTTRA",
            "active_ingredients": [
                {
                    "name": "VUTRISIRAN",
                    "strength": "25 mg/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71336-1003-1",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (71336-1003-1)  / .5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20220613",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Alnylam Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2604788",
                    "2604794"
                ],
                "spl_set_id": [
                    "8db0facb-81b6-4006-9239-27dc6409c5d3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193849",
                    "N0000193848",
                    "M0406100",
                    "N0000008852",
                    "N0000009531"
                ],
                "pharm_class_epc": [
                    "Transthyretin-directed RNA Interaction [EPC]",
                    "Small Interfering RNA [EPC]"
                ],
                "pharm_class_cs": [
                    "RNA, Small Interfering [CS]"
                ],
                "pharm_class_pe": [
                    "Decreased RNA Integrity [PE]",
                    "Increased Protein Breakdown [PE]"
                ],
                "unii": [
                    "GB4I2JI8UI"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "0a7f82da-c2c4-4e6d-8708-15d128b6a460",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220613",
            "product_id": "71336-1003_0a7f82da-c2c4-4e6d-8708-15d128b6a460",
            "application_number": "NDA215515",
            "brand_name_base": "AMVUTTRA",
            "pharm_class": [
                "Decreased RNA Integrity [PE]",
                "Increased Protein Breakdown [PE]",
                "RNA",
                "Small Interfering [CS]",
                "Small Interfering RNA [EPC]",
                "Transthyretin-directed RNA Interaction [EPC]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "53943-128",
            "generic_name": "DIPHENHYDRAMINE HYDROCHLORIDE",
            "labeler_name": "DISCOUNT DRUG MART",
            "brand_name": "Nyt Time Sleep Caps",
            "active_ingredients": [
                {
                    "name": "DIPHENHYDRAMINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "53943-128-03",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (53943-128-03)  / 72 TABLET in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20070627",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "DISCOUNT DRUG MART"
                ],
                "rxcui": [
                    "1049630"
                ],
                "spl_set_id": [
                    "e3f4d063-921d-4503-89a6-26cc9c46b4c9"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0093351123030"
                ],
                "unii": [
                    "TC2D6JAD40"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "TABLET",
            "spl_id": "d202855d-3e0a-0a45-e053-2995a90a76d6",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20070627",
            "product_id": "53943-128_d202855d-3e0a-0a45-e053-2995a90a76d6",
            "application_number": "part338",
            "brand_name_base": "Nyt Time Sleep Caps",
            "pharm_class": [
                "Histamine H1 Receptor Antagonists [MoA]",
                "Histamine-1 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0310-3200",
            "generic_name": "andexanet alfa",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "ANDEXXA",
            "active_ingredients": [
                {
                    "name": "ANDEXANET ALFA",
                    "strength": "200 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-3200-04",
                    "description": "4 VIAL, SINGLE-USE in 1 CARTON (0310-3200-04)  / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)",
                    "marketing_start_date": "20220712",
                    "sample": false
                },
                {
                    "package_ndc": "0310-3200-05",
                    "description": "5 VIAL, SINGLE-USE in 1 CARTON (0310-3200-05)  / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)",
                    "marketing_start_date": "20230703",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2108128",
                    "2108130"
                ],
                "spl_set_id": [
                    "2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "BI009E452R"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "0bbb6c1a-65b2-480a-8360-e70322ccd510",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220712",
            "product_id": "0310-3200_0bbb6c1a-65b2-480a-8360-e70322ccd510",
            "application_number": "BLA125586",
            "brand_name_base": "ANDEXXA"
        },
        {
            "product_ndc": "0173-0859",
            "generic_name": "fluticasone furoate and vilanterol trifenatate",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Breo Ellipta",
            "active_ingredients": [
                {
                    "name": "FLUTICASONE FUROATE",
                    "strength": "100 ug/1"
                },
                {
                    "name": "VILANTEROL TRIFENATATE",
                    "strength": "25 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0859-10",
                    "description": "1 TRAY in 1 CARTON (0173-0859-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-14",
                    "description": "1 TRAY in 1 CARTON (0173-0859-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-61",
                    "description": "1 TRAY in 1 CARTON (0173-0859-61)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "marketing_end_date": "20240630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1424889",
                    "1424899",
                    "1539891",
                    "1539893",
                    "1648783",
                    "1648785",
                    "1648788",
                    "1648789",
                    "2637473",
                    "2637476"
                ],
                "spl_set_id": [
                    "96428df1-ea05-431a-98d3-1ec2c4b63878"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "40AHO2C6DG",
                    "JS86977WNV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER",
            "spl_id": "dea41e66-87ce-42ee-8391-e0c25938ea73",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20130826",
            "product_id": "0173-0859_dea41e66-87ce-42ee-8391-e0c25938ea73",
            "application_number": "NDA204275",
            "brand_name_base": "Breo Ellipta",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "0088-2500",
            "generic_name": "insulin glulisine",
            "labeler_name": "sanofi-aventis U.S. LLC",
            "brand_name": "Apidra",
            "active_ingredients": [
                {
                    "name": "INSULIN GLULISINE",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0088-2500-33",
                    "description": "1 VIAL, GLASS in 1 CARTON (0088-2500-33)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20090224",
                    "sample": false
                },
                {
                    "package_ndc": "0088-2500-34",
                    "description": "1 VIAL, GLASS in 1 CARTON (0088-2500-34)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20090224",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "sanofi-aventis U.S. LLC"
                ],
                "rxcui": [
                    "485210",
                    "803194",
                    "847259",
                    "847261"
                ],
                "spl_set_id": [
                    "e7af6a7a-8046-4fb4-9979-4ec4230b23aa"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000004931",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [Chemical/Ingredient]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "7XIY785AZD"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "3ad0d2f5-b5e2-4da9-8b4a-29ca1338eaad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20090224",
            "product_id": "0088-2500_3ad0d2f5-b5e2-4da9-8b4a-29ca1338eaad",
            "application_number": "BLA021629",
            "brand_name_base": "Apidra",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [Chemical/Ingredient]"
            ]
        },
        {
            "product_ndc": "47426-401",
            "generic_name": "APREPITANT",
            "labeler_name": "Heron Therapeutics, Inc.",
            "brand_name": "APONVIE",
            "active_ingredients": [
                {
                    "name": "APREPITANT",
                    "strength": "32 mg/4.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "47426-401-10",
                    "description": "10 VIAL, GLASS in 1 CARTON (47426-401-10)  / 4.4 mL in 1 VIAL, GLASS (47426-401-01)",
                    "marketing_start_date": "20230306",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Heron Therapeutics, Inc."
                ],
                "rxcui": [
                    "2631783",
                    "2631788"
                ],
                "spl_set_id": [
                    "d1b111eb-659a-496b-a86a-8f0fa370f147"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000010262",
                    "N0000175786",
                    "N0000182141",
                    "N0000185507",
                    "N0000185506"
                ],
                "pharm_class_moa": [
                    "Neurokinin 1 Antagonists [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]"
                ],
                "pharm_class_epc": [
                    "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "1NF15YR6UY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "EMULSION",
            "spl_id": "c9dbc0e9-3b37-415a-a98c-d1b56dfe4cc7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230306",
            "product_id": "47426-401_c9dbc0e9-3b37-415a-a98c-d1b56dfe4cc7",
            "application_number": "NDA216457",
            "brand_name_base": "APONVIE",
            "pharm_class": [
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Neurokinin 1 Antagonists [MoA]",
                "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "49702-264",
            "generic_name": "Cabotegravir",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "Apretude",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-264-23",
                    "description": "1 KIT in 1 CARTON (49702-264-23)  *  3 mL in 1 VIAL (49702-238-03)",
                    "marketing_start_date": "20211220",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "2588077",
                    "2588080"
                ],
                "spl_set_id": [
                    "4338428e-43d4-4e02-ac9d-bd98e738a7da"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "1ce2d4f4-bfa3-49c0-a22c-83f8fe316086",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20211220",
            "product_id": "49702-264_1ce2d4f4-bfa3-49c0-a22c-83f8fe316086",
            "application_number": "NDA215499",
            "brand_name_base": "Apretude"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "55513-003",
            "generic_name": "darbepoetin alfa",
            "labeler_name": "Amgen Inc",
            "brand_name": "ARANESP",
            "active_ingredients": [
                {
                    "name": "DARBEPOETIN ALFA",
                    "strength": "40 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-003-04",
                    "description": "4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-003-04)  / 1 mL in 1 VIAL, SINGLE-DOSE (55513-003-01)",
                    "marketing_start_date": "20060911",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "349273",
                    "349274",
                    "349275",
                    "349276",
                    "352044",
                    "352045",
                    "352046",
                    "352047",
                    "730044",
                    "730046",
                    "731167",
                    "731171",
                    "731174",
                    "731176",
                    "731179",
                    "731181",
                    "731184",
                    "731227",
                    "731229",
                    "731231",
                    "731235",
                    "731241",
                    "731245",
                    "731250",
                    "1605171",
                    "1605172",
                    "1654954",
                    "1654955"
                ],
                "spl_set_id": [
                    "0fd36cb9-c4f6-4167-93c9-8530865db3f9"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513006019"
                ],
                "nui": [
                    "N0000175665",
                    "M0007726",
                    "N0000009319"
                ],
                "pharm_class_epc": [
                    "Erythropoiesis-stimulating Agent [EPC]"
                ],
                "pharm_class_cs": [
                    "Erythropoietin [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Erythroid Cell Production [PE]"
                ],
                "unii": [
                    "15UQ94PT4P"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "d4b13c08-a06e-4706-846c-7562385f170c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20060911",
            "product_id": "55513-003_d4b13c08-a06e-4706-846c-7562385f170c",
            "application_number": "BLA103951",
            "brand_name_base": "ARANESP",
            "pharm_class": [
                "Erythropoiesis-stimulating Agent [EPC]",
                "Erythropoietin [CS]",
                "Increased Erythroid Cell Production [PE]"
            ]
        },
        {
            "product_ndc": "0187-2098",
            "generic_name": "tazarotene",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Arazlo",
            "active_ingredients": [
                {
                    "name": "TAZAROTENE",
                    "strength": ".45 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-2098-10",
                    "description": "10 TUBE in 1 CARTON (0187-2098-10)  / 3 g in 1 TUBE (0187-2098-03)",
                    "marketing_start_date": "20191219",
                    "sample": true
                },
                {
                    "package_ndc": "0187-2098-45",
                    "description": "1 TUBE in 1 CARTON (0187-2098-45)  / 45 g in 1 TUBE",
                    "marketing_start_date": "20191219",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "2267561",
                    "2267566"
                ],
                "spl_set_id": [
                    "d941ff25-c221-4a55-8012-0dcf3bbcbbd1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175607",
                    "M0018962"
                ],
                "pharm_class_epc": [
                    "Retinoid [EPC]"
                ],
                "pharm_class_cs": [
                    "Retinoids [CS]"
                ],
                "unii": [
                    "81BDR9Y8PS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "LOTION",
            "spl_id": "06456968-fe83-2c27-e063-6294a90af3ea",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20191219",
            "product_id": "0187-2098_06456968-fe83-2c27-e063-6294a90af3ea",
            "application_number": "NDA211882",
            "brand_name_base": "Arazlo",
            "pharm_class": [
                "Retinoid [EPC]",
                "Retinoids [CS]"
            ]
        },
        {
            "product_ndc": "71558-590",
            "generic_name": "Amikacin",
            "labeler_name": "Insmed Incorporated",
            "brand_name": "ARIKAYCE",
            "active_ingredients": [
                {
                    "name": "AMIKACIN",
                    "strength": "590 mg/8.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71558-590-28",
                    "description": "28 VIAL in 1 CARTON (71558-590-28)  / 8.4 mL in 1 VIAL",
                    "marketing_start_date": "20181012",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Insmed Incorporated"
                ],
                "rxcui": [
                    "2059184",
                    "2059189"
                ],
                "spl_set_id": [
                    "499ab990-2b21-474f-aaba-d86388965f40"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175477",
                    "M0000946"
                ],
                "pharm_class_epc": [
                    "Aminoglycoside Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminoglycosides [CS]"
                ],
                "unii": [
                    "84319SGC3C"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "6234782d-94c1-428b-b34b-c5d0db96d9d7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20181012",
            "product_id": "71558-590_6234782d-94c1-428b-b34b-c5d0db96d9d7",
            "application_number": "NDA207356",
            "brand_name_base": "ARIKAYCE",
            "pharm_class": [
                "Aminoglycoside Antibacterial [EPC]",
                "Aminoglycosides [CS]"
            ]
        },
        {
            "product_ndc": "65757-403",
            "generic_name": "aripiprazole lauroxil",
            "labeler_name": "Alkermes, Inc.",
            "brand_name": "ARISTADA",
            "active_ingredients": [
                {
                    "name": "ARIPIPRAZOLE LAUROXIL",
                    "strength": "882 mg/3.2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65757-403-03",
                    "description": "1 SYRINGE in 1 CARTON (65757-403-03)  / 3.2 mL in 1 SYRINGE",
                    "marketing_start_date": "20151005",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Alkermes, Inc."
                ],
                "rxcui": [
                    "1673269",
                    "1673274",
                    "1673277",
                    "1673278",
                    "1673279",
                    "1673280",
                    "1925262",
                    "1925264"
                ],
                "spl_set_id": [
                    "17a8d11b-73b0-4833-a0b4-cf1ef85edefb"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "B786J7A343"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE",
            "spl_id": "d7e63a3f-06f0-41fd-a4db-8c0646fda89a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20151005",
            "product_id": "65757-403_d7e63a3f-06f0-41fd-a4db-8c0646fda89a",
            "application_number": "NDA207533",
            "brand_name_base": "ARISTADA"
        },
        {
            "product_ndc": "67457-594",
            "generic_name": "fondaparinux sodium",
            "labeler_name": "Mylan Institutional LLC",
            "brand_name": "Arixtra",
            "active_ingredients": [
                {
                    "name": "FONDAPARINUX SODIUM",
                    "strength": "7.5 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "67457-594-06",
                    "description": "10 SYRINGE, PLASTIC in 1 CARTON (67457-594-06)  / .6 mL in 1 SYRINGE, PLASTIC (67457-594-00)",
                    "marketing_start_date": "20160211",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Institutional LLC"
                ],
                "rxcui": [
                    "861356",
                    "861358",
                    "861360",
                    "861362",
                    "861363",
                    "861364",
                    "861365",
                    "861366"
                ],
                "spl_set_id": [
                    "d3b30c68-cf45-4b46-8ba6-72090f7ba01a"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "X0Q6N9USOZ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "71681d56-23b6-483c-92ae-a73a2a6c1757",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20160211",
            "product_id": "67457-594_71681d56-23b6-483c-92ae-a73a2a6c1757",
            "application_number": "NDA021345",
            "brand_name_base": "Arixtra",
            "pharm_class": [
                "Factor Xa Inhibitor [EPC]",
                "Factor Xa Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "23155-071",
            "generic_name": "Methimazole",
            "labeler_name": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.",
            "brand_name": "Methimazole",
            "active_ingredients": [
                {
                    "name": "METHIMAZOLE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "23155-071-01",
                    "description": "100 TABLET in 1 BOTTLE (23155-071-01)",
                    "marketing_start_date": "20120115",
                    "sample": false
                },
                {
                    "package_ndc": "23155-071-10",
                    "description": "1000 TABLET in 1 BOTTLE (23155-071-10)",
                    "marketing_start_date": "20120115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "197941",
                    "197942"
                ],
                "spl_set_id": [
                    "8c3a9aaa-cdde-404b-9af6-5a88ef649aac"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0323155071016",
                    "0323155070019"
                ],
                "nui": [
                    "N0000175918",
                    "N0000175917"
                ],
                "pharm_class_epc": [
                    "Thyroid Hormone Synthesis Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Thyroid Hormone Synthesis Inhibitors [MoA]"
                ],
                "unii": [
                    "554Z48XN5E"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "649d3946-dc8c-4319-814f-a991d417d380",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120115",
            "product_id": "23155-071_649d3946-dc8c-4319-814f-a991d417d380",
            "application_number": "ANDA040734",
            "brand_name_base": "Methimazole",
            "pharm_class": [
                "Thyroid Hormone Synthesis Inhibitor [EPC]",
                "Thyroid Hormone Synthesis Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0173-0859",
            "generic_name": "fluticasone furoate and vilanterol trifenatate",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Breo Ellipta",
            "active_ingredients": [
                {
                    "name": "FLUTICASONE FUROATE",
                    "strength": "100 ug/1"
                },
                {
                    "name": "VILANTEROL TRIFENATATE",
                    "strength": "25 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0859-10",
                    "description": "1 TRAY in 1 CARTON (0173-0859-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-14",
                    "description": "1 TRAY in 1 CARTON (0173-0859-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-61",
                    "description": "1 TRAY in 1 CARTON (0173-0859-61)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "marketing_end_date": "20240630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1424889",
                    "1424899",
                    "1539891",
                    "1539893",
                    "1648783",
                    "1648785",
                    "1648788",
                    "1648789",
                    "2637473",
                    "2637476"
                ],
                "spl_set_id": [
                    "96428df1-ea05-431a-98d3-1ec2c4b63878"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "40AHO2C6DG",
                    "JS86977WNV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER",
            "spl_id": "dea41e66-87ce-42ee-8391-e0c25938ea73",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20130826",
            "product_id": "0173-0859_dea41e66-87ce-42ee-8391-e0c25938ea73",
            "application_number": "NDA204275",
            "brand_name_base": "Breo Ellipta",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "72694-515",
            "generic_name": "calaspargase pegol",
            "labeler_name": "Servier Pharmaceuticals LLC",
            "brand_name": "asparlas",
            "active_ingredients": [
                {
                    "name": "CALASPARGASE PEGOL",
                    "strength": "750 U/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72694-515-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (72694-515-01)  / 5 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20190927",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Servier Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "2121421",
                    "2121426"
                ],
                "spl_set_id": [
                    "6585bd0d-bd78-4341-9e87-0f7664821f05"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372694515017"
                ],
                "nui": [
                    "M0001815",
                    "N0000175669"
                ],
                "pharm_class_cs": [
                    "Asparaginase [CS]"
                ],
                "pharm_class_epc": [
                    "Asparagine-specific Enzyme [EPC]"
                ],
                "unii": [
                    "T9FVH03HMZ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "ffe80517-c3ca-462a-9c38-573a3c724bcb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190927",
            "product_id": "72694-515_ffe80517-c3ca-462a-9c38-573a3c724bcb",
            "application_number": "BLA761102",
            "brand_name_base": "asparlas",
            "pharm_class": [
                "Asparaginase [CS]",
                "Asparagine-specific Enzyme [EPC]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "15584-0101",
            "generic_name": "efavirenz, emtricitabine, and tenofovir disoproxil fumarate",
            "labeler_name": "Gilead Sciences, LLC",
            "brand_name": "Atripla",
            "active_ingredients": [
                {
                    "name": "EFAVIRENZ",
                    "strength": "600 mg/1"
                },
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "TENOFOVIR DISOPROXIL FUMARATE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "15584-0101-1",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (15584-0101-1)",
                    "marketing_start_date": "20060720",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, LLC"
                ],
                "rxcui": [
                    "643066",
                    "643070"
                ],
                "spl_set_id": [
                    "2e97aa6d-09f7-46df-9499-63db7e9bac35"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0315584010117"
                ],
                "nui": [
                    "N0000175463",
                    "N0000175460",
                    "N0000009948",
                    "N0000190118",
                    "N0000187064",
                    "N0000185504",
                    "N0000182140",
                    "N0000182141",
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "Cytochrome P450 2C19 Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "unii": [
                    "JE6H2O27P8",
                    "G70B4ETF4S",
                    "OTT9J7900I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "a618c51f-5e21-4c41-9607-417fd04ee8ba",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20060720",
            "product_id": "15584-0101_a618c51f-5e21-4c41-9607-417fd04ee8ba",
            "application_number": "NDA021937",
            "brand_name_base": "Atripla",
            "pharm_class": [
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "10451-001",
            "generic_name": "Oxygen",
            "labeler_name": "General Distributing Co.",
            "brand_name": "Oxygen",
            "active_ingredients": [
                {
                    "name": "OXYGEN",
                    "strength": "992 mL/L"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10451-001-01",
                    "description": "663 L in 1 CYLINDER (10451-001-01)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-02",
                    "description": "408 L in 1 CYLINDER (10451-001-02)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-03",
                    "description": "120 L in 1 CYLINDER (10451-001-03)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-04",
                    "description": "129621 L in 1 CYLINDER (10451-001-04)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-07",
                    "description": "3511 L in 1 CYLINDER (10451-001-07)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-08",
                    "description": "2350 L in 1 CYLINDER (10451-001-08)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-09",
                    "description": "143 L in 1 CYLINDER (10451-001-09)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-10",
                    "description": "158 L in 1 CYLINDER (10451-001-10)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-11",
                    "description": "174 L in 1 CYLINDER (10451-001-11)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-12",
                    "description": "7079 L in 1 CYLINDER (10451-001-12)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-13",
                    "description": "8495 L in 1 CYLINDER (10451-001-13)",
                    "marketing_start_date": "19690101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "General Distributing Co."
                ],
                "rxcui": [
                    "348831"
                ],
                "spl_set_id": [
                    "ffa52347-b223-4ff8-acaa-1462f2dfb528"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "S88TT14065"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GAS",
            "spl_id": "0761147f-1335-606e-e063-6394a90abd5d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "19690101",
            "product_id": "10451-001_0761147f-1335-606e-e063-6394a90abd5d",
            "application_number": "NDA205889",
            "brand_name_base": "Oxygen"
        },
        {
            "product_ndc": "0003-4040",
            "generic_name": "repotrectinib",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "Augtyro",
            "active_ingredients": [
                {
                    "name": "REPOTRECTINIB",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-4040-12",
                    "description": "120 CAPSULE in 1 BOTTLE (0003-4040-12)",
                    "marketing_start_date": "20231205",
                    "sample": false
                },
                {
                    "package_ndc": "0003-4040-60",
                    "description": "60 CAPSULE in 1 BOTTLE (0003-4040-60)",
                    "marketing_start_date": "20231205",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "spl_set_id": [
                    "fb526827-40ba-4462-94cf-179ae3b0cb8a"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300000000001"
                ],
                "nui": [
                    "N0000175605",
                    "N0000194093",
                    "N0000194094",
                    "N0000194095",
                    "N0000194096",
                    "N0000185506"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]",
                    "Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]",
                    "Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]",
                    "Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]"
                ],
                "unii": [
                    "08O3FQ4UNP"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "99d2c52a-2108-4456-a873-5c6d4af4f003",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20231205",
            "product_id": "0003-4040_99d2c52a-2108-4456-a873-5c6d4af4f003",
            "application_number": "NDA218213",
            "brand_name_base": "Augtyro",
            "pharm_class": [
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Kinase Inhibitor [EPC]",
                "Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]",
                "Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]",
                "Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]",
                "Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "68546-176",
            "generic_name": "deutetrabenazine",
            "labeler_name": "Teva Neuroscience, Inc.",
            "brand_name": "AUSTEDO",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68546-176-28",
                    "description": "1 BLISTER PACK in 1 CARTON (68546-176-28)  / 1 KIT in 1 BLISTER PACK",
                    "marketing_start_date": "20200201",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Teva Neuroscience, Inc."
                ],
                "rxcui": [
                    "1876910",
                    "1876916",
                    "1876918",
                    "1876920",
                    "1876922",
                    "1876924",
                    "2281114",
                    "2281115",
                    "2281116",
                    "2281117",
                    "2541518",
                    "2541519",
                    "2541520",
                    "2630144",
                    "2630147",
                    "2630150",
                    "2630153",
                    "2630155",
                    "2630157",
                    "2630159",
                    "2630160",
                    "2683282",
                    "2683285",
                    "2683288",
                    "2683291",
                    "2683294",
                    "2683297",
                    "2683300",
                    "2683303"
                ],
                "spl_set_id": [
                    "7ea3c60a-45c7-44cc-afc2-d87fa53993c0"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "P341G6W9NB"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "b9331b4b-1208-4dd4-9db2-fba6e6a2a1f1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20200201",
            "product_id": "68546-176_b9331b4b-1208-4dd4-9db2-fba6e6a2a1f1",
            "application_number": "NDA208082",
            "brand_name_base": "AUSTEDO"
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "71872-7173",
            "generic_name": "epinephrine",
            "labeler_name": "Medical Purchasing Solutions, LLC",
            "brand_name": "Auvi-Q",
            "active_ingredients": [
                {
                    "name": "EPINEPHRINE",
                    "strength": ".3 mg/.3mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71872-7173-1",
                    "description": "1 DOSE PACK in 1 BAG (71872-7173-1)  / .3 mL in 1 DOSE PACK",
                    "marketing_start_date": "20190715",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Medical Purchasing Solutions, LLC"
                ],
                "rxcui": [
                    "1305269",
                    "1870205"
                ],
                "spl_set_id": [
                    "8f110633-bf37-458d-e053-2a95a90a8fa9"
                ],
                "nui": [
                    "N0000000209",
                    "N0000000245",
                    "N0000175552",
                    "N0000175555",
                    "N0000175570",
                    "M0003647"
                ],
                "pharm_class_moa": [
                    "Adrenergic alpha-Agonists [MoA]",
                    "Adrenergic beta-Agonists [MoA]"
                ],
                "pharm_class_epc": [
                    "alpha-Adrenergic Agonist [EPC]",
                    "beta-Adrenergic Agonist [EPC]",
                    "Catecholamine [EPC]"
                ],
                "pharm_class_cs": [
                    "Catecholamines [CS]"
                ],
                "unii": [
                    "YKH834O4BH"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "0141ff31-c242-8ad1-e063-6294a90a229a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20121115",
            "product_id": "71872-7173_0141ff31-c242-8ad1-e063-6294a90a229a",
            "application_number": "NDA201739",
            "brand_name_base": "Auvi-Q",
            "pharm_class": [
                "Adrenergic alpha-Agonists [MoA]",
                "Adrenergic beta-Agonists [MoA]",
                "Catecholamine [EPC]",
                "Catecholamines [CS]",
                "alpha-Adrenergic Agonist [EPC]",
                "beta-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "50242-060",
            "generic_name": "bevacizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Avastin",
            "active_ingredients": [
                {
                    "name": "BEVACIZUMAB",
                    "strength": "100 mg/4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-060-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-060-01)  / 4 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20040226",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1657066",
                    "1657068",
                    "1657073",
                    "1657074"
                ],
                "spl_set_id": [
                    "939b5d1f-9fb2-4499-80ef-0607aa6b114e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193543",
                    "N0000178291",
                    "N0000193542"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "unii": [
                    "2S9ZZM9Q9V"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "3580958a-7a01-45c0-8d9c-87d9a3963158",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20040226",
            "product_id": "50242-060_3580958a-7a01-45c0-8d9c-87d9a3963158",
            "application_number": "BLA125085",
            "brand_name_base": "Avastin",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]",
                "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "59627-003",
            "generic_name": "Interferon Beta-1a",
            "labeler_name": "Biogen Inc.",
            "brand_name": "Avonex Pen",
            "active_ingredients": [
                {
                    "name": "INTERFERON BETA-1A",
                    "strength": "30 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59627-003-01",
                    "description": "1 SYRINGE in 1 CARTON (59627-003-01)  / .5 mL in 1 SYRINGE",
                    "marketing_start_date": "20030523",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Biogen Inc."
                ],
                "rxcui": [
                    "727813",
                    "727816",
                    "797544",
                    "1650899",
                    "1650901"
                ],
                "spl_set_id": [
                    "d70a39cc-de15-4c12-a1ec-8063b69ea0e1"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0359627002066"
                ],
                "nui": [
                    "M0025715",
                    "N0000191625"
                ],
                "pharm_class_cs": [
                    "Interferon-beta [CS]"
                ],
                "pharm_class_epc": [
                    "Interferon beta [EPC]"
                ],
                "unii": [
                    "XRO4566Q4R"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "3ff19956-a793-4256-bff4-7f7443d7238a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20030523",
            "product_id": "59627-003_3ff19956-a793-4256-bff4-7f7443d7238a",
            "application_number": "BLA103628",
            "brand_name_base": "Avonex Pen",
            "pharm_class": [
                "Interferon beta [EPC]",
                "Interferon-beta [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0456-2700",
            "generic_name": "ceftazidime, avibactam",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "AVYCAZ",
            "active_ingredients": [
                {
                    "name": "AVIBACTAM SODIUM",
                    "strength": ".5 g/1"
                },
                {
                    "name": "CEFTAZIDIME",
                    "strength": "2 g/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0456-2700-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0456-2700-10)  / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0456-2700-01)",
                    "marketing_start_date": "20141226",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "1603840",
                    "1603845"
                ],
                "spl_set_id": [
                    "d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9V824P8TAI",
                    "9M416Z9QNR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SOLUTION",
            "spl_id": "80709382-5cb9-4f79-a490-4ebe7daf0f82",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20141226",
            "product_id": "0456-2700_80709382-5cb9-4f79-a490-4ebe7daf0f82",
            "application_number": "NDA206494",
            "brand_name_base": "AVYCAZ",
            "pharm_class": [
                "Cephalosporin Antibacterial [EPC]",
                "Cephalosporins [CS]",
                "beta Lactamase Inhibitor [EPC]",
                "beta Lactamase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "51285-424",
            "marketing_end_date": "20240831",
            "generic_name": "Norethindrone Acetate",
            "labeler_name": "Teva Women's Health LLC",
            "brand_name": "Aygestin",
            "active_ingredients": [
                {
                    "name": "NORETHINDRONE ACETATE",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51285-424-10",
                    "description": "50 TABLET in 1 BOTTLE (51285-424-10)",
                    "marketing_start_date": "20030612",
                    "marketing_end_date": "20240831",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Teva Women's Health LLC"
                ],
                "rxcui": [
                    "1000405",
                    "1000407"
                ],
                "spl_set_id": [
                    "69f5bc4b-758d-471b-ad8d-17c94f8e0963"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0351285424105"
                ],
                "unii": [
                    "9S44LIC7OJ"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "8cfac7d2-c6b7-4211-93b6-46441b1ba0e9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030612",
            "product_id": "51285-424_8cfac7d2-c6b7-4211-93b6-46441b1ba0e9",
            "application_number": "ANDA075951",
            "brand_name_base": "Aygestin",
            "pharm_class": [
                "Progesterone Congeners [CS]",
                "Progestin [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "69387-001",
            "generic_name": "monomethyl fumarate",
            "labeler_name": "Banner Life Sciences LLC",
            "brand_name": "BAFIERTAM",
            "active_ingredients": [
                {
                    "name": "MONOMETHYL FUMARATE",
                    "strength": "95 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69387-001-01",
                    "description": "120 CAPSULE in 1 BOTTLE (69387-001-01)",
                    "marketing_start_date": "20200428",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Banner Life Sciences LLC"
                ],
                "rxcui": [
                    "2393587",
                    "2393593"
                ],
                "spl_set_id": [
                    "a161f9d4-70f1-4097-957a-eafb35d3274f"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "45IUB1PX8R"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "464a8176-3082-409f-848d-445562fc9212",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200428",
            "product_id": "69387-001_464a8176-3082-409f-848d-445562fc9212",
            "application_number": "NDA210296",
            "brand_name_base": "BAFIERTAM"
        },
        {
            "product_ndc": "59676-030",
            "generic_name": "Erdafitinib",
            "labeler_name": "Janssen Products LP",
            "brand_name": "BALVERSA",
            "active_ingredients": [
                {
                    "name": "ERDAFITINIB",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59676-030-56",
                    "description": "1 BOTTLE in 1 CARTON (59676-030-56)  / 56 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20190412",
                    "sample": false
                },
                {
                    "package_ndc": "59676-030-84",
                    "description": "1 BOTTLE in 1 CARTON (59676-030-84)  / 84 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20190412",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Products LP"
                ],
                "rxcui": [
                    "2123131",
                    "2123137",
                    "2123139",
                    "2123141",
                    "2123143",
                    "2123145"
                ],
                "spl_set_id": [
                    "2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000194026",
                    "N0000182141",
                    "N0000185506",
                    "N0000185503",
                    "N0000187061"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Cation Transporter 2 Inhibitors [MoA]"
                ],
                "unii": [
                    "890E37NHMV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "10565ae5-8217-b96a-e063-6394a90a2f0c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190412",
            "product_id": "59676-030_10565ae5-8217-b96a-e063-6394a90a2f0c",
            "application_number": "NDA212018",
            "brand_name_base": "BALVERSA",
            "pharm_class": [
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Organic Cation Transporter 2 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0003-1614",
            "generic_name": "entecavir",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "BARACLUDE",
            "active_ingredients": [
                {
                    "name": "ENTECAVIR",
                    "strength": ".05 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-1614-12",
                    "description": "1 BOTTLE in 1 CARTON (0003-1614-12)  / 210 mL in 1 BOTTLE",
                    "marketing_start_date": "20050329",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "485434",
                    "485436",
                    "485536",
                    "578457",
                    "578459",
                    "607579"
                ],
                "spl_set_id": [
                    "046e61c9-9298-4b2e-b76e-b26b81fecd20"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5968Y6H45M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "6047929c-ab1b-4f23-8d26-2cdd6b67aadb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20050329",
            "product_id": "0003-1614_6047929c-ab1b-4f23-8d26-2cdd6b67aadb",
            "application_number": "NDA021798",
            "brand_name_base": "BARACLUDE",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Analog [EXT]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0002-8214",
            "generic_name": "Insulin glargine",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "BASAGLAR Tempo Pen",
            "brand_name_suffix": "Tempo Pen",
            "active_ingredients": [
                {
                    "name": "INSULIN GLARGINE",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-8214-05",
                    "description": "5 SYRINGE in 1 CARTON (0002-8214-05)  / 3 mL in 1 SYRINGE (0002-8214-01)",
                    "marketing_start_date": "20191115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "847230",
                    "1736863",
                    "2268064",
                    "2268065"
                ],
                "spl_set_id": [
                    "0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "2ZM8CX04RZ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "dbb5654d-96c0-4cce-adba-5ae8c36acf80",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20151216",
            "product_id": "0002-8214_dbb5654d-96c0-4cce-adba-5ae8c36acf80",
            "application_number": "BLA205692",
            "brand_name_base": "BASAGLAR",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "44087-3535",
            "generic_name": "avelumab",
            "labeler_name": "EMD Serono, Inc.",
            "brand_name": "BAVENCIO",
            "active_ingredients": [
                {
                    "name": "AVELUMAB",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "44087-3535-1",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (44087-3535-1)  / 10 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20170323",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "EMD Serono, Inc."
                ],
                "rxcui": [
                    "1875542",
                    "1875547"
                ],
                "spl_set_id": [
                    "5cd725a1-2fa4-408a-a651-57a7b84b2118"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193338",
                    "N0000193337",
                    "N0000193336",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Programmed Death Ligand-1 Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Ligand-1 Antagonists [MoA]",
                    "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "KXG2PJ551I"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "94a98178-33c6-41ef-943f-f1916c380e35",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170323",
            "product_id": "44087-3535_94a98178-33c6-41ef-943f-f1916c380e35",
            "application_number": "BLA761049",
            "brand_name_base": "BAVENCIO",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Programmed Death Ligand-1 Antagonists [MoA]",
                "Programmed Death Ligand-1 Blocker [EPC]",
                "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "42367-521",
            "generic_name": "bendamustine hydrochloride",
            "labeler_name": "Eagle Pharmaceuticals, Inc",
            "brand_name": "BELRAPZO",
            "active_ingredients": [
                {
                    "name": "BENDAMUSTINE HYDROCHLORIDE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42367-521-25",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25)  / 1 INJECTION in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20190603",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eagle Pharmaceuticals, Inc"
                ],
                "rxcui": [
                    "1726097",
                    "2178266"
                ],
                "spl_set_id": [
                    "9759a4ae-82ca-40cf-9c02-e1cadb21cbdc"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0342367521256"
                ],
                "unii": [
                    "981Y8SX18M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "40f22200-7d2f-43c1-b179-91403be6c1c2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190603",
            "product_id": "42367-521_40f22200-7d2f-43c1-b179-91403be6c1c2",
            "application_number": "NDA205580",
            "brand_name_base": "BELRAPZO",
            "pharm_class": [
                "Alkylating Activity [MoA]",
                "Alkylating Drug [EPC]"
            ]
        },
        {
            "product_ndc": "0006-0005",
            "generic_name": "suvorexant",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "dea_schedule": "CIV",
            "brand_name": "BELSOMRA",
            "active_ingredients": [
                {
                    "name": "SUVOREXANT",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-0005-13",
                    "description": "1 BLISTER PACK in 1 CASE (0006-0005-13)  / 3 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20140829",
                    "sample": false
                },
                {
                    "package_ndc": "0006-0005-30",
                    "description": "3 CASE in 1 CARTON (0006-0005-30)  / 1 BLISTER PACK in 1 CASE (0006-0005-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20140829",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "1547104",
                    "1547110",
                    "1547112",
                    "1547114",
                    "1547116",
                    "1547118",
                    "1547573",
                    "1547575"
                ],
                "spl_set_id": [
                    "e5b72731-1acb-45b7-9c13-290ad12d3951"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191000",
                    "N0000190998",
                    "N0000185503",
                    "N0000190114"
                ],
                "pharm_class_epc": [
                    "Orexin Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Orexin Receptor Antagonists [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]"
                ],
                "unii": [
                    "081L192FO9"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "18f09198-23e9-48c9-8426-e39828d75ad8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20140829",
            "product_id": "0006-0005_18f09198-23e9-48c9-8426-e39828d75ad8",
            "application_number": "NDA204569",
            "brand_name_base": "BELSOMRA",
            "pharm_class": [
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Orexin Receptor Antagonist [EPC]",
                "Orexin Receptor Antagonists [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "49401-088",
            "generic_name": "belimumab",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "BENLYSTA",
            "active_ingredients": [
                {
                    "name": "BELIMUMAB",
                    "strength": "200 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49401-088-02",
                    "description": "1 SYRINGE in 1 CARTON (49401-088-02)  / 1 mL in 1 SYRINGE (49401-088-01)",
                    "marketing_start_date": "20170720",
                    "sample": false
                },
                {
                    "package_ndc": "49401-088-35",
                    "description": "4 SYRINGE in 1 CARTON (49401-088-35)  / 1 mL in 1 SYRINGE (49401-088-01)",
                    "marketing_start_date": "20170720",
                    "sample": false
                },
                {
                    "package_ndc": "49401-088-47",
                    "description": "4 SYRINGE in 1 CARTON (49401-088-47)  / 1 mL in 1 SYRINGE (49401-088-42)",
                    "marketing_start_date": "20170720",
                    "sample": false
                },
                {
                    "package_ndc": "49401-088-50",
                    "description": "1 SYRINGE in 1 CARTON (49401-088-50)  / 1 mL in 1 SYRINGE (49401-088-42)",
                    "marketing_start_date": "20170720",
                    "sample": false
                },
                {
                    "package_ndc": "49401-088-61",
                    "description": "1 SYRINGE in 1 CARTON (49401-088-61)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20200602",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1656395",
                    "1656398",
                    "1656400",
                    "1656402",
                    "1939296",
                    "1939299",
                    "1939346",
                    "1939348"
                ],
                "spl_set_id": [
                    "2fa3c528-1777-4628-8a55-a69dae2381a3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000182156",
                    "N0000182637",
                    "N0000182636"
                ],
                "pharm_class_pe": [
                    "Decreased B Lymphocyte Activation [PE]"
                ],
                "pharm_class_epc": [
                    "B Lymphocyte Stimulator-specific Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "B Lymphocyte Stimulator-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "73B0K5S26A"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "8231e252-f199-4b90-96a8-8e55d047c220",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20170720",
            "product_id": "49401-088_8231e252-f199-4b90-96a8-8e55d047c220",
            "application_number": "BLA761043",
            "brand_name_base": "BENLYSTA",
            "pharm_class": [
                "B Lymphocyte Stimulator-directed Antibody Interactions [MoA]",
                "B Lymphocyte Stimulator-specific Inhibitor [EPC]",
                "Decreased B Lymphocyte Activation [PE]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "0078-0827",
            "generic_name": "brolucizumab",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "BEOVU",
            "active_ingredients": [
                {
                    "name": "BROLUCIZUMAB",
                    "strength": "6 mg/.05mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0827-60",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0078-0827-60)  / .05 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20220309",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0827-98",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0078-0827-98)  / .05 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20220309",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2204920",
                    "2204925",
                    "2602276",
                    "2602279"
                ],
                "spl_set_id": [
                    "5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "XSZ53G39H5"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "c79ba9ae-a1d4-4297-8127-f178916026aa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20191007",
            "product_id": "0078-0827_c79ba9ae-a1d4-4297-8127-f178916026aa",
            "application_number": "BLA761125",
            "brand_name_base": "BEOVU"
        },
        {
            "product_ndc": "63833-825",
            "generic_name": "HUMAN C1-ESTERASE INHIBITOR",
            "labeler_name": "CSL Behring GmbH",
            "brand_name": "Berinert",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63833-825-02",
                    "description": "1 KIT in 1 CARTON (63833-825-02)  *  10 mL in 1 VIAL (63833-835-01)  *  10 mL in 1 VIAL (63833-765-15)",
                    "marketing_start_date": "20111222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "6f3826cd-77fd-4ae0-909c-66a91dbe5f72",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20111222",
            "product_id": "63833-825_6f3826cd-77fd-4ae0-909c-66a91dbe5f72",
            "application_number": "BLA125287",
            "brand_name_base": "Berinert"
        },
        {
            "product_ndc": "24208-446",
            "generic_name": "Besifloxacin",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Besivance",
            "active_ingredients": [
                {
                    "name": "BESIFLOXACIN",
                    "strength": "6 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-446-02",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-446-02)  / 2 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20090528",
                    "sample": false
                },
                {
                    "package_ndc": "24208-446-05",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-446-05)  / 5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20090528",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "850305",
                    "850309"
                ],
                "spl_set_id": [
                    "a3e6d688-7e5e-4ca3-b27e-79756c322a32"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0324208446058"
                ],
                "nui": [
                    "N0000175937",
                    "M0023650"
                ],
                "pharm_class_epc": [
                    "Quinolone Antimicrobial [EPC]"
                ],
                "pharm_class_cs": [
                    "Quinolones [CS]"
                ],
                "unii": [
                    "BFE2NBZ7NX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "2b3a99b3-0edb-428b-ae41-67d297956a65",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20090528",
            "product_id": "24208-446_2b3a99b3-0edb-428b-ae41-67d297956a65",
            "application_number": "NDA022308",
            "brand_name_base": "Besivance",
            "pharm_class": [
                "Quinolone Antimicrobial [EPC]",
                "Quinolones [CS]"
            ]
        },
        {
            "product_ndc": "0008-0100",
            "generic_name": "inotuzumab ozogamicin",
            "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
            "brand_name": "Besponsa",
            "active_ingredients": [
                {
                    "name": "INOTUZUMAB OZOGAMICIN",
                    "strength": ".25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0008-0100-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01)  / 4 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20170818",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
                ],
                "rxcui": [
                    "1942954",
                    "1942959"
                ],
                "spl_set_id": [
                    "cc7014b1-c775-411d-b374-8113248b4077"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193617",
                    "N0000193616",
                    "N0000008576",
                    "N0000009176",
                    "M0028142"
                ],
                "pharm_class_epc": [
                    "CD22-directed Immunoconjugate [EPC]"
                ],
                "pharm_class_moa": [
                    "CD22-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased DNA Integrity [PE]",
                    "Increased Cellular Death [PE]"
                ],
                "pharm_class_cs": [
                    "Immunoconjugates [CS]"
                ],
                "unii": [
                    "P93RUU11P7"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "e46f2c8d-4df5-4670-8c6d-a1f1c269cefb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170818",
            "product_id": "0008-0100_e46f2c8d-4df5-4670-8c6d-a1f1c269cefb",
            "application_number": "BLA761040",
            "brand_name_base": "Besponsa",
            "pharm_class": [
                "CD22-directed Antibody Interactions [MoA]",
                "CD22-directed Immunoconjugate [EPC]",
                "Decreased DNA Integrity [PE]",
                "Immunoconjugates [CS]",
                "Increased Cellular Death [PE]"
            ]
        },
        {
            "product_ndc": "73536-500",
            "generic_name": "ropeginterferon alfa-2b",
            "labeler_name": "Pharmaessentia Usa Corporation",
            "brand_name": "BESREMi",
            "active_ingredients": [
                {
                    "name": "ROPEGINTERFERON ALFA-2B",
                    "strength": "500 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73536-500-01",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (73536-500-01)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20211112",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pharmaessentia Usa Corporation"
                ],
                "rxcui": [
                    "2587064",
                    "2587070"
                ],
                "spl_set_id": [
                    "9583405d-53a0-49dc-88eb-5e6384ebabcb"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193982",
                    "M0023695"
                ],
                "pharm_class_epc": [
                    "Interferon alfa-2b [EPC]"
                ],
                "pharm_class_cs": [
                    "Interferon alfa-2b [CS]"
                ],
                "unii": [
                    "981TME683S"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "e438bf5d-b40f-454b-beaf-de59455dcbc4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20211112",
            "product_id": "73536-500_e438bf5d-b40f-454b-beaf-de59455dcbc4",
            "application_number": "BLA761166",
            "brand_name_base": "BESREMi",
            "pharm_class": [
                "Interferon alfa-2b [CS]",
                "Interferon alfa-2b [EPC]"
            ]
        },
        {
            "product_ndc": "50419-524",
            "generic_name": "interferon beta-1b",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Betaseron",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-524-05",
                    "description": "5 CARTON in 1 BOX (50419-524-05)  / 1 KIT in 1 CARTON (50419-524-01)  *  1 mL in 1 VIAL, SINGLE-USE *  1.2 mL in 1 SYRINGE",
                    "marketing_start_date": "20090811",
                    "sample": false
                },
                {
                    "package_ndc": "50419-524-09",
                    "description": "1 CARTON in 1 BOX (50419-524-09)  / 1 KIT in 1 CARTON (50419-524-01)  *  1 mL in 1 VIAL, SINGLE-USE *  1.2 mL in 1 SYRINGE",
                    "marketing_start_date": "20090811",
                    "sample": false
                },
                {
                    "package_ndc": "50419-524-35",
                    "description": "14 CARTON in 1 BOX (50419-524-35)  / 1 KIT in 1 CARTON (50419-524-01)  *  1 mL in 1 VIAL, SINGLE-USE *  1.2 mL in 1 SYRINGE",
                    "marketing_start_date": "20090811",
                    "sample": false
                },
                {
                    "package_ndc": "50419-524-81",
                    "description": "14 CARTON in 1 BOX (50419-524-81)  / 1 KIT in 1 CARTON (50419-524-01)  *  1 mL in 1 VIAL, SINGLE-USE *  1.2 mL in 1 SYRINGE",
                    "marketing_start_date": "20160901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "198360",
                    "207059"
                ],
                "spl_set_id": [
                    "66311f74-0472-4fa3-848a-06002ca0def5"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "8028db70-d490-4d61-94ad-0220b25df27a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20090709",
            "product_id": "50419-524_8028db70-d490-4d61-94ad-0220b25df27a",
            "application_number": "BLA103471",
            "brand_name_base": "Betaseron"
        },
        {
            "product_ndc": "0310-4600",
            "generic_name": "Glycopyrrolate and formoterol fumarate",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "BEVESPI AEROSPHERE",
            "active_ingredients": [
                {
                    "name": "FORMOTEROL FUMARATE",
                    "strength": "4.8 ug/1"
                },
                {
                    "name": "GLYCOPYRROLATE",
                    "strength": "9 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-4600-12",
                    "description": "120 AEROSOL, METERED in 1 INHALER (0310-4600-12)",
                    "marketing_start_date": "20161003",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "1790639",
                    "1790644"
                ],
                "spl_set_id": [
                    "ae02436e-9528-490e-a844-0c0f6f2843f9"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "W34SHF8J2K",
                    "V92SO9WP2I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "AEROSOL, METERED",
            "spl_id": "4de58592-1f9d-4bf9-bf77-2356095c1745",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20161003",
            "product_id": "0310-4600_4de58592-1f9d-4bf9-bf77-2356095c1745",
            "application_number": "NDA208294",
            "brand_name_base": "BEVESPI AEROSPHERE",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Anticholinergic [EPC]",
                "Cholinergic Antagonists [MoA]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "50090-6247",
            "generic_name": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "Biktarvy",
            "active_ingredients": [
                {
                    "name": "BICTEGRAVIR SODIUM",
                    "strength": "50 mg/1"
                },
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-6247-0",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0)",
                    "marketing_start_date": "20221128",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "1999667",
                    "1999673"
                ],
                "spl_set_id": [
                    "0476d7eb-1024-4821-bbe7-abaacfda32a2"
                ],
                "nui": [
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "4L5MP1Y7W7",
                    "G70B4ETF4S",
                    "FWF6Q91TZO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "a3c4a0eb-71e8-4b35-9706-240874b78ee0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180207",
            "product_id": "50090-6247_a3c4a0eb-71e8-4b35-9706-240874b78ee0",
            "application_number": "NDA210251",
            "brand_name_base": "Biktarvy",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "50474-781",
            "generic_name": "bimekizumab",
            "labeler_name": "UCB, Inc.",
            "brand_name": "Bimzelx",
            "active_ingredients": [
                {
                    "name": "BIMEKIZUMAB",
                    "strength": "160 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50474-781-85",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (50474-781-85)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20231017",
                    "sample": false
                },
                {
                    "package_ndc": "50474-781-87",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (50474-781-87)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20231017",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "rxcui": [
                    "2668086",
                    "2668093",
                    "2668099",
                    "2668103"
                ],
                "spl_set_id": [
                    "26b88358-871f-4c80-9d80-b2fb16477f81"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "09495UIM6V"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "c202fa01-c0e8-4876-9043-0645b78c82e4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20231017",
            "product_id": "50474-781_c202fa01-c0e8-4876-9043-0645b78c82e4",
            "application_number": "BLA761151",
            "brand_name_base": "Bimzelx"
        },
        {
            "product_ndc": "55513-160",
            "generic_name": "blinatumomab",
            "labeler_name": "Amgen Inc",
            "brand_name": "BLINCYTO",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-160-01",
                    "description": "1 KIT in 1 PACKAGE (55513-160-01)  *  3.088 mL in 1 VIAL (55513-150-01)  *  10.6 mL in 1 VIAL (55513-155-01)",
                    "marketing_start_date": "20141218",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "spl_set_id": [
                    "38b482a8-960b-4591-9857-5031ecb830aa"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "dbdeae58-7097-4ca0-bbca-0fc85ba5413b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20141218",
            "product_id": "55513-160_dbdeae58-7097-4ca0-bbca-0fc85ba5413b",
            "application_number": "BLA125557",
            "brand_name_base": "BLINCYTO"
        },
        {
            "product_ndc": "50090-1831",
            "generic_name": "Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "BOOSTRIX",
            "active_ingredients": [
                {
                    "name": "BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "8 ug/.5mL"
                },
                {
                    "name": "BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "2.5 ug/.5mL"
                },
                {
                    "name": "BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)",
                    "strength": "8 ug/.5mL"
                },
                {
                    "name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "5 [iU]/.5mL"
                },
                {
                    "name": "CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "2.5 [iU]/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-1831-0",
                    "description": "10 VIAL in 1 POUCH (50090-1831-0)  / .5 mL in 1 VIAL (50090-1831-9)",
                    "marketing_start_date": "20090724",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "SUSPENSION",
            "spl_id": "8e96021c-e64e-4b03-af42-52891dc7fe39",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20090724",
            "product_id": "50090-1831_8e96021c-e64e-4b03-af42-52891dc7fe39",
            "application_number": "BLA125106",
            "brand_name_base": "BOOSTRIX",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Diphtheria Toxoid [CS]",
                "Inactivated Bordetella Pertussis Vaccine [EPC]",
                "Inactivated Bordetella Pertussis Vaccine [EPC]",
                "Inactivated Bordetella Pertussis Vaccine [EPC]",
                "Inactivated Clostridium Tetani Vaccine [EPC]",
                "Inactivated Corynebacterium Diphtheriae Vaccine [EPC]",
                "Pertussis Vaccine [CS]",
                "Pertussis Vaccine [CS]",
                "Pertussis Vaccine [CS]",
                "Tetanus Toxoid [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]"
            ]
        },
        {
            "product_ndc": "0069-0135",
            "generic_name": "Bosutinib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "BOSULIF",
            "active_ingredients": [
                {
                    "name": "BOSUTINIB MONOHYDRATE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0135-01",
                    "description": "120 TABLET, FILM COATED in 1 BOTTLE (0069-0135-01)",
                    "marketing_start_date": "20120904",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "1307624",
                    "1307630",
                    "1307633",
                    "1307635",
                    "1987732",
                    "1987734",
                    "2669663",
                    "2669665",
                    "2672326",
                    "2672328"
                ],
                "spl_set_id": [
                    "adc84ad5-a04d-4fee-9ba8-91f7abd928e3"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300690504308",
                    "0300690193014",
                    "0300690136011",
                    "0300690135014"
                ],
                "unii": [
                    "844ZJE6I55"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "291aeaa4-56f1-492a-bda9-bf98559a5c37",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120904",
            "product_id": "0069-0135_291aeaa4-56f1-492a-bda9-bf98559a5c37",
            "application_number": "NDA203341",
            "brand_name_base": "BOSULIF",
            "pharm_class": [
                "Bcr-Abl Tyrosine Kinase Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "0023-3921",
            "generic_name": "onabotulinumtoxinA",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "BOTOX",
            "active_ingredients": [
                {
                    "name": "BOTULINUM TOXIN TYPE A",
                    "strength": "200 [USP'U]/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-3921-02",
                    "description": "1 VIAL in 1 CARTON (0023-3921-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL",
                    "marketing_start_date": "20100111",
                    "sample": false
                },
                {
                    "package_ndc": "0023-3921-03",
                    "description": "1 VIAL in 1 CARTON (0023-3921-03)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL",
                    "marketing_start_date": "20100111",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "860192",
                    "860195",
                    "897366",
                    "897368"
                ],
                "spl_set_id": [
                    "33d066a9-34ff-4a1a-b38b-d10983df3300"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175771",
                    "N0000193962",
                    "N0000175731",
                    "N0000175770"
                ],
                "pharm_class_epc": [
                    "Acetylcholine Release Inhibitor [EPC]",
                    "Neuromuscular Blocker [EPC]"
                ],
                "pharm_class_pe": [
                    "Neuromuscular Blockade [PE]"
                ],
                "pharm_class_moa": [
                    "Acetylcholine Release Inhibitors [MoA]"
                ],
                "unii": [
                    "E211KPY694"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "3e2dabaf-f520-4c84-9472-ec7f590d02aa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRADERMAL",
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20100111",
            "product_id": "0023-3921_3e2dabaf-f520-4c84-9472-ec7f590d02aa",
            "application_number": "BLA103000",
            "brand_name_base": "BOTOX",
            "pharm_class": [
                "Acetylcholine Release Inhibitor [EPC]",
                "Acetylcholine Release Inhibitors [MoA]",
                "Neuromuscular Blockade [PE]",
                "Neuromuscular Blocker [EPC]"
            ]
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0173-0859",
            "generic_name": "fluticasone furoate and vilanterol trifenatate",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Breo Ellipta",
            "active_ingredients": [
                {
                    "name": "FLUTICASONE FUROATE",
                    "strength": "100 ug/1"
                },
                {
                    "name": "VILANTEROL TRIFENATATE",
                    "strength": "25 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0859-10",
                    "description": "1 TRAY in 1 CARTON (0173-0859-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-14",
                    "description": "1 TRAY in 1 CARTON (0173-0859-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-61",
                    "description": "1 TRAY in 1 CARTON (0173-0859-61)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "marketing_end_date": "20240630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1424889",
                    "1424899",
                    "1539891",
                    "1539893",
                    "1648783",
                    "1648785",
                    "1648788",
                    "1648789",
                    "2637473",
                    "2637476"
                ],
                "spl_set_id": [
                    "96428df1-ea05-431a-98d3-1ec2c4b63878"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "40AHO2C6DG",
                    "JS86977WNV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER",
            "spl_id": "dea41e66-87ce-42ee-8391-e0c25938ea73",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20130826",
            "product_id": "0173-0859_dea41e66-87ce-42ee-8391-e0c25938ea73",
            "application_number": "NDA204275",
            "brand_name_base": "Breo Ellipta",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "73153-900",
            "generic_name": "Lisocabtagene maraleucel",
            "labeler_name": "Juno Therapeutics, Inc.",
            "brand_name": "BREYANZI",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73153-900-01",
                    "description": "1 KIT in 1 CARTON (73153-900-01)  *  5 mL in 1 VIAL, SINGLE-DOSE (73153-902-04)  *  5 mL in 1 VIAL, SINGLE-DOSE (73153-901-08)",
                    "marketing_start_date": "20210205",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Juno Therapeutics, Inc."
                ],
                "rxcui": [
                    "2479140",
                    "2479145"
                ],
                "spl_set_id": [
                    "594bb413-af3b-4b97-afb3-bfe2b174f2ed"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "ea6c9893-927d-4e29-8be7-643b34f2d319",
            "product_type": "CELLULAR THERAPY",
            "marketing_start_date": "20210205",
            "product_id": "73153-900_ea6c9893-927d-4e29-8be7-643b34f2d319",
            "application_number": "BLA125714",
            "brand_name_base": "BREYANZI"
        },
        {
            "product_ndc": "10451-001",
            "generic_name": "Oxygen",
            "labeler_name": "General Distributing Co.",
            "brand_name": "Oxygen",
            "active_ingredients": [
                {
                    "name": "OXYGEN",
                    "strength": "992 mL/L"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10451-001-01",
                    "description": "663 L in 1 CYLINDER (10451-001-01)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-02",
                    "description": "408 L in 1 CYLINDER (10451-001-02)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-03",
                    "description": "120 L in 1 CYLINDER (10451-001-03)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-04",
                    "description": "129621 L in 1 CYLINDER (10451-001-04)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-07",
                    "description": "3511 L in 1 CYLINDER (10451-001-07)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-08",
                    "description": "2350 L in 1 CYLINDER (10451-001-08)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-09",
                    "description": "143 L in 1 CYLINDER (10451-001-09)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-10",
                    "description": "158 L in 1 CYLINDER (10451-001-10)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-11",
                    "description": "174 L in 1 CYLINDER (10451-001-11)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-12",
                    "description": "7079 L in 1 CYLINDER (10451-001-12)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-13",
                    "description": "8495 L in 1 CYLINDER (10451-001-13)",
                    "marketing_start_date": "19690101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "General Distributing Co."
                ],
                "rxcui": [
                    "348831"
                ],
                "spl_set_id": [
                    "ffa52347-b223-4ff8-acaa-1462f2dfb528"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "S88TT14065"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GAS",
            "spl_id": "0761147f-1335-606e-e063-6394a90abd5d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "19690101",
            "product_id": "10451-001_0761147f-1335-606e-e063-6394a90abd5d",
            "application_number": "NDA205889",
            "brand_name_base": "Oxygen"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "68135-811",
            "generic_name": "cerliponase alfa",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "Brineura",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-811-02",
                    "description": "1 KIT in 1 CARTON (68135-811-02)  *  5 mL in 1 VIAL, GLASS (68135-500-00)  *  5 mL in 1 VIAL, GLASS (68135-495-04)",
                    "marketing_start_date": "20170427",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "1922453",
                    "1922458"
                ],
                "spl_set_id": [
                    "485ab3c5-0359-4878-872f-2fe1e7df4047"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "16b9611a-cd8a-4505-b095-de5ab4054b37",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20170427",
            "product_id": "68135-811_16b9611a-cd8a-4505-b095-de5ab4054b37",
            "application_number": "BLA761052",
            "brand_name_base": "Brineura"
        },
        {
            "product_ndc": "73150-150",
            "generic_name": "ublituximab",
            "labeler_name": "TG Therapeutics, Inc.",
            "brand_name": "BRIUMVI",
            "active_ingredients": [
                {
                    "name": "UBLITUXIMAB",
                    "strength": "150 mg/6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73150-150-06",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06)  / 6 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20221228",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TG Therapeutics, Inc."
                ],
                "rxcui": [
                    "2626353",
                    "2626359"
                ],
                "spl_set_id": [
                    "3a77cd8c-811b-407c-9140-d0c5c26435c2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0373150150063"
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "U59UGK3IPC"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "f2a493dd-3d7e-5ecf-e053-2995a90abe22",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20221228",
            "product_id": "73150-150_f2a493dd-3d7e-5ecf-e053-2995a90abe22",
            "application_number": "BLA761238",
            "brand_name_base": "BRIUMVI"
        },
        {
            "product_ndc": "50474-370",
            "generic_name": "brivaracetam",
            "labeler_name": "UCB, Inc.",
            "dea_schedule": "CV",
            "brand_name": "Briviact",
            "active_ingredients": [
                {
                    "name": "BRIVARACETAM",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50474-370-66",
                    "description": "1 BOTTLE in 1 CARTON (50474-370-66)  / 60 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20160512",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "rxcui": [
                    "1739749",
                    "1739754",
                    "1739761",
                    "1739766",
                    "1739768",
                    "1739770",
                    "1739772",
                    "1739774",
                    "1739776",
                    "1739778",
                    "1739780",
                    "1739782",
                    "1739785",
                    "1739788"
                ],
                "spl_set_id": [
                    "3cf2f439-0e97-443e-8e33-25ecef616f6c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192345"
                ],
                "pharm_class_moa": [
                    "Epoxide Hydrolase Inhibitors [MoA]"
                ],
                "unii": [
                    "U863JGG2IA"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "c6efa4e8-aa1f-4436-b0a7-2ccffb971275",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160512",
            "product_id": "50474-370_c6efa4e8-aa1f-4436-b0a7-2ccffb971275",
            "application_number": "NDA205836",
            "brand_name_base": "Briviact",
            "pharm_class": [
                "Epoxide Hydrolase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "10451-001",
            "generic_name": "Oxygen",
            "labeler_name": "General Distributing Co.",
            "brand_name": "Oxygen",
            "active_ingredients": [
                {
                    "name": "OXYGEN",
                    "strength": "992 mL/L"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10451-001-01",
                    "description": "663 L in 1 CYLINDER (10451-001-01)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-02",
                    "description": "408 L in 1 CYLINDER (10451-001-02)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-03",
                    "description": "120 L in 1 CYLINDER (10451-001-03)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-04",
                    "description": "129621 L in 1 CYLINDER (10451-001-04)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-07",
                    "description": "3511 L in 1 CYLINDER (10451-001-07)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-08",
                    "description": "2350 L in 1 CYLINDER (10451-001-08)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-09",
                    "description": "143 L in 1 CYLINDER (10451-001-09)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-10",
                    "description": "158 L in 1 CYLINDER (10451-001-10)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-11",
                    "description": "174 L in 1 CYLINDER (10451-001-11)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-12",
                    "description": "7079 L in 1 CYLINDER (10451-001-12)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-13",
                    "description": "8495 L in 1 CYLINDER (10451-001-13)",
                    "marketing_start_date": "19690101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "General Distributing Co."
                ],
                "rxcui": [
                    "348831"
                ],
                "spl_set_id": [
                    "ffa52347-b223-4ff8-acaa-1462f2dfb528"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "S88TT14065"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GAS",
            "spl_id": "0761147f-1335-606e-e063-6394a90abd5d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "19690101",
            "product_id": "10451-001_0761147f-1335-606e-e063-6394a90abd5d",
            "application_number": "NDA205889",
            "brand_name_base": "Oxygen"
        },
        {
            "product_ndc": "72579-011",
            "generic_name": "zanubrutinib",
            "labeler_name": "BEIGENE USA, INC.",
            "brand_name": "BRUKINSA",
            "active_ingredients": [
                {
                    "name": "ZANUBRUTINIB",
                    "strength": "80 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72579-011-02",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (72579-011-02)  / 120 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20191114",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "BEIGENE USA, INC."
                ],
                "rxcui": [
                    "2262440",
                    "2262446"
                ],
                "spl_set_id": [
                    "3e08fe23-d70e-424c-bc51-1222e320f902"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000193934"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Bruton's Tyrosine Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "AG9MHG098Z"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "f169b373-7d81-4fe0-bcd0-de0d82145a99",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191114",
            "product_id": "72579-011_f169b373-7d81-4fe0-bcd0-de0d82145a99",
            "application_number": "NDA213217",
            "brand_name_base": "BRUKINSA",
            "pharm_class": [
                "Bruton's Tyrosine Kinase Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "76354-133",
            "generic_name": "Homosalate, Octisalate, Avobenzone",
            "labeler_name": "e.l.f. Cosmetics, Inc.",
            "brand_name": "Naturium Dew Glow Tinted Moisturizer SPF50-deep",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "3 g/50mL"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "10 g/50mL"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 g/50mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76354-133-01",
                    "description": "1 TUBE in 1 CARTON (76354-133-01)  / 50 mL in 1 TUBE",
                    "marketing_start_date": "20231227",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "e.l.f. Cosmetics, Inc."
                ],
                "spl_set_id": [
                    "0d865e74-1baf-6a44-e063-6394a90a37ac"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0810120261249"
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4X49Y0596W"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "LOTION",
            "spl_id": "0d869813-3632-5b6a-e063-6294a90a6d1d",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20231227",
            "product_id": "76354-133_0d869813-3632-5b6a-e063-6294a90a6d1d",
            "application_number": "M020",
            "brand_name_base": "Naturium Dew Glow Tinted Moisturizer SPF50-deep"
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0310-6540",
            "generic_name": "exenatide",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "BYDUREON BCise",
            "active_ingredients": [
                {
                    "name": "EXENATIDE",
                    "strength": "2 mg/.85mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-6540-04",
                    "description": "4 CARTRIDGE in 1 CARTON (0310-6540-04)  / .85 mL in 1 CARTRIDGE (0310-6540-01)",
                    "marketing_start_date": "20171201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "1990866",
                    "1990869"
                ],
                "spl_set_id": [
                    "2d18cfc4-e0de-4814-a712-c1b7c504bff5"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000178480",
                    "M0160181",
                    "N0000020058"
                ],
                "pharm_class_epc": [
                    "GLP-1 Receptor Agonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glucagon-Like Peptide 1 [CS]"
                ],
                "pharm_class_moa": [
                    "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
                ],
                "unii": [
                    "9P1872D4OL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE",
            "spl_id": "5ed6c44e-a8f9-4bc1-8048-07060f8f4d23",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20171201",
            "product_id": "0310-6540_5ed6c44e-a8f9-4bc1-8048-07060f8f4d23",
            "application_number": "NDA209210",
            "brand_name_base": "BYDUREON BCise",
            "pharm_class": [
                "GLP-1 Receptor Agonist [EPC]",
                "Glucagon-Like Peptide 1 [CS]",
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "15054-3302",
            "generic_name": "odevixibat",
            "labeler_name": "Ipsen Biopharmaceuticals, Inc.",
            "brand_name": "Bylvay",
            "active_ingredients": [
                {
                    "name": "ODEVIXIBAT",
                    "strength": "400 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "15054-3302-1",
                    "description": "1 BOTTLE in 1 CARTON (15054-3302-1)  / 30 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20240110",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Ipsen Biopharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2563983",
                    "2563989",
                    "2563991",
                    "2563993",
                    "2563997",
                    "2564001",
                    "2564003",
                    "2564005"
                ],
                "spl_set_id": [
                    "0935cd31-3251-4a0a-ac23-25ca4be12be9"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193957",
                    "N0000193958"
                ],
                "pharm_class_epc": [
                    "Ileal Bile Acid Transporter Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Ileal Bile Acid Transporter Inhibitors [MoA]"
                ],
                "unii": [
                    "2W150K0UUC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "a821c8c4-e643-4239-8e84-733f65aa8711",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240110",
            "product_id": "15054-3302_a821c8c4-e643-4239-8e84-733f65aa8711",
            "application_number": "NDA215498",
            "brand_name_base": "Bylvay",
            "pharm_class": [
                "Ileal Bile Acid Transporter Inhibitor [EPC]",
                "Ileal Bile Acid Transporter Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "64406-019",
            "generic_name": "ranibizumab-nuna",
            "labeler_name": "BIOGEN INC.",
            "brand_name": "Byooviz",
            "active_ingredients": [
                {
                    "name": "RANIBIZUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64406-019-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (64406-019-01)  / .05 mL in 1 VIAL, SINGLE-DOSE (64406-019-07)",
                    "marketing_start_date": "20220601",
                    "sample": false
                },
                {
                    "package_ndc": "64406-019-08",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (64406-019-08)  / .05 mL in 1 VIAL, SINGLE-DOSE (64406-019-09)",
                    "marketing_start_date": "20221003",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BIOGEN INC."
                ],
                "rxcui": [
                    "2602353",
                    "2602359"
                ],
                "spl_set_id": [
                    "e46db299-edd1-4457-89b2-c1e2e505f1b0"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193542",
                    "N0000193543"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "unii": [
                    "ZL1R02VT79"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "bc93c0a1-2d15-47c6-aadb-29244dfcc202",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20220601",
            "product_id": "64406-019_bc93c0a1-2d15-47c6-aadb-29244dfcc202",
            "application_number": "BLA761202",
            "brand_name_base": "Byooviz",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "49702-240",
            "generic_name": "cabotegravir and rilpivirine",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "Cabenuva",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-240-15",
                    "description": "1 KIT in 1 CARTON (49702-240-15)  *  3 mL in 1 VIAL (49702-238-01)  *  3 mL in 1 VIAL (49702-243-02)",
                    "marketing_start_date": "20210121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "2475415",
                    "2475416",
                    "2475417",
                    "2475418",
                    "2588077",
                    "2594978",
                    "2594980",
                    "2594982"
                ],
                "spl_set_id": [
                    "1698baf3-f895-4c42-a1b1-e9ee3f20da36"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "fcbe5dbd-7435-4683-9546-8f185b3b8f2f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20210121",
            "product_id": "49702-240_fcbe5dbd-7435-4683-9546-8f185b3b8f2f",
            "application_number": "NDA212888",
            "brand_name_base": "Cabenuva"
        },
        {
            "product_ndc": "58468-0225",
            "generic_name": "caplacizumab",
            "labeler_name": "Genzyme Corporation",
            "brand_name": "Cablivi",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58468-0225-1",
                    "description": "1 KIT in 1 CARTON (58468-0225-1)  *  1 mL in 1 VIAL, GLASS (58468-0227-1)  *  1 mL in 1 SYRINGE, GLASS (58468-0229-1)",
                    "marketing_start_date": "20190206",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genzyme Corporation"
                ],
                "rxcui": [
                    "2110616",
                    "2110618"
                ],
                "spl_set_id": [
                    "2348f06e-8004-4040-832e-e9e86a39f905"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "969588cd-84cf-4f62-996f-4679a820b132",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20190206",
            "product_id": "58468-0225_969588cd-84cf-4f62-996f-4679a820b132",
            "application_number": "BLA761112",
            "brand_name_base": "Cablivi"
        },
        {
            "product_ndc": "42388-023",
            "generic_name": "cabozantinib",
            "labeler_name": "Exelixis, Inc.",
            "brand_name": "CABOMETYX",
            "active_ingredients": [
                {
                    "name": "CABOZANTINIB S-MALATE",
                    "strength": "60 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42388-023-26",
                    "description": "30 TABLET in 1 BOTTLE (42388-023-26)",
                    "marketing_start_date": "20160425",
                    "sample": false
                },
                {
                    "package_ndc": "42388-023-36",
                    "description": "30 TABLET in 1 BOTTLE (42388-023-36)",
                    "marketing_start_date": "20171116",
                    "sample": true
                },
                {
                    "package_ndc": "42388-023-37",
                    "description": "15 TABLET in 1 BOTTLE (42388-023-37)",
                    "marketing_start_date": "20181003",
                    "sample": true
                },
                {
                    "package_ndc": "42388-023-46",
                    "description": "1 BOTTLE in 1 CARTON (42388-023-46)  / 30 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20230109",
                    "sample": false
                },
                {
                    "package_ndc": "42388-023-57",
                    "description": "1 BOTTLE in 1 CARTON (42388-023-57)  / 15 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20230109",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Exelixis, Inc."
                ],
                "rxcui": [
                    "1790161",
                    "1790167",
                    "1790169",
                    "1790171",
                    "1790173",
                    "1790175"
                ],
                "spl_set_id": [
                    "3850cce2-6137-42e5-a792-d318c4a4b3b5"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "DR7ST46X58"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "7ba5219b-5a32-42c9-a00a-6afc22f31bb1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160425",
            "product_id": "42388-023_7ba5219b-5a32-42c9-a00a-6afc22f31bb1",
            "application_number": "NDA208692",
            "brand_name_base": "CABOMETYX",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0069-7810",
            "generic_name": "amlodipine and atorvastatin",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Caduet",
            "active_ingredients": [
                {
                    "name": "AMLODIPINE BESYLATE",
                    "strength": "10 mg/1"
                },
                {
                    "name": "ATORVASTATIN CALCIUM TRIHYDRATE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-7810-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0069-7810-30)",
                    "marketing_start_date": "20220606",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "404011",
                    "404013",
                    "597967",
                    "597977",
                    "597980",
                    "597984",
                    "597987",
                    "597990",
                    "750199",
                    "750203",
                    "750207",
                    "750211",
                    "750227",
                    "750231",
                    "750235",
                    "750239"
                ],
                "spl_set_id": [
                    "6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300692150305",
                    "0300692250302",
                    "0300692170303",
                    "0300692160304",
                    "0300692190301",
                    "0300696565303",
                    "0300696747303",
                    "0300697810303",
                    "0300692270300",
                    "0300697232303",
                    "0300697476301",
                    "0300696180308",
                    "0300696323309",
                    "0300692260301",
                    "0300697654303"
                ],
                "unii": [
                    "48A5M73Z4Q",
                    "864V2Q084H"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "cea383e2-bf78-4907-bd2b-a591d390953c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220606",
            "product_id": "0069-7810_cea383e2-bf78-4907-bd2b-a591d390953c",
            "application_number": "NDA021540",
            "brand_name_base": "Caduet",
            "pharm_class": [
                "Calcium Channel Antagonists [MoA]",
                "Calcium Channel Blocker [EPC]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Dihydropyridine Calcium Channel Blocker [EPC]",
                "Dihydropyridines [CS]",
                "HMG-CoA Reductase Inhibitor [EPC]",
                "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0310-3512",
            "generic_name": "acalabrutinib",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "CALQUENCE",
            "active_ingredients": [
                {
                    "name": "ACALABRUTINIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-3512-60",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (0310-3512-60)",
                    "marketing_start_date": "20220804",
                    "sample": false
                },
                {
                    "package_ndc": "0310-3512-95",
                    "description": "60 TABLET, FILM COATED in 1 BLISTER PACK (0310-3512-95)",
                    "marketing_start_date": "20220804",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2607734",
                    "2607737"
                ],
                "spl_set_id": [
                    "b1409184-3267-4d8c-8f17-4e01f69828b1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020001"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tyrosine Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "I42748ELQW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "75147dc4-a0e1-4aa7-a7c3-f37afdb33204",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220804",
            "product_id": "0310-3512_75147dc4-a0e1-4aa7-a7c3-f37afdb33204",
            "application_number": "NDA216387",
            "brand_name_base": "CALQUENCE",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "69448-014",
            "generic_name": "LEUPROLIDE",
            "labeler_name": "Accord BioPharma, Inc.",
            "brand_name": "CAMCEVI",
            "active_ingredients": [
                {
                    "name": "LEUPROLIDE MESYLATE",
                    "strength": "42 mg/.37g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69448-014-63",
                    "description": "1 SYRINGE in 1 CARTON (69448-014-63)  / .37 g in 1 SYRINGE",
                    "marketing_start_date": "20220405",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Accord BioPharma, Inc."
                ],
                "rxcui": [
                    "2595044",
                    "2595049"
                ],
                "spl_set_id": [
                    "d7a8761a-d953-413a-e053-2a95a90a60ee"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0369448014636"
                ],
                "unii": [
                    "8E3C3C493W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, EMULSION",
            "spl_id": "f86fb59e-2cfd-e617-e053-6394a90ae577",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220405",
            "product_id": "69448-014_f86fb59e-2cfd-e617-e053-6394a90ae577",
            "application_number": "NDA211488",
            "brand_name_base": "CAMCEVI",
            "pharm_class": [
                "Gonadotropin Releasing Hormone Receptor Agonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "73625-111",
            "generic_name": "mavacamten",
            "labeler_name": "Myokardia, Inc.",
            "brand_name": "CAMZYOS",
            "active_ingredients": [
                {
                    "name": "MAVACAMTEN",
                    "strength": "2.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73625-111-11",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (73625-111-11)",
                    "marketing_start_date": "20220428",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Myokardia, Inc."
                ],
                "rxcui": [
                    "2600872",
                    "2600878",
                    "2600880",
                    "2600882",
                    "2600884",
                    "2600886",
                    "2600888",
                    "2600890"
                ],
                "spl_set_id": [
                    "669c936b-3ee6-4e36-8a22-79dd11b1255b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194047",
                    "N0000194048"
                ],
                "pharm_class_epc": [
                    "Cardiac Myosin Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Cardiac Myosin Inhibitors [MoA]"
                ],
                "unii": [
                    "QX45B99R3J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "843e88ee-6397-4115-ae38-b07ca5429dfc",
            "product_type": "CELLULAR THERAPY",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220428",
            "product_id": "73625-111_843e88ee-6397-4115-ae38-b07ca5429dfc",
            "application_number": "NDA214998",
            "brand_name_base": "CAMZYOS",
            "pharm_class": [
                "Cardiac Myosin Inhibitor [EPC]",
                "Cardiac Myosin Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "58914-501",
            "generic_name": "Mesalamine",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "Canasa",
            "active_ingredients": [
                {
                    "name": "MESALAMINE",
                    "strength": "1000 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58914-501-33",
                    "description": "3 SUPPOSITORY in 1 BOX (58914-501-33)",
                    "marketing_start_date": "20010105",
                    "sample": true
                },
                {
                    "package_ndc": "58914-501-42",
                    "description": "42 SUPPOSITORY in 1 BOX (58914-501-42)",
                    "marketing_start_date": "20010105",
                    "sample": false
                },
                {
                    "package_ndc": "58914-501-56",
                    "description": "30 SUPPOSITORY in 1 BOX (58914-501-56)",
                    "marketing_start_date": "20010105",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "248420",
                    "583257"
                ],
                "spl_set_id": [
                    "89d91601-152b-4398-bebe-af1c023e9935"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175781",
                    "M0000971"
                ],
                "pharm_class_epc": [
                    "Aminosalicylate [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminosalicylic Acids [CS]"
                ],
                "unii": [
                    "4Q81I59GXC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUPPOSITORY",
            "spl_id": "606ce6e4-c2ee-44f2-b9eb-8ecdb7a99c93",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RECTAL"
            ],
            "marketing_start_date": "20010105",
            "product_id": "58914-501_606ce6e4-c2ee-44f2-b9eb-8ecdb7a99c93",
            "application_number": "NDA021252",
            "brand_name_base": "Canasa",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "70518-3497",
            "generic_name": "lumateperone",
            "labeler_name": "REMEDYREPACK INC.",
            "brand_name": "CAPLYTA",
            "active_ingredients": [
                {
                    "name": "LUMATEPERONE",
                    "strength": "42 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70518-3497-0",
                    "description": "30 POUCH in 1 BOX (70518-3497-0)  / 1 CAPSULE in 1 POUCH (70518-3497-1)",
                    "marketing_start_date": "20220824",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "REMEDYREPACK INC."
                ],
                "rxcui": [
                    "2275607",
                    "2275613"
                ],
                "spl_set_id": [
                    "2ecc0f15-1d46-4b87-a6ae-aebb7b38bc73"
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "70BSQ12069"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "0ec3cb38-e77b-993e-e063-6394a90a7b74",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220824",
            "product_id": "70518-3497_0ec3cb38-e77b-993e-e063-6394a90a7b74",
            "application_number": "NDA209500",
            "brand_name_base": "CAPLYTA",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "58468-7820",
            "generic_name": "Vandetanib",
            "labeler_name": "Genzyme Corporation",
            "brand_name": "CAPRELSA",
            "active_ingredients": [
                {
                    "name": "VANDETANIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58468-7820-3",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (58468-7820-3)  / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20110725",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genzyme Corporation"
                ],
                "rxcui": [
                    "1098416",
                    "1098418",
                    "1114074",
                    "1114096"
                ],
                "spl_set_id": [
                    "e5721cb8-4185-47b9-bbb3-1c587e558a03"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076",
                    "N0000185503",
                    "N0000187061"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Cation Transporter 2 Inhibitors [MoA]"
                ],
                "unii": [
                    "YO460OQ37K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "f4de7f26-bf5f-4631-b48d-a44d618664fd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110725",
            "product_id": "58468-7820_f4de7f26-bf5f-4631-b48d-a44d618664fd",
            "application_number": "NDA022405",
            "brand_name_base": "CAPRELSA",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Organic Cation Transporter 2 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "52276-312",
            "generic_name": "Carglumic Acid",
            "labeler_name": "Recordati Rare Diseases",
            "brand_name": "Carbaglu",
            "active_ingredients": [
                {
                    "name": "CARGLUMIC ACID",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52276-312-05",
                    "description": "5 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-05)",
                    "marketing_start_date": "20100318",
                    "sample": false
                },
                {
                    "package_ndc": "52276-312-60",
                    "description": "60 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-60)",
                    "marketing_start_date": "20100318",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Recordati Rare Diseases"
                ],
                "rxcui": [
                    "905390",
                    "905394"
                ],
                "spl_set_id": [
                    "10175e73-5172-4dde-a508-8a88b7afc0a1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000184144",
                    "N0000184143"
                ],
                "pharm_class_epc": [
                    "Carbamoyl Phosphate Synthetase 1 Activator [EPC]"
                ],
                "pharm_class_moa": [
                    "Carbamoyl Phosphate Synthetase 1 Activators [MoA]"
                ],
                "unii": [
                    "5L0HB4V1EW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FOR SUSPENSION",
            "spl_id": "7238020c-dcef-42ca-947b-6162e1488608",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100318",
            "product_id": "52276-312_7238020c-dcef-42ca-947b-6162e1488608",
            "application_number": "NDA022562",
            "brand_name_base": "Carbaglu",
            "pharm_class": [
                "Carbamoyl Phosphate Synthetase 1 Activator [EPC]",
                "Carbamoyl Phosphate Synthetase 1 Activators [MoA]"
            ]
        },
        {
            "product_ndc": "54092-171",
            "generic_name": "carbamazepine",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Carbatrol",
            "active_ingredients": [
                {
                    "name": "CARBAMAZEPINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54092-171-12",
                    "description": "120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-171-12)",
                    "marketing_start_date": "19991222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "200131",
                    "200133",
                    "308977",
                    "313931",
                    "388311",
                    "404742"
                ],
                "spl_set_id": [
                    "bc03e499-5bac-4293-bff4-6864153a624d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008486",
                    "N0000175751",
                    "N0000185506",
                    "N0000191266",
                    "N0000187064",
                    "N0000185507",
                    "N0000185607"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_epc": [
                    "Mood Stabilizer [EPC]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 1A2 Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]"
                ],
                "unii": [
                    "33CM23913M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, EXTENDED RELEASE",
            "spl_id": "910f1db8-24b2-4406-9b6e-0b5dad5003c2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19991222",
            "product_id": "54092-171_910f1db8-24b2-4406-9b6e-0b5dad5003c2",
            "application_number": "NDA020712",
            "brand_name_base": "Carbatrol",
            "pharm_class": [
                "Cytochrome P450 1A2 Inducers [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Mood Stabilizer [EPC]"
            ]
        },
        {
            "product_ndc": "50242-041",
            "generic_name": "Alteplase",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Cathflo Activase",
            "active_ingredients": [
                {
                    "name": "ALTEPLASE",
                    "strength": "2.2 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-041-10",
                    "description": "10 VIAL in 1 CARTON (50242-041-10)  / 2 mL in 1 VIAL",
                    "marketing_start_date": "20191014",
                    "sample": false
                },
                {
                    "package_ndc": "50242-041-64",
                    "description": "1 VIAL in 1 CARTON (50242-041-64)  / 2 mL in 1 VIAL",
                    "marketing_start_date": "20010904",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "spl_set_id": [
                    "91ecdef2-95ff-42dd-a31c-c8a09cab3ad9"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "1RXS4UE564"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "7595e1d4-9e6f-4887-b051-efd6c7b0e058",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20010904",
            "product_id": "50242-041_7595e1d4-9e6f-4887-b051-efd6c7b0e058",
            "application_number": "BLA103172",
            "brand_name_base": "Cathflo Activase"
        },
        {
            "product_ndc": "61958-0901",
            "generic_name": "aztreonam",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Cayston",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-0901-1",
                    "description": "2 CARTON in 1 PACKAGE (61958-0901-1)  / 1 KIT in 1 CARTON *  1 mL in 1 VIAL *  1 mL in 1 AMPULE",
                    "marketing_start_date": "20100222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "901610",
                    "901614"
                ],
                "spl_set_id": [
                    "67300ca3-8c53-4ce4-8e86-2c03be1f9b8a"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "e3d9f13f-c1a8-4024-b668-b1545293a6f7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20100222",
            "product_id": "61958-0901_e3d9f13f-c1a8-4024-b668-b1545293a6f7",
            "application_number": "NDA050814",
            "brand_name_base": "Cayston"
        },
        {
            "product_ndc": "0025-1525",
            "generic_name": "Celecoxib",
            "labeler_name": "PFIZER LABORATORIES DIV PFIZER INC",
            "brand_name": "CELEBREX",
            "active_ingredients": [
                {
                    "name": "CELECOXIB",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0025-1525-31",
                    "description": "100 CAPSULE in 1 BOTTLE (0025-1525-31)",
                    "marketing_start_date": "19981002",
                    "marketing_end_date": "20250831",
                    "sample": false
                },
                {
                    "package_ndc": "0025-1525-34",
                    "description": "100 BLISTER PACK in 1 CARTON (0025-1525-34)  / 1 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "19981002",
                    "sample": false
                },
                {
                    "package_ndc": "0025-1525-51",
                    "description": "500 CAPSULE in 1 BOTTLE (0025-1525-51)",
                    "marketing_start_date": "19981002",
                    "marketing_end_date": "20250831",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PFIZER LABORATORIES DIV PFIZER INC"
                ],
                "spl_set_id": [
                    "8d52185d-421f-4e34-8db7-f7676db2a226"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300251520310",
                    "0300251515019"
                ],
                "nui": [
                    "N0000000160",
                    "M0001335",
                    "N0000175722"
                ],
                "pharm_class_moa": [
                    "Cyclooxygenase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Anti-Inflammatory Agents, Non-Steroidal [CS]"
                ],
                "pharm_class_epc": [
                    "Nonsteroidal Anti-inflammatory Drug [EPC]"
                ],
                "unii": [
                    "JCX84Q7J1L"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "5ce75dca-991e-4a17-99e2-71a1d7d43b64",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19981002",
            "product_id": "0025-1525_5ce75dca-991e-4a17-99e2-71a1d7d43b64",
            "application_number": "NDA020998",
            "brand_name_base": "CELEBREX",
            "pharm_class": [
                "Anti-Inflammatory Agents",
                "Non-Steroidal [CS]",
                "Cyclooxygenase Inhibitors [MoA]",
                "Nonsteroidal Anti-inflammatory Drug [EPC]"
            ]
        },
        {
            "product_ndc": "0004-0259",
            "generic_name": "Mycophenolate Mofetil",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "CellCept",
            "active_ingredients": [
                {
                    "name": "MYCOPHENOLATE MOFETIL",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0004-0259-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-01)  / 100 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "19950503",
                    "sample": false
                },
                {
                    "package_ndc": "0004-0259-43",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43)  / 500 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "19950503",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "199058",
                    "200060",
                    "213394",
                    "311880",
                    "311881",
                    "616435",
                    "616444",
                    "616447"
                ],
                "spl_set_id": [
                    "37241e87-4af4-4dc3-a1aa-ea6f20d8dc40"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "UXH81S8ZVB",
                    "9242ECW6R0"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "51881971-82e1-45e4-bd02-f5b2a87bb70b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19950503",
            "product_id": "0004-0259_51881971-82e1-45e4-bd02-f5b2a87bb70b",
            "application_number": "NDA050722",
            "brand_name_base": "CellCept",
            "pharm_class": [
                "Antimetabolite Immunosuppressant [EPC]"
            ]
        },
        {
            "product_ndc": "0071-0525",
            "generic_name": "methsuximide",
            "labeler_name": "Parke-Davis Div of Pfizer Inc",
            "brand_name": "Celontin",
            "active_ingredients": [
                {
                    "name": "METHSUXIMIDE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0071-0525-24",
                    "description": "100 CAPSULE in 1 BOTTLE (0071-0525-24)",
                    "marketing_start_date": "19570208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Parke-Davis Div of Pfizer Inc"
                ],
                "rxcui": [
                    "197949",
                    "207088"
                ],
                "spl_set_id": [
                    "64a6ee88-c6b1-4e13-8208-b6772ef65a74"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300710525245"
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "unii": [
                    "0G76K8X6C0"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "7125a267-65f7-40b7-88cb-fbfc4a750ef7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19570208",
            "product_id": "0071-0525_7125a267-65f7-40b7-88cb-fbfc4a750ef7",
            "application_number": "NDA010596",
            "brand_name_base": "Celontin",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "68974-876",
            "generic_name": "Chenodiol",
            "labeler_name": "Travere Therapeutics",
            "brand_name": "Chenodal",
            "active_ingredients": [
                {
                    "name": "CHENODIOL",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68974-876-40",
                    "description": "100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68974-876-40)",
                    "marketing_start_date": "20151228",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Travere Therapeutics"
                ],
                "rxcui": [
                    "618469",
                    "877417"
                ],
                "spl_set_id": [
                    "769e0a3b-826d-4faf-9129-5eeb7ebe0b67"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "0GEI24LG0J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7575f72a-6d23-4d7e-b2a7-ca8f5c70b3e3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151228",
            "product_id": "68974-876_7575f72a-6d23-4d7e-b2a7-ca8f5c70b3e3",
            "application_number": "ANDA091019",
            "brand_name_base": "Chenodal"
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "0002-4464",
            "generic_name": "Tadalafil",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Cialis",
            "active_ingredients": [
                {
                    "name": "TADALAFIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-4464-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0002-4464-30)",
                    "marketing_start_date": "20031126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "402019",
                    "402096",
                    "402097",
                    "403957",
                    "404711",
                    "484814",
                    "757707",
                    "762660"
                ],
                "spl_set_id": [
                    "bcd8f8ab-81a2-4891-83db-24a0b0e25895"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300024462304",
                    "0300024463301",
                    "0300024464308"
                ],
                "nui": [
                    "N0000175599",
                    "N0000020026"
                ],
                "pharm_class_epc": [
                    "Phosphodiesterase 5 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Phosphodiesterase 5 Inhibitors [MoA]"
                ],
                "unii": [
                    "742SXX0ICT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "21516130-0eb4-48d3-ba98-80465523793a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20031126",
            "product_id": "0002-4464_21516130-0eb4-48d3-ba98-80465523793a",
            "application_number": "NDA021368",
            "brand_name_base": "Cialis",
            "pharm_class": [
                "Phosphodiesterase 5 Inhibitor [EPC]",
                "Phosphodiesterase 5 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0069-0335",
            "generic_name": "abrocitinib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Cibinqo",
            "active_ingredients": [
                {
                    "name": "ABROCITINIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0335-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0069-0335-30)",
                    "marketing_start_date": "20220224",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2591481",
                    "2591487",
                    "2591489",
                    "2591491",
                    "2591493",
                    "2591495"
                ],
                "spl_set_id": [
                    "3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300690235301",
                    "0300690335308",
                    "0300690435305"
                ],
                "nui": [
                    "N0000190858",
                    "N0000190857",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Janus Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Janus Kinase Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "73SM5SF3OR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "9a98f605-9595-4c3e-a722-9cda77031e21",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220224",
            "product_id": "0069-0335_9a98f605-9595-4c3e-a722-9cda77031e21",
            "application_number": "NDA213871",
            "brand_name_base": "Cibinqo",
            "pharm_class": [
                "Janus Kinase Inhibitor [EPC]",
                "Janus Kinase Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70114-441",
            "generic_name": "ranibizumab-eqrn",
            "labeler_name": "Coherus BioSciences Inc",
            "brand_name": "CIMERLI",
            "active_ingredients": [
                {
                    "name": "RANIBIZUMAB",
                    "strength": ".5 mg/.05mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70114-441-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (70114-441-01)  / .05 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20221003",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Coherus BioSciences Inc"
                ],
                "rxcui": [
                    "2612675",
                    "2612681",
                    "2612684",
                    "2612687"
                ],
                "spl_set_id": [
                    "e0e23118-1490-a554-e053-2995a90ab90c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193542",
                    "N0000193543"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "unii": [
                    "ZL1R02VT79"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "aedb8f66-7456-4be4-b149-bf46f08a7512",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20221003",
            "product_id": "70114-441_aedb8f66-7456-4be4-b149-bf46f08a7512",
            "application_number": "BLA761165",
            "brand_name_base": "CIMERLI",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50474-700",
            "generic_name": "certolizumab pegol",
            "labeler_name": "UCB, Inc.",
            "brand_name": "Cimzia",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50474-700-61",
                    "description": "2 KIT in 1 CARTON (50474-700-61)  / 1 KIT in 1 KIT *  1 mL in 1 VIAL, GLASS *  1 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20080420",
                    "sample": false
                },
                {
                    "package_ndc": "50474-700-62",
                    "description": "2 KIT in 1 CARTON (50474-700-62)  / 1 KIT in 1 KIT *  1 mL in 1 VIAL, GLASS *  1 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20080420",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "rxcui": [
                    "795081",
                    "795085",
                    "849597",
                    "849599"
                ],
                "spl_set_id": [
                    "b4c2c9dc-a0bb-4d64-a667-a67ebe88392d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "unii": [
                    "UMD07X179E"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "f161a8e2-b6e2-27d7-e053-2995a90aa01c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20080420",
            "product_id": "50474-700_f161a8e2-b6e2-27d7-e053-2995a90aa01c",
            "application_number": "BLA125160",
            "brand_name_base": "Cimzia"
        },
        {
            "product_ndc": "59310-610",
            "generic_name": "Reslizumab",
            "labeler_name": "Teva Respiratory, LLC",
            "brand_name": "CINQAIR",
            "active_ingredients": [
                {
                    "name": "RESLIZUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59310-610-31",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20160418",
                    "sample": false
                },
                {
                    "package_ndc": "59310-610-33",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (59310-610-33)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20170604",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Teva Respiratory, LLC"
                ],
                "rxcui": [
                    "1746893",
                    "1746898"
                ],
                "spl_set_id": [
                    "053b9158-2a5b-48b9-bf47-5fa78a35ec33"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191872",
                    "N0000191871"
                ],
                "pharm_class_epc": [
                    "Interleukin-5 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-5 Antagonists [MoA]"
                ],
                "unii": [
                    "35A26E427H"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "c3617953-03c5-4746-bfdb-e731faf705d7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20160418",
            "product_id": "59310-610_c3617953-03c5-4746-bfdb-e731faf705d7",
            "application_number": "BLA761033",
            "brand_name_base": "CINQAIR",
            "pharm_class": [
                "Interleukin-5 Antagonist [EPC]",
                "Interleukin-5 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "47426-201",
            "generic_name": "aprepitant",
            "labeler_name": "Heron Therapeutics, Inc.",
            "brand_name": "CINVANTI",
            "active_ingredients": [
                {
                    "name": "APREPITANT",
                    "strength": "130 mg/18mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "47426-201-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (47426-201-01)  / 18 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20180103",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Heron Therapeutics, Inc."
                ],
                "rxcui": [
                    "1995150",
                    "1995155"
                ],
                "spl_set_id": [
                    "4c218d3a-a508-4abc-9ed8-a6e8e191d1b4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000010262",
                    "N0000175786",
                    "N0000182141",
                    "N0000185507",
                    "N0000185506"
                ],
                "pharm_class_moa": [
                    "Neurokinin 1 Antagonists [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]"
                ],
                "pharm_class_epc": [
                    "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "1NF15YR6UY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, EMULSION",
            "spl_id": "ea76407c-7d5a-4920-9909-c509d329ae1c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20180103",
            "product_id": "47426-201_ea76407c-7d5a-4920-9909-c509d329ae1c",
            "application_number": "NDA209296",
            "brand_name_base": "CINVANTI",
            "pharm_class": [
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Neurokinin 1 Antagonists [MoA]",
                "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "51079-288",
            "generic_name": "clozapine",
            "labeler_name": "Mylan Institutional Inc.",
            "brand_name": "Clozapine",
            "active_ingredients": [
                {
                    "name": "CLOZAPINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51079-288-04",
                    "description": "40 BLISTER PACK in 1 CARTON (51079-288-04)  / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (51079-288-01)",
                    "marketing_start_date": "20160926",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Institutional Inc."
                ],
                "rxcui": [
                    "476177"
                ],
                "spl_set_id": [
                    "976be6e3-a9db-49c6-9b02-1ab168cf17b1"
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "J60AR2IKIC"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, ORALLY DISINTEGRATING",
            "spl_id": "0eaeb920-5452-13c4-e063-6394a90a2291",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160926",
            "product_id": "51079-288_0eaeb920-5452-13c4-e063-6394a90a2291",
            "application_number": "ANDA201824",
            "brand_name_base": "Clozapine",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0568",
            "generic_name": "artemether and lumefantrine",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "COARTEM",
            "active_ingredients": [
                {
                    "name": "ARTEMETHER",
                    "strength": "20 mg/1"
                },
                {
                    "name": "LUMEFANTRINE",
                    "strength": "120 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0568-45",
                    "description": "24 TABLET in 1 BOTTLE (0078-0568-45)",
                    "marketing_start_date": "20090407",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "847731",
                    "847734"
                ],
                "spl_set_id": [
                    "7866ec19-dfac-47d4-a53f-511a12643cbf"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175482"
                ],
                "pharm_class_epc": [
                    "Antimalarial [EPC]"
                ],
                "unii": [
                    "C7D6T3H22J",
                    "F38R0JR742"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "7963de9b-c2cb-4d65-9b14-9511509fb1a1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20090407",
            "product_id": "0078-0568_7963de9b-c2cb-4d65-9b14-9511509fb1a1",
            "application_number": "NDA022268",
            "brand_name_base": "COARTEM",
            "pharm_class": [
                "Antimalarial [EPC]",
                "Antimalarial [EPC]"
            ]
        },
        {
            "product_ndc": "65649-101",
            "generic_name": "balsalazide disodium",
            "labeler_name": "Salix Pharmaceuticals, Inc",
            "brand_name": "Colazal",
            "active_ingredients": [
                {
                    "name": "BALSALAZIDE DISODIUM",
                    "strength": "750 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65649-101-02",
                    "description": "280 CAPSULE in 1 BOTTLE (65649-101-02)",
                    "marketing_start_date": "20000718",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Salix Pharmaceuticals, Inc"
                ],
                "rxcui": [
                    "885857",
                    "885859"
                ],
                "spl_set_id": [
                    "22f41e83-b9fb-4c9e-8cc3-f457034191a8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "1XL6BJI034"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "092f61af-2996-0c58-e063-6394a90a3753",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20000718",
            "product_id": "65649-101_092f61af-2996-0c58-e063-6394a90a3753",
            "application_number": "NDA020610",
            "brand_name_base": "Colazal",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "10451-001",
            "generic_name": "Oxygen",
            "labeler_name": "General Distributing Co.",
            "brand_name": "Oxygen",
            "active_ingredients": [
                {
                    "name": "OXYGEN",
                    "strength": "992 mL/L"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10451-001-01",
                    "description": "663 L in 1 CYLINDER (10451-001-01)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-02",
                    "description": "408 L in 1 CYLINDER (10451-001-02)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-03",
                    "description": "120 L in 1 CYLINDER (10451-001-03)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-04",
                    "description": "129621 L in 1 CYLINDER (10451-001-04)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-07",
                    "description": "3511 L in 1 CYLINDER (10451-001-07)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-08",
                    "description": "2350 L in 1 CYLINDER (10451-001-08)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-09",
                    "description": "143 L in 1 CYLINDER (10451-001-09)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-10",
                    "description": "158 L in 1 CYLINDER (10451-001-10)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-11",
                    "description": "174 L in 1 CYLINDER (10451-001-11)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-12",
                    "description": "7079 L in 1 CYLINDER (10451-001-12)",
                    "marketing_start_date": "19690101",
                    "sample": false
                },
                {
                    "package_ndc": "10451-001-13",
                    "description": "8495 L in 1 CYLINDER (10451-001-13)",
                    "marketing_start_date": "19690101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "General Distributing Co."
                ],
                "rxcui": [
                    "348831"
                ],
                "spl_set_id": [
                    "ffa52347-b223-4ff8-acaa-1462f2dfb528"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "S88TT14065"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GAS",
            "spl_id": "0761147f-1335-606e-e063-6394a90abd5d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "19690101",
            "product_id": "10451-001_0761147f-1335-606e-e063-6394a90abd5d",
            "application_number": "NDA205889",
            "brand_name_base": "Oxygen"
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "0069-2362",
            "generic_name": "COVID-19 Vaccine, mRNA",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Comirnaty",
            "active_ingredients": [
                {
                    "name": "RAXTOZINAMERAN",
                    "strength": ".048 mg/.48mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-2362-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0069-2362-10)  / .48 mL in 1 VIAL, SINGLE-DOSE (0069-2362-01)",
                    "marketing_start_date": "20230911",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "1b485cc3-65e2-4ea2-a043-68bb337b0013",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20230911",
            "product_id": "0069-2362_1b485cc3-65e2-4ea2-a043-68bb337b0013",
            "application_number": "BLA125742",
            "brand_name_base": "Comirnaty"
        },
        {
            "product_ndc": "61958-1101",
            "generic_name": "emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "COMPLERA",
            "active_ingredients": [
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "RILPIVIRINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                },
                {
                    "name": "TENOFOVIR DISOPROXIL FUMARATE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-1101-1",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (61958-1101-1)",
                    "marketing_start_date": "20110810",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1147334",
                    "1147337"
                ],
                "spl_set_id": [
                    "d637cfab-f1e8-4eb3-a1b3-f85ca3bec612"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "G70B4ETF4S",
                    "212WAX8KDD",
                    "OTT9J7900I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0fb2e5c4-f94a-4b12-b502-df7d58371018",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110810",
            "product_id": "61958-1101_0fb2e5c4-f94a-4b12-b502-df7d58371018",
            "application_number": "NDA202123",
            "brand_name_base": "COMPLERA",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "68546-317",
            "generic_name": "Glatiramer Acetate",
            "labeler_name": "Teva Neuroscience, Inc.",
            "brand_name": "Copaxone",
            "active_ingredients": [
                {
                    "name": "GLATIRAMER ACETATE",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68546-317-30",
                    "description": "30 BLISTER PACK in 1 CARTON (68546-317-30)  / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20080428",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Teva Neuroscience, Inc."
                ],
                "rxcui": [
                    "1111641",
                    "1111642",
                    "1487361",
                    "1487363"
                ],
                "spl_set_id": [
                    "aa88f583-4f5f-433b-80b4-1f4c9fb28357"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5M691HL4BO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "d3c2bb3f-c354-430c-9cad-68ff376f0508",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20080428",
            "product_id": "68546-317_d3c2bb3f-c354-430c-9cad-68ff376f0508",
            "application_number": "NDA020622",
            "brand_name_base": "Copaxone"
        },
        {
            "product_ndc": "63833-518",
            "generic_name": "Factor XIII Concentrate (Human)",
            "labeler_name": "CSL Behring GmbH",
            "brand_name": "Corifact",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63833-518-02",
                    "description": "1 KIT in 1 CARTON (63833-518-02)  *  20 mL in 1 VIAL, SINGLE-USE (63833-528-01)  *  20 mL in 1 VIAL, SINGLE-USE (63833-734-65)",
                    "marketing_start_date": "20110217",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "5834bcd0-b7c1-4591-8ec7-f0c847c5e428",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20110217",
            "product_id": "63833-518_5834bcd0-b7c1-4591-8ec7-f0c847c5e428",
            "application_number": "BLA125385",
            "brand_name_base": "Corifact"
        },
        {
            "product_ndc": "55513-813",
            "generic_name": "ivabradine",
            "labeler_name": "Amgen Inc",
            "brand_name": "Corlanor",
            "active_ingredients": [
                {
                    "name": "IVABRADINE HYDROCHLORIDE",
                    "strength": "5 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-813-28",
                    "description": "28 AMPULE in 1 CARTON (55513-813-28)  / 5 mL in 1 AMPULE (55513-813-01)",
                    "marketing_start_date": "20190419",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1649485",
                    "1649491",
                    "1649493",
                    "1649495",
                    "2168592",
                    "2168596"
                ],
                "spl_set_id": [
                    "92018a65-38f6-45f7-91d4-a34921b81d0d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513810609",
                    "0355513800600"
                ],
                "unii": [
                    "TP19837BZK"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "9f7f886a-6d34-48f7-9f13-a34e315aeafe",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190419",
            "product_id": "55513-813_9f7f886a-6d34-48f7-9f13-a34e315aeafe",
            "application_number": "NDA209964",
            "brand_name_base": "Corlanor",
            "pharm_class": [
                "Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]",
                "Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]"
            ]
        },
        {
            "product_ndc": "0037-6830",
            "generic_name": "hydrocortisone acetate",
            "labeler_name": "Meda Pharmaceuticals Inc.",
            "brand_name": "Cortifoam",
            "active_ingredients": [
                {
                    "name": "HYDROCORTISONE ACETATE",
                    "strength": "1500 mg/15g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0037-6830-15",
                    "description": "1 CANISTER in 1 CARTON (0037-6830-15)  / 15 g in 1 CANISTER",
                    "marketing_start_date": "20150615",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Meda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1545172",
                    "1545174"
                ],
                "spl_set_id": [
                    "0093b694-9fcb-46ae-b1ab-7d0fa204c6c8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "3X7931PO74"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "AEROSOL, FOAM",
            "spl_id": "0bfc3606-5ca8-48c1-9908-71634c152ac9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20150615",
            "product_id": "0037-6830_0bfc3606-5ca8-48c1-9908-71634c152ac9",
            "application_number": "NDA017351",
            "brand_name_base": "Cortifoam",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "73462-101",
            "generic_name": "trilaciclib",
            "labeler_name": "G1 Therapeutics, Inc.",
            "brand_name": "COSELA",
            "active_ingredients": [
                {
                    "name": "TRILACICLIB DIHYDROCHLORIDE",
                    "strength": "300 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73462-101-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (73462-101-01)  / 20 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20210212",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "G1 Therapeutics, Inc."
                ],
                "rxcui": [
                    "2479705",
                    "2479710"
                ],
                "spl_set_id": [
                    "4b06922c-498d-4871-a037-84a44e6a6b6c"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0373462101012"
                ],
                "unii": [
                    "4BX07W725T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "771900a0-4eee-4197-9051-ffe0fdc0f1d4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210212",
            "product_id": "73462-101_771900a0-4eee-4197-9051-ffe0fdc0f1d4",
            "application_number": "NDA214200",
            "brand_name_base": "COSELA",
            "pharm_class": [
                "Cyclin-dependent Kinase 4 Inhibitors [MoA]",
                "Cyclin-dependent Kinase 6 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]",
                "Organic Cation Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-1168",
            "generic_name": "secukinumab",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "COSENTYX",
            "active_ingredients": [
                {
                    "name": "SECUKINUMAB",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-1168-61",
                    "description": "5 mL in 1 VIAL, GLASS (0078-1168-61)",
                    "marketing_start_date": "20231006",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1599792",
                    "1599797",
                    "1653241",
                    "1653243",
                    "2550712",
                    "2550713",
                    "2637347",
                    "2637348",
                    "2667419",
                    "2667423"
                ],
                "spl_set_id": [
                    "77c4b13e-7df3-42d4-81db-3d0cddb7f67a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191495",
                    "N0000191494"
                ],
                "pharm_class_epc": [
                    "Interleukin-17A Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-17A Antagonists [MoA]"
                ],
                "unii": [
                    "DLG4EML025"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "4b137729-6060-43e8-8cf3-89c6c04aad21",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231006",
            "product_id": "0078-1168_4b137729-6060-43e8-8cf3-89c6c04aad21",
            "application_number": "BLA761349",
            "brand_name_base": "COSENTYX",
            "pharm_class": [
                "Interleukin-17A Antagonist [EPC]",
                "Interleukin-17A Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "50242-717",
            "generic_name": "COBIMETINIB",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Cotellic",
            "active_ingredients": [
                {
                    "name": "COBIMETINIB FUMARATE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-717-01",
                    "description": "63 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50242-717-01)",
                    "marketing_start_date": "20151110",
                    "sample": false
                },
                {
                    "package_ndc": "50242-717-86",
                    "description": "63 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50242-717-86)",
                    "marketing_start_date": "20151110",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1722370",
                    "1722376"
                ],
                "spl_set_id": [
                    "c387579e-cee0-4334-bd1e-73f93ac1bde6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "6EXI96H8SV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "1728ab50-4d7c-4342-9587-5f734576f70b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151110",
            "product_id": "50242-717_1728ab50-4d7c-4342-9587-5f734576f70b",
            "application_number": "NDA206192",
            "brand_name_base": "Cotellic",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "76420-494",
            "generic_name": "Zolpidem Tartrate",
            "labeler_name": "Asclemed USA, Inc.",
            "dea_schedule": "CIV",
            "brand_name": "Zolpidem Tartrate",
            "active_ingredients": [
                {
                    "name": "ZOLPIDEM TARTRATE",
                    "strength": "6.25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76420-494-01",
                    "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-01)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-30",
                    "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-30)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-60",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-60)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-90",
                    "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-90)",
                    "marketing_start_date": "20221005",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Asclemed USA, Inc."
                ],
                "rxcui": [
                    "854880",
                    "854894"
                ],
                "spl_set_id": [
                    "35f6c1ab-a61c-4625-b932-11a7483f1d84"
                ],
                "unii": [
                    "WY6W63843K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "ea435212-caf8-164b-e053-2a95a90a0bf6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201217",
            "product_id": "76420-494_ea435212-caf8-164b-e053-2a95a90a0bf6",
            "application_number": "ANDA213592",
            "brand_name_base": "Zolpidem Tartrate",
            "pharm_class": [
                "Central Nervous System Depression [PE]",
                "GABA A Agonists [MoA]",
                "Pyridines [CS]",
                "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0023-6151",
            "generic_name": "progesterone",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "Crinone",
            "active_ingredients": [
                {
                    "name": "PROGESTERONE",
                    "strength": "90 mg/1.125g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-6151-08",
                    "description": "15 APPLICATOR in 1 CARTON (0023-6151-08)  / 1.125 g in 1 APPLICATOR",
                    "marketing_start_date": "19970513",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "153579",
                    "153580",
                    "312643",
                    "312645"
                ],
                "spl_set_id": [
                    "75e97aa1-daa4-45f9-b2e2-1a371302914e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0017672",
                    "N0000175601"
                ],
                "pharm_class_cs": [
                    "Progesterone [CS]"
                ],
                "pharm_class_epc": [
                    "Progesterone [EPC]"
                ],
                "unii": [
                    "4G7DS2Q64Y"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GEL",
            "spl_id": "dce022aa-0832-4197-ab9f-5514436f3c43",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "19970513",
            "product_id": "0023-6151_dce022aa-0832-4197-ab9f-5514436f3c43",
            "application_number": "NDA020701",
            "brand_name_base": "Crinone",
            "pharm_class": [
                "Progesterone [CS]",
                "Progesterone [EPC]"
            ]
        },
        {
            "product_ndc": "69794-304",
            "generic_name": "Burosumab",
            "labeler_name": "Ultragenyx Pharmaceutical Inc.",
            "brand_name": "CRYSVITA",
            "active_ingredients": [
                {
                    "name": "BUROSUMAB",
                    "strength": "30 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69794-304-01",
                    "description": "1 mL in 1 VIAL, SINGLE-USE (69794-304-01)",
                    "marketing_start_date": "20180418",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Ultragenyx Pharmaceutical Inc."
                ],
                "rxcui": [
                    "2043859",
                    "2043864",
                    "2043868",
                    "2043870",
                    "2043876",
                    "2043878"
                ],
                "spl_set_id": [
                    "6f5f3556-3197-477a-993c-96b2c29a91ac"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G9WJT6RD29"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "81078e03-384d-40f9-a5e9-9b8b49163a32",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20180418",
            "product_id": "69794-304_81078e03-384d-40f9-a5e9-9b8b49163a32",
            "application_number": "BLA761068",
            "brand_name_base": "CRYSVITA"
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0597-0375",
            "generic_name": "adalimumab-adbm",
            "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "brand_name": "Cyltezo",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0597-0375-16",
                    "description": "6 KIT in 1 CARTON (0597-0375-16)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET",
                    "marketing_start_date": "20230701",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0375-23",
                    "description": "4 KIT in 1 CARTON (0597-0375-23)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET",
                    "marketing_start_date": "20230701",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0375-48",
                    "description": "1 KIT in 1 CARTON (0597-0375-48)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET",
                    "marketing_start_date": "20230701",
                    "sample": true
                },
                {
                    "package_ndc": "0597-0375-53",
                    "description": "1 KIT in 1 CARTON (0597-0375-53)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET",
                    "marketing_start_date": "20230701",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0375-97",
                    "description": "2 KIT in 1 CARTON (0597-0375-97)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE *  2 PACKET in 1 TRAY / 1 mL in 1 PACKET",
                    "marketing_start_date": "20230701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Boehringer Ingelheim Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "797544",
                    "2640883",
                    "2640889",
                    "2640891",
                    "2640892",
                    "2640893",
                    "2640894",
                    "2640895",
                    "2640898",
                    "2640900",
                    "2640901",
                    "2640902",
                    "2640903",
                    "2680743",
                    "2680746",
                    "2680748",
                    "2680750",
                    "2680756",
                    "2680757",
                    "2680759",
                    "2680760"
                ],
                "spl_set_id": [
                    "115ea79b-7209-7f19-b35d-36ec0828fbf5"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "b9a21704-58a7-4806-beab-2518b7a3e6fc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20230701",
            "product_id": "0597-0375_b9a21704-58a7-4806-beab-2518b7a3e6fc",
            "application_number": "BLA761058",
            "brand_name_base": "Cyltezo"
        },
        {
            "product_ndc": "0002-3235",
            "generic_name": "Duloxetine hydrochloride",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Cymbalta",
            "active_ingredients": [
                {
                    "name": "DULOXETINE HYDROCHLORIDE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-3235-60",
                    "description": "60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0002-3235-60)",
                    "marketing_start_date": "20040824",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "596926",
                    "596928",
                    "596930",
                    "596932",
                    "596934",
                    "615186"
                ],
                "spl_set_id": [
                    "2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300023235602",
                    "0300023240309",
                    "0300023270306"
                ],
                "unii": [
                    "9044SC542W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "9b59611f-2b1b-46d7-8d7e-9d0779811309",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20040824",
            "product_id": "0002-3235_9b59611f-2b1b-46d7-8d7e-9d0779811309",
            "application_number": "NDA021427",
            "brand_name_base": "Cymbalta",
            "pharm_class": [
                "Norepinephrine Uptake Inhibitors [MoA]",
                "Serotonin Uptake Inhibitors [MoA]",
                "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "0002-7669",
            "generic_name": "ramucirumab",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "CYRAMZA",
            "active_ingredients": [
                {
                    "name": "RAMUCIRUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-7669-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01)  / 10 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20140421",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "1657775",
                    "1657777",
                    "1657780",
                    "1657781"
                ],
                "spl_set_id": [
                    "c6080942-dee6-423e-b688-1272c2ae90d4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191009",
                    "N0000020032"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "VEGFR2 Inhibitors [MoA]"
                ],
                "unii": [
                    "D99YVK4L0X"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "7ba2dde4-bb6d-4c7b-af6a-361ed01bfdf6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20140421",
            "product_id": "0002-7669_7ba2dde4-bb6d-4c7b-af6a-361ed01bfdf6",
            "application_number": "BLA125477",
            "brand_name_base": "CYRAMZA",
            "pharm_class": [
                "VEGFR2 Inhibitors [MoA]",
                "Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "52276-400",
            "generic_name": "betaine",
            "labeler_name": "Recordati Rare Diseases",
            "brand_name": "Cystadane",
            "active_ingredients": [
                {
                    "name": "BETAINE",
                    "strength": "1 g/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52276-400-01",
                    "description": "180 g in 1 BOTTLE (52276-400-01)",
                    "marketing_start_date": "20170413",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Recordati Rare Diseases"
                ],
                "rxcui": [
                    "404539",
                    "562847"
                ],
                "spl_set_id": [
                    "31a684d0-cd98-4e46-b43a-ccbd17c41559"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0352276400016"
                ],
                "nui": [
                    "N0000175804",
                    "N0000175805"
                ],
                "pharm_class_moa": [
                    "Methylating Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Methylating Agent [EPC]"
                ],
                "unii": [
                    "3SCV180C9W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SOLUTION",
            "spl_id": "1f286147-1f5c-4f83-984e-af1298b8712c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19961025",
            "product_id": "52276-400_1f286147-1f5c-4f83-984e-af1298b8712c",
            "application_number": "NDA020576",
            "brand_name_base": "Cystadane",
            "pharm_class": [
                "Methylating Activity [MoA]",
                "Methylating Agent [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0378-9040",
            "generic_name": "cysteamine bitartrate",
            "labeler_name": "Mylan Pharmaceuticals Inc.",
            "brand_name": "Cystagon",
            "active_ingredients": [
                {
                    "name": "CYSTEAMINE BITARTRATE",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0378-9040-05",
                    "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (0378-9040-05)",
                    "marketing_start_date": "20050411",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "209788",
                    "209789",
                    "309636",
                    "309637"
                ],
                "spl_set_id": [
                    "f495b76d-96c6-48e5-8fa3-30a4336628eb"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0303789045058",
                    "0303789040053"
                ],
                "unii": [
                    "QO84GZ3TST"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "3152f70b-070d-47e0-80b2-6bb826793ee1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20050411",
            "product_id": "0378-9040_3152f70b-070d-47e0-80b2-6bb826793ee1",
            "application_number": "NDA020392",
            "brand_name_base": "Cystagon",
            "pharm_class": [
                "Cystine Depleting Agent [EPC]",
                "Cystine Disulfide Reduction [MoA]"
            ]
        },
        {
            "product_ndc": "76670-0014",
            "generic_name": "Silicon dioxide, Sodium monofluorophosphate",
            "labeler_name": "DOCSMEDI OralBiome Co., Ltd.",
            "brand_name": "DOCTRUST K Tooth",
            "active_ingredients": [
                {
                    "name": "SILICON DIOXIDE",
                    "strength": "16 g/100g"
                },
                {
                    "name": "SODIUM MONOFLUOROPHOSPHATE",
                    "strength": ".74 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76670-0014-2",
                    "description": "1 TUBE in 1 CARTON (76670-0014-2)  / 60 g in 1 TUBE (76670-0014-1)",
                    "marketing_start_date": "20221201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "DOCSMEDI OralBiome Co., Ltd."
                ],
                "spl_set_id": [
                    "a02f8865-e7be-4ef4-b09c-dad846639764"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "ETJ7Z6XBU4",
                    "C810JCZ56Q"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "GEL, DENTIFRICE",
            "spl_id": "90ad77d8-c0d4-4649-92b9-41ebb6ec561d",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "DENTAL"
            ],
            "marketing_start_date": "20221201",
            "product_id": "76670-0014_90ad77d8-c0d4-4649-92b9-41ebb6ec561d",
            "brand_name_base": "DOCTRUST K Tooth"
        },
        {
            "product_ndc": "57970-100",
            "generic_name": "Dalbavancin",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "DALVANCE",
            "active_ingredients": [
                {
                    "name": "DALBAVANCIN HYDROCHLORIDE",
                    "strength": "500 mg/25mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57970-100-01",
                    "description": "1 VIAL in 1 PACKAGE (57970-100-01)  / 25 mL in 1 VIAL",
                    "marketing_start_date": "20140523",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "1539243",
                    "1539248"
                ],
                "spl_set_id": [
                    "4b4674d8-4d1e-4728-8465-d42ada33fa5c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "33WDQ7T81E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
            "spl_id": "b5c03094-ef8b-44d2-86ae-82c7c24949d7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20140523",
            "product_id": "57970-100_b5c03094-ef8b-44d2-86ae-82c7c24949d7",
            "application_number": "NDA021883",
            "brand_name_base": "DALVANCE",
            "pharm_class": [
                "Lipoglycopeptide Antibacterial [EPC]",
                "Lipoglycopeptides [CS]"
            ]
        },
        {
            "product_ndc": "73042-201",
            "generic_name": "Naxitamab",
            "labeler_name": "Y-mAbs Therapeutics, Inc.",
            "brand_name": "DANYELZA",
            "active_ingredients": [
                {
                    "name": "NAXITAMAB",
                    "strength": "40 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73042-201-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (73042-201-01)  / 10 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20201125",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Y-mAbs Therapeutics, Inc."
                ],
                "rxcui": [
                    "2474239",
                    "2474244"
                ],
                "spl_set_id": [
                    "29a80c6b-8bad-4650-8c7f-f18490c868ec"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191500",
                    "N0000191499"
                ],
                "pharm_class_epc": [
                    "Glycolipid Disialoganglioside-directed Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "9K8GNJ2874"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "ae1c018a-8fc9-48ee-918e-89f00a82744c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20201125",
            "product_id": "73042-201_ae1c018a-8fc9-48ee-918e-89f00a82744c",
            "application_number": "BLA761171",
            "brand_name_base": "DANYELZA",
            "pharm_class": [
                "Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]",
                "Glycolipid Disialoganglioside-directed Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "57894-503",
            "generic_name": "daratumumab and hyaluronidase-fihj (human recombinant)",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "Darzalex Faspro",
            "active_ingredients": [
                {
                    "name": "DARATUMUMAB",
                    "strength": "1800 mg/15mL"
                },
                {
                    "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
                    "strength": "30000 U/15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-503-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01)  / 15 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "2375136",
                    "2375141"
                ],
                "spl_set_id": [
                    "4bb241af-4299-4373-8762-2d6709515db0"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0357894503019"
                ],
                "nui": [
                    "N0000192336",
                    "N0000192335",
                    "M0001357",
                    "N0000175531",
                    "M0009499"
                ],
                "pharm_class_epc": [
                    "CD38-directed Cytolytic Antibody [EPC]",
                    "Endoglycosidase [EPC]"
                ],
                "pharm_class_moa": [
                    "CD38-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]",
                    "Glycoside Hydrolases [CS]"
                ],
                "unii": [
                    "4Z63YK6E0E",
                    "743QUY4VD8"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "0b3a8b34-5dd8-e8d8-e063-6294a90a980b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20200501",
            "product_id": "57894-503_0b3a8b34-5dd8-e8d8-e063-6294a90a980b",
            "application_number": "BLA761145",
            "brand_name_base": "Darzalex Faspro",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "CD38-directed Antibody Interactions [MoA]",
                "CD38-directed Cytolytic Antibody [EPC]",
                "Endoglycosidase [EPC]",
                "Glycoside Hydrolases [CS]"
            ]
        },
        {
            "product_ndc": "57894-503",
            "generic_name": "daratumumab and hyaluronidase-fihj (human recombinant)",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "Darzalex Faspro",
            "active_ingredients": [
                {
                    "name": "DARATUMUMAB",
                    "strength": "1800 mg/15mL"
                },
                {
                    "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
                    "strength": "30000 U/15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-503-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01)  / 15 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "2375136",
                    "2375141"
                ],
                "spl_set_id": [
                    "4bb241af-4299-4373-8762-2d6709515db0"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0357894503019"
                ],
                "nui": [
                    "N0000192336",
                    "N0000192335",
                    "M0001357",
                    "N0000175531",
                    "M0009499"
                ],
                "pharm_class_epc": [
                    "CD38-directed Cytolytic Antibody [EPC]",
                    "Endoglycosidase [EPC]"
                ],
                "pharm_class_moa": [
                    "CD38-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]",
                    "Glycoside Hydrolases [CS]"
                ],
                "unii": [
                    "4Z63YK6E0E",
                    "743QUY4VD8"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "0b3a8b34-5dd8-e8d8-e063-6294a90a980b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20200501",
            "product_id": "57894-503_0b3a8b34-5dd8-e8d8-e063-6294a90a980b",
            "application_number": "BLA761145",
            "brand_name_base": "Darzalex Faspro",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "CD38-directed Antibody Interactions [MoA]",
                "CD38-directed Cytolytic Antibody [EPC]",
                "Endoglycosidase [EPC]",
                "Glycoside Hydrolases [CS]"
            ]
        },
        {
            "product_ndc": "0069-1531",
            "generic_name": "glasdegib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Daurismo",
            "active_ingredients": [
                {
                    "name": "GLASDEGIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-1531-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0069-1531-30)",
                    "marketing_start_date": "20181210",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2105850",
                    "2105856",
                    "2105858",
                    "2105860"
                ],
                "spl_set_id": [
                    "204a6f7e-c9a4-472b-abd2-9527bda64d17"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300690298603",
                    "0300691531303"
                ],
                "nui": [
                    "N0000184149",
                    "N0000184148"
                ],
                "pharm_class_epc": [
                    "Hedgehog Pathway Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Smoothened Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "K673DMO5H9"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "9695bbad-259b-4ac3-80af-36f1ca94d433",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181210",
            "product_id": "0069-1531_9695bbad-259b-4ac3-80af-36f1ca94d433",
            "application_number": "NDA210656",
            "brand_name_base": "Daurismo",
            "pharm_class": [
                "Hedgehog Pathway Inhibitor [EPC]",
                "Smoothened Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "62856-405",
            "generic_name": "lemborexant",
            "labeler_name": "Eisai Inc.",
            "dea_schedule": "CIV",
            "brand_name": "DAYVIGO",
            "active_ingredients": [
                {
                    "name": "LEMBOREXANT",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "62856-405-10",
                    "description": "1 BLISTER PACK in 1 CARTON (62856-405-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20200407",
                    "sample": true
                },
                {
                    "package_ndc": "62856-405-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (62856-405-30)",
                    "marketing_start_date": "20200407",
                    "sample": false
                },
                {
                    "package_ndc": "62856-405-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (62856-405-90)",
                    "marketing_start_date": "20200407",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eisai Inc."
                ],
                "rxcui": [
                    "2272408",
                    "2272414",
                    "2288425",
                    "2288427"
                ],
                "spl_set_id": [
                    "7074cb65-77b3-45d2-8e8d-da8dc0f70bfd"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0362856410304",
                    "0362856405300",
                    "0362856410908",
                    "0362856405904"
                ],
                "nui": [
                    "N0000191000",
                    "N0000190998",
                    "N0000187064"
                ],
                "pharm_class_epc": [
                    "Orexin Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Orexin Receptor Antagonists [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]"
                ],
                "unii": [
                    "0K5743G68X"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "fab80860-4be1-4a9b-a2f5-81a7d31f7d20",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200407",
            "product_id": "62856-405_fab80860-4be1-4a9b-a2f5-81a7d31f7d20",
            "application_number": "NDA212028",
            "brand_name_base": "DAYVIGO",
            "pharm_class": [
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Orexin Receptor Antagonist [EPC]",
                "Orexin Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "68727-800",
            "generic_name": "defibrotide sodium",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "brand_name": "DEFITELIO",
            "active_ingredients": [
                {
                    "name": "DEFIBROTIDE SODIUM",
                    "strength": "80 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68727-800-01",
                    "description": "2.5 mL in 1 VIAL (68727-800-01)",
                    "marketing_start_date": "20160330",
                    "sample": false
                },
                {
                    "package_ndc": "68727-800-02",
                    "description": "25 mL in 1 CARTON (68727-800-02)",
                    "marketing_start_date": "20160330",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1746527",
                    "1746532"
                ],
                "spl_set_id": [
                    "2c3db989-d7ad-41ed-9ebf-698dcf6c24ec"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0368727800021"
                ],
                "unii": [
                    "L7CHH2B2J0"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "0173efe0-e4e2-41f6-b044-81f707120906",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20160330",
            "product_id": "68727-800_0173efe0-e4e2-41f6-b044-81f707120906",
            "application_number": "NDA208114",
            "brand_name_base": "DEFITELIO"
        },
        {
            "product_ndc": "0006-5007",
            "generic_name": "doravirine, lamivudine, and tenofovir disoproxil fumarate",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "DELSTRIGO",
            "active_ingredients": [
                {
                    "name": "DORAVIRINE",
                    "strength": "100 mg/1"
                },
                {
                    "name": "LAMIVUDINE",
                    "strength": "300 mg/1"
                },
                {
                    "name": "TENOFOVIR DISOPROXIL FUMARATE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-5007-01",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01)",
                    "marketing_start_date": "20180720",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "2055813",
                    "2055815"
                ],
                "spl_set_id": [
                    "cd1e9f84-607a-46d3-b01e-2736018d67b6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300065007014"
                ],
                "nui": [
                    "N0000175463",
                    "N0000009948",
                    "N0000175460",
                    "N0000175656",
                    "N0000175462",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                    "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "913P6LK81M",
                    "2T8Q726O95",
                    "OTT9J7900I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "159c05bc-4bee-42d5-90a8-70da539ed1b5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180720",
            "product_id": "0006-5007_159c05bc-4bee-42d5-90a8-70da539ed1b5",
            "application_number": "NDA210807",
            "brand_name_base": "DELSTRIGO",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "71796-019",
            "generic_name": "Apalutamide",
            "labeler_name": "Dr. Reddys Laboratories Limited",
            "active_ingredients": [
                {
                    "name": "APALUTAMIDE",
                    "strength": "1 kg/kg"
                }
            ],
            "finished": false,
            "packaging": [
                {
                    "package_ndc": "71796-019-00",
                    "description": "1 kg in 1 DRUM (71796-019-00)",
                    "marketing_start_date": "24-MAR-20"
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BULK INGREDIENT",
            "dosage_form": "POWDER",
            "spl_id": "8a1025bd-6be7-ca63-783a-bc8f7624e3a1",
            "product_type": "BULK INGREDIENT",
            "marketing_start_date": "20200324",
            "product_id": "71796-019_8a1025bd-6be7-ca63-783a-bc8f7624e3a1",
            "brand_name_base": null
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0378-9720",
            "generic_name": "penciclovir",
            "labeler_name": "Mylan Pharmaceuticals Inc.",
            "brand_name": "Denavir",
            "active_ingredients": [
                {
                    "name": "PENCICLOVIR",
                    "strength": "10 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0378-9720-55",
                    "description": "1 TUBE in 1 CARTON (0378-9720-55)  / 5 g in 1 TUBE",
                    "marketing_start_date": "20180924",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "211343",
                    "312255"
                ],
                "spl_set_id": [
                    "61229829-55a0-4d6f-a423-4b48a2b4d8e5"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000020060",
                    "N0000175468",
                    "N0000175459"
                ],
                "pharm_class_moa": [
                    "DNA Polymerase Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
                ],
                "unii": [
                    "359HUE8FJC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "ed286bc3-dda6-4f75-9338-3eb0987a2a7d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20180924",
            "product_id": "0378-9720_ed286bc3-dda6-4f75-9338-3eb0987a2a7d",
            "application_number": "NDA020629",
            "brand_name_base": "Denavir",
            "pharm_class": [
                "DNA Polymerase Inhibitors [MoA]",
                "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
                "Nucleoside Analog [EXT]"
            ]
        },
        {
            "product_ndc": "0074-7326",
            "generic_name": "Divalproex Sodium",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Depakote",
            "active_ingredients": [
                {
                    "name": "DIVALPROEX SODIUM",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-7326-13",
                    "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-7326-13)",
                    "marketing_start_date": "20230630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "1099625",
                    "1099626",
                    "1099678",
                    "1099679",
                    "1099870",
                    "1099871"
                ],
                "spl_set_id": [
                    "08a65cf4-7749-4ceb-6895-8f4805e2b01f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300747326136",
                    "0300747327133",
                    "0300747325139"
                ],
                "unii": [
                    "644VL95AO6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, DELAYED RELEASE",
            "spl_id": "8bd3bca2-461a-4de9-a597-7e7f3a9cf96f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230630",
            "product_id": "0074-7326_8bd3bca2-461a-4de9-a597-7e7f3a9cf96f",
            "application_number": "NDA018723",
            "brand_name_base": "Depakote",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Mood Stabilizer [EPC]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "79929-005",
            "generic_name": "norethindrone and ethinyl estradiol and ferrous fumarate tablet",
            "labeler_name": "Naari Pte Limited",
            "brand_name": "Norethindrone and ethinyl estradiol and ferrous fumarate",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "79929-005-07",
                    "description": "3 BLISTER PACK in 1 CARTON (79929-005-07)  / 1 KIT in 1 BLISTER PACK",
                    "marketing_start_date": "20221231",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Naari Pte Limited"
                ],
                "rxcui": [
                    "433718",
                    "1095223",
                    "1095224"
                ],
                "spl_set_id": [
                    "1f7a19f1-fd30-4bd2-aab6-926d911d2579"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "KIT",
            "spl_id": "16aa10e9-750c-b39a-e063-6294a90ab603",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20221231",
            "product_id": "79929-005_16aa10e9-750c-b39a-e063-6294a90ab603",
            "application_number": "ANDA207066",
            "brand_name_base": "Norethindrone and ethinyl estradiol and ferrous fumarate"
        },
        {
            "product_ndc": "61958-2002",
            "generic_name": "emtricitabine and tenofovir alafenamide",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "DESCOVY",
            "active_ingredients": [
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-2002-1",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2002-1)",
                    "marketing_start_date": "20160404",
                    "sample": false
                },
                {
                    "package_ndc": "61958-2002-2",
                    "description": "30 TABLET in 1 BLISTER PACK (61958-2002-2)",
                    "marketing_start_date": "20200122",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1747691",
                    "1747697",
                    "2590641",
                    "2590643"
                ],
                "spl_set_id": [
                    "06f66e98-e6ee-4538-9506-6c1282cc14c1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "G70B4ETF4S",
                    "FWF6Q91TZO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "571559a0-e4c8-450f-9d29-0a1943330c6e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160404",
            "product_id": "61958-2002_571559a0-e4c8-450f-9d29-0a1943330c6e",
            "application_number": "NDA208215",
            "brand_name_base": "DESCOVY",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "0009-5190",
            "marketing_end_date": "20241231",
            "generic_name": "tolterodine tartrate",
            "labeler_name": "Pharmacia and Upjohn Company LLC",
            "brand_name": "Detrol LA",
            "active_ingredients": [
                {
                    "name": "TOLTERODINE TARTRATE",
                    "strength": "2 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-5190-01",
                    "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-01)",
                    "marketing_start_date": "20000222",
                    "marketing_end_date": "20241231",
                    "sample": false
                },
                {
                    "package_ndc": "0009-5190-02",
                    "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-02)",
                    "marketing_start_date": "20000222",
                    "marketing_end_date": "20241231",
                    "sample": false
                },
                {
                    "package_ndc": "0009-5190-03",
                    "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-03)",
                    "marketing_start_date": "20000222",
                    "marketing_end_date": "20240831",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Pharmacia and Upjohn Company LLC"
                ],
                "rxcui": [
                    "855182",
                    "855184",
                    "855189",
                    "855191"
                ],
                "spl_set_id": [
                    "c98eb213-9c80-4698-9710-a9855059b8bb"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5T619TQR3R"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, EXTENDED RELEASE",
            "spl_id": "ca150420-9d83-429a-adbd-015687bbeb9b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20000222",
            "product_id": "0009-5190_ca150420-9d83-429a-adbd-015687bbeb9b",
            "application_number": "NDA021228",
            "brand_name_base": "Detrol LA",
            "pharm_class": [
                "Cholinergic Muscarinic Antagonist [EPC]",
                "Cholinergic Muscarinic Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "49967-994",
            "generic_name": "Avobenzone, Homosalate, Octisalate and Octocrylene",
            "labeler_name": "L'Oreal USA Products Inc",
            "brand_name": "La Roche Posay Laboratoire Dermatologique Anthelios 60 Breakout Free Oil Free Face Dry Touch Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "30 mg/mL"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "150 mg/mL"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "50 mg/mL"
                },
                {
                    "name": "OCTOCRYLENE",
                    "strength": "70 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49967-994-01",
                    "description": "1 BOTTLE in 1 CARTON (49967-994-01)  / 50 mL in 1 BOTTLE",
                    "marketing_start_date": "20160101",
                    "sample": false
                },
                {
                    "package_ndc": "49967-994-02",
                    "description": "3 mL in 1 PACKET (49967-994-02)",
                    "marketing_start_date": "20160101",
                    "sample": false
                },
                {
                    "package_ndc": "49967-994-03",
                    "description": "1 TUBE in 1 CARTON (49967-994-03)  / 50 mL in 1 TUBE",
                    "marketing_start_date": "20160101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "L'Oreal USA Products Inc"
                ],
                "spl_set_id": [
                    "06f2ced8-273e-454f-92b4-2846f6674b37"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4X49Y0596W",
                    "5A68WGF6WM"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "LOTION",
            "spl_id": "5d281644-19de-4e1f-9086-0ffe8ed80d07",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20150101",
            "product_id": "49967-994_5d281644-19de-4e1f-9086-0ffe8ed80d07",
            "application_number": "M020",
            "brand_name_base": "La Roche Posay Laboratoire Dermatologique Anthelios 60 Breakout Free Oil Free Face Dry Touch Broad Spectrum SPF 60 Sunscreen Water Resistant 80 Minutes"
        },
        {
            "product_ndc": "63479-1816",
            "generic_name": "ADENOSINE TRIPHOSPHATE, CALCAREA IODATA, CUPRUM METALLICUM, IGNATIA AMARA, PLATINUM METALLICUM, SILICEA, THUJA OCCIDENTALIS",
            "labeler_name": "Apex Energetics Inc.",
            "brand_name": "R16 BRONCHI",
            "brand_name_suffix": "BRONCHI",
            "active_ingredients": [
                {
                    "name": "ADENOSINE TRIPHOSPHATE",
                    "strength": "5 [hp_X]/mL"
                },
                {
                    "name": "CALCIUM IODIDE",
                    "strength": "2 [hp_Q]/mL"
                },
                {
                    "name": "COPPER",
                    "strength": "2 [hp_Q]/mL"
                },
                {
                    "name": "PLATINUM",
                    "strength": "2 [hp_Q]/mL"
                },
                {
                    "name": "SILICON DIOXIDE",
                    "strength": "1 [hp_Q]/mL"
                },
                {
                    "name": "STRYCHNOS IGNATII SEED",
                    "strength": "2 [hp_Q]/mL"
                },
                {
                    "name": "THUJA OCCIDENTALIS LEAFY TWIG",
                    "strength": "1 [hp_Q]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63479-1816-1",
                    "description": "30 mL in 1 BOTTLE, GLASS (63479-1816-1)",
                    "marketing_start_date": "19941201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Apex Energetics Inc."
                ],
                "spl_set_id": [
                    "c0f759b1-d7f8-12b3-e053-2a95a90a8768"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0005152",
                    "N0000175831",
                    "N0000008595",
                    "N0000008924",
                    "N0000175830"
                ],
                "pharm_class_cs": [
                    "Copper [CS]"
                ],
                "pharm_class_epc": [
                    "Copper-containing Intrauterine Device [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Embryonic Implantation [PE]",
                    "Decreased Sperm Motility [PE]",
                    "Inhibit Ovum Fertilization [PE]"
                ],
                "unii": [
                    "8L70Q75FXE",
                    "8EKI9QEE2H",
                    "789U1901C5",
                    "49DFR088MY",
                    "ETJ7Z6XBU4",
                    "1NM3M2487K",
                    "1NT28V9397"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "SOLUTION/ DROPS",
            "spl_id": "0e7729de-1050-e578-e063-6394a90a7de6",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "SUBLINGUAL"
            ],
            "marketing_start_date": "19941201",
            "product_id": "63479-1816_0e7729de-1050-e578-e063-6394a90a7de6",
            "brand_name_base": "R16",
            "pharm_class": [
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Cations",
                "Divalent [CS]",
                "Copper [CS]",
                "Copper-containing Intrauterine Device [EPC]",
                "Decreased Embryonic Implantation [PE]",
                "Decreased Sperm Motility [PE]",
                "Increased Coagulation Factor Activity [PE]",
                "Inhibit Ovum Fertilization [PE]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]"
            ]
        },
        {
            "product_ndc": "64764-171",
            "generic_name": "dexlansoprazole",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Dexilant",
            "active_ingredients": [
                {
                    "name": "DEXLANSOPRAZOLE",
                    "strength": "30 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-171-00",
                    "description": "7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-00)",
                    "marketing_start_date": "20100412",
                    "sample": false
                },
                {
                    "package_ndc": "64764-171-01",
                    "description": "5 BLISTER PACK in 1 TRAY (64764-171-01)  / 4 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK",
                    "marketing_start_date": "20100412",
                    "sample": false
                },
                {
                    "package_ndc": "64764-171-03",
                    "description": "1 BOTTLE in 1 CARTON (64764-171-03)  / 5 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100412",
                    "sample": false
                },
                {
                    "package_ndc": "64764-171-11",
                    "description": "10 BLISTER PACK in 1 CARTON (64764-171-11)  / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK",
                    "marketing_start_date": "20100412",
                    "sample": false
                },
                {
                    "package_ndc": "64764-171-19",
                    "description": "1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-19)",
                    "marketing_start_date": "20100412",
                    "sample": false
                },
                {
                    "package_ndc": "64764-171-30",
                    "description": "30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-30)",
                    "marketing_start_date": "20100412",
                    "sample": false
                },
                {
                    "package_ndc": "64764-171-90",
                    "description": "90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-90)",
                    "marketing_start_date": "20100412",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "833204",
                    "833213",
                    "902624",
                    "902626"
                ],
                "spl_set_id": [
                    "9819f033-3bbe-442e-8e92-45fec77b237d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364764175306",
                    "0364764171308"
                ],
                "nui": [
                    "N0000175525",
                    "N0000000147"
                ],
                "pharm_class_epc": [
                    "Proton Pump Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Proton Pump Inhibitors [MoA]"
                ],
                "unii": [
                    "UYE4T5I70X"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "c34971cf-0a79-428a-a456-20c48ee627e8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100412",
            "product_id": "64764-171_c34971cf-0a79-428a-a456-20c48ee627e8",
            "application_number": "NDA022287",
            "brand_name_base": "Dexilant",
            "pharm_class": [
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70382-204",
            "generic_name": "dexamethasone",
            "labeler_name": "Ocular Therapeutix, Inc.",
            "brand_name": "DEXTENZA",
            "active_ingredients": [
                {
                    "name": "DEXAMETHASONE",
                    "strength": ".4 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70382-204-01",
                    "description": "1 POUCH in 1 BOX, UNIT-DOSE (70382-204-01)  / 1 INSERT in 1 POUCH (70382-204-88)",
                    "marketing_start_date": "20190107",
                    "sample": false
                },
                {
                    "package_ndc": "70382-204-10",
                    "description": "10 POUCH in 1 BOX, UNIT-DOSE (70382-204-10)  / 1 INSERT in 1 POUCH (70382-204-88)",
                    "marketing_start_date": "20190107",
                    "sample": false
                },
                {
                    "package_ndc": "70382-204-99",
                    "description": "1 POUCH in 1 BOX, UNIT-DOSE (70382-204-99)  / 1 INSERT in 1 POUCH (70382-204-88)",
                    "marketing_start_date": "20190107",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Ocular Therapeutix, Inc."
                ],
                "rxcui": [
                    "2108015",
                    "2108020"
                ],
                "spl_set_id": [
                    "7514e6b8-c33f-4fbf-8810-ef520e1eb4bd"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370382204885",
                    "0370382204014",
                    "0370382204106",
                    "0370382204991"
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "7S5I7G3JQL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INSERT",
            "spl_id": "dc8152c2-9452-4ae6-85d8-e47723b32c5a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRACANALICULAR",
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20190107",
            "product_id": "70382-204_dc8152c2-9452-4ae6-85d8-e47723b32c5a",
            "application_number": "NDA208742",
            "brand_name_base": "DEXTENZA",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "0037-6860",
            "generic_name": "olsalazine sodium",
            "labeler_name": "Meda Pharmaceuticals Inc.",
            "brand_name": "Dipentum",
            "active_ingredients": [
                {
                    "name": "OLSALAZINE SODIUM",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0037-6860-10",
                    "description": "100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0037-6860-10)",
                    "marketing_start_date": "20150515",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "905162",
                    "905164"
                ],
                "spl_set_id": [
                    "8512d0c6-db4e-4673-b3b4-28975c18413f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300376860100"
                ],
                "unii": [
                    "Y7JEW0XG7I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "f463a4ea-ba23-47da-af7f-92c2d7367a82",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150515",
            "product_id": "0037-6860_f463a4ea-ba23-47da-af7f-92c2d7367a82",
            "application_number": "NDA019715",
            "brand_name_base": "Dipentum",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "69794-050",
            "generic_name": "Triheptanoin",
            "labeler_name": "Ultragenyx Pharmaceutical Inc.",
            "brand_name": "DOJOLVI",
            "active_ingredients": [
                {
                    "name": "TRIHEPTANOIN",
                    "strength": ".96 g/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69794-050-50",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (69794-050-50)  / 500 mL in 1 BOTTLE, GLASS",
                    "marketing_start_date": "20200701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Ultragenyx Pharmaceutical Inc."
                ],
                "rxcui": [
                    "2383555",
                    "2383561"
                ],
                "spl_set_id": [
                    "4cfeb8bd-143e-4dd7-bc34-b0bcda02460d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194023",
                    "M0021969"
                ],
                "pharm_class_epc": [
                    "Medium-chain Triglyceride [EPC]"
                ],
                "pharm_class_cs": [
                    "Triglycerides [CS]"
                ],
                "unii": [
                    "2P6O7CFW5K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "LIQUID",
            "spl_id": "1ebc609a-c9b5-4c9a-b434-26c25afc608b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200701",
            "product_id": "69794-050_1ebc609a-c9b5-4c9a-b434-26c25afc608b",
            "application_number": "NDA213687",
            "brand_name_base": "DOJOLVI",
            "pharm_class": [
                "Medium-chain Triglyceride [EPC]",
                "Triglycerides [CS]"
            ]
        },
        {
            "product_ndc": "71369-020",
            "generic_name": "avatrombopag maleate",
            "labeler_name": "AkaRx, Inc.",
            "brand_name": "DOPTELET",
            "active_ingredients": [
                {
                    "name": "AVATROMBOPAG MALEATE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71369-020-10",
                    "description": "1 BLISTER PACK in 1 CARTON (71369-020-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (71369-020-11)",
                    "marketing_start_date": "20180523",
                    "sample": false
                },
                {
                    "package_ndc": "71369-020-15",
                    "description": "1 BLISTER PACK in 1 CARTON (71369-020-15)  / 15 TABLET, FILM COATED in 1 BLISTER PACK (71369-020-16)",
                    "marketing_start_date": "20180523",
                    "sample": false
                },
                {
                    "package_ndc": "71369-020-30",
                    "description": "2 BLISTER PACK in 1 CARTON (71369-020-30)  / 15 TABLET, FILM COATED in 1 BLISTER PACK (71369-020-16)",
                    "marketing_start_date": "20190626",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AkaRx, Inc."
                ],
                "rxcui": [
                    "2045951",
                    "2045952",
                    "2045958",
                    "2045959",
                    "2045960",
                    "2045961"
                ],
                "spl_set_id": [
                    "e2d5960d-6c18-46cc-86bd-089222b09852"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "GDW7M2P1IS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "a5da2f23-d04a-44aa-970c-865d000a49d9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180523",
            "product_id": "71369-020_a5da2f23-d04a-44aa-970c-865d000a49d9",
            "application_number": "NDA210238",
            "brand_name_base": "DOPTELET"
        },
        {
            "product_ndc": "49702-246",
            "generic_name": "dolutegravir sodium and lamivudine",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "Dovato",
            "active_ingredients": [
                {
                    "name": "DOLUTEGRAVIR SODIUM",
                    "strength": "50 mg/1"
                },
                {
                    "name": "LAMIVUDINE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-246-13",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-246-13)",
                    "marketing_start_date": "20190408",
                    "sample": false
                },
                {
                    "package_ndc": "49702-246-33",
                    "description": "1 BLISTER PACK in 1 CARTON (49702-246-33)  / 30 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20240101",
                    "sample": false
                },
                {
                    "package_ndc": "49702-246-61",
                    "description": "14 TABLET, FILM COATED in 1 BOTTLE (49702-246-61)",
                    "marketing_start_date": "20190806",
                    "sample": false
                },
                {
                    "package_ndc": "49702-246-62",
                    "description": "1 BLISTER PACK in 1 CARTON (49702-246-62)  / 14 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20240101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "2122519",
                    "2122526"
                ],
                "spl_set_id": [
                    "68e45422-43ed-4cfb-9356-fae88d14a53a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175656",
                    "N0000175462",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "1Q1V9V5WYQ",
                    "2T8Q726O95"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "05453e9c-1af7-494f-a888-17f3a9e53c61",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190408",
            "product_id": "49702-246_05453e9c-1af7-494f-a888-17f3a9e53c61",
            "application_number": "NDA211994",
            "brand_name_base": "Dovato",
            "pharm_class": [
                "HIV Integrase Inhibitors [MoA]",
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Organic Cation Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0187-0653",
            "generic_name": "halobetasol propionate and tazarotene",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Duobrii",
            "active_ingredients": [
                {
                    "name": "HALOBETASOL PROPIONATE",
                    "strength": ".1 mg/g"
                },
                {
                    "name": "TAZAROTENE",
                    "strength": ".45 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-0653-01",
                    "description": "1 TUBE in 1 CARTON (0187-0653-01)  / 100 g in 1 TUBE",
                    "marketing_start_date": "20190425",
                    "sample": false
                },
                {
                    "package_ndc": "0187-0653-03",
                    "description": "6 TUBE in 1 CARTON (0187-0653-03)  / 3 g in 1 TUBE",
                    "marketing_start_date": "20190425",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "2166089",
                    "2166094"
                ],
                "spl_set_id": [
                    "b3f0cdc0-69fd-43d1-baf2-d776a3a20715"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175607",
                    "M0018962"
                ],
                "pharm_class_epc": [
                    "Retinoid [EPC]"
                ],
                "pharm_class_cs": [
                    "Retinoids [CS]"
                ],
                "unii": [
                    "91A0K1TY3Z",
                    "81BDR9Y8PS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "LOTION",
            "spl_id": "dbee276a-6a2e-4565-a106-09a5bcca8778",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190425",
            "product_id": "0187-0653_dbee276a-6a2e-4565-a106-09a5bcca8778",
            "application_number": "NDA209354",
            "brand_name_base": "Duobrii",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "Retinoid [EPC]",
                "Retinoids [CS]"
            ]
        },
        {
            "product_ndc": "0074-3012",
            "generic_name": "Carbidopa and Levodopa",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Duopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "4.63 mg/mL"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-3012-07",
                    "description": "7 CARTRIDGE in 1 CARTON (0074-3012-07)  / 100 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20150115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "1599846",
                    "1599852"
                ],
                "spl_set_id": [
                    "7066d371-dc6a-0d6f-7bed-e5dd4ee912da"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300743012071"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "6e98ea6e-244d-4901-9189-a04dd334d872",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ENTERAL"
            ],
            "marketing_start_date": "20150115",
            "product_id": "0074-3012_6e98ea6e-244d-4901-9189-a04dd334d872",
            "application_number": "NDA203952",
            "brand_name_base": "Duopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0024-5918",
            "generic_name": "Dupilumab",
            "labeler_name": "sanofi-aventis U.S. LLC",
            "brand_name": "Dupixent",
            "active_ingredients": [
                {
                    "name": "DUPILUMAB",
                    "strength": "200 mg/1.14mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5918-01",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (0024-5918-01)  / 1.14 mL in 1 SYRINGE, GLASS (0024-5918-00)",
                    "marketing_start_date": "20181019",
                    "sample": false
                },
                {
                    "package_ndc": "0024-5918-02",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (0024-5918-02)  / 1.14 mL in 1 SYRINGE, GLASS (0024-5918-20)",
                    "marketing_start_date": "20181019",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "sanofi-aventis U.S. LLC"
                ],
                "rxcui": [
                    "1876401",
                    "1876406",
                    "2099300",
                    "2099302",
                    "2375327",
                    "2375329",
                    "2559706",
                    "2559707",
                    "2583634",
                    "2583635"
                ],
                "spl_set_id": [
                    "595f437d-2729-40bb-9c62-c8ece1f82780"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193342",
                    "N0000193341",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Interleukin-4 Receptor alpha Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin 4 Receptor alpha Antagonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "420K487FSG"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "71a2cc73-c697-45fb-8e49-667d4c7b2f76",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20181019",
            "product_id": "0024-5918_71a2cc73-c697-45fb-8e49-667d4c7b2f76",
            "application_number": "BLA761055",
            "brand_name_base": "Dupixent",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Interleukin 4 Receptor alpha Antagonists [MoA]",
                "Interleukin-4 Receptor alpha Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0023-9652",
            "generic_name": "bimatoprost",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "DURYSTA",
            "active_ingredients": [
                {
                    "name": "BIMATOPROST",
                    "strength": "10 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-9652-01",
                    "description": "1 IMPLANT in 1 POUCH (0023-9652-01)",
                    "marketing_start_date": "20200304",
                    "sample": false
                },
                {
                    "package_ndc": "0023-9652-03",
                    "description": "1 IMPLANT in 1 POUCH (0023-9652-03)",
                    "marketing_start_date": "20200304",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "2286602",
                    "2286607"
                ],
                "spl_set_id": [
                    "3f59da84-0bcc-4c84-b3e2-e215681ef341"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175454",
                    "M0017805"
                ],
                "pharm_class_epc": [
                    "Prostaglandin Analog [EPC]"
                ],
                "pharm_class_cs": [
                    "Prostaglandins [CS]"
                ],
                "unii": [
                    "QXS94885MZ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "IMPLANT",
            "spl_id": "2c17d8fb-6fe2-4336-b7ae-83949eb82499",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRACAMERAL"
            ],
            "marketing_start_date": "20200304",
            "product_id": "0023-9652_2c17d8fb-6fe2-4336-b7ae-83949eb82499",
            "application_number": "NDA211911",
            "brand_name_base": "DURYSTA",
            "pharm_class": [
                "Prostaglandin Analog [EPC]",
                "Prostaglandins [CS]"
            ]
        },
        {
            "product_ndc": "11673-943",
            "generic_name": "Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone",
            "labeler_name": "TARGET CORPORATION",
            "brand_name": "Target Up and Up Sport SPF 50",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "30 mg/g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "100 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "50 mg/g"
                },
                {
                    "name": "OCTOCRYLENE",
                    "strength": "40 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "50 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11673-943-32",
                    "description": "473 CAN in 1 PACKAGE (11673-943-32)  / 236.5 g in 1 CAN (11673-943-88)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-38",
                    "description": "312 g in 1 CAN (11673-943-38)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-48",
                    "description": "258 g in 1 CAN (11673-943-48)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-62",
                    "description": "468 CAN in 1 PACKAGE (11673-943-62)  / 156 g in 1 CAN (11673-943-37)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-63",
                    "description": "312 CAN in 1 PACKAGE (11673-943-63)  / 156 g in 1 CAN (11673-943-37)",
                    "marketing_start_date": "20140110",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TARGET CORPORATION"
                ],
                "spl_set_id": [
                    "b8434856-77ae-7c65-e053-2a95a90a8f76"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4X49Y0596W",
                    "5A68WGF6WM",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "SPRAY",
            "spl_id": "bc315679-c011-b41c-e053-2a95a90ad144",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20140110",
            "product_id": "11673-943_bc315679-c011-b41c-e053-2a95a90ad144",
            "application_number": "part352",
            "brand_name_base": "Target Up and Up Sport SPF 50"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "59676-280",
            "generic_name": "rilpivirine hydrochloride",
            "labeler_name": "Janssen Products, LP",
            "brand_name": "EDURANT PED",
            "active_ingredients": [
                {
                    "name": "RILPIVIRINE HYDROCHLORIDE",
                    "strength": "2.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59676-280-90",
                    "description": "9 BLISTER PACK in 1 CARTON (59676-280-90)  / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (59676-280-01)",
                    "marketing_start_date": "20240315",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Products, LP"
                ],
                "rxcui": [
                    "1102273",
                    "1102277",
                    "2678244",
                    "2678248"
                ],
                "spl_set_id": [
                    "03880372-2c68-45c6-a53a-f420c49541d6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0359676278016"
                ],
                "unii": [
                    "212WAX8KDD"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FOR SUSPENSION",
            "spl_id": "1779f11a-3650-16c0-e063-6294a90abafa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240315",
            "product_id": "59676-280_1779f11a-3650-16c0-e063-6294a90abafa",
            "application_number": "NDA219016",
            "brand_name_base": "EDURANT PED",
            "pharm_class": [
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "0187-3204",
            "generic_name": "Fluorouracil",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Efudex",
            "active_ingredients": [
                {
                    "name": "FLUOROURACIL",
                    "strength": "2 g/40g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-3204-47",
                    "description": "1 TUBE in 1 CARTON (0187-3204-47)  / 40 g in 1 TUBE",
                    "marketing_start_date": "19700729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "105583",
                    "213045",
                    "213268",
                    "213517",
                    "310379",
                    "310380"
                ],
                "spl_set_id": [
                    "35de1c1c-bef5-46c5-b6f8-ea032147411c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000233",
                    "N0000175595"
                ],
                "pharm_class_moa": [
                    "Nucleic Acid Synthesis Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Nucleoside Metabolic Inhibitor [EPC]"
                ],
                "unii": [
                    "U3P01618RT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "b0fa0cc7-4ecb-4966-9b38-0bf4dd1cf352",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "19700729",
            "product_id": "0187-3204_b0fa0cc7-4ecb-4966-9b38-0bf4dd1cf352",
            "application_number": "NDA016831",
            "brand_name_base": "Efudex",
            "pharm_class": [
                "Nucleic Acid Synthesis Inhibitors [MoA]",
                "Nucleoside Metabolic Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "69693-413",
            "generic_name": "MENTHOL",
            "labeler_name": "Clarion Brands, LLC",
            "brand_name": "ABSORBINE JR PLUS ULTRA STRENGTH PAIN",
            "active_ingredients": [
                {
                    "name": "MENTHOL",
                    "strength": "6500 mg/h"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69693-413-01",
                    "description": "1 PATCH in 1 POUCH (69693-413-01)  / 8 h in 1 PATCH",
                    "marketing_start_date": "20150815",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Clarion Brands, LLC"
                ],
                "rxcui": [
                    "1248743",
                    "1439997"
                ],
                "spl_set_id": [
                    "cf329707-d90a-29dd-f2c2-acfd5af614f3"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "L7T10EIP3A"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "PATCH",
            "spl_id": "4a44ff49-ea80-4055-a87c-0c58a09ed450",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20150815",
            "product_id": "69693-413_4a44ff49-ea80-4055-a87c-0c58a09ed450",
            "application_number": "M017",
            "brand_name_base": "ABSORBINE JR PLUS ULTRA STRENGTH PAIN"
        },
        {
            "product_ndc": "0069-0106",
            "generic_name": "Taliglucerase alfa",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "ELELYSO",
            "active_ingredients": [
                {
                    "name": "TALIGLUCERASE ALFA",
                    "strength": "200 U/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0106-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (0069-0106-01)  / 5 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20120501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "1292879",
                    "1292881"
                ],
                "spl_set_id": [
                    "fa3cbd5d-677c-4b19-9032-d9182cb69a83"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175820",
                    "M0009360"
                ],
                "pharm_class_epc": [
                    "Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"
                ],
                "pharm_class_cs": [
                    "Glucosylceramidase [CS]"
                ],
                "unii": [
                    "0R4NLX88O4"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "196cccfb-5bf4-498a-80dd-c138c29e6816",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20120501",
            "product_id": "0069-0106_196cccfb-5bf4-498a-80dd-c138c29e6816",
            "application_number": "BLA022458",
            "brand_name_base": "ELELYSO",
            "pharm_class": [
                "Glucosylceramidase [CS]",
                "Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"
            ]
        },
        {
            "product_ndc": "60923-514",
            "generic_name": "delandistrogene moxeparvovec-rokl",
            "labeler_name": "Sarepta Therapeutics, Inc.",
            "brand_name": "ELEVIDYS",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "60923-514-23",
                    "description": "1 KIT in 1 CARTON (60923-514-23)  *  10 mL in 1 VIAL, SINGLE-USE (60923-562-01)  *  23 POUCH in 1 BOX / 1 SWAB in 1 POUCH",
                    "marketing_start_date": "20230622",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sarepta Therapeutics, Inc."
                ],
                "rxcui": [
                    "797544",
                    "2641679",
                    "2641685",
                    "2641687",
                    "2641688",
                    "2641689",
                    "2641690",
                    "2641691",
                    "2641692",
                    "2641693",
                    "2641694",
                    "2641695",
                    "2641696",
                    "2641697",
                    "2641698",
                    "2641699",
                    "2641700",
                    "2641701",
                    "2641702",
                    "2641703",
                    "2641704",
                    "2641705",
                    "2641706",
                    "2641707",
                    "2641708",
                    "2641709",
                    "2641710",
                    "2641711",
                    "2641712",
                    "2641713",
                    "2641714",
                    "2641715",
                    "2641716",
                    "2641717",
                    "2641718",
                    "2641719",
                    "2641720",
                    "2641721",
                    "2641722",
                    "2641723",
                    "2641724",
                    "2641725",
                    "2641726",
                    "2641727",
                    "2641728",
                    "2641729",
                    "2641730",
                    "2641731",
                    "2641732",
                    "2641733",
                    "2641734",
                    "2641735",
                    "2641736",
                    "2641737",
                    "2641738",
                    "2641739",
                    "2641740",
                    "2641741",
                    "2641742",
                    "2641743",
                    "2641744",
                    "2641745",
                    "2641746",
                    "2641747",
                    "2641748",
                    "2641750",
                    "2641751",
                    "2641752",
                    "2641753",
                    "2641754",
                    "2641755",
                    "2641756",
                    "2641757",
                    "2641758",
                    "2641759",
                    "2641760",
                    "2641761",
                    "2641762",
                    "2641763",
                    "2641764",
                    "2641765",
                    "2641766",
                    "2641767",
                    "2641768",
                    "2641769",
                    "2641770",
                    "2641771",
                    "2641772",
                    "2641773",
                    "2641774",
                    "2641775",
                    "2641776",
                    "2641777",
                    "2641778",
                    "2641779",
                    "2641780",
                    "2641781",
                    "2641782",
                    "2641783",
                    "2641784",
                    "2641785",
                    "2641786",
                    "2641787",
                    "2641788",
                    "2641789",
                    "2641830",
                    "2641831",
                    "2641832",
                    "2641833",
                    "2641834",
                    "2641835",
                    "2641836",
                    "2641837",
                    "2641838",
                    "2641839",
                    "2641840",
                    "2641841",
                    "2641842",
                    "2641843",
                    "2641844",
                    "2641845",
                    "2641846",
                    "2641847",
                    "2641848",
                    "2641849"
                ],
                "spl_set_id": [
                    "3525abcd-fbd2-46c5-9706-cffdf2e8a361"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0360923561706",
                    "0360923539484",
                    "0360923560693",
                    "0360923538470",
                    "0360923546550",
                    "0360923507162",
                    "0360923521304",
                    "0360923533420",
                    "0360923558676",
                    "0360923501108",
                    "0360923511206",
                    "0360923508176",
                    "0360923542514",
                    "0360923544532",
                    "0360923545546",
                    "0360923553626",
                    "0360923549582",
                    "0360923510193",
                    "0360923548578",
                    "0360923514238",
                    "0360923535448",
                    "0360923532416",
                    "0360923529386",
                    "0360923531402",
                    "0360923554630",
                    "0360923519288",
                    "0360923536452",
                    "0360923537466",
                    "0360923512210",
                    "0360923525340",
                    "0360923516256",
                    "0360923541500",
                    "0360923518274",
                    "0360923520291",
                    "0360923515242",
                    "0360923524336",
                    "0360923526354",
                    "0360923504130",
                    "0360923502112",
                    "0360923503126",
                    "0360923528372",
                    "0360923506158",
                    "0360923513224",
                    "0360923509180",
                    "0360923557662",
                    "0360923556658",
                    "0360923534434",
                    "0360923540497",
                    "0360923527368",
                    "0360923550595",
                    "0360923517260",
                    "0360923522318",
                    "0360923559680",
                    "0360923543528",
                    "0360923555644",
                    "0360923505144",
                    "0360923551608",
                    "0360923547564",
                    "0360923530399",
                    "0360923552612",
                    "0360923523322"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "80df21b6-b985-4b52-af98-e4da9506954a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230622",
            "product_id": "60923-514_80df21b6-b985-4b52-af98-e4da9506954a",
            "application_number": "BLA125781",
            "brand_name_base": "ELEVIDYS"
        },
        {
            "product_ndc": "10122-160",
            "generic_name": "pegunigalsidase alfa",
            "labeler_name": "Chiesi USA, Inc.",
            "brand_name": "ELFABRIO",
            "active_ingredients": [
                {
                    "name": "PEGUNIGALSIDASE ALFA",
                    "strength": "20 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10122-160-02",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (10122-160-02)  / 10 mL in 1 VIAL, SINGLE-DOSE (10122-160-01)",
                    "marketing_start_date": "20230523",
                    "sample": false
                },
                {
                    "package_ndc": "10122-160-05",
                    "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (10122-160-05)  / 10 mL in 1 VIAL, SINGLE-DOSE (10122-160-01)",
                    "marketing_start_date": "20230523",
                    "sample": false
                },
                {
                    "package_ndc": "10122-160-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (10122-160-10)  / 10 mL in 1 VIAL, SINGLE-DOSE (10122-160-01)",
                    "marketing_start_date": "20230523",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Chiesi USA, Inc."
                ],
                "rxcui": [
                    "2637456",
                    "2637462",
                    "2676759",
                    "2676760"
                ],
                "spl_set_id": [
                    "6fb674bf-744e-431f-92ef-b2a5a66c8cf3"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8M7V7Q6537"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "6247beeb-79ca-4d77-b3cb-3f5aea8e8b9f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230523",
            "product_id": "10122-160_6247beeb-79ca-4d77-b3cb-3f5aea8e8b9f",
            "application_number": "BLA761161",
            "brand_name_base": "ELFABRIO"
        },
        {
            "product_ndc": "0187-5100",
            "generic_name": "Pimecrolimus",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "ELIDEL",
            "active_ingredients": [
                {
                    "name": "PIMECROLIMUS",
                    "strength": "10 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-5100-01",
                    "description": "1 TUBE in 1 CARTON (0187-5100-01)  / 30 g in 1 TUBE",
                    "marketing_start_date": "20011202",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "352085",
                    "562806"
                ],
                "spl_set_id": [
                    "e4027e5a-0f9b-4070-b196-f60172f45c4c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175457",
                    "N0000175458"
                ],
                "pharm_class_epc": [
                    "Calcineurin Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Calcineurin Inhibitors [MoA]"
                ],
                "unii": [
                    "7KYV510875"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "2f802a3f-c021-45c1-8693-5689c30c3fc6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20011202",
            "product_id": "0187-5100_2f802a3f-c021-45c1-8693-5689c30c3fc6",
            "application_number": "NDA021302",
            "brand_name_base": "ELIDEL",
            "pharm_class": [
                "Calcineurin Inhibitor Immunosuppressant [EPC]",
                "Calcineurin Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "62935-227",
            "generic_name": "Leuprolide acetate",
            "labeler_name": "TOLMAR Inc.",
            "brand_name": "Eligard",
            "active_ingredients": [
                {
                    "name": "LEUPROLIDE ACETATE",
                    "strength": "22.5 mg/.375mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "62935-227-10",
                    "description": "1 SYRINGE in 1 CARTON (62935-227-10)  / .375 mL in 1 SYRINGE",
                    "marketing_start_date": "20231127",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "TOLMAR Inc."
                ],
                "rxcui": [
                    "752884",
                    "752889",
                    "752894",
                    "752899",
                    "825325",
                    "825333",
                    "825334",
                    "825335"
                ],
                "spl_set_id": [
                    "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "37JNS02E7V"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE",
            "spl_id": "aaf94d76-aa16-42d6-bbc2-7906ecdf7985",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20231127",
            "product_id": "62935-227_aaf94d76-aa16-42d6-bbc2-7906ecdf7985",
            "application_number": "NDA021379",
            "brand_name_base": "Eligard",
            "pharm_class": [
                "Gonadotropin Releasing Hormone Receptor Agonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "70518-1861",
            "generic_name": "apixaban",
            "labeler_name": "REMEDYREPACK INC.",
            "brand_name": "ELIQUIS",
            "active_ingredients": [
                {
                    "name": "APIXABAN",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70518-1861-0",
                    "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1861-0)",
                    "marketing_start_date": "20190208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "REMEDYREPACK INC."
                ],
                "rxcui": [
                    "1364445",
                    "1364447"
                ],
                "spl_set_id": [
                    "f1be363d-6fc5-4b08-9b96-976933db19e1"
                ],
                "nui": [
                    "N0000175637",
                    "N0000175635"
                ],
                "pharm_class_epc": [
                    "Factor Xa Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Factor Xa Inhibitors [MoA]"
                ],
                "unii": [
                    "3Z9Y7UWC1J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "120ec431-57eb-27e7-e063-6394a90af34a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190208",
            "product_id": "70518-1861_120ec431-57eb-27e7-e063-6394a90af34a",
            "application_number": "NDA202155",
            "brand_name_base": "ELIQUIS",
            "pharm_class": [
                "Factor Xa Inhibitor [EPC]",
                "Factor Xa Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0024-5150",
            "generic_name": "rasburicase",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Elitek",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5150-10",
                    "description": "3 KIT in 1 CARTON (0024-5150-10)  / 1 KIT in 1 KIT *  1 mL in 1 VIAL, SINGLE-USE (0024-5154-11)  *  1 mL in 1 AMPULE (0024-5152-11)",
                    "marketing_start_date": "20020712",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "1790344",
                    "1790347",
                    "1790349",
                    "1790351"
                ],
                "spl_set_id": [
                    "0ae10bc4-6b65-402f-9db5-2d7753054922"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "619ea95d-54eb-4525-a7fa-7bfccc0cc80d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20020712",
            "product_id": "0024-5150_619ea95d-54eb-4525-a7fa-7bfccc0cc80d",
            "application_number": "BLA103946",
            "brand_name_base": "Elitek"
        },
        {
            "product_ndc": "50458-098",
            "generic_name": "PENTOSAN POLYSULFATE SODIUM",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "ELMIRON",
            "active_ingredients": [
                {
                    "name": "PENTOSAN POLYSULFATE SODIUM",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-098-01",
                    "description": "100 CAPSULE, GELATIN COATED in 1 BOTTLE (50458-098-01)",
                    "marketing_start_date": "19960926",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "199498",
                    "211140"
                ],
                "spl_set_id": [
                    "f0ba651e-3d8a-11df-8fbe-119855d89593"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350458098013"
                ],
                "unii": [
                    "914032762Y"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "ed2029cb-3288-c2f0-e053-2a95a90a8023",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19960926",
            "product_id": "50458-098_ed2029cb-3288-c2f0-e053-2a95a90a8023",
            "application_number": "NDA020193",
            "brand_name_base": "ELMIRON",
            "pharm_class": [
                "Glycosaminoglycan [EPC]",
                "Glycosaminoglycans [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0069-2522",
            "generic_name": "elranatamab-bcmm",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Elrexfio",
            "active_ingredients": [
                {
                    "name": "ELRANATAMAB",
                    "strength": "44 mg/1.1mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-2522-02",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02)  / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)",
                    "marketing_start_date": "20230815",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2644885",
                    "2644891",
                    "2644893",
                    "2644894"
                ],
                "spl_set_id": [
                    "f6fea598-ff58-4a20-b5e8-8a51f37d8beb"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "L0HR9A577V"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f6fea598-ff58-4a20-b5e8-8a51f37d8beb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230815",
            "product_id": "0069-2522_f6fea598-ff58-4a20-b5e8-8a51f37d8beb",
            "application_number": "BLA761345",
            "brand_name_base": "Elrexfio"
        },
        {
            "product_ndc": "72187-0401",
            "generic_name": "tagraxofusp",
            "labeler_name": "Stemline Therapeutics, Inc.",
            "brand_name": "Elzonris",
            "active_ingredients": [
                {
                    "name": "TAGRAXOFUSP",
                    "strength": "1000 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72187-0401-1",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72187-0401-1)  / 1 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190118",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Stemline Therapeutics, Inc."
                ],
                "rxcui": [
                    "2109059",
                    "2109064"
                ],
                "spl_set_id": [
                    "80eb1080-fe20-4af0-b2a5-a67999923fa8"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372187040118"
                ],
                "nui": [
                    "N0000193864",
                    "N0000193865",
                    "N0000193862",
                    "M0005633"
                ],
                "pharm_class_epc": [
                    "CD123 Interaction [EPC]",
                    "Cytotoxin [EPC]"
                ],
                "pharm_class_moa": [
                    "CD123 Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Cytotoxins [CS]"
                ],
                "unii": [
                    "8ZHS5657EH"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "fb0fe1fc-42ab-4a79-a73d-7f2999af9786",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190118",
            "product_id": "72187-0401_fb0fe1fc-42ab-4a79-a73d-7f2999af9786",
            "application_number": "BLA761116",
            "brand_name_base": "Elzonris",
            "pharm_class": [
                "CD123 Interaction [EPC]",
                "CD123 Interactions [MoA]",
                "Cytotoxin [EPC]",
                "Cytotoxins [CS]"
            ]
        },
        {
            "product_ndc": "0006-0464",
            "generic_name": "aprepitant",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "EMEND",
            "active_ingredients": [
                {
                    "name": "APREPITANT",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "403810",
                    "403811",
                    "404465",
                    "404466",
                    "644088",
                    "644278",
                    "754508",
                    "754509",
                    "1729308",
                    "1729311"
                ],
                "spl_set_id": [
                    "696f9e80-9cae-403b-de9e-078343ce4713"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000010262",
                    "N0000175786",
                    "N0000182141",
                    "N0000185507",
                    "N0000185506"
                ],
                "pharm_class_moa": [
                    "Neurokinin 1 Antagonists [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]"
                ],
                "pharm_class_epc": [
                    "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "1NF15YR6UY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "40da276a-ade0-4306-a0ad-f812325c4399",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030326",
            "product_id": "0006-0464_40da276a-ade0-4306-a0ad-f812325c4399",
            "application_number": "NDA021549",
            "brand_name_base": "EMEND",
            "pharm_class": [
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Neurokinin 1 Antagonists [MoA]",
                "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "52856-502",
            "generic_name": "deflazacort",
            "labeler_name": "PTC Therapeutics, Inc.",
            "brand_name": "EMFLAZA",
            "active_ingredients": [
                {
                    "name": "DEFLAZACORT",
                    "strength": "18 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52856-502-03",
                    "description": "30 TABLET in 1 BOTTLE (52856-502-03)",
                    "marketing_start_date": "20180910",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "PTC Therapeutics, Inc."
                ],
                "rxcui": [
                    "153098",
                    "153880",
                    "1870950",
                    "1870952",
                    "1870954",
                    "1870956",
                    "1870958",
                    "1870960",
                    "1870964",
                    "1870968"
                ],
                "spl_set_id": [
                    "31b347d2-f156-4055-9d8f-7cf0df420296"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "KR5YZ6AE4B"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "880650ec-dac5-4e10-be94-f4e92e4861f8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180910",
            "product_id": "52856-502_880650ec-dac5-4e10-be94-f4e92e4861f8",
            "application_number": "NDA208684",
            "brand_name_base": "EMFLAZA",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "73606-010",
            "generic_name": "Pegcetacoplan",
            "labeler_name": "Apellis Pharmaceuticals, Inc.",
            "brand_name": "Empaveli",
            "active_ingredients": [
                {
                    "name": "PEGCETACOPLAN",
                    "strength": "1080 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73606-010-01",
                    "description": "1 VIAL in 1 CARTON (73606-010-01)  / 20 mL in 1 VIAL",
                    "marketing_start_date": "20210514",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Apellis Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2557386",
                    "2557391"
                ],
                "spl_set_id": [
                    "c23d89e9-b00b-4520-e053-2995a90a95af"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175575",
                    "N0000175974"
                ],
                "pharm_class_epc": [
                    "Complement Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Complement Inhibitors [MoA]"
                ],
                "unii": [
                    "TO3JYR3BOU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "53b505ad-1b5f-4c47-91cc-d5a717c8c263",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20210514",
            "product_id": "73606-010_53b505ad-1b5f-4c47-91cc-d5a717c8c263",
            "application_number": "NDA215014",
            "brand_name_base": "Empaveli",
            "pharm_class": [
                "Complement Inhibitor [EPC]",
                "Complement Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0003-4522",
            "generic_name": "elotuzumab",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "EMPLICITI",
            "active_ingredients": [
                {
                    "name": "ELOTUZUMAB",
                    "strength": "400 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-4522-11",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-4522-11)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20151130",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "spl_set_id": [
                    "80686b7e-f6f4-4154-b5c0-c846425e2d91"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300032291118"
                ],
                "nui": [
                    "N0000192338",
                    "N0000192337",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "SLAMF7-directed Immunostimulatory Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "SLAMF7-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "1351PE5UGS"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "8441efc2-338a-4d1d-8fa1-9b9863a49ffd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20151130",
            "product_id": "0003-4522_8441efc2-338a-4d1d-8fa1-9b9863a49ffd",
            "application_number": "BLA761035",
            "brand_name_base": "EMPLICITI",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "SLAMF7-directed Antibody Interactions [MoA]",
                "SLAMF7-directed Immunostimulatory Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "49502-900",
            "generic_name": "selegiline",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "EMSAM",
            "active_ingredients": [
                {
                    "name": "SELEGILINE",
                    "strength": "6 mg/24h"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-900-05",
                    "description": "5 POUCH in 1 CARTON (49502-900-05)  / 1 PATCH in 1 POUCH (49502-900-11)  / 24 h in 1 PATCH",
                    "marketing_start_date": "20060227",
                    "sample": true
                },
                {
                    "package_ndc": "49502-900-30",
                    "description": "30 POUCH in 1 CARTON (49502-900-30)  / 1 PATCH in 1 POUCH (49502-900-01)  / 24 h in 1 PATCH",
                    "marketing_start_date": "20060227",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "865206",
                    "865208",
                    "865210",
                    "865212",
                    "865214",
                    "865216"
                ],
                "spl_set_id": [
                    "b891bd9f-fdb8-4862-89c5-ecdd700398a3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175744",
                    "N0000000184",
                    "N0000175762",
                    "N0000175761"
                ],
                "pharm_class_epc": [
                    "Monoamine Oxidase Inhibitor [EPC]",
                    "Monoamine Oxidase Type B Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Monoamine Oxidase Inhibitors [MoA]",
                    "Monoamine Oxidase-B Inhibitors [MoA]"
                ],
                "unii": [
                    "2K1V7GP655"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "PATCH",
            "spl_id": "cd3db8f7-5826-4db3-8db0-4bfca69288fe",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TRANSDERMAL"
            ],
            "marketing_start_date": "20060227",
            "product_id": "49502-900_cd3db8f7-5826-4db3-8db0-4bfca69288fe",
            "application_number": "NDA021336",
            "brand_name_base": "EMSAM",
            "pharm_class": [
                "Monoamine Oxidase Inhibitor [EPC]",
                "Monoamine Oxidase Inhibitors [MoA]",
                "Monoamine Oxidase Type B Inhibitor [EPC]",
                "Monoamine Oxidase-B Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "61958-0601",
            "generic_name": "EMTRICITABINE",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Emtriva",
            "active_ingredients": [
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-0601-1",
                    "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (61958-0601-1)",
                    "marketing_start_date": "20030702",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "403875",
                    "404587",
                    "597291",
                    "616148"
                ],
                "spl_set_id": [
                    "d6599395-3944-44f9-97f2-e0424c6b6a1f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "G70B4ETF4S"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "d392554c-dace-47f9-8b2f-1e2b29c98ea4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030702",
            "product_id": "61958-0601_d392554c-dace-47f9-8b2f-1e2b29c98ea4",
            "application_number": "NDA021500",
            "brand_name_base": "Emtriva",
            "pharm_class": [
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "64896-669",
            "generic_name": "mebendazole",
            "labeler_name": "Amneal Pharmaceuticals LLC",
            "brand_name": "Emverm",
            "active_ingredients": [
                {
                    "name": "MEBENDAZOLE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64896-669-30",
                    "description": "1 BLISTER PACK in 1 CARTON (64896-669-30)  / 1 TABLET, CHEWABLE in 1 BLISTER PACK",
                    "marketing_start_date": "20160215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amneal Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "105347",
                    "1737789"
                ],
                "spl_set_id": [
                    "a8c46363-f739-4f6e-bca8-1ce5e8d3f78d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175481"
                ],
                "pharm_class_epc": [
                    "Anthelmintic [EPC]"
                ],
                "unii": [
                    "81G6I5V05I"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, CHEWABLE",
            "spl_id": "7f1e08e7-417f-4466-892b-ee637ac6bc0d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160215",
            "product_id": "64896-669_7f1e08e7-417f-4466-892b-ee637ac6bc0d",
            "application_number": "ANDA073580",
            "brand_name_base": "Emverm",
            "pharm_class": [
                "Anthelmintic [EPC]"
            ]
        },
        {
            "product_ndc": "58406-010",
            "generic_name": "etanercept",
            "labeler_name": "Immunex Corporation",
            "brand_name": "ENBREL",
            "active_ingredients": [
                {
                    "name": "ETANERCEPT",
                    "strength": "25 mg/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58406-010-04",
                    "description": "4 SYRINGE in 1 CARTON (58406-010-04)  / .5 mL in 1 SYRINGE (58406-010-01)",
                    "marketing_start_date": "20190607",
                    "sample": false
                },
                {
                    "package_ndc": "58406-010-96",
                    "description": "1 SYRINGE in 1 CARTON (58406-010-96)  / .5 mL in 1 SYRINGE",
                    "marketing_start_date": "20190607",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Immunex Corporation"
                ],
                "rxcui": [
                    "253014",
                    "261105",
                    "727757",
                    "802652",
                    "809158",
                    "809159",
                    "1653223",
                    "1653225",
                    "2182338",
                    "2182340",
                    "2392140",
                    "2392142"
                ],
                "spl_set_id": [
                    "a002b40c-097d-47a5-957f-7a7b1807af7f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0358406055040",
                    "0358406021045",
                    "0358406032041",
                    "0358406044044",
                    "0358406010049"
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "unii": [
                    "OP401G7OJC"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "29187b7c-d166-45e4-bc8c-4cbf71a67702",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190607",
            "product_id": "58406-010_29187b7c-d166-45e4-bc8c-4cbf71a67702",
            "application_number": "BLA103795",
            "brand_name_base": "ENBREL",
            "pharm_class": [
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "16571-754",
            "generic_name": "Neomycin and Polymyxin B Sulfates and Bacitracin Zinc",
            "labeler_name": "Rising Pharma Holdings, Inc.",
            "brand_name": "Neomycin and Polymyxin B Sulfates and Bacitracin Zinc",
            "active_ingredients": [
                {
                    "name": "BACITRACIN ZINC",
                    "strength": "400 [USP'U]/g"
                },
                {
                    "name": "NEOMYCIN SULFATE",
                    "strength": "3.5 mg/g"
                },
                {
                    "name": "POLYMYXIN B SULFATE",
                    "strength": "10000 [USP'U]/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "16571-754-53",
                    "description": "1 TUBE in 1 CARTON (16571-754-53)  / 3.5 g in 1 TUBE",
                    "marketing_start_date": "20211101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Rising Pharma Holdings, Inc."
                ],
                "rxcui": [
                    "308493"
                ],
                "spl_set_id": [
                    "48173c90-79ed-459d-b259-947bc7952c13"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0316571754533"
                ],
                "unii": [
                    "89Y4M234ES",
                    "057Y626693",
                    "19371312D4"
                ]
            },
            "marketing_category": "NDA AUTHORIZED GENERIC",
            "dosage_form": "OINTMENT",
            "spl_id": "48173c90-79ed-459d-b259-947bc7952c13",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20170407",
            "product_id": "16571-754_48173c90-79ed-459d-b259-947bc7952c13",
            "application_number": "NDA050417",
            "brand_name_base": "Neomycin and Polymyxin B Sulfates and Bacitracin Zinc",
            "pharm_class": [
                "Aminoglycoside Antibacterial [EPC]",
                "Aminoglycosides [CS]",
                "Decreased Cell Wall Synthesis & Repair [PE]",
                "Polymyxin-class Antibacterial [EPC]",
                "Polymyxins [CS]"
            ]
        },
        {
            "product_ndc": "65597-406",
            "generic_name": "fam-trastuzumab deruxtecan-nxki",
            "labeler_name": "Daiichi Sankyo Inc.",
            "brand_name": "Enhertu",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB DERUXTECAN",
                    "strength": "100 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65597-406-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (65597-406-01)  / 5 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20191220",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Daiichi Sankyo Inc."
                ],
                "rxcui": [
                    "2267576",
                    "2267581"
                ],
                "spl_set_id": [
                    "7e67e73e-ddf4-4e4d-8b50-09d7514910b6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5384HK7574"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "61f5f65e-01ef-4363-84ed-3a9722a6052f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20191220",
            "product_id": "65597-406_61f5f65e-01ef-4363-84ed-3a9722a6052f",
            "application_number": "BLA761139",
            "brand_name_base": "Enhertu"
        },
        {
            "product_ndc": "80203-347",
            "generic_name": "sutimlimab-jome",
            "labeler_name": "Bioverativ Therapeutics Inc.",
            "brand_name": "Enjaymo",
            "active_ingredients": [
                {
                    "name": "SUTIMLIMAB",
                    "strength": "50 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "80203-347-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (80203-347-01)  / 22 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20220204",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bioverativ Therapeutics Inc."
                ],
                "rxcui": [
                    "2591419",
                    "2591425"
                ],
                "spl_set_id": [
                    "281cf1d4-6296-4416-858e-9bff46d01b71"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193991",
                    "N0000193990"
                ],
                "pharm_class_epc": [
                    "Classical Complement Pathway Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Classical Complement Pathway Inhibitors [MoA]"
                ],
                "unii": [
                    "GNWE7KJ995"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "486710f9-4172-4fe4-b05f-64413cc8fbfc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220204",
            "product_id": "80203-347_486710f9-4172-4fe4-b05f-64413cc8fbfc",
            "application_number": "BLA761164",
            "brand_name_base": "Enjaymo",
            "pharm_class": [
                "Classical Complement Pathway Inhibitor [EPC]",
                "Classical Complement Pathway Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "11822-0485",
            "generic_name": "Diphenhydramine HCl and Phenylephrine HCl",
            "labeler_name": "Rite Aid Corporation",
            "brand_name": "Allergy Plus Sinus Relief",
            "active_ingredients": [
                {
                    "name": "DIPHENHYDRAMINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                },
                {
                    "name": "PHENYLEPHRINE HYDROCHLORIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11822-0485-8",
                    "description": "2 BLISTER PACK in 1 CARTON (11822-0485-8)  / 12 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20050810",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Rite Aid Corporation"
                ],
                "rxcui": [
                    "1052928"
                ],
                "spl_set_id": [
                    "54623e2e-5f9a-426e-8f7e-ea755ff8b3f8"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0011822660990"
                ],
                "unii": [
                    "TC2D6JAD40",
                    "04JA59TNSJ"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "3119c5d1-e2c7-446b-ab7f-7c5add99dd76",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20050810",
            "product_id": "11822-0485_3119c5d1-e2c7-446b-ab7f-7c5add99dd76",
            "application_number": "M012",
            "brand_name_base": "Allergy Plus Sinus Relief",
            "pharm_class": [
                "Adrenergic alpha1-Agonists [MoA]",
                "Histamine H1 Receptor Antagonists [MoA]",
                "Histamine-1 Receptor Antagonist [EPC]",
                "alpha-1 Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "0078-1231",
            "generic_name": "Sacubitril and Valsartan",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "ENTRESTO",
            "active_ingredients": [
                {
                    "name": "SACUBITRIL",
                    "strength": "6 mg/1"
                },
                {
                    "name": "VALSARTAN",
                    "strength": "6 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-1231-20",
                    "description": "60 PELLET in 1 BOTTLE (0078-1231-20)",
                    "marketing_start_date": "20240412",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1656340",
                    "1656346",
                    "1656349",
                    "1656351",
                    "1656354",
                    "1656356",
                    "2679793",
                    "2679797",
                    "2679800",
                    "2679802"
                ],
                "spl_set_id": [
                    "000dc81d-ab91-450c-8eae-8eb74e72296f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300780696203",
                    "0300780659208",
                    "0300780777209"
                ],
                "nui": [
                    "N0000000070",
                    "N0000175561"
                ],
                "pharm_class_moa": [
                    "Angiotensin 2 Receptor Antagonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Angiotensin 2 Receptor Blocker [EPC]"
                ],
                "unii": [
                    "80M03YXJ7I",
                    "17ERJ0MKGI"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "PELLET",
            "spl_id": "5547844d-83b2-4ce0-9f71-aacad8bf919d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240412",
            "product_id": "0078-1231_5547844d-83b2-4ce0-9f71-aacad8bf919d",
            "application_number": "NDA218591",
            "brand_name_base": "ENTRESTO",
            "pharm_class": [
                "Angiotensin 2 Receptor Antagonists [MoA]",
                "Angiotensin 2 Receptor Blocker [EPC]",
                "Neprilysin Inhibitor [EPC]",
                "Neprilysin Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "64764-105",
            "generic_name": "Budesonide",
            "labeler_name": "TAKEDA PHARMACEUTICALS AMERICA, INC.",
            "brand_name": "Eohilia",
            "active_ingredients": [
                {
                    "name": "BUDESONIDE",
                    "strength": "2 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-105-00",
                    "description": "10 POUCH in 1 CARTON (64764-105-00)  / 10 mL in 1 POUCH (64764-105-01)",
                    "marketing_start_date": "20240209",
                    "sample": false
                },
                {
                    "package_ndc": "64764-105-60",
                    "description": "60 POUCH in 1 CARTON (64764-105-60)  / 10 mL in 1 POUCH (64764-105-10)",
                    "marketing_start_date": "20240209",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "TAKEDA PHARMACEUTICALS AMERICA, INC."
                ],
                "rxcui": [
                    "2675280",
                    "2675286"
                ],
                "spl_set_id": [
                    "56f2023a-69b2-4470-b4ad-af7ec1be527a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "Q3OKS62Q6X"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "5ea806af-e798-42cb-9572-4f4accf88b2e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240209",
            "product_id": "64764-105_5ea806af-e798-42cb-9572-4f4accf88b2e",
            "application_number": "NDA213976",
            "brand_name_base": "Eohilia",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "61958-2201",
            "generic_name": "Velpatasvir and Sofosbuvir",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Epclusa",
            "active_ingredients": [
                {
                    "name": "SOFOSBUVIR",
                    "strength": "400 mg/1"
                },
                {
                    "name": "VELPATASVIR",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-2201-1",
                    "description": "28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2201-1)",
                    "marketing_start_date": "20160628",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1799212",
                    "1799218",
                    "2288814",
                    "2288816",
                    "2584196",
                    "2584199",
                    "2584200",
                    "2584201"
                ],
                "spl_set_id": [
                    "7f30631a-ee3b-4cfe-866b-964df3f0a44f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191256",
                    "N0000190113",
                    "N0000185503",
                    "N0000190107",
                    "N0000190108",
                    "N0000190109",
                    "N0000191493",
                    "N0000191258"
                ],
                "pharm_class_epc": [
                    "Hepatitis C Virus NS5A Inhibitor [EPC]",
                    "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]",
                    "RNA Replicase Inhibitors [MoA]"
                ],
                "unii": [
                    "KCU0C7RS7Z",
                    "WJ6CA3ZU8B"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "85cbcc07-c565-4805-a4ad-4f055dd5d990",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160628",
            "product_id": "61958-2201_85cbcc07-c565-4805-a4ad-4f055dd5d990",
            "application_number": "NDA208341",
            "brand_name_base": "Epclusa",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Hepatitis C Virus NS5A Inhibitor [EPC]",
                "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "RNA Replicase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70127-100",
            "generic_name": "cannabidiol",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "brand_name": "Epidiolex",
            "active_ingredients": [
                {
                    "name": "CANNABIDIOL",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70127-100-10",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (70127-100-10)  / 100 mL in 1 BOTTLE, GLASS (70127-100-01)",
                    "marketing_start_date": "20181005",
                    "sample": false
                },
                {
                    "package_ndc": "70127-100-60",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (70127-100-60)  / 60 mL in 1 BOTTLE, GLASS (70127-100-06)",
                    "marketing_start_date": "20211006",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2058900",
                    "2058906"
                ],
                "spl_set_id": [
                    "8bf27097-4870-43fb-94f0-f3d0871d1eec"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0003267",
                    "N0000187062",
                    "N0000185504",
                    "N0000182140",
                    "N0000191278",
                    "N0000191273",
                    "N0000182138",
                    "N0000182139",
                    "N0000187064"
                ],
                "pharm_class_cs": [
                    "Cannabinoids [CS]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "Cytochrome P450 2C19 Inhibitors [MoA]",
                    "UGT1A9 Inhibitors [MoA]",
                    "UGT2B7 Inhibitors [MoA]",
                    "Cytochrome P450 1A2 Inhibitors [MoA]",
                    "Cytochrome P450 2B6 Inhibitors [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]"
                ],
                "unii": [
                    "19GBJ60SN5"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "94674ebc-469e-4aa3-afee-46658077aafc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181005",
            "product_id": "70127-100_94674ebc-469e-4aa3-afee-46658077aafc",
            "application_number": "NDA210365",
            "brand_name_base": "Epidiolex",
            "pharm_class": [
                "Cannabinoids [CS]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2B6 Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "UGT1A9 Inhibitors [MoA]",
                "UGT2B7 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "51662-1507",
            "generic_name": "Epinephrine",
            "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst",
            "brand_name": "Epinephrine Convenience Kit",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51662-1507-1",
                    "description": "1 VIAL, SINGLE-DOSE in 1 KIT (51662-1507-1)  / 1 KIT in 1 VIAL, SINGLE-DOSE *  1 mL in 1 VIAL, SINGLE-DOSE (51662-1290-1)",
                    "marketing_start_date": "20200208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "HF Acquisition Co LLC, DBA HealthFirst"
                ],
                "rxcui": [
                    "1660014",
                    "1660016"
                ],
                "spl_set_id": [
                    "9df23744-3b5b-5815-e053-2a95a90acc47"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "a035fca6-f253-75c3-e053-2a95a90a785f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20200208",
            "product_id": "51662-1507_a035fca6-f253-75c3-e053-2a95a90a785f",
            "application_number": "NDA204200",
            "brand_name_base": "Epinephrine Convenience Kit"
        },
        {
            "product_ndc": "70518-1224",
            "generic_name": "epinephrine",
            "labeler_name": "REMEDYREPACK INC.",
            "brand_name": "EPIPEN",
            "active_ingredients": [
                {
                    "name": "EPINEPHRINE",
                    "strength": ".3 mg/.3mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70518-1224-0",
                    "description": "2 CONTAINER in 1 CARTON (70518-1224-0)  / 1 SYRINGE, GLASS in 1 CONTAINER / .3 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20180525",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "REMEDYREPACK INC."
                ],
                "rxcui": [
                    "727347",
                    "1870207"
                ],
                "spl_set_id": [
                    "6ee4fecf-83b1-46f9-9b40-f8594710d2f5"
                ],
                "nui": [
                    "N0000000209",
                    "N0000000245",
                    "N0000175552",
                    "N0000175555",
                    "N0000175570",
                    "M0003647"
                ],
                "pharm_class_moa": [
                    "Adrenergic alpha-Agonists [MoA]",
                    "Adrenergic beta-Agonists [MoA]"
                ],
                "pharm_class_epc": [
                    "alpha-Adrenergic Agonist [EPC]",
                    "beta-Adrenergic Agonist [EPC]",
                    "Catecholamine [EPC]"
                ],
                "pharm_class_cs": [
                    "Catecholamines [CS]"
                ],
                "unii": [
                    "YKH834O4BH"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "116db076-e4c3-5485-e063-6294a90ad57e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20180525",
            "product_id": "70518-1224_116db076-e4c3-5485-e063-6294a90ad57e",
            "application_number": "NDA019430",
            "brand_name_base": "EPIPEN",
            "pharm_class": [
                "Adrenergic alpha-Agonists [MoA]",
                "Adrenergic beta-Agonists [MoA]",
                "Catecholamine [EPC]",
                "Catecholamines [CS]",
                "alpha-Adrenergic Agonist [EPC]",
                "beta-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "69693-413",
            "generic_name": "MENTHOL",
            "labeler_name": "Clarion Brands, LLC",
            "brand_name": "ABSORBINE JR PLUS ULTRA STRENGTH PAIN",
            "active_ingredients": [
                {
                    "name": "MENTHOL",
                    "strength": "6500 mg/h"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69693-413-01",
                    "description": "1 PATCH in 1 POUCH (69693-413-01)  / 8 h in 1 PATCH",
                    "marketing_start_date": "20150815",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Clarion Brands, LLC"
                ],
                "rxcui": [
                    "1248743",
                    "1439997"
                ],
                "spl_set_id": [
                    "cf329707-d90a-29dd-f2c2-acfd5af614f3"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "L7T10EIP3A"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "PATCH",
            "spl_id": "4a44ff49-ea80-4055-a87c-0c58a09ed450",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20150815",
            "product_id": "69693-413_4a44ff49-ea80-4055-a87c-0c58a09ed450",
            "application_number": "M017",
            "brand_name_base": "ABSORBINE JR PLUS ULTRA STRENGTH PAIN"
        },
        {
            "product_ndc": "49702-203",
            "generic_name": "lamivudine",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "EPIVIR",
            "active_ingredients": [
                {
                    "name": "LAMIVUDINE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-203-18",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (49702-203-18)",
                    "marketing_start_date": "20101004",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "152931",
                    "152932",
                    "199147",
                    "199148",
                    "349491",
                    "352230"
                ],
                "spl_set_id": [
                    "89226149-47fa-4f7d-bb1f-1aa7034486b8"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0349702203181",
                    "0349702204133"
                ],
                "nui": [
                    "N0000175656",
                    "N0000175462",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "2T8Q726O95"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "f91606a6-2657-4320-bbab-aee338efcfd7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20101004",
            "product_id": "49702-203_f91606a6-2657-4320-bbab-aee338efcfd7",
            "application_number": "NDA020564",
            "brand_name_base": "EPIVIR",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "52652-9001",
            "generic_name": "Topiramate",
            "labeler_name": "Azurity Pharmaceuticals, Inc.",
            "brand_name": "Eprontia",
            "active_ingredients": [
                {
                    "name": "TOPIRAMATE",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52652-9001-1",
                    "description": "473 mL in 1 BOTTLE (52652-9001-1)",
                    "marketing_start_date": "20211206",
                    "sample": false
                },
                {
                    "package_ndc": "52652-9001-2",
                    "description": "1 BOTTLE in 1 CARTON (52652-9001-2)  / 240 mL in 1 BOTTLE",
                    "marketing_start_date": "20230102",
                    "sample": false
                },
                {
                    "package_ndc": "52652-9001-3",
                    "description": "1 BOTTLE in 1 CARTON (52652-9001-3)  / 120 mL in 1 BOTTLE",
                    "marketing_start_date": "20230102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Azurity Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2586427",
                    "2586433"
                ],
                "spl_set_id": [
                    "e2a4df59-fead-4a01-9021-9eda02c48010"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008486",
                    "N0000185506",
                    "N0000182140"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inhibitors [MoA]"
                ],
                "unii": [
                    "0H73WJJ391"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "1a446045-8c3b-3970-e063-6394a90a5939",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20211206",
            "product_id": "52652-9001_1a446045-8c3b-3970-e063-6394a90a5939",
            "application_number": "NDA214679",
            "brand_name_base": "Eprontia",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "30698-419",
            "generic_name": "Carbamazepine",
            "labeler_name": "Validus Pharmaceuticals LLC",
            "brand_name": "EQUETRO",
            "active_ingredients": [
                {
                    "name": "CARBAMAZEPINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "30698-419-12",
                    "description": "120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (30698-419-12)",
                    "marketing_start_date": "20041210",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Validus Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "200131",
                    "200133",
                    "388311",
                    "672908",
                    "672909",
                    "672910"
                ],
                "spl_set_id": [
                    "be478f3c-40f6-47cc-8ab9-f420a9372b1c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008486",
                    "N0000175751",
                    "N0000185506",
                    "N0000191266",
                    "N0000187064",
                    "N0000185507",
                    "N0000185607"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_epc": [
                    "Mood Stabilizer [EPC]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 1A2 Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]"
                ],
                "unii": [
                    "33CM23913M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, EXTENDED RELEASE",
            "spl_id": "6668b078-d0cd-4a79-b304-e1b70c9f8753",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20041210",
            "product_id": "30698-419_6668b078-d0cd-4a79-b304-e1b70c9f8753",
            "application_number": "NDA021710",
            "brand_name_base": "EQUETRO",
            "pharm_class": [
                "Cytochrome P450 1A2 Inducers [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Mood Stabilizer [EPC]"
            ]
        },
        {
            "product_ndc": "66733-958",
            "generic_name": "cetuximab",
            "labeler_name": "ImClone LLC",
            "brand_name": "ERBITUX",
            "active_ingredients": [
                {
                    "name": "CETUXIMAB",
                    "strength": "2 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66733-958-23",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (66733-958-23)  / 100 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20071002",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "ImClone LLC"
                ],
                "rxcui": [
                    "1657658",
                    "1657660",
                    "1657663",
                    "1657664"
                ],
                "spl_set_id": [
                    "8bc6397e-4bd8-4d37-a007-a327e4da34d9"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175664",
                    "N0000020010"
                ],
                "pharm_class_epc": [
                    "Epidermal Growth Factor Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER1 Antagonists [MoA]"
                ],
                "unii": [
                    "PQX0D8J21J"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "998a1220-14b4-413f-8d3f-51bfeec3cd73",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20071002",
            "product_id": "66733-958_998a1220-14b4-413f-8d3f-51bfeec3cd73",
            "application_number": "BLA125084",
            "brand_name_base": "ERBITUX",
            "pharm_class": [
                "Epidermal Growth Factor Receptor Antagonist [EPC]",
                "HER1 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "50242-140",
            "generic_name": "vismodegib",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "ERIVEDGE",
            "active_ingredients": [
                {
                    "name": "VISMODEGIB",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-140-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01)  / 28 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20120130",
                    "sample": false
                },
                {
                    "package_ndc": "50242-140-86",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-140-86)  / 28 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20130409",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1242992",
                    "1242998"
                ],
                "spl_set_id": [
                    "eb368bb6-80e3-4df9-8a85-91df0a2ada6a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000184149",
                    "N0000184148"
                ],
                "pharm_class_epc": [
                    "Hedgehog Pathway Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Smoothened Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "25X868M3DS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "e0e041f9-94d4-4ec0-8aa5-f6b06e5b6320",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120130",
            "product_id": "50242-140_e0e041f9-94d4-4ec0-8aa5-f6b06e5b6320",
            "application_number": "NDA203388",
            "brand_name_base": "ERIVEDGE",
            "pharm_class": [
                "Hedgehog Pathway Inhibitor [EPC]",
                "Smoothened Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "49502-378",
            "generic_name": "levothyroxine sodium",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "ERMEZA",
            "active_ingredients": [
                {
                    "name": "LEVOTHYROXINE SODIUM",
                    "strength": "30 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-378-15",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (49502-378-15)  / 150 mL in 1 BOTTLE, GLASS",
                    "marketing_start_date": "20221214",
                    "sample": false
                },
                {
                    "package_ndc": "49502-378-75",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (49502-378-75)  / 75 mL in 1 BOTTLE, GLASS",
                    "marketing_start_date": "20221214",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "2626050",
                    "2626056"
                ],
                "spl_set_id": [
                    "8ceeadb4-18be-46c7-9204-68b4edfbb96b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9J765S329G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "5bbfafaa-e558-45f5-9ae4-c26aecb5815c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20221214",
            "product_id": "49502-378_5bbfafaa-e558-45f5-9ae4-c26aecb5815c",
            "application_number": "NDA215809",
            "brand_name_base": "ERMEZA",
            "pharm_class": [
                "Thyroxine [CS]",
                "l-Thyroxine [EPC]"
            ]
        },
        {
            "product_ndc": "50242-121",
            "generic_name": "PIRFENIDONE",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "ESBRIET",
            "active_ingredients": [
                {
                    "name": "PIRFENIDONE",
                    "strength": "267 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-121-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-121-01)  / 270 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20141015",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1592279",
                    "1592285",
                    "1868014",
                    "1868016",
                    "1868018",
                    "1868020"
                ],
                "spl_set_id": [
                    "2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191420",
                    "M0018236"
                ],
                "pharm_class_epc": [
                    "Pyridone [EPC]"
                ],
                "pharm_class_cs": [
                    "Pyridones [CS]"
                ],
                "unii": [
                    "D7NLD2JX7U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "6b98edca-c605-4883-9f0e-1fe47ea3890e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20141015",
            "product_id": "50242-121_6b98edca-c605-4883-9f0e-1fe47ea3890e",
            "application_number": "NDA022535",
            "brand_name_base": "ESBRIET",
            "pharm_class": [
                "Pyridone [EPC]",
                "Pyridones [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0013-2150",
            "marketing_end_date": "20241231",
            "generic_name": "estradiol",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Estring",
            "active_ingredients": [
                {
                    "name": "ESTRADIOL",
                    "strength": "2 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0013-2150-36",
                    "description": "1 POUCH in 1 CARTON (0013-2150-36)  / 1 RING in 1 POUCH",
                    "marketing_start_date": "19960426",
                    "marketing_end_date": "20241231",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "848328",
                    "848330"
                ],
                "spl_set_id": [
                    "aa530dfd-3a48-46b9-9678-a7bc48316e41"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0447348",
                    "N0000175825",
                    "N0000000100"
                ],
                "pharm_class_cs": [
                    "Estradiol Congeners [CS]"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "unii": [
                    "4TI98Z838E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "RING",
            "spl_id": "ec0d8d00-c87b-483a-8c28-e97d46cf821b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "19960426",
            "product_id": "0013-2150_ec0d8d00-c87b-483a-8c28-e97d46cf821b",
            "application_number": "NDA020472",
            "brand_name_base": "Estring",
            "pharm_class": [
                "Estradiol Congeners [CS]",
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]"
            ]
        },
        {
            "product_ndc": "55724-211",
            "generic_name": "crisaborole",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Eucrisa",
            "active_ingredients": [
                {
                    "name": "CRISABOROLE",
                    "strength": "20 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55724-211-11",
                    "description": "1 TUBE in 1 CARTON (55724-211-11)  / 100 g in 1 TUBE",
                    "marketing_start_date": "20170130",
                    "sample": false
                },
                {
                    "package_ndc": "55724-211-21",
                    "description": "1 TUBE in 1 CARTON (55724-211-21)  / 60 g in 1 TUBE",
                    "marketing_start_date": "20170130",
                    "sample": false
                },
                {
                    "package_ndc": "55724-211-23",
                    "description": "1 TUBE in 1 CARTON (55724-211-23)  / 60 g in 1 TUBE",
                    "marketing_start_date": "20170130",
                    "sample": false
                },
                {
                    "package_ndc": "55724-211-42",
                    "description": "6 TUBE in 1 CARTON (55724-211-42)  / 2.5 g in 1 TUBE",
                    "marketing_start_date": "20170130",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "1865957",
                    "1865962"
                ],
                "spl_set_id": [
                    "609b77de-1ca3-4783-b8f5-01a9c0f1d77d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000182961",
                    "N0000182960"
                ],
                "pharm_class_epc": [
                    "Phosphodiesterase 4 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Phosphodiesterase 4 Inhibitors [MoA]"
                ],
                "unii": [
                    "Q2R47HGR7P"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "OINTMENT",
            "spl_id": "003cff9f-bd65-46cd-8e19-2c8c8b4e5bbd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20170130",
            "product_id": "55724-211_003cff9f-bd65-46cd-8e19-2c8c8b4e5bbd",
            "application_number": "NDA207695",
            "brand_name_base": "Eucrisa",
            "pharm_class": [
                "Phosphodiesterase 4 Inhibitor [EPC]",
                "Phosphodiesterase 4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "55513-880",
            "generic_name": "romosozumab-aqqg",
            "labeler_name": "Amgen Inc",
            "brand_name": "Evenity",
            "active_ingredients": [
                {
                    "name": "ROMOSOZUMAB",
                    "strength": "105 mg/1.17mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-880-02",
                    "description": "2 SYRINGE in 1 CARTON (55513-880-02)  / 1.17 mL in 1 SYRINGE (55513-880-01)",
                    "marketing_start_date": "20190409",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "63052695-e229-428a-ac1b-29d80568736c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190409",
            "product_id": "55513-880_63052695-e229-428a-ac1b-29d80568736c",
            "application_number": "BLA761062",
            "brand_name_base": "Evenity"
        },
        {
            "product_ndc": "0002-4184",
            "generic_name": "Raloxifene hydrochloride",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Evista",
            "active_ingredients": [
                {
                    "name": "RALOXIFENE HYDROCHLORIDE",
                    "strength": "60 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-4184-30",
                    "description": "30 TABLET in 1 BOTTLE (0002-4184-30)",
                    "marketing_start_date": "20161216",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "1490065",
                    "1490067"
                ],
                "spl_set_id": [
                    "fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300024184305"
                ],
                "unii": [
                    "4F86W47BR6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "736ef754-5dd5-422b-81fa-bf12e9ee8afb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19980106",
            "product_id": "0002-4184_736ef754-5dd5-422b-81fa-bf12e9ee8afb",
            "application_number": "NDA020815",
            "brand_name_base": "Evista",
            "pharm_class": [
                "Estrogen Agonist/Antagonist [EPC]",
                "Selective Estrogen Receptor Modulators [MoA]"
            ]
        },
        {
            "product_ndc": "61755-010",
            "generic_name": "evinacumab",
            "labeler_name": "Regeneron Pharmaceuticals, Inc.",
            "brand_name": "Evkeeza",
            "active_ingredients": [
                {
                    "name": "EVINACUMAB",
                    "strength": "150 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61755-010-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (61755-010-01)  / 8 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20210211",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Regeneron Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2478648",
                    "2478650",
                    "2478731",
                    "2478732"
                ],
                "spl_set_id": [
                    "73412138-6d8f-4ea6-bb72-a740190470ff"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193915",
                    "N0000193916"
                ],
                "pharm_class_epc": [
                    "Angiopoietin-like 3 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Angiopoietin-like 3 Inhibitors [MoA]"
                ],
                "unii": [
                    "T8B2ORP1DW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "5464d387-1c29-4d8e-86ef-c114a223d722",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210211",
            "product_id": "61755-010_5464d387-1c29-4d8e-86ef-c114a223d722",
            "application_number": "BLA761181",
            "brand_name_base": "Evkeeza",
            "pharm_class": [
                "Angiopoietin-like 3 Inhibitor [EPC]",
                "Angiopoietin-like 3 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72893-001",
            "generic_name": "Melphalan",
            "labeler_name": "Acrotech Biopharma Inc",
            "brand_name": "EVOMELA",
            "active_ingredients": [
                {
                    "name": "MELPHALAN HYDROCHLORIDE",
                    "strength": "50 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72893-001-01",
                    "description": "1 VIAL in 1 CARTON (72893-001-01)  / 20 mL in 1 VIAL",
                    "marketing_start_date": "20160331",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Acrotech Biopharma Inc"
                ],
                "rxcui": [
                    "311487",
                    "1745090"
                ],
                "spl_set_id": [
                    "69f55869-dc11-408e-8fc7-47634269a52c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "1VXP4V453T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "4dd3db2d-aa56-4952-bcad-70fa22e8e93c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20160331",
            "product_id": "72893-001_4dd3db2d-aa56-4952-bcad-70fa22e8e93c",
            "application_number": "NDA207155",
            "brand_name_base": "EVOMELA",
            "pharm_class": [
                "Alkylating Activity [MoA]",
                "Alkylating Drug [EPC]"
            ]
        },
        {
            "product_ndc": "50242-175",
            "generic_name": "Risdiplam",
            "labeler_name": "Genentech Inc.",
            "brand_name": "EVRYSDI",
            "active_ingredients": [
                {
                    "name": "RISDIPLAM",
                    "strength": ".75 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-175-07",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (50242-175-07)  / 80 mL in 1 BOTTLE, GLASS",
                    "marketing_start_date": "20200807",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech Inc."
                ],
                "rxcui": [
                    "2390940",
                    "2390946"
                ],
                "spl_set_id": [
                    "eceb9a99-7191-4be5-87c3-0102707cf98e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194059",
                    "N0000194060",
                    "N0000009533",
                    "N0000191423",
                    "N0000193932"
                ],
                "pharm_class_epc": [
                    "Survival of Motor Neuron 2 Splicing Modifier [EPC]"
                ],
                "pharm_class_moa": [
                    "Survival of Motor Neuron 2 Splicing Modifiers [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Increased Protein Synthesis [PE]"
                ],
                "unii": [
                    "76RS4S2ET1"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SOLUTION",
            "spl_id": "d8a68de9-27f5-4ed0-afab-27fb2978b147",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200807",
            "product_id": "50242-175_d8a68de9-27f5-4ed0-afab-27fb2978b147",
            "application_number": "NDA213535",
            "brand_name_base": "EVRYSDI",
            "pharm_class": [
                "Increased Protein Synthesis [PE]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]",
                "Survival of Motor Neuron 2 Splicing Modifier [EPC]",
                "Survival of Motor Neuron 2 Splicing Modifiers [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0468",
            "generic_name": "deferasirox",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Exjade",
            "active_ingredients": [
                {
                    "name": "DEFERASIROX",
                    "strength": "125 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0468-15",
                    "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0468-15)",
                    "marketing_start_date": "20051130",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "597768",
                    "597770",
                    "597772",
                    "616159",
                    "616161",
                    "616163"
                ],
                "spl_set_id": [
                    "3495a70c-870c-4968-940e-8baea152cf85"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000144",
                    "N0000175522",
                    "N0000185506",
                    "N0000187062",
                    "N0000182138"
                ],
                "pharm_class_moa": [
                    "Iron Chelating Activity [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 1A2 Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Iron Chelator [EPC]"
                ],
                "unii": [
                    "V8G4MOF2V9"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FOR SUSPENSION",
            "spl_id": "7dc3e0ba-efd7-4d96-99d5-199df65bcd0b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20051130",
            "product_id": "0078-0468_7dc3e0ba-efd7-4d96-99d5-199df65bcd0b",
            "application_number": "NDA021882",
            "brand_name_base": "Exjade",
            "pharm_class": [
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Iron Chelating Activity [MoA]",
                "Iron Chelator [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0620",
            "generic_name": "everolimus",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Afinitor",
            "active_ingredients": [
                {
                    "name": "EVEROLIMUS",
                    "strength": "7.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0620-51",
                    "description": "28 BLISTER PACK in 1 CARTON (0078-0620-51)  / 1 TABLET in 1 BLISTER PACK (0078-0620-61)",
                    "marketing_start_date": "20110729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "845507",
                    "845512",
                    "845515",
                    "845518",
                    "998189",
                    "998191",
                    "1119400",
                    "1119402",
                    "1308428",
                    "1308430",
                    "1308432",
                    "1310138",
                    "1310144",
                    "1310147"
                ],
                "spl_set_id": [
                    "2150f73a-179b-4afc-b8ce-67c85cc72f04"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076",
                    "N0000182141",
                    "N0000182137",
                    "N0000175625",
                    "N0000175624",
                    "N0000175550"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]",
                    "mTOR Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "mTOR Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased Immunologic Activity [PE]"
                ],
                "unii": [
                    "9HW64Q8G6G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110729",
            "product_id": "0078-0620_fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "application_number": "NDA022334",
            "brand_name_base": "Afinitor",
            "pharm_class": [
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Decreased Immunologic Activity [PE]",
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]",
                "mTOR Inhibitor Immunosuppressant [EPC]",
                "mTOR Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "57660-000",
            "generic_name": "SODIUM FLUORIDE",
            "labeler_name": "TJA Health LLC",
            "brand_name": "PLAQUE HD ANTICAVITY FRESH MINT FLAVOR Professional Plaque-Identifying",
            "brand_name_suffix": "Professional Plaque-Identifying",
            "active_ingredients": [
                {
                    "name": "SODIUM FLUORIDE",
                    "strength": ".14 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57660-000-01",
                    "description": "1 TUBE in 1 PACKAGE (57660-000-01)  / 116 g in 1 TUBE",
                    "marketing_start_date": "20130610",
                    "sample": false
                },
                {
                    "package_ndc": "57660-000-02",
                    "description": "1 TUBE in 1 PACKAGE (57660-000-02)  / 21 g in 1 TUBE",
                    "marketing_start_date": "20130610",
                    "sample": false
                },
                {
                    "package_ndc": "57660-000-03",
                    "description": "1 TUBE in 1 PACKAGE (57660-000-03)  / 116 g in 1 TUBE",
                    "marketing_start_date": "20130610",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TJA Health LLC"
                ],
                "rxcui": [
                    "416783"
                ],
                "spl_set_id": [
                    "98d07260-5274-42b7-bbf8-9683c5e8b624"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0868384000104"
                ],
                "unii": [
                    "8ZYQ1474W7"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "PASTE, DENTIFRICE",
            "spl_id": "0d773370-d63a-c88c-e063-6394a90ae4d0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "DENTAL"
            ],
            "marketing_start_date": "20130610",
            "product_id": "57660-000_0d773370-d63a-c88c-e063-6394a90ae4d0",
            "application_number": "M021",
            "brand_name_base": "PLAQUE HD ANTICAVITY FRESH MINT FLAVOR"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0078-1189",
            "generic_name": "iptacopan",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "FABHALTA",
            "active_ingredients": [
                {
                    "name": "IPTACOPAN HYDROCHLORIDE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-1189-20",
                    "description": "60 CAPSULE in 1 BOTTLE (0078-1189-20)",
                    "marketing_start_date": "20231205",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2671074",
                    "2671080"
                ],
                "spl_set_id": [
                    "a76b5845-6e21-4d3b-ad07-cd8df1b60bee"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "XW5CK7C6YH"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "dcd12534-0ff3-4f78-818e-ed97db3965a5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20231205",
            "product_id": "0078-1189_dcd12534-0ff3-4f78-818e-ed97db3965a5",
            "application_number": "NDA218276",
            "brand_name_base": "FABHALTA"
        },
        {
            "product_ndc": "43068-101",
            "generic_name": "iloperidone",
            "labeler_name": "Vanda Pharmaceuticals Inc.",
            "brand_name": "Fanapt",
            "active_ingredients": [
                {
                    "name": "ILOPERIDONE",
                    "strength": "1 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "43068-101-02",
                    "description": "60 TABLET in 1 BOTTLE (43068-101-02)",
                    "marketing_start_date": "20160501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Vanda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "848722",
                    "848726",
                    "848728",
                    "848730",
                    "848732",
                    "848734",
                    "848736",
                    "848738",
                    "848740",
                    "848742",
                    "848744",
                    "848746",
                    "848748",
                    "848750",
                    "848751",
                    "848752"
                ],
                "spl_set_id": [
                    "33f60b40-3fca-11de-8f56-0002a5d5c51b"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0343068108029",
                    "0343068110022",
                    "0343068101020",
                    "0343068106025",
                    "0343068112026",
                    "0343068104021",
                    "0343068102027"
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "VPO7KJ050N"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "9046e246-989c-4fdc-98a7-19c16dca4bcf",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160501",
            "product_id": "43068-101_9046e246-989c-4fdc-98a7-19c16dca4bcf",
            "application_number": "NDA022192",
            "brand_name_base": "Fanapt",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0310-1830",
            "generic_name": "Benralizumab",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "FASENRA",
            "active_ingredients": [
                {
                    "name": "BENRALIZUMAB",
                    "strength": "30 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-1830-30",
                    "description": "1 CARTRIDGE in 1 CARTON (0310-1830-30)  / 1 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20191004",
                    "sample": false
                },
                {
                    "package_ndc": "0310-1830-85",
                    "description": "1 CARTRIDGE in 1 CARTON (0310-1830-85)  / 1 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20191004",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "1989104",
                    "1989109",
                    "2205632",
                    "2205634",
                    "2679499",
                    "2679502"
                ],
                "spl_set_id": [
                    "da6aca1a-19ed-44a4-abb7-696c7d58b784"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193803",
                    "N0000193802"
                ],
                "pharm_class_epc": [
                    "Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "71492GE1FX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7ed0d509-0b56-4f35-b37b-c6bb04e007d0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20191004",
            "product_id": "0310-1830_7ed0d509-0b56-4f35-b37b-c6bb04e007d0",
            "application_number": "BLA761070",
            "brand_name_base": "FASENRA",
            "pharm_class": [
                "Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]",
                "Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "64764-108",
            "generic_name": "vedolizumab",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "ENTYVIO Pen",
            "active_ingredients": [
                {
                    "name": "VEDOLIZUMAB",
                    "strength": "108 mg/.68mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-108-21",
                    "description": "1 TRAY in 1 CARTON (64764-108-21)  / 1 SYRINGE in 1 TRAY (64764-108-20)  / .68 mL in 1 SYRINGE",
                    "marketing_start_date": "20230927",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1538137",
                    "1538142",
                    "2667332",
                    "2667336",
                    "2667339",
                    "2667342"
                ],
                "spl_set_id": [
                    "6e94621c-1a95-4af9-98d1-52b9e6f1949c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175775",
                    "N0000175774"
                ],
                "pharm_class_epc": [
                    "Integrin Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Integrin Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "9RV78Q2002"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "20d33a84-56b9-4ef1-9481-eda11bd8de0e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230927",
            "product_id": "64764-108_20d33a84-56b9-4ef1-9481-eda11bd8de0e",
            "application_number": "BLA761133",
            "brand_name_base": "ENTYVIO Pen",
            "pharm_class": [
                "Integrin Receptor Antagonist [EPC]",
                "Integrin Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0310-0720",
            "generic_name": "Fulvestrant",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "FASLODEX",
            "active_ingredients": [
                {
                    "name": "FULVESTRANT",
                    "strength": "50 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-0720-10",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (0310-0720-10)  / 5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20101101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "727762",
                    "727954"
                ],
                "spl_set_id": [
                    "83d7a440-e904-4e36-afb5-cb02b1c919f7"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175582",
                    "N0000000145",
                    "N0000000168"
                ],
                "pharm_class_epc": [
                    "Estrogen Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Antagonists [MoA]",
                    "Selective Estrogen Receptor Modulators [MoA]"
                ],
                "unii": [
                    "22X328QOC4"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "cfc021b9-2943-4667-8ef3-44d4408d47b8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20101101",
            "product_id": "0310-0720_cfc021b9-2943-4667-8ef3-44d4408d47b8",
            "application_number": "NDA021344",
            "brand_name_base": "FASLODEX",
            "pharm_class": [
                "Estrogen Receptor Antagonist [EPC]",
                "Estrogen Receptor Antagonists [MoA]",
                "Selective Estrogen Receptor Modulators [MoA]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0037-0431",
            "generic_name": "felbamate",
            "labeler_name": "Meda Pharmaceuticals Inc.",
            "brand_name": "Felbatol",
            "active_ingredients": [
                {
                    "name": "FELBAMATE",
                    "strength": "600 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0037-0431-01",
                    "description": "100 TABLET in 1 BOTTLE, PLASTIC (0037-0431-01)",
                    "marketing_start_date": "19930729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "198358",
                    "198359",
                    "209026",
                    "209027",
                    "209028",
                    "310285"
                ],
                "spl_set_id": [
                    "2f522701-397a-11de-8a39-0800200c9a66"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "unii": [
                    "X72RBB02N8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "7bbea585-978a-44c8-be8f-48a7dfabaced",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19930729",
            "product_id": "0037-0431_7bbea585-978a-44c8-be8f-48a7dfabaced",
            "application_number": "NDA020189",
            "brand_name_base": "Felbatol",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "62935-153",
            "generic_name": "Leuprolide Acetate",
            "labeler_name": "TOLMAR Inc.",
            "brand_name": "Fensolvi",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "62935-153-50",
                    "description": "1 KIT in 1 CARTON (62935-153-50)  *  .375 mL in 1 SYRINGE (62935-154-50)  *  .375 mL in 1 SYRINGE (62935-155-40)",
                    "marketing_start_date": "20200603",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TOLMAR Inc."
                ],
                "rxcui": [
                    "752884",
                    "2371773"
                ],
                "spl_set_id": [
                    "dfb6e01c-f138-471d-bf5b-2be38247e3f0"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "eeda0531-099b-4b55-b287-8c534c3bb5f0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20200603",
            "product_id": "62935-153_eeda0531-099b-4b55-b287-8c534c3bb5f0",
            "application_number": "NDA213150",
            "brand_name_base": "Fensolvi"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "10122-100",
            "generic_name": "deferiprone",
            "labeler_name": "Chiesi USA, Inc.",
            "brand_name": "FERRIPROX",
            "active_ingredients": [
                {
                    "name": "DEFERIPRONE",
                    "strength": "500 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10122-100-10",
                    "description": "100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (10122-100-10)",
                    "marketing_start_date": "20210101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Chiesi USA, Inc."
                ],
                "rxcui": [
                    "389242",
                    "1190357",
                    "2180997",
                    "2180999",
                    "2685014",
                    "2685015"
                ],
                "spl_set_id": [
                    "946718ff-df43-1baa-74d1-e5bcfbe8ad86"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0310722100101"
                ],
                "nui": [
                    "N0000000144",
                    "N0000175522"
                ],
                "pharm_class_moa": [
                    "Iron Chelating Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Iron Chelator [EPC]"
                ],
                "unii": [
                    "2BTY8KH53L"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "4f6573ca-2d61-4602-8a51-f9e30af2e489",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20111125",
            "product_id": "10122-100_4f6573ca-2d61-4602-8a51-f9e30af2e489",
            "application_number": "NDA021825",
            "brand_name_base": "FERRIPROX",
            "pharm_class": [
                "Iron Chelating Activity [MoA]",
                "Iron Chelator [EPC]"
            ]
        },
        {
            "product_ndc": "76420-494",
            "generic_name": "Zolpidem Tartrate",
            "labeler_name": "Asclemed USA, Inc.",
            "dea_schedule": "CIV",
            "brand_name": "Zolpidem Tartrate",
            "active_ingredients": [
                {
                    "name": "ZOLPIDEM TARTRATE",
                    "strength": "6.25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76420-494-01",
                    "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-01)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-30",
                    "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-30)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-60",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-60)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-90",
                    "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-90)",
                    "marketing_start_date": "20221005",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Asclemed USA, Inc."
                ],
                "rxcui": [
                    "854880",
                    "854894"
                ],
                "spl_set_id": [
                    "35f6c1ab-a61c-4625-b932-11a7483f1d84"
                ],
                "unii": [
                    "WY6W63843K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "ea435212-caf8-164b-e053-2a95a90a0bf6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201217",
            "product_id": "76420-494_ea435212-caf8-164b-e053-2a95a90a0bf6",
            "application_number": "ANDA213592",
            "brand_name_base": "Zolpidem Tartrate",
            "pharm_class": [
                "Central Nervous System Depression [PE]",
                "GABA A Agonists [MoA]",
                "Pyridines [CS]",
                "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "0169-3201",
            "generic_name": "insulin aspart injection",
            "labeler_name": "Novo Nordisk",
            "brand_name": "Fiasp",
            "active_ingredients": [
                {
                    "name": "INSULIN ASPART",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-3201-11",
                    "description": "1 VIAL, GLASS in 1 CARTON (0169-3201-11)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20171020",
                    "sample": false
                },
                {
                    "package_ndc": "0169-3201-90",
                    "description": "1 VIAL, GLASS in 1 CARTON (0169-3201-90)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20171020",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "311040",
                    "1653196",
                    "1653202",
                    "1986354",
                    "1986356",
                    "2205454",
                    "2642808",
                    "2642809"
                ],
                "spl_set_id": [
                    "834e7efc-393f-4c55-9125-628562a8a5cf"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "D933668QVX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "133d5f6e-b40f-47b6-ab47-10dc37114d79",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20171020",
            "product_id": "0169-3201_133d5f6e-b40f-47b6-ab47-10dc37114d79",
            "application_number": "BLA208751",
            "brand_name_base": "Fiasp",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "68974-400",
            "generic_name": "sparsentan",
            "labeler_name": "Travere Therapeutics, Inc.",
            "brand_name": "FILSPARI",
            "active_ingredients": [
                {
                    "name": "SPARSENTAN",
                    "strength": "400 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68974-400-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (68974-400-30)",
                    "marketing_start_date": "20230217",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Travere Therapeutics, Inc."
                ],
                "rxcui": [
                    "2630540",
                    "2630546",
                    "2630548",
                    "2630550"
                ],
                "spl_set_id": [
                    "d7354af1-f304-f4d9-e053-2995a90ab219"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175581",
                    "N0000175364",
                    "N0000175561",
                    "N0000180999",
                    "N0000187064",
                    "N0000185507",
                    "N0000185607",
                    "N0000185503",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Endothelin Receptor Antagonist [EPC]",
                    "Angiotensin 2 Receptor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Endothelin Receptor Antagonists [MoA]",
                    "Angiotensin 2 Type 1 Receptor Antagonists [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "9242RO5URM"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "6ed15d2c-3348-4c27-9853-414cb9e4bb94",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230217",
            "product_id": "68974-400_6ed15d2c-3348-4c27-9853-414cb9e4bb94",
            "application_number": "NDA216403",
            "brand_name_base": "FILSPARI"
        },
        {
            "product_ndc": "43376-322",
            "generic_name": "fenfluramine",
            "labeler_name": "UCB, Inc.",
            "brand_name": "Fintepla",
            "active_ingredients": [
                {
                    "name": "FENFLURAMINE",
                    "strength": "2.2 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "43376-322-30",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (43376-322-30)  / 30 mL in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20200715",
                    "sample": false
                },
                {
                    "package_ndc": "43376-322-36",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (43376-322-36)  / 360 mL in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20200715",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "rxcui": [
                    "2381138",
                    "2381144"
                ],
                "spl_set_id": [
                    "e88f360e-33ad-4cd6-b2de-5ef885857c5d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "2DS058H2CF"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "5dc79cac-29be-48b8-9dd1-0613731abc9d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200715",
            "product_id": "43376-322_5dc79cac-29be-48b8-9dd1-0613731abc9d",
            "application_number": "NDA212102",
            "brand_name_base": "Fintepla"
        },
        {
            "product_ndc": "69616-211",
            "generic_name": "amifampridine phosphate",
            "labeler_name": "Catalyst Pharmaceuticals, Inc.",
            "brand_name": "Firdapse",
            "active_ingredients": [
                {
                    "name": "AMIFAMPRIDINE PHOSPHATE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69616-211-03",
                    "description": "240 TABLET in 1 BOTTLE, PLASTIC (69616-211-03)",
                    "marketing_start_date": "20190107",
                    "sample": false
                },
                {
                    "package_ndc": "69616-211-06",
                    "description": "12 BLISTER PACK in 1 CARTON (69616-211-06)  / 10 TABLET in 1 BLISTER PACK (69616-211-04)",
                    "marketing_start_date": "20190107",
                    "sample": false
                },
                {
                    "package_ndc": "69616-211-08",
                    "description": "60 TABLET in 1 BOTTLE, PLASTIC (69616-211-08)",
                    "marketing_start_date": "20190107",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Catalyst Pharmaceuticals, Inc."
                ],
                "spl_set_id": [
                    "f015fe60-3128-4a43-8c31-19fc6b5def3f"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8HF8FIN815"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "55bc5d79-864c-4a58-a75c-a2ea62b0bf58",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190107",
            "product_id": "69616-211_55bc5d79-864c-4a58-a75c-a2ea62b0bf58",
            "application_number": "NDA208078",
            "brand_name_base": "Firdapse",
            "pharm_class": [
                "Potassium Channel Antagonists [MoA]",
                "Potassium Channel Blocker [EPC]"
            ]
        },
        {
            "product_ndc": "33332-323",
            "marketing_end_date": "20240731",
            "generic_name": "INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Darwin/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Austria/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Phuket/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)",
            "labeler_name": "Seqirus PTY LTD.",
            "brand_name": "Afluria Quadrivalent",
            "active_ingredients": [
                {
                    "name": "INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)",
                    "strength": "15 ug/.5mL"
                },
                {
                    "name": "INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)",
                    "strength": "15 ug/.5mL"
                },
                {
                    "name": "INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)",
                    "strength": "15 ug/.5mL"
                },
                {
                    "name": "INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)",
                    "strength": "15 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "33332-323-03",
                    "description": "10 SYRINGE, GLASS in 1 CARTON (33332-323-03)  / .5 mL in 1 SYRINGE, GLASS (33332-323-04)",
                    "marketing_start_date": "20230701",
                    "marketing_end_date": "20240731",
                    "sample": false
                }
            ],
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "0375b637-66ce-48ca-b6df-526c141af364",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20230701",
            "product_id": "33332-323_0375b637-66ce-48ca-b6df-526c141af364",
            "application_number": "BLA125254",
            "brand_name_base": "Afluria Quadrivalent"
        },
        {
            "product_ndc": "72893-005",
            "generic_name": "pralatrexate",
            "labeler_name": "Acrotech Biopharma Inc",
            "brand_name": "Folotyn",
            "active_ingredients": [
                {
                    "name": "PRALATREXATE",
                    "strength": "40 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72893-005-01",
                    "description": "1 VIAL in 1 CARTON (72893-005-01)  / 2 mL in 1 VIAL",
                    "marketing_start_date": "20090924",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Acrotech Biopharma Inc"
                ],
                "rxcui": [
                    "1796419",
                    "1796421",
                    "1796424",
                    "1796425"
                ],
                "spl_set_id": [
                    "9f3d9c4d-9386-4451-b712-0fbdc5478d8f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0348818001025",
                    "0072893003017"
                ],
                "nui": [
                    "N0000175584"
                ],
                "pharm_class_epc": [
                    "Folate Analog Metabolic Inhibitor [EPC]"
                ],
                "unii": [
                    "A8Q8I19Q20"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "993134b8-c368-49c6-b6ca-565a35a26ec5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20090924",
            "product_id": "72893-005_993134b8-c368-49c6-b6ca-565a35a26ec5",
            "application_number": "NDA022468",
            "brand_name_base": "Folotyn",
            "pharm_class": [
                "Folate Analog Metabolic Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "0002-8400",
            "generic_name": "Teriparatide",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Forteo",
            "active_ingredients": [
                {
                    "name": "TERIPARATIDE",
                    "strength": "250 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-8400-01",
                    "description": "1 SYRINGE in 1 CARTON (0002-8400-01)  / 2.4 mL in 1 SYRINGE",
                    "marketing_start_date": "20081001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "1435115",
                    "1435117"
                ],
                "spl_set_id": [
                    "aae667c5-381f-4f92-93df-2ed6158d07b0"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0015931",
                    "N0000180852"
                ],
                "pharm_class_cs": [
                    "Parathyroid Hormone [CS]"
                ],
                "pharm_class_epc": [
                    "Parathyroid Hormone Analog [EPC]"
                ],
                "unii": [
                    "10T9CSU89I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "ee8cffaa-b78b-4c3f-bcf5-ffc76bf515ca",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20021126",
            "product_id": "0002-8400_ee8cffaa-b78b-4c3f-bcf5-ffc76bf515ca",
            "application_number": "NDA021318",
            "brand_name_base": "Forteo",
            "pharm_class": [
                "Parathyroid Hormone Analog [EPC]",
                "Parathyroid Hormone [CS]"
            ]
        },
        {
            "product_ndc": "54092-254",
            "generic_name": "lanthanum carbonate",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Fosrenol",
            "active_ingredients": [
                {
                    "name": "LANTHANUM CARBONATE",
                    "strength": "1000 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54092-254-90",
                    "description": "9 BOTTLE in 1 PACKAGE (54092-254-90)  / 10 TABLET, CHEWABLE in 1 BOTTLE (54092-254-10)",
                    "marketing_start_date": "20051123",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "477347",
                    "542465",
                    "602635",
                    "603112",
                    "603122",
                    "642452",
                    "1551881",
                    "1551884",
                    "1551885",
                    "1551886"
                ],
                "spl_set_id": [
                    "f10776b2-2c25-4343-aabe-68f302e5cb54"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0354092253159",
                    "0354092254101",
                    "0354092252459"
                ],
                "unii": [
                    "490D9F069T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, CHEWABLE",
            "spl_id": "5624059d-27f2-44d4-a8dc-3eeba15446c8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20051123",
            "product_id": "54092-254_5624059d-27f2-44d4-a8dc-3eeba15446c8",
            "application_number": "NDA021468",
            "brand_name_base": "Fosrenol",
            "pharm_class": [
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]"
            ]
        },
        {
            "product_ndc": "45629-134",
            "generic_name": "Tivozanib",
            "labeler_name": "AVEO Pharmaceuticals, Inc.",
            "brand_name": "FOTIVDA",
            "active_ingredients": [
                {
                    "name": "TIVOZANIB HYDROCHLORIDE",
                    "strength": "1.34 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "45629-134-01",
                    "description": "24 BOTTLE, PLASTIC in 1 CARTON (45629-134-01)  / 21 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20210310",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AVEO Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2534238",
                    "2534244",
                    "2534247",
                    "2534249"
                ],
                "spl_set_id": [
                    "de77155c-ecf2-4f15-9758-21d271449d83"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8A9H4VK35Z"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "22d362c3-0746-49c4-8109-6f30bfc86cb8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210310",
            "product_id": "45629-134_22d362c3-0746-49c4-8109-6f30bfc86cb8",
            "application_number": "NDA212904",
            "brand_name_base": "FOTIVDA",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "63020-225",
            "generic_name": "fruquintinib",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Fruzaqla",
            "active_ingredients": [
                {
                    "name": "FRUQUINTINIB",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63020-225-21",
                    "description": "1 BOTTLE in 1 CARTON (63020-225-21)  / 21 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20231108",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "2670184",
                    "2670190",
                    "2670196",
                    "2670198"
                ],
                "spl_set_id": [
                    "186d786e-dc8a-45f2-b5e1-01ac0201879f"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "49DXG3M5ZW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "3c650217-753f-45bb-9d9c-b48d96f9dfe2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20231108",
            "product_id": "63020-225_3c650217-753f-45bb-9d9c-b48d96f9dfe2",
            "application_number": "NDA217564",
            "brand_name_base": "Fruzaqla"
        },
        {
            "product_ndc": "83257-005",
            "generic_name": "pegfilgrastim-jmdb",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "Fulphila",
            "active_ingredients": [
                {
                    "name": "PEGFILGRASTIM",
                    "strength": "6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-005-41",
                    "description": "1 SYRINGE in 1 CARTON (83257-005-41)  / .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2048020",
                    "2048025"
                ],
                "spl_set_id": [
                    "9bfc4d3e-6120-7fec-f1d6-0b3743752034"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "3a4278b0-b169-9ca2-99f9-0bbf261f7566",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-005_3a4278b0-b169-9ca2-99f9-0bbf261f7566",
            "application_number": "BLA761075",
            "brand_name_base": "Fulphila",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "0004-0381",
            "generic_name": "Enfuvirtide",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "FUZEON",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0004-0381-40",
                    "description": "1 KIT in 1 CARTON (0004-0381-40)  *  1 mL in 1 VIAL, SINGLE-USE *  1 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20120410",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "401981",
                    "404460"
                ],
                "spl_set_id": [
                    "6935e846-d5a1-49e5-89a2-f8ebe4d5590d"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "c73e3929-f256-4abf-b2a5-5bec18dadf71",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20120410",
            "product_id": "0004-0381_c73e3929-f256-4abf-b2a5-5bec18dadf71",
            "application_number": "NDA021481",
            "brand_name_base": "FUZEON"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "70121-1627",
            "generic_name": "pegfilgrastim",
            "labeler_name": "Amneal Pharmaceuticals LLC",
            "brand_name": "FYLNETRA",
            "active_ingredients": [
                {
                    "name": "PEGFILGRASTIM",
                    "strength": "6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70121-1627-1",
                    "description": "1 SYRINGE in 1 CARTON (70121-1627-1)  / .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20220531",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amneal Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "2602781",
                    "2602787"
                ],
                "spl_set_id": [
                    "eeadd641-573d-47fe-897a-61006e5f9e03"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0470121162718",
                    "0370121162711"
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "b512ecac-1a1c-41ad-bbeb-f46cc90c1333",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220531",
            "product_id": "70121-1627_b512ecac-1a1c-41ad-bbeb-f46cc90c1333",
            "application_number": "BLA761084",
            "brand_name_base": "FYLNETRA",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "71904-100",
            "generic_name": "migalastat hydrochloride",
            "labeler_name": "Amicus Therapeutics US, LLC",
            "brand_name": "Galafold",
            "active_ingredients": [
                {
                    "name": "MIGALASTAT HYDROCHLORIDE",
                    "strength": "123 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71904-100-01",
                    "description": "14 BLISTER PACK in 1 CARTON (71904-100-01)  / 1 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20180810",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amicus Therapeutics US, LLC"
                ],
                "rxcui": [
                    "2054257",
                    "2054263",
                    "2054266",
                    "2054275"
                ],
                "spl_set_id": [
                    "66dbd928-0f1c-48b1-a832-54e4abd9f1db"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "CLY7M0XD20"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "65034bd9-a577-4c9e-a980-a32fc8d7d01b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180810",
            "product_id": "71904-100_65034bd9-a577-4c9e-a980-a32fc8d7d01b",
            "application_number": "NDA208623",
            "brand_name_base": "Galafold"
        },
        {
            "product_ndc": "57844-215",
            "generic_name": "Zinc Acetate",
            "labeler_name": "Teva Pharmaceuticals USA, Inc.",
            "brand_name": "GALZIN",
            "active_ingredients": [
                {
                    "name": "ZINC ACETATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57844-215-52",
                    "description": "250 CAPSULE in 1 BOTTLE (57844-215-52)",
                    "marketing_start_date": "19970303",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Teva Pharmaceuticals USA, Inc."
                ],
                "rxcui": [
                    "199994",
                    "199995",
                    "213049",
                    "213050"
                ],
                "spl_set_id": [
                    "a0c72bff-20f3-4241-b966-34a95178d1a3"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "FM5526K07A"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "f9a5c8cf-8faa-40e2-9775-1bde1b30408a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19970303",
            "product_id": "57844-215_f9a5c8cf-8faa-40e2-9775-1bde1b30408a",
            "application_number": "NDA020458",
            "brand_name_base": "GALZIN",
            "pharm_class": [
                "Copper Absorption Inhibitor [EPC]",
                "Decreased Copper Ion Absorption [PE]"
            ]
        },
        {
            "product_ndc": "66658-505",
            "generic_name": "emapalumab-lzsg",
            "labeler_name": "Swedish Orphan Biovitrum AB (publ)",
            "brand_name": "GAMIFANT",
            "active_ingredients": [
                {
                    "name": "EMAPALUMAB",
                    "strength": "50 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66658-505-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (66658-505-01)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20190517",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Swedish Orphan Biovitrum AB (publ)"
                ],
                "rxcui": [
                    "2104611",
                    "2104616",
                    "2104621",
                    "2104622",
                    "2380771",
                    "2380772",
                    "2665325",
                    "2665328",
                    "2665330",
                    "2665331",
                    "2665332",
                    "2665333",
                    "2665334",
                    "2665335"
                ],
                "spl_set_id": [
                    "a865e0ef-8685-4f69-8838-648c4f3bab47"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0366658505015",
                    "0366658510019",
                    "0366658501017",
                    "0366658525013",
                    "0366658522012"
                ],
                "nui": [
                    "N0000193856",
                    "N0000193855"
                ],
                "pharm_class_epc": [
                    "Interferon gamma Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Interferon gamma Antagonists [MoA]"
                ],
                "unii": [
                    "3S252O2Z4X"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "924766fc-c878-4a8e-b1f5-3fc40136be17",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190517",
            "product_id": "66658-505_924766fc-c878-4a8e-b1f5-3fc40136be17",
            "application_number": "BLA761107",
            "brand_name_base": "GAMIFANT",
            "pharm_class": [
                "Interferon gamma Antagonists [MoA]",
                "Interferon gamma Blocker [EPC]"
            ]
        },
        {
            "product_ndc": "0068-0599",
            "marketing_end_date": "20251031",
            "generic_name": "rifampin",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Rifadin IV NOVAPLUS",
            "active_ingredients": [
                {
                    "name": "RIFAMPIN",
                    "strength": "600 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0068-0599-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (0068-0599-01)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20170201",
                    "marketing_end_date": "20251031",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "207436",
                    "312821"
                ],
                "spl_set_id": [
                    "87839f65-cb33-412e-929e-564136501a84"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175500",
                    "M0019113"
                ],
                "pharm_class_epc": [
                    "Rifamycin Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Rifamycins [CS]"
                ],
                "unii": [
                    "VJT6J7R4TR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ed3e312a-b258-4b9b-bdb4-2f149c73e8c1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170201",
            "product_id": "0068-0599_ed3e312a-b258-4b9b-bdb4-2f149c73e8c1",
            "application_number": "NDA050627",
            "brand_name_base": "Rifadin IV NOVAPLUS",
            "pharm_class": [
                "Rifamycin Antibacterial [EPC]",
                "Rifamycins [CS]"
            ]
        },
        {
            "product_ndc": "45634-254",
            "generic_name": "TITANIUM DIOXIDE",
            "labeler_name": "N.V Perricone LLC",
            "brand_name": "VITAMIN C ESTER PHOTO-BRIGHTENING MOISTURIZER BROAD SPECTRUM SPF 30 59mL",
            "active_ingredients": [
                {
                    "name": "TITANIUM DIOXIDE",
                    "strength": "2.48 g/59g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "45634-254-20",
                    "description": "82 g in 1 BOTTLE, GLASS (45634-254-20)",
                    "marketing_start_date": "20220728",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "N.V Perricone LLC"
                ],
                "spl_set_id": [
                    "e4e0dc64-fa1e-3e00-e053-2a95a90a54b7"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "15FIX9V2JP"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "CREAM",
            "spl_id": "00235822-ef50-6fb5-e063-6394a90a0864",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20220728",
            "product_id": "45634-254_00235822-ef50-6fb5-e063-6394a90a0864",
            "application_number": "M020",
            "brand_name_base": "VITAMIN C ESTER PHOTO-BRIGHTENING MOISTURIZER BROAD SPECTRUM SPF 30 59mL"
        },
        {
            "product_ndc": "73408-260",
            "generic_name": "Lidocaine",
            "labeler_name": "Crane Safety LLC",
            "brand_name": "Crane Safety Burn",
            "active_ingredients": [
                {
                    "name": "BENZALKONIUM CHLORIDE",
                    "strength": "1.3 mg/g"
                },
                {
                    "name": "LIDOCAINE HYDROCHLORIDE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73408-260-12",
                    "description": "10 PACKET in 1 BOX (73408-260-12)  / .9 g in 1 PACKET",
                    "marketing_start_date": "20200117",
                    "sample": false
                },
                {
                    "package_ndc": "73408-260-73",
                    "description": "25 PACKET in 1 BOX (73408-260-73)  / .9 g in 1 PACKET",
                    "marketing_start_date": "20200117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Crane Safety LLC"
                ],
                "rxcui": [
                    "1012100"
                ],
                "spl_set_id": [
                    "96d81566-6321-731e-e053-2995a90ad07d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "F5UM2KM3W7",
                    "V13007Z41A"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "CREAM",
            "spl_id": "0f165cba-86f6-e45d-e063-6394a90a936e",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20200117",
            "product_id": "73408-260_0f165cba-86f6-e45d-e063-6394a90a936e",
            "application_number": "M015",
            "brand_name_base": "Crane Safety Burn",
            "pharm_class": [
                "Amide Local Anesthetic [EPC]",
                "Amides [CS]",
                "Antiarrhythmic [EPC]",
                "Local Anesthesia [PE]"
            ]
        },
        {
            "product_ndc": "50242-210",
            "generic_name": "Pralsetinib",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Gavreto",
            "active_ingredients": [
                {
                    "name": "PRALSETINIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-210-12",
                    "description": "1 BOTTLE in 1 CARTON (50242-210-12)  / 120 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20220928",
                    "sample": false
                },
                {
                    "package_ndc": "50242-210-60",
                    "description": "1 BOTTLE in 1 CARTON (50242-210-60)  / 60 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20210701",
                    "sample": false
                },
                {
                    "package_ndc": "50242-210-83",
                    "description": "1 BOTTLE in 1 CARTON (50242-210-83)  / 60 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20210701",
                    "sample": true
                },
                {
                    "package_ndc": "50242-210-90",
                    "description": "1 BOTTLE in 1 CARTON (50242-210-90)  / 90 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20210701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2394941",
                    "2394947"
                ],
                "spl_set_id": [
                    "59984249-e3ff-4f97-8d7a-c1a905d604a8"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000193947"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Rearranged during Transfection (RET) Inhibitors [MoA]"
                ],
                "unii": [
                    "1WPE73O1WV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "b64ef09e-3ba0-4381-915c-45ec16e1e3f1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210701",
            "product_id": "50242-210_b64ef09e-3ba0-4381-915c-45ec16e1e3f1",
            "application_number": "NDA213721",
            "brand_name_base": "Gavreto",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Rearranged during Transfection (RET) Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50242-070",
            "generic_name": "obinutuzumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Gazyva",
            "active_ingredients": [
                {
                    "name": "OBINUTUZUMAB",
                    "strength": "1000 mg/40mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-070-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01)  / 40 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20131101",
                    "sample": false
                },
                {
                    "package_ndc": "50242-070-86",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-070-86)  / 40 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20131104",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1442693",
                    "1442698"
                ],
                "spl_set_id": [
                    "df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "O43472U9X8"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "46ab013a-7f43-41f7-8ee8-fc77437561ee",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20131101",
            "product_id": "50242-070_46ab013a-7f43-41f7-8ee8-fc77437561ee",
            "application_number": "BLA125486",
            "brand_name_base": "Gazyva",
            "pharm_class": [
                "CD20-directed Antibody Interactions [MoA]",
                "CD20-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "22840-9306",
            "generic_name": "Xanthium strumarium, Chenopodium album, Amaranthus retroflexus",
            "labeler_name": "Greer Laboratories, Inc.",
            "brand_name": "3 Weed Mix",
            "active_ingredients": [
                {
                    "name": "AMARANTHUS RETROFLEXUS POLLEN",
                    "strength": ".01666 g/mL"
                },
                {
                    "name": "CHENOPODIUM ALBUM POLLEN",
                    "strength": ".01666 g/mL"
                },
                {
                    "name": "XANTHIUM STRUMARIUM POLLEN",
                    "strength": ".01666 g/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "22840-9306-2",
                    "description": "10 mL in 1 VIAL, MULTI-DOSE (22840-9306-2)",
                    "marketing_start_date": "19810915",
                    "sample": false
                },
                {
                    "package_ndc": "22840-9306-4",
                    "description": "50 mL in 1 VIAL, MULTI-DOSE (22840-9306-4)",
                    "marketing_start_date": "19810915",
                    "sample": false
                },
                {
                    "package_ndc": "22840-9306-5",
                    "description": "5 mL in 1 BOTTLE, DROPPER (22840-9306-5)",
                    "marketing_start_date": "19810915",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "f89eba01-cc76-7aed-e053-6294a90a3a97",
            "product_type": "NON-STANDARDIZED ALLERGENIC",
            "route": [
                "INTRADERMAL",
                "PERCUTANEOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19810915",
            "product_id": "22840-9306_f89eba01-cc76-7aed-e053-6294a90a3a97",
            "application_number": "BLA101833",
            "brand_name_base": "3 Weed Mix",
            "pharm_class": [
                "Allergens [CS]",
                "Allergens [CS]",
                "Allergens [CS]",
                "Cell-mediated Immunity [PE]",
                "Cell-mediated Immunity [PE]",
                "Cell-mediated Immunity [PE]",
                "Increased Histamine Release [PE]",
                "Increased Histamine Release [PE]",
                "Increased Histamine Release [PE]",
                "Increased IgG Production [PE]",
                "Increased IgG Production [PE]",
                "Non-Standardized Pollen Allergenic Extract [EPC]",
                "Non-Standardized Pollen Allergenic Extract [EPC]",
                "Non-Standardized Pollen Allergenic Extract [EPC]",
                "Pollen [CS]",
                "Pollen [CS]",
                "Pollen [CS]"
            ]
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "61958-1901",
            "generic_name": "elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Genvoya",
            "active_ingredients": [
                {
                    "name": "COBICISTAT",
                    "strength": "150 mg/1"
                },
                {
                    "name": "ELVITEGRAVIR",
                    "strength": "150 mg/1"
                },
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-1901-1",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-1901-1)",
                    "marketing_start_date": "20151105",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1721613",
                    "1721619"
                ],
                "spl_set_id": [
                    "34784acf-15ed-4715-b504-eb30430518e9"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190114",
                    "N0000191001",
                    "N0000185503",
                    "N0000182137",
                    "N0000190107",
                    "N0000190108",
                    "N0000190113",
                    "N0000191423",
                    "N0000000127",
                    "N0000175887",
                    "N0000185507",
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                    "HIV Integrase Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Cytochrome P450 3A Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "unii": [
                    "LW2E03M5PG",
                    "4GDQ854U53",
                    "G70B4ETF4S",
                    "FWF6Q91TZO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "a7b28a9f-4395-4552-8ba6-4ba9eb30809c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151105",
            "product_id": "61958-1901_a7b28a9f-4395-4552-8ba6-4ba9eb30809c",
            "application_number": "NDA207561",
            "brand_name_base": "Genvoya",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitor [EPC]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "HIV Integrase Inhibitors [MoA]",
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0607",
            "generic_name": "Fingolimod hcl",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Gilenya",
            "active_ingredients": [
                {
                    "name": "FINGOLIMOD HYDROCHLORIDE",
                    "strength": ".5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0607-15",
                    "description": "30 CAPSULE in 1 BOTTLE (0078-0607-15)",
                    "marketing_start_date": "20100921",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1012895",
                    "1012899",
                    "2045491",
                    "2045493"
                ],
                "spl_set_id": [
                    "cc9e1c8c-0e2b-44e2-878b-27057f786be9"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G926EC510T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "c17bea26-e911-4cb3-acf6-dfb8f6dfc315",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100921",
            "product_id": "0078-0607_c17bea26-e911-4cb3-acf6-dfb8f6dfc315",
            "application_number": "NDA022527",
            "brand_name_base": "Gilenya",
            "pharm_class": [
                "Sphingosine 1-Phosphate Receptor Modulators [MoA]",
                "Sphingosine 1-phosphate Receptor Modulator [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72089-307",
            "generic_name": "METOCLOPRAMIDE HYDROCHLORIDE",
            "labeler_name": "Evoke Pharma, Inc.",
            "brand_name": "GIMOTI",
            "active_ingredients": [
                {
                    "name": "METOCLOPRAMIDE HYDROCHLORIDE",
                    "strength": "15 mg/.07mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72089-307-15",
                    "description": "1 BOTTLE, PUMP in 1 CARTON (72089-307-15)  / 9.8 mL in 1 BOTTLE, PUMP",
                    "marketing_start_date": "20200619",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Evoke Pharma, Inc."
                ],
                "rxcui": [
                    "2380564",
                    "2380570"
                ],
                "spl_set_id": [
                    "95269b1f-779c-4ca0-9f86-e74e677f9900"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "W1792A2RVD"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY",
            "spl_id": "5c51299b-82cb-416d-aeb4-c0ff2826a6cb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "NASAL"
            ],
            "marketing_start_date": "20200619",
            "product_id": "72089-307_5c51299b-82cb-416d-aeb4-c0ff2826a6cb",
            "application_number": "NDA209388",
            "brand_name_base": "GIMOTI",
            "pharm_class": [
                "Dopamine D2 Antagonists [MoA]",
                "Dopamine-2 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "71336-1001",
            "generic_name": "givosiran sodium",
            "labeler_name": "Alnylam Pharmaceuticals, Inc.",
            "brand_name": "GIVLAARI",
            "active_ingredients": [
                {
                    "name": "GIVOSIRAN SODIUM",
                    "strength": "189 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71336-1001-1",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1)  / 1 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20191212",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Alnylam Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2265716",
                    "2265721"
                ],
                "spl_set_id": [
                    "167e663c-11e1-497b-a3fc-951d65d58eaa"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5XE21E41RT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "5457f986-9970-450d-9da0-937d791f658d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20191212",
            "product_id": "71336-1001_5457f986-9970-450d-9da0-937d791f658d",
            "application_number": "NDA212194",
            "brand_name_base": "GIVLAARI",
            "pharm_class": [
                "Aminolevulinate Synthase 1-directed RNA Interaction [EPC]",
                "Decreased RNA Integrity [PE]",
                "RNA",
                "Small Interfering [CS]",
                "Small Interfering RNA [EPC]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0649",
            "generic_name": "imatinib mesylate",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Gleevec",
            "active_ingredients": [
                {
                    "name": "IMATINIB MESYLATE",
                    "strength": "400 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0649-13",
                    "description": "3 BLISTER PACK in 1 CARTON (0078-0649-13)  / 10 TABLET in 1 BLISTER PACK (0078-0649-26)",
                    "marketing_start_date": "20240301",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0649-30",
                    "description": "30 TABLET in 1 BOX, UNIT-DOSE (0078-0649-30)",
                    "marketing_start_date": "20141223",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "403878",
                    "403879",
                    "404588",
                    "404589"
                ],
                "spl_set_id": [
                    "211ef2da-2868-4a77-8055-1cb2cd78e24b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8A1O1M485B"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "b01fcb36-b055-4226-a860-e81b9c6f3acb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20141223",
            "product_id": "0078-0649_b01fcb36-b055-4226-a860-e81b9c6f3acb",
            "application_number": "NDA021588",
            "brand_name_base": "Gleevec",
            "pharm_class": [
                "Bcr-Abl Tyrosine Kinase Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "24338-050",
            "generic_name": "carmustine",
            "labeler_name": "Arbor Pharmaceuticals",
            "brand_name": "Gliadel",
            "active_ingredients": [
                {
                    "name": "CARMUSTINE",
                    "strength": "7.7 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24338-050-08",
                    "description": "8 POUCH in 1 BOX (24338-050-08)  / 1 WAFER in 1 POUCH",
                    "marketing_start_date": "20121213",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Arbor Pharmaceuticals"
                ],
                "rxcui": [
                    "212994",
                    "309013"
                ],
                "spl_set_id": [
                    "38962a55-a514-4c48-bea5-f99a8da4beec"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000236",
                    "N0000175558"
                ],
                "pharm_class_moa": [
                    "Alkylating Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Alkylating Drug [EPC]"
                ],
                "unii": [
                    "U68WG3173Y"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "WAFER",
            "spl_id": "38ee529a-9515-4e98-8722-5b6c848f7d74",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRACAVITARY"
            ],
            "marketing_start_date": "20121213",
            "product_id": "24338-050_38ee529a-9515-4e98-8722-5b6c848f7d74",
            "application_number": "NDA020637",
            "brand_name_base": "Gliadel",
            "pharm_class": [
                "Alkylating Activity [MoA]",
                "Alkylating Drug [EPC]"
            ]
        },
        {
            "product_ndc": "59469-310",
            "generic_name": "Artemisia Abrotanum Flowering Top, Phosphoric Acid, Silver Nitrate, Barium Carbonate, Lycopodium Clavatum Spore, Delphinium Staphisagria Seed, Calcium Hypophosphite, And Cinchona Officinalis Bark",
            "labeler_name": "PEKANA Naturheilmittel GmbH",
            "brand_name": "JUVE-CAL",
            "active_ingredients": [
                {
                    "name": "ARTEMISIA ABROTANUM FLOWERING TOP",
                    "strength": "8 [hp_X]/250mL"
                },
                {
                    "name": "BARIUM CARBONATE",
                    "strength": "12 [hp_X]/250mL"
                },
                {
                    "name": "CALCIUM HYPOPHOSPHITE",
                    "strength": "4 [hp_X]/250mL"
                },
                {
                    "name": "CINCHONA OFFICINALIS BARK",
                    "strength": "8 [hp_X]/250mL"
                },
                {
                    "name": "DELPHINIUM STAPHISAGRIA SEED",
                    "strength": "6 [hp_X]/250mL"
                },
                {
                    "name": "LYCOPODIUM CLAVATUM SPORE",
                    "strength": "12 [hp_X]/250mL"
                },
                {
                    "name": "PHOSPHORIC ACID",
                    "strength": "4 [hp_X]/250mL"
                },
                {
                    "name": "SILVER NITRATE",
                    "strength": "6 [hp_X]/250mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59469-310-50",
                    "description": "1 BOTTLE, GLASS in 1 BOX (59469-310-50)  / 250 mL in 1 BOTTLE, GLASS",
                    "marketing_start_date": "20190624",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "PEKANA Naturheilmittel GmbH"
                ],
                "spl_set_id": [
                    "df17fb22-d710-4d97-897d-c1f6aabdecbc"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "QG07G580U0",
                    "6P669D8HQ8",
                    "CUI83R2732",
                    "S003A158SB",
                    "00543AP1JV",
                    "C88X29Y479",
                    "E4GA8884NN",
                    "95IT3W8JZE"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "SYRUP",
            "spl_id": "2ac5dadc-a1d4-4f2b-a6a3-a2ec087429c4",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190624",
            "product_id": "59469-310_2ac5dadc-a1d4-4f2b-a6a3-a2ec087429c4",
            "brand_name_base": "JUVE-CAL",
            "pharm_class": [
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]"
            ]
        },
        {
            "product_ndc": "65044-9971",
            "generic_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "labeler_name": "Jubilant HollisterStier LLC",
            "brand_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65044-9971-1",
                    "description": "1 KIT in 1 TRAY (65044-9971-1)  *  1.2 mL in 1 VIAL (65044-9981-2)",
                    "marketing_start_date": "19820222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "b9289dcf-445f-4a93-89f7-f513569254fd",
            "product_type": "STANDARDIZED ALLERGENIC",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19820222",
            "product_id": "65044-9971_b9289dcf-445f-4a93-89f7-f513569254fd",
            "application_number": "BLA103885",
            "brand_name_base": "White Faced Hornet Hymenoptera Venom Venomil Maintenance"
        },
        {
            "product_ndc": "55550-102",
            "generic_name": "Homosalate, Octinoxate, Octisalate, Oxybenzone",
            "labeler_name": "Total Resources International",
            "brand_name": "Sunscreen",
            "active_ingredients": [
                {
                    "name": "HOMOSALATE",
                    "strength": "6 mg/g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55550-102-01",
                    "description": "1.5 g in 1 PACKET (55550-102-01)",
                    "marketing_start_date": "20230120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Total Resources International"
                ],
                "spl_set_id": [
                    "7d4f820d-e154-428e-89c2-2e26e088ceef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LOTION",
            "spl_id": "f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20230120",
            "product_id": "55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "application_number": "part352",
            "brand_name_base": "Sunscreen"
        },
        {
            "product_ndc": "82715-112",
            "generic_name": "Avobenzone, Octinoxate",
            "labeler_name": "ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI",
            "brand_name": "GOLDEN ROSE GLOW KISS TINTED LIP BALM PEACH SHAKE",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "2.7 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "6 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "82715-112-01",
                    "description": "3 g in 1 TUBE (82715-112-01)",
                    "marketing_start_date": "20220722",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI"
                ],
                "spl_set_id": [
                    "d1c5b7a5-73f9-4df6-9469-ce42e4f33ae8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "4Y5P7MUD51"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "LIPSTICK",
            "spl_id": "0fb77b09-9450-4730-8d71-5e292821a6a8",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20220722",
            "product_id": "82715-112_0fb77b09-9450-4730-8d71-5e292821a6a8",
            "application_number": "part352",
            "brand_name_base": "GOLDEN ROSE GLOW KISS TINTED LIP BALM PEACH SHAKE"
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "70482-085",
            "generic_name": "AMANTADINE",
            "labeler_name": "Adamas Pharma, LLC",
            "brand_name": "GOCOVRI",
            "active_ingredients": [
                {
                    "name": "AMANTADINE",
                    "strength": "68.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70482-085-21",
                    "description": "21 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-085-21)",
                    "marketing_start_date": "20170824",
                    "sample": true
                },
                {
                    "package_ndc": "70482-085-60",
                    "description": "60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-085-60)",
                    "marketing_start_date": "20170824",
                    "sample": false
                },
                {
                    "package_ndc": "70482-085-61",
                    "description": "60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-085-61)",
                    "marketing_start_date": "20170824",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Adamas Pharma, LLC"
                ],
                "rxcui": [
                    "1944370",
                    "1944376",
                    "1944380",
                    "1944382"
                ],
                "spl_set_id": [
                    "82ff865f-78f3-4c94-b6a9-727a54944b28"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175543",
                    "N0000175542"
                ],
                "pharm_class_epc": [
                    "Influenza A M2 Protein Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "M2 Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "BF4C9Z1J53"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, COATED PELLETS",
            "spl_id": "10e40f95-90fd-a612-e063-6294a90a55b9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170824",
            "product_id": "70482-085_10e40f95-90fd-a612-e063-6294a90a55b9",
            "application_number": "NDA208944",
            "brand_name_base": "GOCOVRI",
            "pharm_class": [
                "Influenza A M2 Protein Inhibitor [EPC]",
                "M2 Protein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "63833-828",
            "generic_name": "HUMAN C1-ESTERASE INHIBITOR",
            "labeler_name": "CSL Behring GmbH",
            "brand_name": "HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)",
            "brand_name_suffix": "C1 Esterase Inhibitor Subcutaneous (Human)",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63833-828-02",
                    "description": "1 KIT in 1 CARTON (63833-828-02)  *  4 mL in 1 VIAL, SINGLE-USE (63833-838-01)  *  4 mL in 1 VIAL, SINGLE-USE (63833-765-18)",
                    "marketing_start_date": "20170622",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "c53fd34d-f366-4ee5-bbea-88201bf6b7c8",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20170622",
            "product_id": "63833-828_c53fd34d-f366-4ee5-bbea-88201bf6b7c8",
            "application_number": "BLA125606",
            "brand_name_base": "HAEGARDA"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "82111-955",
            "generic_name": "dexamethasone",
            "labeler_name": "Edenbridge Pharmaceuticals LLC.",
            "brand_name": "Hemady",
            "active_ingredients": [
                {
                    "name": "DEXAMETHASONE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "82111-955-01",
                    "description": "1 BOTTLE in 1 CARTON (82111-955-01)  / 24 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20231201",
                    "sample": false
                },
                {
                    "package_ndc": "82111-955-02",
                    "description": "1 BOTTLE in 1 CARTON (82111-955-02)  / 100 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20231201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Edenbridge Pharmaceuticals LLC."
                ],
                "rxcui": [
                    "2261802",
                    "2286261"
                ],
                "spl_set_id": [
                    "6b9cf32c-6d60-4853-bbfd-2304ffc2c129"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "7S5I7G3JQL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "c40533d1-0079-49d3-9125-d7ec623b78cd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191003",
            "product_id": "82111-955_c40533d1-0079-49d3-9125-d7ec623b78cd",
            "application_number": "NDA211379",
            "brand_name_base": "Hemady",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "0053-0270",
            "generic_name": "etranacogene dezaparvovec",
            "labeler_name": "CSL Behring",
            "brand_name": "HEMGENIX",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0053-0270-27",
                    "description": "1 KIT in 1 CARTON (0053-0270-27)  *  1 INJECTION, SUSPENSION in 1 VIAL, GLASS (0053-0099-01)",
                    "marketing_start_date": "20221122",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "CSL Behring"
                ],
                "rxcui": [
                    "2626772",
                    "2626778",
                    "2626780",
                    "2626781",
                    "2626782",
                    "2626783",
                    "2626784",
                    "2626785",
                    "2626786",
                    "2626787",
                    "2626788",
                    "2626789",
                    "2626790",
                    "2626791",
                    "2626792",
                    "2626793",
                    "2626794",
                    "2626795",
                    "2626796",
                    "2626797",
                    "2626798",
                    "2626799",
                    "2626800",
                    "2626801",
                    "2626802",
                    "2626803",
                    "2626804",
                    "2626805",
                    "2626806",
                    "2626807",
                    "2626808",
                    "2626809",
                    "2626810",
                    "2626811",
                    "2626812",
                    "2626813",
                    "2626814",
                    "2626815",
                    "2626816",
                    "2626817",
                    "2626818",
                    "2626819",
                    "2626820",
                    "2626821",
                    "2626822",
                    "2626823",
                    "2626824",
                    "2626825",
                    "2626829",
                    "2626830",
                    "2626831",
                    "2626832",
                    "2626833",
                    "2626834",
                    "2626835",
                    "2626836",
                    "2626837",
                    "2626838",
                    "2626839",
                    "2626840",
                    "2626843",
                    "2626844",
                    "2626845",
                    "2626846",
                    "2626847",
                    "2626848",
                    "2626849",
                    "2626850",
                    "2626851",
                    "2626852",
                    "2626853",
                    "2626854",
                    "2626855",
                    "2626856",
                    "2626857",
                    "2626858",
                    "2626859",
                    "2626860",
                    "2627141",
                    "2627142"
                ],
                "spl_set_id": [
                    "35b2db65-4c6c-4173-ab56-b2bca69193bd"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "37461df8-e3a4-4052-bcf5-eb1e5cc56de1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20221122",
            "product_id": "0053-0270_37461df8-e3a4-4052-bcf5-eb1e5cc56de1",
            "application_number": "BLA125772",
            "brand_name_base": "HEMGENIX"
        },
        {
            "product_ndc": "50242-921",
            "generic_name": "emicizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Hemlibra",
            "active_ingredients": [
                {
                    "name": "EMICIZUMAB",
                    "strength": "60 mg/.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-921-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-921-01)  / .4 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20171116",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1989799",
                    "1989804",
                    "1989809",
                    "1989811",
                    "1989814",
                    "1989815",
                    "1989816",
                    "1989817",
                    "2632728",
                    "2632729",
                    "2675567",
                    "2675568"
                ],
                "spl_set_id": [
                    "2483adba-fab6-4d1b-96c5-c195577ed071"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "7NL2E3F6K3"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "bc112715-2870-4223-90e6-09d21f4d70fd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20171116",
            "product_id": "50242-921_bc112715-2870-4223-90e6-09d21f4d70fd",
            "application_number": "BLA761083",
            "brand_name_base": "Hemlibra"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "50242-077",
            "generic_name": "Trastuzumab and hyaluronidase-oysk",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Herceptin Hylecta",
            "active_ingredients": [
                {
                    "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
                    "strength": "10000 U/5mL"
                },
                {
                    "name": "TRASTUZUMAB",
                    "strength": "600 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-077-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01)  / 6 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190228",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2119714",
                    "2119719"
                ],
                "spl_set_id": [
                    "ebf30894-41cf-480c-8bc3-56f592a13813"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175531",
                    "M0009499",
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "Endoglycosidase [EPC]",
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glycoside Hydrolases [CS]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "743QUY4VD8",
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e1b28acf-9e32-4bdf-b2bc-5e7b27d98268",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190228",
            "product_id": "50242-077_e1b28acf-9e32-4bdf-b2bc-5e7b27d98268",
            "application_number": "BLA761106",
            "brand_name_base": "Herceptin Hylecta",
            "pharm_class": [
                "Endoglycosidase [EPC]",
                "Glycoside Hydrolases [CS]",
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "50242-077",
            "generic_name": "Trastuzumab and hyaluronidase-oysk",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Herceptin Hylecta",
            "active_ingredients": [
                {
                    "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
                    "strength": "10000 U/5mL"
                },
                {
                    "name": "TRASTUZUMAB",
                    "strength": "600 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-077-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01)  / 6 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190228",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2119714",
                    "2119719"
                ],
                "spl_set_id": [
                    "ebf30894-41cf-480c-8bc3-56f592a13813"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175531",
                    "M0009499",
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "Endoglycosidase [EPC]",
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glycoside Hydrolases [CS]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "743QUY4VD8",
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e1b28acf-9e32-4bdf-b2bc-5e7b27d98268",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190228",
            "product_id": "50242-077_e1b28acf-9e32-4bdf-b2bc-5e7b27d98268",
            "application_number": "BLA761106",
            "brand_name_base": "Herceptin Hylecta",
            "pharm_class": [
                "Endoglycosidase [EPC]",
                "Glycoside Hydrolases [CS]",
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "63459-303",
            "generic_name": "TRASTUZUMAB",
            "labeler_name": "Cephalon, Inc.",
            "brand_name": "HERZUMA",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63459-303-43",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63459-303-43)  / 20 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200316",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Cephalon, Inc."
                ],
                "rxcui": [
                    "2107053",
                    "2107058",
                    "2169359",
                    "2169362"
                ],
                "spl_set_id": [
                    "ae71c003-883a-4cd8-ad50-e8cc9a54e971"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "9f5e71fd-0a0d-4eb3-bb36-b87c1818542f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200316",
            "product_id": "63459-303_9f5e71fd-0a0d-4eb3-bb36-b87c1818542f",
            "application_number": "BLA761091",
            "brand_name_base": "HERZUMA",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "43068-220",
            "generic_name": "tasimelteon",
            "labeler_name": "Vanda Pharmaceuticals Inc.",
            "brand_name": "Hetlioz",
            "active_ingredients": [
                {
                    "name": "TASIMELTEON",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "43068-220-01",
                    "description": "30 CAPSULE in 1 BOTTLE (43068-220-01)",
                    "marketing_start_date": "20140404",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Vanda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1490473",
                    "1491624",
                    "2468312",
                    "2468316"
                ],
                "spl_set_id": [
                    "ca4a9b63-708e-49e9-8f9b-010625443b90"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175743",
                    "N0000000250"
                ],
                "pharm_class_epc": [
                    "Melatonin Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Melatonin Receptor Agonists [MoA]"
                ],
                "unii": [
                    "SHS4PU80D9"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "3248eef5-6bad-4844-a6f9-2f5fddd39c8d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20140404",
            "product_id": "43068-220_3248eef5-6bad-4844-a6f9-2f5fddd39c8d",
            "application_number": "NDA205677",
            "brand_name_base": "Hetlioz",
            "pharm_class": [
                "Melatonin Receptor Agonist [EPC]",
                "Melatonin Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "59672-1516",
            "generic_name": "avena sativa flowering top, capsicum, strychnos nux-vomica seed, veratrum album root, and zinc",
            "labeler_name": "Miers Laboratories",
            "brand_name": "Drink Ease",
            "active_ingredients": [
                {
                    "name": "AVENA SATIVA FLOWERING TOP",
                    "strength": "30 [hp_C]/1"
                },
                {
                    "name": "CAPSICUM",
                    "strength": "30 [hp_C]/1"
                },
                {
                    "name": "STRYCHNOS NUX-VOMICA SEED",
                    "strength": "30 [hp_C]/1"
                },
                {
                    "name": "VERATRUM ALBUM ROOT",
                    "strength": "30 [hp_C]/1"
                },
                {
                    "name": "ZINC",
                    "strength": "30 [hp_C]/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59672-1516-1",
                    "description": "2 BLISTER PACK in 1 BOX (59672-1516-1)  / 16 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20220128",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Miers Laboratories"
                ],
                "spl_set_id": [
                    "23317bc3-deac-4756-8f99-d08fa32fbbfc"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000185375",
                    "N0000185371",
                    "N0000175629",
                    "N0000184306",
                    "M0000728",
                    "M0006342",
                    "M0016962",
                    "M0022575",
                    "N0000185001",
                    "M0516536"
                ],
                "pharm_class_epc": [
                    "Non-Standardized Plant Allergenic Extract [EPC]",
                    "Non-Standardized Food Allergenic Extract [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Histamine Release [PE]",
                    "Cell-mediated Immunity [PE]",
                    "Increased IgG Production [PE]"
                ],
                "pharm_class_cs": [
                    "Allergens [CS]",
                    "Dietary Proteins [CS]",
                    "Plant Proteins [CS]",
                    "Vegetable Proteins [CS]",
                    "Seed Storage Proteins [CS]"
                ],
                "unii": [
                    "MA9CQJ3F7F",
                    "00UK7646FG",
                    "269XH13919",
                    "QNS6W5US1Z",
                    "J41CSQ7QDS"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "TABLET",
            "spl_id": "212a6c69-1fb5-4d94-ac5d-4f5470792a70",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220128",
            "product_id": "59672-1516_212a6c69-1fb5-4d94-ac5d-4f5470792a70",
            "brand_name_base": "Drink Ease",
            "pharm_class": [
                "Allergens [CS]",
                "Allergens [CS]",
                "Cell-mediated Immunity [PE]",
                "Cell-mediated Immunity [PE]",
                "Dietary Proteins [CS]",
                "Increased Histamine Release [PE]",
                "Increased Histamine Release [PE]",
                "Increased IgG Production [PE]",
                "Non-Standardized Food Allergenic Extract [EPC]",
                "Non-Standardized Plant Allergenic Extract [EPC]",
                "Non-Standardized Plant Allergenic Extract [EPC]",
                "Plant Proteins [CS]",
                "Plant Proteins [CS]",
                "Seed Storage Proteins [CS]",
                "Vegetable Proteins [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0002-7510",
            "generic_name": "Insulin lispro",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Humalog",
            "active_ingredients": [
                {
                    "name": "INSULIN LISPRO",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-7510-01",
                    "description": "1 VIAL in 1 CARTON (0002-7510-01)  / 10 mL in 1 VIAL",
                    "marketing_start_date": "19960724",
                    "sample": false
                },
                {
                    "package_ndc": "0002-7510-17",
                    "description": "1 VIAL in 1 CARTON (0002-7510-17)  / 3 mL in 1 VIAL",
                    "marketing_start_date": "20091204",
                    "sample": false
                },
                {
                    "package_ndc": "0002-7510-99",
                    "description": "1 VIAL in 1 CARTON (0002-7510-99)  / 10 mL in 1 VIAL",
                    "marketing_start_date": "19960724",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "242120",
                    "865098",
                    "1652239",
                    "1652242",
                    "1652639",
                    "1652640",
                    "1652644",
                    "1652646",
                    "1926331",
                    "1926332",
                    "2621571",
                    "2621572"
                ],
                "spl_set_id": [
                    "c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000004931",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [Chemical/Ingredient]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "GFX7QIS1II"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e57e8ab9-295b-4fb7-b723-e7b008117e9a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19960614",
            "product_id": "0002-7510_e57e8ab9-295b-4fb7-b723-e7b008117e9a",
            "application_number": "BLA020563",
            "brand_name_base": "Humalog",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [Chemical/Ingredient]"
            ]
        },
        {
            "product_ndc": "48951-3154",
            "generic_name": "Chelidonium Curcuma P",
            "labeler_name": "Uriel Pharmacy Inc.",
            "brand_name": "Chelidonium Curcuma P",
            "active_ingredients": [
                {
                    "name": "CHELIDONIUM MAJUS ROOT",
                    "strength": "1 [hp_X]/mL"
                },
                {
                    "name": "TURMERIC",
                    "strength": "1 [hp_X]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "48951-3154-3",
                    "description": "60 mL in 1 BOTTLE, DROPPER (48951-3154-3)",
                    "marketing_start_date": "20090901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Uriel Pharmacy Inc."
                ],
                "spl_set_id": [
                    "59566c5e-02bf-42a6-8a63-53d5bfe30909"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "FLT36UCF0N",
                    "856YO1Z64F"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "LIQUID",
            "spl_id": "6a9df35e-68f2-6759-e053-2a91aa0afc2a",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20090901",
            "product_id": "48951-3154_6a9df35e-68f2-6759-e053-2a91aa0afc2a",
            "brand_name_base": "Chelidonium Curcuma P"
        },
        {
            "product_ndc": "0074-0554",
            "generic_name": "Adalimumab",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Humira",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-0554-01",
                    "description": "1 KIT in 1 CARTON (0074-0554-01)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE *  1 mL in 1 PACKET",
                    "marketing_start_date": "20160309",
                    "sample": false
                },
                {
                    "package_ndc": "0074-0554-02",
                    "description": "2 KIT in 1 CARTON (0074-0554-02)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE *  1 mL in 1 PACKET",
                    "marketing_start_date": "20160309",
                    "sample": false
                },
                {
                    "package_ndc": "0074-0554-71",
                    "description": "2 KIT in 1 CARTON (0074-0554-71)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE *  1 mL in 1 PACKET",
                    "marketing_start_date": "20160309",
                    "sample": true
                },
                {
                    "package_ndc": "0074-0554-74",
                    "description": "1 KIT in 1 CARTON (0074-0554-74)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE *  1 mL in 1 PACKET",
                    "marketing_start_date": "20160309",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "351290",
                    "352334",
                    "727703",
                    "727705",
                    "763564",
                    "763565",
                    "797544",
                    "825169",
                    "825170",
                    "1551887",
                    "1551888",
                    "1594352",
                    "1594357",
                    "1594358",
                    "1655726",
                    "1655728",
                    "1656703",
                    "1726844",
                    "1726846",
                    "1801277",
                    "1801278",
                    "1855523",
                    "1855524",
                    "1855526",
                    "1855527",
                    "1872979",
                    "1872980",
                    "1872983",
                    "1872984",
                    "1872985",
                    "1872986",
                    "1873086",
                    "1873087",
                    "1921009",
                    "1921010",
                    "1921016",
                    "1921017",
                    "1921238",
                    "1921240",
                    "1921244",
                    "1921245",
                    "1921467",
                    "1921468",
                    "2531133",
                    "2531134"
                ],
                "spl_set_id": [
                    "608d4f0d-b19f-46d3-749a-7159aa5f933d"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "c8f3937d-66ea-4bdb-b502-fcb33594c8b3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20160309",
            "product_id": "0074-0554_c8f3937d-66ea-4bdb-b502-fcb33594c8b3",
            "application_number": "BLA125057",
            "brand_name_base": "Humira"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "13533-318",
            "generic_name": "Rabies Immune Globulin (Human)",
            "labeler_name": "GRIFOLS USA, LLC",
            "brand_name": "HyperRAB",
            "active_ingredients": [
                {
                    "name": "HUMAN RABIES VIRUS IMMUNE GLOBULIN",
                    "strength": "300 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "13533-318-01",
                    "description": "1 VIAL in 1 CARTON (13533-318-01)  / 1 mL in 1 VIAL (13533-318-10)",
                    "marketing_start_date": "19740612",
                    "sample": false
                },
                {
                    "package_ndc": "13533-318-03",
                    "description": "1 VIAL in 1 CARTON (13533-318-03)  / 3 mL in 1 VIAL (13533-318-30)",
                    "marketing_start_date": "19740612",
                    "sample": false
                },
                {
                    "package_ndc": "13533-318-05",
                    "description": "1 VIAL in 1 CARTON (13533-318-05)  / 5 mL in 1 VIAL (13533-318-50)",
                    "marketing_start_date": "19740612",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e17482c9-3bbf-4f63-a026-e8826768864d",
            "product_type": "PLASMA DERIVATIVE",
            "route": [
                "INFILTRATION",
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "19740612",
            "product_id": "13533-318_e17482c9-3bbf-4f63-a026-e8826768864d",
            "application_number": "BLA101144",
            "brand_name_base": "HyperRAB"
        },
        {
            "product_ndc": "13533-634",
            "generic_name": "Tetanus Immune Globulin (Human)",
            "labeler_name": "GRIFOLS USA, LLC",
            "brand_name": "HyperTET",
            "active_ingredients": [
                {
                    "name": "HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN",
                    "strength": "250 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "13533-634-02",
                    "description": "1 SYRINGE, GLASS in 1 BOX (13533-634-02)  / 1 mL in 1 SYRINGE, GLASS (13533-634-20)",
                    "marketing_start_date": "19960814",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "c35adc4a-1bb3-4816-936a-8a331c1cde5e",
            "product_type": "PLASMA DERIVATIVE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "19960814",
            "product_id": "13533-634_c35adc4a-1bb3-4816-936a-8a331c1cde5e",
            "application_number": "BLA101142",
            "brand_name_base": "HyperTET"
        },
        {
            "product_ndc": "83457-102",
            "generic_name": "adalimumab-adaz",
            "labeler_name": "Cordavis Limited",
            "brand_name": "HYRIMOZ",
            "active_ingredients": [
                {
                    "name": "ADALIMUMAB",
                    "strength": "40 mg/.8mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83457-102-01",
                    "description": "2 SYRINGE in 1 CARTON (83457-102-01)  / .8 mL in 1 SYRINGE",
                    "marketing_start_date": "20230921",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Cordavis Limited"
                ],
                "rxcui": [
                    "2641653",
                    "2641654",
                    "2641655",
                    "2641658",
                    "2641660",
                    "2641661",
                    "2641662",
                    "2641663",
                    "2641664",
                    "2641665",
                    "2641670",
                    "2641671",
                    "2665419",
                    "2665422",
                    "2665424",
                    "2665426"
                ],
                "spl_set_id": [
                    "3e303a4a-980b-4f2a-9d03-786928758637"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "FYS6T7F842"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e937bde8-d78d-4fca-acb0-ea2aac54e579",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230921",
            "product_id": "83457-102_e937bde8-d78d-4fca-acb0-ea2aac54e579",
            "application_number": "BLA761071",
            "brand_name_base": "HYRIMOZ",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0069-0284",
            "generic_name": "palbociclib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Ibrance",
            "active_ingredients": [
                {
                    "name": "PALBOCICLIB",
                    "strength": "75 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0284-03",
                    "description": "3 DOSE PACK in 1 CARTON (0069-0284-03)  / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0284-07)",
                    "marketing_start_date": "20200330",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2284102",
                    "2284104",
                    "2284105",
                    "2284106",
                    "2284107",
                    "2284108"
                ],
                "spl_set_id": [
                    "fecbdd7d-b729-41b5-9872-231b8fe104ce"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175082",
                    "N0000190114"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]"
                ],
                "unii": [
                    "G9ZF61LE7G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "2ab7db9e-5d14-431f-a3a3-a2da3d1047b2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200330",
            "product_id": "0069-0284_2ab7db9e-5d14-431f-a3a3-a2da3d1047b2",
            "application_number": "NDA212436",
            "brand_name_base": "Ibrance",
            "pharm_class": [
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "63020-536",
            "generic_name": "ponatinib hydrochloride",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Iclusig",
            "active_ingredients": [
                {
                    "name": "PONATINIB HYDROCHLORIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63020-536-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (63020-536-30)",
                    "marketing_start_date": "20210111",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1364352",
                    "1364358",
                    "1364360",
                    "1364362",
                    "1726637",
                    "1726639",
                    "2473040",
                    "2473042"
                ],
                "spl_set_id": [
                    "16d804b6-4957-43ee-b18c-3b36ec37c5ac"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "96R6PU3D8J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "161f3d00-ee83-41fd-8ebd-53b073b39b67",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210111",
            "product_id": "63020-536_161f3d00-ee83-41fd-8ebd-53b073b39b67",
            "application_number": "NDA203469",
            "brand_name_base": "Iclusig",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "65219-556",
            "generic_name": "adalimumab",
            "labeler_name": "Fresenius Kabi USA, LLC",
            "brand_name": "Idacio",
            "active_ingredients": [
                {
                    "name": "ADALIMUMAB",
                    "strength": "40 mg/.8mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65219-556-18",
                    "description": "2 SYRINGE, GLASS in 1 CARTON (65219-556-18)  / .8 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20230701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Fresenius Kabi USA, LLC"
                ],
                "rxcui": [
                    "2640851",
                    "2640857",
                    "2640859",
                    "2640862",
                    "2640864",
                    "2640865",
                    "2640869",
                    "2640870"
                ],
                "spl_set_id": [
                    "43de75ac-1a37-4609-9edd-68bda2448a47"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0365219556183",
                    "0365219554387",
                    "0365219554080",
                    "0365219554288"
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "FYS6T7F842"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "b2bd7097-fca7-473f-a7a4-a216eff496f2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230701",
            "product_id": "65219-556_b2bd7097-fca7-473f-a7a4-a216eff496f2",
            "application_number": "BLA761255",
            "brand_name_base": "Idacio",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "69911-867",
            "generic_name": "Coagulation Factor IX Recombinant Human",
            "labeler_name": "CSL Behring Lengnau AG",
            "brand_name": "IDELVION",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69911-867-02",
                    "description": "1 KIT in 1 CARTON (69911-867-02)  *  5 mL in 1 VIAL, SINGLE-USE (69911-877-01)  *  5 mL in 1 VIAL, SINGLE-USE (69911-765-85)",
                    "marketing_start_date": "20160304",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "fc29c907-a767-4a0e-b077-8c197e7ce8b3",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20160304",
            "product_id": "69911-867_fc29c907-a767-4a0e-b077-8c197e7ce8b3",
            "application_number": "BLA125582",
            "brand_name_base": "IDELVION"
        },
        {
            "product_ndc": "59572-710",
            "generic_name": "enasidenib mesylate",
            "labeler_name": "Celgene Corporation",
            "brand_name": "Idhifa",
            "active_ingredients": [
                {
                    "name": "ENASIDENIB MESYLATE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-710-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (59572-710-30)",
                    "marketing_start_date": "20170801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "1940370",
                    "1940372",
                    "1940374",
                    "1940376"
                ],
                "spl_set_id": [
                    "a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "UF6PC17XAV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "01043cba-240a-4cbc-9466-fded4c738efb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170801",
            "product_id": "59572-710_01043cba-240a-4cbc-9466-fded4c738efb",
            "application_number": "NDA209606",
            "brand_name_base": "Idhifa",
            "pharm_class": [
                "Isocitrate Dehydrogenase 2 Inhibitor [EPC]",
                "Isocitrate Dehydrogenase 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0734",
            "generic_name": "canakinumab",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Ilaris",
            "active_ingredients": [
                {
                    "name": "CANAKINUMAB",
                    "strength": "150 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0734-61",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (0078-0734-61)  / 1 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20161222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1864324",
                    "1864326"
                ],
                "spl_set_id": [
                    "7d271f3b-e4f9-4d80-8dcf-28d49123f80e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "37CQ2C7X93"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7bef4ad8-f2e8-45f5-8e01-cdbd07fd91c4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20161222",
            "product_id": "0078-0734_7bef4ad8-f2e8-45f5-8e01-cdbd07fd91c4",
            "application_number": "BLA125319",
            "brand_name_base": "Ilaris"
        },
        {
            "product_ndc": "47335-177",
            "generic_name": "tildrakizumab-asmn",
            "labeler_name": "Sun Pharmaceutical Industries, Inc.",
            "brand_name": "ILUMYA",
            "active_ingredients": [
                {
                    "name": "TILDRAKIZUMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "47335-177-01",
                    "description": "1 mL in 1 SYRINGE, GLASS (47335-177-01)",
                    "marketing_start_date": "20180806",
                    "sample": true
                },
                {
                    "package_ndc": "47335-177-10",
                    "description": "1 mL in 1 CARTON (47335-177-10)",
                    "marketing_start_date": "20180806",
                    "sample": true
                },
                {
                    "package_ndc": "47335-177-95",
                    "description": "1 mL in 1 CARTON (47335-177-95)",
                    "marketing_start_date": "20180806",
                    "sample": false
                },
                {
                    "package_ndc": "47335-177-96",
                    "description": "1 mL in 1 SYRINGE, GLASS (47335-177-96)",
                    "marketing_start_date": "20180806",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sun Pharmaceutical Industries, Inc."
                ],
                "rxcui": [
                    "2053453",
                    "2053458"
                ],
                "spl_set_id": [
                    "c6a322bb-51b9-4f0e-8642-62a9682ffcde"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192799",
                    "N0000192798"
                ],
                "pharm_class_epc": [
                    "Interleukin-23 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-23 Antagonists [MoA]"
                ],
                "unii": [
                    "DEW6X41BEK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "33c31616-62c9-4380-96c4-0ada352f47aa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20180806",
            "product_id": "47335-177_33c31616-62c9-4380-96c4-0ada352f47aa",
            "application_number": "BLA761067",
            "brand_name_base": "ILUMYA",
            "pharm_class": [
                "Interleukin-23 Antagonist [EPC]",
                "Interleukin-23 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "68611-190",
            "generic_name": "fluocinolone acetonide",
            "labeler_name": "Alimera Sciences, Inc.",
            "brand_name": "Iluvien",
            "active_ingredients": [
                {
                    "name": "FLUOCINOLONE ACETONIDE",
                    "strength": ".19 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68611-190-02",
                    "description": "1 TRAY in 1 CARTON (68611-190-02)  / 1 APPLICATOR in 1 TRAY / 1 IMPLANT in 1 APPLICATOR",
                    "marketing_start_date": "20141015",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Alimera Sciences, Inc."
                ],
                "rxcui": [
                    "1552351",
                    "1552356"
                ],
                "spl_set_id": [
                    "4400e471-7402-11df-93f2-0800200c9a66"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "0CD5FD6S2M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "IMPLANT",
            "spl_id": "2e50d171-115e-4ccd-b0d2-d0c4bc335f6a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20141015",
            "product_id": "68611-190_2e50d171-115e-4ccd-b0d2-d0c4bc335f6a",
            "application_number": "NDA201923",
            "brand_name_base": "Iluvien",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "72829-010",
            "generic_name": "setmelanotide",
            "labeler_name": "Rhythm Pharmaceuticals, Inc",
            "brand_name": "Imcivree",
            "active_ingredients": [
                {
                    "name": "SETMELANOTIDE",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72829-010-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72829-010-01)  / 1 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20201214",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Rhythm Pharmaceuticals, Inc"
                ],
                "rxcui": [
                    "2469346",
                    "2469351"
                ],
                "spl_set_id": [
                    "70c3ccf7-4df0-4c75-ba07-fede9970c8d9"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193940",
                    "N0000193941"
                ],
                "pharm_class_epc": [
                    "Melanocortin 4 Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Melanocortin 4 Receptor Agonists [MoA]"
                ],
                "unii": [
                    "N7T15V1FUY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "4c3f963c-e963-44ac-af35-a815a1460985",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20201214",
            "product_id": "72829-010_4c3f963c-e963-44ac-af35-a815a1460985",
            "application_number": "NDA213793",
            "brand_name_base": "Imcivree",
            "pharm_class": [
                "Melanocortin 4 Receptor Agonist [EPC]",
                "Melanocortin 4 Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "55513-059",
            "generic_name": "Tarlatamab-dlle",
            "labeler_name": "Amgen Inc",
            "brand_name": "IMDELLTRA (AMG757)",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-059-01",
                    "description": "1 KIT in 1 PACKAGE (55513-059-01)  *  1 mg in 1 VIAL (55513-103-01)  *  7 mL in 1 VIAL (55513-068-01)",
                    "marketing_start_date": "20240516",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "2682961",
                    "2682967",
                    "2682969",
                    "2682971"
                ],
                "spl_set_id": [
                    "1e7b6163-5d83-42ea-82c9-cf7620cdc782"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "277417f6-4e36-4e77-a088-73f2638660ed",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20240516",
            "product_id": "55513-059_277417f6-4e36-4e77-a088-73f2638660ed",
            "application_number": "BLA761344",
            "brand_name_base": "IMDELLTRA (AMG757)"
        },
        {
            "product_ndc": "0310-4611",
            "generic_name": "Durvalumab",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "IMFINZI",
            "active_ingredients": [
                {
                    "name": "DURVALUMAB",
                    "strength": "500 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-4611-50",
                    "description": "1 VIAL in 1 CARTON (0310-4611-50)  / 10 mL in 1 VIAL",
                    "marketing_start_date": "20170501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "spl_set_id": [
                    "8baba4ea-2855-42fa-9bd9-5a7548d4cec3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193338",
                    "N0000193337",
                    "N0000193336",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Programmed Death Ligand-1 Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Ligand-1 Antagonists [MoA]",
                    "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "28X28X9OKV"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "50e38f84-b8c6-41fd-b9a1-f32bd9b4756d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170501",
            "product_id": "0310-4611_50e38f84-b8c6-41fd-b9a1-f32bd9b4756d",
            "application_number": "BLA761069",
            "brand_name_base": "IMFINZI",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Programmed Death Ligand-1 Antagonists [MoA]",
                "Programmed Death Ligand-1 Blocker [EPC]",
                "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "0310-4505",
            "generic_name": "tremelimumab",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "IMJUDO",
            "active_ingredients": [
                {
                    "name": "TREMELIMUMAB",
                    "strength": "25 mg/1.25mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-4505-25",
                    "description": "1 VIAL in 1 CARTON (0310-4505-25)  / 1.25 mL in 1 VIAL",
                    "marketing_start_date": "20221021",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2619317",
                    "2619323",
                    "2619325",
                    "2619326"
                ],
                "spl_set_id": [
                    "6690679c-be2f-4588-a2e4-89fff74dd6be"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000182635",
                    "N0000182634",
                    "N0000182157"
                ],
                "pharm_class_epc": [
                    "CTLA-4-directed Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "CTLA-4-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_pe": [
                    "Increased T Lymphocyte Activation [PE]"
                ],
                "unii": [
                    "QEN1X95CIX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "9b18a4f0-f19c-470b-b149-60db4a48fb99",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20221021",
            "product_id": "0310-4505_9b18a4f0-f19c-470b-b149-60db4a48fb99",
            "application_number": "BLA761289",
            "brand_name_base": "IMJUDO",
            "pharm_class": [
                "CTLA-4-directed Antibody Interactions [MoA]",
                "CTLA-4-directed Blocking Antibody [EPC]",
                "Increased T Lymphocyte Activation [PE]"
            ]
        },
        {
            "product_ndc": "55513-078",
            "generic_name": "talimogene laherparepvec",
            "labeler_name": "Amgen Inc",
            "brand_name": "Imlygic",
            "active_ingredients": [
                {
                    "name": "TALIMOGENE LAHERPAREPVEC",
                    "strength": "1000000 [PFU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-078-01",
                    "description": "1 VIAL in 1 CARTON (55513-078-01)  / 1 mL in 1 VIAL",
                    "marketing_start_date": "20151102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1721278",
                    "1721283",
                    "1721287",
                    "1721289"
                ],
                "spl_set_id": [
                    "64ffb680-ea8c-42fc-9649-9e8c0eb77ddb"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513078016",
                    "0355513079013"
                ],
                "unii": [
                    "07730V90L6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "c314612a-7d20-43a9-b323-6cb2c3f083ed",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRALESIONAL"
            ],
            "marketing_start_date": "20151102",
            "product_id": "55513-078_c314612a-7d20-43a9-b323-6cb2c3f083ed",
            "application_number": "BLA125518",
            "brand_name_base": "Imlygic"
        },
        {
            "product_ndc": "49281-252",
            "generic_name": "RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER",
            "labeler_name": "Sanofi Pasteur Inc.",
            "brand_name": "IMOVAX RABIES",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49281-252-51",
                    "description": "1 KIT in 1 PACKAGE (49281-252-51)  *  1 mL in 1 VIAL, SINGLE-USE (49281-246-58)  *  1 mL in 1 SYRINGE (49281-263-58)",
                    "marketing_start_date": "20191025",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "dc017ee4-79fc-400a-8a11-d2f613bcb817",
            "product_type": "VACCINE",
            "marketing_start_date": "20191025",
            "product_id": "49281-252_dc017ee4-79fc-400a-8a11-d2f613bcb817",
            "application_number": "BLA103931",
            "brand_name_base": "IMOVAX RABIES"
        },
        {
            "product_ndc": "10144-342",
            "generic_name": "levodopa",
            "labeler_name": "Acorda Therapeutics, Inc.",
            "brand_name": "Inbrija",
            "active_ingredients": [
                {
                    "name": "LEVODOPA",
                    "strength": "42 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10144-342-04",
                    "description": "1 BLISTER PACK in 1 CARTON (10144-342-04)  / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)",
                    "marketing_start_date": "20190829",
                    "sample": false
                },
                {
                    "package_ndc": "10144-342-12",
                    "description": "3 BLISTER PACK in 1 CARTON (10144-342-12)  / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)",
                    "marketing_start_date": "20190829",
                    "sample": false
                },
                {
                    "package_ndc": "10144-342-16",
                    "description": "4 BLISTER PACK in 1 CARTON (10144-342-16)  / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)",
                    "marketing_start_date": "20181222",
                    "sample": true
                },
                {
                    "package_ndc": "10144-342-32",
                    "description": "8 BLISTER PACK in 1 CARTON (10144-342-32)  / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)",
                    "marketing_start_date": "20181222",
                    "sample": true
                },
                {
                    "package_ndc": "10144-342-60",
                    "description": "15 BLISTER PACK in 1 CARTON (10144-342-60)  / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)",
                    "marketing_start_date": "20181222",
                    "sample": false
                },
                {
                    "package_ndc": "10144-342-92",
                    "description": "23 BLISTER PACK in 1 CARTON (10144-342-92)  / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)",
                    "marketing_start_date": "20181222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Acorda Therapeutics, Inc."
                ],
                "rxcui": [
                    "2107616",
                    "2107621"
                ],
                "spl_set_id": [
                    "a906f8e1-6e1c-480a-8276-c01bc65dd3be"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "46627O600J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "f2a3ac4a-132d-6200-e053-2995a90af649",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20181222",
            "product_id": "10144-342_f2a3ac4a-132d-6200-e053-2995a90af649",
            "application_number": "NDA209184",
            "brand_name_base": "Inbrija",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0173-0859",
            "generic_name": "fluticasone furoate and vilanterol trifenatate",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Breo Ellipta",
            "active_ingredients": [
                {
                    "name": "FLUTICASONE FUROATE",
                    "strength": "100 ug/1"
                },
                {
                    "name": "VILANTEROL TRIFENATATE",
                    "strength": "25 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0859-10",
                    "description": "1 TRAY in 1 CARTON (0173-0859-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-14",
                    "description": "1 TRAY in 1 CARTON (0173-0859-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-61",
                    "description": "1 TRAY in 1 CARTON (0173-0859-61)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "marketing_end_date": "20240630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1424889",
                    "1424899",
                    "1539891",
                    "1539893",
                    "1648783",
                    "1648785",
                    "1648788",
                    "1648789",
                    "2637473",
                    "2637476"
                ],
                "spl_set_id": [
                    "96428df1-ea05-431a-98d3-1ec2c4b63878"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "40AHO2C6DG",
                    "JS86977WNV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER",
            "spl_id": "dea41e66-87ce-42ee-8391-e0c25938ea73",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20130826",
            "product_id": "0173-0859_dea41e66-87ce-42ee-8391-e0c25938ea73",
            "application_number": "NDA204275",
            "brand_name_base": "Breo Ellipta",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "0069-0809",
            "generic_name": "infliximab-dyyb",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "INFLECTRA",
            "active_ingredients": [
                {
                    "name": "INFLIXIMAB",
                    "strength": "100 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0809-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (0069-0809-01)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20161121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "1790541",
                    "1790546"
                ],
                "spl_set_id": [
                    "37eaca10-d812-48bc-8b8e-b836bfa9968f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300690809014"
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "unii": [
                    "B72HH48FLU"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "f041e774-dde4-4092-800c-ca211690fb2a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20161121",
            "product_id": "0069-0809_f041e774-dde4-4092-800c-ca211690fb2a",
            "application_number": "BLA125544",
            "brand_name_base": "INFLECTRA",
            "pharm_class": [
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "70370-1080",
            "generic_name": "Valbenazine",
            "labeler_name": "Neurocrine Biosciences, Inc.",
            "brand_name": "INGREZZA",
            "active_ingredients": [
                {
                    "name": "VALBENAZINE TOSYLATE",
                    "strength": "80 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70370-1080-1",
                    "description": "30 CAPSULE in 1 BOTTLE (70370-1080-1)",
                    "marketing_start_date": "20171004",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Neurocrine Biosciences, Inc."
                ],
                "rxcui": [
                    "1918224",
                    "1918230",
                    "1986329",
                    "1986331",
                    "2054268",
                    "2054269",
                    "2541511",
                    "2541513",
                    "2665627",
                    "2665628",
                    "2680779",
                    "2680780",
                    "2680781",
                    "2680782",
                    "2680783",
                    "2680784"
                ],
                "spl_set_id": [
                    "4c970164-cafb-421f-9eb5-c226ef0a3417"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370370408011",
                    "0370370404013",
                    "0370370406017"
                ],
                "unii": [
                    "5SML1T733B"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "069ca9bd-7d7e-4358-b1f2-ce3ab7bca189",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20171004",
            "product_id": "70370-1080_069ca9bd-7d7e-4358-b1f2-ce3ab7bca189",
            "application_number": "NDA209241",
            "brand_name_base": "INGREZZA",
            "pharm_class": [
                "Vesicular Monoamine Transporter 2 Inhibitor [EPC]",
                "Vesicular Monoamine Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0517-0602",
            "generic_name": "Ferric Carboxymaltose Injection",
            "labeler_name": "American Regent, Inc.",
            "brand_name": "Injectafer",
            "active_ingredients": [
                {
                    "name": "FERRIC CARBOXYMALTOSE",
                    "strength": "50 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0517-0602-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 BOX (0517-0602-01)  / 2 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20220728",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "American Regent, Inc."
                ],
                "rxcui": [
                    "1435169",
                    "1435174",
                    "2552400",
                    "2552401",
                    "2602296",
                    "2602297"
                ],
                "spl_set_id": [
                    "517b4a19-45b3-4286-9f6a-ced4e10447de"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "6897GXD6OE"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "72f9297d-5eb4-4e10-9545-c4d6f686c2c5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220601",
            "product_id": "0517-0602_72f9297d-5eb4-4e10-9545-c4d6f686c2c5",
            "application_number": "NDA203565",
            "brand_name_base": "Injectafer",
            "pharm_class": [
                "Iron [CS]",
                "Parenteral Iron Replacement [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]"
            ]
        },
        {
            "product_ndc": "63539-026",
            "generic_name": "axitinib",
            "labeler_name": "U.S. Pharmaceuticals",
            "brand_name": "INLYTA",
            "active_ingredients": [
                {
                    "name": "AXITINIB",
                    "strength": "1 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63539-026-01",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (63539-026-01)",
                    "marketing_start_date": "20120127",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "U.S. Pharmaceuticals"
                ],
                "rxcui": [
                    "1243004",
                    "1243010",
                    "1243012",
                    "1243014"
                ],
                "spl_set_id": [
                    "8a903e31-936e-4ed7-8a59-59f32374f338"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020000"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Receptor Tyrosine Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "C9LVQ0YUXG"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "e931bcdd-b961-4f8f-a0e2-d6d6b7678ac2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120127",
            "product_id": "63539-026_e931bcdd-b961-4f8f-a0e2-d6d6b7678ac2",
            "application_number": "NDA202324",
            "brand_name_base": "INLYTA",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Receptor Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "64842-0727",
            "generic_name": "CEDAZURIDINE and DECITABINE",
            "labeler_name": "Taiho Pharmaceutical Co., Ltd.",
            "brand_name": "INQOVI",
            "active_ingredients": [
                {
                    "name": "CEDAZURIDINE",
                    "strength": "100 mg/1"
                },
                {
                    "name": "DECITABINE",
                    "strength": "35 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64842-0727-9",
                    "description": "1 BLISTER PACK in 1 CARTON (64842-0727-9)  / 5 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20200825",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Taiho Pharmaceutical Co., Ltd."
                ],
                "rxcui": [
                    "2384457",
                    "2384458",
                    "2384464",
                    "2384465"
                ],
                "spl_set_id": [
                    "91a0f80b-f865-4d06-a40d-4d148d99ee71"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000233",
                    "N0000175595"
                ],
                "pharm_class_moa": [
                    "Nucleic Acid Synthesis Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Nucleoside Metabolic Inhibitor [EPC]"
                ],
                "unii": [
                    "39IS23Q1EW",
                    "776B62CQ27"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "8a42c130-411f-4614-a0ce-bba065e85210",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200707",
            "product_id": "64842-0727_8a42c130-411f-4614-a0ce-bba065e85210",
            "application_number": "NDA212576",
            "brand_name_base": "INQOVI",
            "pharm_class": [
                "Nucleic Acid Synthesis Inhibitors [MoA]",
                "Nucleoside Metabolic Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "59572-720",
            "generic_name": "Fedratinib Hydrochloride",
            "labeler_name": "Celgene Corporation",
            "brand_name": "Inrebic",
            "active_ingredients": [
                {
                    "name": "FEDRATINIB HYDROCHLORIDE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-720-12",
                    "description": "120 CAPSULE in 1 BOTTLE, PLASTIC (59572-720-12)",
                    "marketing_start_date": "20190816",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "2197495",
                    "2197501"
                ],
                "spl_set_id": [
                    "f0f55a2a-4e0c-4cba-8571-03e1424486d7"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "UH9J2HBQWJ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "e9e69209-db31-45b6-8793-9767983facf7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190816",
            "product_id": "59572-720_e9e69209-db31-45b6-8793-9767983facf7",
            "application_number": "NDA212327",
            "brand_name_base": "Inrebic"
        },
        {
            "product_ndc": "59676-571",
            "generic_name": "etravirine",
            "labeler_name": "Janssen Products LP",
            "brand_name": "Intelence",
            "active_ingredients": [
                {
                    "name": "ETRAVIRINE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59676-571-01",
                    "description": "60 TABLET in 1 BOTTLE, PLASTIC (59676-571-01)",
                    "marketing_start_date": "20101222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Products LP"
                ],
                "rxcui": [
                    "754761",
                    "758555",
                    "1052658",
                    "1052660",
                    "1250721",
                    "1250723"
                ],
                "spl_set_id": [
                    "6a9cbc29-9f15-4b24-8d86-206b82887f3d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0359676570011",
                    "0359676571018",
                    "0359676572015"
                ],
                "nui": [
                    "N0000175463",
                    "N0000175460",
                    "N0000009948",
                    "N0000190118",
                    "N0000185504",
                    "N0000182140",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "Cytochrome P450 2C19 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "0C50HW4FO1"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "02fc6f4f-330d-b32e-e063-6294a90a028a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20101222",
            "product_id": "59676-571_02fc6f4f-330d-b32e-e063-6294a90a028a",
            "application_number": "NDA022187",
            "brand_name_base": "Intelence",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "76420-494",
            "generic_name": "Zolpidem Tartrate",
            "labeler_name": "Asclemed USA, Inc.",
            "dea_schedule": "CIV",
            "brand_name": "Zolpidem Tartrate",
            "active_ingredients": [
                {
                    "name": "ZOLPIDEM TARTRATE",
                    "strength": "6.25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76420-494-01",
                    "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-01)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-30",
                    "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-30)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-60",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-60)",
                    "marketing_start_date": "20221005",
                    "sample": false
                },
                {
                    "package_ndc": "76420-494-90",
                    "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-494-90)",
                    "marketing_start_date": "20221005",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Asclemed USA, Inc."
                ],
                "rxcui": [
                    "854880",
                    "854894"
                ],
                "spl_set_id": [
                    "35f6c1ab-a61c-4625-b932-11a7483f1d84"
                ],
                "unii": [
                    "WY6W63843K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "ea435212-caf8-164b-e053-2a95a90a0bf6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201217",
            "product_id": "76420-494_ea435212-caf8-164b-e053-2a95a90a0bf6",
            "application_number": "ANDA213592",
            "brand_name_base": "Zolpidem Tartrate",
            "pharm_class": [
                "Central Nervous System Depression [PE]",
                "GABA A Agonists [MoA]",
                "Pyridines [CS]",
                "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "50458-562",
            "generic_name": "paliperidone palmitate",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "INVEGA SUSTENNA",
            "active_ingredients": [
                {
                    "name": "PALIPERIDONE PALMITATE",
                    "strength": "117 mg/.75mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-562-01",
                    "description": "1 SYRINGE in 1 KIT (50458-562-01)  / .75 mL in 1 SYRINGE",
                    "marketing_start_date": "20090731",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "858048",
                    "858051",
                    "858052",
                    "858053",
                    "858054",
                    "858055",
                    "858056",
                    "858057",
                    "858073",
                    "858074"
                ],
                "spl_set_id": [
                    "1af14e42-951d-414d-8564-5d5fce138554"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "R8P8USM8FR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "1a2a404f-d78e-6d15-e063-6294a90a2c94",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20090731",
            "product_id": "50458-562_1a2a404f-d78e-6d15-e063-6294a90a2c94",
            "application_number": "NDA022264",
            "brand_name_base": "INVEGA SUSTENNA",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "50458-562",
            "generic_name": "paliperidone palmitate",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "INVEGA SUSTENNA",
            "active_ingredients": [
                {
                    "name": "PALIPERIDONE PALMITATE",
                    "strength": "117 mg/.75mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-562-01",
                    "description": "1 SYRINGE in 1 KIT (50458-562-01)  / .75 mL in 1 SYRINGE",
                    "marketing_start_date": "20090731",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "858048",
                    "858051",
                    "858052",
                    "858053",
                    "858054",
                    "858055",
                    "858056",
                    "858057",
                    "858073",
                    "858074"
                ],
                "spl_set_id": [
                    "1af14e42-951d-414d-8564-5d5fce138554"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "R8P8USM8FR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "1a2a404f-d78e-6d15-e063-6294a90a2c94",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20090731",
            "product_id": "50458-562_1a2a404f-d78e-6d15-e063-6294a90a2c94",
            "application_number": "NDA022264",
            "brand_name_base": "INVEGA SUSTENNA",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "50458-562",
            "generic_name": "paliperidone palmitate",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "INVEGA SUSTENNA",
            "active_ingredients": [
                {
                    "name": "PALIPERIDONE PALMITATE",
                    "strength": "117 mg/.75mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-562-01",
                    "description": "1 SYRINGE in 1 KIT (50458-562-01)  / .75 mL in 1 SYRINGE",
                    "marketing_start_date": "20090731",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "858048",
                    "858051",
                    "858052",
                    "858053",
                    "858054",
                    "858055",
                    "858056",
                    "858057",
                    "858073",
                    "858074"
                ],
                "spl_set_id": [
                    "1af14e42-951d-414d-8564-5d5fce138554"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "R8P8USM8FR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "1a2a404f-d78e-6d15-e063-6294a90a2c94",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20090731",
            "product_id": "50458-562_1a2a404f-d78e-6d15-e063-6294a90a2c94",
            "application_number": "NDA022264",
            "brand_name_base": "INVEGA SUSTENNA",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "50458-543",
            "generic_name": "canagliflozin and metformin hydrochloride",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "INVOKAMET",
            "active_ingredients": [
                {
                    "name": "CANAGLIFLOZIN",
                    "strength": "150 mg/1"
                },
                {
                    "name": "METFORMIN HYDROCHLORIDE",
                    "strength": "1000 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-543-60",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (50458-543-60)",
                    "marketing_start_date": "20140808",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1545150",
                    "1545156",
                    "1545157",
                    "1545159",
                    "1545161",
                    "1545163",
                    "1545164",
                    "1545166",
                    "1810997",
                    "1810999",
                    "1811002",
                    "1811003",
                    "1811006",
                    "1811007",
                    "1811010",
                    "1811011"
                ],
                "spl_set_id": [
                    "6868666b-c25e-40d1-9d1f-306bbe9390c1"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350458940015"
                ],
                "unii": [
                    "786Z46389E",
                    "0SAC974Z85"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "102d2ebd-7a95-9b4a-e063-6394a90a8e14",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20140808",
            "product_id": "50458-543_102d2ebd-7a95-9b4a-e063-6394a90a8e14",
            "application_number": "NDA204353",
            "brand_name_base": "INVOKAMET",
            "pharm_class": [
                "Biguanide [EPC]",
                "Biguanides [CS]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
                "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "50458-140",
            "generic_name": "canagliflozin",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "INVOKANA",
            "active_ingredients": [
                {
                    "name": "CANAGLIFLOZIN",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-140-01",
                    "description": "5 TABLET, FILM COATED in 1 BOTTLE (50458-140-01)",
                    "marketing_start_date": "20130329",
                    "sample": true
                },
                {
                    "package_ndc": "50458-140-10",
                    "description": "10 BLISTER PACK in 1 CARTON (50458-140-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20130329",
                    "sample": false
                },
                {
                    "package_ndc": "50458-140-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (50458-140-30)",
                    "marketing_start_date": "20130329",
                    "sample": false
                },
                {
                    "package_ndc": "50458-140-50",
                    "description": "500 TABLET, FILM COATED in 1 BOTTLE (50458-140-50)",
                    "marketing_start_date": "20130329",
                    "sample": false
                },
                {
                    "package_ndc": "50458-140-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (50458-140-90)",
                    "marketing_start_date": "20130329",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1373463",
                    "1373469",
                    "1373471",
                    "1373473"
                ],
                "spl_set_id": [
                    "b9057d3b-b104-4f09-8a61-c61ef9d4a3f3"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350458140903",
                    "0350458141900"
                ],
                "unii": [
                    "0SAC974Z85"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "004c990c-b658-432f-e063-6394a90aa93d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130329",
            "product_id": "50458-140_004c990c-b658-432f-e063-6394a90aa93d",
            "application_number": "NDA204042",
            "brand_name_base": "INVOKANA",
            "pharm_class": [
                "P-Glycoprotein Inhibitors [MoA]",
                "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
                "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0310-0482",
            "generic_name": "Gefitinib",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "IRESSA",
            "active_ingredients": [
                {
                    "name": "GEFITINIB",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-0482-30",
                    "description": "30 TABLET, COATED in 1 BOTTLE (0310-0482-30)",
                    "marketing_start_date": "20150713",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "349472",
                    "402091"
                ],
                "spl_set_id": [
                    "827d60e8-7e07-41b7-c28b-49ef1c4a5a41"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "S65743JHBS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "1655359e-01b6-456e-adcc-005cf83d9e20",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150713",
            "product_id": "0310-0482_1655359e-01b6-456e-adcc-005cf83d9e20",
            "application_number": "NDA206995",
            "brand_name_base": "IRESSA",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0006-3080",
            "generic_name": "RALTEGRAVIR",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "ISENTRESS",
            "active_ingredients": [
                {
                    "name": "RALTEGRAVIR POTASSIUM",
                    "strength": "600 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-3080-01",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (0006-3080-01)",
                    "marketing_start_date": "20170526",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "744842",
                    "744846",
                    "1235588",
                    "1235591",
                    "1235593",
                    "1235595",
                    "1486838",
                    "1486841",
                    "1924313",
                    "1924315"
                ],
                "spl_set_id": [
                    "89a5ec53-d956-4329-8004-0f40f51c88a3"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300060227615",
                    "0300060473616",
                    "0300063080019"
                ],
                "unii": [
                    "43Y000U234"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "6898502e-696b-4ccc-aa35-f00e2f172c39",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170526",
            "product_id": "0006-3080_6898502e-696b-4ccc-aa35-f00e2f172c39",
            "application_number": "NDA022145",
            "brand_name_base": "ISENTRESS",
            "pharm_class": [
                "HIV Integrase Inhibitors [MoA]",
                "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "62207-927",
            "generic_name": "GABAPENTIN",
            "labeler_name": "Granules India Limited",
            "brand_name": "GABAPENTIN",
            "active_ingredients": [
                {
                    "name": "GABAPENTIN",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "62207-927-49",
                    "description": "1000 CAPSULE in 1 BOTTLE (62207-927-49)",
                    "marketing_start_date": "20210901",
                    "sample": false
                },
                {
                    "package_ndc": "62207-927-54",
                    "description": "30 CAPSULE in 1 BOTTLE (62207-927-54)",
                    "marketing_start_date": "20210901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Granules India Limited"
                ],
                "rxcui": [
                    "310430",
                    "310431",
                    "310432"
                ],
                "spl_set_id": [
                    "bda0a0db-693b-b1e6-e053-2a95a90a5ce1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008486"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "unii": [
                    "6CW7F3G59X"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE",
            "spl_id": "eca48cc3-0a88-7c06-e053-2a95a90aa850",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210901",
            "product_id": "62207-927_eca48cc3-0a88-7c06-e053-2a95a90aa850",
            "application_number": "ANDA075360",
            "brand_name_base": "GABAPENTIN",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "50090-6244",
            "generic_name": "sitagliptin and metformin hydrochloride",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "JANUMET XR",
            "active_ingredients": [
                {
                    "name": "METFORMIN HYDROCHLORIDE",
                    "strength": "1000 mg/1"
                },
                {
                    "name": "SITAGLIPTIN PHOSPHATE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-6244-0",
                    "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-6244-0)",
                    "marketing_start_date": "20221128",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "1243827",
                    "1243833"
                ],
                "spl_set_id": [
                    "ed768466-bea6-4672-a599-a7ad3a2a2209"
                ],
                "unii": [
                    "786Z46389E",
                    "TS63EW8X6F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
            "spl_id": "39f19064-5e8d-4b96-b4de-7a18fc265310",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120202",
            "product_id": "50090-6244_39f19064-5e8d-4b96-b4de-7a18fc265310",
            "application_number": "NDA202270",
            "brand_name_base": "JANUMET XR",
            "pharm_class": [
                "Biguanide [EPC]",
                "Biguanides [CS]",
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "0006-0221",
            "generic_name": "sitagliptin",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "JANUVIA",
            "active_ingredients": [
                {
                    "name": "SITAGLIPTIN PHOSPHATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-0221-28",
                    "description": "100 BLISTER PACK in 1 CARTON (0006-0221-28)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (0006-0221-01)",
                    "marketing_start_date": "20061016",
                    "sample": false
                },
                {
                    "package_ndc": "0006-0221-31",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0006-0221-31)",
                    "marketing_start_date": "20061016",
                    "sample": false
                },
                {
                    "package_ndc": "0006-0221-54",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (0006-0221-54)",
                    "marketing_start_date": "20061016",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "665033",
                    "665036",
                    "665038",
                    "665040",
                    "665042",
                    "665044"
                ],
                "spl_set_id": [
                    "f85a48d0-0407-4c50-b0fa-7673a160bf01"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300060221316",
                    "0300060112317",
                    "0300060277313"
                ],
                "unii": [
                    "TS63EW8X6F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "6970c5e9-bd40-4847-9321-ab5826b7b7e5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20061016",
            "product_id": "0006-0221_6970c5e9-bd40-4847-9321-ab5826b7b7e5",
            "application_number": "NDA021995",
            "brand_name_base": "JANUVIA",
            "pharm_class": [
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "43598-096",
            "generic_name": "Sapropterin Dihydrochloride",
            "labeler_name": "Dr. Reddys Laboratories Inc",
            "brand_name": "JAVYGTOR",
            "active_ingredients": [
                {
                    "name": "SAPROPTERIN DIHYDROCHLORIDE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "43598-096-04",
                    "description": "120 TABLET in 1 BOTTLE (43598-096-04)",
                    "marketing_start_date": "20221003",
                    "sample": false
                },
                {
                    "package_ndc": "43598-096-05",
                    "description": "500 TABLET in 1 BOTTLE (43598-096-05)",
                    "marketing_start_date": "20221003",
                    "sample": false
                },
                {
                    "package_ndc": "43598-096-30",
                    "description": "30 TABLET in 1 BOTTLE (43598-096-30)",
                    "marketing_start_date": "20221003",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Dr. Reddys Laboratories Inc"
                ],
                "rxcui": [
                    "1486687",
                    "2612671"
                ],
                "spl_set_id": [
                    "d9f3723f-bf7d-9a72-2ef9-41c5508d6ab4"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0343598096049"
                ],
                "unii": [
                    "RG277LF5B3"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "a9701d52-15de-5762-9bd5-651f4764f1c1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20221003",
            "product_id": "43598-096_a9701d52-15de-5762-9bd5-651f4764f1c1",
            "application_number": "ANDA207685",
            "brand_name_base": "JAVYGTOR",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Phenylalanine Hydroxylase Activator [EPC]",
                "Phenylalanine Hydroxylase Activators [MoA]"
            ]
        },
        {
            "product_ndc": "0002-6902",
            "generic_name": "pirtobrutinib",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "JAYPIRCA",
            "active_ingredients": [
                {
                    "name": "PIRTOBRUTINIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-6902-30",
                    "description": "30 TABLET, COATED in 1 BOTTLE (0002-6902-30)",
                    "marketing_start_date": "20230127",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "2629343",
                    "2629349",
                    "2629351",
                    "2629353"
                ],
                "spl_set_id": [
                    "bd551845-0878-49a4-860f-839b83f6b801"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000193934",
                    "N0000185503",
                    "N0000187062",
                    "N0000182140",
                    "N0000190114",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Bruton's Tyrosine Kinase Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 2C19 Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "JNA39I7ZVB"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "8dd89a71-8bf0-46bd-9297-850f74f279f1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230127",
            "product_id": "0002-6902_8dd89a71-8bf0-46bd-9297-850f74f279f1",
            "application_number": "NDA216059",
            "brand_name_base": "JAYPIRCA",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Bruton's Tyrosine Kinase Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72493-103",
            "generic_name": "mitomycin",
            "labeler_name": "UroGen Pharma, Inc.",
            "brand_name": "JELMYTO",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72493-103-03",
                    "description": "1 KIT in 1 CARTON (72493-103-03)  *  20 mL in 1 VIAL, SINGLE-DOSE (72493-102-20)  *  1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72493-101-40)",
                    "marketing_start_date": "20200501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "UroGen Pharma, Inc."
                ],
                "rxcui": [
                    "2375818",
                    "2375823"
                ],
                "spl_set_id": [
                    "3d3d5053-5427-4a68-a40b-edb60699521e"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "c7838eec-38c2-4b99-b590-d396658313b9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20200501",
            "product_id": "72493-103_c7838eec-38c2-4b99-b590-d396658313b9",
            "application_number": "NDA211728",
            "brand_name_base": "JELMYTO"
        },
        {
            "product_ndc": "0173-0898",
            "generic_name": "dostarlimab",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Jemperli",
            "active_ingredients": [
                {
                    "name": "DOSTARLIMAB",
                    "strength": "50 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0898-03",
                    "description": "1 VIAL in 1 CARTON (0173-0898-03)  / 10 mL in 1 VIAL",
                    "marketing_start_date": "20210422",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "2539972",
                    "2539977"
                ],
                "spl_set_id": [
                    "095eab9f-545a-4f12-bfb7-19477fb901a5"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "P0GVQ9A4S5"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "eb8f4f07-600f-447e-84a9-dba2c39c112b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210422",
            "product_id": "0173-0898_eb8f4f07-600f-447e-84a9-dba2c39c112b",
            "application_number": "BLA761174",
            "brand_name_base": "Jemperli",
            "pharm_class": [
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "65044-9971",
            "generic_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "labeler_name": "Jubilant HollisterStier LLC",
            "brand_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65044-9971-1",
                    "description": "1 KIT in 1 TRAY (65044-9971-1)  *  1.2 mL in 1 VIAL (65044-9981-2)",
                    "marketing_start_date": "19820222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "b9289dcf-445f-4a93-89f7-f513569254fd",
            "product_type": "STANDARDIZED ALLERGENIC",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19820222",
            "product_id": "65044-9971_b9289dcf-445f-4a93-89f7-f513569254fd",
            "application_number": "BLA103885",
            "brand_name_base": "White Faced Hornet Hymenoptera Venom Venomil Maintenance"
        },
        {
            "product_ndc": "55550-102",
            "generic_name": "Homosalate, Octinoxate, Octisalate, Oxybenzone",
            "labeler_name": "Total Resources International",
            "brand_name": "Sunscreen",
            "active_ingredients": [
                {
                    "name": "HOMOSALATE",
                    "strength": "6 mg/g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55550-102-01",
                    "description": "1.5 g in 1 PACKET (55550-102-01)",
                    "marketing_start_date": "20230120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Total Resources International"
                ],
                "spl_set_id": [
                    "7d4f820d-e154-428e-89c2-2e26e088ceef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LOTION",
            "spl_id": "f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20230120",
            "product_id": "55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "application_number": "part352",
            "brand_name_base": "Sunscreen"
        },
        {
            "product_ndc": "0024-5824",
            "generic_name": "cabazitaxel",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Jevtana",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5824-11",
                    "description": "1 KIT in 1 CARTON (0024-5824-11)  *  5.7 mL in 1 VIAL, GLASS (0024-5822-01)  *  5.7 mL in 1 VIAL, GLASS (0024-5823-15)",
                    "marketing_start_date": "20100617",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "1001433",
                    "1376084"
                ],
                "spl_set_id": [
                    "de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "a2143f39-0543-4e3d-bba8-4d21f4bb5efb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20100617",
            "product_id": "0024-5824_a2143f39-0543-4e3d-bba8-4d21f4bb5efb",
            "application_number": "NDA201023",
            "brand_name_base": "Jevtana"
        },
        {
            "product_ndc": "0026-3942",
            "generic_name": "Antihemophilic Factor (Recombinant) Pegylated-aucl",
            "labeler_name": "Bayer HealthCare LLC",
            "brand_name": "Jivi",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0026-3942-25",
                    "description": "1 KIT in 1 BOX (0026-3942-25)  *  2.5 mL in 1 VIAL (0026-4942-99)  *  2.5 mL in 1 SYRINGE (0026-0426-02)  *  2.5 mL in 1 VIAL, SINGLE-USE (0026-4942-01)",
                    "marketing_start_date": "20180830",
                    "sample": false
                },
                {
                    "package_ndc": "0026-3942-99",
                    "description": "1 KIT in 1 BOX (0026-3942-99)  *  2.5 mL in 1 VIAL (0026-4942-99)  *  2.5 mL in 1 SYRINGE (0026-0426-02)  *  2.5 mL in 1 VIAL, SINGLE-USE (0026-4942-01)",
                    "marketing_start_date": "20180830",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "7785a352-6c1a-4989-87bb-0630600c04db",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20180830",
            "product_id": "0026-3942_7785a352-6c1a-4989-87bb-0630600c04db",
            "application_number": "BLA125661",
            "brand_name_base": "Jivi"
        },
        {
            "product_ndc": "71274-170",
            "generic_name": "Leniolisib",
            "labeler_name": "Pharming Healthcare Inc.",
            "brand_name": "Joenja",
            "active_ingredients": [
                {
                    "name": "LENIOLISIB PHOSPHATE",
                    "strength": "70 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71274-170-60",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (71274-170-60)  / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20230329",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pharming Healthcare Inc."
                ],
                "rxcui": [
                    "2633015",
                    "2633021"
                ],
                "spl_set_id": [
                    "eefbcef8-2130-4654-8f29-b58077e08212"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "3700M1H39Q"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7cfc3968-6a21-4c48-b72c-01ee71b7e6cf",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230329",
            "product_id": "71274-170_7cfc3968-6a21-4c48-b72c-01ee71b7e6cf",
            "application_number": "NDA217759",
            "brand_name_base": "Joenja",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "Phosphoinositide 3-Kinase delta Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0187-5400",
            "generic_name": "efinaconazole",
            "labeler_name": "Bausch Health US LLC",
            "brand_name": "JUBLIA",
            "active_ingredients": [
                {
                    "name": "EFINACONAZOLE",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-5400-02",
                    "description": "1 BOTTLE, WITH APPLICATOR in 1 CARTON (0187-5400-02)  / 2 mL in 1 BOTTLE, WITH APPLICATOR",
                    "marketing_start_date": "20151217",
                    "sample": false
                },
                {
                    "package_ndc": "0187-5400-04",
                    "description": "1 BOTTLE, WITH APPLICATOR in 1 CARTON (0187-5400-04)  / 4 mL in 1 BOTTLE, WITH APPLICATOR",
                    "marketing_start_date": "20140606",
                    "sample": false
                },
                {
                    "package_ndc": "0187-5400-08",
                    "description": "1 BOTTLE, WITH APPLICATOR in 1 CARTON (0187-5400-08)  / 8 mL in 1 BOTTLE, WITH APPLICATOR",
                    "marketing_start_date": "20140606",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US LLC"
                ],
                "rxcui": [
                    "1539757",
                    "1539762"
                ],
                "spl_set_id": [
                    "922d4d25-c530-11e1-9b21-0800200c9a66"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175487",
                    "M0002083"
                ],
                "pharm_class_epc": [
                    "Azole Antifungal [EPC]"
                ],
                "pharm_class_cs": [
                    "Azoles [CS]"
                ],
                "unii": [
                    "J82SB7FXWB"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "f3c0bfe9-3cdf-41df-8e6e-77901a8c8f3e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20140606",
            "product_id": "0187-5400_f3c0bfe9-3cdf-41df-8e6e-77901a8c8f3e",
            "application_number": "NDA203567",
            "brand_name_base": "JUBLIA",
            "pharm_class": [
                "Azole Antifungal [EPC]",
                "Azoles [CS]"
            ]
        },
        {
            "product_ndc": "49702-242",
            "generic_name": "dolutegravir sodium and rilpivirine hydrochloride",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "Juluca",
            "active_ingredients": [
                {
                    "name": "DOLUTEGRAVIR SODIUM",
                    "strength": "50 mg/1"
                },
                {
                    "name": "RILPIVIRINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-242-13",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-242-13)",
                    "marketing_start_date": "20171121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "1989500",
                    "1989506"
                ],
                "spl_set_id": [
                    "806653d1-bf35-4924-b999-ad5d21821cc1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "1Q1V9V5WYQ",
                    "212WAX8KDD"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "dc1d3c69-1119-4ad8-ab86-3b6a9a1c3f1f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20171121",
            "product_id": "49702-242_dc1d3c69-1119-4ad8-ab86-3b6a9a1c3f1f",
            "application_number": "NDA210192",
            "brand_name_base": "Juluca",
            "pharm_class": [
                "HIV Integrase Inhibitors [MoA]",
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Organic Cation Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "59148-082",
            "generic_name": "tolvaptan",
            "labeler_name": "Otsuka America Pharmaceutical, Inc.",
            "brand_name": "JYNARQUE",
            "active_ingredients": [
                {
                    "name": "TOLVAPTAN",
                    "strength": "15 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59148-082-13",
                    "description": "1 BOTTLE in 1 CARTON (59148-082-13)  / 30 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20180423",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Otsuka America Pharmaceutical, Inc."
                ],
                "rxcui": [
                    "849827",
                    "849833",
                    "2044355",
                    "2044357",
                    "2044359",
                    "2044361",
                    "2044363",
                    "2044365",
                    "2044367",
                    "2044369",
                    "2044966",
                    "2044967",
                    "2044968",
                    "2044969",
                    "2044970",
                    "2044971",
                    "2274813",
                    "2274814",
                    "2274815",
                    "2274816"
                ],
                "spl_set_id": [
                    "3febc0a1-9e5a-4ce0-843d-210f21d862c4"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0359148079073",
                    "0359148080079",
                    "0359148089072",
                    "0359148087078",
                    "0359148088075"
                ],
                "nui": [
                    "N0000193181",
                    "N0000193178"
                ],
                "pharm_class_epc": [
                    "Vasopressin V2 Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Vasopressin V2 Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "21G72T1950"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "7d0942d7-af91-43ce-a85c-6d49976f06ee",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180423",
            "product_id": "59148-082_7d0942d7-af91-43ce-a85c-6d49976f06ee",
            "application_number": "NDA204441",
            "brand_name_base": "JYNARQUE",
            "pharm_class": [
                "Vasopressin V2 Receptor Antagonist [EPC]",
                "Vasopressin V2 Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "50242-088",
            "generic_name": "ADO-TRASTUZUMAB EMTANSINE",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "KADCYLA",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB EMTANSINE",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-088-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-088-01)  / 5 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20130222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1658084",
                    "1658087",
                    "1658089",
                    "1658091"
                ],
                "spl_set_id": [
                    "23f3c1f4-0fc8-4804-a9e3-04cf25dd302e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SE2KH7T06F"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "e40e1696-14c3-4366-a516-f36d0d9004b1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20130222",
            "product_id": "50242-088_e40e1696-14c3-4366-a516-f36d0d9004b1",
            "application_number": "BLA125427",
            "brand_name_base": "KADCYLA"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "51167-200",
            "generic_name": "ivacaftor",
            "labeler_name": "Vertex Pharmaceuticals Incorporated",
            "brand_name": "Kalydeco",
            "active_ingredients": [
                {
                    "name": "IVACAFTOR",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51167-200-01",
                    "description": "4 BLISTER PACK in 1 CARTON (51167-200-01)  / 14 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20120131",
                    "sample": false
                },
                {
                    "package_ndc": "51167-200-02",
                    "description": "1 BOTTLE in 1 CARTON (51167-200-02)  / 60 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20120131",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Vertex Pharmaceuticals Incorporated"
                ],
                "spl_set_id": [
                    "0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000184146",
                    "N0000184145",
                    "N0000185504",
                    "N0000185503",
                    "N0000190114"
                ],
                "pharm_class_epc": [
                    "Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]"
                ],
                "pharm_class_moa": [
                    "Chloride Channel Activation Potentiators [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]"
                ],
                "unii": [
                    "1Y740ILL1Z"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "67053315-1695-4673-912c-cf2e3ec4aa81",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120131",
            "product_id": "51167-200_67053315-1695-4673-912c-cf2e3ec4aa81",
            "application_number": "NDA203188",
            "brand_name_base": "Kalydeco",
            "pharm_class": [
                "Chloride Channel Activation Potentiators [MoA]",
                "Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "25682-007",
            "generic_name": "Sebelipase alfa",
            "labeler_name": "Alexion Pharmaceuticals, Inc.",
            "brand_name": "KANUMA",
            "active_ingredients": [
                {
                    "name": "SEBELIPASE ALFA",
                    "strength": "2 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "25682-007-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (25682-007-01)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20151208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Alexion Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1726979",
                    "1726984"
                ],
                "spl_set_id": [
                    "83a77b9d-42f0-4645-8420-786285da7326"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192342",
                    "N0000192343",
                    "M0004273"
                ],
                "pharm_class_epc": [
                    "Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]",
                    "Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]"
                ],
                "pharm_class_cs": [
                    "Sterol Esterase [CS]"
                ],
                "unii": [
                    "K4YTU42T8G"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "5b55da2a-7a4d-435b-bf23-34a23e960a6d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20151208",
            "product_id": "25682-007_5b55da2a-7a4d-435b-bf23-34a23e960a6d",
            "application_number": "BLA125561",
            "brand_name_base": "KANUMA",
            "pharm_class": [
                "Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC]",
                "Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC]",
                "Sterol Esterase [CS]"
            ]
        },
        {
            "product_ndc": "52652-5001",
            "generic_name": "Amlodipine",
            "labeler_name": "Azurity Pharmaceuticals, Inc.",
            "brand_name": "Katerzia",
            "active_ingredients": [
                {
                    "name": "AMLODIPINE BENZOATE",
                    "strength": "1 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52652-5001-1",
                    "description": "1 BOTTLE in 1 CARTON (52652-5001-1)  / 150 mL in 1 BOTTLE",
                    "marketing_start_date": "20190815",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Azurity Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2184120",
                    "2184126"
                ],
                "spl_set_id": [
                    "df673a4d-acb8-444c-a472-c87ab8cbd366"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "XD75TQ8A2P"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "78965c75-1ba7-48f0-bc14-029d5bb34f88",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190815",
            "product_id": "52652-5001_78965c75-1ba7-48f0-bc14-029d5bb34f88",
            "application_number": "NDA211340",
            "brand_name_base": "Katerzia",
            "pharm_class": [
                "Calcium Channel Antagonists [MoA]",
                "Calcium Channel Blocker [EPC]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Dihydropyridine Calcium Channel Blocker [EPC]",
                "Dihydropyridines [CS]"
            ]
        },
        {
            "product_ndc": "64764-335",
            "generic_name": "alogliptin and metformin hydrochloride",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "KAZANO",
            "active_ingredients": [
                {
                    "name": "ALOGLIPTIN BENZOATE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "METFORMIN HYDROCHLORIDE",
                    "strength": "500 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-335-01",
                    "description": "4 CARTON in 1 TRAY (64764-335-01)  / 1 BLISTER PACK in 1 CARTON / 14 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-335-60",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (64764-335-60)",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-335-77",
                    "description": "500 TABLET, FILM COATED in 1 BOTTLE (64764-335-77)",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-335-80",
                    "description": "180 TABLET, FILM COATED in 1 BOTTLE (64764-335-80)",
                    "marketing_start_date": "20130125",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1368385",
                    "1368391",
                    "1368392",
                    "1368398"
                ],
                "spl_set_id": [
                    "83cb7914-a683-47bb-a713-f2bc6a596bd2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364764335601"
                ],
                "unii": [
                    "EEN99869SC",
                    "786Z46389E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7e03a27c-c802-48a0-801c-785f55f1df36",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130125",
            "product_id": "64764-335_7e03a27c-c802-48a0-801c-785f55f1df36",
            "application_number": "NDA203414",
            "brand_name_base": "KAZANO",
            "pharm_class": [
                "Biguanide [EPC]",
                "Biguanides [CS]",
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "50419-540",
            "generic_name": "finerenone",
            "labeler_name": "Bayer Healthcare Pharmaceuticals Inc.",
            "brand_name": "Kerendia",
            "active_ingredients": [
                {
                    "name": "FINERENONE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-540-01",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-01)",
                    "marketing_start_date": "20210709",
                    "sample": false
                },
                {
                    "package_ndc": "50419-540-02",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-02)",
                    "marketing_start_date": "20210709",
                    "sample": false
                },
                {
                    "package_ndc": "50419-540-70",
                    "description": "7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-540-70)",
                    "marketing_start_date": "20210709",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer Healthcare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2562816",
                    "2562822",
                    "2562824",
                    "2562826"
                ],
                "spl_set_id": [
                    "fc726765-5d5a-4d6e-b037-b847bda9fb7c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193970",
                    "N0000000139"
                ],
                "pharm_class_epc": [
                    "Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Mineralocorticoid Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "DE2O63YV8R"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "a02ada67-06d1-47f8-bdc9-8b8e692ff6b4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210709",
            "product_id": "50419-540_a02ada67-06d1-47f8-bdc9-8b8e692ff6b4",
            "application_number": "NDA215341",
            "brand_name_base": "Kerendia",
            "pharm_class": [
                "Mineralocorticoid Receptor Antagonists [MoA]",
                "Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0024-5910",
            "generic_name": "sarilumab",
            "labeler_name": "sanofi-aventis U.S. LLC",
            "brand_name": "KEVZARA",
            "active_ingredients": [
                {
                    "name": "SARILUMAB",
                    "strength": "200 mg/1.14mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5910-01",
                    "description": "2 SYRINGE in 1 PACKAGE (0024-5910-01)  / 1.14 mL in 1 SYRINGE (0024-5910-00)",
                    "marketing_start_date": "20170522",
                    "sample": false
                },
                {
                    "package_ndc": "0024-5910-02",
                    "description": "2 SYRINGE in 1 PACKAGE (0024-5910-02)  / 1.14 mL in 1 SYRINGE",
                    "marketing_start_date": "20170522",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "sanofi-aventis U.S. LLC"
                ],
                "rxcui": [
                    "1923333",
                    "1923338",
                    "1923345",
                    "1923347",
                    "2003755",
                    "2003757",
                    "2003766",
                    "2003767"
                ],
                "spl_set_id": [
                    "827bc01c-d379-4266-a18c-c7f904b76af3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190478",
                    "N0000190480"
                ],
                "pharm_class_moa": [
                    "Interleukin 6 Receptor Antagonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Interleukin-6 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "NU90V55F8I"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f95d68f6-56a2-4091-9e20-2c034e03fb8f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20170522",
            "product_id": "0024-5910_f95d68f6-56a2-4091-9e20-2c034e03fb8f",
            "application_number": "BLA761037",
            "brand_name_base": "KEVZARA",
            "pharm_class": [
                "Interleukin 6 Receptor Antagonists [MoA]",
                "Interleukin-6 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0006-3026",
            "generic_name": "pembrolizumab",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "KEYTRUDA",
            "active_ingredients": [
                {
                    "name": "PEMBROLIZUMAB",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-3026-02",
                    "description": "1 VIAL in 1 CARTON (0006-3026-02)  / 4 mL in 1 VIAL (0006-3026-01)",
                    "marketing_start_date": "20150115",
                    "sample": false
                },
                {
                    "package_ndc": "0006-3026-04",
                    "description": "2 VIAL in 1 CARTON (0006-3026-04)  / 4 mL in 1 VIAL (0006-3026-01)",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "1657746",
                    "1657749",
                    "1657750",
                    "1657751"
                ],
                "spl_set_id": [
                    "9333c79b-d487-4538-a9f0-71b91a02b287"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "DPT0O3T46P"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "1894315d-5247-4b32-9a66-f7bfdff18c54",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20150115",
            "product_id": "0006-3026_1894315d-5247-4b32-9a66-f7bfdff18c54",
            "application_number": "BLA125514",
            "brand_name_base": "KEYTRUDA",
            "pharm_class": [
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "72893-004",
            "generic_name": "levoleucovorin",
            "labeler_name": "Acrotech Biopharma Inc",
            "brand_name": "KHAPZORY",
            "active_ingredients": [
                {
                    "name": "LEVOLEUCOVORIN DISODIUM",
                    "strength": "175 mg/3.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72893-004-01",
                    "description": "1 VIAL in 1 CARTON (72893-004-01)  / 3.5 mL in 1 VIAL",
                    "marketing_start_date": "20190102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Acrotech Biopharma Inc"
                ],
                "rxcui": [
                    "1858561",
                    "2106373"
                ],
                "spl_set_id": [
                    "344f65ac-9f04-49d7-b7c3-4ba19bd7b429"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5TXQ76K65T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "b35d64e8-b5c1-431c-bb70-ce6f2ffcd31d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190102",
            "product_id": "72893-004_b35d64e8-b5c1-431c-bb70-ce6f2ffcd31d",
            "application_number": "NDA211226",
            "brand_name_base": "KHAPZORY",
            "pharm_class": [
                "Folate Analog [EPC]",
                "Folic Acid [CS]"
            ]
        },
        {
            "product_ndc": "80446-401",
            "generic_name": "TEBENTAFUSP",
            "labeler_name": "Immunocore Commercial LLC",
            "brand_name": "KIMMTRAK",
            "active_ingredients": [
                {
                    "name": "TEBENTAFUSP",
                    "strength": "100 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "80446-401-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (80446-401-01)  / .5 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20220126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Immunocore Commercial LLC"
                ],
                "rxcui": [
                    "2590748",
                    "2590754"
                ],
                "spl_set_id": [
                    "24a49f57-d2fc-4ffe-9eb1-fe0460c6b067"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0380446401013"
                ],
                "nui": [
                    "N0000193989",
                    "N0000193994",
                    "N0000175617",
                    "N0000175618"
                ],
                "pharm_class_epc": [
                    "Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]"
                ],
                "pharm_class_moa": [
                    "Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]",
                    "CD3-directed Antibody Interactions [MoA]",
                    "CD3 Receptor Agonists [MoA]"
                ],
                "unii": [
                    "N658GY6L3E"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "13013832-e680-4078-e063-6294a90ab1a1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220126",
            "product_id": "80446-401_13013832-e680-4078-e063-6294a90ab1a1",
            "application_number": "BLA761228",
            "brand_name_base": "KIMMTRAK",
            "pharm_class": [
                "Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]",
                "CD3 Receptor Agonists [MoA]",
                "CD3-directed Antibody Interactions [MoA]",
                "Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "70842-225",
            "generic_name": "oritavancin diphosphate",
            "labeler_name": "Melinta Therapeutics, LLC",
            "brand_name": "Kimyrsa",
            "active_ingredients": [
                {
                    "name": "ORITAVANCIN DIPHOSPHATE",
                    "strength": "1200 mg/40mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70842-225-01",
                    "description": "1 VIAL in 1 CARTON (70842-225-01)  / 40 mL in 1 VIAL",
                    "marketing_start_date": "20210323",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Melinta Therapeutics, LLC"
                ],
                "rxcui": [
                    "2532361",
                    "2532366"
                ],
                "spl_set_id": [
                    "5e755c40-6e73-4572-b474-4d8a131693d1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "VL1P93MKZN"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "118241c8-6cba-41af-90f7-97258175710f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210323",
            "product_id": "70842-225_118241c8-6cba-41af-90f7-97258175710f",
            "application_number": "NDA214155",
            "brand_name_base": "Kimyrsa",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Lipoglycopeptide Antibacterial [EPC]",
                "Lipoglycopeptides [CS]"
            ]
        },
        {
            "product_ndc": "66658-234",
            "generic_name": "anakinra",
            "labeler_name": "Swedish Orphan Biovitrum AB (publ)",
            "brand_name": "Kineret",
            "active_ingredients": [
                {
                    "name": "ANAKINRA",
                    "strength": "100 mg/.67mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66658-234-07",
                    "description": "7 SYRINGE, GLASS in 1 CARTON (66658-234-07)  / .67 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20091215",
                    "sample": false
                },
                {
                    "package_ndc": "66658-234-28",
                    "description": "4 CARTON in 1 CASE (66658-234-28)  / 7 SYRINGE, GLASS in 1 CARTON (66658-234-07)  / .67 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20091215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Swedish Orphan Biovitrum AB (publ)"
                ],
                "rxcui": [
                    "727711",
                    "727714"
                ],
                "spl_set_id": [
                    "d9d74915-6606-4570-9c52-c4001d3177de"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175709",
                    "N0000175710"
                ],
                "pharm_class_moa": [
                    "Interleukin 1 Receptor Antagonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Interleukin-1 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "9013DUQ28K"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7c3433fa-6e70-4740-9d58-b2cae670e639",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20091215",
            "product_id": "66658-234_7c3433fa-6e70-4740-9d58-b2cae670e639",
            "application_number": "BLA103950",
            "brand_name_base": "Kineret",
            "pharm_class": [
                "Interleukin 1 Receptor Antagonists [MoA]",
                "Interleukin-1 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0860",
            "generic_name": "ribociclib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "KISQALI",
            "active_ingredients": [
                {
                    "name": "RIBOCICLIB SUCCINATE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0860-01",
                    "description": "1 BLISTER PACK in 1 CARTON (0078-0860-01)  / 21 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20170313",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1873983",
                    "1873989",
                    "1873990",
                    "1873991",
                    "1873992",
                    "1873993",
                    "1873994",
                    "1873995"
                ],
                "spl_set_id": [
                    "aaeaef94-f3f5-4367-8ea2-b181d7be2da8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "BG7HLX2919"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0916c545-7f68-439d-86f8-66b166eab6d0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170313",
            "product_id": "0078-0860_0916c545-7f68-439d-86f8-66b166eab6d0",
            "application_number": "NDA209092",
            "brand_name_base": "KISQALI",
            "pharm_class": [
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "14141-223",
            "generic_name": "zinc oxide,octinoxate",
            "labeler_name": "Bel Star S.A. (Colombia)",
            "brand_name": "MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 BEIGE 220-C",
            "active_ingredients": [
                {
                    "name": "OCTINOXATE",
                    "strength": "5 g/100mL"
                },
                {
                    "name": "ZINC OXIDE",
                    "strength": "4.2 g/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "14141-223-01",
                    "description": "30 mL in 1 JAR (14141-223-01)",
                    "marketing_start_date": "20210414",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bel Star S.A. (Colombia)"
                ],
                "spl_set_id": [
                    "c0843363-a5da-7be7-e053-2a95a90ae0d5"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SOI2LOH54Z",
                    "4Y5P7MUD51"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "EMULSION",
            "spl_id": "c0843363-a5db-7be7-e053-2a95a90ae0d5",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210414",
            "product_id": "14141-223_c0843363-a5db-7be7-e053-2a95a90ae0d5",
            "application_number": "part352",
            "brand_name_base": "MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 BEIGE 220-C"
        },
        {
            "product_ndc": "14141-223",
            "generic_name": "zinc oxide,octinoxate",
            "labeler_name": "Bel Star S.A. (Colombia)",
            "brand_name": "MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 BEIGE 220-C",
            "active_ingredients": [
                {
                    "name": "OCTINOXATE",
                    "strength": "5 g/100mL"
                },
                {
                    "name": "ZINC OXIDE",
                    "strength": "4.2 g/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "14141-223-01",
                    "description": "30 mL in 1 JAR (14141-223-01)",
                    "marketing_start_date": "20210414",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bel Star S.A. (Colombia)"
                ],
                "spl_set_id": [
                    "c0843363-a5da-7be7-e053-2a95a90ae0d5"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SOI2LOH54Z",
                    "4Y5P7MUD51"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "EMULSION",
            "spl_id": "c0843363-a5db-7be7-e053-2a95a90ae0d5",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210414",
            "product_id": "14141-223_c0843363-a5db-7be7-e053-2a95a90ae0d5",
            "application_number": "part352",
            "brand_name_base": "MATTE PRO DEFENSE Base mate con multiproteccion de la piel FPS 20 Matte foundation with skin multiprotection SPF 20 BEIGE 220-C"
        },
        {
            "product_ndc": "65628-272",
            "generic_name": "omeprazole and sodium bicarbonate",
            "labeler_name": "Azurity Pharmaceuticals, Inc.",
            "brand_name": "Konvomep",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65628-272-03",
                    "description": "1 KIT in 1 CARTON (65628-272-03)  *  150 mL in 1 BOTTLE (65628-270-05)  *  300 mL in 1 BOTTLE (65628-270-10)  *  150 mL in 1 BOTTLE (65628-271-05)  *  300 mL in 1 BOTTLE (65628-271-10)  *  90 mL in 1 BOTTLE (65628-271-03)  *  90 mL in 1 BOTTLE (65628-270-03)",
                    "marketing_start_date": "20230215",
                    "sample": false
                },
                {
                    "package_ndc": "65628-272-05",
                    "description": "1 KIT in 1 CARTON (65628-272-05)  *  150 mL in 1 BOTTLE (65628-270-05)  *  300 mL in 1 BOTTLE (65628-270-10)  *  150 mL in 1 BOTTLE (65628-271-05)  *  300 mL in 1 BOTTLE (65628-271-10)  *  90 mL in 1 BOTTLE (65628-271-03)  *  90 mL in 1 BOTTLE (65628-270-03)",
                    "marketing_start_date": "20230215",
                    "sample": false
                },
                {
                    "package_ndc": "65628-272-10",
                    "description": "1 KIT in 1 CARTON (65628-272-10)  *  150 mL in 1 BOTTLE (65628-270-05)  *  300 mL in 1 BOTTLE (65628-270-10)  *  150 mL in 1 BOTTLE (65628-271-05)  *  300 mL in 1 BOTTLE (65628-271-10)  *  90 mL in 1 BOTTLE (65628-271-03)  *  90 mL in 1 BOTTLE (65628-270-03)",
                    "marketing_start_date": "20230215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Azurity Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2625144",
                    "2625150"
                ],
                "spl_set_id": [
                    "688ed6f1-d78a-4006-a682-57021cb38a3e"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0365628270106",
                    "0365628271103"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "6fc0a7c7-babb-4ab2-8e18-8a212803ce2d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20230215",
            "product_id": "65628-272_6fc0a7c7-babb-4ab2-8e18-8a212803ce2d",
            "application_number": "NDA213593",
            "brand_name_base": "Konvomep"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "0310-0610",
            "generic_name": "SELUMETINIB",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "KOSELUGO",
            "active_ingredients": [
                {
                    "name": "SELUMETINIB",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-0610-28",
                    "description": "28 CAPSULE in 1 BOTTLE (0310-0610-28)",
                    "marketing_start_date": "20210611",
                    "sample": false
                },
                {
                    "package_ndc": "0310-0610-60",
                    "description": "60 CAPSULE in 1 BOTTLE (0310-0610-60)",
                    "marketing_start_date": "20200416",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2289418",
                    "2289424",
                    "2289426",
                    "2289428"
                ],
                "spl_set_id": [
                    "7d042c61-f28f-4ab5-ab10-d7558c0d49ff"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000193943",
                    "N0000193944"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]",
                    "Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]"
                ],
                "unii": [
                    "6UH91I579U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "a72315f8-268a-4e47-b6ea-885370a17e7f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200416",
            "product_id": "0310-0610_a72315f8-268a-4e47-b6ea-885370a17e7f",
            "application_number": "NDA213756",
            "brand_name_base": "KOSELUGO",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]",
                "Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0026-3824",
            "generic_name": "Antihemophilic Factor (Recombinant)",
            "labeler_name": "Bayer HealthCare LLC",
            "brand_name": "Kovaltry",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0026-3824-25",
                    "description": "1 KIT in 1 BOX (0026-3824-25)  *  2.5 mL in 1 VIAL, SINGLE-USE (0026-4824-99)  *  2.5 mL in 1 SYRINGE (0026-0426-02)  *  2.5 mL in 1 VIAL, SINGLE-USE (0026-4824-01)",
                    "marketing_start_date": "20160317",
                    "sample": false
                },
                {
                    "package_ndc": "0026-3824-99",
                    "description": "1 KIT in 1 BOX (0026-3824-99)  *  2.5 mL in 1 VIAL, SINGLE-USE (0026-4824-99)  *  2.5 mL in 1 SYRINGE (0026-0426-02)  *  2.5 mL in 1 VIAL, SINGLE-USE (0026-4824-01)",
                    "marketing_start_date": "20160317",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "8d9498f7-77e5-4bf8-b68a-69464ada2790",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20160317",
            "product_id": "0026-3824_8d9498f7-77e5-4bf8-b68a-69464ada2790",
            "application_number": "BLA125574",
            "brand_name_base": "Kovaltry"
        },
        {
            "product_ndc": "80739-812",
            "generic_name": "adagrasib",
            "labeler_name": "Mirati Therapeutics, Inc",
            "brand_name": "KRAZATI",
            "active_ingredients": [
                {
                    "name": "ADAGRASIB",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "80739-812-12",
                    "description": "1 BOTTLE in 1 CARTON (80739-812-12)  / 120 TABLET, COATED in 1 BOTTLE",
                    "marketing_start_date": "20221212",
                    "sample": false
                },
                {
                    "package_ndc": "80739-812-18",
                    "description": "1 BOTTLE in 1 CARTON (80739-812-18)  / 180 TABLET, COATED in 1 BOTTLE",
                    "marketing_start_date": "20221212",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Mirati Therapeutics, Inc"
                ],
                "rxcui": [
                    "2625917",
                    "2625923"
                ],
                "spl_set_id": [
                    "0b8bf078-34c2-4f45-9012-38a8ac082b01"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8EOO6HQF8Y"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "ee144384-d3cc-4f4c-8d2b-feffdd202896",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20221212",
            "product_id": "80739-812_ee144384-d3cc-4f4c-8d2b-feffdd202896",
            "application_number": "NDA216340",
            "brand_name_base": "KRAZATI"
        },
        {
            "product_ndc": "0068-0599",
            "marketing_end_date": "20251031",
            "generic_name": "rifampin",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Rifadin IV NOVAPLUS",
            "active_ingredients": [
                {
                    "name": "RIFAMPIN",
                    "strength": "600 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0068-0599-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (0068-0599-01)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20170201",
                    "marketing_end_date": "20251031",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "207436",
                    "312821"
                ],
                "spl_set_id": [
                    "87839f65-cb33-412e-929e-564136501a84"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175500",
                    "M0019113"
                ],
                "pharm_class_epc": [
                    "Rifamycin Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Rifamycins [CS]"
                ],
                "unii": [
                    "VJT6J7R4TR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ed3e312a-b258-4b9b-bdb4-2f149c73e8c1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170201",
            "product_id": "0068-0599_ed3e312a-b258-4b9b-bdb4-2f149c73e8c1",
            "application_number": "NDA050627",
            "brand_name_base": "Rifadin IV NOVAPLUS",
            "pharm_class": [
                "Rifamycin Antibacterial [EPC]",
                "Rifamycins [CS]"
            ]
        },
        {
            "product_ndc": "68135-301",
            "generic_name": "SAPROPTERIN DIHYDROCHLORIDE",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "Kuvan",
            "active_ingredients": [
                {
                    "name": "SAPROPTERIN DIHYDROCHLORIDE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-301-22",
                    "description": "30 PACKET in 1 CARTON (68135-301-22)  / 1 POWDER, FOR SOLUTION in 1 PACKET (68135-301-11)",
                    "marketing_start_date": "20140221",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "1111018",
                    "1111020",
                    "1486687",
                    "1486691",
                    "1653217",
                    "1653221"
                ],
                "spl_set_id": [
                    "af38711e-8873-4790-a92d-4d583e23fb89"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "RG277LF5B3"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SOLUTION",
            "spl_id": "066f16a3-911d-43b6-950d-fde21585985b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20140221",
            "product_id": "68135-301_066f16a3-911d-43b6-950d-fde21585985b",
            "application_number": "NDA205065",
            "brand_name_base": "Kuvan",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Phenylalanine Hydroxylase Activator [EPC]",
                "Phenylalanine Hydroxylase Activators [MoA]"
            ]
        },
        {
            "product_ndc": "50419-424",
            "generic_name": "Levonorgestrel",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Kyleena",
            "active_ingredients": [
                {
                    "name": "LEVONORGESTREL",
                    "strength": "19.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-424-01",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-424-01)",
                    "marketing_start_date": "20160919",
                    "sample": false
                },
                {
                    "package_ndc": "50419-424-08",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-424-08)",
                    "marketing_start_date": "20160919",
                    "sample": false
                },
                {
                    "package_ndc": "50419-424-71",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-424-71)",
                    "marketing_start_date": "20160919",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1811886",
                    "1856546"
                ],
                "spl_set_id": [
                    "2e07c155-21e1-4781-9633-ce8bddd47080"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175830",
                    "M0447349",
                    "N0000175602",
                    "N0000175832"
                ],
                "pharm_class_pe": [
                    "Inhibit Ovum Fertilization [PE]"
                ],
                "pharm_class_cs": [
                    "Progesterone Congeners [CS]"
                ],
                "pharm_class_epc": [
                    "Progestin [EPC]",
                    "Progestin-containing Intrauterine System [EPC]"
                ],
                "unii": [
                    "5W7SIA7YZW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INTRAUTERINE DEVICE",
            "spl_id": "610ebea6-16a0-4ba5-b621-ac47e3baf07c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAUTERINE"
            ],
            "marketing_start_date": "20160919",
            "product_id": "50419-424_610ebea6-16a0-4ba5-b621-ac47e3baf07c",
            "application_number": "NDA208224",
            "brand_name_base": "Kyleena",
            "pharm_class": [
                "Inhibit Ovum Fertilization [PE]",
                "Progesterone Congeners [CS]",
                "Progesterone Congeners [CS]",
                "Progestin [EPC]",
                "Progestin-containing Intrauterine Device [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "82182-773",
            "generic_name": "brimonidine tartrate",
            "labeler_name": "Pacific Pharma, Inc.",
            "brand_name": "Brimonidine tartrate",
            "active_ingredients": [
                {
                    "name": "BRIMONIDINE TARTRATE",
                    "strength": "1.5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "82182-773-05",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (82182-773-05)  / 5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20220228",
                    "sample": false
                },
                {
                    "package_ndc": "82182-773-10",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (82182-773-10)  / 10 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20220228",
                    "sample": false
                },
                {
                    "package_ndc": "82182-773-15",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (82182-773-15)  / 15 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20220228",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pacific Pharma, Inc."
                ],
                "rxcui": [
                    "861204",
                    "861208"
                ],
                "spl_set_id": [
                    "5c4aea88-95ca-4da8-a3da-02f10c8b6623"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "4S9CL2DY2H"
                ]
            },
            "marketing_category": "NDA AUTHORIZED GENERIC",
            "dosage_form": "SOLUTION/ DROPS",
            "spl_id": "4c90a66d-535b-445e-85be-ba5ff4b71351",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20220228",
            "product_id": "82182-773_4c90a66d-535b-445e-85be-ba5ff4b71351",
            "application_number": "NDA021262",
            "brand_name_base": "Brimonidine tartrate",
            "pharm_class": [
                "Adrenergic alpha-Agonists [MoA]",
                "alpha-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "0173-0642",
            "generic_name": "lamotrigine",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "LAMICTAL",
            "active_ingredients": [
                {
                    "name": "LAMOTRIGINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0642-55",
                    "description": "100 TABLET in 1 BOTTLE (0173-0642-55)",
                    "marketing_start_date": "19950117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "103968",
                    "105018",
                    "105019",
                    "108782",
                    "198427",
                    "198428",
                    "198429",
                    "198430",
                    "201239",
                    "201240",
                    "206201",
                    "252478",
                    "252479",
                    "282401",
                    "311264",
                    "311265",
                    "349010",
                    "542426",
                    "751139",
                    "751563",
                    "753451",
                    "795772",
                    "795774",
                    "795778",
                    "849049",
                    "849050",
                    "849051",
                    "849052",
                    "851748",
                    "851749",
                    "851750",
                    "851751",
                    "851752",
                    "851753"
                ],
                "spl_set_id": [
                    "d7e3572d-56fe-4727-2bb4-013ccca22678"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0301730642554",
                    "0301730644602",
                    "0301730526007",
                    "0301730699008",
                    "0301730527004",
                    "0301730643605"
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486",
                    "N0000175751",
                    "N0000187061",
                    "N0000000191"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]",
                    "Mood Stabilizer [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_moa": [
                    "Organic Cation Transporter 2 Inhibitors [MoA]",
                    "Dihydrofolate Reductase Inhibitors [MoA]"
                ],
                "unii": [
                    "U3H27498KS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "d15a5607-7757-4f62-9269-154d706b67e9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19950117",
            "product_id": "0173-0642_d15a5607-7757-4f62-9269-154d706b67e9",
            "application_number": "NDA020241",
            "brand_name_base": "LAMICTAL",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Dihydrofolate Reductase Inhibitors [MoA]",
                "Mood Stabilizer [EPC]",
                "Organic Cation Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0173-0642",
            "generic_name": "lamotrigine",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "LAMICTAL",
            "active_ingredients": [
                {
                    "name": "LAMOTRIGINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0642-55",
                    "description": "100 TABLET in 1 BOTTLE (0173-0642-55)",
                    "marketing_start_date": "19950117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "103968",
                    "105018",
                    "105019",
                    "108782",
                    "198427",
                    "198428",
                    "198429",
                    "198430",
                    "201239",
                    "201240",
                    "206201",
                    "252478",
                    "252479",
                    "282401",
                    "311264",
                    "311265",
                    "349010",
                    "542426",
                    "751139",
                    "751563",
                    "753451",
                    "795772",
                    "795774",
                    "795778",
                    "849049",
                    "849050",
                    "849051",
                    "849052",
                    "851748",
                    "851749",
                    "851750",
                    "851751",
                    "851752",
                    "851753"
                ],
                "spl_set_id": [
                    "d7e3572d-56fe-4727-2bb4-013ccca22678"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0301730642554",
                    "0301730644602",
                    "0301730526007",
                    "0301730699008",
                    "0301730527004",
                    "0301730643605"
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486",
                    "N0000175751",
                    "N0000187061",
                    "N0000000191"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]",
                    "Mood Stabilizer [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_moa": [
                    "Organic Cation Transporter 2 Inhibitors [MoA]",
                    "Dihydrofolate Reductase Inhibitors [MoA]"
                ],
                "unii": [
                    "U3H27498KS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "d15a5607-7757-4f62-9269-154d706b67e9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19950117",
            "product_id": "0173-0642_d15a5607-7757-4f62-9269-154d706b67e9",
            "application_number": "NDA020241",
            "brand_name_base": "LAMICTAL",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Dihydrofolate Reductase Inhibitors [MoA]",
                "Mood Stabilizer [EPC]",
                "Organic Cation Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0173-0642",
            "generic_name": "lamotrigine",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "LAMICTAL",
            "active_ingredients": [
                {
                    "name": "LAMOTRIGINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0642-55",
                    "description": "100 TABLET in 1 BOTTLE (0173-0642-55)",
                    "marketing_start_date": "19950117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "103968",
                    "105018",
                    "105019",
                    "108782",
                    "198427",
                    "198428",
                    "198429",
                    "198430",
                    "201239",
                    "201240",
                    "206201",
                    "252478",
                    "252479",
                    "282401",
                    "311264",
                    "311265",
                    "349010",
                    "542426",
                    "751139",
                    "751563",
                    "753451",
                    "795772",
                    "795774",
                    "795778",
                    "849049",
                    "849050",
                    "849051",
                    "849052",
                    "851748",
                    "851749",
                    "851750",
                    "851751",
                    "851752",
                    "851753"
                ],
                "spl_set_id": [
                    "d7e3572d-56fe-4727-2bb4-013ccca22678"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0301730642554",
                    "0301730644602",
                    "0301730526007",
                    "0301730699008",
                    "0301730527004",
                    "0301730643605"
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486",
                    "N0000175751",
                    "N0000187061",
                    "N0000000191"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]",
                    "Mood Stabilizer [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_moa": [
                    "Organic Cation Transporter 2 Inhibitors [MoA]",
                    "Dihydrofolate Reductase Inhibitors [MoA]"
                ],
                "unii": [
                    "U3H27498KS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "d15a5607-7757-4f62-9269-154d706b67e9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19950117",
            "product_id": "0173-0642_d15a5607-7757-4f62-9269-154d706b67e9",
            "application_number": "NDA020241",
            "brand_name_base": "LAMICTAL",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Dihydrofolate Reductase Inhibitors [MoA]",
                "Mood Stabilizer [EPC]",
                "Organic Cation Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "50419-750",
            "generic_name": "nifurtimox",
            "labeler_name": "Bayer Healthcare Pharmaceuticals INC.",
            "brand_name": "LAMPIT",
            "active_ingredients": [
                {
                    "name": "NIFURTIMOX",
                    "strength": "30 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-750-01",
                    "description": "1 BOTTLE in 1 CARTON (50419-750-01)  / 100 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20201001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer Healthcare Pharmaceuticals INC."
                ],
                "rxcui": [
                    "430512",
                    "2395842",
                    "2397991",
                    "2397994"
                ],
                "spl_set_id": [
                    "90d09714-a8b1-4696-8ada-f99dc54d0721"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "M84I3K7C2O"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7194979e-ee8a-49b4-8710-16db445b6d21",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201001",
            "product_id": "50419-750_7194979e-ee8a-49b4-8710-16db445b6d21",
            "application_number": "NDA213464",
            "brand_name_base": "LAMPIT"
        },
        {
            "product_ndc": "10122-180",
            "generic_name": "Velmanase alfa-tycv",
            "labeler_name": "Chiesi USA, Inc.",
            "brand_name": "Lamzede",
            "active_ingredients": [
                {
                    "name": "VELMANASE ALFA-TYCV",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10122-180-02",
                    "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02)",
                    "marketing_start_date": "20230301",
                    "sample": false
                },
                {
                    "package_ndc": "10122-180-05",
                    "description": "5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-05)",
                    "marketing_start_date": "20230301",
                    "sample": false
                },
                {
                    "package_ndc": "10122-180-10",
                    "description": "10 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-10)",
                    "marketing_start_date": "20230301",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Chiesi USA, Inc."
                ],
                "rxcui": [
                    "2630729",
                    "2630734"
                ],
                "spl_set_id": [
                    "36d50a08-60bd-40eb-807c-778d69bf2d2e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "M91TG242P2"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "27cf090b-196e-4330-8184-c72d9bb90660",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230301",
            "product_id": "10122-180_27cf090b-196e-4330-8184-c72d9bb90660",
            "application_number": "BLA761278",
            "brand_name_base": "Lamzede"
        },
        {
            "product_ndc": "0088-2219",
            "generic_name": "insulin glargine",
            "labeler_name": "sanofi-aventis U.S. LLC",
            "brand_name": "Lantus Solostar",
            "active_ingredients": [
                {
                    "name": "INSULIN GLARGINE",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0088-2219-00",
                    "description": "1 SYRINGE in 1 CARTON (0088-2219-00)  / 3 mL in 1 SYRINGE",
                    "marketing_start_date": "20090923",
                    "sample": true
                },
                {
                    "package_ndc": "0088-2219-05",
                    "description": "5 SYRINGE in 1 CARTON (0088-2219-05)  / 3 mL in 1 SYRINGE (0088-2219-01)",
                    "marketing_start_date": "20090923",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "sanofi-aventis U.S. LLC"
                ],
                "rxcui": [
                    "285018",
                    "311041",
                    "847230",
                    "847232"
                ],
                "spl_set_id": [
                    "d5e07a0c-7e14-4756-9152-9fea485d654a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "2ZM8CX04RZ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "0d076ab9-bbf9-4932-9ed8-31a4b5c6657b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20090923",
            "product_id": "0088-2219_0d076ab9-bbf9-4932-9ed8-31a4b5c6657b",
            "application_number": "BLA021081",
            "brand_name_base": "Lantus Solostar",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "64764-108",
            "generic_name": "vedolizumab",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "ENTYVIO Pen",
            "active_ingredients": [
                {
                    "name": "VEDOLIZUMAB",
                    "strength": "108 mg/.68mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-108-21",
                    "description": "1 TRAY in 1 CARTON (64764-108-21)  / 1 SYRINGE in 1 TRAY (64764-108-20)  / .68 mL in 1 SYRINGE",
                    "marketing_start_date": "20230927",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1538137",
                    "1538142",
                    "2667332",
                    "2667336",
                    "2667339",
                    "2667342"
                ],
                "spl_set_id": [
                    "6e94621c-1a95-4af9-98d1-52b9e6f1949c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175775",
                    "N0000175774"
                ],
                "pharm_class_epc": [
                    "Integrin Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Integrin Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "9RV78Q2002"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "20d33a84-56b9-4ef1-9481-eda11bd8de0e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230927",
            "product_id": "64764-108_20d33a84-56b9-4ef1-9481-eda11bd8de0e",
            "application_number": "BLA761133",
            "brand_name_base": "ENTYVIO Pen",
            "pharm_class": [
                "Integrin Receptor Antagonist [EPC]",
                "Integrin Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "58468-0200",
            "generic_name": "ALEMTUZUMAB",
            "labeler_name": "Genzyme Corporation",
            "brand_name": "LEMTRADA",
            "active_ingredients": [
                {
                    "name": "ALEMTUZUMAB",
                    "strength": "12 mg/1.2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58468-0200-1",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1)  / 1.2 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20141118",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genzyme Corporation"
                ],
                "rxcui": [
                    "1594658",
                    "1594663"
                ],
                "spl_set_id": [
                    "6236b0bc-82e9-4447-9a78-f57d94770269"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175079",
                    "N0000175659"
                ],
                "pharm_class_moa": [
                    "CD52-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD52-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "3A189DH42V"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "ab7fdc51-0593-49ad-b264-0c9feeb9d8da",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20141118",
            "product_id": "58468-0200_ab7fdc51-0593-49ad-b264-0c9feeb9d8da",
            "application_number": "BLA103948",
            "brand_name_base": "LEMTRADA",
            "pharm_class": [
                "CD52-directed Antibody Interactions [MoA]",
                "CD52-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "62856-710",
            "generic_name": "Lenvatinib",
            "labeler_name": "Eisai Inc.",
            "brand_name": "Lenvima",
            "active_ingredients": [
                {
                    "name": "LENVATINIB",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "62856-710-30",
                    "description": "6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-710-30)  / 5 CAPSULE in 1 BLISTER PACK (62856-710-05)",
                    "marketing_start_date": "20150213",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eisai Inc."
                ],
                "rxcui": [
                    "1604345",
                    "1604348",
                    "1604349",
                    "1604350",
                    "1604351",
                    "1604352",
                    "1604383",
                    "1604384",
                    "1604394",
                    "1604395",
                    "1792377",
                    "1792392",
                    "1792393",
                    "1796538",
                    "1796664",
                    "1796665",
                    "2054156",
                    "2054157",
                    "2054158",
                    "2054159"
                ],
                "spl_set_id": [
                    "f4bedd21-efde-44c6-9d9c-b48b78d7ed1e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020000"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Receptor Tyrosine Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "EE083865G2"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "55fc0687-d30e-4537-9aef-dc6a9c65d9f5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150213",
            "product_id": "62856-710_55fc0687-d30e-4537-9aef-dc6a9c65d9f5",
            "application_number": "NDA206947",
            "brand_name_base": "Lenvima",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Receptor Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "62856-212",
            "generic_name": "lecanemab",
            "labeler_name": "Eisai Inc.",
            "brand_name": "LEQEMBI",
            "active_ingredients": [
                {
                    "name": "LECANEMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "62856-212-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01)  / 2 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20230106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eisai Inc."
                ],
                "rxcui": [
                    "2626147",
                    "2626153",
                    "2626155",
                    "2626156"
                ],
                "spl_set_id": [
                    "9d1ff786-e577-410a-a273-c4d7d0e4e975"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193951",
                    "N0000193950"
                ],
                "pharm_class_epc": [
                    "Amyloid Beta-directed Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Amyloid Beta-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "12PYH0FTU9"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "20f823f7-6d11-42cd-9d60-56dbf86eed21",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230106",
            "product_id": "62856-212_20f823f7-6d11-42cd-9d60-56dbf86eed21",
            "application_number": "BLA761269",
            "brand_name_base": "LEQEMBI",
            "pharm_class": [
                "Amyloid Beta-directed Antibody Interactions [MoA]",
                "Amyloid Beta-directed Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "0078-1000",
            "generic_name": "inclisiran",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "LEQVIO",
            "active_ingredients": [
                {
                    "name": "INCLISIRAN SODIUM",
                    "strength": "284 mg/1.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-1000-60",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1000-60)  / 1.5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20211222",
                    "sample": false
                },
                {
                    "package_ndc": "0078-1000-98",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1000-98)  / 1.5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20230217",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "spl_set_id": [
                    "6fc0afca-4513-4c35-b594-6544aee29a44"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "UPC6BTX7PY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "bbf35f47-fe81-4c3a-828d-6e0c1756977b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20211222",
            "product_id": "0078-1000_bbf35f47-fe81-4c3a-828d-6e0c1756977b",
            "application_number": "NDA214012",
            "brand_name_base": "LEQVIO"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "71837-5843",
            "generic_name": "SARGRAMOSTIM",
            "labeler_name": "Partner Therapeutics, Inc.",
            "brand_name": "Leukine",
            "active_ingredients": [
                {
                    "name": "SARGRAMOSTIM",
                    "strength": "250 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71837-5843-5",
                    "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (71837-5843-5)  / 1 mL in 1 VIAL, SINGLE-DOSE (71837-5843-1)",
                    "marketing_start_date": "20230901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Partner Therapeutics, Inc."
                ],
                "rxcui": [
                    "208083",
                    "315199"
                ],
                "spl_set_id": [
                    "bb9a3820-f31a-4dd9-bef4-97094c01a398"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0371837584354"
                ],
                "nui": [
                    "M0024696",
                    "M0024695",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]",
                    "Granulocyte-Macrophage Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "5TAA004E22"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "c67e7850-15ba-4170-ab70-7b567daf51bd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230901",
            "product_id": "71837-5843_c67e7850-15ba-4170-ab70-7b567daf51bd",
            "application_number": "BLA103362",
            "brand_name_base": "Leukine",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "54092-476",
            "generic_name": "mesalamine",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Lialda",
            "active_ingredients": [
                {
                    "name": "MESALAMINE",
                    "strength": "1.2 g/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54092-476-01",
                    "description": "120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)",
                    "marketing_start_date": "20070116",
                    "sample": false
                },
                {
                    "package_ndc": "54092-476-02",
                    "description": "12 BOTTLE in 1 CARTON (54092-476-02)  / 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)",
                    "marketing_start_date": "20070116",
                    "sample": false
                },
                {
                    "package_ndc": "54092-476-08",
                    "description": "3 CARTON in 1 CARTON (54092-476-08)  / 8 BLISTER PACK in 1 CARTON / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK",
                    "marketing_start_date": "20070116",
                    "sample": false
                },
                {
                    "package_ndc": "54092-476-12",
                    "description": "120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-12)",
                    "marketing_start_date": "20070116",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "686429",
                    "686433"
                ],
                "spl_set_id": [
                    "3098a080-be86-4265-9818-7fc4beab77b7"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175781",
                    "M0000971"
                ],
                "pharm_class_epc": [
                    "Aminosalicylate [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminosalicylic Acids [CS]"
                ],
                "unii": [
                    "4Q81I59GXC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, DELAYED RELEASE",
            "spl_id": "466df3d0-83f7-4082-b08a-1674b8e6a9e5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20070116",
            "product_id": "54092-476_466df3d0-83f7-4082-b08a-1674b8e6a9e5",
            "application_number": "NDA022000",
            "brand_name_base": "Lialda",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70257-562",
            "marketing_end_date": "20241130",
            "generic_name": "baclofen",
            "labeler_name": "Saol Therapeutics Inc.",
            "brand_name": "Lioresal (baclofen)",
            "active_ingredients": [
                {
                    "name": "BACLOFEN",
                    "strength": ".05 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70257-562-55",
                    "description": "5 AMPULE in 1 BOX (70257-562-55)  / 1 mL in 1 AMPULE (70257-562-11)",
                    "marketing_start_date": "20220612",
                    "marketing_end_date": "20241130",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Saol Therapeutics Inc."
                ],
                "rxcui": [
                    "308516",
                    "308517",
                    "805678",
                    "805679",
                    "1666613",
                    "1666620",
                    "1666622",
                    "1666623"
                ],
                "spl_set_id": [
                    "4e478edb-e340-4976-ac24-4bb32c5e12e3"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0049100007533"
                ],
                "nui": [
                    "N0000000196",
                    "N0000000116",
                    "N0000175759"
                ],
                "pharm_class_moa": [
                    "GABA A Agonists [MoA]",
                    "GABA B Agonists [MoA]"
                ],
                "pharm_class_epc": [
                    "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
                ],
                "unii": [
                    "H789N3FKE8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "7280e190-0f51-11ed-aa05-0800200c9a66",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRATHECAL"
            ],
            "marketing_start_date": "20220612",
            "product_id": "70257-562_7280e190-0f51-11ed-aa05-0800200c9a66",
            "application_number": "NDA020075",
            "brand_name_base": "Lioresal (baclofen)",
            "pharm_class": [
                "GABA A Agonists [MoA]",
                "GABA B Agonists [MoA]",
                "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "63539-334",
            "generic_name": "ritlecitinib",
            "labeler_name": "U.S. Pharmaceuticals",
            "brand_name": "Litfulo",
            "active_ingredients": [
                {
                    "name": "RITLECITINIB TOSYLATE",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63539-334-28",
                    "description": "28 CAPSULE in 1 BOTTLE (63539-334-28)",
                    "marketing_start_date": "20230706",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "U.S. Pharmaceuticals"
                ],
                "rxcui": [
                    "2641601",
                    "2641607"
                ],
                "spl_set_id": [
                    "1882f799-61b0-4813-965a-4910c4ae419c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "EAG4T1459K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "1882f799-61b0-4813-965a-4910c4ae419c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230706",
            "product_id": "63539-334_1882f799-61b0-4813-965a-4910c4ae419c",
            "application_number": "NDA215830",
            "brand_name_base": "Litfulo"
        },
        {
            "product_ndc": "66869-104",
            "generic_name": "pitavastatin calcium",
            "labeler_name": "Kowa Pharmaceuticals America, Inc.",
            "brand_name": "Livalo",
            "active_ingredients": [
                {
                    "name": "PITAVASTATIN CALCIUM",
                    "strength": "1.045 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66869-104-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-104-90)",
                    "marketing_start_date": "20190516",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Kowa Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "861643",
                    "861646",
                    "861648",
                    "861650",
                    "861652",
                    "861654"
                ],
                "spl_set_id": [
                    "44dcbf97-99ec-427c-ba50-207e0069d6d2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0366869404909",
                    "0366869104908"
                ],
                "unii": [
                    "IYD54XEG3W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "6ffd5e6a-11b9-4b0f-b30a-edf8b9477dc6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190516",
            "product_id": "66869-104_6ffd5e6a-11b9-4b0f-b30a-edf8b9477dc6",
            "application_number": "NDA022363",
            "brand_name_base": "Livalo",
            "pharm_class": [
                "HMG-CoA Reductase Inhibitor [EPC]",
                "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "64764-800",
            "generic_name": "MARIBAVIR",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Livtencity",
            "active_ingredients": [
                {
                    "name": "MARIBAVIR",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-800-28",
                    "description": "1 BOTTLE in 1 CARTON (64764-800-28)  / 28 TABLET, COATED in 1 BOTTLE",
                    "marketing_start_date": "20211123",
                    "sample": false
                },
                {
                    "package_ndc": "64764-800-56",
                    "description": "1 BOTTLE in 1 CARTON (64764-800-56)  / 56 TABLET, COATED in 1 BOTTLE",
                    "marketing_start_date": "20211123",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "2586073",
                    "2586079"
                ],
                "spl_set_id": [
                    "c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193976",
                    "N0000193977",
                    "N0000182141",
                    "N0000185503",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Cytomegalovirus pUL97 Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Cytomegalovirus pUL97 Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "PTB4X93HE1"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "99b7c58c-7480-44f2-95f3-a66b2dbb9acd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20211123",
            "product_id": "64764-800_99b7c58c-7480-44f2-95f3-a66b2dbb9acd",
            "application_number": "NDA215596",
            "brand_name_base": "Livtencity",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Cytomegalovirus pUL97 Kinase Inhibitor [EPC]",
                "Cytomegalovirus pUL97 Kinase Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "69488-017",
            "generic_name": "kit for the preparation of gallium Ga 68 gozetotide",
            "labeler_name": "Advanced Accelerator Applications USA, Inc",
            "brand_name": "LOCAMETZ",
            "active_ingredients": [
                {
                    "name": "GOZETOTIDE",
                    "strength": "25 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69488-017-61",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (69488-017-61)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20220323",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Advanced Accelerator Applications USA, Inc"
                ],
                "spl_set_id": [
                    "1ea62b65-8138-4a88-8a33-4060ececa42f"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9AG41L3AOQ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "57a75417-a744-4fc4-b647-86aa8d65e337",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220323",
            "product_id": "69488-017_57a75417-a744-4fc4-b647-86aa8d65e337",
            "application_number": "NDA215841",
            "brand_name_base": "LOCAMETZ"
        },
        {
            "product_ndc": "16781-384",
            "generic_name": "HYDROCORTISONE BUTYRATE",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Locoid Lipocream",
            "active_ingredients": [
                {
                    "name": "HYDROCORTISONE BUTYRATE",
                    "strength": "1 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "16781-384-45",
                    "description": "1 TUBE in 1 CARTON (16781-384-45)  / 45 g in 1 TUBE",
                    "marketing_start_date": "20130703",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "1370770",
                    "1370772"
                ],
                "spl_set_id": [
                    "f950988c-0bcc-4d07-bdc2-2426959a85a4"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "05RMF7YPWN"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "d087a8ef-b68a-49f2-a4db-e708a49addc1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20130703",
            "product_id": "16781-384_d087a8ef-b68a-49f2-a4db-e708a49addc1",
            "application_number": "NDA020769",
            "brand_name_base": "Locoid Lipocream",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0310-1105",
            "generic_name": "sodium zirconium cyclosilicate",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "LOKELMA",
            "active_ingredients": [
                {
                    "name": "SODIUM ZIRCONIUM CYCLOSILICATE",
                    "strength": "5 g/5g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-1105-30",
                    "description": "30 PACKET in 1 BOX (0310-1105-30)  / 5 g in 1 PACKET (0310-1105-01)",
                    "marketing_start_date": "20180904",
                    "sample": false
                },
                {
                    "package_ndc": "0310-1105-39",
                    "description": "11 PACKET in 1 BOX (0310-1105-39)  / 5 g in 1 PACKET (0310-1105-01)",
                    "marketing_start_date": "20190102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "spl_set_id": [
                    "90bf8e28-748d-4e4b-a19f-9cf483370eff"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "D652ZWF066"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SUSPENSION",
            "spl_id": "0f703250-886e-44c1-a3fd-e01328213593",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180904",
            "product_id": "0310-1105_0f703250-886e-44c1-a3fd-e01328213593",
            "application_number": "NDA207078",
            "brand_name_base": "LOKELMA"
        },
        {
            "product_ndc": "64842-1020",
            "generic_name": "trifluridine and tipiracil",
            "labeler_name": "Taiho Pharmaceutical Co., Ltd.",
            "brand_name": "LONSURF",
            "active_ingredients": [
                {
                    "name": "TIPIRACIL HYDROCHLORIDE",
                    "strength": "8.19 mg/1"
                },
                {
                    "name": "TRIFLURIDINE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64842-1020-1",
                    "description": "20 TABLET, FILM COATED in 1 BOTTLE (64842-1020-1)",
                    "marketing_start_date": "20151007",
                    "sample": false
                },
                {
                    "package_ndc": "64842-1020-2",
                    "description": "40 TABLET, FILM COATED in 1 BOTTLE (64842-1020-2)",
                    "marketing_start_date": "20151111",
                    "sample": false
                },
                {
                    "package_ndc": "64842-1020-3",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (64842-1020-3)",
                    "marketing_start_date": "20151021",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Taiho Pharmaceutical Co., Ltd."
                ],
                "rxcui": [
                    "1670311",
                    "1670316",
                    "1670322",
                    "1670324"
                ],
                "spl_set_id": [
                    "f5beed22-d71d-4c0d-8dca-2c7317d65d85"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175459",
                    "N0000175466",
                    "N0000175595",
                    "N0000000233"
                ],
                "pharm_class_epc": [
                    "Nucleoside Analog Antiviral [EPC]",
                    "Nucleoside Metabolic Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Nucleic Acid Synthesis Inhibitors [MoA]"
                ],
                "unii": [
                    "RMW9V5RW38",
                    "4H59KLQ0A4"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "1376bc92-67d0-403d-b9d3-602d58df9d8c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150922",
            "product_id": "64842-1020_1376bc92-67d0-403d-b9d3-602d58df9d8c",
            "application_number": "NDA207981",
            "brand_name_base": "LONSURF",
            "pharm_class": [
                "Nucleic Acid Synthesis Inhibitors [MoA]",
                "Nucleoside Analog Antiviral [EPC]",
                "Nucleoside Analog [EXT]",
                "Nucleoside Metabolic Inhibitor [EPC]",
                "Thymidine Phosphorylase Inhibitor [EPC]",
                "Thymidine Phosphorylase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70114-340",
            "generic_name": "toripalimab-tpzi",
            "labeler_name": "Coherus BioSciences, Inc.",
            "brand_name": "LOQTORZI",
            "active_ingredients": [
                {
                    "name": "TORIPALIMAB",
                    "strength": "240 mg/6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70114-340-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (70114-340-01)  / 6 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20231027",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Coherus BioSciences, Inc."
                ],
                "rxcui": [
                    "2669413",
                    "2669420"
                ],
                "spl_set_id": [
                    "82e7921a-1e84-4988-9799-0ad7d19b2a75"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "8JXN261VVA"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "c1b4fba3-2097-4bd7-88f0-5893fe54a078",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231027",
            "product_id": "70114-340_c1b4fba3-2097-4bd7-88f0-5893fe54a078",
            "application_number": "BLA761240",
            "brand_name_base": "LOQTORZI",
            "pharm_class": [
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "0069-0231",
            "generic_name": "lorlatinib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Lorbrena",
            "active_ingredients": [
                {
                    "name": "LORLATINIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0231-01",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0069-0231-01)",
                    "marketing_start_date": "20181119",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2103169",
                    "2103175",
                    "2103177",
                    "2103179"
                ],
                "spl_set_id": [
                    "2b34d62d-e02a-4af3-bc0d-1571dd4ee76d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300690227016",
                    "0300690231013"
                ],
                "nui": [
                    "N0000175605",
                    "N0000175082",
                    "N0000190118",
                    "N0000191264",
                    "N0000187064",
                    "N0000191265",
                    "N0000190111",
                    "N0000191423",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]",
                    "P-Glycoprotein Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Organic Cation Transporter 1 Inhibitors [MoA]",
                    "Organic Anion Transporter 3 Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "OSP71S83EU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "ea2ec3c5-caaa-4157-ac52-3c6adfff115e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181119",
            "product_id": "0069-0231_ea2ec3c5-caaa-4157-ac52-3c6adfff115e",
            "application_number": "NDA210868",
            "brand_name_base": "Lorbrena",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Organic Anion Transporter 3 Inhibitors [MoA]",
                "Organic Cation Transporter 1 Inhibitors [MoA]",
                "P-Glycoprotein Inducers [MoA]"
            ]
        },
        {
            "product_ndc": "54766-894",
            "generic_name": "alosetron hydrochloride",
            "labeler_name": "Sebela Pharmaceuticals Inc.",
            "brand_name": "LOTRONEX",
            "active_ingredients": [
                {
                    "name": "ALOSETRON HYDROCHLORIDE",
                    "strength": ".5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54766-894-03",
                    "description": "30 TABLET in 1 BOTTLE (54766-894-03)",
                    "marketing_start_date": "20160711",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sebela Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "259306",
                    "261362",
                    "403975",
                    "540181"
                ],
                "spl_set_id": [
                    "35cbb9d5-639b-207a-e054-00144ff88e88"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0354766895036",
                    "0354766894039"
                ],
                "unii": [
                    "2F5R1A46YW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "87fd4e30-01d6-6ab3-e053-2995a90a522f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160711",
            "product_id": "54766-894_87fd4e30-01d6-6ab3-e053-2995a90a522f",
            "application_number": "NDA021107",
            "brand_name_base": "LOTRONEX",
            "pharm_class": [
                "Serotonin 3 Receptor Antagonists [MoA]",
                "Serotonin-3 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0075-8016",
            "generic_name": "enoxaparin sodium",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Lovenox",
            "active_ingredients": [
                {
                    "name": "ENOXAPARIN SODIUM",
                    "strength": "60 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0075-8016-10",
                    "description": "10 CELLO PACK in 1 CARTON (0075-8016-10)  / 1 SYRINGE in 1 CELLO PACK / .6 mL in 1 SYRINGE (0075-8016-01)",
                    "marketing_start_date": "19930329",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "854228",
                    "854232",
                    "854235",
                    "854236",
                    "854238",
                    "854239",
                    "854241",
                    "854242",
                    "854245",
                    "854247",
                    "854248",
                    "854249",
                    "854252",
                    "854253",
                    "854255",
                    "854256"
                ],
                "spl_set_id": [
                    "de6fb917-a94a-41ea-9d7d-937d4080ffcd"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300758030015"
                ],
                "unii": [
                    "8NZ41MIK1O"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "5651b020-2238-46af-9068-dd3b2795928d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19930329",
            "product_id": "0075-8016_5651b020-2238-46af-9068-dd3b2795928d",
            "application_number": "NDA020164",
            "brand_name_base": "Lovenox",
            "pharm_class": [
                "Heparin",
                "Low-Molecular-Weight [CS]",
                "Low Molecular Weight Heparin [EPC]"
            ]
        },
        {
            "product_ndc": "78670-050",
            "generic_name": "lofexidine hydrochloride",
            "labeler_name": "USWM, LLC",
            "brand_name": "Lucemyra",
            "active_ingredients": [
                {
                    "name": "LOFEXIDINE HYDROCHLORIDE",
                    "strength": ".2 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "78670-050-03",
                    "description": "1 BOTTLE in 1 CARTON (78670-050-03)  / 36 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210209",
                    "sample": false
                },
                {
                    "package_ndc": "78670-050-36",
                    "description": "1 BOTTLE in 1 CARTON (78670-050-36)  / 36 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210209",
                    "sample": false
                },
                {
                    "package_ndc": "78670-050-96",
                    "description": "1 BOTTLE in 1 CARTON (78670-050-96)  / 96 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210209",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "USWM, LLC"
                ],
                "rxcui": [
                    "2046591",
                    "2046597"
                ],
                "spl_set_id": [
                    "b748f308-ba71-4fd9-84ec-ec7e0f210885"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V47G1SDI1B"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0df35cf0-1630-403e-b051-7212027f1f26",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210209",
            "product_id": "78670-050_0df35cf0-1630-403e-b051-7212027f1f26",
            "application_number": "NDA209229",
            "brand_name_base": "Lucemyra"
        },
        {
            "product_ndc": "50242-080",
            "generic_name": "RANIBIZUMAB",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "LUCENTIS",
            "active_ingredients": [
                {
                    "name": "RANIBIZUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-080-03",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (50242-080-03)  / .05 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20161013",
                    "sample": false
                },
                {
                    "package_ndc": "50242-080-88",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (50242-080-88)  / .05 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20161013",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1864423",
                    "1864425",
                    "2045501",
                    "2045502"
                ],
                "spl_set_id": [
                    "de4e66cc-ca05-4dc9-8262-e00e9b41c36d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193542",
                    "N0000193543"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "unii": [
                    "ZL1R02VT79"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "b458c73c-3f13-4998-8084-b3202d18386e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20060630",
            "product_id": "50242-080_b458c73c-3f13-4998-8084-b3202d18386e",
            "application_number": "BLA125156",
            "brand_name_base": "LUCENTIS",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "55513-488",
            "generic_name": "sotorasib",
            "labeler_name": "Amgen Inc",
            "brand_name": "LUMAKRAS",
            "active_ingredients": [
                {
                    "name": "SOTORASIB",
                    "strength": "120 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-488-02",
                    "description": "2 BOTTLE, PLASTIC in 1 CARTON (55513-488-02)  / 120 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-488-01)",
                    "marketing_start_date": "20210528",
                    "sample": false
                },
                {
                    "package_ndc": "55513-488-24",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (55513-488-24)  / 240 TABLET, COATED in 1 BOTTLE, PLASTIC (55513-488-40)",
                    "marketing_start_date": "20210528",
                    "sample": false
                },
                {
                    "package_ndc": "55513-488-96",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (55513-488-96)  / 120 TABLET, COATED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20210528",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "2550719",
                    "2550725",
                    "2628240",
                    "2628242"
                ],
                "spl_set_id": [
                    "c80a362c-7ac3-4894-a076-0691e68ef8c1"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513488242",
                    "0355513504508",
                    "0355513488020"
                ],
                "unii": [
                    "2B2VM6UC8G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "336c6783-a078-4639-ba70-b59fdc55ce43",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210528",
            "product_id": "55513-488_336c6783-a078-4639-ba70-b59fdc55ce43",
            "application_number": "NDA214665",
            "brand_name_base": "LUMAKRAS"
        },
        {
            "product_ndc": "0023-3205",
            "generic_name": "bimatoprost",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "LUMIGAN",
            "active_ingredients": [
                {
                    "name": "BIMATOPROST",
                    "strength": ".1 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-3205-02",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (0023-3205-02)  / 2.5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20100910",
                    "sample": false
                },
                {
                    "package_ndc": "0023-3205-03",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (0023-3205-03)  / 2.5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20100910",
                    "sample": false
                },
                {
                    "package_ndc": "0023-3205-05",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (0023-3205-05)  / 5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20100910",
                    "sample": false
                },
                {
                    "package_ndc": "0023-3205-08",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (0023-3205-08)  / 7.5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20100910",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "1009339",
                    "1009341"
                ],
                "spl_set_id": [
                    "a5e67c75-db88-4372-bb07-c8dd15c97631"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175454",
                    "M0017805"
                ],
                "pharm_class_epc": [
                    "Prostaglandin Analog [EPC]"
                ],
                "pharm_class_cs": [
                    "Prostaglandins [CS]"
                ],
                "unii": [
                    "QXS94885MZ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION/ DROPS",
            "spl_id": "157ec58b-058b-4a9f-988e-38d19ff72cab",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20100910",
            "product_id": "0023-3205_157ec58b-058b-4a9f-988e-38d19ff72cab",
            "application_number": "NDA022184",
            "brand_name_base": "LUMIGAN",
            "pharm_class": [
                "Prostaglandin Analog [EPC]",
                "Prostaglandins [CS]"
            ]
        },
        {
            "product_ndc": "50242-142",
            "generic_name": "Mosunetuzumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Lunsumio",
            "active_ingredients": [
                {
                    "name": "MOSUNETUZUMAB",
                    "strength": "30 mg/30mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-142-01",
                    "description": "1 VIAL in 1 CARTON (50242-142-01)  / 30 mL in 1 VIAL",
                    "marketing_start_date": "20221222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2625129",
                    "2625135",
                    "2625137",
                    "2625138"
                ],
                "spl_set_id": [
                    "2ef0cf38-101c-4681-98fe-c05dc9ead443"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "LDJ89SS0YG"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "CONCENTRATE",
            "spl_id": "3c8d2a27-5057-4c5a-b9fc-c6d67afdd2f7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20221222",
            "product_id": "50242-142_3c8d2a27-5057-4c5a-b9fc-c6d67afdd2f7",
            "application_number": "BLA761263",
            "brand_name_base": "Lunsumio"
        },
        {
            "product_ndc": "75626-001",
            "generic_name": "Voclosporin",
            "labeler_name": "Aurinia Pharma U.S., Inc.",
            "brand_name": "LUPKYNIS",
            "active_ingredients": [
                {
                    "name": "VOCLOSPORIN",
                    "strength": "7.9 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75626-001-02",
                    "description": "3 PACKET in 1 CARTON (75626-001-02)  / 4 BLISTER PACK in 1 PACKET (75626-001-01)  / 15 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20210122",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Aurinia Pharma U.S., Inc."
                ],
                "rxcui": [
                    "2475400",
                    "2475406"
                ],
                "spl_set_id": [
                    "9f489295-1156-52c7-5fd0-5c4c52f9b813"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175457",
                    "N0000175458",
                    "N0000185503",
                    "N0000190107",
                    "N0000190108"
                ],
                "pharm_class_epc": [
                    "Calcineurin Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Calcineurin Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]"
                ],
                "unii": [
                    "2PN063X6B1"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "4000aa38-2050-4708-91a7-613eafdace22",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210122",
            "product_id": "75626-001_4000aa38-2050-4708-91a7-613eafdace22",
            "application_number": "NDA213716",
            "brand_name_base": "LUPKYNIS",
            "pharm_class": [
                "Calcineurin Inhibitor Immunosuppressant [EPC]",
                "Calcineurin Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0811",
            "generic_name": "octreotide acetate",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Sandostatin LAR Depot",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0811-81",
                    "description": "1 KIT in 1 KIT (0078-0811-81)  *  6 mL in 1 VIAL (0078-0790-61)  *  2 mL in 1 SYRINGE",
                    "marketing_start_date": "20160722",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "898589",
                    "898591",
                    "898601",
                    "898603",
                    "898605",
                    "898607"
                ],
                "spl_set_id": [
                    "d0b7fe9e-7000-4b79-ba3b-291ce92c14f9"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "09e3ff5f-554a-4922-9478-d87d52e842d0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20160722",
            "product_id": "0078-0811_09e3ff5f-554a-4922-9478-d87d52e842d0",
            "application_number": "NDA021008",
            "brand_name_base": "Sandostatin LAR Depot"
        },
        {
            "product_ndc": "0078-0811",
            "generic_name": "octreotide acetate",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Sandostatin LAR Depot",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0811-81",
                    "description": "1 KIT in 1 KIT (0078-0811-81)  *  6 mL in 1 VIAL (0078-0790-61)  *  2 mL in 1 SYRINGE",
                    "marketing_start_date": "20160722",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "898589",
                    "898591",
                    "898601",
                    "898603",
                    "898605",
                    "898607"
                ],
                "spl_set_id": [
                    "d0b7fe9e-7000-4b79-ba3b-291ce92c14f9"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "09e3ff5f-554a-4922-9478-d87d52e842d0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20160722",
            "product_id": "0078-0811_09e3ff5f-554a-4922-9478-d87d52e842d0",
            "application_number": "NDA021008",
            "brand_name_base": "Sandostatin LAR Depot"
        },
        {
            "product_ndc": "69488-003",
            "generic_name": "Lutetium Lu 177 dotatate",
            "labeler_name": "Advanced Accelerator Applications USA, Inc",
            "brand_name": "Lutathera",
            "active_ingredients": [
                {
                    "name": "LUTETIUM OXODOTREOTIDE LU-177",
                    "strength": "10 mCi/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69488-003-01",
                    "description": "1 VIAL in 1 PACKAGE (69488-003-01)  / 20.5 mL in 1 VIAL",
                    "marketing_start_date": "20180126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Advanced Accelerator Applications USA, Inc"
                ],
                "rxcui": [
                    "1999682",
                    "1999687"
                ],
                "spl_set_id": [
                    "72d1a024-00b7-418a-b36e-b2cb48f2ab55"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "AE221IM3BB"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "120f30d8-94dd-4d23-abee-b816504de909",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20180126",
            "product_id": "69488-003_120f30d8-94dd-4d23-abee-b816504de909",
            "application_number": "NDA208700",
            "brand_name_base": "Lutathera"
        },
        {
            "product_ndc": "71394-415",
            "generic_name": "voretigene neparvovec-rzyl",
            "labeler_name": "Spark Therapeutics, Inc.",
            "brand_name": "LUXTURNA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71394-415-01",
                    "description": "1 KIT in 1 CARTON (71394-415-01)  *  1 INJECTION, SUSPENSION in 1 VIAL, PLASTIC (71394-065-01)  *  1 INJECTION, SOLUTION in 1 VIAL, PLASTIC (71394-716-01)",
                    "marketing_start_date": "20171219",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Spark Therapeutics, Inc."
                ],
                "rxcui": [
                    "1995884",
                    "1995886"
                ],
                "spl_set_id": [
                    "08313a24-e7ce-457a-bb3f-161bc45517ee"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "904b2c3a-1db9-4e7b-848b-670e00b1b7e4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20171219",
            "product_id": "71394-415_904b2c3a-1db9-4e7b-848b-670e00b1b7e4",
            "application_number": "BLA125610",
            "brand_name_base": "LUXTURNA"
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "65757-651",
            "generic_name": "olanzapine and samidorphan L-malate",
            "labeler_name": "Alkermes, Inc.",
            "brand_name": "LYBALVI",
            "active_ingredients": [
                {
                    "name": "OLANZAPINE",
                    "strength": "5 mg/1"
                },
                {
                    "name": "SAMIDORPHAN L-MALATE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65757-651-40",
                    "description": "1 BOTTLE in 1 CARTON (65757-651-40)  / 7 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210920",
                    "sample": false
                },
                {
                    "package_ndc": "65757-651-41",
                    "description": "1 BOTTLE in 1 CARTON (65757-651-41)  / 7 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210920",
                    "sample": true
                },
                {
                    "package_ndc": "65757-651-42",
                    "description": "1 BOTTLE in 1 CARTON (65757-651-42)  / 30 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210920",
                    "sample": false
                },
                {
                    "package_ndc": "65757-651-44",
                    "description": "1 BOTTLE in 1 CARTON (65757-651-44)  / 90 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210920",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Alkermes, Inc."
                ],
                "rxcui": [
                    "2570392",
                    "2570398",
                    "2570399",
                    "2570401",
                    "2570402",
                    "2570404",
                    "2570405",
                    "2570407"
                ],
                "spl_set_id": [
                    "32ffddd1-4e2b-45d9-9b36-bb730167ec80"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "0AJQ5N56E0",
                    "N7U69T4SZR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "05f97042-13ee-4ca2-af3d-857998656ff1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210920",
            "product_id": "65757-651_05f97042-13ee-4ca2-af3d-857998656ff1",
            "application_number": "NDA213378",
            "brand_name_base": "LYBALVI",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]",
                "Opioid Antagonist [EPC]",
                "Opioid Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0310-0668",
            "generic_name": "olaparib",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "Lynparza",
            "active_ingredients": [
                {
                    "name": "OLAPARIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-0668-12",
                    "description": "120 TABLET, FILM COATED in 1 BOTTLE (0310-0668-12)",
                    "marketing_start_date": "20170817",
                    "sample": false
                },
                {
                    "package_ndc": "0310-0668-60",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (0310-0668-60)",
                    "marketing_start_date": "20170817",
                    "sample": false
                },
                {
                    "package_ndc": "0310-0668-95",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (0310-0668-95)",
                    "marketing_start_date": "20220901",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "1942482",
                    "1942485",
                    "1942487",
                    "1942489"
                ],
                "spl_set_id": [
                    "741ff3e3-dc1a-45a6-84e5-2481b27131aa"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191623",
                    "N0000191622"
                ],
                "pharm_class_epc": [
                    "Poly(ADP-Ribose) Polymerase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"
                ],
                "unii": [
                    "WOH1JD9AR8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "c0888bfa-cba4-4d26-9fdb-f60c6858e022",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170817",
            "product_id": "0310-0668_c0888bfa-cba4-4d26-9fdb-f60c6858e022",
            "application_number": "NDA208558",
            "brand_name_base": "Lynparza",
            "pharm_class": [
                "Poly(ADP-Ribose) Polymerase Inhibitor [EPC]",
                "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "64842-0120",
            "generic_name": "FUTIBATINIB",
            "labeler_name": "TAIHO PHARMACEUTICAL CO., LTD.",
            "brand_name": "LYTGOBI",
            "active_ingredients": [
                {
                    "name": "FUTIBATINIB",
                    "strength": "4 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64842-0120-4",
                    "description": "1 BLISTER PACK in 1 CARTON (64842-0120-4)  / 21 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20230203",
                    "sample": false
                },
                {
                    "package_ndc": "64842-0120-5",
                    "description": "1 BLISTER PACK in 1 CARTON (64842-0120-5)  / 28 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20230203",
                    "sample": false
                },
                {
                    "package_ndc": "64842-0120-6",
                    "description": "1 BLISTER PACK in 1 CARTON (64842-0120-6)  / 35 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20230203",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "TAIHO PHARMACEUTICAL CO., LTD."
                ],
                "rxcui": [
                    "2628195",
                    "2628201",
                    "2628203",
                    "2628204",
                    "2628205",
                    "2628206",
                    "2628207",
                    "2628208"
                ],
                "spl_set_id": [
                    "0b1332a1-0581-4707-9bf6-1eccfa39bef4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000194026",
                    "N0000185503",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "4B93MGE4AL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "41bd4c25-4c06-48c4-8e71-821a5711fd18",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230203",
            "product_id": "64842-0120_41bd4c25-4c06-48c4-8e71-821a5711fd18",
            "application_number": "NDA214801",
            "brand_name_base": "LYTGOBI",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0002-8228",
            "generic_name": "Insulin lispro-aabc",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "LYUMJEV KwikPen",
            "brand_name_suffix": "KwikPen",
            "active_ingredients": [
                {
                    "name": "INSULIN LISPRO",
                    "strength": "200 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-8228-27",
                    "description": "2 SYRINGE in 1 CARTON (0002-8228-27)  / 3 mL in 1 SYRINGE (0002-8228-01)",
                    "marketing_start_date": "20200615",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "2380231",
                    "2380236",
                    "2380248",
                    "2380250",
                    "2380254",
                    "2380256",
                    "2380259",
                    "2380260",
                    "2380265",
                    "2380266",
                    "2380267",
                    "2380268"
                ],
                "spl_set_id": [
                    "c5a056e2-b568-4ca6-9ed8-79c010942d00"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300027728018"
                ],
                "nui": [
                    "N0000004931",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [Chemical/Ingredient]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "GFX7QIS1II"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "6f84ba56-a2a5-440e-9d3f-334655934a53",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20200615",
            "product_id": "0002-8228_6f84ba56-a2a5-440e-9d3f-334655934a53",
            "application_number": "BLA761109",
            "brand_name_base": "LYUMJEV",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [Chemical/Ingredient]"
            ]
        },
        {
            "product_ndc": "70257-414",
            "generic_name": "baclofen",
            "labeler_name": "Saol Therapeutics Inc",
            "brand_name": "Lyvispah",
            "active_ingredients": [
                {
                    "name": "BACLOFEN",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70257-414-87",
                    "description": "90 PACKET in 1 BOTTLE, UNIT-DOSE (70257-414-87)  / 1 GRANULE in 1 PACKET",
                    "marketing_start_date": "20211122",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Saol Therapeutics Inc"
                ],
                "rxcui": [
                    "2586589",
                    "2586595",
                    "2586596",
                    "2586598",
                    "2586599",
                    "2586601"
                ],
                "spl_set_id": [
                    "a7d2dc58-e167-4ebc-ac1d-932f000fb412"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000196",
                    "N0000000116",
                    "N0000175759"
                ],
                "pharm_class_moa": [
                    "GABA A Agonists [MoA]",
                    "GABA B Agonists [MoA]"
                ],
                "pharm_class_epc": [
                    "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
                ],
                "unii": [
                    "H789N3FKE8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GRANULE",
            "spl_id": "4057e10f-332f-48e1-8c97-e80b93331add",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20211122",
            "product_id": "70257-414_4057e10f-332f-48e1-8c97-e80b93331add",
            "application_number": "NDA215422",
            "brand_name_base": "Lyvispah",
            "pharm_class": [
                "GABA A Agonists [MoA]",
                "GABA B Agonists [MoA]",
                "gamma-Aminobutyric Acid-ergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "76420-769",
            "generic_name": "Dexamethasone Sodium Phosphate, Lidocaine Hydrochloride, maricaine, Povidine Iodine",
            "labeler_name": "Asclemed USA, Inc.",
            "brand_name": "Dexlido-M Kit",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76420-769-01",
                    "description": "1 KIT in 1 CARTON (76420-769-01)  *  10 mL in 1 VIAL, SINGLE-DOSE (0409-1159-18)  *  .9 mL in 1 PACKET (67777-419-02)  *  5 mL in 1 POUCH *  10 AMPULE in 1 CARTON (55150-158-72)  / 2 mL in 1 AMPULE *  25 VIAL in 1 TRAY (63323-506-01)  / 1 mL in 1 VIAL",
                    "marketing_start_date": "20160523",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Asclemed USA, Inc."
                ],
                "rxcui": [
                    "797544",
                    "797730",
                    "1725078",
                    "1737568",
                    "1812079"
                ],
                "spl_set_id": [
                    "d3fd1d51-7749-4e1e-a8b5-8a151392f66d"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "KIT",
            "spl_id": "efdc15d7-beba-2ee8-e053-2995a90aa80c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "EPIDURAL",
                "INFILTRATION",
                "INTRAMUSCULAR",
                "INTRAVENOUS",
                "TOPICAL"
            ],
            "marketing_start_date": "20140725",
            "product_id": "76420-769_efdc15d7-beba-2ee8-e053-2995a90aa80c",
            "brand_name_base": "Dexlido-M Kit"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "74527-022",
            "generic_name": "margetuximab-cmkb",
            "labeler_name": "MacroGenics, Inc",
            "brand_name": "MARGENZA",
            "active_ingredients": [
                {
                    "name": "MARGETUXIMAB",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "74527-022-02",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-02)  / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)",
                    "marketing_start_date": "20210115",
                    "sample": false
                },
                {
                    "package_ndc": "74527-022-03",
                    "description": "4 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-03)  / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)",
                    "marketing_start_date": "20210115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "MacroGenics, Inc"
                ],
                "rxcui": [
                    "2474028",
                    "2474033"
                ],
                "spl_set_id": [
                    "e97a5872-eabf-463b-8f4c-5b5aed9c7bf0"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "K911R84KEW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "ecffdaa1-85ce-4114-9815-d90ae7ec3258",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210115",
            "product_id": "74527-022_ecffdaa1-85ce-4114-9815-d90ae7ec3258",
            "application_number": "BLA761150",
            "brand_name_base": "MARGENZA",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "44087-4000",
            "generic_name": "Cladribine",
            "labeler_name": "EMD Serono, Inc.",
            "brand_name": "Mavenclad",
            "active_ingredients": [
                {
                    "name": "CLADRIBINE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "44087-4000-0",
                    "description": "5 BLISTER PACK in 1 CARTON (44087-4000-0)  / 2 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                },
                {
                    "package_ndc": "44087-4000-4",
                    "description": "4 BLISTER PACK in 1 CARTON (44087-4000-4)  / 1 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                },
                {
                    "package_ndc": "44087-4000-5",
                    "description": "5 BLISTER PACK in 1 CARTON (44087-4000-5)  / 1 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                },
                {
                    "package_ndc": "44087-4000-6",
                    "description": "6 BLISTER PACK in 1 CARTON (44087-4000-6)  / 1 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                },
                {
                    "package_ndc": "44087-4000-7",
                    "description": "7 BLISTER PACK in 1 CARTON (44087-4000-7)  / 1 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                },
                {
                    "package_ndc": "44087-4000-8",
                    "description": "8 BLISTER PACK in 1 CARTON (44087-4000-8)  / 1 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                },
                {
                    "package_ndc": "44087-4000-9",
                    "description": "9 BLISTER PACK in 1 CARTON (44087-4000-9)  / 1 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20190401",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "EMD Serono, Inc."
                ],
                "rxcui": [
                    "2122634",
                    "2122635",
                    "2122641",
                    "2122642",
                    "2122647",
                    "2122648",
                    "2122649",
                    "2122650",
                    "2122654",
                    "2122655",
                    "2122656",
                    "2122657",
                    "2122658",
                    "2122659",
                    "2122660",
                    "2122661"
                ],
                "spl_set_id": [
                    "9c75e30a-a410-40f1-b653-04d532bd9144"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175712"
                ],
                "pharm_class_epc": [
                    "Purine Antimetabolite [EPC]"
                ],
                "unii": [
                    "47M74X9YT5"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "01f76c5f-0f92-42d5-b2de-18a330c27876",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190401",
            "product_id": "44087-4000_01f76c5f-0f92-42d5-b2de-18a330c27876",
            "application_number": "NDA022561",
            "brand_name_base": "Mavenclad",
            "pharm_class": [
                "Purine Antimetabolite [EPC]"
            ]
        },
        {
            "product_ndc": "0074-2600",
            "generic_name": "Glecaprevir and Pibrentasvir",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Mavyret",
            "active_ingredients": [
                {
                    "name": "GLECAPREVIR",
                    "strength": "50 mg/1"
                },
                {
                    "name": "PIBRENTASVIR",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-2600-28",
                    "description": "1 PACKET in 1 CARTON (0074-2600-28)  / 28 PELLET in 1 PACKET",
                    "marketing_start_date": "20210622",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "1940703",
                    "1940709",
                    "2557906",
                    "2557910"
                ],
                "spl_set_id": [
                    "7bf99777-0401-9095-8645-16c6e907fcc0"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300742625807"
                ],
                "nui": [
                    "N0000191256",
                    "N0000185503",
                    "N0000190113",
                    "N0000190107",
                    "N0000190108",
                    "N0000190114",
                    "N0000182138",
                    "N0000191272",
                    "N0000182639",
                    "N0000182638"
                ],
                "pharm_class_epc": [
                    "Hepatitis C Virus NS5A Inhibitor [EPC]",
                    "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "Cytochrome P450 1A2 Inhibitors [MoA]",
                    "UGT1A1 Inhibitors [MoA]",
                    "HCV NS3/4A Protease Inhibitors [MoA]"
                ],
                "unii": [
                    "2WU922TK3L",
                    "K6BUU8J72P"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "PELLET",
            "spl_id": "085d0018-b2f0-4da6-b528-a2866430599c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210610",
            "product_id": "0074-2600_085d0018-b2f0-4da6-b528-a2866430599c",
            "application_number": "NDA215110",
            "brand_name_base": "Mavyret",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "HCV NS3/4A Protease Inhibitors [MoA]",
                "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]",
                "Hepatitis C Virus NS5A Inhibitor [EPC]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "UGT1A1 Inhibitors [MoA]",
                "UGT1A1 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0979",
            "generic_name": "siponimod",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "MAYZENT",
            "active_ingredients": [
                {
                    "name": "SIPONIMOD",
                    "strength": ".25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0979-12",
                    "description": "12 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-12)",
                    "marketing_start_date": "20190326",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0979-50",
                    "description": "28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-50)",
                    "marketing_start_date": "20190326",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0979-89",
                    "description": "7 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-89)",
                    "marketing_start_date": "20220301",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0979-92",
                    "description": "28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-92)",
                    "marketing_start_date": "20190326",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2121090",
                    "2121096",
                    "2121098",
                    "2121100",
                    "2123313",
                    "2123314",
                    "2594606",
                    "2594608",
                    "2594796",
                    "2594797"
                ],
                "spl_set_id": [
                    "44492772-5aed-4627-bd85-e8e89f308bb3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000181816",
                    "N0000181815"
                ],
                "pharm_class_epc": [
                    "Sphingosine 1-phosphate Receptor Modulator [EPC]"
                ],
                "pharm_class_moa": [
                    "Sphingosine 1-Phosphate Receptor Modulators [MoA]"
                ],
                "unii": [
                    "RR6P8L282I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "f39a21f8-4208-4b89-b206-3e8b7d6850fd",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190326",
            "product_id": "0078-0979_f39a21f8-4208-4b89-b206-3e8b7d6850fd",
            "application_number": "NDA209884",
            "brand_name_base": "MAYZENT",
            "pharm_class": [
                "Sphingosine 1-Phosphate Receptor Modulators [MoA]",
                "Sphingosine 1-phosphate Receptor Modulator [EPC]"
            ]
        },
        {
            "product_ndc": "0078-1161",
            "generic_name": "trametinib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Mekinist",
            "active_ingredients": [
                {
                    "name": "TRAMETINIB DIMETHYL SULFOXIDE",
                    "strength": ".05 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-1161-47",
                    "description": "90 mL in 1 BOTTLE (0078-1161-47)",
                    "marketing_start_date": "20230316",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1425104",
                    "1425118",
                    "2632560",
                    "2632564",
                    "1425110",
                    "1425116"
                ],
                "spl_set_id": [
                    "0002ad27-779d-42ab-83b5-bc65453412a1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "BSB9VJ5TUT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SOLUTION",
            "spl_id": "d234ab35-eca7-46f7-8e33-6d421bb47211",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230316",
            "product_id": "0078-1161_d234ab35-eca7-46f7-8e33-6d421bb47211",
            "application_number": "NDA217513",
            "brand_name_base": "Mekinist",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "50419-455",
            "generic_name": "estradiol",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Menostar",
            "active_ingredients": [
                {
                    "name": "ESTRADIOL",
                    "strength": "14 ug/d"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-455-04",
                    "description": "4 PATCH in 1 CARTON (50419-455-04)  / 7 d in 1 PATCH",
                    "marketing_start_date": "20040608",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "476545",
                    "545276"
                ],
                "spl_set_id": [
                    "a78708cd-04d4-4221-a4e4-53680bbe2912"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0447348",
                    "N0000175825",
                    "N0000000100"
                ],
                "pharm_class_cs": [
                    "Estradiol Congeners [CS]"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "unii": [
                    "4TI98Z838E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "PATCH",
            "spl_id": "546794ef-9847-480e-a12a-e14f0c9575de",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TRANSDERMAL"
            ],
            "marketing_start_date": "20040608",
            "product_id": "50419-455_546794ef-9847-480e-a12a-e14f0c9575de",
            "application_number": "NDA020375",
            "brand_name_base": "Menostar",
            "pharm_class": [
                "Estradiol Congeners [CS]",
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]"
            ]
        },
        {
            "product_ndc": "49281-590",
            "generic_name": "NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN",
            "labeler_name": "Sanofi Pasteur Inc.",
            "brand_name": "MenQuadfi",
            "active_ingredients": [
                {
                    "name": "NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN",
                    "strength": "10 ug/.5mL"
                },
                {
                    "name": "NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN",
                    "strength": "10 ug/.5mL"
                },
                {
                    "name": "NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN",
                    "strength": "10 ug/.5mL"
                },
                {
                    "name": "NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN",
                    "strength": "10 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49281-590-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-01)  / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)",
                    "marketing_start_date": "20200423",
                    "sample": false
                },
                {
                    "package_ndc": "49281-590-05",
                    "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-05)  / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)",
                    "marketing_start_date": "20200423",
                    "sample": false
                },
                {
                    "package_ndc": "49281-590-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-10)  / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)",
                    "marketing_start_date": "20200423",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "2b310d55-5658-40df-9e9f-ca278ed33310",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20200423",
            "product_id": "49281-590_2b310d55-5658-40df-9e9f-ca278ed33310",
            "application_number": "BLA125701",
            "brand_name_base": "MenQuadfi"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "79481-0647",
            "generic_name": "Magnesium hydroxide",
            "labeler_name": "Meijer, Inc.",
            "brand_name": "Milk of Magnesia mint",
            "active_ingredients": [
                {
                    "name": "MAGNESIUM HYDROXIDE",
                    "strength": "1200 mg/15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "79481-0647-1",
                    "description": "769 mL in 1 BOTTLE (79481-0647-1)",
                    "marketing_start_date": "20210201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meijer, Inc."
                ],
                "rxcui": [
                    "253017"
                ],
                "spl_set_id": [
                    "bb8ba371-f53c-1088-e053-2a95a90a4cbf"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "NBZ3QY004S"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "SUSPENSION",
            "spl_id": "09a7136c-d359-6d30-e063-6294a90ab07f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210201",
            "product_id": "79481-0647_09a7136c-d359-6d30-e063-6294a90ab07f",
            "application_number": "M007",
            "brand_name_base": "Milk of Magnesia mint",
            "pharm_class": [
                "Calculi Dissolution Agent [EPC]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"
            ]
        },
        {
            "product_ndc": "69794-001",
            "generic_name": "vestronidase alfa",
            "labeler_name": "Ultragenyx Pharmaceutical Inc.",
            "brand_name": "MEPSEVII",
            "active_ingredients": [
                {
                    "name": "VESTRONIDASE ALFA",
                    "strength": "2 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69794-001-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (69794-001-01)  / 5 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20171115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Ultragenyx Pharmaceutical Inc."
                ],
                "rxcui": [
                    "1989823",
                    "1989828"
                ],
                "spl_set_id": [
                    "925d4e21-fd98-474d-a34d-a0b3558ed750"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193804"
                ],
                "pharm_class_epc": [
                    "Lysosomal beta Glucuronidase [EPC]"
                ],
                "unii": [
                    "7XZ4062R17"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "1b14c170-a976-444f-a1be-edc59d532721",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20171115",
            "product_id": "69794-001_1b14c170-a976-444f-a1be-edc59d532721",
            "application_number": "BLA761047",
            "brand_name_base": "MEPSEVII",
            "pharm_class": [
                "Lysosomal beta Glucuronidase [EPC]"
            ]
        },
        {
            "product_ndc": "72078-038",
            "generic_name": "calcitonin salmon",
            "labeler_name": "Mylan Institutional LLC",
            "brand_name": "Miacalcin",
            "active_ingredients": [
                {
                    "name": "CALCITONIN SALMON",
                    "strength": "200 [USP'U]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72078-038-02",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72078-038-02)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20220616",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Institutional LLC"
                ],
                "rxcui": [
                    "213570",
                    "308866"
                ],
                "spl_set_id": [
                    "753ecc6a-07be-4fc6-9032-cc6ad116a662"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0003145",
                    "N0000175942"
                ],
                "pharm_class_cs": [
                    "Calcitonin [CS]"
                ],
                "pharm_class_epc": [
                    "Calcitonin [EPC]"
                ],
                "unii": [
                    "7SFC6U2VI5"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "fddf56ea-530f-41aa-a913-f2557527fb12",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220616",
            "product_id": "72078-038_fddf56ea-530f-41aa-a913-f2557527fb12",
            "application_number": "NDA017808",
            "brand_name_base": "Miacalcin",
            "pharm_class": [
                "Calcitonin [CS]",
                "Calcitonin [EPC]"
            ]
        },
        {
            "product_ndc": "24208-377",
            "generic_name": "Perfluorohexyloctane",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "MIEBO",
            "active_ingredients": [
                {
                    "name": "PERFLUOROHEXYLOCTANE",
                    "strength": "1 mg/mg"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-377-01",
                    "description": "1 BOTTLE in 1 CARTON (24208-377-01)  / 3 mg in 1 BOTTLE",
                    "marketing_start_date": "20230518",
                    "sample": true
                },
                {
                    "package_ndc": "24208-377-05",
                    "description": "1 BOTTLE in 1 CARTON (24208-377-05)  / 3 mg in 1 BOTTLE",
                    "marketing_start_date": "20230518",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "2637551",
                    "2637556"
                ],
                "spl_set_id": [
                    "6b283c02-7df4-4c00-951b-555cddffe77c"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0324208377055"
                ],
                "unii": [
                    "7VYX4ELWQM"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "6f59fdbc-2b39-4101-aa1f-1d3a27be76fb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20230518",
            "product_id": "24208-377_6f59fdbc-2b39-4101-aa1f-1d3a27be76fb",
            "application_number": "NDA216675",
            "brand_name_base": "MIEBO"
        },
        {
            "product_ndc": "50419-423",
            "generic_name": "Levonorgestrel",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Mirena",
            "active_ingredients": [
                {
                    "name": "LEVONORGESTREL",
                    "strength": "52 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-423-01",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-423-01)",
                    "marketing_start_date": "20140530",
                    "sample": false
                },
                {
                    "package_ndc": "50419-423-08",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-423-08)",
                    "marketing_start_date": "20161208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "804156",
                    "807283"
                ],
                "spl_set_id": [
                    "dcbd6aa2-b3fa-479a-a676-56ea742962fc"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175830",
                    "M0447349",
                    "N0000175602",
                    "N0000175832"
                ],
                "pharm_class_pe": [
                    "Inhibit Ovum Fertilization [PE]"
                ],
                "pharm_class_cs": [
                    "Progesterone Congeners [CS]"
                ],
                "pharm_class_epc": [
                    "Progestin [EPC]",
                    "Progestin-containing Intrauterine System [EPC]"
                ],
                "unii": [
                    "5W7SIA7YZW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INTRAUTERINE DEVICE",
            "spl_id": "c252476c-7dc8-4ef5-a7c7-380b8016ca27",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAUTERINE"
            ],
            "marketing_start_date": "20091001",
            "product_id": "50419-423_c252476c-7dc8-4ef5-a7c7-380b8016ca27",
            "application_number": "NDA021225",
            "brand_name_base": "Mirena",
            "pharm_class": [
                "Inhibit Ovum Fertilization [PE]",
                "Progesterone Congeners [CS]",
                "Progesterone Congeners [CS]",
                "Progestin [EPC]",
                "Progestin-containing Intrauterine System [EPC]"
            ]
        },
        {
            "product_ndc": "73535-208",
            "generic_name": "Tafasitamab-cxix",
            "labeler_name": "MorphoSys US Inc.",
            "brand_name": "MONJUVI",
            "active_ingredients": [
                {
                    "name": "TAFASITAMAB",
                    "strength": "200 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73535-208-01",
                    "description": "1 VIAL in 1 CARTON (73535-208-01)  / 5 mL in 1 VIAL",
                    "marketing_start_date": "20200805",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "MorphoSys US Inc."
                ],
                "rxcui": [
                    "2387338",
                    "2387343"
                ],
                "spl_set_id": [
                    "ec13ac6b-bfde-4e84-907a-83bd69584d95"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0373535208013"
                ],
                "unii": [
                    "QQA9MLH692"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "3e360b52-bf17-4064-8c61-64efb8772e0d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200805",
            "product_id": "73535-208_3e360b52-bf17-4064-8c61-64efb8772e0d",
            "application_number": "BLA761163",
            "brand_name_base": "MONJUVI"
        },
        {
            "product_ndc": "73594-9310",
            "generic_name": "Ferric derisomaltose",
            "labeler_name": "Pharmacosmos Therapeutics Inc.",
            "brand_name": "Monoferric",
            "active_ingredients": [
                {
                    "name": "FERRIC DERISOMALTOSE",
                    "strength": "1000 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73594-9310-1",
                    "description": "1 VIAL in 1 BOX (73594-9310-1)  / 10 mL in 1 VIAL",
                    "marketing_start_date": "20200116",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pharmacosmos Therapeutics Inc."
                ],
                "rxcui": [
                    "2274398",
                    "2274403",
                    "2274406",
                    "2274407",
                    "2274408",
                    "2274409"
                ],
                "spl_set_id": [
                    "55859d2d-0456-4fa9-b41f-f535accc97db"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0373594931013"
                ],
                "unii": [
                    "AHU547PI9H"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "0f173598-daee-2e65-e063-6394a90af6bc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200116",
            "product_id": "73594-9310_0f173598-daee-2e65-e063-6394a90af6bc",
            "application_number": "NDA208171",
            "brand_name_base": "Monoferric"
        },
        {
            "product_ndc": "54092-546",
            "generic_name": "PRUCALOPRIDE",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "MOTEGRITY",
            "active_ingredients": [
                {
                    "name": "PRUCALOPRIDE SUCCINATE",
                    "strength": "1 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54092-546-01",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (54092-546-01)",
                    "marketing_start_date": "20181214",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "2107345",
                    "2107351",
                    "2107353",
                    "2107355"
                ],
                "spl_set_id": [
                    "bca1e4c6-4b2b-4876-8ab3-654629c4ff1b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "4V2G75E1CK"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "84219f75-9a6d-4e43-833c-9149193cf079",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181214",
            "product_id": "54092-546_84219f75-9a6d-4e43-833c-9149193cf079",
            "application_number": "NDA210166",
            "brand_name_base": "MOTEGRITY",
            "pharm_class": [
                "Serotonin 4 Receptor Agonists [MoA]",
                "Serotonin-4 Receptor Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "65649-201",
            "generic_name": "POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE",
            "labeler_name": "Salix Pharmaceuticals, Inc.",
            "brand_name": "MoviPrep",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65649-201-75",
                    "description": "1 KIT in 1 CONTAINER (65649-201-75)  *  1 L in 1 POUCH *  1 L in 1 POUCH",
                    "marketing_start_date": "20061001",
                    "sample": false
                },
                {
                    "package_ndc": "65649-201-76",
                    "description": "1 KIT in 1 CONTAINER (65649-201-76)  *  1 L in 1 POUCH *  1 L in 1 POUCH",
                    "marketing_start_date": "20061001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Salix Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "800915",
                    "800918"
                ],
                "spl_set_id": [
                    "8ff46193-2a3b-4de0-9572-775dda8cd8b2"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "aeede670-8fd9-4e9b-a694-143fc5044f83",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20061001",
            "product_id": "65649-201_aeede670-8fd9-4e9b-a694-143fc5044f83",
            "application_number": "NDA021881",
            "brand_name_base": "MoviPrep"
        },
        {
            "product_ndc": "0024-5862",
            "generic_name": "PLERIXAFOR",
            "labeler_name": "sanofi-aventis U.S. LLC",
            "brand_name": "Mozobil",
            "active_ingredients": [
                {
                    "name": "PLERIXAFOR",
                    "strength": "24 mg/1.2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5862-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (0024-5862-01)  / 1.2 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20130901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "sanofi-aventis U.S. LLC"
                ],
                "rxcui": [
                    "828700",
                    "828703"
                ],
                "spl_set_id": [
                    "0ed08d2b-5051-46b2-aa37-1d6275bf9003"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000178326",
                    "N0000178324"
                ],
                "pharm_class_epc": [
                    "Hematopoietic Stem Cell Mobilizer [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Hematopoietic Stem Cell Mobilization [PE]"
                ],
                "unii": [
                    "S915P5499N"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "0abe8d3a-2518-4581-b150-75f03ae30641",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20130901",
            "product_id": "0024-5862_0abe8d3a-2518-4581-b150-75f03ae30641",
            "application_number": "NDA022311",
            "brand_name_base": "Mozobil",
            "pharm_class": [
                "Hematopoietic Stem Cell Mobilizer [EPC]",
                "Increased Hematopoietic Stem Cell Mobilization [PE]"
            ]
        },
        {
            "product_ndc": "55154-8104",
            "generic_name": "Dronedarone",
            "labeler_name": "Cardinal Health 107, LLC",
            "brand_name": "Multaq",
            "active_ingredients": [
                {
                    "name": "DRONEDARONE",
                    "strength": "400 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55154-8104-2",
                    "description": "1260 TABLET, FILM COATED in 1 BOTTLE (55154-8104-2)",
                    "marketing_start_date": "20090701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Cardinal Health 107, LLC"
                ],
                "rxcui": [
                    "854856",
                    "854859"
                ],
                "spl_set_id": [
                    "3bd4006a-8bad-4909-ac6d-b6d84390155c"
                ],
                "upc": [
                    "0355154810426"
                ],
                "nui": [
                    "N0000175426"
                ],
                "pharm_class_epc": [
                    "Antiarrhythmic [EPC]"
                ],
                "unii": [
                    "JQZ1L091Y2"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "4a0c1e4c-981d-4f0b-afe9-8d97b90c5220",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20090701",
            "product_id": "55154-8104_4a0c1e4c-981d-4f0b-afe9-8d97b90c5220",
            "application_number": "NDA022425",
            "brand_name_base": "Multaq",
            "pharm_class": [
                "Antiarrhythmic [EPC]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "69777-260",
            "generic_name": "Homosalate, Octocrylene, Octisalate, Avobenzone",
            "labeler_name": "NATURE & NATURE CO.,LTD.",
            "brand_name": "Secret Muse Vita Blue Sun",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/50mL"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "4.75 g/50mL"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "2.25 g/50mL"
                },
                {
                    "name": "OCTOCRYLENE",
                    "strength": "2.5 g/50mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69777-260-02",
                    "description": "1 CONTAINER in 1 CARTON (69777-260-02)  / 50 mL in 1 CONTAINER (69777-260-01)",
                    "marketing_start_date": "20180501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NATURE & NATURE CO.,LTD."
                ],
                "spl_set_id": [
                    "e88e8875-c8af-4726-8367-d826614bfe73"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4X49Y0596W",
                    "5A68WGF6WM"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "e85ff1c0-0b65-41d1-9b77-6af8e2dc6778",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20180501",
            "product_id": "69777-260_e85ff1c0-0b65-41d1-9b77-6af8e2dc6778",
            "application_number": "part352",
            "brand_name_base": "Secret Muse Vita Blue Sun"
        },
        {
            "product_ndc": "55513-206",
            "generic_name": "bevacizumab-awwb",
            "labeler_name": "Amgen Inc",
            "brand_name": "MVASI",
            "active_ingredients": [
                {
                    "name": "BEVACIZUMAB",
                    "strength": "100 mg/4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-206-01",
                    "description": "1 VIAL in 1 CARTON (55513-206-01)  / 4 mL in 1 VIAL",
                    "marketing_start_date": "20180601",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "2046140",
                    "2046145",
                    "2046148",
                    "2046149"
                ],
                "spl_set_id": [
                    "0a562b4e-67ce-4bab-852c-d9ee71e55fb8"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193543",
                    "N0000178291",
                    "N0000193542"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "unii": [
                    "2S9ZZM9Q9V"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "11156d95-bd9a-4d3c-bff3-371869ea13e8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20180601",
            "product_id": "55513-206_11156d95-bd9a-4d3c-bff3-371869ea13e8",
            "application_number": "BLA761028",
            "brand_name_base": "MVASI",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]",
                "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "72974-415",
            "generic_name": "relugolix, estradiol hemihydrate, and norethindrone acetate",
            "labeler_name": "Sumitomo Pharma America, Inc",
            "brand_name": "Myfembree",
            "active_ingredients": [
                {
                    "name": "ESTRADIOL HEMIHYDRATE",
                    "strength": "1 mg/1"
                },
                {
                    "name": "NORETHINDRONE ACETATE",
                    "strength": ".5 mg/1"
                },
                {
                    "name": "RELUGOLIX",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72974-415-01",
                    "description": "28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-01)",
                    "marketing_start_date": "20210526",
                    "sample": false
                },
                {
                    "package_ndc": "72974-415-99",
                    "description": "7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-99)",
                    "marketing_start_date": "20210707",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sumitomo Pharma America, Inc"
                ],
                "rxcui": [
                    "2556799",
                    "2556800"
                ],
                "spl_set_id": [
                    "fc3feb73-cc84-43a8-aa32-b262460495e8"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372974415013"
                ],
                "nui": [
                    "N0000175839",
                    "N0000175084",
                    "N0000008638",
                    "N0000190118",
                    "N0000187064",
                    "N0000190113",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased GnRH Secretion [PE]"
                ],
                "unii": [
                    "CXY7B3Q98Z",
                    "9S44LIC7OJ",
                    "P76B05O5V6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "fca5d0ae-57ce-4dd8-9c07-82bc9571d6a9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210526",
            "product_id": "72974-415_fca5d0ae-57ce-4dd8-9c07-82bc9571d6a9",
            "application_number": "NDA214846",
            "brand_name_base": "Myfembree",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Decreased GnRH Secretion [PE]",
                "Estradiol Congeners [CS]",
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]",
                "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Progesterone Congeners [CS]",
                "Progestin [EPC]"
            ]
        },
        {
            "product_ndc": "0008-4510",
            "generic_name": "gemtuzumab ozogamicin",
            "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
            "brand_name": "Mylotarg",
            "active_ingredients": [
                {
                    "name": "GEMTUZUMAB OZOGAMICIN",
                    "strength": "5 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0008-4510-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0008-4510-01)  / 5 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20170907",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
                ],
                "rxcui": [
                    "1944701",
                    "1944704"
                ],
                "spl_set_id": [
                    "32fd2bb2-1cfa-4250-feb8-d7956c794e05"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175571",
                    "N0000175077"
                ],
                "pharm_class_epc": [
                    "CD33-directed Immunoconjugate [EPC]"
                ],
                "pharm_class_moa": [
                    "CD33-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "8GZG754X6M"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "8323fbb8-fc24-472f-b6a7-c9bd0af1acee",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170907",
            "product_id": "0008-4510_8323fbb8-fc24-472f-b6a7-c9bd0af1acee",
            "application_number": "BLA761060",
            "brand_name_base": "Mylotarg",
            "pharm_class": [
                "CD33-directed Antibody Interactions [MoA]",
                "CD33-directed Immunoconjugate [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "70518-3158",
            "generic_name": "mirabegron",
            "labeler_name": "REMEDYREPACK INC.",
            "brand_name": "Myrbetriq",
            "active_ingredients": [
                {
                    "name": "MIRABEGRON",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70518-3158-0",
                    "description": "30 POUCH in 1 BOX (70518-3158-0)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 POUCH (70518-3158-1)",
                    "marketing_start_date": "20210715",
                    "sample": false
                },
                {
                    "package_ndc": "70518-3158-2",
                    "description": "30 POUCH in 1 BOX (70518-3158-2)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 POUCH (70518-3158-3)",
                    "marketing_start_date": "20220131",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "REMEDYREPACK INC."
                ],
                "rxcui": [
                    "1300791",
                    "1300797"
                ],
                "spl_set_id": [
                    "caddf108-5ee6-4f1b-8888-e389f11c8f25"
                ],
                "nui": [
                    "N0000185008",
                    "N0000185007",
                    "N0000182137",
                    "N0000190114",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "beta3-Adrenergic Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Adrenergic beta3-Agonists [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "MVR3JL3B2V"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
            "spl_id": "138ca0a1-8be7-57d8-e063-6294a90ab680",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210715",
            "product_id": "70518-3158_138ca0a1-8be7-57d8-e063-6294a90ab680",
            "application_number": "NDA202611",
            "brand_name_base": "Myrbetriq",
            "pharm_class": [
                "Adrenergic beta3-Agonists [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "beta3-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "68135-020",
            "generic_name": "galsulfase",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "NAGLAZYME",
            "active_ingredients": [
                {
                    "name": "GALSULFASE",
                    "strength": "5 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-020-01",
                    "description": "1 VIAL in 1 CARTON (68135-020-01)  / 5 mL in 1 VIAL",
                    "marketing_start_date": "20050609",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "578037",
                    "584222"
                ],
                "spl_set_id": [
                    "59341250-deac-ed71-3823-a4f5d64dbd77"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0000794",
                    "N0000175823"
                ],
                "pharm_class_cs": [
                    "alpha-Glucosidases [CS]"
                ],
                "pharm_class_epc": [
                    "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]"
                ],
                "unii": [
                    "59UA429E5G"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "88747f73-fa02-4a28-8ab8-63ff7ded49ec",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20050609",
            "product_id": "68135-020_88747f73-fa02-4a28-8ab8-63ff7ded49ec",
            "application_number": "BLA125117",
            "brand_name_base": "NAGLAZYME",
            "pharm_class": [
                "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]",
                "alpha-Glucosidases [CS]"
            ]
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0071-0350",
            "generic_name": "Phenelzine Sulfate",
            "labeler_name": "Parke-Davis Div of Pfizer Inc",
            "brand_name": "Nardil",
            "active_ingredients": [
                {
                    "name": "PHENELZINE SULFATE",
                    "strength": "15 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0071-0350-60",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (0071-0350-60)",
                    "marketing_start_date": "19610609",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Parke-Davis Div of Pfizer Inc"
                ],
                "rxcui": [
                    "104836",
                    "312347"
                ],
                "spl_set_id": [
                    "513a41d0-37d4-4355-8a6d-a2c643bce6fa"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300710350601"
                ],
                "unii": [
                    "2681D7P965"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "fb832db5-b964-43c1-b52f-c2b701b0ce94",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19610609",
            "product_id": "0071-0350_fb832db5-b964-43c1-b52f-c2b701b0ce94",
            "application_number": "NDA011909",
            "brand_name_base": "Nardil",
            "pharm_class": [
                "Monoamine Oxidase Inhibitor [EPC]",
                "Monoamine Oxidase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50419-409",
            "generic_name": "estradiol valerate and estradiol valerate/dienogest",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Natazia",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-409-00",
                    "description": "90 BLISTER PACK in 1 PACKAGE (50419-409-00)  / 1 KIT in 1 BLISTER PACK",
                    "marketing_start_date": "20100506",
                    "sample": false
                },
                {
                    "package_ndc": "50419-409-03",
                    "description": "3 BLISTER PACK in 1 PACKAGE (50419-409-03)  / 1 KIT in 1 BLISTER PACK (50419-409-01)",
                    "marketing_start_date": "20100506",
                    "sample": false
                },
                {
                    "package_ndc": "50419-409-73",
                    "description": "5 BLISTER PACK in 1 PACKAGE (50419-409-73)  / 1 KIT in 1 BLISTER PACK",
                    "marketing_start_date": "20100506",
                    "sample": false
                },
                {
                    "package_ndc": "50419-409-76",
                    "description": "2 BLISTER PACK in 1 PACKAGE (50419-409-76)  / 1 KIT in 1 BLISTER PACK (50419-409-70)",
                    "marketing_start_date": "20100506",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "748797",
                    "978941",
                    "978944",
                    "978946",
                    "978948",
                    "978949",
                    "978950"
                ],
                "spl_set_id": [
                    "02c91fba-9c47-43ef-ac78-e82369798834"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "9829fdd3-fb12-4039-8c6e-de634fe5b6db",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20100506",
            "product_id": "50419-409_9829fdd3-fb12-4039-8c6e-de634fe5b6db",
            "application_number": "NDA022252",
            "brand_name_base": "Natazia"
        },
        {
            "product_ndc": "50474-500",
            "generic_name": "midazolam",
            "labeler_name": "UCB, Inc.",
            "dea_schedule": "CIV",
            "brand_name": "Nayzilam",
            "active_ingredients": [
                {
                    "name": "MIDAZOLAM",
                    "strength": "5 mg/.1mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50474-500-15",
                    "description": "2 BLISTER PACK in 1 CARTON (50474-500-15)  / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (50474-500-14)  / .1 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190517",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "rxcui": [
                    "2173494",
                    "2173500"
                ],
                "spl_set_id": [
                    "2b29422e-54d5-4a49-8522-e9cf752368c3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "R60L0SM5BC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY",
            "spl_id": "5776d86f-c632-429f-ac0b-88ade1a3930c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "NASAL"
            ],
            "marketing_start_date": "20190517",
            "product_id": "50474-500_5776d86f-c632-429f-ac0b-88ade1a3930c",
            "application_number": "NDA211321",
            "brand_name_base": "Nayzilam",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "21130-825",
            "generic_name": "miconazole nitrate",
            "labeler_name": "Safeway",
            "brand_name": "signature care miconazole 7",
            "active_ingredients": [
                {
                    "name": "MICONAZOLE NITRATE",
                    "strength": "2 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "21130-825-29",
                    "description": "1 TUBE, WITH APPLICATOR in 1 CARTON (21130-825-29)  / 45 g in 1 TUBE, WITH APPLICATOR",
                    "marketing_start_date": "20181106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Safeway"
                ],
                "rxcui": [
                    "998540"
                ],
                "spl_set_id": [
                    "2e04ac2d-cfbc-4261-a8f9-03715f819c1c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "VW4H1CYW1K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CREAM",
            "spl_id": "8fb5cd26-54da-4d81-943b-1b029706e77a",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "20181106",
            "product_id": "21130-825_8fb5cd26-54da-4d81-943b-1b029706e77a",
            "application_number": "ANDA074760",
            "brand_name_base": "signature care miconazole 7",
            "pharm_class": [
                "Azole Antifungal [EPC]",
                "Azoles [CS]"
            ]
        },
        {
            "product_ndc": "70437-240",
            "generic_name": "neratinib",
            "labeler_name": "Puma Biotechnology, Inc.",
            "brand_name": "Nerlynx",
            "active_ingredients": [
                {
                    "name": "NERATINIB MALEATE ANHYDROUS",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70437-240-18",
                    "description": "1 BOTTLE in 1 BOX (70437-240-18)  / 180 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20170717",
                    "sample": false
                },
                {
                    "package_ndc": "70437-240-26",
                    "description": "1 BOTTLE in 1 BOX (70437-240-26)  / 126 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20170717",
                    "sample": false
                },
                {
                    "package_ndc": "70437-240-33",
                    "description": "1 BOTTLE in 1 BOX (70437-240-33)  / 133 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20170717",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Puma Biotechnology, Inc."
                ],
                "rxcui": [
                    "1940648",
                    "1940654"
                ],
                "spl_set_id": [
                    "d1e41dcf-e82a-47c2-a0ad-6c6eef621834"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370437240264"
                ],
                "unii": [
                    "9RM7XY23ZS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "1484ac4d-7db5-fd0e-e063-6394a90a2b17",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170717",
            "product_id": "70437-240_1484ac4d-7db5-fd0e-e063-6394a90a2b17",
            "application_number": "NDA208051",
            "brand_name_base": "Nerlynx",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "64764-250",
            "generic_name": "alogliptin",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Nesina",
            "active_ingredients": [
                {
                    "name": "ALOGLIPTIN BENZOATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-250-02",
                    "description": "4 CARTON in 1 TRAY (64764-250-02)  / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-250-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-250-30)",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-250-50",
                    "description": "500 TABLET, FILM COATED in 1 BOTTLE (64764-250-50)",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-250-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (64764-250-90)",
                    "marketing_start_date": "20130125",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1368006",
                    "1368012",
                    "1368018",
                    "1368020",
                    "1368034",
                    "1368036"
                ],
                "spl_set_id": [
                    "a3768c7e-aa4c-44d3-bc53-43bb7346c0b0"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364764125301",
                    "0364764625306",
                    "0364764250300"
                ],
                "unii": [
                    "EEN99869SC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "c5487e88-84e3-41df-ab12-fd2140cc6ef2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130125",
            "product_id": "64764-250_c5487e88-84e3-41df-ab12-fd2140cc6ef2",
            "application_number": "NDA022271",
            "brand_name_base": "Nesina",
            "pharm_class": [
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "69488-001",
            "generic_name": "68Ga-DOTATATE",
            "labeler_name": "Advanced Accelerator Applications USA, Inc",
            "brand_name": "NETSPOT",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69488-001-40",
                    "description": "1 KIT in 1 KIT (69488-001-40)  *  1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20160601",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Advanced Accelerator Applications USA, Inc"
                ],
                "spl_set_id": [
                    "b2b3be70-17d8-4093-896c-f1c54a2cf242"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "7cacee37-0437-4775-8c30-e7f654342165",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20160601",
            "product_id": "69488-001_7cacee37-0437-4775-8c30-e7f654342165",
            "application_number": "NDA208547",
            "brand_name_base": "NETSPOT"
        },
        {
            "product_ndc": "55513-192",
            "generic_name": "pegfilgrastim",
            "labeler_name": "Amgen Inc",
            "brand_name": "Neulasta",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-192-01",
                    "description": "1 KIT in 1 CARTON (55513-192-01)  *  .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20150220",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "727539",
                    "727542",
                    "2549331",
                    "2549333"
                ],
                "spl_set_id": [
                    "fdfe5d72-6b80-435a-afa4-c5d74dd852ce"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "50374606-0a76-45df-8b19-8323cc511e87",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20020401",
            "product_id": "55513-192_50374606-0a76-45df-8b19-8323cc511e87",
            "application_number": "BLA125031",
            "brand_name_base": "Neulasta"
        },
        {
            "product_ndc": "55513-530",
            "generic_name": "Filgrastim",
            "labeler_name": "Amgen Inc",
            "brand_name": "NEUPOGEN",
            "active_ingredients": [
                {
                    "name": "FILGRASTIM",
                    "strength": "300 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-530-10",
                    "description": "10 VIAL in 1 PACKAGE (55513-530-10)  / 1 mL in 1 VIAL (55513-530-01)",
                    "marketing_start_date": "19970519",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "727535",
                    "727537",
                    "727544",
                    "727545",
                    "1649944",
                    "1649946",
                    "1649963",
                    "1649964"
                ],
                "spl_set_id": [
                    "97cc73cc-b5b7-458a-a933-77b00523e193"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513546102",
                    "0355513530101"
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "PVI5M0M1GW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "2eacc44a-29a9-49e6-a93e-63aa38725478",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19970519",
            "product_id": "55513-530_2eacc44a-29a9-49e6-a93e-63aa38725478",
            "application_number": "BLA103353",
            "brand_name_base": "NEUPOGEN",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "72789-178",
            "generic_name": "Primidone",
            "labeler_name": "PD-Rx Pharmaceuticals, Inc.",
            "brand_name": "Primidone",
            "active_ingredients": [
                {
                    "name": "PRIMIDONE",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72789-178-30",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (72789-178-30)",
                    "marketing_start_date": "20230728",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "PD-Rx Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "96304",
                    "198150"
                ],
                "spl_set_id": [
                    "0193c0a4-f593-609c-e063-6294a90aaa68"
                ],
                "upc": [
                    "0372789177823",
                    "0372789178820"
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "unii": [
                    "13AFD7670Q"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "0192ea0c-9a13-dcc6-e063-6294a90ab6a4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210222",
            "product_id": "72789-178_0192ea0c-9a13-dcc6-e063-6294a90ab6a4",
            "application_number": "ANDA040586",
            "brand_name_base": "Primidone",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "63020-400",
            "generic_name": "ixazomib",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "NINLARO",
            "active_ingredients": [
                {
                    "name": "IXAZOMIB CITRATE",
                    "strength": "4 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63020-400-02",
                    "description": "3 BLISTER PACK in 1 CARTON (63020-400-02)  / 1 CAPSULE in 1 BLISTER PACK (63020-400-01)",
                    "marketing_start_date": "20151120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1723757",
                    "1723763",
                    "1723765",
                    "1723767",
                    "1723770",
                    "1723772"
                ],
                "spl_set_id": [
                    "038f2461-834b-4488-9ebd-863c83eef5a7"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "46CWK97Z3K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "118ee2ad-8119-4877-a034-02e2b81b1c2c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151120",
            "product_id": "63020-400_118ee2ad-8119-4877-a034-02e2b81b1c2c",
            "application_number": "NDA208462",
            "brand_name_base": "NINLARO",
            "pharm_class": [
                "Proteasome Inhibitor [EPC]",
                "Proteasome Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70709-000",
            "generic_name": "Nitisinone",
            "labeler_name": "Cycle Pharmaceuticals Ltd.",
            "brand_name": "NITYR",
            "active_ingredients": [
                {
                    "name": "NITISINONE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70709-000-60",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (70709-000-60)  / 60 TABLET in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20170726",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Cycle Pharmaceuticals Ltd."
                ],
                "rxcui": [
                    "1941464",
                    "1941470",
                    "1941471",
                    "1941473",
                    "1941474",
                    "1941476"
                ],
                "spl_set_id": [
                    "00fd1905-27e4-420e-8dc5-a69e4ddc1526"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370709000602",
                    "0370709002606",
                    "0370709005607"
                ],
                "nui": [
                    "N0000175809",
                    "N0000175808",
                    "N0000185504",
                    "N0000193955",
                    "N0000190110",
                    "N0000190111"
                ],
                "pharm_class_epc": [
                    "4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "Cytochrome P450 2E1 Inducers [MoA]",
                    "Organic Anion Transporter 1 Inhibitors [MoA]",
                    "Organic Anion Transporter 3 Inhibitors [MoA]"
                ],
                "unii": [
                    "K5BN214699"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "34d598e3-169a-4d87-a7a7-465849098316",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170726",
            "product_id": "70709-000_34d598e3-169a-4d87-a7a7-465849098316",
            "application_number": "NDA209449",
            "brand_name_base": "NITYR",
            "pharm_class": [
                "4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 2E1 Inducers [MoA]",
                "Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]",
                "Organic Anion Transporter 1 Inhibitors [MoA]",
                "Organic Anion Transporter 3 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0069-0293",
            "generic_name": "filgrastim-aafi",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Nivestym",
            "active_ingredients": [
                {
                    "name": "FILGRASTIM",
                    "strength": "300 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0293-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0069-0293-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (0069-0293-01)",
                    "marketing_start_date": "20190311",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2057200",
                    "2057205",
                    "2057209",
                    "2057212",
                    "2057215",
                    "2057216",
                    "2057218",
                    "2057219"
                ],
                "spl_set_id": [
                    "d23ab39c-b6ec-41cf-a529-9dd2852c9d9a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "PVI5M0M1GW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "1f114496-8599-4760-8227-1133a47127ef",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190311",
            "product_id": "0069-0293_1f114496-8599-4760-8227-1133a47127ef",
            "application_number": "BLA761080",
            "brand_name_base": "Nivestym",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "0025-2752",
            "generic_name": "disopyramide phosphate",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Norpace",
            "active_ingredients": [
                {
                    "name": "DISOPYRAMIDE PHOSPHATE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0025-2752-31",
                    "description": "100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-31)",
                    "marketing_start_date": "19770901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "209066",
                    "209692",
                    "309958",
                    "309960",
                    "636793",
                    "636794",
                    "902648",
                    "902652"
                ],
                "spl_set_id": [
                    "e2aa1642-d262-4520-bc6a-9fd3ad795677"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300252762313",
                    "0300252752314"
                ],
                "unii": [
                    "N6BOM1935W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "bad34f2f-efbc-453a-b783-fba7a05ba580",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19770901",
            "product_id": "0025-2752_bad34f2f-efbc-453a-b783-fba7a05ba580",
            "application_number": "NDA017447",
            "brand_name_base": "Norpace",
            "pharm_class": [
                "Antiarrhythmic [EPC]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "42747-602",
            "generic_name": "istradefylline",
            "labeler_name": "Kyowa Kirin, Inc.",
            "brand_name": "NOURIANZ",
            "active_ingredients": [
                {
                    "name": "ISTRADEFYLLINE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42747-602-07",
                    "description": "1 BLISTER PACK in 1 BOX (42747-602-07)  / 7 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20190827",
                    "sample": true
                },
                {
                    "package_ndc": "42747-602-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (42747-602-90)",
                    "marketing_start_date": "20190827",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Kyowa Kirin, Inc."
                ],
                "rxcui": [
                    "2199020",
                    "2199026",
                    "2199028",
                    "2199030"
                ],
                "spl_set_id": [
                    "a7d008cb-b273-4049-a5d2-9c6902910d58"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0342747604906",
                    "0342747602902"
                ],
                "unii": [
                    "2GZ0LIK7T4"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "5098d63d-fee7-4043-bcf5-a463613d662f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190827",
            "product_id": "42747-602_5098d63d-fee7-4043-bcf5-a463613d662f",
            "application_number": "NDA022075",
            "brand_name_base": "NOURIANZ"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0591-3875",
            "marketing_end_date": "20280229",
            "generic_name": "memantine hydrochloride",
            "labeler_name": "Actavis Pharma, Inc.",
            "brand_name": "memantine hydrochloride",
            "active_ingredients": [
                {
                    "name": "MEMANTINE HYDROCHLORIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0591-3875-44",
                    "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (0591-3875-44)  / 10 TABLET in 1 BLISTER PACK (0591-3875-45)",
                    "marketing_start_date": "20150401",
                    "marketing_end_date": "20270731",
                    "sample": false
                },
                {
                    "package_ndc": "0591-3875-60",
                    "description": "60 TABLET in 1 BOTTLE (0591-3875-60)",
                    "marketing_start_date": "20150401",
                    "marketing_end_date": "20280229",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Actavis Pharma, Inc."
                ],
                "rxcui": [
                    "996561",
                    "996571",
                    "996572"
                ],
                "spl_set_id": [
                    "72973b46-f307-4a9e-8fb1-ad2cbccfd736"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "JY0WD0UA60"
                ]
            },
            "marketing_category": "NDA AUTHORIZED GENERIC",
            "dosage_form": "TABLET",
            "spl_id": "985e1190-b8a0-4775-9a20-ad1924b14fb2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150401",
            "product_id": "0591-3875_985e1190-b8a0-4775-9a20-ad1924b14fb2",
            "application_number": "NDA021487",
            "brand_name_base": "memantine hydrochloride",
            "pharm_class": [
                "N-methyl-D-aspartate Receptor Antagonist [EPC]",
                "NMDA Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "70020-1910",
            "generic_name": "ixabepilone",
            "labeler_name": "R-Pharm US Operating, LLC",
            "brand_name": "IXEMPRA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70020-1910-1",
                    "description": "1 KIT in 1 PACKAGE, COMBINATION (70020-1910-1)  *  15 mg in 1 VIAL, SINGLE-USE *  8 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20071016",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "R-Pharm US Operating, LLC"
                ],
                "rxcui": [
                    "1726271",
                    "1726274",
                    "1726276",
                    "1726278"
                ],
                "spl_set_id": [
                    "241f0b1e-8b95-470d-876f-bf1804daaf18"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "f316ca9e-c6df-3ee3-e053-2995a90a7e67",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20071016",
            "product_id": "70020-1910_f316ca9e-c6df-3ee3-e053-2995a90a7e67",
            "application_number": "NDA022065",
            "brand_name_base": "IXEMPRA"
        },
        {
            "product_ndc": "50090-1678",
            "generic_name": "insulin aspart",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "NOVOLOG",
            "active_ingredients": [
                {
                    "name": "INSULIN ASPART",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-1678-0",
                    "description": "5 SYRINGE, PLASTIC in 1 CARTON (50090-1678-0)  / 3 mL in 1 SYRINGE, PLASTIC",
                    "marketing_start_date": "20150130",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "311040",
                    "351926",
                    "1653196",
                    "1653198",
                    "1653202",
                    "1653204"
                ],
                "spl_set_id": [
                    "e172b4f8-9b25-4019-8e09-afc10b2f30c9"
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "D933668QVX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "b01617ba-efae-44d9-b8ce-15a977d2fed5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20030122",
            "product_id": "50090-1678_b01617ba-efae-44d9-b8ce-15a977d2fed5",
            "application_number": "BLA020986",
            "brand_name_base": "NOVOLOG",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0085-1328",
            "generic_name": "posaconazole",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "NOXAFIL",
            "active_ingredients": [
                {
                    "name": "POSACONAZOLE",
                    "strength": "40 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0085-1328-01",
                    "description": "1 BOTTLE, GLASS in 1 CARTON (0085-1328-01)  / 105 mL in 1 BOTTLE, GLASS",
                    "marketing_start_date": "20060915",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "665019",
                    "665022",
                    "1482908",
                    "1482912",
                    "1492043",
                    "1492047",
                    "2558603",
                    "2558607"
                ],
                "spl_set_id": [
                    "b073b082-7b57-4423-8c06-4fd4263d6f84"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300854324025"
                ],
                "nui": [
                    "N0000175487",
                    "M0002083"
                ],
                "pharm_class_epc": [
                    "Azole Antifungal [EPC]"
                ],
                "pharm_class_cs": [
                    "Azoles [CS]"
                ],
                "unii": [
                    "6TK1G07BHZ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "50e517fb-4c04-4639-9359-e20907ca822e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20060915",
            "product_id": "0085-1328_50e517fb-4c04-4639-9359-e20907ca822e",
            "application_number": "NDA022003",
            "brand_name_base": "NOXAFIL",
            "pharm_class": [
                "Azole Antifungal [EPC]",
                "Azoles [CS]"
            ]
        },
        {
            "product_ndc": "55513-221",
            "generic_name": "romiplostim",
            "labeler_name": "Amgen Inc",
            "brand_name": "Nplate",
            "active_ingredients": [
                {
                    "name": "ROMIPLOSTIM",
                    "strength": "250 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-221-01",
                    "description": "1 VIAL in 1 CARTON (55513-221-01)  / .5 mL in 1 VIAL",
                    "marketing_start_date": "20080825",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1728092",
                    "1728095",
                    "1728097",
                    "1728099",
                    "2201538",
                    "2201540"
                ],
                "spl_set_id": [
                    "c45f9a58-37c1-4f76-8e36-97d38c577037"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513222013",
                    "0355513221016"
                ],
                "nui": [
                    "N0000175969",
                    "N0000175970",
                    "N0000175973",
                    "N0000175968"
                ],
                "pharm_class_pe": [
                    "Increased Megakaryocyte Maturation [PE]",
                    "Increased Platelet Production [PE]"
                ],
                "pharm_class_epc": [
                    "Thrombopoietin Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Thrombopoietin Receptor Agonists [MoA]"
                ],
                "unii": [
                    "GN5XU2DXKV"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "3e6f88f4-b351-41c3-809b-7abd712d92f8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20080825",
            "product_id": "55513-221_3e6f88f4-b351-41c3-809b-7abd712d92f8",
            "application_number": "BLA125268",
            "brand_name_base": "Nplate",
            "pharm_class": [
                "Increased Megakaryocyte Maturation [PE]",
                "Increased Platelet Production [PE]",
                "Thrombopoietin Receptor Agonist [EPC]",
                "Thrombopoietin Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "50419-395",
            "generic_name": "darolutamide",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "NUBEQA",
            "active_ingredients": [
                {
                    "name": "DAROLUTAMIDE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-395-01",
                    "description": "1 BOTTLE in 1 CARTON (50419-395-01)  / 120 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20190731",
                    "sample": false
                },
                {
                    "package_ndc": "50419-395-72",
                    "description": "1 BOTTLE in 1 CARTON (50419-395-72)  / 120 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210303",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2180330",
                    "2180336"
                ],
                "spl_set_id": [
                    "1a7cb212-56e4-4b9d-a73d-bfee7fe4735e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "X05U0N2RCO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "78565601-df32-45a6-9d08-ac84738c8963",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190731",
            "product_id": "50419-395_78565601-df32-45a6-9d08-ac84738c8963",
            "application_number": "NDA212099",
            "brand_name_base": "NUBEQA"
        },
        {
            "product_ndc": "0173-0881",
            "generic_name": "mepolizumab",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Nucala",
            "active_ingredients": [
                {
                    "name": "MEPOLIZUMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0881-01",
                    "description": "1 VIAL in 1 CARTON (0173-0881-01)  / 1 mL in 1 VIAL",
                    "marketing_start_date": "20151104",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0881-61",
                    "description": "1 VIAL in 1 CARTON (0173-0881-61)  / 1 mL in 1 VIAL",
                    "marketing_start_date": "20160617",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1720601",
                    "1720606",
                    "2170990",
                    "2170993",
                    "2173820",
                    "2173822",
                    "2596444",
                    "2596445"
                ],
                "spl_set_id": [
                    "fefb887c-e4ac-431e-8893-e9d1a5a63fea"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191872",
                    "N0000191871"
                ],
                "pharm_class_epc": [
                    "Interleukin-5 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-5 Antagonists [MoA]"
                ],
                "unii": [
                    "90Z2UF0E52"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
            "spl_id": "6aaacdeb-43d4-4367-9d37-a9d6876344f1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20151104",
            "product_id": "0173-0881_6aaacdeb-43d4-4367-9d37-a9d6876344f1",
            "application_number": "BLA125526",
            "brand_name_base": "Nucala",
            "pharm_class": [
                "Interleukin-5 Antagonist [EPC]",
                "Interleukin-5 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "64597-301",
            "generic_name": "dextromethorphan hydrobromide and quinidine sulfate",
            "labeler_name": "Avanir Pharmaceuticals, Inc.",
            "brand_name": "NUEDEXTA",
            "active_ingredients": [
                {
                    "name": "DEXTROMETHORPHAN HYDROBROMIDE",
                    "strength": "20 mg/1"
                },
                {
                    "name": "QUINIDINE SULFATE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64597-301-13",
                    "description": "1 BOTTLE in 1 CARTON (64597-301-13)  / 13 CAPSULE, GELATIN COATED in 1 BOTTLE",
                    "marketing_start_date": "20101201",
                    "sample": false
                },
                {
                    "package_ndc": "64597-301-60",
                    "description": "60 CAPSULE, GELATIN COATED in 1 BOTTLE (64597-301-60)",
                    "marketing_start_date": "20101201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Avanir Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1040054",
                    "1040058"
                ],
                "spl_set_id": [
                    "484e0918-3442-49dc-8ccf-177f1f3ee9f3"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9D2RTI9KYH",
                    "J13S2394HE"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "0f916cea-0d2b-4d75-8b68-25be67cbcd99",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20101201",
            "product_id": "64597-301_0f916cea-0d2b-4d75-8b68-25be67cbcd99",
            "application_number": "NDA021879",
            "brand_name_base": "NUEDEXTA",
            "pharm_class": [
                "Antiarrhythmic [EPC]",
                "Cytochrome P450 2D6 Inhibitor [EPC]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Sigma-1 Agonist [EPC]",
                "Sigma-1 Receptor Agonists [MoA]",
                "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
                "Uncompetitive NMDA Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "42358-295",
            "generic_name": "fosdenopterin hydrobromide",
            "labeler_name": "Sentynl Therapeutics, Inc.",
            "brand_name": "Nulibry",
            "active_ingredients": [
                {
                    "name": "FOSDENOPTERIN HYDROBROMIDE",
                    "strength": "9.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42358-295-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (42358-295-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20230415",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sentynl Therapeutics, Inc."
                ],
                "rxcui": [
                    "2531292",
                    "2531297"
                ],
                "spl_set_id": [
                    "736aeea3-f206-454d-95d0-fd30964e8aab"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "X41B5W735T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "f2d66860-2840-4060-82ba-5fa50f4724c4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210330",
            "product_id": "42358-295_f2d66860-2840-4060-82ba-5fa50f4724c4",
            "application_number": "NDA214018",
            "brand_name_base": "Nulibry",
            "pharm_class": [
                "Cyclic Pyranopterin Monophosphate [EPC]",
                "Cyclic Pyranopterin Monophosphate [EXT]"
            ]
        },
        {
            "product_ndc": "0003-0371",
            "generic_name": "BELATACEPT",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "NULOJIX",
            "active_ingredients": [
                {
                    "name": "BELATACEPT",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-0371-13",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20110615",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "1112976",
                    "1112980"
                ],
                "spl_set_id": [
                    "c16ac648-d5d2-9f7d-8637-e2328572754e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000182829",
                    "N0000182830",
                    "N0000182150",
                    "N0000182151"
                ],
                "pharm_class_pe": [
                    "T Lymphocyte Costimulation Activity Blockade [PE]"
                ],
                "pharm_class_epc": [
                    "Selective T Cell Costimulation Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "CD80-directed Antibody Interactions [MoA]",
                    "CD86-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "E3B2GI648A"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "9057087d-7e59-4e5a-8e4a-96a532efb0ab",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20110615",
            "product_id": "0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab",
            "application_number": "BLA125288",
            "brand_name_base": "NULOJIX",
            "pharm_class": [
                "CD80-directed Antibody Interactions [MoA]",
                "CD86-directed Antibody Interactions [MoA]",
                "Selective T Cell Costimulation Blocker [EPC]",
                "T Lymphocyte Costimulation Activity Blockade [PE]"
            ]
        },
        {
            "product_ndc": "63090-100",
            "generic_name": "pimavanserin tartrate",
            "labeler_name": "Acadia Pharmaceuticals Inc.",
            "brand_name": "NUPLAZID",
            "active_ingredients": [
                {
                    "name": "PIMAVANSERIN TARTRATE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63090-100-30",
                    "description": "30 TABLET, COATED in 1 BOTTLE, PLASTIC (63090-100-30)",
                    "marketing_start_date": "20180628",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Acadia Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2049269",
                    "2049271",
                    "2049275",
                    "2049278"
                ],
                "spl_set_id": [
                    "1e6bea44-57d6-4bac-9328-46e1ee59f83b"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0363090340303",
                    "0363090100303"
                ],
                "unii": [
                    "NA83F1SJSR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "02c10e00-7f20-41ea-ad45-b239c8b7098a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180628",
            "product_id": "63090-100_02c10e00-7f20-41ea-ad45-b239c8b7098a",
            "application_number": "NDA207318",
            "brand_name_base": "NUPLAZID",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "0052-0316",
            "generic_name": "follitropin",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "Follistim AQ",
            "active_ingredients": [
                {
                    "name": "FOLLITROPIN",
                    "strength": "650 [iU]/.78mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0052-0316-01",
                    "description": "1 KIT in 1 CARTON (0052-0316-01)  / 1 CARTRIDGE in 1 KIT / .78 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20040324",
                    "sample": false
                },
                {
                    "package_ndc": "0052-0316-81",
                    "description": "1 KIT in 1 CARTON (0052-0316-81)  / 1 CARTRIDGE in 1 KIT / .78 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20040324",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "854787",
                    "854788",
                    "854790",
                    "1361563",
                    "1361569",
                    "1361572"
                ],
                "spl_set_id": [
                    "96f11b5d-cc7b-48aa-830a-a28e1962d871"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175838",
                    "M0009540"
                ],
                "pharm_class_epc": [
                    "Gonadotropin [EPC]"
                ],
                "pharm_class_cs": [
                    "Gonadotropins [CS]"
                ],
                "unii": [
                    "076WHW89TW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "24d5b4a2-b184-4c46-8bde-e0d4c7cc3f8b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20040324",
            "product_id": "0052-0316_24d5b4a2-b184-4c46-8bde-e0d4c7cc3f8b",
            "application_number": "BLA021211",
            "brand_name_base": "Follistim AQ",
            "pharm_class": [
                "Gonadotropin [EPC]",
                "Gonadotropins [CS]"
            ]
        },
        {
            "product_ndc": "71715-002",
            "generic_name": "omadacycline",
            "labeler_name": "Paratek Pharmaceuticals, Inc.",
            "brand_name": "NUZYRA",
            "active_ingredients": [
                {
                    "name": "OMADACYCLINE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71715-002-21",
                    "description": "1 BLISTER PACK in 1 CARTON (71715-002-21)  / 6 TABLET, FILM COATED in 1 BLISTER PACK (71715-002-28)",
                    "marketing_start_date": "20200201",
                    "sample": false
                },
                {
                    "package_ndc": "71715-002-27",
                    "description": "5 BLISTER PACK in 1 CARTON (71715-002-27)  / 6 TABLET, FILM COATED in 1 BLISTER PACK (71715-002-28)",
                    "marketing_start_date": "20200201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Paratek Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2059274",
                    "2059280",
                    "2059281",
                    "2059282",
                    "2059283",
                    "2059284",
                    "2059288",
                    "2059292"
                ],
                "spl_set_id": [
                    "51591524-4703-44c6-8bde-dce3e6a463d1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175938",
                    "M0021223"
                ],
                "pharm_class_epc": [
                    "Tetracycline-class Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Tetracyclines [CS]"
                ],
                "unii": [
                    "090IP5RV8F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "54a39fe1-7a22-4f65-858d-f04c872c1c65",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190201",
            "product_id": "71715-002_54a39fe1-7a22-4f65-858d-f04c872c1c65",
            "application_number": "NDA209816",
            "brand_name_base": "NUZYRA",
            "pharm_class": [
                "Tetracycline-class Antibacterial [EPC]",
                "Tetracyclines [CS]"
            ]
        },
        {
            "product_ndc": "0069-0324",
            "generic_name": "pegfilgrastim-apgf",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "NYVEPRIA",
            "active_ingredients": [
                {
                    "name": "PEGFILGRASTIM",
                    "strength": "6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0324-01",
                    "description": "1 CARTON in 1 CARTON (0069-0324-01)  / 1 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20201215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2469335",
                    "2469340"
                ],
                "spl_set_id": [
                    "99d30b99-2743-446b-98f3-0430bf4ea869"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "a89f35d2-46e6-457b-a617-3c7537e6f709",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20201215",
            "product_id": "0069-0324_a89f35d2-46e6-457b-a617-3c7537e6f709",
            "application_number": "BLA761111",
            "brand_name_base": "NYVEPRIA",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "69516-010",
            "generic_name": "Obeticholic Acid",
            "labeler_name": "Intercept Pharmaceuticals Inc",
            "brand_name": "Ocaliva",
            "active_ingredients": [
                {
                    "name": "OBETICHOLIC ACID",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69516-010-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69516-010-30)",
                    "marketing_start_date": "20160527",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Intercept Pharmaceuticals Inc"
                ],
                "rxcui": [
                    "1798364",
                    "1798370",
                    "1798373",
                    "1798375"
                ],
                "spl_set_id": [
                    "cdfbe0cd-eb15-45a1-ac17-531bcda21aec"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0369516010300",
                    "0369516005306"
                ],
                "nui": [
                    "N0000192561",
                    "N0000192560"
                ],
                "pharm_class_epc": [
                    "Farnesoid X Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Farnesoid X Receptor Agonists [MoA]"
                ],
                "unii": [
                    "0462Z4S4OZ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "1d6c9e9d-e17d-4609-91fa-75e5bdbc5114",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160527",
            "product_id": "69516-010_1d6c9e9d-e17d-4609-91fa-75e5bdbc5114",
            "application_number": "NDA207999",
            "brand_name_base": "Ocaliva",
            "pharm_class": [
                "Farnesoid X Receptor Agonist [EPC]",
                "Farnesoid X Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "50242-150",
            "generic_name": "ocrelizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "OCREVUS",
            "active_ingredients": [
                {
                    "name": "OCRELIZUMAB",
                    "strength": "300 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-150-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-150-01)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20170328",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1876380",
                    "1876385"
                ],
                "spl_set_id": [
                    "9da42362-3bb5-4b83-b4bb-b59fd4e55f0d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657",
                    "M0001357",
                    "M0556300"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]",
                    "Antibodies, Monoclonal, Humanized [CS]"
                ],
                "unii": [
                    "A10SJL62JY"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "efefefb3-852f-44e4-971f-3be5ae7c4b99",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170328",
            "product_id": "50242-150_efefefb3-852f-44e4-971f-3be5ae7c4b99",
            "application_number": "BLA761053",
            "brand_name_base": "OCREVUS",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Antibodies",
                "Monoclonal",
                "Humanized [CS]",
                "CD20-directed Antibody Interactions [MoA]",
                "CD20-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "61958-2101",
            "generic_name": "emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "ODEFSEY",
            "active_ingredients": [
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "RILPIVIRINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                },
                {
                    "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-2101-1",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2101-1)",
                    "marketing_start_date": "20160301",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1741733",
                    "1741739"
                ],
                "spl_set_id": [
                    "ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "G70B4ETF4S",
                    "212WAX8KDD",
                    "FWF6Q91TZO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "2178fe00-9d08-4b76-bb2e-b4d8cbf33c43",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160301",
            "product_id": "61958-2101_2178fe00-9d08-4b76-bb2e-b4d8cbf33c43",
            "application_number": "NDA208351",
            "brand_name_base": "ODEFSEY",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "47335-303",
            "generic_name": "sonidegib",
            "labeler_name": "Sun Pharmaceutical Industries, Inc.",
            "brand_name": "Odomzo",
            "active_ingredients": [
                {
                    "name": "SONIDEGIB PHOSPHATE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "47335-303-15",
                    "description": "30 CAPSULE in 1 BOTTLE (47335-303-15)",
                    "marketing_start_date": "20170921",
                    "sample": false
                },
                {
                    "package_ndc": "47335-303-83",
                    "description": "30 CAPSULE in 1 BOTTLE (47335-303-83)",
                    "marketing_start_date": "20170921",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sun Pharmaceutical Industries, Inc."
                ],
                "rxcui": [
                    "1659921",
                    "1659927"
                ],
                "spl_set_id": [
                    "028312dc-d155-4fd5-8abd-6bb9f011d3cc"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "W421AI34UW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "a2951b0d-10fe-447c-8f83-2c244fbc8815",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170921",
            "product_id": "47335-303_a2951b0d-10fe-447c-8f83-2c244fbc8815",
            "application_number": "NDA205266",
            "brand_name_base": "Odomzo",
            "pharm_class": [
                "Hedgehog Pathway Inhibitor [EPC]",
                "Smoothened Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "82448-150",
            "generic_name": "nirogacestat",
            "labeler_name": "SpringWorks Therapeutics, Inc.",
            "brand_name": "OGSIVEO",
            "active_ingredients": [
                {
                    "name": "NIROGACESTAT",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "82448-150-14",
                    "description": "14 TABLET, FILM COATED in 1 BLISTER PACK (82448-150-14)",
                    "marketing_start_date": "20231127",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "SpringWorks Therapeutics, Inc."
                ],
                "rxcui": [
                    "2670637",
                    "2670643",
                    "2680360",
                    "2680362",
                    "2680363",
                    "2680364",
                    "2680366",
                    "2680368",
                    "2680369",
                    "2680370"
                ],
                "spl_set_id": [
                    "f172e6ff-3190-41b0-b95a-58a7ef9e9e1e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "QZ62892OFJ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "02884b8e-36bf-4f34-a42b-a3927bf6dcab",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20231127",
            "product_id": "82448-150_02884b8e-36bf-4f34-a42b-a3927bf6dcab",
            "application_number": "NDA217677",
            "brand_name_base": "OGSIVEO"
        },
        {
            "product_ndc": "81864-101",
            "generic_name": "Momelotinib",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Ojjaara",
            "active_ingredients": [
                {
                    "name": "MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "81864-101-30",
                    "description": "30 TABLET in 1 BOTTLE (81864-101-30)",
                    "marketing_start_date": "20230915",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "2665210",
                    "2665216",
                    "2665218",
                    "2665220",
                    "2665222",
                    "2665224"
                ],
                "spl_set_id": [
                    "4a672fd1-eb7b-4aa9-9b23-845e4b5dc400"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0381864103305",
                    "0381864102308",
                    "0381864101301"
                ],
                "unii": [
                    "LDX8893L5D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "06ff7cff-7d39-470d-ba52-1c61c74f4a05",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230915",
            "product_id": "81864-101_06ff7cff-7d39-470d-ba52-1c61c74f4a05",
            "application_number": "NDA216873",
            "brand_name_base": "Ojjaara"
        },
        {
            "product_ndc": "79481-0647",
            "generic_name": "Magnesium hydroxide",
            "labeler_name": "Meijer, Inc.",
            "brand_name": "Milk of Magnesia mint",
            "active_ingredients": [
                {
                    "name": "MAGNESIUM HYDROXIDE",
                    "strength": "1200 mg/15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "79481-0647-1",
                    "description": "769 mL in 1 BOTTLE (79481-0647-1)",
                    "marketing_start_date": "20210201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meijer, Inc."
                ],
                "rxcui": [
                    "253017"
                ],
                "spl_set_id": [
                    "bb8ba371-f53c-1088-e053-2a95a90a4cbf"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "NBZ3QY004S"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "SUSPENSION",
            "spl_id": "09a7136c-d359-6d30-e063-6294a90ab07f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210201",
            "product_id": "79481-0647_09a7136c-d359-6d30-e063-6294a90ab07f",
            "application_number": "M007",
            "brand_name_base": "Milk of Magnesia mint",
            "pharm_class": [
                "Calculi Dissolution Agent [EPC]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"
            ]
        },
        {
            "product_ndc": "0002-4182",
            "generic_name": "baricitinib",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Olumiant",
            "active_ingredients": [
                {
                    "name": "BARICITINIB",
                    "strength": "2 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-4182-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0002-4182-30)",
                    "marketing_start_date": "20180531",
                    "sample": false
                },
                {
                    "package_ndc": "0002-4182-61",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0002-4182-61)",
                    "marketing_start_date": "20180531",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "2047241",
                    "2047247",
                    "2205472",
                    "2205474",
                    "2588561",
                    "2601725"
                ],
                "spl_set_id": [
                    "866e9f35-9035-4581-a4b1-75a621ab55cf"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300024182301",
                    "0300024732308",
                    "0300024479302"
                ],
                "nui": [
                    "N0000190858",
                    "N0000190857"
                ],
                "pharm_class_epc": [
                    "Janus Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Janus Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "ISP4442I3Y"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "44ded0f7-8c82-4875-ad44-db5b0354a094",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180531",
            "product_id": "0002-4182_44ded0f7-8c82-4875-ad44-db5b0354a094",
            "application_number": "NDA207924",
            "brand_name_base": "Olumiant",
            "pharm_class": [
                "Janus Kinase Inhibitor [EPC]",
                "Janus Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "11401-6994",
            "generic_name": "Oxygen",
            "labeler_name": "Hawaii Home Infusion Associates, Ltd.",
            "brand_name": "Oxygen",
            "active_ingredients": [
                {
                    "name": "OXYGEN",
                    "strength": "99 L/100L"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11401-6994-1",
                    "description": "680 L in 1 CYLINDER (11401-6994-1)",
                    "marketing_start_date": "20100111",
                    "sample": false
                },
                {
                    "package_ndc": "11401-6994-2",
                    "description": "415 L in 1 CYLINDER (11401-6994-2)",
                    "marketing_start_date": "20100111",
                    "sample": false
                },
                {
                    "package_ndc": "11401-6994-3",
                    "description": "164 L in 1 CYLINDER (11401-6994-3)",
                    "marketing_start_date": "20100111",
                    "sample": false
                },
                {
                    "package_ndc": "11401-6994-4",
                    "description": "1699 L in 1 CYLINDER (11401-6994-4)",
                    "marketing_start_date": "20100111",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Hawaii Home Infusion Associates, Ltd."
                ],
                "rxcui": [
                    "312172"
                ],
                "spl_set_id": [
                    "88b00c55-4200-4041-aabc-11fd431376ef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "S88TT14065"
                ]
            },
            "marketing_category": "UNAPPROVED MEDICAL GAS",
            "dosage_form": "GAS",
            "spl_id": "075f9001-085f-9f47-e063-6294a90af788",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20100111",
            "product_id": "11401-6994_075f9001-085f-9f47-e063-6294a90af788",
            "brand_name_base": "Oxygen"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72694-954",
            "generic_name": "Pegaspargase",
            "labeler_name": "Servier Pharmaceuticals LLC",
            "brand_name": "ONCASPAR",
            "active_ingredients": [
                {
                    "name": "PEGASPARGASE",
                    "strength": "750 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72694-954-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (72694-954-01)  / 5 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20200102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Servier Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "213040",
                    "240906"
                ],
                "spl_set_id": [
                    "ac7b6a6f-6ddb-48c6-8088-d8a8e3fea6ce"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0001815",
                    "N0000175669"
                ],
                "pharm_class_cs": [
                    "Asparaginase [CS]"
                ],
                "pharm_class_epc": [
                    "Asparagine-specific Enzyme [EPC]"
                ],
                "unii": [
                    "7D96IR0PPM"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "77bb099f-bfc1-4e5d-a4e9-42071faffce1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200102",
            "product_id": "72694-954_77bb099f-bfc1-4e5d-a4e9-42071faffce1",
            "application_number": "BLA103411",
            "brand_name_base": "ONCASPAR",
            "pharm_class": [
                "Asparaginase [CS]",
                "Asparagine-specific Enzyme [EPC]"
            ]
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "71336-1000",
            "generic_name": "patisiran",
            "labeler_name": "Alnylam Pharmaceuticals, Inc.",
            "brand_name": "Onpattro",
            "active_ingredients": [
                {
                    "name": "PATISIRAN SODIUM",
                    "strength": "2 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71336-1000-1",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (71336-1000-1)  / 5 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20180813",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Alnylam Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2053524",
                    "2053529"
                ],
                "spl_set_id": [
                    "e87ec36f-b4b4-49d4-aea4-d4ffb09b0970"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "WO0YM16LKG"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, LIPID COMPLEX",
            "spl_id": "ffbc20c4-35ca-4779-ab28-57828b566694",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20180813",
            "product_id": "71336-1000_ffbc20c4-35ca-4779-ab28-57828b566694",
            "application_number": "NDA210922",
            "brand_name_base": "Onpattro",
            "pharm_class": [
                "Decreased RNA Integrity [PE]",
                "Increased Protein Breakdown [PE]",
                "RNA",
                "Small Interfering [CS]",
                "Small Interfering RNA [EPC]",
                "Transthyretin-directed RNA Interaction [EPC]"
            ]
        },
        {
            "product_ndc": "78206-147",
            "generic_name": "trastuzumab",
            "labeler_name": "Organon LLC",
            "brand_name": "Ontruzant",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "78206-147-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99)",
                    "marketing_start_date": "20210601",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Organon LLC"
                ],
                "rxcui": [
                    "2289227",
                    "2289232",
                    "2289234",
                    "2289237"
                ],
                "spl_set_id": [
                    "ce2a2492-85e3-4b0a-872a-047f44e4203d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0378206147011",
                    "0378206148018"
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ad98aa3b-8438-40df-9a42-f034962edec5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210601",
            "product_id": "78206-147_ad98aa3b-8438-40df-9a42-f034962edec5",
            "application_number": "BLA761100",
            "brand_name_base": "Ontruzant",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "59572-730",
            "generic_name": "azacitidine",
            "labeler_name": "Celgene Corporation",
            "brand_name": "ONUREG",
            "active_ingredients": [
                {
                    "name": "AZACITIDINE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-730-07",
                    "description": "7 TABLET, FILM COATED in 1 BLISTER PACK (59572-730-07)",
                    "marketing_start_date": "20201218",
                    "sample": false
                },
                {
                    "package_ndc": "59572-730-14",
                    "description": "14 TABLET, FILM COATED in 1 BOTTLE (59572-730-14)",
                    "marketing_start_date": "20200901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "2396764",
                    "2396770",
                    "2396772",
                    "2396774"
                ],
                "spl_set_id": [
                    "0e95e33f-8aba-4f19-b332-2416580d358b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000233",
                    "N0000175595"
                ],
                "pharm_class_moa": [
                    "Nucleic Acid Synthesis Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Nucleoside Metabolic Inhibitor [EPC]"
                ],
                "unii": [
                    "M801H13NRU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "5a9f7082-45d4-478c-9757-4e7b884e1951",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200901",
            "product_id": "59572-730_5a9f7082-45d4-478c-9757-4e7b884e1951",
            "application_number": "NDA214120",
            "brand_name_base": "ONUREG",
            "pharm_class": [
                "Nucleic Acid Synthesis Inhibitors [MoA]",
                "Nucleoside Metabolic Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "0003-3774",
            "generic_name": "nivolumab",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "OPDIVO",
            "active_ingredients": [
                {
                    "name": "NIVOLUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-3774-12",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0003-3774-12)  / 10 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20141222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "1657190",
                    "1657192",
                    "1657195",
                    "1657196",
                    "1991412",
                    "1991413",
                    "2569080",
                    "2569081"
                ],
                "spl_set_id": [
                    "f570b9c4-6846-4de2-abfa-4d0a4ae4e394"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "31YO63LBSN"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "029e0283-4b1b-4ab2-9782-9f2ce2713dd1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20141222",
            "product_id": "0003-3774_029e0283-4b1b-4ab2-9782-9f2ce2713dd1",
            "application_number": "BLA125554",
            "brand_name_base": "OPDIVO",
            "pharm_class": [
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0003-7125",
            "generic_name": "nivolumab and relatlimab-rmbw",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "OPDUALAG",
            "active_ingredients": [
                {
                    "name": "NIVOLUMAB",
                    "strength": "12 mg/mL"
                },
                {
                    "name": "RELATLIMAB",
                    "strength": "4 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-7125-11",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11)  / 20 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20220318",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "2596778",
                    "2596784"
                ],
                "spl_set_id": [
                    "b22c9d83-3256-4e17-85f7-f331a504adc6"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259",
                    "N0000194003",
                    "N0000194002"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                    "Lymphocyte Activation Gene-3 Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
                    "Lymphocyte Activation Gene-3 Antagonists [MoA]"
                ],
                "unii": [
                    "31YO63LBSN",
                    "AF75XOF6W3"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "1150d07b-4d33-4285-a242-1ecf12ed5a4c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220318",
            "product_id": "0003-7125_1150d07b-4d33-4285-a242-1ecf12ed5a4c",
            "application_number": "BLA761234",
            "brand_name_base": "OPDUALAG",
            "pharm_class": [
                "Lymphocyte Activation Gene-3 Antagonists [MoA]",
                "Lymphocyte Activation Gene-3 Blocker [EPC]",
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "71904-300",
            "generic_name": "miglustat",
            "labeler_name": "AMICUS THERAPEUTICS US, LLC",
            "brand_name": "OPFOLDA",
            "active_ingredients": [
                {
                    "name": "MIGLUSTAT",
                    "strength": "65 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71904-300-01",
                    "description": "4 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-01)  / 1 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20231011",
                    "sample": false
                },
                {
                    "package_ndc": "71904-300-02",
                    "description": "24 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-02)  / 1 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20231011",
                    "sample": false
                },
                {
                    "package_ndc": "71904-300-03",
                    "description": "100 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-03)  / 1 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20231011",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AMICUS THERAPEUTICS US, LLC"
                ],
                "rxcui": [
                    "2667426",
                    "2667432"
                ],
                "spl_set_id": [
                    "d7c38298-37db-5a80-e053-2995a90aee40"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0371904300016",
                    "0371904300023",
                    "0371904300030"
                ],
                "nui": [
                    "N0000175783",
                    "N0000020019",
                    "N0000194077",
                    "N0000194078"
                ],
                "pharm_class_epc": [
                    "Glucosylceramide Synthase Inhibitor [EPC]",
                    "Enzyme Stabilizer [EPC]"
                ],
                "pharm_class_moa": [
                    "Glucosylceramide Synthase Inhibitors [MoA]",
                    "Enzyme Stabilizers [MoA]"
                ],
                "unii": [
                    "ADN3S497AZ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "608208ec-6d30-4796-9d61-fed1159b8b38",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20231011",
            "product_id": "71904-300_608208ec-6d30-4796-9d61-fed1159b8b38",
            "application_number": "NDA215211",
            "brand_name_base": "OPFOLDA",
            "pharm_class": [
                "Glucosylceramide Synthase Inhibitor [EPC]",
                "Glucosylceramide Synthase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "66215-814",
            "generic_name": "macitentan and tadalafil",
            "labeler_name": "Actelion Pharmaceuticals US, Inc.",
            "brand_name": "OPSYNVI",
            "active_ingredients": [
                {
                    "name": "MACITENTAN",
                    "strength": "10 mg/1"
                },
                {
                    "name": "TADALAFIL",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66215-814-10",
                    "description": "1 BLISTER PACK in 1 CARTON (66215-814-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (66215-814-01)",
                    "marketing_start_date": "20240322",
                    "sample": false
                },
                {
                    "package_ndc": "66215-814-30",
                    "description": "1 BOTTLE in 1 CARTON (66215-814-30)  / 30 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20240322",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Actelion Pharmaceuticals US, Inc."
                ],
                "rxcui": [
                    "2677765",
                    "2677771",
                    "2677773",
                    "2677775"
                ],
                "spl_set_id": [
                    "6945b183-18d3-40de-afd1-c88e33cc1a63"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175581",
                    "N0000175364",
                    "N0000175599",
                    "N0000020026"
                ],
                "pharm_class_epc": [
                    "Endothelin Receptor Antagonist [EPC]",
                    "Phosphodiesterase 5 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Endothelin Receptor Antagonists [MoA]",
                    "Phosphodiesterase 5 Inhibitors [MoA]"
                ],
                "unii": [
                    "Z9K9Y9WMVL",
                    "742SXX0ICT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "15220f02-7842-7726-e063-6294a90a5492",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240322",
            "product_id": "66215-814_15220f02-7842-7726-e063-6294a90a5492",
            "application_number": "NDA218490",
            "brand_name_base": "OPSYNVI",
            "pharm_class": [
                "Endothelin Receptor Antagonist [EPC]",
                "Endothelin Receptor Antagonists [MoA]",
                "Phosphodiesterase 5 Inhibitor [EPC]",
                "Phosphodiesterase 5 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "70842-140",
            "generic_name": "oritavancin",
            "labeler_name": "Melinta Therapeutics, LLC",
            "brand_name": "Orbactiv",
            "active_ingredients": [
                {
                    "name": "ORITAVANCIN",
                    "strength": "400 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70842-140-03",
                    "description": "3 VIAL, GLASS in 1 CARTON (70842-140-03)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01)",
                    "marketing_start_date": "20140901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Melinta Therapeutics, LLC"
                ],
                "rxcui": [
                    "1547615",
                    "1547620"
                ],
                "spl_set_id": [
                    "ff09a726-9f9b-4e30-b509-396781293220"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191281",
                    "M000640741",
                    "N0000182140",
                    "N0000185504",
                    "N0000185506",
                    "N0000191267"
                ],
                "pharm_class_epc": [
                    "Lipoglycopeptide Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Lipoglycopeptides [CS]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 2C19 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 2D6 Inducers [MoA]"
                ],
                "unii": [
                    "PUG62FRZ2E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "14923de6-b8b7-4283-b8a7-53b32df2d9a2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20140901",
            "product_id": "70842-140_14923de6-b8b7-4283-b8a7-53b32df2d9a2",
            "application_number": "NDA206334",
            "brand_name_base": "Orbactiv",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Lipoglycopeptide Antibacterial [EPC]",
                "Lipoglycopeptides [CS]"
            ]
        },
        {
            "product_ndc": "0003-2188",
            "generic_name": "abatacept",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "ORENCIA",
            "active_ingredients": [
                {
                    "name": "ABATACEPT",
                    "strength": "125 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-2188-11",
                    "description": "4 SYRINGE, GLASS in 1 CARTON (0003-2188-11)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20131001",
                    "sample": false
                },
                {
                    "package_ndc": "0003-2188-21",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0003-2188-21)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20131001",
                    "sample": false
                },
                {
                    "package_ndc": "0003-2188-50",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0003-2188-50)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20160705",
                    "sample": false
                },
                {
                    "package_ndc": "0003-2188-51",
                    "description": "4 SYRINGE, GLASS in 1 CARTON (0003-2188-51)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20160607",
                    "sample": false
                },
                {
                    "package_ndc": "0003-2188-90",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0003-2188-90)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20160712",
                    "sample": true
                },
                {
                    "package_ndc": "0003-2188-91",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0003-2188-91)  / 1 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20131001",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "616015",
                    "616018",
                    "1145929",
                    "1145932",
                    "1799228",
                    "1799230",
                    "1925254",
                    "1925255",
                    "1925256",
                    "1925257"
                ],
                "spl_set_id": [
                    "0836c6ac-ee37-5640-2fed-a3185a0b16eb"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008571",
                    "N0000182159",
                    "M0018640"
                ],
                "pharm_class_pe": [
                    "Decreased Cytokine Activity [PE]"
                ],
                "pharm_class_epc": [
                    "Selective T Cell Costimulation Modulator [EPC]"
                ],
                "pharm_class_cs": [
                    "Recombinant Fusion Proteins [CS]"
                ],
                "unii": [
                    "7D0YB67S97"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "ab2fcc7c-0902-487b-ac76-d720d57a02e8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20110729",
            "product_id": "0003-2188_ab2fcc7c-0902-487b-ac76-d720d57a02e8",
            "application_number": "BLA125118",
            "brand_name_base": "ORENCIA",
            "pharm_class": [
                "Decreased Cytokine Activity [PE]",
                "Recombinant Fusion Proteins [CS]",
                "Selective T Cell Costimulation Modulator [EPC]"
            ]
        },
        {
            "product_ndc": "66658-110",
            "generic_name": "Nitisinone",
            "labeler_name": "SWEDISH ORPHAN BIOVITRUM AB (PUBL)",
            "brand_name": "Orfadin",
            "active_ingredients": [
                {
                    "name": "NITISINONE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66658-110-60",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (66658-110-60)  / 60 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20160701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "SWEDISH ORPHAN BIOVITRUM AB (PUBL)"
                ],
                "rxcui": [
                    "351173",
                    "351174",
                    "351175",
                    "352119",
                    "352120",
                    "352121",
                    "1798999",
                    "1799001"
                ],
                "spl_set_id": [
                    "5d449b73-d503-4132-b978-d890491975df"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175809",
                    "N0000175808",
                    "N0000185504",
                    "N0000193955",
                    "N0000190110",
                    "N0000190111"
                ],
                "pharm_class_epc": [
                    "4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "Cytochrome P450 2E1 Inducers [MoA]",
                    "Organic Anion Transporter 1 Inhibitors [MoA]",
                    "Organic Anion Transporter 3 Inhibitors [MoA]"
                ],
                "unii": [
                    "K5BN214699"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "f9c6cef5-fb71-4cb0-9793-5c23ac04572e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160701",
            "product_id": "66658-110_f9c6cef5-fb71-4cb0-9793-5c23ac04572e",
            "application_number": "NDA021232",
            "brand_name_base": "Orfadin",
            "pharm_class": [
                "4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 2E1 Inducers [MoA]",
                "Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]",
                "Organic Anion Transporter 1 Inhibitors [MoA]",
                "Organic Anion Transporter 3 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72974-120",
            "generic_name": "relugolix",
            "labeler_name": "Sumitomo Pharma America, Inc",
            "brand_name": "Orgovyx",
            "active_ingredients": [
                {
                    "name": "RELUGOLIX",
                    "strength": "120 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72974-120-01",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01)",
                    "marketing_start_date": "20201218",
                    "sample": false
                },
                {
                    "package_ndc": "72974-120-95",
                    "description": "16 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-95)",
                    "marketing_start_date": "20230127",
                    "sample": true
                },
                {
                    "package_ndc": "72974-120-97",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-97)",
                    "marketing_start_date": "20211021",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sumitomo Pharma America, Inc"
                ],
                "rxcui": [
                    "2472783",
                    "2472789"
                ],
                "spl_set_id": [
                    "077a92f6-9f1b-479a-87c7-c92b5db6aa9c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175839",
                    "N0000175084",
                    "N0000008638",
                    "N0000190118",
                    "N0000187064",
                    "N0000190113",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased GnRH Secretion [PE]"
                ],
                "unii": [
                    "P76B05O5V6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0f405496-84c9-3f79-e063-6394a90acf02",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201218",
            "product_id": "72974-120_0f405496-84c9-3f79-e063-6394a90acf02",
            "application_number": "NDA214621",
            "brand_name_base": "Orgovyx",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Decreased GnRH Secretion [PE]",
                "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0074-1017",
            "generic_name": "Elagolix and Estradiol and Norethisterone",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Oriahnn",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-1017-14",
                    "description": "1 BLISTER PACK in 1 CARTON (0074-1017-14)  / 1 KIT in 1 BLISTER PACK *  7 CAPSULE in 1 BLISTER PACK *  7 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20200924",
                    "sample": true
                },
                {
                    "package_ndc": "0074-1017-56",
                    "description": "4 BLISTER PACK in 1 CARTON (0074-1017-56)  / 1 KIT in 1 BLISTER PACK *  7 CAPSULE in 1 BLISTER PACK *  7 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20200529",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "2371764",
                    "2371766",
                    "2371767",
                    "2371768"
                ],
                "spl_set_id": [
                    "99f6eee7-7e52-6999-7eb8-488d06dd1710"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "cc29473d-8559-4b6d-ab31-64c818e5d9df",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20200529",
            "product_id": "0074-1017_cc29473d-8559-4b6d-ab31-64c818e5d9df",
            "application_number": "NDA213388",
            "brand_name_base": "Oriahnn"
        },
        {
            "product_ndc": "0074-0038",
            "generic_name": "Elagolix",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Orilissa",
            "active_ingredients": [
                {
                    "name": "ELAGOLIX SODIUM",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-0038-07",
                    "description": "1 BLISTER PACK in 1 CARTON (0074-0038-07)  / 7 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20180723",
                    "sample": true
                },
                {
                    "package_ndc": "0074-0038-28",
                    "description": "4 BLISTER PACK in 1 CARTON (0074-0038-28)  / 7 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20180723",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "2049852",
                    "2049858",
                    "2049860",
                    "2049862"
                ],
                "spl_set_id": [
                    "a86757b3-09c5-fd3b-1223-244e94f50a66"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5948VUI423"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0c3c5812-03a4-4ff2-bc62-786488dc4cc4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180723",
            "product_id": "0074-0038_0c3c5812-03a4-4ff2-bc62-786488dc4cc4",
            "application_number": "NDA210450",
            "brand_name_base": "Orilissa",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Decreased GnRH Secretion [PE]",
                "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "51167-122",
            "generic_name": "lumacaftor and ivacaftor",
            "labeler_name": "Vertex Pharmaceuticals Incorporated",
            "brand_name": "ORKAMBI",
            "active_ingredients": [
                {
                    "name": "IVACAFTOR",
                    "strength": "94 mg/1"
                },
                {
                    "name": "LUMACAFTOR",
                    "strength": "75 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51167-122-01",
                    "description": "56 PACKET in 1 CARTON (51167-122-01)  / 1 GRANULE in 1 PACKET",
                    "marketing_start_date": "20220902",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Vertex Pharmaceuticals Incorporated"
                ],
                "spl_set_id": [
                    "3fc1c40e-cfac-47a1-9e1a-61ead3570600"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190118",
                    "N0000187064",
                    "N0000187063",
                    "N0000185507",
                    "N0000185607",
                    "N0000187062",
                    "N0000185504",
                    "N0000191264",
                    "N0000185503",
                    "N0000184146",
                    "N0000184145",
                    "N0000190114"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C8 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]",
                    "P-Glycoprotein Inducers [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Chloride Channel Activation Potentiators [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]"
                ],
                "unii": [
                    "EGP8L81APK",
                    "1Y740ILL1Z"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GRANULE",
            "spl_id": "051a3925-b57f-4362-b9bc-282945980e63",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220902",
            "product_id": "51167-122_051a3925-b57f-4362-b9bc-282945980e63",
            "application_number": "NDA211358",
            "brand_name_base": "ORKAMBI",
            "pharm_class": [
                "Chloride Channel Activation Potentiators [MoA]",
                "Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C8 Inducers [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "P-Glycoprotein Inducers [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72769-101",
            "generic_name": "Berotralstat hydrochloride",
            "labeler_name": "BioCryst Pharmaceuticals Inc.",
            "brand_name": "Orladeyo",
            "active_ingredients": [
                {
                    "name": "BEROTRALSTAT HYDROCHLORIDE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72769-101-01",
                    "description": "4 DOSE PACK in 1 CARTON (72769-101-01)  / 1 BLISTER PACK in 1 DOSE PACK / 7 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20201204",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BioCryst Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2467565",
                    "2467571",
                    "2467573",
                    "2467575"
                ],
                "spl_set_id": [
                    "3527ece1-e7e0-40b1-b0c5-6baeb0deabeb"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "88SH1NBL2B"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "b5c90354-6b1a-411b-8f51-08ab3ba1e136",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201204",
            "product_id": "72769-101_b5c90354-6b1a-411b-8f51-08ab3ba1e136",
            "application_number": "NDA214094",
            "brand_name_base": "Orladeyo",
            "pharm_class": [
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Kallikrein Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Plasma Kallikrein Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "72187-0102",
            "generic_name": "Elacestrant",
            "labeler_name": "Stemline Therapeutics, Inc.",
            "brand_name": "ORSERDU",
            "active_ingredients": [
                {
                    "name": "ELACESTRANT",
                    "strength": "345 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72187-0102-3",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (72187-0102-3)",
                    "marketing_start_date": "20230127",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Stemline Therapeutics, Inc."
                ],
                "rxcui": [
                    "2628478",
                    "2628484",
                    "2628487",
                    "2628489"
                ],
                "spl_set_id": [
                    "aa66ae5c-2bd2-4444-8178-b55651e054ef"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372187010135",
                    "0372187010234"
                ],
                "nui": [
                    "N0000175582",
                    "N0000000145",
                    "N0000185503",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Estrogen Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Antagonists [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "FM6A2627A8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "8195fa6c-91ac-4fe6-af1b-33881aae7e4c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230127",
            "product_id": "72187-0102_8195fa6c-91ac-4fe6-af1b-33881aae7e4c",
            "application_number": "NDA217639",
            "brand_name_base": "ORSERDU",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Estrogen Receptor Antagonist [EPC]",
                "Estrogen Receptor Antagonists [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "64764-251",
            "generic_name": "alogliptin and pioglitazone",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "OSENI",
            "active_ingredients": [
                {
                    "name": "ALOGLIPTIN BENZOATE",
                    "strength": "25 mg/1"
                },
                {
                    "name": "PIOGLITAZONE HYDROCHLORIDE",
                    "strength": "15 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-251-03",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-251-03)",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-251-04",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (64764-251-04)",
                    "marketing_start_date": "20130125",
                    "sample": false
                },
                {
                    "package_ndc": "64764-251-05",
                    "description": "500 TABLET, FILM COATED in 1 BOTTLE (64764-251-05)",
                    "marketing_start_date": "20130125",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1368410",
                    "1368416",
                    "1368424",
                    "1368430",
                    "1368431",
                    "1368437",
                    "1368438",
                    "1368444"
                ],
                "spl_set_id": [
                    "4c619ed9-fe3e-4158-9938-80c6c3493d55"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364764251031",
                    "0364764253035",
                    "0364764254032",
                    "0364764123031"
                ],
                "unii": [
                    "EEN99869SC",
                    "JQT35NPK6C"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "2132de34-57ee-4ffa-8c28-a085d533f8aa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130125",
            "product_id": "64764-251_2132de34-57ee-4ffa-8c28-a085d533f8aa",
            "application_number": "NDA022426",
            "brand_name_base": "OSENI",
            "pharm_class": [
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]",
                "Peroxisome Proliferator Receptor alpha Agonist [EPC]",
                "Peroxisome Proliferator Receptor gamma Agonist [EPC]",
                "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]",
                "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]",
                "Thiazolidinedione [EPC]",
                "Thiazolidinediones [CS]"
            ]
        },
        {
            "product_ndc": "80425-0271",
            "generic_name": "Indomethacin",
            "labeler_name": "Advanced Rx Pharmacy of Tennessee, LLC",
            "brand_name": "Indomethacin ER",
            "brand_name_suffix": "ER",
            "active_ingredients": [
                {
                    "name": "INDOMETHACIN",
                    "strength": "75 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "80425-0271-1",
                    "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (80425-0271-1)",
                    "marketing_start_date": "20230217",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advanced Rx Pharmacy of Tennessee, LLC"
                ],
                "rxcui": [
                    "310992"
                ],
                "spl_set_id": [
                    "f4e8a719-ef9c-a2ef-e053-2995a90ad788"
                ],
                "nui": [
                    "N0000000160",
                    "M0001335",
                    "N0000175722"
                ],
                "pharm_class_moa": [
                    "Cyclooxygenase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Anti-Inflammatory Agents, Non-Steroidal [CS]"
                ],
                "pharm_class_epc": [
                    "Nonsteroidal Anti-inflammatory Drug [EPC]"
                ],
                "unii": [
                    "XXE1CET956"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, EXTENDED RELEASE",
            "spl_id": "f4e8a719-ef9d-a2ef-e053-2995a90ad788",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230217",
            "product_id": "80425-0271_f4e8a719-ef9d-a2ef-e053-2995a90ad788",
            "application_number": "ANDA201807",
            "brand_name_base": "Indomethacin",
            "pharm_class": [
                "Anti-Inflammatory Agents",
                "Non-Steroidal [CS]",
                "Cyclooxygenase Inhibitors [MoA]",
                "Nonsteroidal Anti-inflammatory Drug [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "65044-9971",
            "generic_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "labeler_name": "Jubilant HollisterStier LLC",
            "brand_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65044-9971-1",
                    "description": "1 KIT in 1 TRAY (65044-9971-1)  *  1.2 mL in 1 VIAL (65044-9981-2)",
                    "marketing_start_date": "19820222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "b9289dcf-445f-4a93-89f7-f513569254fd",
            "product_type": "STANDARDIZED ALLERGENIC",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19820222",
            "product_id": "65044-9971_b9289dcf-445f-4a93-89f7-f513569254fd",
            "application_number": "BLA103885",
            "brand_name_base": "White Faced Hornet Hymenoptera Venom Venomil Maintenance"
        },
        {
            "product_ndc": "55550-102",
            "generic_name": "Homosalate, Octinoxate, Octisalate, Oxybenzone",
            "labeler_name": "Total Resources International",
            "brand_name": "Sunscreen",
            "active_ingredients": [
                {
                    "name": "HOMOSALATE",
                    "strength": "6 mg/g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55550-102-01",
                    "description": "1.5 g in 1 PACKET (55550-102-01)",
                    "marketing_start_date": "20230120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Total Resources International"
                ],
                "spl_set_id": [
                    "7d4f820d-e154-428e-89c2-2e26e088ceef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LOTION",
            "spl_id": "f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20230120",
            "product_id": "55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "application_number": "part352",
            "brand_name_base": "Sunscreen"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72786-102",
            "generic_name": "Voxelotor",
            "labeler_name": "Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.",
            "brand_name": "OXBRYTA",
            "active_ingredients": [
                {
                    "name": "VOXELOTOR",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72786-102-02",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72786-102-02)",
                    "marketing_start_date": "20221014",
                    "sample": false
                },
                {
                    "package_ndc": "72786-102-03",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72786-102-03)",
                    "marketing_start_date": "20221014",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc."
                ],
                "rxcui": [
                    "2265683",
                    "2265689",
                    "2588070",
                    "2588074",
                    "2619427",
                    "2619428"
                ],
                "spl_set_id": [
                    "3c557fac-29ec-483f-b691-8a935d4decc3"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372786111035"
                ],
                "nui": [
                    "N0000194027",
                    "N0000194028",
                    "N0000182141"
                ],
                "pharm_class_epc": [
                    "Hemoglobin S Polymerization Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Hemoglobin S Polymerization Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]"
                ],
                "unii": [
                    "3ZO554A4Q8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "e27a3e07-438e-49d3-aae3-095e9379c7b4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191125",
            "product_id": "72786-102_e27a3e07-438e-49d3-aae3-095e9379c7b4",
            "application_number": "NDA213137",
            "brand_name_base": "OXBRYTA",
            "pharm_class": [
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Hemoglobin S Polymerization Inhibitor [EPC]",
                "Hemoglobin S Polymerization Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "71981-001",
            "generic_name": "cenegermin-bkbj",
            "labeler_name": "Domp farmaceutici S.p.A.",
            "brand_name": "OXERVATE",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71981-001-01",
                    "description": "1 KIT in 1 KIT (71981-001-01)  *  7 VIAL, MULTI-DOSE in 1 CARTON / 1 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20181126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Domp farmaceutici S.p.A."
                ],
                "rxcui": [
                    "2104336",
                    "2104341"
                ],
                "spl_set_id": [
                    "89e4bfec-d710-40ed-8885-5d13ba46b1cd"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193854",
                    "M0328210"
                ],
                "pharm_class_epc": [
                    "Recombinant Human Nerve Growth Factor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nerve Growth Factor [CS]"
                ],
                "unii": [
                    "B6E7K36KT8"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "39e193f0-1484-49f9-b162-c64f0a8cb158",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20181126",
            "product_id": "71981-001_39e193f0-1484-49f9-b162-c64f0a8cb158",
            "application_number": "BLA761094",
            "brand_name_base": "OXERVATE"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0169-4772",
            "generic_name": "semaglutide",
            "labeler_name": "Novo Nordisk",
            "brand_name": "Ozempic",
            "active_ingredients": [
                {
                    "name": "SEMAGLUTIDE",
                    "strength": "2.68 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-4772-12",
                    "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-4772-12)  / 3 mL in 1 SYRINGE, PLASTIC (0169-4772-11)",
                    "marketing_start_date": "20220425",
                    "sample": false
                },
                {
                    "package_ndc": "0169-4772-97",
                    "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-4772-97)  / 3 mL in 1 SYRINGE, PLASTIC (0169-4772-90)",
                    "marketing_start_date": "20220425",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "1991306",
                    "1991311",
                    "1991316",
                    "1991317",
                    "2398841",
                    "2398842",
                    "2599362",
                    "2599365",
                    "2619152",
                    "2619154"
                ],
                "spl_set_id": [
                    "adec4fd2-6858-4c99-91d4-531f5f2a2d79"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000178480",
                    "M0160181",
                    "N0000020058"
                ],
                "pharm_class_epc": [
                    "GLP-1 Receptor Agonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glucagon-Like Peptide 1 [CS]"
                ],
                "pharm_class_moa": [
                    "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
                ],
                "unii": [
                    "53AXN4NNHX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7f4b992f-d010-4e6a-a475-d7133df0ebff",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220425",
            "product_id": "0169-4772_7f4b992f-d010-4e6a-a475-d7133df0ebff",
            "application_number": "NDA209637",
            "brand_name_base": "Ozempic",
            "pharm_class": [
                "GLP-1 Receptor Agonist [EPC]",
                "Glucagon-Like Peptide 1 [CS]",
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "0023-3348",
            "generic_name": "dexamethasone",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "OZURDEX",
            "active_ingredients": [
                {
                    "name": "DEXAMETHASONE",
                    "strength": ".7 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-3348-07",
                    "description": "1 POUCH in 1 CARTON (0023-3348-07)  / 1 IMPLANT in 1 POUCH",
                    "marketing_start_date": "20090901",
                    "sample": false
                },
                {
                    "package_ndc": "0023-3348-08",
                    "description": "1 POUCH in 1 CARTON (0023-3348-08)  / 1 IMPLANT in 1 POUCH",
                    "marketing_start_date": "20090901",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "854177",
                    "854181"
                ],
                "spl_set_id": [
                    "4b204f44-6e8a-4d17-803c-268f0b04679f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "7S5I7G3JQL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "IMPLANT",
            "spl_id": "84cd464a-cedc-4775-af92-b985d82fbfbf",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20090901",
            "product_id": "0023-3348_84cd464a-cedc-4775-af92-b985d82fbfbf",
            "application_number": "NDA022315",
            "brand_name_base": "OZURDEX",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "51144-030",
            "generic_name": "ENFORTUMAB VEDOTIN",
            "labeler_name": "SEAGEN INC.",
            "brand_name": "PADCEV EJFV",
            "brand_name_suffix": "EJFV",
            "active_ingredients": [
                {
                    "name": "ENFORTUMAB VEDOTIN",
                    "strength": "30 mg/3mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51144-030-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 BOX (51144-030-01)  / 3 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20191218",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "SEAGEN INC."
                ],
                "rxcui": [
                    "2268311",
                    "2268315",
                    "2268317",
                    "2268319"
                ],
                "spl_set_id": [
                    "b5631d3e-4604-4363-8f20-11dfc5a4a8ed"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "DLE8519RWM"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "3a9b3c3a-d327-4954-8a03-0dd7bbf080aa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20191218",
            "product_id": "51144-030_3a9b3c3a-d327-4954-8a03-0dd7bbf080aa",
            "application_number": "BLA761137",
            "brand_name_base": "PADCEV"
        },
        {
            "product_ndc": "71881-101",
            "generic_name": "Peanut",
            "labeler_name": "Aimmune Therapeutics",
            "brand_name": "PALFORZIA (Level 1)",
            "brand_name_suffix": "(Level 1)",
            "active_ingredients": [
                {
                    "name": "PEANUT",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71881-101-45",
                    "description": "45 CAPSULE in 1 BLISTER PACK (71881-101-45)  / 1 POWDER in 1 CAPSULE",
                    "marketing_start_date": "20200131",
                    "sample": false
                },
                {
                    "package_ndc": "71881-101-99",
                    "description": "18 BLISTER PACK in 1 CARTON (71881-101-99)  / 3 CAPSULE in 1 BLISTER PACK (71881-101-09)  / 1 POWDER in 1 CAPSULE",
                    "marketing_start_date": "20200131",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Aimmune Therapeutics"
                ],
                "rxcui": [
                    "2279407",
                    "2279409",
                    "2279410",
                    "2279416",
                    "2279418",
                    "2279419",
                    "2279421",
                    "2279422",
                    "2279424",
                    "2279425",
                    "2279426",
                    "2279427",
                    "2279428",
                    "2279429",
                    "2279431",
                    "2279432",
                    "2279434",
                    "2279435",
                    "2279436",
                    "2279437",
                    "2279438",
                    "2279439",
                    "2279441",
                    "2279442",
                    "2279444",
                    "2279445",
                    "2279446",
                    "2279447",
                    "2279448",
                    "2279449",
                    "2279450",
                    "2279451",
                    "2279453",
                    "2279454",
                    "2279456",
                    "2279457"
                ],
                "spl_set_id": [
                    "17f5be03-6705-4ac9-b8f3-bc4993ebc0eb"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000185371",
                    "N0000175629",
                    "N0000184306",
                    "M0000728",
                    "M0006342",
                    "N0000185019"
                ],
                "pharm_class_epc": [
                    "Non-Standardized Food Allergenic Extract [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Histamine Release [PE]",
                    "Cell-mediated Immunity [PE]"
                ],
                "pharm_class_cs": [
                    "Allergens [CS]",
                    "Dietary Proteins [CS]"
                ],
                "unii": [
                    "QE1QX6B99R"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "POWDER",
            "spl_id": "f724158a-5c2e-fa1e-e053-6394a90a5519",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200131",
            "product_id": "71881-101_f724158a-5c2e-fa1e-e053-6394a90a5519",
            "application_number": "BLA125696",
            "brand_name_base": "PALFORZIA",
            "pharm_class": [
                "Allergens [CS]",
                "Cell-mediated Immunity [PE]",
                "Dietary Proteins [CS]",
                "Increased Histamine Release [PE]",
                "Non-Standardized Food Allergenic Extract [EPC]",
                "Nut Proteins [EXT]"
            ]
        },
        {
            "product_ndc": "68135-058",
            "generic_name": "pegvaliase-pqpz",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "Palynziq",
            "active_ingredients": [
                {
                    "name": "PEGVALIASE",
                    "strength": "2.5 mg/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-058-90",
                    "description": "1 SYRINGE in 1 CARTON (68135-058-90)  / .5 mL in 1 SYRINGE (68135-058-89)",
                    "marketing_start_date": "20180524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "2046365",
                    "2046370",
                    "2046374",
                    "2046376",
                    "2046379",
                    "2046380"
                ],
                "spl_set_id": [
                    "6dba844a-db02-44f8-8593-ce497ed9406c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193858",
                    "M0016545"
                ],
                "pharm_class_epc": [
                    "Phenylalanine Metabolizing Enzyme [EPC]"
                ],
                "pharm_class_cs": [
                    "Phenylalanine Ammonia-Lyase [CS]"
                ],
                "unii": [
                    "N6UAH27EUV"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "24831ce1-fc13-4fd1-9659-d95257ba807b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20180524",
            "product_id": "68135-058_24831ce1-fc13-4fd1-9659-d95257ba807b",
            "application_number": "BLA761079",
            "brand_name_base": "Palynziq",
            "pharm_class": [
                "Phenylalanine Ammonia-Lyase [CS]",
                "Phenylalanine Metabolizing Enzyme [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "55513-741",
            "generic_name": "etelcalcetide",
            "labeler_name": "Amgen Inc",
            "brand_name": "PARSABIV",
            "active_ingredients": [
                {
                    "name": "ETELCALCETIDE HYDROCHLORIDE",
                    "strength": "5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-741-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (55513-741-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (55513-741-01)",
                    "marketing_start_date": "20170403",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1876127",
                    "1876132",
                    "1876135",
                    "1876136",
                    "1876137",
                    "1876138"
                ],
                "spl_set_id": [
                    "cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513740104",
                    "0355513741101",
                    "0355513742108"
                ],
                "unii": [
                    "72PT5993DU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e4cbc29d-7e7f-4406-8543-3f3ab4ef7b0b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170403",
            "product_id": "55513-741_e4cbc29d-7e7f-4406-8543-3f3ab4ef7b0b",
            "application_number": "NDA208325",
            "brand_name_base": "PARSABIV",
            "pharm_class": [
                "Calcium-sensing Receptor Agonist [EPC]",
                "Increased Calcium-sensing Receptor Sensitivity [MoA]"
            ]
        },
        {
            "product_ndc": "0069-5317",
            "generic_name": "nirmatrelvir and ritonavir",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Paxlovid",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-5317-20",
                    "description": "10 BLISTER PACK in 1 CARTON (0069-5317-20)  / 1 KIT in 1 BLISTER PACK (0069-5317-02)  *  1 TABLET, FILM COATED in 1 BLISTER PACK (0069-2085-11)  *  1 TABLET, FILM COATED in 1 BLISTER PACK (0069-1735-11)",
                    "marketing_start_date": "20231018",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "900575",
                    "2587897",
                    "2587898",
                    "2587899",
                    "2599542",
                    "2599543"
                ],
                "spl_set_id": [
                    "8a99d6d6-fd9e-45bb-b1bf-48c7f761232a"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "5d665f18-f17c-4fad-a42c-af817bb5373a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20231018",
            "product_id": "0069-5317_5d665f18-f17c-4fad-a42c-af817bb5373a",
            "application_number": "NDA217188",
            "brand_name_base": "Paxlovid"
        },
        {
            "product_ndc": "55550-102",
            "generic_name": "Homosalate, Octinoxate, Octisalate, Oxybenzone",
            "labeler_name": "Total Resources International",
            "brand_name": "Sunscreen",
            "active_ingredients": [
                {
                    "name": "HOMOSALATE",
                    "strength": "6 mg/g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55550-102-01",
                    "description": "1.5 g in 1 PACKET (55550-102-01)",
                    "marketing_start_date": "20230120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Total Resources International"
                ],
                "spl_set_id": [
                    "7d4f820d-e154-428e-89c2-2e26e088ceef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LOTION",
            "spl_id": "f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20230120",
            "product_id": "55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "application_number": "part352",
            "brand_name_base": "Sunscreen"
        },
        {
            "product_ndc": "0074-3012",
            "generic_name": "Carbidopa and Levodopa",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Duopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "4.63 mg/mL"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-3012-07",
                    "description": "7 CARTRIDGE in 1 CARTON (0074-3012-07)  / 100 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20150115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "1599846",
                    "1599852"
                ],
                "spl_set_id": [
                    "7066d371-dc6a-0d6f-7bed-e5dd4ee912da"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300743012071"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "6e98ea6e-244d-4901-9189-a04dd334d872",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ENTERAL"
            ],
            "marketing_start_date": "20150115",
            "product_id": "0074-3012_6e98ea6e-244d-4901-9189-a04dd334d872",
            "application_number": "NDA203952",
            "brand_name_base": "Duopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "21130-825",
            "generic_name": "miconazole nitrate",
            "labeler_name": "Safeway",
            "brand_name": "signature care miconazole 7",
            "active_ingredients": [
                {
                    "name": "MICONAZOLE NITRATE",
                    "strength": "2 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "21130-825-29",
                    "description": "1 TUBE, WITH APPLICATOR in 1 CARTON (21130-825-29)  / 45 g in 1 TUBE, WITH APPLICATOR",
                    "marketing_start_date": "20181106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Safeway"
                ],
                "rxcui": [
                    "998540"
                ],
                "spl_set_id": [
                    "2e04ac2d-cfbc-4261-a8f9-03715f819c1c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "VW4H1CYW1K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CREAM",
            "spl_id": "8fb5cd26-54da-4d81-943b-1b029706e77a",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "20181106",
            "product_id": "21130-825_8fb5cd26-54da-4d81-943b-1b029706e77a",
            "application_number": "ANDA074760",
            "brand_name_base": "signature care miconazole 7",
            "pharm_class": [
                "Azole Antifungal [EPC]",
                "Azoles [CS]"
            ]
        },
        {
            "product_ndc": "69145-201",
            "generic_name": "LIDOCAINE",
            "labeler_name": "Desert Harvest Inc.",
            "brand_name": "Desert Harvest RELEVEUM",
            "active_ingredients": [
                {
                    "name": "LIDOCAINE",
                    "strength": "40 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69145-201-04",
                    "description": "118 mL in 1 BOTTLE (69145-201-04)",
                    "marketing_start_date": "20170206",
                    "sample": false
                },
                {
                    "package_ndc": "69145-201-08",
                    "description": "236 mL in 1 BOTTLE (69145-201-08)",
                    "marketing_start_date": "20170206",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Desert Harvest Inc."
                ],
                "rxcui": [
                    "1421893"
                ],
                "spl_set_id": [
                    "5d9010ec-d482-44ff-ba27-3bfec5a241c6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0819791000461",
                    "0819791000454"
                ],
                "nui": [
                    "N0000175682",
                    "M0000897",
                    "N0000175426",
                    "N0000175976"
                ],
                "pharm_class_epc": [
                    "Amide Local Anesthetic [EPC]",
                    "Antiarrhythmic [EPC]"
                ],
                "pharm_class_cs": [
                    "Amides [CS]"
                ],
                "pharm_class_pe": [
                    "Local Anesthesia [PE]"
                ],
                "unii": [
                    "98PI200987"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "CREAM",
            "spl_id": "09745e88-e6dc-aa2c-e063-6394a90a954f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20140730",
            "product_id": "69145-201_09745e88-e6dc-aa2c-e063-6394a90a954f",
            "application_number": "M017",
            "brand_name_base": "Desert Harvest RELEVEUM",
            "pharm_class": [
                "Amide Local Anesthetic [EPC]",
                "Amides [CS]",
                "Antiarrhythmic [EPC]",
                "Local Anesthesia [PE]"
            ]
        },
        {
            "product_ndc": "71052-914",
            "generic_name": "Melanotan I Acetate",
            "labeler_name": "DARMERICA, LLC",
            "active_ingredients": [
                {
                    "name": "PEPTIDE B27PD",
                    "strength": "1 g/g"
                }
            ],
            "finished": false,
            "packaging": [
                {
                    "package_ndc": "71052-914-01",
                    "description": "1 g in 1 CONTAINER (71052-914-01)",
                    "marketing_start_date": "26-AUG-20"
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BULK INGREDIENT",
            "dosage_form": "POWDER",
            "spl_id": "f2b51e84-d062-d2af-e053-2a95a90ac4a9",
            "product_type": "BULK INGREDIENT",
            "marketing_start_date": "20200826",
            "product_id": "71052-914_f2b51e84-d062-d2af-e053-2a95a90ac4a9",
            "brand_name_base": null
        },
        {
            "product_ndc": "71052-914",
            "generic_name": "Melanotan I Acetate",
            "labeler_name": "DARMERICA, LLC",
            "active_ingredients": [
                {
                    "name": "PEPTIDE B27PD",
                    "strength": "1 g/g"
                }
            ],
            "finished": false,
            "packaging": [
                {
                    "package_ndc": "71052-914-01",
                    "description": "1 g in 1 CONTAINER (71052-914-01)",
                    "marketing_start_date": "26-AUG-20"
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BULK INGREDIENT",
            "dosage_form": "POWDER",
            "spl_id": "f2b51e84-d062-d2af-e053-2a95a90ac4a9",
            "product_type": "BULK INGREDIENT",
            "marketing_start_date": "20200826",
            "product_id": "71052-914_f2b51e84-d062-d2af-e053-2a95a90ac4a9",
            "brand_name_base": null
        },
        {
            "product_ndc": "21130-825",
            "generic_name": "miconazole nitrate",
            "labeler_name": "Safeway",
            "brand_name": "signature care miconazole 7",
            "active_ingredients": [
                {
                    "name": "MICONAZOLE NITRATE",
                    "strength": "2 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "21130-825-29",
                    "description": "1 TUBE, WITH APPLICATOR in 1 CARTON (21130-825-29)  / 45 g in 1 TUBE, WITH APPLICATOR",
                    "marketing_start_date": "20181106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Safeway"
                ],
                "rxcui": [
                    "998540"
                ],
                "spl_set_id": [
                    "2e04ac2d-cfbc-4261-a8f9-03715f819c1c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "VW4H1CYW1K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CREAM",
            "spl_id": "8fb5cd26-54da-4d81-943b-1b029706e77a",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "20181106",
            "product_id": "21130-825_8fb5cd26-54da-4d81-943b-1b029706e77a",
            "application_number": "ANDA074760",
            "brand_name_base": "signature care miconazole 7",
            "pharm_class": [
                "Azole Antifungal [EPC]",
                "Azoles [CS]"
            ]
        },
        {
            "product_ndc": "50881-028",
            "generic_name": "pemigatinib",
            "labeler_name": "Incyte Corporation",
            "brand_name": "PEMAZYRE",
            "active_ingredients": [
                {
                    "name": "PEMIGATINIB",
                    "strength": "13.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50881-028-01",
                    "description": "14 TABLET in 1 BOTTLE, PLASTIC (50881-028-01)",
                    "marketing_start_date": "20200417",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Incyte Corporation"
                ],
                "rxcui": [
                    "2359334",
                    "2359340",
                    "2359342",
                    "2359344",
                    "2359346",
                    "2359348"
                ],
                "spl_set_id": [
                    "9e1f2222-1d89-4e63-989c-ccebe2ab1eb4"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350881027017",
                    "0350881028014"
                ],
                "nui": [
                    "N0000175605",
                    "N0000175082",
                    "N0000185503",
                    "N0000187061",
                    "N0000191423"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Kinase Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Cation Transporter 2 Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
                ],
                "unii": [
                    "Y6BX7BL23K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "c6db56e1-8d15-47a3-a247-94583b0f69a3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200417",
            "product_id": "50881-028_c6db56e1-8d15-47a3-a247-94583b0f69a3",
            "application_number": "NDA213736",
            "brand_name_base": "PEMAZYRE",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Organic Cation Transporter 2 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "42367-531",
            "generic_name": "pemetrexed",
            "labeler_name": "Eagle Pharmaceuticals, Inc.",
            "brand_name": "Pemfexy",
            "active_ingredients": [
                {
                    "name": "PEMETREXED MONOHYDRATE",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42367-531-33",
                    "description": "1 VIAL in 1 CARTON (42367-531-33)  / 20 mL in 1 VIAL",
                    "marketing_start_date": "20220201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eagle Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2590672",
                    "2590677"
                ],
                "spl_set_id": [
                    "2308f4e8-21c8-49c1-a5b8-deb8610bac6a"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "236Y2F7D9J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "041cbcd7-a78a-47bd-8288-0e0b828f6706",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220201",
            "product_id": "42367-531_041cbcd7-a78a-47bd-8288-0e0b828f6706",
            "application_number": "NDA209472",
            "brand_name_base": "Pemfexy",
            "pharm_class": [
                "Folate Analog Metabolic Inhibitor [EPC]",
                "Folic Acid Metabolism Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "49281-511",
            "generic_name": "DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED, INACTIVATED POLIOVIRUS AND HAEMOPHILUS B CONJUGATE (TETANUS TOXOID CONJUGATE) VACCINE",
            "labeler_name": "Sanofi Pasteur Inc.",
            "brand_name": "PENTACEL",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49281-511-05",
                    "description": "1 KIT in 1 PACKAGE (49281-511-05)  *  .5 mL in 1 VIAL, SINGLE-DOSE (49281-561-01)  *  .5 mL in 1 VIAL, SINGLE-DOSE (49281-544-58)",
                    "marketing_start_date": "20080620",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "ce07bbe2-7b3f-41f7-aa03-d00beb96f7de",
            "product_type": "VACCINE",
            "marketing_start_date": "20080620",
            "product_id": "49281-511_ce07bbe2-7b3f-41f7-aa03-d00beb96f7de",
            "application_number": "BLA125145",
            "brand_name_base": "PENTACEL"
        },
        {
            "product_ndc": "54092-189",
            "generic_name": "mesalamine",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Pentasa",
            "active_ingredients": [
                {
                    "name": "MESALAMINE",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54092-189-81",
                    "description": "240 CAPSULE in 1 BOTTLE (54092-189-81)",
                    "marketing_start_date": "19930510",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "206791",
                    "314092",
                    "476362",
                    "580286"
                ],
                "spl_set_id": [
                    "e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175781",
                    "M0000971"
                ],
                "pharm_class_epc": [
                    "Aminosalicylate [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminosalicylic Acids [CS]"
                ],
                "unii": [
                    "4Q81I59GXC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "40a2c7d6-1e5d-40bb-a2a6-efe2888f856b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19930510",
            "product_id": "54092-189_40a2c7d6-1e5d-40bb-a2a6-efe2888f856b",
            "application_number": "NDA020049",
            "brand_name_base": "Pentasa",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "49502-605",
            "generic_name": "formoterol fumarate dihydrate",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "Perforomist",
            "active_ingredients": [
                {
                    "name": "FORMOTEROL FUMARATE",
                    "strength": "20 ug/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-605-30",
                    "description": "30 POUCH in 1 CARTON (49502-605-30)  / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL",
                    "marketing_start_date": "20071001",
                    "sample": false
                },
                {
                    "package_ndc": "49502-605-61",
                    "description": "60 POUCH in 1 CARTON (49502-605-61)  / 1 VIAL in 1 POUCH (49502-605-95)  / 2 mL in 1 VIAL",
                    "marketing_start_date": "20071001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "1246319",
                    "1246321"
                ],
                "spl_set_id": [
                    "fb2fe258-fe2e-47f6-8adf-ca75bf6f90af"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "W34SHF8J2K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "e5b5d4fc-4d7c-40c5-adcc-662c711832a1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20071001",
            "product_id": "49502-605_e5b5d4fc-4d7c-40c5-adcc-662c711832a1",
            "application_number": "NDA022007",
            "brand_name_base": "Perforomist",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "50242-145",
            "generic_name": "Pertuzumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "PERJETA",
            "active_ingredients": [
                {
                    "name": "PERTUZUMAB",
                    "strength": "30 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-145-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01)  / 14 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20120608",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1298948",
                    "1298953"
                ],
                "spl_set_id": [
                    "17f85d17-ab71-4f5b-9fe3-0b8c822f69ff"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "K16AIQ8CTM"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "7ad83ddc-5af2-4a0c-ac86-97fcb10ea8a6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20120608",
            "product_id": "50242-145_7ad83ddc-5af2-4a0c-ac86-97fcb10ea8a6",
            "application_number": "BLA125409",
            "brand_name_base": "PERJETA",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "50242-245",
            "generic_name": "pertuzumab, trastuzumab, and hyaluronidase-zzxf",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Phesgo",
            "active_ingredients": [
                {
                    "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
                    "strength": "30000 U/15mL"
                },
                {
                    "name": "PERTUZUMAB",
                    "strength": "1200 mg/15mL"
                },
                {
                    "name": "TRASTUZUMAB",
                    "strength": "600 mg/15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-245-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01)  / 15 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200629",
                    "sample": false
                },
                {
                    "package_ndc": "50242-245-86",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86)  / 15 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20210503",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2382604",
                    "2382609",
                    "2383305",
                    "2383307"
                ],
                "spl_set_id": [
                    "27dd5e6b-72cd-458d-a015-cf4dab5800da"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175531",
                    "M0009499",
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "Endoglycosidase [EPC]",
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glycoside Hydrolases [CS]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "743QUY4VD8",
                    "K16AIQ8CTM",
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "04be6beb-fee6-42cb-8b8d-ee7ac8da3262",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20200629",
            "product_id": "50242-245_04be6beb-fee6-42cb-8b8d-ee7ac8da3262",
            "application_number": "BLA761170",
            "brand_name_base": "Phesgo",
            "pharm_class": [
                "Endoglycosidase [EPC]",
                "Glycoside Hydrolases [CS]",
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "50090-6237",
            "generic_name": "doravirine",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "PIFELTRO",
            "active_ingredients": [
                {
                    "name": "DORAVIRINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-6237-0",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (50090-6237-0)",
                    "marketing_start_date": "20221121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "2055760",
                    "2055766"
                ],
                "spl_set_id": [
                    "6084e889-6092-4d8d-b7d0-18aae29b6817"
                ],
                "nui": [
                    "N0000175463",
                    "N0000009948",
                    "N0000175460"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "913P6LK81M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "b5d06d6e-3e84-4879-a8ee-18a131e9adb0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180720",
            "product_id": "50090-6237_b5d06d6e-3e84-4879-a8ee-18a131e9adb0",
            "application_number": "NDA210806",
            "brand_name_base": "PIFELTRO",
            "pharm_class": [
                "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Non-Nucleoside Analog [EXT]",
                "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0701",
            "generic_name": "alpelisib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "PIQRAY",
            "active_ingredients": [
                {
                    "name": "ALPELISIB",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0701-84",
                    "description": "1 BLISTER PACK in 1 CARTON (0078-0701-84)  / 28 TABLET in 1 BLISTER PACK (0078-0701-51)",
                    "marketing_start_date": "20190524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2169300",
                    "2169307",
                    "2169310",
                    "2169311",
                    "2169313",
                    "2169314",
                    "2169316",
                    "2169318",
                    "2169319",
                    "2169320",
                    "2169321",
                    "2169322"
                ],
                "spl_set_id": [
                    "b20b4e18-7a4b-4500-a08f-06c6dab0ee5b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "08W5N2C97Q"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "ea157b39-d15f-4510-8129-731c5d060ec5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190524",
            "product_id": "0078-0701_ea157b39-d15f-4510-8129-731c5d060ec5",
            "application_number": "NDA212526",
            "brand_name_base": "PIQRAY"
        },
        {
            "product_ndc": "55550-102",
            "generic_name": "Homosalate, Octinoxate, Octisalate, Oxybenzone",
            "labeler_name": "Total Resources International",
            "brand_name": "Sunscreen",
            "active_ingredients": [
                {
                    "name": "HOMOSALATE",
                    "strength": "6 mg/g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55550-102-01",
                    "description": "1.5 g in 1 PACKET (55550-102-01)",
                    "marketing_start_date": "20230120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Total Resources International"
                ],
                "spl_set_id": [
                    "7d4f820d-e154-428e-89c2-2e26e088ceef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LOTION",
            "spl_id": "f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20230120",
            "product_id": "55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "application_number": "part352",
            "brand_name_base": "Sunscreen"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "65649-400",
            "generic_name": "POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE",
            "labeler_name": "Salix Pharmaceuticals, Inc",
            "brand_name": "Plenvu",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65649-400-01",
                    "description": "1 KIT in 1 CARTON (65649-400-01)  *  46.26 POWDER, FOR SOLUTION in 1 POUCH *  55.65 POWDER, FOR SOLUTION in 1 POUCH *  115.96 POWDER, FOR SOLUTION in 1 POUCH",
                    "marketing_start_date": "20180504",
                    "sample": false
                },
                {
                    "package_ndc": "65649-400-02",
                    "description": "1 KIT in 1 CARTON (65649-400-02)  *  46.26 POWDER, FOR SOLUTION in 1 POUCH *  55.65 POWDER, FOR SOLUTION in 1 POUCH *  115.96 POWDER, FOR SOLUTION in 1 POUCH",
                    "marketing_start_date": "20180504",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Salix Pharmaceuticals, Inc"
                ],
                "rxcui": [
                    "2045233",
                    "2045243",
                    "2045244",
                    "2045245"
                ],
                "spl_set_id": [
                    "79f930fa-5674-4f30-8ae8-9448d6243797"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "c23688c3-a0ff-40bd-aa0c-9ebee4f69119",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20180504",
            "product_id": "65649-400_c23688c3-a0ff-40bd-aa0c-9ebee4f69119",
            "application_number": "NDA209381",
            "brand_name_base": "Plenvu"
        },
        {
            "product_ndc": "69488-010",
            "generic_name": "lutetium Lu 177 vipivotide tetraxetan",
            "labeler_name": "Advanced Accelerator Applications USA, Inc",
            "brand_name": "PLUVICTO",
            "active_ingredients": [
                {
                    "name": "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN",
                    "strength": "27 mCi/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69488-010-61",
                    "description": "1 VIAL, GLASS in 1 PACKAGE (69488-010-61)  / 7.5 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20220323",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Advanced Accelerator Applications USA, Inc"
                ],
                "rxcui": [
                    "2597057",
                    "2597060"
                ],
                "spl_set_id": [
                    "fb973a8d-7fea-4a7a-963f-2a8e67a46e55"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194017",
                    "N0000194016"
                ],
                "pharm_class_epc": [
                    "Radioligand Therapeutic Agent [EPC]"
                ],
                "pharm_class_moa": [
                    "Radioligand Activity [MoA]"
                ],
                "unii": [
                    "G6UF363ECX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "2e0b1719-f6f4-4444-ace5-1df604843ffb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220323",
            "product_id": "69488-010_2e0b1719-f6f4-4444-ace5-1df604843ffb",
            "application_number": "NDA215833",
            "brand_name_base": "PLUVICTO",
            "pharm_class": [
                "Radioligand Activity [MoA]",
                "Radioligand Therapeutic Agent [EPC]"
            ]
        },
        {
            "product_ndc": "53645-1160",
            "generic_name": "Silicea",
            "labeler_name": "True Botanica, LLC",
            "brand_name": "Silicea",
            "active_ingredients": [
                {
                    "name": "SILICON DIOXIDE",
                    "strength": "6 [hp_X]/23g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "53645-1160-2",
                    "description": "23 g in 1 BOTTLE (53645-1160-2)",
                    "marketing_start_date": "20130621",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "True Botanica, LLC"
                ],
                "spl_set_id": [
                    "3def456c-f257-46c7-b47c-f18ac610a92e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "ETJ7Z6XBU4"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "GLOBULE",
            "spl_id": "b9ac4f13-9389-d2a6-e053-2a95a90a19ee",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130621",
            "product_id": "53645-1160_b9ac4f13-9389-d2a6-e053-2a95a90a19ee",
            "brand_name_base": "Silicea"
        },
        {
            "product_ndc": "50242-105",
            "generic_name": "polatuzumab vedotin",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "POLIVY",
            "active_ingredients": [
                {
                    "name": "POLATUZUMAB VEDOTIN",
                    "strength": "140 mg/7.52mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-105-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-105-01)  / 20 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190610",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2174095",
                    "2174100",
                    "2398131",
                    "2398133"
                ],
                "spl_set_id": [
                    "20a16ab2-f338-4abb-9dcd-254bd949a2bc"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "KG6VO684Z6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "da43509d-d7da-4355-9e7a-0adbb4c631a6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190610",
            "product_id": "50242-105_da43509d-d7da-4355-9e7a-0adbb4c631a6",
            "application_number": "BLA761121",
            "brand_name_base": "POLIVY"
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "71904-200",
            "generic_name": "cipaglucosidase alfa-atga",
            "labeler_name": "AMICUS THERAPEUTICS US, LLC",
            "brand_name": "POMBILITI ATGA",
            "brand_name_suffix": "ATGA",
            "active_ingredients": [
                {
                    "name": "CIPAGLUCOSIDASE ALFA",
                    "strength": "105 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71904-200-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (71904-200-01)  / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
                    "marketing_start_date": "20231011",
                    "sample": false
                },
                {
                    "package_ndc": "71904-200-02",
                    "description": "10 VIAL, GLASS in 1 CARTON (71904-200-02)  / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
                    "marketing_start_date": "20231011",
                    "sample": false
                },
                {
                    "package_ndc": "71904-200-03",
                    "description": "25 VIAL, GLASS in 1 CARTON (71904-200-03)  / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
                    "marketing_start_date": "20231011",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AMICUS THERAPEUTICS US, LLC"
                ],
                "rxcui": [
                    "2667440",
                    "2667446"
                ],
                "spl_set_id": [
                    "d77aa596-910d-516b-e053-2995a90a0839"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0371904200026",
                    "0371904200019"
                ],
                "unii": [
                    "4SED7F4BSG"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "1ef2779f-6d2a-426a-9cce-b14a4bcf1e9a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231011",
            "product_id": "71904-200_1ef2779f-6d2a-426a-9cce-b14a4bcf1e9a",
            "application_number": "BLA761204",
            "brand_name_base": "POMBILITI"
        },
        {
            "product_ndc": "50458-720",
            "generic_name": "Ponesimod",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "PONVORY",
            "active_ingredients": [
                {
                    "name": "PONESIMOD",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-720-30",
                    "description": "1 BOTTLE in 1 CARTON (50458-720-30)  / 30 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20210318",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2532305",
                    "2532311",
                    "2532314",
                    "2532316",
                    "2532318",
                    "2532320",
                    "2532322",
                    "2532324",
                    "2532327",
                    "2532329",
                    "2532331",
                    "2532333",
                    "2532335",
                    "2532337",
                    "2532339",
                    "2532341",
                    "2532343",
                    "2532345",
                    "2532347",
                    "2532349",
                    "2532350",
                    "2532351"
                ],
                "spl_set_id": [
                    "5be69660-738c-4db7-b0d4-517aa873dc41"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350458720303"
                ],
                "nui": [
                    "N0000181815",
                    "N0000181816"
                ],
                "pharm_class_moa": [
                    "Sphingosine 1-Phosphate Receptor Modulators [MoA]"
                ],
                "pharm_class_epc": [
                    "Sphingosine 1-phosphate Receptor Modulator [EPC]"
                ],
                "unii": [
                    "5G7AKV2MKP"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "855d61a2-8591-4e53-9cfd-03c8a0fd2914",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210318",
            "product_id": "50458-720_855d61a2-8591-4e53-9cfd-03c8a0fd2914",
            "application_number": "NDA213498",
            "brand_name_base": "PONVORY",
            "pharm_class": [
                "Sphingosine 1-Phosphate Receptor Modulators [MoA]",
                "Sphingosine 1-phosphate Receptor Modulator [EPC]"
            ]
        },
        {
            "product_ndc": "42747-761",
            "generic_name": "mogamulizumab-kpkc",
            "labeler_name": "Kyowa Kirin, Inc.",
            "brand_name": "POTELIGEO",
            "active_ingredients": [
                {
                    "name": "MOGAMULIZUMAB",
                    "strength": "4 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42747-761-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (42747-761-01)  / 5 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20180808",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Kyowa Kirin, Inc."
                ],
                "rxcui": [
                    "2054081",
                    "2054086"
                ],
                "spl_set_id": [
                    "e53960ab-42a1-40d1-9c7d-eb013fe7f18f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193866",
                    "N0000193863",
                    "N0000193867",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Chemokine Receptor Type 4 Interaction [EPC]",
                    "Monoclonal Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Chemokine Receptor Type 4 Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "YI437801BE"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "143e751e-e97a-4dc8-aac9-9aa202243d04",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20180808",
            "product_id": "42747-761_143e751e-e97a-4dc8-aac9-9aa202243d04",
            "application_number": "BLA761051",
            "brand_name_base": "POTELIGEO",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Chemokine Receptor Type 4 Interaction [EPC]",
                "Chemokine Receptor Type 4 Interactions [MoA]",
                "Monoclonal Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "0024-5903",
            "generic_name": "alirocumab",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Praluent",
            "active_ingredients": [
                {
                    "name": "ALIROCUMAB",
                    "strength": "75 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "1659156",
                    "1659161",
                    "1659165",
                    "1659167",
                    "1659177",
                    "1659179",
                    "1659182",
                    "1659183"
                ],
                "spl_set_id": [
                    "446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191731",
                    "N0000191730",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "PCSK9 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "PCSK9 Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "PP0SHH6V16"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "bae63af4-1248-4b90-8722-1265577f6cbe",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20150724",
            "product_id": "0024-5903_bae63af4-1248-4b90-8722-1265577f6cbe",
            "application_number": "BLA125559",
            "brand_name_base": "Praluent",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "PCSK9 Inhibitor [EPC]",
                "PCSK9 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0046-1101",
            "generic_name": "estrogens, conjugated",
            "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
            "brand_name": "Premarin",
            "active_ingredients": [
                {
                    "name": "ESTROGENS, CONJUGATED",
                    "strength": ".45 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0046-1101-81",
                    "description": "100 TABLET, FILM COATED in 1 BOTTLE (0046-1101-81)",
                    "marketing_start_date": "20060101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
                ],
                "rxcui": [
                    "150840",
                    "197660",
                    "197661",
                    "197662",
                    "202301",
                    "208513",
                    "208949",
                    "310197",
                    "403849",
                    "404550"
                ],
                "spl_set_id": [
                    "258e1602-a3cf-4ccc-ca80-73dbbfb812ff"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300461103815",
                    "0300461101811"
                ],
                "nui": [
                    "N0000175825",
                    "N0000000100",
                    "M0007792"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Estrogens, Conjugated (USP) [CS]"
                ],
                "unii": [
                    "IU5QR144QX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7b79de48-15f8-42c0-8d61-70fd51cfa459",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20060101",
            "product_id": "0046-1101_7b79de48-15f8-42c0-8d61-70fd51cfa459",
            "application_number": "NDA004782",
            "brand_name_base": "Premarin",
            "pharm_class": [
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]",
                "Estrogens",
                "Conjugated (USP) [CS]"
            ]
        },
        {
            "product_ndc": "0046-2575",
            "generic_name": "conjugated estrogens and medroxyprogesterone acetate",
            "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
            "brand_name": "Premphase",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0046-2575-12",
                    "description": "1 BLISTER PACK in 1 CARTON (0046-2575-12)  / 1 KIT in 1 BLISTER PACK",
                    "marketing_start_date": "20120301",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
                ],
                "rxcui": [
                    "150840",
                    "310197",
                    "1000351",
                    "1000352",
                    "1000355",
                    "1000356",
                    "1000395",
                    "1000398",
                    "1000486",
                    "1000487",
                    "1000490",
                    "1000491",
                    "1000496",
                    "1000497",
                    "1000499",
                    "1000500"
                ],
                "spl_set_id": [
                    "fd0c0836-5d23-2183-da81-9dc7f4287052"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175825",
                    "N0000000100",
                    "M0007792"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Estrogens, Conjugated (USP) [CS]"
                ],
                "unii": [
                    "C2QI4IOI2G",
                    "IU5QR144QX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "53348d40-8eeb-4424-83b2-f959fe51a5c2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20120301",
            "product_id": "0046-2575_53348d40-8eeb-4424-83b2-f959fe51a5c2",
            "application_number": "NDA020527",
            "brand_name_base": "Premphase"
        },
        {
            "product_ndc": "0046-1108",
            "generic_name": "conjugated estrogens and medroxyprogesterone acetate",
            "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
            "brand_name": "Prempro",
            "active_ingredients": [
                {
                    "name": "ESTROGENS, CONJUGATED",
                    "strength": ".625 mg/1"
                },
                {
                    "name": "MEDROXYPROGESTERONE ACETATE",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0046-1108-11",
                    "description": "1 BLISTER PACK in 1 CARTON (0046-1108-11)  / 28 TABLET, SUGAR COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20121203",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
                ],
                "rxcui": [
                    "150840",
                    "310197",
                    "1000351",
                    "1000352",
                    "1000355",
                    "1000356",
                    "1000395",
                    "1000398",
                    "1000486",
                    "1000487",
                    "1000490",
                    "1000491",
                    "1000496",
                    "1000497",
                    "1000499",
                    "1000500"
                ],
                "spl_set_id": [
                    "fd0c0836-5d23-2183-da81-9dc7f4287052"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175825",
                    "N0000000100",
                    "M0007792"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Estrogens, Conjugated (USP) [CS]"
                ],
                "unii": [
                    "C2QI4IOI2G",
                    "IU5QR144QX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, SUGAR COATED",
            "spl_id": "53348d40-8eeb-4424-83b2-f959fe51a5c2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20121203",
            "product_id": "0046-1108_53348d40-8eeb-4424-83b2-f959fe51a5c2",
            "application_number": "NDA020527",
            "brand_name_base": "Prempro",
            "pharm_class": [
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]",
                "Estrogens",
                "Conjugated (USP) [CS]",
                "Progesterone Congeners [CS]",
                "Progestin [EPC]"
            ]
        },
        {
            "product_ndc": "49502-476",
            "generic_name": "Pretomanid",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "Pretomanid",
            "active_ingredients": [
                {
                    "name": "PRETOMANID",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-476-26",
                    "description": "26 TABLET in 1 BOTTLE (49502-476-26)",
                    "marketing_start_date": "20191107",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "2198370"
                ],
                "spl_set_id": [
                    "f1906fc9-cb3c-4e13-8a4a-da76100c1bf3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175483",
                    "N0000190111"
                ],
                "pharm_class_epc": [
                    "Antimycobacterial [EPC]"
                ],
                "pharm_class_moa": [
                    "Organic Anion Transporter 3 Inhibitors [MoA]"
                ],
                "unii": [
                    "2XOI31YC4N"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "5dd0a13a-c8f0-413f-8306-92c479195e0f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191107",
            "product_id": "49502-476_5dd0a13a-c8f0-413f-8306-92c479195e0f",
            "application_number": "NDA212862",
            "brand_name_base": "Pretomanid"
        },
        {
            "product_ndc": "0113-6002",
            "generic_name": "lansoprazole",
            "labeler_name": "L. Perrigo Company",
            "brand_name": "Prevacid 24 HR",
            "active_ingredients": [
                {
                    "name": "LANSOPRAZOLE",
                    "strength": "15 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0113-6002-01",
                    "description": "1 BOTTLE in 1 CARTON (0113-6002-01)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20201105",
                    "sample": false
                },
                {
                    "package_ndc": "0113-6002-03",
                    "description": "3 BOTTLE in 1 CARTON (0113-6002-03)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20201119",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "L. Perrigo Company"
                ],
                "rxcui": [
                    "596843",
                    "596918"
                ],
                "spl_set_id": [
                    "99a97004-e247-4f4d-a38c-f28f521de1c4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175525",
                    "N0000000147",
                    "N0000009724"
                ],
                "pharm_class_epc": [
                    "Proton Pump Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Proton Pump Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Inhibition Gastric Acid Secretion [PE]"
                ],
                "unii": [
                    "0K5C5T2QPG"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "a42786d8-7a3f-4383-a3a6-f662afde73f5",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201105",
            "product_id": "0113-6002_a42786d8-7a3f-4383-a3a6-f662afde73f5",
            "application_number": "NDA022327",
            "brand_name_base": "Prevacid 24 HR",
            "pharm_class": [
                "Inhibition Gastric Acid Secretion [PE]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "76420-815",
            "generic_name": "Levofloxacin",
            "labeler_name": "Asclemed USA, Inc.",
            "brand_name": "Levofloxacin",
            "active_ingredients": [
                {
                    "name": "LEVOFLOXACIN",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76420-815-00",
                    "description": "1000 TABLET, FILM COATED in 1 BOTTLE (76420-815-00)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-05",
                    "description": "5 TABLET, FILM COATED in 1 BOTTLE (76420-815-05)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-07",
                    "description": "7 TABLET, FILM COATED in 1 BOTTLE (76420-815-07)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-10",
                    "description": "10 TABLET, FILM COATED in 1 BOTTLE (76420-815-10)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-14",
                    "description": "14 TABLET, FILM COATED in 1 BOTTLE (76420-815-14)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-20",
                    "description": "20 TABLET, FILM COATED in 1 BOTTLE (76420-815-20)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (76420-815-30)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-50",
                    "description": "50 TABLET, FILM COATED in 1 BOTTLE (76420-815-50)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-60",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (76420-815-60)",
                    "marketing_start_date": "20240513",
                    "sample": false
                },
                {
                    "package_ndc": "76420-815-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (76420-815-90)",
                    "marketing_start_date": "20240513",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Asclemed USA, Inc."
                ],
                "rxcui": [
                    "199884",
                    "199885",
                    "311296"
                ],
                "spl_set_id": [
                    "2e32a8aa-047b-46c6-b67b-d88a9a0a810b"
                ],
                "nui": [
                    "N0000193223",
                    "M0372253"
                ],
                "pharm_class_epc": [
                    "Fluoroquinolone Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Fluoroquinolones [CS]"
                ],
                "unii": [
                    "6GNT3Y5LMF"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "184fff28-0fd3-da61-e063-6294a90ac035",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110620",
            "product_id": "76420-815_184fff28-0fd3-da61-e063-6294a90ac035",
            "application_number": "ANDA201043",
            "brand_name_base": "Levofloxacin"
        },
        {
            "product_ndc": "0006-3075",
            "generic_name": "LETERMOVIR",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "PREVYMIS",
            "active_ingredients": [
                {
                    "name": "LETERMOVIR",
                    "strength": "240 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-3075-02",
                    "description": "4 DOSE PACK in 1 CARTON (0006-3075-02)  / 7 TABLET, FILM COATED in 1 DOSE PACK (0006-3075-01)",
                    "marketing_start_date": "20171108",
                    "sample": false
                },
                {
                    "package_ndc": "0006-3075-04",
                    "description": "14 BLISTER PACK in 1 CARTON (0006-3075-04)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (0006-3075-03)",
                    "marketing_start_date": "20171108",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "1988652",
                    "1988657",
                    "1988660",
                    "1988661",
                    "1988666",
                    "1988671",
                    "1988673",
                    "1988675"
                ],
                "spl_set_id": [
                    "1b49df80-be4f-47e0-a0b7-123f3e69395b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193800",
                    "N0000193801",
                    "N0000190114",
                    "N0000190107",
                    "N0000190108",
                    "N0000187062",
                    "N0000185507",
                    "N0000185607"
                ],
                "pharm_class_epc": [
                    "Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "DNA Terminase Complex Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]"
                ],
                "unii": [
                    "1H09Y5WO1F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "21e739f3-f406-4bfe-8363-b8ee526a0a5e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20171108",
            "product_id": "0006-3075_21e739f3-f406-4bfe-8363-b8ee526a0a5e",
            "application_number": "NDA209939",
            "brand_name_base": "PREVYMIS",
            "pharm_class": [
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]",
                "DNA Terminase Complex Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "59676-564",
            "generic_name": "darunavir",
            "labeler_name": "Janssen Products LP",
            "brand_name": "PREZISTA",
            "active_ingredients": [
                {
                    "name": "DARUNAVIR ETHANOLATE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59676-564-01",
                    "description": "240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-564-01)",
                    "marketing_start_date": "20090427",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Products LP"
                ],
                "rxcui": [
                    "670026",
                    "794610",
                    "831868",
                    "831870",
                    "850455",
                    "850457",
                    "1236628",
                    "1236632",
                    "1359269",
                    "1359271"
                ],
                "spl_set_id": [
                    "814301f9-c990-46a5-b481-2879a521a16f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0359676564010",
                    "0359676563013",
                    "0359676562016",
                    "0359676565017",
                    "0359676566304"
                ],
                "unii": [
                    "33O78XF0BW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "02fd607e-f780-dd47-e063-6394a90aad7d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20090427",
            "product_id": "59676-564_02fd607e-f780-dd47-e063-6394a90aad7d",
            "application_number": "NDA021976",
            "brand_name_base": "PREZISTA",
            "pharm_class": [
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "HIV Protease Inhibitors [MoA]",
                "Protease Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "70720-720",
            "generic_name": "ziconotide acetate",
            "labeler_name": "TerSera Therapeutics LLC",
            "brand_name": "PRIALT",
            "active_ingredients": [
                {
                    "name": "ZICONOTIDE ACETATE",
                    "strength": "100 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70720-720-10",
                    "description": "1 VIAL, GLASS in 1 CARTON (70720-720-10)  / 1 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20190815",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TerSera Therapeutics LLC"
                ],
                "rxcui": [
                    "486133",
                    "583453",
                    "1738353",
                    "1738354",
                    "1738357",
                    "1738358"
                ],
                "spl_set_id": [
                    "b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "T2I226K69M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e54fb2ff-1fa1-479d-8ec4-3eafc5c1920e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRATHECAL"
            ],
            "marketing_start_date": "20181015",
            "product_id": "70720-720_e54fb2ff-1fa1-479d-8ec4-3eafc5c1920e",
            "application_number": "NDA021060",
            "brand_name_base": "PRIALT",
            "pharm_class": [
                "N-Calcium Channel Receptor Antagonists [MoA]",
                "N-type Calcium Channel Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "50090-5063",
            "generic_name": "rifapentine",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "Priftin",
            "active_ingredients": [
                {
                    "name": "RIFAPENTINE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-5063-0",
                    "description": "3 BLISTER PACK in 1 CARTON (50090-5063-0)  / 8 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20200528",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "242671",
                    "261101"
                ],
                "spl_set_id": [
                    "1502544d-1b3a-46bd-84f5-af92cab72ce8"
                ],
                "nui": [
                    "N0000175501",
                    "M0019113"
                ],
                "pharm_class_epc": [
                    "Rifamycin Antimycobacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Rifamycins [CS]"
                ],
                "unii": [
                    "XJM390A33U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "cf6940d8-d272-4b18-bb25-8db6d6c0b3ea",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170208",
            "product_id": "50090-5063_cf6940d8-d272-4b18-bb25-8db6d6c0b3ea",
            "application_number": "NDA021024",
            "brand_name_base": "Priftin",
            "pharm_class": [
                "Rifamycin Antimycobacterial [EPC]",
                "Rifamycins [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0037-6823",
            "generic_name": "pramoxine hydrochloride",
            "labeler_name": "Meda Pharmaceuticals",
            "brand_name": "PROCTOFOAM NS",
            "brand_name_suffix": "NS",
            "active_ingredients": [
                {
                    "name": "PRAMOXINE HYDROCHLORIDE",
                    "strength": "150 mg/15g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0037-6823-15",
                    "description": "1 CANISTER in 1 CARTON (0037-6823-15)  / 15 g in 1 CANISTER",
                    "marketing_start_date": "20140818",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meda Pharmaceuticals"
                ],
                "rxcui": [
                    "828365",
                    "828367"
                ],
                "spl_set_id": [
                    "cddc8d81-21b8-11e4-8c21-0800200c9a66"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "88AYB867L5"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "AEROSOL, FOAM",
            "spl_id": "67f367b7-f7e8-466d-bd32-3e799d522aaf",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "RECTAL"
            ],
            "marketing_start_date": "20140818",
            "product_id": "0037-6823_67f367b7-f7e8-466d-bd32-3e799d522aaf",
            "application_number": "part346",
            "brand_name_base": "PROCTOFOAM"
        },
        {
            "product_ndc": "75987-145",
            "generic_name": "Cysteamine bitartrate",
            "labeler_name": "Horizon Therapeutics USA, Inc.",
            "brand_name": "PROCYSBI",
            "active_ingredients": [
                {
                    "name": "CYSTEAMINE BITARTRATE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75987-145-13",
                    "description": "60 PACKET in 1 CARTON (75987-145-13)  / 1 GRANULE, DELAYED RELEASE in 1 PACKET",
                    "marketing_start_date": "20200214",
                    "sample": false
                },
                {
                    "package_ndc": "75987-145-14",
                    "description": "120 PACKET in 1 CARTON (75987-145-14)  / 1 GRANULE, DELAYED RELEASE in 1 PACKET",
                    "marketing_start_date": "20200214",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Horizon Therapeutics USA, Inc."
                ],
                "rxcui": [
                    "1421467",
                    "1421473",
                    "1421475",
                    "1421477",
                    "2284510",
                    "2284514",
                    "2284515",
                    "2284516"
                ],
                "spl_set_id": [
                    "d3a3ec28-f746-463a-bb92-3bc8826db09e"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375987100044"
                ],
                "unii": [
                    "QO84GZ3TST"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GRANULE, DELAYED RELEASE",
            "spl_id": "e1483d82-8f0b-418b-bd27-6b0bab353f53",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200214",
            "product_id": "75987-145_e1483d82-8f0b-418b-bd27-6b0bab353f53",
            "application_number": "NDA213491",
            "brand_name_base": "PROCYSBI",
            "pharm_class": [
                "Cystine Depleting Agent [EPC]",
                "Cystine Disulfide Reduction [MoA]"
            ]
        },
        {
            "product_ndc": "54568-766",
            "generic_name": "Insulin glargine",
            "labeler_name": "Eli Lilly Italia SPA",
            "active_ingredients": [
                {
                    "name": "INSULIN GLARGINE",
                    "strength": "100 U/mL"
                }
            ],
            "finished": false,
            "packaging": [
                {
                    "package_ndc": "54568-766-10",
                    "description": "1 BOX in 1 BOX (54568-766-10)  / 30 BOX in 1 BOX / 330 CARTRIDGE in 1 BOX / 3 mL in 1 CARTRIDGE",
                    "marketing_start_date": "22-JUN-23"
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "DRUG FOR FURTHER PROCESSING",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "4b3a97cd-8478-4619-bae6-121942de584a",
            "product_type": "DRUG FOR FURTHER PROCESSING",
            "marketing_start_date": "20230622",
            "product_id": "54568-766_4b3a97cd-8478-4619-bae6-121942de584a",
            "brand_name_base": null
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "36800-862",
            "marketing_end_date": "20241230",
            "generic_name": "Docusate Sodium",
            "labeler_name": "TOP CARE (Topco Associates LLC)",
            "brand_name": "Stool Softener",
            "active_ingredients": [
                {
                    "name": "DOCUSATE SODIUM",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "36800-862-25",
                    "description": "1 BOTTLE, PLASTIC in 1 BOX (36800-862-25)  / 25 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20200228",
                    "marketing_end_date": "20241230",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "TOP CARE (Topco Associates LLC)"
                ],
                "rxcui": [
                    "1115005"
                ],
                "spl_set_id": [
                    "67eb6a12-a390-4f55-a99a-0bde9db44e4f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0036800160323"
                ],
                "unii": [
                    "F05Q2T2JA0"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "CAPSULE, LIQUID FILLED",
            "spl_id": "e897f55f-a58d-4678-b664-7ade46b96fe4",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200228",
            "product_id": "36800-862_e897f55f-a58d-4678-b664-7ade46b96fe4",
            "application_number": "M007",
            "brand_name_base": "Stool Softener"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "24208-602",
            "generic_name": "Bromfenac Sodium",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Prolensa",
            "active_ingredients": [
                {
                    "name": "BROMFENAC SODIUM",
                    "strength": ".7 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-602-03",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-602-03)  / 3 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20130405",
                    "sample": false
                },
                {
                    "package_ndc": "24208-602-04",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-602-04)  / 3 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20130405",
                    "sample": false
                },
                {
                    "package_ndc": "24208-602-06",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-602-06)  / .6 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20130405",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "1375917",
                    "1375922"
                ],
                "spl_set_id": [
                    "4e072537-f73c-4a96-a65f-e2805ce112d8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8ECV571Y37"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION/ DROPS",
            "spl_id": "cb93cfd7-e943-4d05-81ca-03ca5cd7680b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20130405",
            "product_id": "24208-602_cb93cfd7-e943-4d05-81ca-03ca5cd7680b",
            "application_number": "NDA203168",
            "brand_name_base": "Prolensa",
            "pharm_class": [
                "Anti-Inflammatory Agents",
                "Non-Steroidal [CS]",
                "Cyclooxygenase Inhibitors [MoA]",
                "Nonsteroidal Anti-inflammatory Drug [EPC]"
            ]
        },
        {
            "product_ndc": "55513-710",
            "generic_name": "denosumab",
            "labeler_name": "Amgen Inc",
            "brand_name": "Prolia",
            "active_ingredients": [
                {
                    "name": "DENOSUMAB",
                    "strength": "60 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-710-01",
                    "description": "1 SYRINGE in 1 CARTON (55513-710-01)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20100605",
                    "sample": false
                },
                {
                    "package_ndc": "55513-710-21",
                    "description": "1 SYRINGE in 1 CARTON (55513-710-21)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20240305",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "993452",
                    "993456"
                ],
                "spl_set_id": [
                    "49e5afe9-a0c7-40c4-af9f-f287a80c5c88"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000187055",
                    "N0000187054"
                ],
                "pharm_class_epc": [
                    "RANK Ligand Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "RANK Ligand Blocking Activity [MoA]"
                ],
                "unii": [
                    "4EQZ6YO2HI"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "64c67222-ef8f-4824-940f-ce76ebd24311",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20100605",
            "product_id": "55513-710_64c67222-ef8f-4824-940f-ce76ebd24311",
            "application_number": "BLA125320",
            "brand_name_base": "Prolia",
            "pharm_class": [
                "RANK Ligand Blocking Activity [MoA]",
                "RANK Ligand Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0685",
            "generic_name": "eltrombopag olamine",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "PROMACTA",
            "active_ingredients": [
                {
                    "name": "ELTROMBOPAG OLAMINE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0685-15",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0078-0685-15)",
                    "marketing_start_date": "20160524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "825421",
                    "825425",
                    "825427",
                    "825429",
                    "884617",
                    "884619",
                    "1245001",
                    "1245003",
                    "1859498",
                    "1859501",
                    "2058980",
                    "2058981"
                ],
                "spl_set_id": [
                    "7714a0ed-34bb-46e6-a0a5-b363908b22c2"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "4U07F515LG"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "d5c932b3-d461-4f98-8962-178f0a1e58a6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160524",
            "product_id": "0078-0685_d5c932b3-d461-4f98-8962-178f0a1e58a6",
            "application_number": "NDA022291",
            "brand_name_base": "PROMACTA",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Increased Megakaryocyte Maturation [PE]",
                "Increased Platelet Production [PE]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Thrombopoietin Receptor Agonist [EPC]",
                "Thrombopoietin Receptor Agonists [MoA]",
                "UGT1A1 Inhibitors [MoA]",
                "UGT1A3 Inhibitors [MoA]",
                "UGT1A4 Inhibitors [MoA]",
                "UGT1A6 Inhibitors [MoA]",
                "UGT1A9 Inhibitors [MoA]",
                "UGT2B15 Inhibitors [MoA]",
                "UGT2B7 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "21130-825",
            "generic_name": "miconazole nitrate",
            "labeler_name": "Safeway",
            "brand_name": "signature care miconazole 7",
            "active_ingredients": [
                {
                    "name": "MICONAZOLE NITRATE",
                    "strength": "2 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "21130-825-29",
                    "description": "1 TUBE, WITH APPLICATOR in 1 CARTON (21130-825-29)  / 45 g in 1 TUBE, WITH APPLICATOR",
                    "marketing_start_date": "20181106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Safeway"
                ],
                "rxcui": [
                    "998540"
                ],
                "spl_set_id": [
                    "2e04ac2d-cfbc-4261-a8f9-03715f819c1c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "VW4H1CYW1K"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CREAM",
            "spl_id": "8fb5cd26-54da-4d81-943b-1b029706e77a",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "20181106",
            "product_id": "21130-825_8fb5cd26-54da-4d81-943b-1b029706e77a",
            "application_number": "ANDA074760",
            "brand_name_base": "signature care miconazole 7",
            "pharm_class": [
                "Azole Antifungal [EPC]",
                "Azoles [CS]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "30237-8900",
            "generic_name": "sipuleucel-T",
            "labeler_name": "Dendreon Pharmaceuticals LLC",
            "brand_name": "PROVENGE",
            "active_ingredients": [
                {
                    "name": "SIPULEUCEL-T",
                    "strength": "50000000 1/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "30237-8900-6",
                    "description": "1 BAG in 1 CARTON (30237-8900-6)  / 1 INJECTION in 1 BAG (30237-8900-5)",
                    "marketing_start_date": "20100429",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Dendreon Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "997264",
                    "997267"
                ],
                "spl_set_id": [
                    "8309b497-5d4e-4408-ac0c-2452c11c8a35"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000184997",
                    "N0000184306",
                    "N0000184310",
                    "M0012412"
                ],
                "pharm_class_epc": [
                    "Autologous Cellular Immunotherapy [EPC]"
                ],
                "pharm_class_pe": [
                    "Cell-mediated Immunity [PE]"
                ],
                "pharm_class_cs": [
                    "Leukocytes, Mononuclear [CS]"
                ],
                "unii": [
                    "8Q622VDR18"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "0800e936-4297-61d4-e063-6394a90a74b1",
            "product_type": "CELLULAR THERAPY",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20100429",
            "product_id": "30237-8900_0800e936-4297-61d4-e063-6394a90a74b1",
            "application_number": "BLA125197",
            "brand_name_base": "PROVENGE",
            "pharm_class": [
                "Autologous Cellular Immunotherapy [EPC]",
                "Cell-mediated Immunity [PE]",
                "Cells",
                "Cultured",
                "Autologous [EXT]",
                "Leukocytes",
                "Mononuclear [CS]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0777-3104",
            "generic_name": "Fluoxetine hydrochloride",
            "labeler_name": "Dista Products Company",
            "brand_name": "Prozac",
            "active_ingredients": [
                {
                    "name": "FLUOXETINE HYDROCHLORIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0777-3104-02",
                    "description": "100 CAPSULE in 1 BOTTLE (0777-3104-02)",
                    "marketing_start_date": "19930113",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Dista Products Company"
                ],
                "rxcui": [
                    "104849",
                    "205535",
                    "261287",
                    "310384",
                    "310385",
                    "313989"
                ],
                "spl_set_id": [
                    "c88f33ed-6dfb-4c5e-bc01-d8e36dd97299"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0307773107302",
                    "0307773104028",
                    "0307773105025"
                ],
                "unii": [
                    "I9W7N6B1KJ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "5c5ab2bb-463a-4a47-ba50-a47a6daee339",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19930113",
            "product_id": "0777-3104_5c5ab2bb-463a-4a47-ba50-a47a6daee339",
            "application_number": "NDA018936",
            "brand_name_base": "Prozac",
            "pharm_class": [
                "Serotonin Reuptake Inhibitor [EPC]",
                "Serotonin Uptake Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0777-3104",
            "generic_name": "Fluoxetine hydrochloride",
            "labeler_name": "Dista Products Company",
            "brand_name": "Prozac",
            "active_ingredients": [
                {
                    "name": "FLUOXETINE HYDROCHLORIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0777-3104-02",
                    "description": "100 CAPSULE in 1 BOTTLE (0777-3104-02)",
                    "marketing_start_date": "19930113",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Dista Products Company"
                ],
                "rxcui": [
                    "104849",
                    "205535",
                    "261287",
                    "310384",
                    "310385",
                    "313989"
                ],
                "spl_set_id": [
                    "c88f33ed-6dfb-4c5e-bc01-d8e36dd97299"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0307773107302",
                    "0307773104028",
                    "0307773105025"
                ],
                "unii": [
                    "I9W7N6B1KJ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "5c5ab2bb-463a-4a47-ba50-a47a6daee339",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19930113",
            "product_id": "0777-3104_5c5ab2bb-463a-4a47-ba50-a47a6daee339",
            "application_number": "NDA018936",
            "brand_name_base": "Prozac",
            "pharm_class": [
                "Serotonin Reuptake Inhibitor [EPC]",
                "Serotonin Uptake Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50242-100",
            "generic_name": "dornase alfa",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Pulmozyme",
            "active_ingredients": [
                {
                    "name": "DORNASE ALFA",
                    "strength": "1 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-100-40",
                    "description": "5 POUCH in 1 CARTON (50242-100-40)  / 6 AMPULE in 1 POUCH (50242-100-39)  / 2.5 mL in 1 AMPULE",
                    "marketing_start_date": "19931230",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "205532",
                    "310014"
                ],
                "spl_set_id": [
                    "d8c78a7e-ff99-48f3-8952-643ec2ea0f86"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008867",
                    "M0006007",
                    "N0000175958",
                    "M0018641"
                ],
                "pharm_class_pe": [
                    "Decreased Respiratory Secretion Viscosity [PE]"
                ],
                "pharm_class_cs": [
                    "Deoxyribonuclease I [CS]",
                    "Recombinant Proteins [CS]"
                ],
                "pharm_class_epc": [
                    "Recombinant Human Deoxyribonuclease 1 [EPC]"
                ],
                "unii": [
                    "953A26OA1Y"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "88d0285d-8db0-4e45-a179-883364239536",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "19931230",
            "product_id": "50242-100_88d0285d-8db0-4e45-a179-883364239536",
            "application_number": "BLA103532",
            "brand_name_base": "Pulmozyme",
            "pharm_class": [
                "Decreased Respiratory Secretion Viscosity [PE]",
                "Deoxyribonuclease I [CS]",
                "Recombinant Human Deoxyribonuclease 1 [EPC]",
                "Recombinant Proteins [CS]"
            ]
        },
        {
            "product_ndc": "58892-107",
            "generic_name": "Zinc Oxide",
            "labeler_name": "Fallien Cosmeceuticals, LTD",
            "brand_name": "TiZO Photoceutical AM Replenish Non-Tinted",
            "active_ingredients": [
                {
                    "name": "ZINC OXIDE",
                    "strength": "160 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58892-107-50",
                    "description": "1 TUBE in 1 CARTON (58892-107-50)  / 50 g in 1 TUBE",
                    "marketing_start_date": "20190723",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Fallien Cosmeceuticals, LTD"
                ],
                "spl_set_id": [
                    "c52a1e04-f3ca-47a1-a26e-d6f5e77b47d6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SOI2LOH54Z"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "4b6239f5-95d9-4e4d-94eb-7f03ab64bab2",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20180305",
            "product_id": "58892-107_4b6239f5-95d9-4e4d-94eb-7f03ab64bab2",
            "application_number": "part352",
            "brand_name_base": "TiZO Photoceutical AM Replenish Non-Tinted"
        },
        {
            "product_ndc": "11822-1616",
            "generic_name": "Benzocaine",
            "labeler_name": "Rite Aid",
            "brand_name": "Toothache and Gum Relief Cushions",
            "active_ingredients": [
                {
                    "name": "BENZOCAINE",
                    "strength": "10 g/100g"
                },
                {
                    "name": "MENTHOL",
                    "strength": ".25 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11822-1616-9",
                    "description": "8 BLISTER PACK in 1 CARTON (11822-1616-9)  / .5 g in 1 BLISTER PACK",
                    "marketing_start_date": "20200626",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Rite Aid"
                ],
                "spl_set_id": [
                    "9970d485-0b78-1438-e053-2995a90ad32c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000185508",
                    "N0000175629",
                    "N0000184306",
                    "M0000728"
                ],
                "pharm_class_epc": [
                    "Standardized Chemical Allergen [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Histamine Release [PE]",
                    "Cell-mediated Immunity [PE]"
                ],
                "pharm_class_cs": [
                    "Allergens [CS]"
                ],
                "unii": [
                    "U3RSY48JW5",
                    "L7T10EIP3A"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "DRESSING",
            "spl_id": "f21502e4-7368-05c7-e053-2a95a90a9336",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200626",
            "product_id": "11822-1616_f21502e4-7368-05c7-e053-2a95a90a9336",
            "application_number": "part356",
            "brand_name_base": "Toothache and Gum Relief Cushions",
            "pharm_class": [
                "Allergens [CS]",
                "Cell-mediated Immunity [PE]",
                "Increased Histamine Release [PE]",
                "Standardized Chemical Allergen [EPC]"
            ]
        },
        {
            "product_ndc": "71334-205",
            "generic_name": "mitapivat",
            "labeler_name": "Agios Pharmaceuticals, Inc.",
            "brand_name": "Pyrukynd",
            "active_ingredients": [
                {
                    "name": "MITAPIVAT",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71334-205-05",
                    "description": "4 BLISTER PACK in 1 CARTON (71334-205-05)  / 14 TABLET, FILM COATED in 1 BLISTER PACK (71334-205-14)",
                    "marketing_start_date": "20220218",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Agios Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2594473",
                    "2594479",
                    "2594496",
                    "2594498",
                    "2594501",
                    "2594503",
                    "2594741",
                    "2594742",
                    "2594743",
                    "2594744",
                    "2594745",
                    "2594746",
                    "2594747",
                    "2594748",
                    "2594749",
                    "2594750",
                    "2594794",
                    "2594795"
                ],
                "spl_set_id": [
                    "4ccee896-e313-4c6c-9674-b4746ada0a90"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194008",
                    "N0000194009",
                    "N0000190118",
                    "N0000187064",
                    "N0000187063",
                    "N0000185507",
                    "N0000185607",
                    "N0000194036",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Pyruvate Kinase Activator [EPC]"
                ],
                "pharm_class_moa": [
                    "Pyruvate Kinase Activators [MoA]",
                    "Cytochrome P450 3A Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C8 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]",
                    "UGT1A1 Inducers [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "2WTV10SIKH"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "1ab4a397-cec3-e21d-e063-6394a90a1cc7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220218",
            "product_id": "71334-205_1ab4a397-cec3-e21d-e063-6394a90a1cc7",
            "application_number": "NDA216196",
            "brand_name_base": "Pyrukynd",
            "pharm_class": [
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C8 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A Inducers [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Pyruvate Kinase Activator [EPC]",
                "Pyruvate Kinase Activators [MoA]",
                "UGT1A1 Inducers [MoA]"
            ]
        },
        {
            "product_ndc": "64406-109",
            "generic_name": "tofersen",
            "labeler_name": "Biogen Inc.",
            "brand_name": "QALSODY",
            "active_ingredients": [
                {
                    "name": "TOFERSEN",
                    "strength": "100 mg/15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64406-109-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (64406-109-01)  / 15 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20230425",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Biogen Inc."
                ],
                "rxcui": [
                    "2634999",
                    "2635005"
                ],
                "spl_set_id": [
                    "81356b45-1cb7-4eef-88ea-e44cc18b47c5"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364406109010"
                ],
                "nui": [
                    "N0000191626",
                    "M0025055"
                ],
                "pharm_class_epc": [
                    "Antisense Oligonucleotide [EPC]"
                ],
                "pharm_class_cs": [
                    "Oligonucleotides, Antisense [CS]"
                ],
                "unii": [
                    "2NU6F9601K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "49746560-541f-415a-9ac6-bf214fce0793",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRATHECAL"
            ],
            "marketing_start_date": "20230425",
            "product_id": "64406-109_49746560-541f-415a-9ac6-bf214fce0793",
            "application_number": "NDA215887",
            "brand_name_base": "QALSODY"
        },
        {
            "product_ndc": "52652-3001",
            "generic_name": "lisinopril",
            "labeler_name": "Azurity Pharmaceuticals, Inc.",
            "brand_name": "Qbrelis",
            "active_ingredients": [
                {
                    "name": "LISINOPRIL",
                    "strength": "1 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52652-3001-1",
                    "description": "150 mL in 1 BOTTLE (52652-3001-1)",
                    "marketing_start_date": "20160829",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Azurity Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1806884",
                    "1806890"
                ],
                "spl_set_id": [
                    "9f6e4e57-a489-4b36-b093-b93865d3717c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "39d16ba9-53e0-4052-8a27-61e75de1528a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160829",
            "product_id": "52652-3001_39d16ba9-53e0-4052-8a27-61e75de1528a",
            "application_number": "NDA208401",
            "brand_name_base": "Qbrelis",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "73207-101",
            "generic_name": "Ripretinib",
            "labeler_name": "Deciphera Pharmaceuticals, LLC",
            "brand_name": "QINLOCK",
            "active_ingredients": [
                {
                    "name": "RIPRETINIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73207-101-30",
                    "description": "1 BOTTLE in 1 CARTON (73207-101-30)  / 90 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20200515",
                    "sample": false
                },
                {
                    "package_ndc": "73207-101-31",
                    "description": "1 BOTTLE in 1 CARTON (73207-101-31)  / 30 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20200515",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Deciphera Pharmaceuticals, LLC"
                ],
                "rxcui": [
                    "2369397",
                    "2369403"
                ],
                "spl_set_id": [
                    "9f18e462-03dd-4296-a02a-a0577e3ee78d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020034",
                    "N0000020028",
                    "N0000187062",
                    "N0000185503",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Stem Cell Factor (KIT) Receptor Inhibitors [MoA]",
                    "Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "9XW757O13D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "b87c6225-a814-4e10-84fd-ebf19ce2f413",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200515",
            "product_id": "73207-101_b87c6225-a814-4e10-84fd-ebf19ce2f413",
            "application_number": "NDA213973",
            "brand_name_base": "QINLOCK",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA]",
                "Stem Cell Factor (KIT) Receptor Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0074-7094",
            "generic_name": "Atogepant",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Qulipta",
            "active_ingredients": [
                {
                    "name": "ATOGEPANT",
                    "strength": "60 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-7094-04",
                    "description": "4 TABLET in 1 BOTTLE (0074-7094-04)",
                    "marketing_start_date": "20211006",
                    "sample": true
                },
                {
                    "package_ndc": "0074-7094-30",
                    "description": "30 TABLET in 1 BOTTLE (0074-7094-30)",
                    "marketing_start_date": "20210930",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "2571836",
                    "2571842",
                    "2571844",
                    "2571846",
                    "2571848",
                    "2571850"
                ],
                "spl_set_id": [
                    "8c8ab8f4-32bd-497a-befa-70c8a51d8d52"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300747096305",
                    "0300747094301"
                ],
                "nui": [
                    "N0000193917",
                    "N0000193918"
                ],
                "pharm_class_epc": [
                    "Calcitonin Gene-related Peptide Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "7CRV8RR151"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "a177175c-6c6f-475e-af22-1f16b1c59fda",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210930",
            "product_id": "0074-7094_a177175c-6c6f-475e-af22-1f16b1c59fda",
            "application_number": "NDA215206",
            "brand_name_base": "Qulipta",
            "pharm_class": [
                "Calcitonin Gene-related Peptide Receptor Antagonist [EPC]",
                "Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0591-3510",
            "generic_name": "Clonidine",
            "labeler_name": "Actavis Pharma, Inc.",
            "brand_name": "Clonidine transdermal system",
            "active_ingredients": [
                {
                    "name": "CLONIDINE",
                    "strength": ".3 mg/d"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0591-3510-04",
                    "description": "4 POUCH in 1 CARTON (0591-3510-04)  / 1 PATCH in 1 POUCH (0591-3510-54)  / 7 d in 1 PATCH",
                    "marketing_start_date": "20140506",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Actavis Pharma, Inc."
                ],
                "rxcui": [
                    "998671",
                    "998675",
                    "998679"
                ],
                "spl_set_id": [
                    "99a59495-2a48-4276-bbe3-cdd55a45aba4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000009918",
                    "N0000175554"
                ],
                "pharm_class_moa": [
                    "Adrenergic alpha2-Agonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Central alpha-2 Adrenergic Agonist [EPC]"
                ],
                "unii": [
                    "MN3L5RMN02"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "PATCH",
            "spl_id": "996f475b-4f8b-4487-b5c1-6e5c4f284045",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TRANSDERMAL"
            ],
            "marketing_start_date": "20140506",
            "product_id": "0591-3510_996f475b-4f8b-4487-b5c1-6e5c4f284045",
            "application_number": "ANDA090873",
            "brand_name_base": "Clonidine transdermal system",
            "pharm_class": [
                "Adrenergic alpha2-Agonists [MoA]",
                "Central alpha-2 Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "70720-100",
            "generic_name": "Cetirizine Hydrochloride",
            "labeler_name": "TerSera Therapeutics LLC",
            "brand_name": "QUZYTTIR",
            "active_ingredients": [
                {
                    "name": "CETIRIZINE HYDROCHLORIDE",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70720-100-10",
                    "description": "1 VIAL, GLASS in 1 CARTON (70720-100-10)  / 1 mL in 1 VIAL, GLASS (70720-100-01)",
                    "marketing_start_date": "20200402",
                    "sample": false
                },
                {
                    "package_ndc": "70720-100-25",
                    "description": "25 VIAL, GLASS in 1 CARTON (70720-100-25)  / 1 mL in 1 VIAL, GLASS (70720-100-01)",
                    "marketing_start_date": "20191113",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TerSera Therapeutics LLC"
                ],
                "rxcui": [
                    "2261746",
                    "2261754"
                ],
                "spl_set_id": [
                    "f33e859d-ebc9-4d4f-a57d-204c48760d20"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370720100107",
                    "0370720100251"
                ],
                "unii": [
                    "64O047KTOA"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "23ae517f-48a0-46e7-a341-6381701b72fc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20191113",
            "product_id": "70720-100_23ae517f-48a0-46e7-a341-6381701b72fc",
            "application_number": "NDA211415",
            "brand_name_base": "QUZYTTIR",
            "pharm_class": [
                "Histamine H1 Receptor Antagonists [MoA]",
                "Histamine-1 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0068-0599",
            "marketing_end_date": "20251031",
            "generic_name": "rifampin",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Rifadin IV NOVAPLUS",
            "active_ingredients": [
                {
                    "name": "RIFAMPIN",
                    "strength": "600 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0068-0599-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (0068-0599-01)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20170201",
                    "marketing_end_date": "20251031",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "207436",
                    "312821"
                ],
                "spl_set_id": [
                    "87839f65-cb33-412e-929e-564136501a84"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175500",
                    "M0019113"
                ],
                "pharm_class_epc": [
                    "Rifamycin Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Rifamycins [CS]"
                ],
                "unii": [
                    "VJT6J7R4TR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ed3e312a-b258-4b9b-bdb4-2f149c73e8c1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170201",
            "product_id": "0068-0599_ed3e312a-b258-4b9b-bdb4-2f149c73e8c1",
            "application_number": "NDA050627",
            "brand_name_base": "Rifadin IV NOVAPLUS",
            "pharm_class": [
                "Rifamycin Antibacterial [EPC]",
                "Rifamycins [CS]"
            ]
        },
        {
            "product_ndc": "70510-2171",
            "generic_name": "EDARAVONE",
            "labeler_name": "Mitsubishi Tanabe Pharma America, Inc.",
            "brand_name": "RADICAVA",
            "active_ingredients": [
                {
                    "name": "EDARAVONE",
                    "strength": "30 mg/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70510-2171-2",
                    "description": "2 BAG in 1 CARTON (70510-2171-2)  / 100 mL in 1 BAG (70510-2171-1)",
                    "marketing_start_date": "20170505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mitsubishi Tanabe Pharma America, Inc."
                ],
                "rxcui": [
                    "1924316",
                    "1924317",
                    "2602117",
                    "2602122"
                ],
                "spl_set_id": [
                    "0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370510232414",
                    "0370510217121",
                    "0370510232315"
                ],
                "unii": [
                    "S798V6YJRP"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "d3d515d2-5301-4038-9eff-558de3b0e48d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170505",
            "product_id": "70510-2171_d3d515d2-5301-4038-9eff-558de3b0e48d",
            "application_number": "NDA209176",
            "brand_name_base": "RADICAVA"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "77578-003",
            "generic_name": "Alcohol, citric acid",
            "labeler_name": "Nutraze, S.C de R.L. de C.V.",
            "brand_name": "Sanitizer",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "80 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "77578-003-01",
                    "description": "500 mL in 1 BOTTLE (77578-003-01)",
                    "marketing_start_date": "20220117",
                    "sample": false
                },
                {
                    "package_ndc": "77578-003-02",
                    "description": "1000000 mL in 1 CONTAINER (77578-003-02)",
                    "marketing_start_date": "20220117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Nutraze, S.C de R.L. de C.V."
                ],
                "rxcui": [
                    "1039339"
                ],
                "spl_set_id": [
                    "aa1b7ea7-c755-ebce-e053-2995a90ad016"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "7503027451365"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LIQUID",
            "spl_id": "d5cfa326-4bde-2829-e053-2995a90a3a2c",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20220117",
            "product_id": "77578-003_d5cfa326-4bde-2829-e053-2995a90a3a2c",
            "application_number": "part333A",
            "brand_name_base": "Sanitizer"
        },
        {
            "product_ndc": "70301-1002",
            "generic_name": "calcifediol",
            "labeler_name": "OPKO Pharmaceuticals LLC",
            "brand_name": "Rayaldee",
            "active_ingredients": [
                {
                    "name": "CALCIFEDIOL",
                    "strength": "30 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70301-1002-1",
                    "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70301-1002-1)",
                    "marketing_start_date": "20240311",
                    "sample": false
                },
                {
                    "package_ndc": "70301-1002-2",
                    "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70301-1002-2)",
                    "marketing_start_date": "20240311",
                    "sample": false
                },
                {
                    "package_ndc": "70301-1002-3",
                    "description": "7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70301-1002-3)",
                    "marketing_start_date": "20240311",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "OPKO Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "1855066",
                    "1855072"
                ],
                "spl_set_id": [
                    "6a95effd-32a5-46b6-a30e-7f4f9bf8cc77"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370301100212",
                    "0370301100113"
                ],
                "unii": [
                    "P6YZ13C99Q"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, EXTENDED RELEASE",
            "spl_id": "e53d9b9c-c126-4c55-8591-c8975fe21dea",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240311",
            "product_id": "70301-1002_e53d9b9c-c126-4c55-8591-c8975fe21dea",
            "application_number": "NDA208010",
            "brand_name_base": "Rayaldee",
            "pharm_class": [
                "Cholecalciferol [CS]",
                "Vitamin D3 Analog [EPC]"
            ]
        },
        {
            "product_ndc": "11429-1010",
            "generic_name": "CHLOROXYLENOL",
            "labeler_name": "Woodbine Products Company",
            "brand_name": "FoamFresh Dye Free Antibacterial Hand Wash",
            "active_ingredients": [
                {
                    "name": "CHLOROXYLENOL",
                    "strength": "2.5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11429-1010-1",
                    "description": "30 mL in 1 BOTTLE, PLASTIC (11429-1010-1)",
                    "marketing_start_date": "20181120",
                    "sample": false
                },
                {
                    "package_ndc": "11429-1010-3",
                    "description": "1000 mL in 1 BOTTLE, PLASTIC (11429-1010-3)",
                    "marketing_start_date": "20181120",
                    "sample": false
                },
                {
                    "package_ndc": "11429-1010-7",
                    "description": "750 mL in 1 BOTTLE, PLASTIC (11429-1010-7)",
                    "marketing_start_date": "20181120",
                    "sample": false
                },
                {
                    "package_ndc": "11429-1010-8",
                    "description": "1250 mL in 1 BOTTLE, PLASTIC (11429-1010-8)",
                    "marketing_start_date": "20181120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Woodbine Products Company"
                ],
                "rxcui": [
                    "1435989"
                ],
                "spl_set_id": [
                    "ba205f78-6e3f-483e-a37a-537f6917b00c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "0F32U78V2Q"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "SOLUTION",
            "spl_id": "9fa71be6-bc0e-4179-9881-e611f4d0e2d8",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20181120",
            "product_id": "11429-1010_9fa71be6-bc0e-4179-9881-e611f4d0e2d8",
            "application_number": "part333A",
            "brand_name_base": "FoamFresh Dye Free Antibacterial Hand Wash"
        },
        {
            "product_ndc": "76045-114",
            "generic_name": "NALOXONE HYDROCHLORIDE",
            "labeler_name": "Fresenius Kabi USA, LLC",
            "brand_name": "Naloxone Hydrochloride",
            "active_ingredients": [
                {
                    "name": "NALOXONE HYDROCHLORIDE",
                    "strength": ".4 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76045-114-10",
                    "description": "24 SYRINGE in 1 CARTON (76045-114-10)  / 1 mL in 1 SYRINGE (76045-114-01)",
                    "marketing_start_date": "20240402",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Fresenius Kabi USA, LLC"
                ],
                "rxcui": [
                    "1191250",
                    "2679504"
                ],
                "spl_set_id": [
                    "201fdedf-1736-4e52-9d7d-de14292547fd"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "F850569PQR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "b74095a7-0bf8-4377-b930-b189681cabda",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20240402",
            "product_id": "76045-114_b74095a7-0bf8-4377-b930-b189681cabda",
            "application_number": "ANDA213573",
            "brand_name_base": "Naloxone Hydrochloride",
            "pharm_class": [
                "Opioid Antagonist [EPC]",
                "Opioid Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0169-7901",
            "generic_name": "coagulation factor IX recombinant, GlycoPEGylated",
            "labeler_name": "Novo Nordisk",
            "brand_name": "REBINYN",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-7901-01",
                    "description": "1 KIT in 1 KIT (0169-7901-01)  *  4 mL in 1 VIAL, GLASS (0169-7911-90)  *  4 mL in 1 SYRINGE, GLASS (0169-7009-98)  *  4 mL in 1 VIAL, GLASS (0169-7911-11)",
                    "marketing_start_date": "20171201",
                    "sample": false
                },
                {
                    "package_ndc": "0169-7901-97",
                    "description": "1 KIT in 1 KIT (0169-7901-97)  *  4 mL in 1 VIAL, GLASS (0169-7911-90)  *  4 mL in 1 SYRINGE, GLASS (0169-7009-98)  *  4 mL in 1 VIAL, GLASS (0169-7911-11)",
                    "marketing_start_date": "20220505",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "1990857",
                    "1990862"
                ],
                "spl_set_id": [
                    "0ea37235-35fd-410d-b8c4-40ba15fe1294"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "66d38606-be95-4216-8afd-b14fcb59203e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20171201",
            "product_id": "0169-7901_66d38606-be95-4216-8afd-b14fcb59203e",
            "application_number": "BLA125611",
            "brand_name_base": "REBINYN"
        },
        {
            "product_ndc": "59572-711",
            "generic_name": "Luspatercept",
            "labeler_name": "Celgene Corporation",
            "brand_name": "Reblozyl",
            "active_ingredients": [
                {
                    "name": "LUSPATERCEPT",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-711-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (59572-711-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
                    "marketing_start_date": "20191108",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "2262906",
                    "2262911",
                    "2262913",
                    "2262915"
                ],
                "spl_set_id": [
                    "82f4d266-3f52-41eb-86ba-0abf3cf468e8"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194025",
                    "N0000009319"
                ],
                "pharm_class_epc": [
                    "Erythroid Maturation Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Erythroid Cell Production [PE]"
                ],
                "unii": [
                    "AQK7UBA1LS"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "cecd297d-3ed0-4f20-8066-ebd9aa687d0d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20191108",
            "product_id": "59572-711_cecd297d-3ed0-4f20-8066-ebd9aa687d0d",
            "application_number": "BLA761136",
            "brand_name_base": "Reblozyl",
            "pharm_class": [
                "Erythroid Maturation Agent [EPC]",
                "Increased Erythroid Cell Production [PE]"
            ]
        },
        {
            "product_ndc": "0006-3856",
            "generic_name": "imipenem anhydrous, cilastatin, and relebactam anhydrous",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "RECARBRIO",
            "active_ingredients": [
                {
                    "name": "CILASTATIN",
                    "strength": "500 mg/100mL"
                },
                {
                    "name": "IMIPENEM ANHYDROUS",
                    "strength": "500 mg/100mL"
                },
                {
                    "name": "RELEBACTAM ANHYDROUS",
                    "strength": "250 mg/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-3856-02",
                    "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (0006-3856-02)  / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01)",
                    "marketing_start_date": "20200106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "2184142",
                    "2184147"
                ],
                "spl_set_id": [
                    "be32f468-738b-40df-a425-591e12f65159"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175513",
                    "N0000175514",
                    "M0024174",
                    "N0000175496",
                    "N0000175930",
                    "N0000000202"
                ],
                "pharm_class_moa": [
                    "Dipeptidase Inhibitors [MoA]",
                    "beta Lactamase Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Renal Dehydropeptidase Inhibitor [EPC]",
                    "Penem Antibacterial [EPC]",
                    "beta Lactamase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Carbapenems [CS]"
                ],
                "unii": [
                    "141A6AMN38",
                    "Q20IM7HE75",
                    "1OQF7TT3PF"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
            "spl_id": "8a65f15d-ca70-46ce-b575-7a1b5092a243",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200106",
            "product_id": "0006-3856_8a65f15d-ca70-46ce-b575-7a1b5092a243",
            "application_number": "NDA212819",
            "brand_name_base": "RECARBRIO",
            "pharm_class": [
                "Carbapenems [CS]",
                "Dipeptidase Inhibitors [MoA]",
                "Penem Antibacterial [EPC]",
                "Renal Dehydropeptidase Inhibitor [EPC]",
                "beta Lactamase Inhibitor [EPC]",
                "beta Lactamase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0944-2841",
            "generic_name": "antihemophilic factor recombinant",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "RECOMBINATE",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0944-2841-10",
                    "description": "1 KIT in 1 CARTON (0944-2841-10)  *  10 mL in 1 VIAL, GLASS (0944-2831-01)  *  5 mL in 1 VIAL, GLASS (64764-515-50)",
                    "marketing_start_date": "20090410",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "cf5623f1-d12f-4960-a25c-695c975310d4",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20090410",
            "product_id": "0944-2841_cf5623f1-d12f-4960-a25c-695c975310d4",
            "application_number": "BLA103375",
            "brand_name_base": "RECOMBINATE"
        },
        {
            "product_ndc": "0006-4995",
            "generic_name": "Hepatitis B Vaccine (Recombinant)",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "RECOMBIVAX HB",
            "active_ingredients": [
                {
                    "name": "HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN",
                    "strength": "10 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-4995-00",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-00)  / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4995-01)",
                    "marketing_start_date": "19860723",
                    "sample": false
                },
                {
                    "package_ndc": "0006-4995-41",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-41)  / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4995-01)",
                    "marketing_start_date": "19860723",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "30c061ac-552c-48bc-83fa-95b10e9fc1ee",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19860723",
            "product_id": "0006-4995_30c061ac-552c-48bc-83fa-95b10e9fc1ee",
            "application_number": "BLA101066",
            "brand_name_base": "RECOMBIVAX HB",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Hepatitis B Vaccines [CS]",
                "Inactivated Hepatitis B Virus Vaccine [EPC]",
                "Vaccines",
                "Inactivated [CS]"
            ]
        },
        {
            "product_ndc": "72065-003",
            "generic_name": "Levoketoconazole",
            "labeler_name": "Xeris Pharmaceuticals, Inc.",
            "brand_name": "Recorlev",
            "active_ingredients": [
                {
                    "name": "LEVOKETOCONAZOLE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72065-003-01",
                    "description": "50 TABLET in 1 BOTTLE (72065-003-01)",
                    "marketing_start_date": "20211230",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Xeris Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2588848",
                    "2588854"
                ],
                "spl_set_id": [
                    "d4c5fead-bc4a-fb02-e053-2a95a90ae4fc"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372065003013"
                ],
                "nui": [
                    "N0000193935",
                    "N0000193936",
                    "N0000193984",
                    "N0000182632",
                    "N0000182141",
                    "N0000185503",
                    "N0000187061",
                    "N0000191423",
                    "N0000182139",
                    "N0000187062"
                ],
                "pharm_class_epc": [
                    "Cortisol Synthesis Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 11B1 Inhibitors [MoA]",
                    "Cytochrome P450 11A1 Inhibitors [MoA]",
                    "Cytochrome P450 17A1 Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Cation Transporter 2 Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                    "Cytochrome P450 2B6 Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]"
                ],
                "unii": [
                    "2DJ8R0NT7K"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "b35f3799-2981-4cd2-b021-65dc50b4d0a9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20211230",
            "product_id": "72065-003_b35f3799-2981-4cd2-b021-65dc50b4d0a9",
            "application_number": "NDA214133",
            "brand_name_base": "Recorlev",
            "pharm_class": [
                "Cortisol Synthesis Inhibitor [EPC]",
                "Cytochrome P450 11A1 Inhibitors [MoA]",
                "Cytochrome P450 11B1 Inhibitors [MoA]",
                "Cytochrome P450 17A1 Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Organic Cation Transporter 2 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "76176-045",
            "generic_name": "menthol",
            "labeler_name": "Ningbo Liyuan Daily Chemical Products Co., Ltd.",
            "brand_name": "U ICE COLD",
            "active_ingredients": [
                {
                    "name": "CAMPHOR, (-)-",
                    "strength": ".5 g/100g"
                },
                {
                    "name": "MENTHOL",
                    "strength": "1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76176-045-01",
                    "description": "227 g in 1 TUBE (76176-045-01)",
                    "marketing_start_date": "20180801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Ningbo Liyuan Daily Chemical Products Co., Ltd."
                ],
                "rxcui": [
                    "2056456"
                ],
                "spl_set_id": [
                    "760be0f2-b5b2-b22a-e053-2991aa0a90d5"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0676979827339"
                ],
                "unii": [
                    "213N3S8275",
                    "L7T10EIP3A"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "OINTMENT",
            "spl_id": "760be0f2-b5b3-b22a-e053-2991aa0a90d5",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20180801",
            "product_id": "76176-045_760be0f2-b5b3-b22a-e053-2991aa0a90d5",
            "application_number": "part348",
            "brand_name_base": "U ICE COLD"
        },
        {
            "product_ndc": "50484-810",
            "generic_name": "becaplermin",
            "labeler_name": "Smith & Nephew, Inc.",
            "brand_name": "REGRANEX",
            "active_ingredients": [
                {
                    "name": "BECAPLERMIN",
                    "strength": "100 ug/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50484-810-15",
                    "description": "1 TUBE in 1 CARTON (50484-810-15)  / 15 g in 1 TUBE",
                    "marketing_start_date": "20140801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Smith & Nephew, Inc."
                ],
                "rxcui": [
                    "213197",
                    "308579"
                ],
                "spl_set_id": [
                    "fd2c7d21-7b07-4ab3-8983-816ab3223771"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350484810153"
                ],
                "nui": [
                    "N0000175885",
                    "M0017024"
                ],
                "pharm_class_epc": [
                    "Human Platelet-derived Growth Factor [EPC]"
                ],
                "pharm_class_cs": [
                    "Platelet-Derived Growth Factor [CS]"
                ],
                "unii": [
                    "1B56C968OA"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "GEL",
            "spl_id": "0c3fee4a-499b-49ec-e063-6394a90ac276",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20111101",
            "product_id": "50484-810_0c3fee4a-499b-49ec-e063-6394a90ac276",
            "application_number": "BLA103691",
            "brand_name_base": "REGRANEX",
            "pharm_class": [
                "Human Platelet-derived Growth Factor [EPC]",
                "Platelet-Derived Growth Factor [CS]"
            ]
        },
        {
            "product_ndc": "0173-0681",
            "generic_name": "zanamivir",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "RELENZA",
            "active_ingredients": [
                {
                    "name": "ZANAMIVIR",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0681-01",
                    "description": "5 PACKAGE in 1 CARTON (0173-0681-01)  / 4 POWDER in 1 PACKAGE",
                    "marketing_start_date": "19990922",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0681-22",
                    "description": "5 PACKAGE in 1 CARTON (0173-0681-22)  / 4 POWDER in 1 PACKAGE",
                    "marketing_start_date": "20070309",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "759471",
                    "759473"
                ],
                "spl_set_id": [
                    "d7c3bcc3-0c0d-4068-fd80-88cf54a376ef"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175524",
                    "N0000175436"
                ],
                "pharm_class_epc": [
                    "Neuraminidase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Neuraminidase Inhibitors [MoA]"
                ],
                "unii": [
                    "L6O3XI777I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER",
            "spl_id": "276882d0-98d8-4f65-a341-62953e316217",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "19990922",
            "product_id": "0173-0681_276882d0-98d8-4f65-a341-62953e316217",
            "application_number": "NDA021036",
            "brand_name_base": "RELENZA",
            "pharm_class": [
                "Neuraminidase Inhibitor [EPC]",
                "Neuraminidase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70121-1571",
            "generic_name": "Filgrastim",
            "labeler_name": "Amneal Pharmaceuticals LLC",
            "brand_name": "RELEUKO",
            "active_ingredients": [
                {
                    "name": "FILGRASTIM",
                    "strength": "480 ug/1.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70121-1571-7",
                    "description": "10 VIAL in 1 PACKAGE (70121-1571-7)  / 1.6 mL in 1 VIAL",
                    "marketing_start_date": "20220225",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amneal Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "2595944",
                    "2595950",
                    "2595953",
                    "2595957",
                    "2595959",
                    "2595960",
                    "2595961",
                    "2595962"
                ],
                "spl_set_id": [
                    "74e1ec6e-1630-4654-895c-2bd355f939e7"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0370121157175",
                    "0370121157014",
                    "0370121156819",
                    "0370121156871",
                    "0370121157076",
                    "0370121156970"
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "PVI5M0M1GW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "453cee35-313d-43db-ad1a-ce8fe5d3a56c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20220225",
            "product_id": "70121-1571_453cee35-313d-43db-ad1a-ce8fe5d3a56c",
            "application_number": "BLA761082",
            "brand_name_base": "RELEUKO",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "0049-2330",
            "generic_name": "eletriptan hydrobromide",
            "labeler_name": "ROERIG",
            "brand_name": "Relpax",
            "active_ingredients": [
                {
                    "name": "ELETRIPTAN HYDROBROMIDE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0049-2330-45",
                    "description": "6 BLISTER PACK in 1 CARTON (0049-2330-45)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (0049-2330-79)",
                    "marketing_start_date": "20021226",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "ROERIG"
                ],
                "rxcui": [
                    "359493",
                    "359494",
                    "404443",
                    "404444"
                ],
                "spl_set_id": [
                    "85745375-fcb6-4edc-b6db-a77b4a5f3e8c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "M41W832TA3"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "20f8821b-f61b-4a2c-aeb8-8f723e3f7f8b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20021226",
            "product_id": "0049-2330_20f8821b-f61b-4a2c-aeb8-8f723e3f7f8b",
            "application_number": "NDA021016",
            "brand_name_base": "Relpax",
            "pharm_class": [
                "Serotonin 1b Receptor Agonists [MoA]",
                "Serotonin 1d Receptor Agonists [MoA]",
                "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "57894-030",
            "generic_name": "INFLIXIMAB",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "REMICADE",
            "active_ingredients": [
                {
                    "name": "INFLIXIMAB",
                    "strength": "100 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-030-01",
                    "description": "1 VIAL, SINGLE-USE in 1 BOX (57894-030-01)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "19980824",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "213361",
                    "310994"
                ],
                "spl_set_id": [
                    "a0a046c1-056d-45a9-bfd9-13b47c24f257"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "unii": [
                    "B72HH48FLU"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "d9c13b29-5863-427e-878d-23ae57012d85",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "19980824",
            "product_id": "57894-030_d9c13b29-5863-427e-878d-23ae57012d85",
            "application_number": "BLA103772",
            "brand_name_base": "REMICADE",
            "pharm_class": [
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0006-4305",
            "generic_name": "infliximab",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "Renflexis",
            "active_ingredients": [
                {
                    "name": "INFLIXIMAB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-4305-02",
                    "description": "1 VIAL in 1 CARTON (0006-4305-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0006-4305-01)",
                    "marketing_start_date": "20170701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "1927285",
                    "1927290"
                ],
                "spl_set_id": [
                    "3827e1be-f328-45f7-b113-311b57039f8c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "unii": [
                    "B72HH48FLU"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "fc8da8a3-76dd-4c0d-a987-236eec11b184",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170701",
            "product_id": "0006-4305_fc8da8a3-76dd-4c0d-a987-236eec11b184",
            "application_number": "BLA761054",
            "brand_name_base": "Renflexis",
            "pharm_class": [
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "0187-5150",
            "generic_name": "Tretinoin",
            "labeler_name": "Bausch Health US LLC",
            "brand_name": "Renova",
            "active_ingredients": [
                {
                    "name": "TRETINOIN",
                    "strength": ".2 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-5150-02",
                    "description": "1 TUBE in 1 CARTON (0187-5150-02)  / 2 g in 1 TUBE",
                    "marketing_start_date": "20000831",
                    "sample": false
                },
                {
                    "package_ndc": "0187-5150-20",
                    "description": "1 TUBE in 1 CARTON (0187-5150-20)  / 20 g in 1 TUBE",
                    "marketing_start_date": "20000831",
                    "sample": false
                },
                {
                    "package_ndc": "0187-5150-40",
                    "description": "1 TUBE in 1 CARTON (0187-5150-40)  / 40 g in 1 TUBE",
                    "marketing_start_date": "20000831",
                    "sample": false
                },
                {
                    "package_ndc": "0187-5150-44",
                    "description": "1 BOTTLE, PUMP in 1 CARTON (0187-5150-44)  / 44 g in 1 BOTTLE, PUMP",
                    "marketing_start_date": "20000831",
                    "sample": false
                },
                {
                    "package_ndc": "0187-5150-60",
                    "description": "1 TUBE in 1 CARTON (0187-5150-60)  / 60 g in 1 TUBE",
                    "marketing_start_date": "20000831",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US LLC"
                ],
                "rxcui": [
                    "252265",
                    "846955"
                ],
                "spl_set_id": [
                    "9f0a0e8d-1051-48a4-80c5-1bd260dd9c36"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175607",
                    "M0018962"
                ],
                "pharm_class_epc": [
                    "Retinoid [EPC]"
                ],
                "pharm_class_cs": [
                    "Retinoids [CS]"
                ],
                "unii": [
                    "5688UTC01R"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "2868c4e2-0f79-46c7-abbf-38f2910b625b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20000831",
            "product_id": "0187-5150_2868c4e2-0f79-46c7-abbf-38f2910b625b",
            "application_number": "NDA021108",
            "brand_name_base": "Renova",
            "pharm_class": [
                "Retinoid [EPC]",
                "Retinoids [CS]"
            ]
        },
        {
            "product_ndc": "55513-770",
            "generic_name": "Evolocumab",
            "labeler_name": "Amgen Inc",
            "brand_name": "REPATHA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-770-01",
                    "description": "1 KIT in 1 CARTON (55513-770-01)  *  1 CARTRIDGE in 1 TRAY / 3.5 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20160801",
                    "sample": false
                },
                {
                    "package_ndc": "55513-770-91",
                    "description": "1 KIT in 1 CARTON (55513-770-91)  *  1 CARTRIDGE in 1 TRAY / 3.5 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20160801",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1665895",
                    "1665900",
                    "1665904",
                    "1665906",
                    "1801319",
                    "1801322"
                ],
                "spl_set_id": [
                    "709338ae-ab8f-44a9-b7d5-abaabec3493a"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372511770018",
                    "0372511760026"
                ],
                "nui": [
                    "N0000191731",
                    "N0000191730",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "PCSK9 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "PCSK9 Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "LKC0U3A8NJ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "ad0cad06-6727-4812-89f4-beb4f2e92a5c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20160801",
            "product_id": "55513-770_ad0cad06-6727-4812-89f4-beb4f2e92a5c",
            "application_number": "BLA125522",
            "brand_name_base": "REPATHA"
        },
        {
            "product_ndc": "0023-9163",
            "generic_name": "cyclosporine",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "RESTASIS",
            "active_ingredients": [
                {
                    "name": "CYCLOSPORINE",
                    "strength": ".5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-9163-12",
                    "description": "5 VIAL, SINGLE-USE in 1 CARTON (0023-9163-12)  / .4 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20030401",
                    "sample": false
                },
                {
                    "package_ndc": "0023-9163-30",
                    "description": "30 VIAL, SINGLE-USE in 1 TRAY (0023-9163-30)  / .4 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20030401",
                    "sample": false
                },
                {
                    "package_ndc": "0023-9163-60",
                    "description": "60 VIAL, SINGLE-USE in 1 TRAY (0023-9163-60)  / .4 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20030401",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "2572292",
                    "2572293"
                ],
                "spl_set_id": [
                    "8e24af2b-bc1c-4849-94f2-6df950cdca89"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300239163607"
                ],
                "nui": [
                    "N0000175457",
                    "N0000175458",
                    "N0000182141",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Calcineurin Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Calcineurin Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "83HN0GTJ6D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "EMULSION",
            "spl_id": "9821a057-4b01-42fd-84ba-3e30e41c2249",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20030401",
            "product_id": "0023-9163_9821a057-4b01-42fd-84ba-3e30e41c2249",
            "application_number": "NDA050790",
            "brand_name_base": "RESTASIS",
            "pharm_class": [
                "Calcineurin Inhibitor Immunosuppressant [EPC]",
                "Calcineurin Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0069-1306",
            "generic_name": "epoetin alfa-epbx",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "RETACRIT",
            "active_ingredients": [
                {
                    "name": "EPOETIN",
                    "strength": "3000 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-1306-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1306-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1306-01)",
                    "marketing_start_date": "20180618",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2047591",
                    "2047596",
                    "2047600",
                    "2047602",
                    "2047606",
                    "2047608",
                    "2047612",
                    "2047614",
                    "2047621",
                    "2047623",
                    "2463731",
                    "2463733",
                    "2463735",
                    "2463737"
                ],
                "spl_set_id": [
                    "3af26b0d-8ad0-44e1-a538-8bdb5ab39374"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "64FS3BFH5W"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "9f52d38c-d64c-4440-b988-5d317f148dc0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20180618",
            "product_id": "0069-1306_9f52d38c-d64c-4440-b988-5d317f148dc0",
            "application_number": "BLA125545",
            "brand_name_base": "RETACRIT",
            "pharm_class": [
                "Erythropoiesis-stimulating Agent [EPC]",
                "Erythropoietin [CS]",
                "Increased Erythroid Cell Production [PE]"
            ]
        },
        {
            "product_ndc": "0002-5562",
            "generic_name": "selpercatinib",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "RETEVMO",
            "active_ingredients": [
                {
                    "name": "SELPERCATINIB",
                    "strength": "160 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-5562-60",
                    "description": "60 TABLET, COATED in 1 BOTTLE (0002-5562-60)",
                    "marketing_start_date": "20240410",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "2370164",
                    "2370170",
                    "2370172",
                    "2370174",
                    "2679805",
                    "2679808",
                    "2679810",
                    "2679812",
                    "2679813",
                    "2679814",
                    "2679815",
                    "2679816"
                ],
                "spl_set_id": [
                    "7fa848ba-a59c-4144-9f52-64d090f4d828"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000193947",
                    "N0000187062",
                    "N0000190114",
                    "N0000185503",
                    "N0000190113",
                    "N0000191423"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Rearranged during Transfection (RET) Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
                ],
                "unii": [
                    "CEGM9YBNGD"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "66493bb5-b09c-4613-94ad-3fe6d7a6a3a5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240410",
            "product_id": "0002-5562_66493bb5-b09c-4613-94ad-3fe6d7a6a3a5",
            "application_number": "NDA218160",
            "brand_name_base": "RETEVMO",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Rearranged during Transfection (RET) Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "14141-212",
            "generic_name": "Octinoxate, Zinc oxide",
            "labeler_name": "BEL STAR S A",
            "brand_name": "Clarite Makeup Foundation for a Clearer Appearance SPF 30 390-N",
            "active_ingredients": [
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 g/100g"
                },
                {
                    "name": "ZINC OXIDE",
                    "strength": "7.84 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "14141-212-01",
                    "description": "9 g in 1 CASE (14141-212-01)",
                    "marketing_start_date": "20201109",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BEL STAR S A"
                ],
                "spl_set_id": [
                    "b56f5883-be57-e0e5-e053-2a95a90adb0c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SOI2LOH54Z",
                    "4Y5P7MUD51"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "PASTE",
            "spl_id": "b56f5883-be58-e0e5-e053-2a95a90adb0c",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20201109",
            "product_id": "14141-212_b56f5883-be58-e0e5-e053-2a95a90adb0c",
            "application_number": "part352",
            "brand_name_base": "Clarite Makeup Foundation for a Clearer Appearance SPF 30 390-N"
        },
        {
            "product_ndc": "24208-416",
            "generic_name": "Fluocinolone Acetonide",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Retisert",
            "active_ingredients": [
                {
                    "name": "FLUOCINOLONE ACETONIDE",
                    "strength": ".59 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-416-01",
                    "description": "1 POUCH in 1 CARTON (24208-416-01)  / 1 IMPLANT in 1 POUCH",
                    "marketing_start_date": "20050408",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "1191323",
                    "1191325"
                ],
                "spl_set_id": [
                    "1ab0f849-2a0d-47ce-ad05-768094da8cc9"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "0CD5FD6S2M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "IMPLANT",
            "spl_id": "0f3a3181-09b9-f448-e063-6394a90a1f68",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20050408",
            "product_id": "24208-416_0f3a3181-09b9-f448-e063-6394a90a1f68",
            "application_number": "NDA021737",
            "brand_name_base": "Retisert",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "49702-211",
            "generic_name": "zidovudine",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "RETROVIR",
            "active_ingredients": [
                {
                    "name": "ZIDOVUDINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-211-20",
                    "description": "100 CAPSULE in 1 BOTTLE (49702-211-20)",
                    "marketing_start_date": "20101028",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "108396",
                    "198352",
                    "201907",
                    "204534",
                    "755298",
                    "756209"
                ],
                "spl_set_id": [
                    "6df09f15-b102-431c-adde-d7aeef6f5d84"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0349702211209"
                ],
                "nui": [
                    "N0000175462",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "4B9XT59T7S"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "095c792a-11f5-4da3-b742-211876d3bc9d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20101028",
            "product_id": "49702-211_095c792a-11f5-4da3-b742-211876d3bc9d",
            "application_number": "NDA019655",
            "brand_name_base": "RETROVIR",
            "pharm_class": [
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "10122-502",
            "generic_name": "elapegademase-lvlr",
            "labeler_name": "Chiesi USA, Inc.",
            "brand_name": "Revcovi",
            "active_ingredients": [
                {
                    "name": "ELAPEGADEMASE",
                    "strength": "1.6 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "10122-502-01",
                    "description": "1 VIAL in 1 CARTON (10122-502-01)  / 1.5 mL in 1 VIAL",
                    "marketing_start_date": "20181005",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Chiesi USA, Inc."
                ],
                "rxcui": [
                    "2059223",
                    "2059228"
                ],
                "spl_set_id": [
                    "8c073f84-cdd0-40e4-b3a9-172687267f28"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9R3D3Y0UHS"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "964401e1-52e5-4c34-b5b5-d028ce092dd9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20181005",
            "product_id": "10122-502_964401e1-52e5-4c34-b5b5-d028ce092dd9",
            "application_number": "BLA761092",
            "brand_name_base": "Revcovi"
        },
        {
            "product_ndc": "59572-405",
            "generic_name": "Lenalidomide",
            "labeler_name": "Celgene Corporation",
            "brand_name": "Revlimid",
            "active_ingredients": [
                {
                    "name": "LENALIDOMIDE",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-405-00",
                    "description": "100 CAPSULE in 1 BOTTLE (59572-405-00)",
                    "marketing_start_date": "20051227",
                    "sample": false
                },
                {
                    "package_ndc": "59572-405-28",
                    "description": "28 CAPSULE in 1 BOTTLE (59572-405-28)",
                    "marketing_start_date": "20090303",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "602910",
                    "602912",
                    "616114",
                    "616116",
                    "643712",
                    "643714",
                    "643720",
                    "643722",
                    "1242231",
                    "1242233",
                    "1428947",
                    "1429367"
                ],
                "spl_set_id": [
                    "5fa97bf5-28a2-48f1-8955-f56012d296be"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000184014"
                ],
                "pharm_class_epc": [
                    "Thalidomide Analog [EPC]"
                ],
                "unii": [
                    "F0P408N6V4"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20051227",
            "product_id": "59572-405_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb",
            "application_number": "NDA021880",
            "brand_name_base": "Revlimid",
            "pharm_class": [
                "Thalidomide Analog [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0002-4312",
            "generic_name": "lasmiditan",
            "labeler_name": "Eli Lilly and Company",
            "dea_schedule": "CV",
            "brand_name": "Reyvow",
            "active_ingredients": [
                {
                    "name": "LASMIDITAN",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-4312-08",
                    "description": "2 BLISTER PACK in 1 CARTON (0002-4312-08)  / 4 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20200131",
                    "sample": false
                },
                {
                    "package_ndc": "0002-4312-61",
                    "description": "1 BLISTER PACK in 1 CARTON (0002-4312-61)  / 4 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20210303",
                    "sample": true
                },
                {
                    "package_ndc": "0002-4312-62",
                    "description": "1 BLISTER PACK in 1 CARTON (0002-4312-62)  / 2 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20220228",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "2256937",
                    "2256943",
                    "2256945",
                    "2256947"
                ],
                "spl_set_id": [
                    "aea3358c-ff41-4490-9e6d-c7bf7b3de13f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300024491083",
                    "0300024312081"
                ],
                "unii": [
                    "760I9WM792"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "5ef14cf2-d634-4a7b-9254-4cc480e8a48d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191011",
            "product_id": "0002-4312_5ef14cf2-d634-4a7b-9254-4cc480e8a48d",
            "application_number": "NDA211280",
            "brand_name_base": "Reyvow"
        },
        {
            "product_ndc": "71332-005",
            "generic_name": "olutasidenib",
            "labeler_name": "Rigel Pharmaceuticals, Inc.",
            "brand_name": "REZLIDHIA",
            "active_ingredients": [
                {
                    "name": "OLUTASIDENIB",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71332-005-01",
                    "description": "30 CAPSULE in 1 BOTTLE (71332-005-01)",
                    "marketing_start_date": "20221201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Rigel Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2623648",
                    "2623654"
                ],
                "spl_set_id": [
                    "4a0c7c8b-b95f-455d-9600-b7351e4397fe"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "0T4IMT8S5Z"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "bef086f5-45c1-443a-9b06-93a445331307",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20221201",
            "product_id": "71332-005_bef086f5-45c1-443a-9b06-93a445331307",
            "application_number": "NDA215814",
            "brand_name_base": "REZLIDHIA"
        },
        {
            "product_ndc": "79802-200",
            "generic_name": "belumosudil",
            "labeler_name": "Kadmon Pharmaceuticals, LLC",
            "brand_name": "Rezurock",
            "active_ingredients": [
                {
                    "name": "BELUMOSUDIL",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "79802-200-30",
                    "description": "1 BOTTLE in 1 CARTON (79802-200-30)  / 30 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20210716",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Kadmon Pharmaceuticals, LLC"
                ],
                "rxcui": [
                    "2564031",
                    "2564037"
                ],
                "spl_set_id": [
                    "102e4ef4-7f84-4e34-8df1-479c24d1575d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "834YJF89WO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "eeb4f072-2d94-4a60-a540-c21c915f3d60",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210716",
            "product_id": "79802-200_eeb4f072-2d94-4a60-a540-c21c915f3d60",
            "application_number": "NDA214783",
            "brand_name_base": "Rezurock"
        },
        {
            "product_ndc": "70842-240",
            "generic_name": "rezafungin",
            "labeler_name": "Melinta Therapeutics, LLC",
            "brand_name": "REZZAYO",
            "active_ingredients": [
                {
                    "name": "REZAFUNGIN",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70842-240-01",
                    "description": "1 VIAL in 1 CARTON (70842-240-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL",
                    "marketing_start_date": "20230609",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Melinta Therapeutics, LLC"
                ],
                "rxcui": [
                    "2639160",
                    "2639165"
                ],
                "spl_set_id": [
                    "90073508-6dca-4d27-aa5a-ed837737c35b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175507",
                    "M0519359"
                ],
                "pharm_class_epc": [
                    "Echinocandin Antifungal [EPC]"
                ],
                "pharm_class_cs": [
                    "Lipopeptides [CS]"
                ],
                "unii": [
                    "G013B5478J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "71befa52-0bd0-463a-bfb4-2259f1dba26c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230609",
            "product_id": "70842-240_71befa52-0bd0-463a-bfb4-2259f1dba26c",
            "application_number": "NDA217417",
            "brand_name_base": "REZZAYO",
            "pharm_class": [
                "Echinocandin Antifungal [EPC]",
                "Lipopeptides [CS]"
            ]
        },
        {
            "product_ndc": "55513-224",
            "generic_name": "rituximab-arrx",
            "labeler_name": "Amgen Inc",
            "brand_name": "Riabni",
            "active_ingredients": [
                {
                    "name": "RITUXIMAB",
                    "strength": "100 mg/10mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-224-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55513-224-01)  / 10 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20210106",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "2472327",
                    "2472332",
                    "2472335",
                    "2472336"
                ],
                "spl_set_id": [
                    "da1c4de7-0e5b-4f72-97ec-7a8d368f085f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "4F4X42SYQ6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "1209ba3f-2877-4851-9e29-da329daa4dc1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210106",
            "product_id": "55513-224_1209ba3f-2877-4851-9e29-da329daa4dc1",
            "application_number": "BLA761140",
            "brand_name_base": "Riabni",
            "pharm_class": [
                "CD20-directed Antibody Interactions [MoA]",
                "CD20-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "63833-891",
            "generic_name": "FIBRINOGEN HUMAN",
            "labeler_name": "CSL Behring GmbH",
            "brand_name": "RiaSTAP",
            "active_ingredients": [
                {
                    "name": "FIBRINOGEN HUMAN",
                    "strength": "1300 mg/50mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63833-891-51",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (63833-891-51)  / 50 mL in 1 VIAL, SINGLE-USE (63833-891-90)",
                    "marketing_start_date": "20090116",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "c325b4a3-416a-4d83-8839-db48ca304816",
            "product_type": "PLASMA DERIVATIVE",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20090116",
            "product_id": "63833-891_c325b4a3-416a-4d83-8839-db48ca304816",
            "application_number": "BLA125317",
            "brand_name_base": "RiaSTAP",
            "pharm_class": [
                "Blood Coagulation Factors [CS]",
                "Human Blood Coagulation Factor [EPC]",
                "Increased Coagulation Activity [PE]"
            ]
        },
        {
            "product_ndc": "54766-093",
            "generic_name": "auranofin",
            "labeler_name": "Sebela Pharmaceuticals Inc.",
            "brand_name": "RIDAURA",
            "active_ingredients": [
                {
                    "name": "AURANOFIN",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "54766-093-06",
                    "description": "60 CAPSULE in 1 BOTTLE (54766-093-06)",
                    "marketing_start_date": "20161215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sebela Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "197386",
                    "213510"
                ],
                "spl_set_id": [
                    "43ba3de1-ab2e-06f6-e054-00144ff8d46c"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0354766093067"
                ],
                "unii": [
                    "3H04W2810V"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "7cfc87e7-a349-eed3-e053-2991aa0afd6a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20161215",
            "product_id": "54766-093_7cfc87e7-a349-eed3-e053-2991aa0afd6a",
            "application_number": "NDA018689",
            "brand_name_base": "RIDAURA"
        },
        {
            "product_ndc": "0074-2306",
            "generic_name": "Upadacitinib",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Rinvoq",
            "active_ingredients": [
                {
                    "name": "UPADACITINIB",
                    "strength": "15 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-2306-30",
                    "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30)",
                    "marketing_start_date": "20190816",
                    "sample": false
                },
                {
                    "package_ndc": "0074-2306-70",
                    "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70)",
                    "marketing_start_date": "20190816",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "2196894",
                    "2196900",
                    "2590051",
                    "2590054",
                    "2596957",
                    "2596960",
                    "2681015",
                    "2681019"
                ],
                "spl_set_id": [
                    "2966aec7-2ef0-923c-d8ff-fe1a957bf095"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190858",
                    "N0000190857"
                ],
                "pharm_class_epc": [
                    "Janus Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Janus Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "4RA0KN46E0"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "1d3ea5d6-5738-4483-9e71-9a77e65f998a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190816",
            "product_id": "0074-2306_1d3ea5d6-5738-4483-9e71-9a77e65f998a",
            "application_number": "NDA211675",
            "brand_name_base": "Rinvoq",
            "pharm_class": [
                "Janus Kinase Inhibitor [EPC]",
                "Janus Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50458-306",
            "generic_name": "risperidone",
            "labeler_name": "Janssen Pharmaceuticals, Inc.",
            "brand_name": "RISPERDAL CONSTA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-306-11",
                    "description": "1 KIT in 1 BOX (50458-306-11)  *  2 mL in 1 SYRINGE *  2 mL in 1 VIAL",
                    "marketing_start_date": "20031029",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "402010",
                    "402011",
                    "402012",
                    "706822",
                    "706825",
                    "706827",
                    "706829",
                    "706831"
                ],
                "spl_set_id": [
                    "bb34ee82-d2c2-43b8-ba21-2825c0954691"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "10e24f9e-cc64-88cf-e063-6394a90aa8e3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20031029",
            "product_id": "50458-306_10e24f9e-cc64-88cf-e063-6394a90aa8e3",
            "application_number": "NDA021346",
            "brand_name_base": "RISPERDAL CONSTA"
        },
        {
            "product_ndc": "50242-051",
            "generic_name": "rituximab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Rituxan",
            "active_ingredients": [
                {
                    "name": "RITUXIMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-051-10",
                    "description": "10 VIAL, SINGLE-USE in 1 CARTON (50242-051-10)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20190603",
                    "sample": false
                },
                {
                    "package_ndc": "50242-051-21",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "19971126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1657862",
                    "1657864",
                    "1657867",
                    "1657868"
                ],
                "spl_set_id": [
                    "b172773b-3905-4a1c-ad95-bab4b6126563"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "4F4X42SYQ6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "2e957336-f4e0-4272-bf24-611f1c20f8e3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "19971126",
            "product_id": "50242-051_2e957336-f4e0-4272-bf24-611f1c20f8e3",
            "application_number": "BLA103705",
            "brand_name_base": "Rituxan",
            "pharm_class": [
                "CD20-directed Antibody Interactions [MoA]",
                "CD20-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "50242-051",
            "generic_name": "rituximab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Rituxan",
            "active_ingredients": [
                {
                    "name": "RITUXIMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-051-10",
                    "description": "10 VIAL, SINGLE-USE in 1 CARTON (50242-051-10)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20190603",
                    "sample": false
                },
                {
                    "package_ndc": "50242-051-21",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "19971126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1657862",
                    "1657864",
                    "1657867",
                    "1657868"
                ],
                "spl_set_id": [
                    "b172773b-3905-4a1c-ad95-bab4b6126563"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "4F4X42SYQ6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "2e957336-f4e0-4272-bf24-611f1c20f8e3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "19971126",
            "product_id": "50242-051_2e957336-f4e0-4272-bf24-611f1c20f8e3",
            "application_number": "BLA103705",
            "brand_name_base": "Rituxan",
            "pharm_class": [
                "CD20-directed Antibody Interactions [MoA]",
                "CD20-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "0944-3026",
            "generic_name": "COAGULATION FACTOR IX (RECOMBINANT)",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "RIXUBIS",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0944-3026-02",
                    "description": "1 KIT in 1 CARTON (0944-3026-02)  *  5 mL in 1 VIAL, GLASS (0944-3025-01)  *  5 mL in 1 VIAL, GLASS (64764-515-50)",
                    "marketing_start_date": "20131004",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "9deedd56-76ae-4eb7-b777-e3ae772306f4",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20131004",
            "product_id": "0944-3026_9deedd56-76ae-4eb7-b777-e3ae772306f4",
            "application_number": "BLA125446",
            "brand_name_base": "RIXUBIS"
        },
        {
            "product_ndc": "68135-927",
            "generic_name": "valoctocogene roxaparvovec-rvox",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "ROCTAVIAN",
            "active_ingredients": [
                {
                    "name": "VALOCTOCOGENE ROXAPARVOVEC",
                    "strength": "20000000000000 {GC}/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-927-48",
                    "description": "1 VIAL in 1 CARTON (68135-927-48)  / 8 mL in 1 VIAL (68135-927-01)",
                    "marketing_start_date": "20230629",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "2641614",
                    "2641620"
                ],
                "spl_set_id": [
                    "0dcf7185-8e1c-456a-9d4e-7cc316400118"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "681K1JDI8M"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7c49308f-9139-4ef8-a16c-3714b8ceca6e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230629",
            "product_id": "68135-927_7c49308f-9139-4ef8-a16c-3714b8ceca6e",
            "application_number": "BLA125720",
            "brand_name_base": "ROCTAVIAN"
        },
        {
            "product_ndc": "76961-101",
            "generic_name": "eflapegrastim-xnst",
            "labeler_name": "Spectrum Pharmaceuticals, Inc.",
            "brand_name": "Rolvedon",
            "active_ingredients": [
                {
                    "name": "EFLAPEGRASTIM",
                    "strength": "13.2 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "76961-101-01",
                    "description": ".6 mL in 1 SYRINGE, GLASS (76961-101-01)",
                    "marketing_start_date": "20221018",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Spectrum Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2612541",
                    "2612547"
                ],
                "spl_set_id": [
                    "6e436115-62e7-4729-aeb0-ff78ea685206"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "UT99UG9QJX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "fef6a8ce-e6c0-4b14-91a2-babbfa72c19f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20221018",
            "product_id": "76961-101_fef6a8ce-e6c0-4b14-91a2-babbfa72c19f",
            "application_number": "BLA761148",
            "brand_name_base": "Rolvedon",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "0037-0066",
            "generic_name": "mesalamine",
            "labeler_name": "Meda Pharmaceuticals Inc.",
            "brand_name": "Rowasa",
            "active_ingredients": [
                {
                    "name": "MESALAMINE",
                    "strength": "4 g/60mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0037-0066-03",
                    "description": "28 BOTTLE, DISPENSING in 1 CARTON (0037-0066-03)  / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06)",
                    "marketing_start_date": "20160324",
                    "sample": false
                },
                {
                    "package_ndc": "0037-0066-05",
                    "description": "7 BOTTLE, DISPENSING in 1 CARTON (0037-0066-05)  / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06)",
                    "marketing_start_date": "20160324",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "206798",
                    "238151"
                ],
                "spl_set_id": [
                    "e505ab99-1943-4216-a178-4d5dbe64e3b2"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175781",
                    "M0000971"
                ],
                "pharm_class_epc": [
                    "Aminosalicylate [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminosalicylic Acids [CS]"
                ],
                "unii": [
                    "4Q81I59GXC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "28f60c73-ba42-4081-b2d3-c83b3298a92e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RECTAL"
            ],
            "marketing_start_date": "20160324",
            "product_id": "0037-0066_28f60c73-ba42-4081-b2d3-c83b3298a92e",
            "application_number": "NDA019618",
            "brand_name_base": "Rowasa",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "64764-805",
            "generic_name": "ramelteon",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Rozerem",
            "active_ingredients": [
                {
                    "name": "RAMELTEON",
                    "strength": "8 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-805-10",
                    "description": "100 TABLET, FILM COATED in 1 BOTTLE (64764-805-10)",
                    "marketing_start_date": "20050722",
                    "sample": false
                },
                {
                    "package_ndc": "64764-805-22",
                    "description": "6 CARTON in 1 TRAY (64764-805-22)  / 1 BLISTER PACK in 1 CARTON / 2 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20050722",
                    "sample": false
                },
                {
                    "package_ndc": "64764-805-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-805-30)",
                    "marketing_start_date": "20050722",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "577348",
                    "603162"
                ],
                "spl_set_id": [
                    "9de82310-70e8-47b9-b1fc-6c6848b99455"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364764805302"
                ],
                "nui": [
                    "N0000175743",
                    "N0000000250"
                ],
                "pharm_class_epc": [
                    "Melatonin Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Melatonin Receptor Agonists [MoA]"
                ],
                "unii": [
                    "901AS54I69"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "2dd3b589-791d-4151-8d80-357f6144d565",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20050722",
            "product_id": "64764-805_2dd3b589-791d-4151-8d80-357f6144d565",
            "application_number": "NDA021782",
            "brand_name_base": "Rozerem",
            "pharm_class": [
                "Melatonin Receptor Agonist [EPC]",
                "Melatonin Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "50242-091",
            "generic_name": "ENTRECTINIB",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Rozlytrek",
            "active_ingredients": [
                {
                    "name": "ENTRECTINIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-091-30",
                    "description": "1 BOTTLE in 1 CARTON (50242-091-30)  / 30 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20190815",
                    "sample": false
                },
                {
                    "package_ndc": "50242-091-86",
                    "description": "1 BOTTLE in 1 CARTON (50242-091-86)  / 30 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20190815",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2197867",
                    "2197873",
                    "2197875",
                    "2197877",
                    "2668595",
                    "2668599"
                ],
                "spl_set_id": [
                    "c7c71b0c-2549-4495-86b6-c2807fa54908"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "L5ORF0AN1I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "ee7c6575-9d2f-4676-8ade-a98937280cad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190815",
            "product_id": "50242-091_ee7c6575-9d2f-4676-8ade-a98937280cad",
            "application_number": "NDA212725",
            "brand_name_base": "Rozlytrek"
        },
        {
            "product_ndc": "69660-202",
            "marketing_end_date": "20250731",
            "generic_name": "rucaparib",
            "labeler_name": "Clovis Oncology, Inc.",
            "brand_name": "Rubraca",
            "active_ingredients": [
                {
                    "name": "RUCAPARIB CAMSYLATE",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69660-202-91",
                    "description": "60 TABLET, FILM COATED in 1 BOTTLE (69660-202-91)",
                    "marketing_start_date": "20170501",
                    "marketing_end_date": "20250731",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Clovis Oncology, Inc."
                ],
                "rxcui": [
                    "1862584",
                    "1862590",
                    "1862593",
                    "1862595",
                    "1921587",
                    "1921589"
                ],
                "spl_set_id": [
                    "a6d46c03-bb1d-417b-b8e5-3bffe352fe29"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0369660202910",
                    "0369660201913",
                    "0369660203917"
                ],
                "unii": [
                    "41AX9SJ8KO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "11e8806a-90c0-33ff-e063-6394a90a5993",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170501",
            "product_id": "69660-202_11e8806a-90c0-33ff-e063-6394a90a5993",
            "application_number": "NDA209115",
            "brand_name_base": "Rubraca",
            "pharm_class": [
                "Poly(ADP-Ribose) Polymerase Inhibitor [EPC]",
                "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "69913-350",
            "generic_name": "c1 esterase inhibitor recombinant",
            "labeler_name": "Tjoapack Netherlands BV",
            "brand_name": "Ruconest",
            "active_ingredients": [
                {
                    "name": "CONESTAT ALFA",
                    "strength": "2100 U/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69913-350-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (69913-350-01)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20160919",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Tjoapack Netherlands BV"
                ],
                "rxcui": [
                    "1599836",
                    "1599841"
                ],
                "spl_set_id": [
                    "3cf4c3f5-5230-277e-e054-00144ff8d46c"
                ],
                "unii": [
                    "5QS67N4551"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
            "spl_id": "ebd482fb-dd8a-6296-e053-2a95a90ad5e1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20160919",
            "product_id": "69913-350_ebd482fb-dd8a-6296-e053-2a95a90ad5e1",
            "application_number": "BLA125495",
            "brand_name_base": "Ruconest"
        },
        {
            "product_ndc": "49702-250",
            "generic_name": "fostemsavir tromethamine",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "Rukobia",
            "active_ingredients": [
                {
                    "name": "FOSTEMSAVIR TROMETHAMINE",
                    "strength": "600 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-250-18",
                    "description": "1 BOTTLE in 1 CARTON (49702-250-18)  / 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20200702",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "2380549",
                    "2380551"
                ],
                "spl_set_id": [
                    "a21006b7-6d6f-4f06-81b4-17978756452b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "2X513P36U0"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
            "spl_id": "8842727b-fc4a-42cc-84cd-82e3b354ffd7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200702",
            "product_id": "49702-250_8842727b-fc4a-42cc-84cd-82e3b354ffd7",
            "application_number": "NDA212950",
            "brand_name_base": "Rukobia"
        },
        {
            "product_ndc": "0169-4303",
            "generic_name": "Oral Semaglutide",
            "labeler_name": "Novo Nordisk",
            "brand_name": "RYBELSUS",
            "active_ingredients": [
                {
                    "name": "SEMAGLUTIDE",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-4303-30",
                    "description": "30 TABLET in 1 BOTTLE, GLASS (0169-4303-30)",
                    "marketing_start_date": "20211004",
                    "sample": false
                },
                {
                    "package_ndc": "0169-4303-99",
                    "description": "30 TABLET in 1 BOTTLE, GLASS (0169-4303-99)",
                    "marketing_start_date": "20211004",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "2200644",
                    "2200650",
                    "2200652",
                    "2200654",
                    "2200656",
                    "2200658"
                ],
                "spl_set_id": [
                    "27f15fac-7d98-4114-a2ec-92494a91da98"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000178480",
                    "M0160181",
                    "N0000020058"
                ],
                "pharm_class_epc": [
                    "GLP-1 Receptor Agonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glucagon-Like Peptide 1 [CS]"
                ],
                "pharm_class_moa": [
                    "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
                ],
                "unii": [
                    "53AXN4NNHX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "0a4a4dee-6b60-4edf-9856-854e7bd49a4b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190920",
            "product_id": "0169-4303_0a4a4dee-6b60-4edf-9856-854e7bd49a4b",
            "application_number": "NDA213051",
            "brand_name_base": "RYBELSUS",
            "pharm_class": [
                "GLP-1 Receptor Agonist [EPC]",
                "Glucagon-Like Peptide 1 [CS]",
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "57894-501",
            "generic_name": "Amivantamab",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "Rybrevant",
            "active_ingredients": [
                {
                    "name": "AMIVANTAMAB",
                    "strength": "350 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-501-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01)  / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00)",
                    "marketing_start_date": "20210521",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "2549734",
                    "2549739"
                ],
                "spl_set_id": [
                    "1466c070-9f97-4fa4-a955-6a6b59981fb8"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0357894501015"
                ],
                "unii": [
                    "0JSR7Z0NB6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "13314d95-72d3-d40e-e063-6294a90a3984",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210521",
            "product_id": "57894-501_13314d95-72d3-d40e-e063-6294a90a3984",
            "application_number": "BLA761210",
            "brand_name_base": "Rybrevant"
        },
        {
            "product_ndc": "0078-0698",
            "generic_name": "RYDAPT",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "RYDAPT",
            "active_ingredients": [
                {
                    "name": "MIDOSTAURIN",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0698-19",
                    "description": "4 CARTON in 1 CARTON (0078-0698-19)  / 14 BLISTER PACK in 1 CARTON (0078-0698-51)  / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)",
                    "marketing_start_date": "20170428",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0698-99",
                    "description": "2 CARTON in 1 CARTON (0078-0698-99)  / 14 BLISTER PACK in 1 CARTON (0078-0698-51)  / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)",
                    "marketing_start_date": "20170428",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1919088"
                ],
                "spl_set_id": [
                    "11fa3fc9-6776-49a6-b1c1-653f627c3e58"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020000"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Receptor Tyrosine Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "ID912S5VON"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, LIQUID FILLED",
            "spl_id": "d33f12ce-c74d-487e-81db-86fd5c265c94",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170428",
            "product_id": "0078-0698_d33f12ce-c74d-487e-81db-86fd5c265c94",
            "application_number": "NDA207997",
            "brand_name_base": "RYDAPT",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Receptor Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "68727-900",
            "generic_name": "asparaginase erwinia chrysanthemi (recombinant)-rywn",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "brand_name": "Rylaze",
            "active_ingredients": [
                {
                    "name": "ASPARAGINASE",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68727-900-03",
                    "description": "3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03)  / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01)",
                    "marketing_start_date": "20210630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2561251",
                    "2561256"
                ],
                "spl_set_id": [
                    "857e53aa-1098-4dad-b654-0276cdd43e03"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0001815",
                    "N0000175669"
                ],
                "pharm_class_cs": [
                    "Asparaginase [CS]"
                ],
                "pharm_class_epc": [
                    "Asparagine-specific Enzyme [EPC]"
                ],
                "unii": [
                    "G4FQ3CKY5R"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "4fedcfdc-413f-4c27-8657-5a446b63d091",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20210630",
            "product_id": "68727-900_4fedcfdc-413f-4c27-8657-5a446b63d091",
            "application_number": "BLA761179",
            "brand_name_base": "Rylaze",
            "pharm_class": [
                "Asparaginase [CS]",
                "Asparagine-specific Enzyme [EPC]"
            ]
        },
        {
            "product_ndc": "50474-981",
            "generic_name": "ROZANOLIXIZUMAB",
            "labeler_name": "UCB, Inc.",
            "brand_name": "RYSTIGGO",
            "active_ingredients": [
                {
                    "name": "ROZANOLIXIZUMAB",
                    "strength": "140 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "spl_set_id": [
                    "3c0eb8c2-c042-4954-b451-3baa77f5e6d1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194004",
                    "N0000194005"
                ],
                "pharm_class_epc": [
                    "Neonatal Fc Receptor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Neonatal Fc Receptor Blockers [MoA]"
                ],
                "unii": [
                    "P7186074QC"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "c6e71126-50c1-4ae2-9d82-b053d605b9cb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20240614",
            "product_id": "50474-981_c6e71126-50c1-4ae2-9d82-b053d605b9cb",
            "application_number": "BLA761286",
            "brand_name_base": "RYSTIGGO",
            "pharm_class": [
                "Neonatal Fc Receptor Blocker [EPC]",
                "Neonatal Fc Receptor Blockers [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "70709-013",
            "generic_name": "ICATIBANT",
            "labeler_name": "Cycle Pharmaceuticals Ltd-Uk",
            "brand_name": "SAJAZIR",
            "active_ingredients": [
                {
                    "name": "ICATIBANT ACETATE",
                    "strength": "30 mg/3mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70709-013-01",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (70709-013-01)  / 3 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20210603",
                    "sample": false
                },
                {
                    "package_ndc": "70709-013-03",
                    "description": "3 SYRINGE, GLASS in 1 CARTON (70709-013-03)  / 3 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20210603",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Cycle Pharmaceuticals Ltd-Uk"
                ],
                "rxcui": [
                    "1148141",
                    "2569480"
                ],
                "spl_set_id": [
                    "1756aca0-21a1-4898-8d6c-9666738db45c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "325O8467XK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION",
            "spl_id": "98f58ca8-04a0-4453-adf0-b000d3bcfae1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20210603",
            "product_id": "70709-013_98f58ca8-04a0-4453-adf0-b000d3bcfae1",
            "application_number": "ANDA212446",
            "brand_name_base": "SAJAZIR",
            "pharm_class": [
                "Bradykinin B2 Receptor Antagonist [EPC]",
                "Bradykinin B2 Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "42747-726",
            "generic_name": "granisetron",
            "labeler_name": "Kyowa Kirin, Inc.",
            "brand_name": "SANCUSO",
            "active_ingredients": [
                {
                    "name": "GRANISETRON",
                    "strength": "3.1 mg/24h"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "42747-726-01",
                    "description": "1 POUCH in 1 CARTON (42747-726-01)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH",
                    "marketing_start_date": "20080912",
                    "sample": false
                },
                {
                    "package_ndc": "42747-726-72",
                    "description": "1 POUCH in 1 CARTON (42747-726-72)  / 1 PATCH in 1 POUCH / 168 h in 1 PATCH",
                    "marketing_start_date": "20080912",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Kyowa Kirin, Inc."
                ],
                "rxcui": [
                    "825003",
                    "825005"
                ],
                "spl_set_id": [
                    "ba44e7d8-0c71-4eb9-a951-3d91038293c5"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175817",
                    "N0000175818"
                ],
                "pharm_class_moa": [
                    "Serotonin 3 Receptor Antagonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Serotonin-3 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "WZG3J2MCOL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "PATCH",
            "spl_id": "20296b0f-9faf-4d20-8a5a-f631d743f7d1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TRANSDERMAL"
            ],
            "marketing_start_date": "20080912",
            "product_id": "42747-726_20296b0f-9faf-4d20-8a5a-f631d743f7d1",
            "application_number": "NDA022198",
            "brand_name_base": "SANCUSO",
            "pharm_class": [
                "Serotonin 3 Receptor Antagonists [MoA]",
                "Serotonin-3 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0811",
            "generic_name": "octreotide acetate",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Sandostatin LAR Depot",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0811-81",
                    "description": "1 KIT in 1 KIT (0078-0811-81)  *  6 mL in 1 VIAL (0078-0790-61)  *  2 mL in 1 SYRINGE",
                    "marketing_start_date": "20160722",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "898589",
                    "898591",
                    "898601",
                    "898603",
                    "898605",
                    "898607"
                ],
                "spl_set_id": [
                    "d0b7fe9e-7000-4b79-ba3b-291ce92c14f9"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "09e3ff5f-554a-4922-9478-d87d52e842d0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20160722",
            "product_id": "0078-0811_09e3ff5f-554a-4922-9478-d87d52e842d0",
            "application_number": "NDA021008",
            "brand_name_base": "Sandostatin LAR Depot"
        },
        {
            "product_ndc": "50484-010",
            "generic_name": "COLLAGENASE SANTYL",
            "labeler_name": "SMITH & NEPHEW, INC",
            "brand_name": "COLLAGENASE SANTYL",
            "active_ingredients": [
                {
                    "name": "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM",
                    "strength": "250 [arb'U]/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50484-010-30",
                    "description": "1 TUBE in 1 CARTON (50484-010-30)  / 30 g in 1 TUBE",
                    "marketing_start_date": "20061018",
                    "sample": false
                },
                {
                    "package_ndc": "50484-010-90",
                    "description": "1 TUBE in 1 CARTON (50484-010-90)  / 90 g in 1 TUBE",
                    "marketing_start_date": "20140310",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "SMITH & NEPHEW, INC"
                ],
                "rxcui": [
                    "309509"
                ],
                "spl_set_id": [
                    "6b6fbfc6-98fa-46aa-88ef-ab00fbb08ffd"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0350484010300"
                ],
                "unii": [
                    "9X7O8V25IT"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "OINTMENT",
            "spl_id": "155959d1-0367-4fb6-8877-29099d08801c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20061018",
            "product_id": "50484-010_155959d1-0367-4fb6-8877-29099d08801c",
            "application_number": "BLA101995",
            "brand_name_base": "COLLAGENASE SANTYL",
            "pharm_class": [
                "Collagen-specific Enzyme [EPC]",
                "Collagenases [Chemical/Ingredient]"
            ]
        },
        {
            "product_ndc": "0310-3040",
            "generic_name": "Anifrolumab",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "SAPHNELO",
            "active_ingredients": [
                {
                    "name": "ANIFROLUMAB",
                    "strength": "300 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-3040-00",
                    "description": "1 VIAL, GLASS in 1 CARTON (0310-3040-00)  / 2 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20210730",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2565280",
                    "2565286"
                ],
                "spl_set_id": [
                    "d6203302-2128-41a7-b0b4-0e6c0704d4dc"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193967",
                    "N0000193968"
                ],
                "pharm_class_epc": [
                    "Type I Interferon Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Type I Interferon Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "38RL9AE51Q"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "93c04307-195c-45f1-abf5-86ec682b1bd9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210730",
            "product_id": "0310-3040_93c04307-195c-45f1-abf5-86ec682b1bd9",
            "application_number": "BLA761123",
            "brand_name_base": "SAPHNELO",
            "pharm_class": [
                "Type I Interferon Receptor Antagonist [EPC]",
                "Type I Interferon Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "58264-0083",
            "generic_name": "Achillea Millefolium, Arnica montana, Hypericum perforatum, Horse Chestnut, and Viscum Album Whole",
            "labeler_name": "DNA Labs, Inc.",
            "brand_name": "D82",
            "active_ingredients": [
                {
                    "name": "ACHILLEA MILLEFOLIUM",
                    "strength": "3 [hp_X]/mL"
                },
                {
                    "name": "ARNICA MONTANA",
                    "strength": "6 [hp_X]/mL"
                },
                {
                    "name": "HORSE CHESTNUT",
                    "strength": "2 [hp_X]/mL"
                },
                {
                    "name": "HYPERICUM PERFORATUM",
                    "strength": "3 [hp_X]/mL"
                },
                {
                    "name": "VISCUM ALBUM WHOLE",
                    "strength": "3 [hp_X]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58264-0083-1",
                    "description": "29.57 mL in 1 BOTTLE, DROPPER (58264-0083-1)",
                    "marketing_start_date": "19900101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "DNA Labs, Inc."
                ],
                "spl_set_id": [
                    "2c24bb97-11be-450a-9cf9-5aadca1e8be1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "2FXJ6SW4PK",
                    "O80TY208ZW",
                    "3C18L6RJAZ",
                    "XK4IUX8MNB",
                    "E6839Q6DO1"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "SOLUTION",
            "spl_id": "e0baf5c9-bcee-366b-e053-2995a90a6343",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "SUBLINGUAL"
            ],
            "marketing_start_date": "19900101",
            "product_id": "58264-0083_e0baf5c9-bcee-366b-e053-2995a90a6343",
            "brand_name_base": "D82"
        },
        {
            "product_ndc": "0024-0656",
            "generic_name": "isatuximab",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "Sarclisa",
            "active_ingredients": [
                {
                    "name": "ISATUXIMAB",
                    "strength": "500 mg/25mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-0656-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0024-0656-01)  / 25 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200302",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "2282023",
                    "2282028",
                    "2282031",
                    "2282032"
                ],
                "spl_set_id": [
                    "a0473462-6f9d-4eca-a5bf-8620aea68e8a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192336",
                    "N0000192335",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "CD38-directed Cytolytic Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "CD38-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "R30772KCU0"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "28ff7199-64c9-49e9-b2bf-bee766b297d3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200302",
            "product_id": "0024-0656_28ff7199-64c9-49e9-b2bf-bee766b297d3",
            "application_number": "BLA761113",
            "brand_name_base": "Sarclisa",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "CD38-directed Antibody Interactions [MoA]",
                "CD38-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "0456-1500",
            "generic_name": "milnacipran hydrochloride",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "Savella",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0456-1500-55",
                    "description": "1 BLISTER PACK in 1 CARTON (0456-1500-55)  / 1 KIT in 1 BLISTER PACK",
                    "marketing_start_date": "20090417",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "833135",
                    "833139",
                    "833141",
                    "833143",
                    "833144",
                    "833146",
                    "833147",
                    "833149",
                    "833150",
                    "833151"
                ],
                "spl_set_id": [
                    "16a4a314-f97e-4e91-95e9-576a3773d284"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0070100006110"
                ],
                "unii": [
                    "RNZ43O5WW5"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "74f2fe94-b6c9-4b23-a696-0d4ed5948a36",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20090417",
            "product_id": "0456-1500_74f2fe94-b6c9-4b23-a696-0d4ed5948a36",
            "application_number": "NDA022256",
            "brand_name_base": "Savella"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "49702-260",
            "generic_name": "maraviroc",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "SELZENTRY",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-260-55",
                    "description": "1 KIT in 1 CARTON (49702-260-55)  *  230 mL in 1 BOTTLE",
                    "marketing_start_date": "20201030",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "728223",
                    "728225",
                    "729201",
                    "729203",
                    "1857911",
                    "1857913",
                    "1857915",
                    "1857917",
                    "1857921",
                    "1857925"
                ],
                "spl_set_id": [
                    "46f30ac5-c96b-429e-976d-8c5ee1c0761b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175572",
                    "N0000175445"
                ],
                "pharm_class_epc": [
                    "CCR5 Co-receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Chemokine Co-receptor 5 Antagonists [MoA]"
                ],
                "unii": [
                    "MD6P741W8A"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "4311f8eb-096c-4fea-b61c-f5c53bb9f869",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20201030",
            "product_id": "49702-260_4311f8eb-096c-4fea-b61c-f5c53bb9f869",
            "application_number": "NDA208984",
            "brand_name_base": "SELZENTRY"
        },
        {
            "product_ndc": "49502-250",
            "generic_name": "insulin glargine-yfgn",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "SEMGLEE",
            "active_ingredients": [
                {
                    "name": "INSULIN GLARGINE",
                    "strength": "100 [iU]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-250-80",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (49502-250-80)  / 10 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20211115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "2563971",
                    "2563973",
                    "2563976",
                    "2563977"
                ],
                "spl_set_id": [
                    "84082072-bfab-4c3f-95f7-3fb3b443bfb2"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "2ZM8CX04RZ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "b48ff049-2c9c-4143-88c9-22e628281502",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20211115",
            "product_id": "49502-250_b48ff049-2c9c-4143-88c9-22e628281502",
            "application_number": "BLA761201",
            "brand_name_base": "SEMGLEE",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "44087-0006",
            "generic_name": "somatropin",
            "labeler_name": "EMD Serono, Inc.",
            "brand_name": "Serostim",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "44087-0006-7",
                    "description": "1 KIT in 1 CARTON (44087-0006-7)  *  1 mL in 1 VIAL *  1 mL in 1 VIAL",
                    "marketing_start_date": "19960823",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "EMD Serono, Inc."
                ],
                "rxcui": [
                    "248288",
                    "249453",
                    "346494",
                    "751566",
                    "751568",
                    "751570"
                ],
                "spl_set_id": [
                    "62b01d29-90f0-45b2-a0c4-3a750ba36c8a"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "40a8b335-3874-4c7c-a332-ae94dd7a48e8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19960823",
            "product_id": "44087-0006_40a8b335-3874-4c7c-a332-ae94dd7a48e8",
            "application_number": "BLA020604",
            "brand_name_base": "Serostim"
        },
        {
            "product_ndc": "71127-1000",
            "generic_name": "Coagulation Factor VIIa Recombinant Human",
            "labeler_name": "Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.)",
            "brand_name": "Sevenfact",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71127-1000-1",
                    "description": "1 KIT in 1 PACKAGE (71127-1000-1)  *  1.1 mL in 1 VIAL, SINGLE-USE (71127-1100-1)  *  1.1 mL in 1 SYRINGE (71127-1200-1)",
                    "marketing_start_date": "20230401",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.)"
                ],
                "rxcui": [
                    "2386865",
                    "2386870",
                    "2386872",
                    "2386874"
                ],
                "spl_set_id": [
                    "b23ad666-8ce0-4e0b-9eff-c6983ac5f7e6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0371127510018",
                    "0371127110010"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "8184fbca-ace3-4cab-bfba-218dc5cadfd3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20230401",
            "product_id": "71127-1000_8184fbca-ace3-4cab-bfba-218dc5cadfd3",
            "application_number": "BLA125641",
            "brand_name_base": "Sevenfact"
        },
        {
            "product_ndc": "0037-0066",
            "generic_name": "mesalamine",
            "labeler_name": "Meda Pharmaceuticals Inc.",
            "brand_name": "Rowasa",
            "active_ingredients": [
                {
                    "name": "MESALAMINE",
                    "strength": "4 g/60mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0037-0066-03",
                    "description": "28 BOTTLE, DISPENSING in 1 CARTON (0037-0066-03)  / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06)",
                    "marketing_start_date": "20160324",
                    "sample": false
                },
                {
                    "package_ndc": "0037-0066-05",
                    "description": "7 BOTTLE, DISPENSING in 1 CARTON (0037-0066-05)  / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06)",
                    "marketing_start_date": "20160324",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Meda Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "206798",
                    "238151"
                ],
                "spl_set_id": [
                    "e505ab99-1943-4216-a178-4d5dbe64e3b2"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175781",
                    "M0000971"
                ],
                "pharm_class_epc": [
                    "Aminosalicylate [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminosalicylic Acids [CS]"
                ],
                "unii": [
                    "4Q81I59GXC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "28f60c73-ba42-4081-b2d3-c83b3298a92e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RECTAL"
            ],
            "marketing_start_date": "20160324",
            "product_id": "0037-0066_28f60c73-ba42-4081-b2d3-c83b3298a92e",
            "application_number": "NDA019618",
            "brand_name_base": "Rowasa",
            "pharm_class": [
                "Aminosalicylate [EPC]",
                "Aminosalicylic Acids [CS]"
            ]
        },
        {
            "product_ndc": "58160-819",
            "marketing_end_date": "20250823",
            "generic_name": "Zoster Vaccine Recombinant, Adjuvanted",
            "labeler_name": "GlaxoSmithKline Biologicals SA",
            "brand_name": "Shingrix",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58160-819-12",
                    "description": "1 KIT in 1 CARTON (58160-819-12)  *  .5 mL in 1 VIAL (58160-828-01)  *  .5 mL in 1 VIAL (58160-829-01)",
                    "marketing_start_date": "20171020",
                    "marketing_end_date": "20250823",
                    "sample": false
                }
            ],
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "864c964b-45aa-4c06-bbd7-2da63e6b3220",
            "product_type": "VACCINE",
            "marketing_start_date": "20171020",
            "product_id": "58160-819_864c964b-45aa-4c06-bbd7-2da63e6b3220",
            "application_number": "BLA125614",
            "brand_name_base": "Shingrix"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "71770-105",
            "generic_name": "hydroxyurea",
            "labeler_name": "Medunik",
            "brand_name": "Siklos",
            "active_ingredients": [
                {
                    "name": "HYDROXYUREA",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71770-105-60",
                    "description": "1 BOTTLE in 1 CARTON (71770-105-60)  / 60 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20201015",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Medunik"
                ],
                "rxcui": [
                    "283475",
                    "1999308",
                    "1999314",
                    "1999316"
                ],
                "spl_set_id": [
                    "76957c0d-0f98-4376-bb06-eee651adc09d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000180853",
                    "M0022315"
                ],
                "pharm_class_epc": [
                    "Antimetabolite [EPC]"
                ],
                "pharm_class_cs": [
                    "Urea [CS]"
                ],
                "unii": [
                    "X6Q56QN5QC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "9a8e5e5d-2225-4d17-ae10-287fa1ee0616",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201015",
            "product_id": "71770-105_9a8e5e5d-2225-4d17-ae10-287fa1ee0616",
            "application_number": "NDA208843",
            "brand_name_base": "Siklos",
            "pharm_class": [
                "Antimetabolite [EPC]",
                "Urea [CS]"
            ]
        },
        {
            "product_ndc": "0187-0004",
            "generic_name": "Brodalumab",
            "labeler_name": "Bausch Health US LLC",
            "brand_name": "Siliq",
            "active_ingredients": [
                {
                    "name": "BRODALUMAB",
                    "strength": "210 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-0004-02",
                    "description": "2 SYRINGE in 1 CARTON (0187-0004-02)  / 1 INJECTION in 1 SYRINGE (0187-0004-00)",
                    "marketing_start_date": "20170215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US LLC"
                ],
                "rxcui": [
                    "1872256",
                    "1872261"
                ],
                "spl_set_id": [
                    "1a550c33-456a-4833-814e-8591aea7c688"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193276",
                    "N0000193279",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Interleukin-17 Receptor A Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin 17 Receptor A Antagonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "6ZA31Y954Z"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "044e3e17-7930-63ae-e063-6294a90acb9b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20170215",
            "product_id": "0187-0004_044e3e17-7930-63ae-e063-6294a90acb9b",
            "application_number": "BLA761032",
            "brand_name_base": "Siliq",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Interleukin 17 Receptor A Antagonists [MoA]",
                "Interleukin-17 Receptor A Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "57894-070",
            "generic_name": "golimumab",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "Simponi",
            "active_ingredients": [
                {
                    "name": "GOLIMUMAB",
                    "strength": "50 mg/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-070-01",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (57894-070-01)  / .5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20090425",
                    "sample": false
                },
                {
                    "package_ndc": "57894-070-02",
                    "description": "1 SYRINGE in 1 CARTON (57894-070-02)  / .5 mL in 1 SYRINGE",
                    "marketing_start_date": "20090425",
                    "sample": false
                },
                {
                    "package_ndc": "57894-070-89",
                    "description": "1 SYRINGE in 1 CARTON (57894-070-89)  / .5 mL in 1 SYRINGE",
                    "marketing_start_date": "20090425",
                    "sample": false
                },
                {
                    "package_ndc": "57894-070-90",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (57894-070-90)  / .5 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20090425",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "848160",
                    "848164",
                    "1482813",
                    "1482814",
                    "1653142",
                    "1653144",
                    "1653165",
                    "1653166"
                ],
                "spl_set_id": [
                    "f86cb4a7-c358-4136-ae57-b32bda9bba00"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175610",
                    "N0000175451"
                ],
                "pharm_class_epc": [
                    "Tumor Necrosis Factor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
                ],
                "unii": [
                    "91X1KLU43E"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "0aad0e31-d37e-4a67-e063-6294a90ac9b0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20090425",
            "product_id": "57894-070_0aad0e31-d37e-4a67-e063-6294a90ac9b0",
            "application_number": "BLA125289",
            "brand_name_base": "Simponi",
            "pharm_class": [
                "Tumor Necrosis Factor Blocker [EPC]",
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "50419-422",
            "generic_name": "Levonorgestrel",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Skyla",
            "active_ingredients": [
                {
                    "name": "LEVONORGESTREL",
                    "strength": "13.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-422-01",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-422-01)",
                    "marketing_start_date": "20130111",
                    "sample": false
                },
                {
                    "package_ndc": "50419-422-08",
                    "description": "1 INTRAUTERINE DEVICE in 1 CARTON (50419-422-08)",
                    "marketing_start_date": "20130111",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1366334",
                    "1366339"
                ],
                "spl_set_id": [
                    "9f44ff35-e052-49cd-a1c2-0bfd87d49309"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175830",
                    "M0447349",
                    "N0000175602",
                    "N0000175832"
                ],
                "pharm_class_pe": [
                    "Inhibit Ovum Fertilization [PE]"
                ],
                "pharm_class_cs": [
                    "Progesterone Congeners [CS]"
                ],
                "pharm_class_epc": [
                    "Progestin [EPC]",
                    "Progestin-containing Intrauterine System [EPC]"
                ],
                "unii": [
                    "5W7SIA7YZW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INTRAUTERINE DEVICE",
            "spl_id": "157ce370-1ff2-4a01-88bf-a1117aeb8c19",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAUTERINE"
            ],
            "marketing_start_date": "20130111",
            "product_id": "50419-422_157ce370-1ff2-4a01-88bf-a1117aeb8c19",
            "application_number": "NDA203159",
            "brand_name_base": "Skyla",
            "pharm_class": [
                "Inhibit Ovum Fertilization [PE]",
                "Progesterone Congeners [CS]",
                "Progesterone Congeners [CS]",
                "Progestin [EPC]",
                "Progestin-containing Intrauterine Device [EPC]"
            ]
        },
        {
            "product_ndc": "0074-1070",
            "generic_name": "Risankizumab-rzaa",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Skyrizi",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-1070-01",
                    "description": "1 KIT in 1 CARTON (0074-1070-01)  *  2.4 mL in 1 CARTRIDGE (0074-1069-02)  *  2.4 mL in 1 CARTRIDGE (0074-1069-01)",
                    "marketing_start_date": "20220616",
                    "sample": false
                },
                {
                    "package_ndc": "0074-1070-02",
                    "description": "1 KIT in 1 CARTON (0074-1070-02)  *  2.4 mL in 1 CARTRIDGE (0074-1069-02)  *  2.4 mL in 1 CARTRIDGE (0074-1069-01)",
                    "marketing_start_date": "20220616",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "797544",
                    "2166136",
                    "2166137",
                    "2166142",
                    "2166143",
                    "2540692",
                    "2540695",
                    "2540698",
                    "2540699",
                    "2604618",
                    "2604622",
                    "2604625",
                    "2604628",
                    "2613758",
                    "2613759",
                    "2632994",
                    "2632997",
                    "2632999",
                    "2633000",
                    "2633001",
                    "2633002"
                ],
                "spl_set_id": [
                    "7148c8eb-b39e-e20a-6494-a6df82392858"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192799",
                    "N0000192798"
                ],
                "pharm_class_epc": [
                    "Interleukin-23 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-23 Antagonists [MoA]"
                ],
                "unii": [
                    "90ZX3Q3FR7"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "ce9135ea-89c8-4519-9d08-8beb4e473336",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220616",
            "product_id": "0074-1070_ce9135ea-89c8-4519-9d08-8beb4e473336",
            "application_number": "BLA761105",
            "brand_name_base": "Skyrizi"
        },
        {
            "product_ndc": "73362-005",
            "generic_name": "Lonapegsomatropin-tcgd",
            "labeler_name": "Ascendis Pharma Endocrinology, Inc.",
            "brand_name": "Skytrofa",
            "active_ingredients": [
                {
                    "name": "LONAPEGSOMATROPIN",
                    "strength": "4.3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73362-005-01",
                    "description": "4 BLISTER PACK in 1 CARTON (73362-005-01)  / 1 CARTRIDGE in 1 BLISTER PACK (73362-005-02)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTRIDGE",
                    "marketing_start_date": "20210825",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Ascendis Pharma Endocrinology, Inc."
                ],
                "rxcui": [
                    "2569603",
                    "2569605",
                    "2569607",
                    "2569609",
                    "2569611",
                    "2569613",
                    "2569615",
                    "2569617",
                    "2569619",
                    "2569621",
                    "2569623",
                    "2569625",
                    "2569627",
                    "2569629",
                    "2569631",
                    "2569633",
                    "2569635",
                    "2569637"
                ],
                "spl_set_id": [
                    "9229f871-bc61-4ddc-8122-d126d40e36ac"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175606",
                    "M0028842"
                ],
                "pharm_class_epc": [
                    "Recombinant Human Growth Hormone [EPC]"
                ],
                "pharm_class_cs": [
                    "Human Growth Hormone [CS]"
                ],
                "unii": [
                    "OP35X9610Y"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "da6dc8ae-337b-415b-a181-069b8a6d54be",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20210825",
            "product_id": "73362-005_da6dc8ae-337b-415b-a181-069b8a6d54be",
            "application_number": "BLA761177",
            "brand_name_base": "Skytrofa",
            "pharm_class": [
                "Human Growth Hormone [CS]",
                "Recombinant Human Growth Hormone [EPC]"
            ]
        },
        {
            "product_ndc": "0169-2030",
            "generic_name": "somapacitan-beco",
            "labeler_name": "Novo Nordisk",
            "brand_name": "SOGROYA",
            "active_ingredients": [
                {
                    "name": "SOMAPACITAN",
                    "strength": "6.7 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-2030-11",
                    "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-2030-11)  / 1.5 mL in 1 SYRINGE, PLASTIC",
                    "marketing_start_date": "20230501",
                    "sample": false
                },
                {
                    "package_ndc": "0169-2030-90",
                    "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-2030-90)  / 1.5 mL in 1 SYRINGE, PLASTIC",
                    "marketing_start_date": "20230501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "2557398",
                    "2557403",
                    "2571802",
                    "2571805",
                    "2636951",
                    "2636954"
                ],
                "spl_set_id": [
                    "eadd03b4-adc3-4b88-8a24-9d205c5b85aa"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8FOJ430U94"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "49f6746f-c935-45c4-af35-02df5db71e87",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230501",
            "product_id": "0169-2030_49f6746f-c935-45c4-af35-02df5db71e87",
            "application_number": "BLA761156",
            "brand_name_base": "SOGROYA"
        },
        {
            "product_ndc": "15054-0010",
            "generic_name": "palovarotene",
            "labeler_name": "Ipsen Biopharmaceuticals, Inc.",
            "brand_name": "SOHONOS",
            "active_ingredients": [
                {
                    "name": "PALOVAROTENE",
                    "strength": "1 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "15054-0010-1",
                    "description": "1 BLISTER PACK in 1 CARTON (15054-0010-1)  / 14 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20230816",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Ipsen Biopharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2663960",
                    "2663966",
                    "2663968",
                    "2663970",
                    "2663972",
                    "2663974",
                    "2663976",
                    "2663978",
                    "2663980",
                    "2663982"
                ],
                "spl_set_id": [
                    "67dce406-7cc4-4d66-92de-ad18b6df0625"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175607",
                    "M0018962"
                ],
                "pharm_class_epc": [
                    "Retinoid [EPC]"
                ],
                "pharm_class_cs": [
                    "Retinoids [CS]"
                ],
                "unii": [
                    "28K6I5M16G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "a370c8c8-9a5f-47df-b230-6ecbcc6dfa88",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230816",
            "product_id": "15054-0010_a370c8c8-9a5f-47df-b230-6ecbcc6dfa88",
            "application_number": "NDA215559",
            "brand_name_base": "SOHONOS"
        },
        {
            "product_ndc": "0024-5761",
            "generic_name": "insulin glargine and lixisenatide",
            "labeler_name": "sanofi-aventis U.S. LLC",
            "brand_name": "Soliqua 100/33",
            "active_ingredients": [
                {
                    "name": "INSULIN GLARGINE",
                    "strength": "100 U/mL"
                },
                {
                    "name": "LIXISENATIDE",
                    "strength": "33 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5761-01",
                    "description": "1 SYRINGE in 1 CARTON (0024-5761-01)  / 3 mL in 1 SYRINGE",
                    "marketing_start_date": "20161121",
                    "sample": true
                },
                {
                    "package_ndc": "0024-5761-05",
                    "description": "5 SYRINGE in 1 CARTON (0024-5761-05)  / 3 mL in 1 SYRINGE (0024-5761-02)",
                    "marketing_start_date": "20161121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "sanofi-aventis U.S. LLC"
                ],
                "rxcui": [
                    "1858995",
                    "1859000"
                ],
                "spl_set_id": [
                    "4bba538b-cf7c-4310-ae8f-cb711ed21bcc"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453",
                    "N0000178480",
                    "M0160181",
                    "N0000020058"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]",
                    "Glucagon-Like Peptide 1 [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]",
                    "GLP-1 Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
                ],
                "unii": [
                    "2ZM8CX04RZ",
                    "74O62BB01U"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "6c6933a6-cede-46c0-8140-7b59797b03d2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20161121",
            "product_id": "0024-5761_6c6933a6-cede-46c0-8140-7b59797b03d2",
            "application_number": "BLA208673",
            "brand_name_base": "Soliqua 100/33",
            "pharm_class": [
                "GLP-1 Receptor Agonist [EPC]",
                "Glucagon-Like Peptide 1 [CS]",
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "25682-001",
            "generic_name": "ECULIZUMAB",
            "labeler_name": "Alexion Pharmaceuticals Inc.",
            "brand_name": "SOLIRIS",
            "active_ingredients": [
                {
                    "name": "ECULIZUMAB",
                    "strength": "300 mg/30mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "25682-001-01",
                    "description": "1 VIAL in 1 CARTON (25682-001-01)  / 30 mL in 1 VIAL",
                    "marketing_start_date": "20070402",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Alexion Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "700384",
                    "700387"
                ],
                "spl_set_id": [
                    "ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175575",
                    "N0000175974"
                ],
                "pharm_class_epc": [
                    "Complement Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Complement Inhibitors [MoA]"
                ],
                "unii": [
                    "A3ULP0F556"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "46c844f7-87ba-4235-af24-8144275207e3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20070402",
            "product_id": "25682-001_46c844f7-87ba-4235-af24-8144275207e3",
            "application_number": "BLA125166",
            "brand_name_base": "SOLIRIS",
            "pharm_class": [
                "Complement Inhibitor [EPC]",
                "Complement Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "99207-466",
            "marketing_end_date": "20241031",
            "generic_name": "minocycline hydrochloride",
            "labeler_name": "Bausch Health US LLC",
            "brand_name": "Solodyn",
            "active_ingredients": [
                {
                    "name": "MINOCYCLINE HYDROCHLORIDE",
                    "strength": "80 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "99207-466-02",
                    "description": "10 BOTTLE in 1 CARTON (99207-466-02)  / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100927",
                    "marketing_end_date": "20241031",
                    "sample": false
                },
                {
                    "package_ndc": "99207-466-30",
                    "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (99207-466-30)",
                    "marketing_start_date": "20100927",
                    "marketing_end_date": "20241031",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US LLC"
                ],
                "rxcui": [
                    "629695",
                    "629697",
                    "629699",
                    "727451",
                    "727452",
                    "750172",
                    "858062",
                    "858064",
                    "858372",
                    "858374",
                    "1013659",
                    "1013662",
                    "1013665",
                    "1014018",
                    "1014022",
                    "1014024"
                ],
                "spl_set_id": [
                    "1b9dfa57-f295-4038-8aec-8efc54817d07"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "0020414E5U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
            "spl_id": "bcf77466-9c0c-4ebf-a1ee-b41456b1e662",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100927",
            "product_id": "99207-466_bcf77466-9c0c-4ebf-a1ee-b41456b1e662",
            "application_number": "NDA050808",
            "brand_name_base": "Solodyn",
            "pharm_class": [
                "Decreased Prothrombin Activity [PE]",
                "Tetracycline-class Drug [EPC]",
                "Tetracyclines [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0009-7199",
            "generic_name": "pegvisomant",
            "labeler_name": "Pharmacia & Upjohn Company LLC",
            "brand_name": "SOMAVERT",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-7199-01",
                    "description": "1 KIT in 1 CARTON (0009-7199-01)  *  1 mL in 1 VIAL, SINGLE-DOSE (0009-5201-04)  *  1 mL in 1 SYRINGE (0009-5936-01)",
                    "marketing_start_date": "20161001",
                    "sample": false
                },
                {
                    "package_ndc": "0009-7199-30",
                    "description": "30 KIT in 1 CARTON (0009-7199-30)  / 1 KIT in 1 KIT *  1 mL in 1 VIAL, SINGLE-DOSE (0009-5201-04)  *  1 mL in 1 SYRINGE (0009-5936-01)",
                    "marketing_start_date": "20220117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pharmacia & Upjohn Company LLC"
                ],
                "rxcui": [
                    "403806",
                    "403807",
                    "403808",
                    "404457",
                    "404458",
                    "404459",
                    "1549323",
                    "1549452",
                    "1549454",
                    "1549456"
                ],
                "spl_set_id": [
                    "3cbb485b-6df1-49ce-8747-592b395b1988"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "390bdccc-18c4-4f26-adda-388273c9dfd0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20161001",
            "product_id": "0009-7199_390bdccc-18c4-4f26-adda-388273c9dfd0",
            "application_number": "BLA021106",
            "brand_name_base": "SOMAVERT"
        },
        {
            "product_ndc": "0003-0895",
            "generic_name": "deucravacitinib",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "SOTYKTU",
            "active_ingredients": [
                {
                    "name": "DEUCRAVACITINIB",
                    "strength": "6 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-0895-11",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0895-11)",
                    "marketing_start_date": "20220909",
                    "sample": false
                },
                {
                    "package_ndc": "0003-0895-91",
                    "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (0003-0895-91)",
                    "marketing_start_date": "20220909",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "2612092",
                    "2612098"
                ],
                "spl_set_id": [
                    "ff4d7258-5068-4cdf-9692-8cae04c3198e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194043",
                    "N0000194044"
                ],
                "pharm_class_epc": [
                    "Tyrosine Kinase 2 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tyrosine Kinase 2 Inhibitors [MoA]"
                ],
                "unii": [
                    "N0A21N6RAU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "ff4d7258-5068-4cdf-9692-8cae04c3198e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220909",
            "product_id": "0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e",
            "application_number": "NDA214958",
            "brand_name_base": "SOTYKTU"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0597-0035",
            "generic_name": "spesolimab-sbzo",
            "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "brand_name": "SPEVIGO",
            "active_ingredients": [
                {
                    "name": "SPESOLIMAB",
                    "strength": "60 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0597-0035-10",
                    "description": "2 VIAL, GLASS in 1 CARTON (0597-0035-10)  / 7.5 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20220901",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Boehringer Ingelheim Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2610422",
                    "2610428",
                    "2678979",
                    "2678984"
                ],
                "spl_set_id": [
                    "41a481ee-3062-45d1-aed5-17e8b105634d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194039",
                    "N0000194040"
                ],
                "pharm_class_epc": [
                    "Interleukin-36 Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-36 Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "5IB2J79MCX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "e9deb860-7f6d-4892-b85f-54faadf06cc5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220901",
            "product_id": "0597-0035_e9deb860-7f6d-4892-b85f-54faadf06cc5",
            "application_number": "BLA761244",
            "brand_name_base": "SPEVIGO",
            "pharm_class": [
                "Interleukin-36 Receptor Antagonist [EPC]",
                "Interleukin-36 Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0597-0160",
            "generic_name": "tiotropium bromide inhalation spray",
            "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "brand_name": "Spiriva Respimat",
            "active_ingredients": [
                {
                    "name": "TIOTROPIUM BROMIDE ANHYDROUS",
                    "strength": "1.562 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0597-0160-28",
                    "description": "1 CARTRIDGE in 1 CARTON (0597-0160-28)  / 28 SPRAY, METERED in 1 CARTRIDGE",
                    "marketing_start_date": "20150915",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0160-61",
                    "description": "1 CARTRIDGE in 1 CARTON (0597-0160-61)  / 60 SPRAY, METERED in 1 CARTRIDGE",
                    "marketing_start_date": "20150915",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Boehringer Ingelheim Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1552002",
                    "1552004",
                    "1552008",
                    "1552009",
                    "1667880",
                    "1667882",
                    "1667885",
                    "1667886",
                    "2166203",
                    "2166204"
                ],
                "spl_set_id": [
                    "7b656b14-fcaa-2741-f6f0-e0be48971c02"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "XX112XZP0J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY, METERED",
            "spl_id": "bf4399ac-101f-486b-8c8f-d48dffe32d63",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20150915",
            "product_id": "0597-0160_bf4399ac-101f-486b-8c8f-d48dffe32d63",
            "application_number": "NDA207070",
            "brand_name_base": "Spiriva Respimat",
            "pharm_class": [
                "Anticholinergic [EPC]",
                "Cholinergic Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "11673-943",
            "generic_name": "Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone",
            "labeler_name": "TARGET CORPORATION",
            "brand_name": "Target Up and Up Sport SPF 50",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "30 mg/g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "100 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "50 mg/g"
                },
                {
                    "name": "OCTOCRYLENE",
                    "strength": "40 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "50 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11673-943-32",
                    "description": "473 CAN in 1 PACKAGE (11673-943-32)  / 236.5 g in 1 CAN (11673-943-88)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-38",
                    "description": "312 g in 1 CAN (11673-943-38)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-48",
                    "description": "258 g in 1 CAN (11673-943-48)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-62",
                    "description": "468 CAN in 1 PACKAGE (11673-943-62)  / 156 g in 1 CAN (11673-943-37)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-63",
                    "description": "312 CAN in 1 PACKAGE (11673-943-63)  / 156 g in 1 CAN (11673-943-37)",
                    "marketing_start_date": "20140110",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TARGET CORPORATION"
                ],
                "spl_set_id": [
                    "b8434856-77ae-7c65-e053-2a95a90a8f76"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4X49Y0596W",
                    "5A68WGF6WM",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "SPRAY",
            "spl_id": "bc315679-c011-b41c-e053-2a95a90ad144",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20140110",
            "product_id": "11673-943_bc315679-c011-b41c-e053-2a95a90ad144",
            "application_number": "part352",
            "brand_name_base": "Target Up and Up Sport SPF 50"
        },
        {
            "product_ndc": "50458-028",
            "generic_name": "Esketamine Hydrochloride",
            "labeler_name": "Janssen Pharmaceuticals Inc.",
            "dea_schedule": "CIII",
            "brand_name": "Spravato",
            "active_ingredients": [
                {
                    "name": "ESKETAMINE HYDROCHLORIDE",
                    "strength": "28 mg/.2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50458-028-02",
                    "description": "2 BLISTER PACK in 1 KIT (50458-028-02)  / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00)",
                    "marketing_start_date": "20190305",
                    "sample": false
                },
                {
                    "package_ndc": "50458-028-03",
                    "description": "3 BLISTER PACK in 1 KIT (50458-028-03)  / 1 VIAL, SINGLE-USE in 1 BLISTER PACK / .2 mL in 1 VIAL, SINGLE-USE (50458-028-00)",
                    "marketing_start_date": "20190305",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2119381",
                    "2119387",
                    "2119388",
                    "2119389",
                    "2119390",
                    "2119391"
                ],
                "spl_set_id": [
                    "d81a6a79-a74a-44b7-822c-0dfa3036eaed"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "L8P1H35P2Z"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "088b53cb-a931-d9a7-e063-6294a90afb43",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "NASAL"
            ],
            "marketing_start_date": "20190305",
            "product_id": "50458-028_088b53cb-a931-d9a7-e063-6294a90afb43",
            "application_number": "NDA211243",
            "brand_name_base": "Spravato"
        },
        {
            "product_ndc": "0003-0528",
            "generic_name": "dasatinib",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "SPRYCEL",
            "active_ingredients": [
                {
                    "name": "DASATINIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-0528-11",
                    "description": "1 BOTTLE in 1 CARTON (0003-0528-11)  / 60 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20060627",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "643105",
                    "643107",
                    "643109",
                    "643173",
                    "643175",
                    "643177",
                    "799047",
                    "799830",
                    "1045402",
                    "1045404",
                    "1045406",
                    "1045408"
                ],
                "spl_set_id": [
                    "4764f37b-c9e6-4ede-bcc2-8a03b7c521df"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "RBZ1571X5H"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20060627",
            "product_id": "0003-0528_e69fc9e9-9b62-48ef-8c2d-7e07ba2fa5cf",
            "application_number": "NDA021986",
            "brand_name_base": "SPRYCEL",
            "pharm_class": [
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "57894-061",
            "generic_name": "ustekinumab",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "STELARA",
            "active_ingredients": [
                {
                    "name": "USTEKINUMAB",
                    "strength": "90 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-061-03",
                    "description": "1 SYRINGE in 1 CARTON (57894-061-03)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20090925",
                    "sample": false
                },
                {
                    "package_ndc": "57894-061-04",
                    "description": "1 SYRINGE in 1 CARTON (57894-061-04)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20090925",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "853350",
                    "853354",
                    "853355",
                    "853356",
                    "1654077",
                    "1654079",
                    "1811255",
                    "1811257"
                ],
                "spl_set_id": [
                    "c77a9664-e3bb-4023-b400-127aa53bca2b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192797",
                    "N0000192796",
                    "N0000192799",
                    "N0000192798"
                ],
                "pharm_class_epc": [
                    "Interleukin-12 Antagonist [EPC]",
                    "Interleukin-23 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-12 Antagonists [MoA]",
                    "Interleukin-23 Antagonists [MoA]"
                ],
                "unii": [
                    "FU77B4U5Z0"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "14ba0c93-924a-2455-e063-6294a90a4577",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20090925",
            "product_id": "57894-061_14ba0c93-924a-2455-e063-6294a90a4577",
            "application_number": "BLA125261",
            "brand_name_base": "STELARA",
            "pharm_class": [
                "Interleukin-12 Antagonist [EPC]",
                "Interleukin-12 Antagonists [MoA]",
                "Interleukin-23 Antagonist [EPC]",
                "Interleukin-23 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "65219-371",
            "generic_name": "pegflilgrastim-fpgk",
            "labeler_name": "Fresenius Kabi USA, LLC",
            "brand_name": "STIMUFEND",
            "active_ingredients": [
                {
                    "name": "PEGFILGRASTIM",
                    "strength": "6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65219-371-10",
                    "description": "1 BLISTER PACK in 1 CARTON (65219-371-10)  / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20221006",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Fresenius Kabi USA, LLC"
                ],
                "rxcui": [
                    "2613763",
                    "2613769"
                ],
                "spl_set_id": [
                    "b44bcb82-7e60-4dab-a658-115bdf5c053c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "90fa8a88-1bd6-49cf-a482-ccbc0d315b3d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20221006",
            "product_id": "65219-371_90fa8a88-1bd6-49cf-a482-ccbc0d315b3d",
            "application_number": "BLA761173",
            "brand_name_base": "STIMUFEND",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "0597-0155",
            "generic_name": "tiotropium bromide and olodaterol",
            "labeler_name": "Boehringer Ingelheim Pharmaceuticals Inc.",
            "brand_name": "Stiolto Respimat",
            "active_ingredients": [
                {
                    "name": "OLODATEROL HYDROCHLORIDE",
                    "strength": "2.736 ug/1"
                },
                {
                    "name": "TIOTROPIUM BROMIDE MONOHYDRATE",
                    "strength": "3.124 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0597-0155-28",
                    "description": "1 CARTRIDGE in 1 CARTON (0597-0155-28)  / 28 SPRAY, METERED in 1 CARTRIDGE",
                    "marketing_start_date": "20150521",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0155-61",
                    "description": "1 CARTRIDGE in 1 CARTON (0597-0155-61)  / 60 SPRAY, METERED in 1 CARTRIDGE",
                    "marketing_start_date": "20150521",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0155-70",
                    "description": "1 CARTRIDGE in 1 CARTON (0597-0155-70)  / 10 SPRAY, METERED in 1 CARTRIDGE",
                    "marketing_start_date": "20190322",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Boehringer Ingelheim Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1651266",
                    "1651271",
                    "1651274",
                    "1651275",
                    "2166927",
                    "2166928"
                ],
                "spl_set_id": [
                    "01e15aee-40e0-23f3-537f-c96dd63e2cb1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "65R445W3V9",
                    "L64SXO195N"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY, METERED",
            "spl_id": "dd969dec-1e23-4cac-a42b-2f7f06a07f13",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20150521",
            "product_id": "0597-0155_dd969dec-1e23-4cac-a42b-2f7f06a07f13",
            "application_number": "NDA206756",
            "brand_name_base": "Stiolto Respimat",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Anticholinergic [EPC]",
                "Cholinergic Antagonists [MoA]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "50419-171",
            "generic_name": "regorafenib",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "Stivarga",
            "active_ingredients": [
                {
                    "name": "REGORAFENIB",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-171-00",
                    "description": "210 BOTTLE in 1 BOX (50419-171-00)  / 28 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20120927",
                    "sample": false
                },
                {
                    "package_ndc": "50419-171-03",
                    "description": "3 BOTTLE, PLASTIC in 1 BOX (50419-171-03)  / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)",
                    "marketing_start_date": "20120927",
                    "sample": false
                },
                {
                    "package_ndc": "50419-171-04",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04)  / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20120927",
                    "sample": false
                },
                {
                    "package_ndc": "50419-171-06",
                    "description": "4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06)  / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)",
                    "marketing_start_date": "20210501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1312402",
                    "1312408"
                ],
                "spl_set_id": [
                    "824f19c9-0546-4a8a-8d8f-c4055c04f7c7"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "MGN125FS9D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "e41b7882-eaee-4c0d-8117-2203fe3cd73f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120927",
            "product_id": "50419-171_e41b7882-eaee-4c0d-8117-2203fe3cd73f",
            "application_number": "NDA203085",
            "brand_name_base": "Stivarga",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]",
                "UGT1A1 Inhibitors [MoA]",
                "UGT1A9 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70581-003",
            "generic_name": "AVOBENZONE, OCTISALATE, OCTOCRYLENE",
            "labeler_name": "BPS 60",
            "brand_name": "Absolue Premium Bx Sunscreen Broad Spectrum SPF 15 Absolute Replenishing",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "30 mg/mL"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "30 mg/mL"
                },
                {
                    "name": "OCTOCRYLENE",
                    "strength": "80 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70581-003-75",
                    "description": "1 BOTTLE in 1 BOX (70581-003-75)  / 75 mL in 1 BOTTLE",
                    "marketing_start_date": "20160409",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BPS 60"
                ],
                "spl_set_id": [
                    "3ca1c26f-0a4a-42af-ab67-76f6840c11aa"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "3605533374405"
                ],
                "unii": [
                    "G63QQF2NOX",
                    "4X49Y0596W",
                    "5A68WGF6WM"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "CREAM",
            "spl_id": "0c10187b-9943-d230-e063-6394a90a882d",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL",
                "TOPICAL"
            ],
            "marketing_start_date": "20160409",
            "product_id": "70581-003_0c10187b-9943-d230-e063-6394a90a882d",
            "application_number": "M020",
            "brand_name_base": "Absolue Premium Bx Sunscreen Broad Spectrum SPF 15 Absolute Replenishing"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "11673-943",
            "generic_name": "Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone",
            "labeler_name": "TARGET CORPORATION",
            "brand_name": "Target Up and Up Sport SPF 50",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "30 mg/g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "100 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "50 mg/g"
                },
                {
                    "name": "OCTOCRYLENE",
                    "strength": "40 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "50 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "11673-943-32",
                    "description": "473 CAN in 1 PACKAGE (11673-943-32)  / 236.5 g in 1 CAN (11673-943-88)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-38",
                    "description": "312 g in 1 CAN (11673-943-38)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-48",
                    "description": "258 g in 1 CAN (11673-943-48)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-62",
                    "description": "468 CAN in 1 PACKAGE (11673-943-62)  / 156 g in 1 CAN (11673-943-37)",
                    "marketing_start_date": "20140110",
                    "sample": false
                },
                {
                    "package_ndc": "11673-943-63",
                    "description": "312 CAN in 1 PACKAGE (11673-943-63)  / 156 g in 1 CAN (11673-943-37)",
                    "marketing_start_date": "20140110",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TARGET CORPORATION"
                ],
                "spl_set_id": [
                    "b8434856-77ae-7c65-e053-2a95a90a8f76"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4X49Y0596W",
                    "5A68WGF6WM",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "SPRAY",
            "spl_id": "bc315679-c011-b41c-e053-2a95a90ad144",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20140110",
            "product_id": "11673-943_bc315679-c011-b41c-e053-2a95a90ad144",
            "application_number": "part352",
            "brand_name_base": "Target Up and Up Sport SPF 50"
        },
        {
            "product_ndc": "0006-0032",
            "generic_name": "ivermectin",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "STROMECTOL",
            "active_ingredients": [
                {
                    "name": "IVERMECTIN",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-0032-20",
                    "description": "2 BLISTER PACK in 1 CARTON (0006-0032-20)  / 10 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "19961122",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "261314",
                    "311207"
                ],
                "spl_set_id": [
                    "681888c9-af79-4b7d-ae80-c3f4f6f1effd"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175484",
                    "N0000181811"
                ],
                "pharm_class_epc": [
                    "Antiparasitic [EPC]",
                    "Pediculicide [EPC]"
                ],
                "unii": [
                    "8883YP2R6D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "18baa032-5219-4c30-a76b-5b2c8e1174c5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19961122",
            "product_id": "0006-0032_18baa032-5219-4c30-a76b-5b2c8e1174c5",
            "application_number": "NDA050742",
            "brand_name_base": "STROMECTOL",
            "pharm_class": [
                "Antiparasitic [EPC]",
                "Pediculicide [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "61958-3002",
            "generic_name": "LENACAPAVIR SODIUM",
            "labeler_name": "Gilead Sciences",
            "brand_name": "Sunlenca",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-3002-1",
                    "description": "1 KIT in 1 CARTON (61958-3002-1)  *  1.5 mL in 1 VIAL (61958-3004-1)",
                    "marketing_start_date": "20221222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences"
                ],
                "rxcui": [
                    "2625890",
                    "2625896",
                    "2625897",
                    "2625898",
                    "2625899",
                    "2625900",
                    "2625904",
                    "2625909",
                    "2625911",
                    "2625912"
                ],
                "spl_set_id": [
                    "e5652804-29c4-40d7-aeb2-0142ed2a7b5b"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "BDT58WJ9WE"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "bd4fa706-84af-4011-a69d-663fc0a3bf6b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20221222",
            "product_id": "61958-3002_bd4fa706-84af-4011-a69d-663fc0a3bf6b",
            "application_number": "NDA215973",
            "brand_name_base": "Sunlenca"
        },
        {
            "product_ndc": "47426-101",
            "generic_name": "granisetron",
            "labeler_name": "Heron Therapeutics, Inc.",
            "brand_name": "SUSTOL",
            "active_ingredients": [
                {
                    "name": "GRANISETRON",
                    "strength": "10 mg/.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "47426-101-06",
                    "description": "6 KIT in 1 CARTON (47426-101-06)  / 1 SYRINGE, GLASS in 1 KIT / .4 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20160809",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Heron Therapeutics, Inc."
                ],
                "rxcui": [
                    "1810484",
                    "1810489"
                ],
                "spl_set_id": [
                    "f7c7ffdd-8270-4030-bc1e-a1cb28a6de56"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175817",
                    "N0000175818"
                ],
                "pharm_class_moa": [
                    "Serotonin 3 Receptor Antagonists [MoA]"
                ],
                "pharm_class_epc": [
                    "Serotonin-3 Receptor Antagonist [EPC]"
                ],
                "unii": [
                    "WZG3J2MCOL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION",
            "spl_id": "495b6512-53e3-4b64-a08a-45958b08bfd0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20160809",
            "product_id": "47426-101_495b6512-53e3-4b64-a08a-45958b08bfd0",
            "application_number": "NDA022445",
            "brand_name_base": "SUSTOL",
            "pharm_class": [
                "Serotonin 3 Receptor Antagonists [MoA]",
                "Serotonin-3 Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "50242-078",
            "generic_name": "Ranibizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "Susvimo",
            "active_ingredients": [
                {
                    "name": "RANIBIZUMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-078-12",
                    "description": "1 VIAL in 1 CARTON (50242-078-12)  / 1 mL in 1 VIAL",
                    "marketing_start_date": "20211022",
                    "sample": false
                },
                {
                    "package_ndc": "50242-078-55",
                    "description": "1 VIAL in 1 CARTON (50242-078-55)  / 1 mL in 1 VIAL",
                    "marketing_start_date": "20211022",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2584857",
                    "2584863"
                ],
                "spl_set_id": [
                    "9c6d9e2a-9a77-4d11-b692-de87cfde3444"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193542",
                    "N0000193543"
                ],
                "pharm_class_moa": [
                    "Vascular Endothelial Growth Factor Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Vascular Endothelial Growth Factor Inhibitor [EPC]"
                ],
                "unii": [
                    "ZL1R02VT79"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "38c9bd01-2138-4960-98fe-d5ac801f9ae8",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20211022",
            "product_id": "50242-078_38c9bd01-2138-4960-98fe-d5ac801f9ae8",
            "application_number": "BLA761197",
            "brand_name_base": "Susvimo",
            "pharm_class": [
                "Vascular Endothelial Growth Factor Inhibitor [EPC]",
                "Vascular Endothelial Growth Factor Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73606-020",
            "generic_name": "Pegcetacoplan",
            "labeler_name": "Apellis Pharmaceuticals, Inc.",
            "brand_name": "Syfovre",
            "active_ingredients": [
                {
                    "name": "PEGCETACOPLAN",
                    "strength": "15 mg/.1mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73606-020-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (73606-020-01)  / 3 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20230217",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Apellis Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2630847",
                    "2630853"
                ],
                "spl_set_id": [
                    "b4434e61-9ec9-4e0e-bd60-45aaa0a87e64"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175575",
                    "N0000175974"
                ],
                "pharm_class_epc": [
                    "Complement Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Complement Inhibitors [MoA]"
                ],
                "unii": [
                    "TO3JYR3BOU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "115af330-db33-4d23-ab6e-4dfc02b2022d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20230217",
            "product_id": "73606-020_115af330-db33-4d23-ab6e-4dfc02b2022d",
            "application_number": "NDA217171",
            "brand_name_base": "Syfovre",
            "pharm_class": [
                "Complement Inhibitor [EPC]",
                "Complement Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73090-421",
            "generic_name": "Siltuximab",
            "labeler_name": "EUSA Pharma (UK) Ltd",
            "brand_name": "Sylvant",
            "active_ingredients": [
                {
                    "name": "SILTUXIMAB",
                    "strength": "400 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73090-421-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 BOX (73090-421-01)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20140423",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "EUSA Pharma (UK) Ltd"
                ],
                "rxcui": [
                    "1658132",
                    "1658135",
                    "1658139",
                    "1658141"
                ],
                "spl_set_id": [
                    "8d663642-f52e-49c0-a023-2da083fdfc0b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191006",
                    "N0000191004"
                ],
                "pharm_class_epc": [
                    "Interleukin-6 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-6 Antagonists [MoA]"
                ],
                "unii": [
                    "T4H8FMA7IM"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
            "spl_id": "11ed1a70-63b5-cff0-e063-6394a90a0ec7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20140423",
            "product_id": "73090-421_11ed1a70-63b5-cff0-e063-6394a90a0ec7",
            "application_number": "BLA125496",
            "brand_name_base": "Sylvant",
            "pharm_class": [
                "Interleukin-6 Antagonist [EPC]",
                "Interleukin-6 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "59676-800",
            "generic_name": "Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide",
            "labeler_name": "Janssen Products LP",
            "brand_name": "Symtuza",
            "active_ingredients": [
                {
                    "name": "COBICISTAT",
                    "strength": "150 mg/1"
                },
                {
                    "name": "DARUNAVIR",
                    "strength": "800 mg/1"
                },
                {
                    "name": "EMTRICITABINE",
                    "strength": "200 mg/1"
                },
                {
                    "name": "TENOFOVIR ALAFENAMIDE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59676-800-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (59676-800-30)",
                    "marketing_start_date": "20180717",
                    "sample": false
                },
                {
                    "package_ndc": "59676-800-99",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (59676-800-99)",
                    "marketing_start_date": "20180717",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Products LP"
                ],
                "rxcui": [
                    "2049671",
                    "2049677"
                ],
                "spl_set_id": [
                    "85a17d00-6b7c-41ea-a6b3-5ad924820dab"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0359676800309"
                ],
                "nui": [
                    "N0000190114",
                    "N0000191001",
                    "N0000185503",
                    "N0000182137",
                    "N0000190107",
                    "N0000190108",
                    "N0000190113",
                    "N0000191423",
                    "N0000000246",
                    "N0000175889",
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                    "HIV Protease Inhibitors [MoA]",
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Cytochrome P450 3A Inhibitor [EPC]",
                    "Protease Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "unii": [
                    "LW2E03M5PG",
                    "YO603Y8113",
                    "G70B4ETF4S",
                    "EL9943AG5J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "03342109-cd66-bd0f-e063-6394a90aaf40",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180717",
            "product_id": "59676-800_03342109-cd66-bd0f-e063-6394a90aaf40",
            "application_number": "NDA210455",
            "brand_name_base": "Symtuza",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitor [EPC]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "HIV Protease Inhibitors [MoA]",
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Protease Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "66658-230",
            "generic_name": "palivizumab",
            "labeler_name": "Swedish Orphan Biovitrum AB (publ)",
            "brand_name": "Synagis",
            "active_ingredients": [
                {
                    "name": "PALIVIZUMAB",
                    "strength": "50 mg/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66658-230-01",
                    "description": ".5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01)",
                    "marketing_start_date": "20050928",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Swedish Orphan Biovitrum AB (publ)"
                ],
                "rxcui": [
                    "1657341",
                    "1657343",
                    "1657361",
                    "1657362"
                ],
                "spl_set_id": [
                    "3a0096c7-8139-44cd-bba4-520ab05c2cb2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0366658231013"
                ],
                "nui": [
                    "M0001357",
                    "N0000175615",
                    "N0000175623"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "pharm_class_moa": [
                    "Fusion Protein Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]"
                ],
                "unii": [
                    "DQ448MW7KS"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "2f379d7b-dcfd-4629-b14c-2f1d37891f7e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "19991209",
            "product_id": "66658-230_2f379d7b-dcfd-4629-b14c-2f1d37891f7e",
            "application_number": "BLA103770",
            "brand_name_base": "Synagis",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Fusion Protein Inhibitors [MoA]",
                "Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "0025-0166",
            "generic_name": "nafarelin acetate",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Synarel",
            "active_ingredients": [
                {
                    "name": "NAFARELIN ACETATE",
                    "strength": "2 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0025-0166-08",
                    "description": "1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08)  / 8 mL in 1 BOTTLE, SPRAY",
                    "marketing_start_date": "19900213",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "1797878",
                    "1797880"
                ],
                "spl_set_id": [
                    "d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8ENZ0QJW4H"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY, METERED",
            "spl_id": "bbb3315f-c436-4ae0-8374-300bf31826ed",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "NASAL"
            ],
            "marketing_start_date": "19900213",
            "product_id": "0025-0166_bbb3315f-c436-4ae0-8374-300bf31826ed",
            "application_number": "NDA019886",
            "brand_name_base": "Synarel",
            "pharm_class": [
                "Gonadotropin Releasing Hormone Receptor Agonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "0597-0159",
            "generic_name": "empagliflozin and metformin hydrochloride",
            "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "brand_name": "Synjardy",
            "active_ingredients": [
                {
                    "name": "EMPAGLIFLOZIN",
                    "strength": "5 mg/1"
                },
                {
                    "name": "METFORMIN HYDROCHLORIDE",
                    "strength": "500 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0597-0159-18",
                    "description": "180 TABLET in 1 BOTTLE (0597-0159-18)",
                    "marketing_start_date": "20150912",
                    "sample": false
                },
                {
                    "package_ndc": "0597-0159-60",
                    "description": "60 TABLET in 1 BOTTLE (0597-0159-60)",
                    "marketing_start_date": "20150912",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Boehringer Ingelheim Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1664315",
                    "1664321",
                    "1664323",
                    "1664325",
                    "1664326",
                    "1664328",
                    "1665367",
                    "1665369"
                ],
                "spl_set_id": [
                    "0fdd0255-0055-65f3-b2c0-db8fbb87beae"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000187059",
                    "N0000187058"
                ],
                "pharm_class_epc": [
                    "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
                ],
                "unii": [
                    "786Z46389E",
                    "HDC1R2M35U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "4e4007fa-04eb-4e76-96b5-1d2a8fe58218",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20150826",
            "product_id": "0597-0159_4e4007fa-04eb-4e76-96b5-1d2a8fe58218",
            "application_number": "NDA206111",
            "brand_name_base": "Synjardy",
            "pharm_class": [
                "Biguanide [EPC]",
                "Biguanides [CS]",
                "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
                "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "49035-397",
            "generic_name": "Omeprazole Magnesium 20.6mg Capsules",
            "labeler_name": "Wal-Mart Stores Inc",
            "brand_name": "Omeprazole Magnesium",
            "active_ingredients": [
                {
                    "name": "OMEPRAZOLE MAGNESIUM",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49035-397-27",
                    "description": "2 BOTTLE in 1 CARTON (49035-397-27)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-33",
                    "description": "3 BOTTLE in 1 CARTON (49035-397-33)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                },
                {
                    "package_ndc": "49035-397-52",
                    "description": "1 BOTTLE in 1 CARTON (49035-397-52)  / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE",
                    "marketing_start_date": "20100115",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wal-Mart Stores Inc"
                ],
                "rxcui": [
                    "198051"
                ],
                "spl_set_id": [
                    "3160e212-9ee9-8316-f51e-4628862f654c"
                ],
                "unii": [
                    "426QFE7XLK"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100115",
            "product_id": "49035-397_7e7066c4-ccf9-1dae-8b40-a076df63879f",
            "application_number": "ANDA078878",
            "brand_name_base": "Omeprazole Magnesium",
            "pharm_class": [
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Proton Pump Inhibitor [EPC]",
                "Proton Pump Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0709",
            "generic_name": "capmatinib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "TABRECTA",
            "active_ingredients": [
                {
                    "name": "CAPMATINIB HYDROCHLORIDE",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0709-56",
                    "description": "56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-56)",
                    "marketing_start_date": "20200506",
                    "sample": false
                },
                {
                    "package_ndc": "0078-0709-94",
                    "description": "56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94)",
                    "marketing_start_date": "20200506",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2362234",
                    "2362240",
                    "2362242",
                    "2362244"
                ],
                "spl_set_id": [
                    "455892c3-d144-4ba8-9ab4-79cabff9876d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "C2A374O70X"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "c25127cd-ea3a-42cd-ab89-ffb9cc41ebb0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200506",
            "product_id": "0078-0709_c25127cd-ea3a-42cd-ab89-ffb9cc41ebb0",
            "application_number": "NDA213591",
            "brand_name_base": "TABRECTA",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Mesenchymal Epithelial Transition Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0681",
            "generic_name": "dabrafenib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Tafinlar",
            "active_ingredients": [
                {
                    "name": "DABRAFENIB MESYLATE",
                    "strength": "75 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0681-66",
                    "description": "120 CAPSULE in 1 BOTTLE (0078-0681-66)",
                    "marketing_start_date": "20160401",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "1424916",
                    "1424918",
                    "1425228",
                    "1425230",
                    "2632552",
                    "2632556"
                ],
                "spl_set_id": [
                    "fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "B6DC89I63E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "c3fb1dfd-7605-460f-b9df-005599528077",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160401",
            "product_id": "0078-0681_c3fb1dfd-7605-460f-b9df-005599528077",
            "application_number": "NDA202806",
            "brand_name_base": "Tafinlar",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C8 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Kinase Inhibitor [EPC]",
                "Organic Anion Transporter 1 Inhibitors [MoA]",
                "Organic Anion Transporter 3 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0310-1349",
            "generic_name": "osimertinib",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "TAGRISSO",
            "active_ingredients": [
                {
                    "name": "OSIMERTINIB",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-1349-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0310-1349-30)",
                    "marketing_start_date": "20151113",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "1721565",
                    "1721571",
                    "1721581",
                    "1721583"
                ],
                "spl_set_id": [
                    "5e81b4a7-b971-45e1-9c31-29cea8c87ce7"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175082",
                    "N0000190114",
                    "N0000185506",
                    "N0000191266",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 1A2 Inducers [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "3C06JJ0Z2O"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "a62aa024-af56-4d9c-8d82-c0eaf316da00",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151113",
            "product_id": "0310-1349_a62aa024-af56-4d9c-8d82-c0eaf316da00",
            "application_number": "NDA208065",
            "brand_name_base": "TAGRISSO",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inducers [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0002-8900",
            "generic_name": "ixekizumab",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "TALTZ",
            "active_ingredients": [
                {
                    "name": "IXEKIZUMAB",
                    "strength": "20 mg/.25mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-8900-11",
                    "description": "1 SYRINGE in 1 CARTON (0002-8900-11)  / 1 mL in 1 SYRINGE (0002-8900-01)",
                    "marketing_start_date": "20240202",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "1745103",
                    "1745108",
                    "1745112",
                    "1745114",
                    "2674931",
                    "2674932",
                    "2674933",
                    "2674934"
                ],
                "spl_set_id": [
                    "ac96658a-d7dc-4c7c-8928-2adcdf4318b2"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191495",
                    "N0000191494"
                ],
                "pharm_class_epc": [
                    "Interleukin-17A Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-17A Antagonists [MoA]"
                ],
                "unii": [
                    "BTY153760O"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "fb955abf-31e2-41df-b4cf-a40798cbc276",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20160322",
            "product_id": "0002-8900_fb955abf-31e2-41df-b4cf-a40798cbc276",
            "application_number": "BLA125521",
            "brand_name_base": "TALTZ",
            "pharm_class": [
                "Interleukin-17A Antagonist [EPC]",
                "Interleukin-17A Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "57894-469",
            "generic_name": "talquetamab",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "TALVEY",
            "active_ingredients": [
                {
                    "name": "TALQUETAMAB",
                    "strength": "3 mg/1.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-469-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (57894-469-01)  / 1.5 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20230809",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "2644452",
                    "2644458",
                    "2644461",
                    "2644464"
                ],
                "spl_set_id": [
                    "9001355e-003d-4d4e-b4ce-337e0fd14952"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0357894470014",
                    "0357894469018"
                ],
                "unii": [
                    "4W3KFI3TN3"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "0333c380-455e-03c1-e063-6394a90a998d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230809",
            "product_id": "57894-469_0333c380-455e-03c1-e063-6394a90a998d",
            "application_number": "BLA761342",
            "brand_name_base": "TALVEY"
        },
        {
            "product_ndc": "0069-0655",
            "generic_name": "talazoparib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Talzenna",
            "active_ingredients": [
                {
                    "name": "TALAZOPARIB TOSYLATE",
                    "strength": ".75 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0655-30",
                    "description": "30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0655-30)",
                    "marketing_start_date": "20240417",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2099946",
                    "2099952",
                    "2099954",
                    "2099956",
                    "2591510",
                    "2591512",
                    "2591520",
                    "2591521",
                    "2639960",
                    "2639962",
                    "2639964",
                    "2639966"
                ],
                "spl_set_id": [
                    "c6fd147f-a77e-4a0b-9280-e82ecc41b4be"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300690353302",
                    "0300690252308",
                    "0300690655307",
                    "0300690757308",
                    "0300690454306",
                    "0300690546308"
                ],
                "unii": [
                    "02WK9U5NZC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, LIQUID FILLED",
            "spl_id": "c6fd147f-a77e-4a0b-9280-e82ecc41b4be",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240417",
            "product_id": "0069-0655_c6fd147f-a77e-4a0b-9280-e82ecc41b4be",
            "application_number": "NDA217439",
            "brand_name_base": "Talzenna",
            "pharm_class": [
                "Poly(ADP-Ribose) Polymerase Inhibitor [EPC]",
                "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0187-5525",
            "generic_name": "bexarotene",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Targretin",
            "active_ingredients": [
                {
                    "name": "BEXAROTENE",
                    "strength": "1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-5525-60",
                    "description": "1 TUBE in 1 CARTON (0187-5525-60)  / 60 g in 1 TUBE",
                    "marketing_start_date": "20000628",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "308724",
                    "991233"
                ],
                "spl_set_id": [
                    "d35b4697-3f3b-4aa1-b5d9-153993e83811"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175607",
                    "M0018962"
                ],
                "pharm_class_epc": [
                    "Retinoid [EPC]"
                ],
                "pharm_class_cs": [
                    "Retinoids [CS]"
                ],
                "unii": [
                    "A61RXM4375"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GEL",
            "spl_id": "0b3ebeef-832b-420e-8d6e-e48b2fc494c3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20000628",
            "product_id": "0187-5525_0b3ebeef-832b-420e-8d6e-e48b2fc494c3",
            "application_number": "NDA021056",
            "brand_name_base": "Targretin",
            "pharm_class": [
                "Retinoid [EPC]",
                "Retinoids [CS]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "68016-088",
            "generic_name": "Loratadine",
            "labeler_name": "Chain Drug Consortium, LLC",
            "brand_name": "Loratadine ODT",
            "active_ingredients": [
                {
                    "name": "LORATADINE",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68016-088-10",
                    "description": "1 BLISTER PACK in 1 CARTON (68016-088-10)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK",
                    "marketing_start_date": "20180411",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Chain Drug Consortium, LLC"
                ],
                "rxcui": [
                    "311373"
                ],
                "spl_set_id": [
                    "7674009d-492d-4005-a652-f12b91428c0d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0358602744830"
                ],
                "unii": [
                    "7AJO3BO7QN"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, ORALLY DISINTEGRATING",
            "spl_id": "38d1e80f-4bba-4acb-bc49-89bd3653c2cd",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180411",
            "product_id": "68016-088_38d1e80f-4bba-4acb-bc49-89bd3653c2cd",
            "application_number": "ANDA208477",
            "brand_name_base": "Loratadine ODT"
        },
        {
            "product_ndc": "0078-0951",
            "generic_name": "nilotinib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Tasigna",
            "active_ingredients": [
                {
                    "name": "NILOTINIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0951-66",
                    "description": "120 CAPSULE in 1 BOTTLE, PLASTIC (0078-0951-66)",
                    "marketing_start_date": "20180322",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "746606",
                    "746609",
                    "997653",
                    "1002300",
                    "2002717",
                    "2002719"
                ],
                "spl_set_id": [
                    "6093952a-5248-45cb-ad17-33716a411146"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020009",
                    "N0000187062",
                    "N0000182137",
                    "N0000187064",
                    "N0000187063",
                    "N0000191272",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Bcr-Abl Tyrosine Kinase Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C8 Inducers [MoA]",
                    "UGT1A1 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "F41401512X"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "cacfe02f-71d6-457c-9244-c09745402c6f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20071029",
            "product_id": "0078-0951_cacfe02f-71d6-457c-9244-c09745402c6f",
            "application_number": "NDA022068",
            "brand_name_base": "Tasigna",
            "pharm_class": [
                "Bcr-Abl Tyrosine Kinase Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C8 Inducers [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "P-Glycoprotein Inhibitors [MoA]",
                "UGT1A1 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "71332-002",
            "generic_name": "FOSTAMATINIB",
            "labeler_name": "Rigel Pharmaceuticals, Inc.",
            "brand_name": "TAVALISSE",
            "active_ingredients": [
                {
                    "name": "FOSTAMATINIB",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71332-002-01",
                    "description": "60 TABLET in 1 BOTTLE (71332-002-01)",
                    "marketing_start_date": "20180509",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Rigel Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2044922",
                    "2044928",
                    "2044930",
                    "2044932"
                ],
                "spl_set_id": [
                    "21149cc3-049b-43e2-b141-c9499160556c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SQ8A3S5101"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "4e078ea4-5a66-4a51-af70-24777b4a2d59",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20180509",
            "product_id": "71332-002_4e078ea4-5a66-4a51-af70-24777b4a2d59",
            "application_number": "NDA209299",
            "brand_name_base": "TAVALISSE"
        },
        {
            "product_ndc": "73556-168",
            "generic_name": "avacopan",
            "labeler_name": "ChemoCentryx, Inc.",
            "brand_name": "TAVNEOS",
            "active_ingredients": [
                {
                    "name": "AVACOPAN",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73556-168-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (73556-168-01)  / 180 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20211018",
                    "sample": false
                },
                {
                    "package_ndc": "73556-168-02",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (73556-168-02)  / 30 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20211018",
                    "sample": false
                },
                {
                    "package_ndc": "73556-168-96",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (73556-168-96)  / 30 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20211018",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ChemoCentryx, Inc."
                ],
                "rxcui": [
                    "2572105",
                    "2572111"
                ],
                "spl_set_id": [
                    "c93cbc0b-29a3-46a5-9c85-41815ea5cf4a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193973",
                    "N0000193974",
                    "N0000182141"
                ],
                "pharm_class_epc": [
                    "Complement 5a Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Complement 5a Receptor Antagonists [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]"
                ],
                "unii": [
                    "O880NM097T"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "91d9ba79-96a0-4130-bde1-0fb3f7e439bb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20211018",
            "product_id": "73556-168_91d9ba79-96a0-4130-bde1-0fb3f7e439bb",
            "application_number": "NDA214487",
            "brand_name_base": "TAVNEOS",
            "pharm_class": [
                "Complement 5a Receptor Antagonist [EPC]",
                "Complement 5a Receptor Antagonists [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72607-100",
            "generic_name": "tazemetostat",
            "labeler_name": "Epizyme, Inc.",
            "brand_name": "TAZVERIK",
            "active_ingredients": [
                {
                    "name": "TAZEMETOSTAT HYDROBROMIDE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72607-100-00",
                    "description": "240 TABLET, FILM COATED in 1 BOTTLE (72607-100-00)",
                    "marketing_start_date": "20200123",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Epizyme, Inc."
                ],
                "rxcui": [
                    "2274384",
                    "2274390"
                ],
                "spl_set_id": [
                    "7db07b5f-4e22-467c-9c0a-f830b08dbb1d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "6P89T5M073"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "6656919b-73f1-4d41-9da9-944e72f0356d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200123",
            "product_id": "72607-100_6656919b-73f1-4d41-9da9-944e72f0356d",
            "application_number": "NDA211723",
            "brand_name_base": "TAZVERIK",
            "pharm_class": [
                "Methyltransferase Inhibitor [EPC]",
                "Methyltransferase Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
                "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "71287-219",
            "generic_name": "brexucabtagene autoleucel",
            "labeler_name": "Kite Pharma, Inc.",
            "brand_name": "TECARTUS",
            "active_ingredients": [
                {
                    "name": "BREXUCABTAGENE AUTOLEUCEL",
                    "strength": "2000000 1/68mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71287-219-02",
                    "description": "1 BAG in 1 PACKAGE (71287-219-02)  / 68 mL in 1 BAG (71287-219-01)",
                    "marketing_start_date": "20200724",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Kite Pharma, Inc."
                ],
                "spl_set_id": [
                    "a16108c2-7ca7-45af-965e-54bda4713022"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "4MD2J2T8SJ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SUSPENSION",
            "spl_id": "766473ab-2795-4c9f-bbb3-1c25129626b9",
            "product_type": "CELLULAR THERAPY",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200724",
            "product_id": "71287-219_766473ab-2795-4c9f-bbb3-1c25129626b9",
            "application_number": "BLA125703",
            "brand_name_base": "TECARTUS"
        },
        {
            "product_ndc": "50242-917",
            "generic_name": "atezolizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "TECENTRIQ",
            "active_ingredients": [
                {
                    "name": "ATEZOLIZUMAB",
                    "strength": "1200 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-917-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01)  / 20 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20160518",
                    "sample": false
                },
                {
                    "package_ndc": "50242-917-86",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86)  / 20 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20160811",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1792780",
                    "1792785",
                    "2119695",
                    "2119696"
                ],
                "spl_set_id": [
                    "6fa682c9-a312-4932-9831-f286908660ee"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259",
                    "M0556300",
                    "M0001357",
                    "M0001352"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal, Humanized [CS]",
                    "Antibodies, Monoclonal [CS]",
                    "Antibodies [CS]"
                ],
                "unii": [
                    "52CMI0WC3Y"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "73ff407f-82c6-4984-ae55-c151f727ca33",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20160518",
            "product_id": "50242-917_73ff407f-82c6-4984-ae55-c151f727ca33",
            "application_number": "BLA761034",
            "brand_name_base": "TECENTRIQ",
            "pharm_class": [
                "Antibodies [CS]",
                "Antibodies",
                "Monoclonal [CS]",
                "Antibodies",
                "Monoclonal",
                "Humanized [CS]",
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "57894-449",
            "generic_name": "teclistamab",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "TECVAYLI",
            "active_ingredients": [
                {
                    "name": "TECLISTAMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-449-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (57894-449-01)  / 3 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20221025",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "spl_set_id": [
                    "54e0f974-ccee-44ea-9254-40e9883cee1e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "54534MX6Z9"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "1ba49b88-c8ec-6eda-e063-6394a90a288c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20221025",
            "product_id": "57894-449_1ba49b88-c8ec-6eda-e063-6394a90a288c",
            "application_number": "BLA761291",
            "brand_name_base": "TECVAYLI"
        },
        {
            "product_ndc": "0456-0600",
            "generic_name": "ceftaroline fosamil",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "Teflaro",
            "active_ingredients": [
                {
                    "name": "CEFTAROLINE FOSAMIL",
                    "strength": "600 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0456-0600-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0456-0600-10)  / 20 mL in 1 VIAL, SINGLE-DOSE (0456-0600-01)",
                    "marketing_start_date": "20101029",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "1040008",
                    "1040012",
                    "1040014",
                    "1040016"
                ],
                "spl_set_id": [
                    "3ecde48b-75a2-4beb-9999-369f3f61bb8a"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0304560400103"
                ],
                "unii": [
                    "7P6FQA5D21"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SOLUTION",
            "spl_id": "f3413056-1388-43ce-8ea5-580274f099fb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20101029",
            "product_id": "0456-0600_f3413056-1388-43ce-8ea5-580274f099fb",
            "application_number": "NDA200327",
            "brand_name_base": "Teflaro",
            "pharm_class": [
                "Cephalosporin Antibacterial [EPC]",
                "Cephalosporins [CS]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "49281-215",
            "generic_name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
            "labeler_name": "Sanofi Pasteur Inc.",
            "brand_name": "TENIVAC",
            "active_ingredients": [
                {
                    "name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "5 [Lf]/.5mL"
                },
                {
                    "name": "CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "2 [Lf]/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49281-215-10",
                    "description": "10 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-215-10)  / .5 mL in 1 VIAL, SINGLE-DOSE (49281-215-58)",
                    "marketing_start_date": "20101208",
                    "sample": false
                },
                {
                    "package_ndc": "49281-215-15",
                    "description": "10 SYRINGE in 1 PACKAGE (49281-215-15)  / .5 mL in 1 SYRINGE (49281-215-88)",
                    "marketing_start_date": "20101208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "b1577139-1734-43fc-836b-13bcfa7b5cf0",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20101208",
            "product_id": "49281-215_b1577139-1734-43fc-836b-13bcfa7b5cf0",
            "application_number": "BLA103171",
            "brand_name_base": "TENIVAC",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Diphtheria Toxoid [CS]",
                "Inactivated Clostridium Tetani Vaccine [EPC]",
                "Inactivated Corynebacterium Diphtheriae Vaccine [EPC]",
                "Tetanus Toxoid [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]"
            ]
        },
        {
            "product_ndc": "75987-130",
            "generic_name": "teprotumumab",
            "labeler_name": "Horizon Therapeutics USA, Inc.",
            "brand_name": "TEPEZZA",
            "active_ingredients": [
                {
                    "name": "TEPROTUMUMAB",
                    "strength": "500 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75987-130-15",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Horizon Therapeutics USA, Inc."
                ],
                "spl_set_id": [
                    "3e6c54a1-cefd-4a5b-a855-ab9f268b6cce"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193926",
                    "N0000193927"
                ],
                "pharm_class_epc": [
                    "Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]"
                ],
                "unii": [
                    "Y64GQ0KC0A"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "055c9298-15f1-4ba2-861d-7cae69c49696",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200121",
            "product_id": "75987-130_055c9298-15f1-4ba2-861d-7cae69c49696",
            "application_number": "BLA761143",
            "brand_name_base": "TEPEZZA",
            "pharm_class": [
                "Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]",
                "Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "44087-5000",
            "generic_name": "Tepotinib Hydrochloride",
            "labeler_name": "EMD Serono, Inc.",
            "brand_name": "TEPMETKO",
            "active_ingredients": [
                {
                    "name": "TEPOTINIB HYDROCHLORIDE",
                    "strength": "225 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "44087-5000-3",
                    "description": "3 BLISTER PACK in 1 CARTON (44087-5000-3)  / 10 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20210203",
                    "sample": false
                },
                {
                    "package_ndc": "44087-5000-6",
                    "description": "6 BLISTER PACK in 1 CARTON (44087-5000-6)  / 10 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20210203",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "EMD Serono, Inc."
                ],
                "rxcui": [
                    "2477266",
                    "2477272"
                ],
                "spl_set_id": [
                    "80a0f1b9-071a-47f5-9e67-32d638a669dc"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "VY5YX2TQ1F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "053ca19e-7ede-415c-8d4d-b02cc192d15a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210203",
            "product_id": "44087-5000_053ca19e-7ede-415c-8d4d-b02cc192d15a",
            "application_number": "NDA214096",
            "brand_name_base": "TEPMETKO",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Mesenchymal Epithelial Transition Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "55513-100",
            "generic_name": "tezepelumab-ekko",
            "labeler_name": "Amgen, Inc",
            "brand_name": "TEZSPIRE",
            "active_ingredients": [
                {
                    "name": "TEZEPELUMAB",
                    "strength": "210 mg/1.9mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-100-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (55513-100-01)  / 1.91 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20211217",
                    "sample": false
                },
                {
                    "package_ndc": "55513-100-96",
                    "description": "1 VIAL, GLASS in 1 CARTON (55513-100-96)  / 1.91 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20211217",
                    "sample": true
                },
                {
                    "package_ndc": "55513-100-99",
                    "description": "1.91 mL in 1 VIAL, GLASS (55513-100-99)",
                    "marketing_start_date": "20211217",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen, Inc"
                ],
                "rxcui": [
                    "2587794",
                    "2587800",
                    "2587803",
                    "2587806",
                    "2628920",
                    "2628923"
                ],
                "spl_set_id": [
                    "60f0aa03-ad25-4d48-80ce-7fcfa76f325f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194010",
                    "N0000194011"
                ],
                "pharm_class_epc": [
                    "Thymic Stromal Lymphopoietin Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Thymic Stromal Lymphopoietin Blockers [MoA]"
                ],
                "unii": [
                    "RJ1IW3B4QX"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "9e383013-1950-489d-bfa8-a8dbb8e2fd1e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20211217",
            "product_id": "55513-100_9e383013-1950-489d-bfa8-a8dbb8e2fd1e",
            "application_number": "BLA761224",
            "brand_name_base": "TEZSPIRE",
            "pharm_class": [
                "Thymic Stromal Lymphopoietin Blocker [EPC]",
                "Thymic Stromal Lymphopoietin Blockers [MoA]"
            ]
        },
        {
            "product_ndc": "59572-210",
            "generic_name": "Thalidomide",
            "labeler_name": "Celgene Corporation",
            "brand_name": "Thalomid",
            "active_ingredients": [
                {
                    "name": "THALIDOMIDE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-210-95",
                    "description": "5 BLISTER PACK in 1 BOX (59572-210-95)  / 28 CAPSULE in 1 BLISTER PACK (59572-210-15)",
                    "marketing_start_date": "20030620",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "200390",
                    "213360",
                    "360176",
                    "360177",
                    "404449",
                    "404450",
                    "700416",
                    "700418"
                ],
                "spl_set_id": [
                    "2eda833b-1357-4ed4-a093-194524fcb061"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000008663"
                ],
                "pharm_class_pe": [
                    "Decreased Immunologically Active Molecule Activity [PE]"
                ],
                "unii": [
                    "4Z8R6ORS6L"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "58b287d1-24f5-4dfe-84ca-898a8a5b9302",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030620",
            "product_id": "59572-210_58b287d1-24f5-4dfe-84ca-898a8a5b9302",
            "application_number": "NDA020785",
            "brand_name_base": "Thalomid",
            "pharm_class": [
                "Decreased Immunologically Active Molecule Activity [PE]"
            ]
        },
        {
            "product_ndc": "0178-0900",
            "generic_name": "tiopronin",
            "labeler_name": "Mission Pharmacal Company",
            "brand_name": "Thiola",
            "active_ingredients": [
                {
                    "name": "TIOPRONIN",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0178-0900-01",
                    "description": "100 TABLET, SUGAR COATED in 1 BOTTLE (0178-0900-01)",
                    "marketing_start_date": "19880811",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Mission Pharmacal Company"
                ],
                "rxcui": [
                    "198287",
                    "207840"
                ],
                "spl_set_id": [
                    "494a714e-923c-cd57-df6c-12886afb265a"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0301780900017"
                ],
                "nui": [
                    "N0000175549",
                    "M0289359",
                    "N0000175898"
                ],
                "pharm_class_moa": [
                    "Cystine Disulfide Reduction [MoA]"
                ],
                "pharm_class_cs": [
                    "N-substituted Glycines [CS]"
                ],
                "pharm_class_epc": [
                    "Reducing and Complexing Thiol [EPC]"
                ],
                "unii": [
                    "C5W04GO61S"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, SUGAR COATED",
            "spl_id": "0e764c29-02df-6485-e063-6394a90a6a45",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19880811",
            "product_id": "0178-0900_0e764c29-02df-6485-e063-6394a90a6a45",
            "application_number": "NDA019569",
            "brand_name_base": "Thiola",
            "pharm_class": [
                "Cystine Disulfide Reduction [MoA]",
                "N-substituted Glycines [CS]",
                "Reducing and Complexing Thiol [EPC]"
            ]
        },
        {
            "product_ndc": "69437-416",
            "generic_name": "naproxen",
            "labeler_name": "Canton Laboratories",
            "brand_name": "EC-Naprosyn",
            "active_ingredients": [
                {
                    "name": "NAPROXEN",
                    "strength": "500 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69437-416-01",
                    "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (69437-416-01)",
                    "marketing_start_date": "20160601",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Canton Laboratories"
                ],
                "rxcui": [
                    "105899",
                    "198014",
                    "311915",
                    "603103",
                    "608793",
                    "835560",
                    "849431",
                    "849438"
                ],
                "spl_set_id": [
                    "8bff5df5-d856-4237-b6a8-ae445b454844"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0369437316017",
                    "0369437415017",
                    "0369437203010"
                ],
                "nui": [
                    "N0000000160",
                    "M0001335",
                    "N0000175722"
                ],
                "pharm_class_moa": [
                    "Cyclooxygenase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Anti-Inflammatory Agents, Non-Steroidal [CS]"
                ],
                "pharm_class_epc": [
                    "Nonsteroidal Anti-inflammatory Drug [EPC]"
                ],
                "unii": [
                    "9TN87S3A3C",
                    "57Y76R9ATQ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, DELAYED RELEASE",
            "spl_id": "30e34aeb-4e90-4ba5-adc7-343806b104c6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160601",
            "product_id": "69437-416_30e34aeb-4e90-4ba5-adc7-343806b104c6",
            "application_number": "NDA020067",
            "brand_name_base": "EC-Naprosyn",
            "pharm_class": [
                "Anti-Inflammatory Agents",
                "Non-Steroidal [CS]",
                "Cyclooxygenase Inhibitors [MoA]",
                "Nonsteroidal Anti-inflammatory Drug [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72694-617",
            "generic_name": "ivosidenib",
            "labeler_name": "Servier Pharmaceutical LLC",
            "brand_name": "TIBSOVO",
            "active_ingredients": [
                {
                    "name": "IVOSIDENIB",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72694-617-60",
                    "description": "1 BOTTLE in 1 CARTON (72694-617-60)  / 60 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20211019",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Servier Pharmaceutical LLC"
                ],
                "rxcui": [
                    "2049878",
                    "2049884"
                ],
                "spl_set_id": [
                    "65d254c0-67ad-42c4-b972-ad463b755b2d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193987",
                    "N0000193988",
                    "N0000185506",
                    "N0000185507"
                ],
                "pharm_class_epc": [
                    "Isocitrate Dehydrogenase 1 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Isocitrate Dehydrogenase 1 Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]"
                ],
                "unii": [
                    "Q2PCN8MAM6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "e41af141-5e59-46f0-b6d3-56c57f59ee70",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20211019",
            "product_id": "72694-617_e41af141-5e59-46f0-b6d3-56c57f59ee70",
            "application_number": "NDA211192",
            "brand_name_base": "TIBSOVO",
            "pharm_class": [
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Isocitrate Dehydrogenase 1 Inhibitor [EPC]",
                "Isocitrate Dehydrogenase 1 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0069-5820",
            "generic_name": "dofetilide",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Tikosyn",
            "active_ingredients": [
                {
                    "name": "DOFETILIDE",
                    "strength": ".5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-5820-43",
                    "description": "40 BLISTER PACK in 1 CARTON (0069-5820-43)  / 1 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "19991001",
                    "marketing_end_date": "20250131",
                    "sample": false
                },
                {
                    "package_ndc": "0069-5820-60",
                    "description": "60 CAPSULE in 1 BOTTLE (0069-5820-60)",
                    "marketing_start_date": "19991001",
                    "sample": false
                },
                {
                    "package_ndc": "0069-5820-61",
                    "description": "14 CAPSULE in 1 BOTTLE (0069-5820-61)",
                    "marketing_start_date": "19991001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "284404",
                    "284405",
                    "285016",
                    "310003",
                    "310004",
                    "310005"
                ],
                "spl_set_id": [
                    "02438044-d6a3-49e9-a1ac-3aad21ef2c8c"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300695810602",
                    "0300695800603",
                    "0300695820601"
                ],
                "nui": [
                    "N0000175426"
                ],
                "pharm_class_epc": [
                    "Antiarrhythmic [EPC]"
                ],
                "unii": [
                    "R4Z9X1N2ND"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "1707916f-4647-4afd-ae60-db3d0434b521",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "19991001",
            "product_id": "0069-5820_1707916f-4647-4afd-ae60-db3d0434b521",
            "application_number": "NDA020931",
            "brand_name_base": "Tikosyn",
            "pharm_class": [
                "Antiarrhythmic [EPC]"
            ]
        },
        {
            "product_ndc": "71858-0005",
            "generic_name": "levothyroxine sodium",
            "labeler_name": "IBSA Pharma Inc.",
            "brand_name": "Tirosint",
            "active_ingredients": [
                {
                    "name": "LEVOTHYROXINE SODIUM",
                    "strength": "13 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71858-0005-1",
                    "description": "1 BLISTER PACK in 1 CARTON (71858-0005-1)  / 10 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20181201",
                    "sample": false
                },
                {
                    "package_ndc": "71858-0005-4",
                    "description": "3 BLISTER PACK in 1 CARTON (71858-0005-4)  / 10 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20181201",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "IBSA Pharma Inc."
                ],
                "rxcui": [
                    "905451",
                    "905453",
                    "905455",
                    "905457",
                    "905458",
                    "905460",
                    "905462",
                    "905464",
                    "966404",
                    "966405",
                    "966406",
                    "966407",
                    "966412",
                    "966413",
                    "966415",
                    "966417",
                    "966420",
                    "966423",
                    "966426",
                    "966434",
                    "1923047",
                    "1923049",
                    "1923050",
                    "1923052",
                    "2630738",
                    "2630740",
                    "2630742",
                    "2630744",
                    "2630746",
                    "2630748"
                ],
                "spl_set_id": [
                    "7a7ade79-0165-4e31-b84e-667416c00c7e"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0371858001540",
                    "0371858006040",
                    "0371858003049",
                    "0371858004541",
                    "0371858001045",
                    "0371858004046",
                    "0371858001243",
                    "0371858001748",
                    "0371858002042",
                    "0371858003544",
                    "0371858001342",
                    "0371858005043"
                ],
                "unii": [
                    "9J765S329G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "0b274758-a84c-4e19-e063-6294a90a3b89",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181201",
            "product_id": "71858-0005_0b274758-a84c-4e19-e063-6294a90a3b89",
            "application_number": "NDA021924",
            "brand_name_base": "Tirosint",
            "pharm_class": [
                "Thyroxine [CS]",
                "l-Thyroxine [EPC]"
            ]
        },
        {
            "product_ndc": "15631-2846",
            "generic_name": "MERC SOL",
            "labeler_name": "Rxhomeo Private Limited d.b.a. Rxhomeo, Inc",
            "brand_name": "MERC SOL",
            "active_ingredients": [
                {
                    "name": "MERCURIUS SOLUBILIS",
                    "strength": "6 [hp_X]/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "15631-2846-0",
                    "description": "10 mL in 1 BOTTLE (15631-2846-0)",
                    "marketing_start_date": "20240523",
                    "sample": false
                },
                {
                    "package_ndc": "15631-2846-1",
                    "description": "30 mL in 1 BOTTLE (15631-2846-1)",
                    "marketing_start_date": "20240523",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Rxhomeo Private Limited d.b.a. Rxhomeo, Inc"
                ],
                "spl_set_id": [
                    "19cf3fb0-e565-acbc-e063-6294a90a22f4"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "324Y4038G2"
                ]
            },
            "marketing_category": "UNAPPROVED HOMEOPATHIC",
            "dosage_form": "LIQUID",
            "spl_id": "19cf48fe-b4d3-d37b-e063-6394a90aeb52",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240523",
            "product_id": "15631-2846_19cf48fe-b4d3-d37b-e063-6394a90aeb52",
            "brand_name_base": "MERC SOL"
        },
        {
            "product_ndc": "51144-003",
            "generic_name": "tisotumab vedotin",
            "labeler_name": "Seagen Inc.",
            "brand_name": "TIVDAK",
            "active_ingredients": [
                {
                    "name": "TISOTUMAB VEDOTIN",
                    "strength": "40 mg/4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51144-003-01",
                    "description": "1 VIAL in 1 CARTON (51144-003-01)  / 4 mL in 1 VIAL",
                    "marketing_start_date": "20210920",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Seagen Inc."
                ],
                "rxcui": [
                    "2571099",
                    "2571104"
                ],
                "spl_set_id": [
                    "c9fe3f32-4219-466e-acb9-3f609b4f4df1"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0351144003014"
                ],
                "unii": [
                    "T41737F88A"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
            "spl_id": "f6946125-b909-4296-a549-4fabb2680bc9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210920",
            "product_id": "51144-003_f6946125-b909-4296-a549-4fabb2680bc9",
            "application_number": "BLA761208",
            "brand_name_base": "TIVDAK"
        },
        {
            "product_ndc": "72789-408",
            "generic_name": "Tadalafil",
            "labeler_name": "PD-Rx Pharmaceuticals, Inc.",
            "brand_name": "Tadalafil",
            "active_ingredients": [
                {
                    "name": "TADALAFIL",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72789-408-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-408-30)",
                    "marketing_start_date": "20240611",
                    "sample": false
                },
                {
                    "package_ndc": "72789-408-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-408-90)",
                    "marketing_start_date": "20240611",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PD-Rx Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "484814"
                ],
                "spl_set_id": [
                    "828f0ee1-b9fc-4743-9394-fc086bcf5345"
                ],
                "upc": [
                    "0372789408309"
                ],
                "nui": [
                    "N0000175599",
                    "N0000020026"
                ],
                "pharm_class_epc": [
                    "Phosphodiesterase 5 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Phosphodiesterase 5 Inhibitors [MoA]"
                ],
                "unii": [
                    "742SXX0ICT"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "1aa173bb-c5eb-5a52-e063-6294a90ae88c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201102",
            "product_id": "72789-408_1aa173bb-c5eb-5a52-e063-6294a90ae88c",
            "application_number": "ANDA211298",
            "brand_name_base": "Tadalafil",
            "pharm_class": [
                "Phosphodiesterase 5 Inhibitor [EPC]",
                "Phosphodiesterase 5 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "50242-120",
            "generic_name": "tenecteplase",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "TNKase",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-120-47",
                    "description": "1 KIT in 1 CARTON (50242-120-47)  *  1 VIAL, SINGLE-USE in 1 CARTON (50242-901-09)  / 10 mL in 1 VIAL, SINGLE-USE *  1 VIAL, SINGLE-USE in 1 CARTON (50242-037-06)  / 50 mg in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20181107",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "284422",
                    "313212"
                ],
                "spl_set_id": [
                    "739a3c53-caf6-40d6-a6af-84ce733a948b"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "b1dff2e2-a09b-4ebd-bd7a-93906a4b1b0f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20181107",
            "product_id": "50242-120_b1dff2e2-a09b-4ebd-bd7a-93906a4b1b0f",
            "application_number": "BLA103909",
            "brand_name_base": "TNKase"
        },
        {
            "product_ndc": "49502-345",
            "generic_name": "Tobramycin",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "TOBI",
            "active_ingredients": [
                {
                    "name": "TOBRAMYCIN",
                    "strength": "300 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-345-73",
                    "description": "56 POUCH in 1 CARTON (49502-345-73)  / 4 AMPULE in 1 POUCH (49502-345-99)  / 5 mL in 1 AMPULE",
                    "marketing_start_date": "20220623",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "213194",
                    "348719"
                ],
                "spl_set_id": [
                    "6a3c3871-1d3a-44d6-8be3-526b30123ef7"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175477",
                    "M0000946"
                ],
                "pharm_class_epc": [
                    "Aminoglycoside Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminoglycosides [CS]"
                ],
                "unii": [
                    "VZ8RRZ51VK"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "8061b21d-5a04-48c1-b0fe-f769560f4a59",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL",
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20220623",
            "product_id": "49502-345_8061b21d-5a04-48c1-b0fe-f769560f4a59",
            "application_number": "NDA050753",
            "brand_name_base": "TOBI",
            "pharm_class": [
                "Aminoglycoside Antibacterial [EPC]",
                "Aminoglycosides [CS]"
            ]
        },
        {
            "product_ndc": "0024-5869",
            "generic_name": "insulin glargine",
            "labeler_name": "Sanofi-Aventis U.S. LLC",
            "brand_name": "TOUJEO",
            "active_ingredients": [
                {
                    "name": "INSULIN GLARGINE",
                    "strength": "300 U/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0024-5869-00",
                    "description": "1 SYRINGE in 1 CARTON (0024-5869-00)  / 1.5 mL in 1 SYRINGE",
                    "marketing_start_date": "20150215",
                    "sample": true
                },
                {
                    "package_ndc": "0024-5869-03",
                    "description": "3 SYRINGE in 1 CARTON (0024-5869-03)  / 1.5 mL in 1 SYRINGE (0024-5869-01)",
                    "marketing_start_date": "20150215",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sanofi-Aventis U.S. LLC"
                ],
                "rxcui": [
                    "1604539",
                    "1604544",
                    "2002419",
                    "2002420"
                ],
                "spl_set_id": [
                    "c9561d96-124d-48ca-982f-0aa1575bff36"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "2ZM8CX04RZ"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "23d7263b-16d4-4b17-bc45-8e499861015d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20150215",
            "product_id": "0024-5869_23d7263b-16d4-4b17-bc45-8e499861015d",
            "application_number": "BLA206538",
            "brand_name_base": "TOUJEO",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "55154-0410",
            "generic_name": "linagliptin",
            "labeler_name": "Cardinal Health 107, LLC",
            "brand_name": "Tradjenta",
            "active_ingredients": [
                {
                    "name": "LINAGLIPTIN",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55154-0410-8",
                    "description": "2640 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-0410-8)",
                    "marketing_start_date": "20110509",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Cardinal Health 107, LLC"
                ],
                "rxcui": [
                    "1100702",
                    "1100706"
                ],
                "spl_set_id": [
                    "dfe327e8-f6ab-41e5-bdef-d520118cd83a"
                ],
                "upc": [
                    "0355154041080"
                ],
                "nui": [
                    "N0000175912",
                    "N0000175913"
                ],
                "pharm_class_moa": [
                    "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Dipeptidyl Peptidase 4 Inhibitor [EPC]"
                ],
                "unii": [
                    "3X29ZEJ4R2"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "b3054328-9fd6-4abb-bc33-a27d4d358d55",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110509",
            "product_id": "55154-0410_b3054328-9fd6-4abb-bc33-a27d4d358d55",
            "application_number": "NDA201280",
            "brand_name_base": "Tradjenta",
            "pharm_class": [
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0069-0308",
            "generic_name": "trastuzumab-qyyp",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Trazimera",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.15mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-0308-01",
                    "description": "1 VIAL in 1 CARTON (0069-0308-01)  / 7.15 mL in 1 VIAL",
                    "marketing_start_date": "20210310",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2280732",
                    "2280737",
                    "2472791",
                    "2472794"
                ],
                "spl_set_id": [
                    "b9c5e894-27d2-4245-a653-df986fed3c56"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "24399684-3818-4410-aecb-32b822817a4b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210310",
            "product_id": "0069-0308_24399684-3818-4410-aecb-32b822817a4b",
            "application_number": "BLA761081",
            "brand_name_base": "Trazimera",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "0173-0859",
            "generic_name": "fluticasone furoate and vilanterol trifenatate",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "Breo Ellipta",
            "active_ingredients": [
                {
                    "name": "FLUTICASONE FUROATE",
                    "strength": "100 ug/1"
                },
                {
                    "name": "VILANTEROL TRIFENATATE",
                    "strength": "25 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0859-10",
                    "description": "1 TRAY in 1 CARTON (0173-0859-10)  / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-14",
                    "description": "1 TRAY in 1 CARTON (0173-0859-14)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0859-61",
                    "description": "1 TRAY in 1 CARTON (0173-0859-61)  / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER",
                    "marketing_start_date": "20130826",
                    "marketing_end_date": "20240630",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "1424889",
                    "1424899",
                    "1539891",
                    "1539893",
                    "1648783",
                    "1648785",
                    "1648788",
                    "1648789",
                    "2637473",
                    "2637476"
                ],
                "spl_set_id": [
                    "96428df1-ea05-431a-98d3-1ec2c4b63878"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "40AHO2C6DG",
                    "JS86977WNV"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER",
            "spl_id": "dea41e66-87ce-42ee-8391-e0c25938ea73",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20130826",
            "product_id": "0173-0859_dea41e66-87ce-42ee-8391-e0c25938ea73",
            "application_number": "NDA204275",
            "brand_name_base": "Breo Ellipta",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "57894-640",
            "generic_name": "Guselkumab",
            "labeler_name": "Janssen Biotech, Inc.",
            "brand_name": "Tremfya",
            "active_ingredients": [
                {
                    "name": "GUSELKUMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "57894-640-01",
                    "description": "1 SYRINGE in 1 CARTON (57894-640-01)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20170713",
                    "sample": false
                },
                {
                    "package_ndc": "57894-640-04",
                    "description": "1 SYRINGE in 1 CARTON (57894-640-04)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20170713",
                    "sample": true
                },
                {
                    "package_ndc": "57894-640-11",
                    "description": "1 SYRINGE in 1 CARTON (57894-640-11)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20190128",
                    "sample": false
                },
                {
                    "package_ndc": "57894-640-99",
                    "description": "1 SYRINGE in 1 CARTON (57894-640-99)  / 1 mL in 1 SYRINGE",
                    "marketing_start_date": "20190128",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Biotech, Inc."
                ],
                "rxcui": [
                    "1928686",
                    "1928689",
                    "2118739",
                    "2118741"
                ],
                "spl_set_id": [
                    "1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0357894640110"
                ],
                "nui": [
                    "N0000192799",
                    "N0000192798"
                ],
                "pharm_class_epc": [
                    "Interleukin-23 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Interleukin-23 Antagonists [MoA]"
                ],
                "unii": [
                    "089658A12D"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "09bab28f-d731-f2e7-e063-6294a90a1b79",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20170713",
            "product_id": "57894-640_09bab28f-d731-f2e7-e063-6294a90a1b79",
            "application_number": "BLA761061",
            "brand_name_base": "Tremfya",
            "pharm_class": [
                "Interleukin-23 Antagonist [EPC]",
                "Interleukin-23 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0169-2662",
            "generic_name": "insulin degludec",
            "labeler_name": "Novo Nordisk",
            "brand_name": "Tresiba",
            "active_ingredients": [
                {
                    "name": "INSULIN DEGLUDEC",
                    "strength": "100 U/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-2662-11",
                    "description": "1 VIAL, GLASS in 1 CARTON (0169-2662-11)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20190205",
                    "sample": false
                },
                {
                    "package_ndc": "0169-2662-90",
                    "description": "1 VIAL, GLASS in 1 CARTON (0169-2662-90)  / 10 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20190205",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "1670011",
                    "1670016",
                    "1670021",
                    "1670023",
                    "2107520",
                    "2107522"
                ],
                "spl_set_id": [
                    "456c5e87-3dfd-46fa-8ac0-c6128d4c97c6"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]"
                ],
                "unii": [
                    "54Q18076QB"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "e5571110-ca7e-4fcc-88a8-9f1d0104c508",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20181121",
            "product_id": "0169-2662_e5571110-ca7e-4fcc-88a8-9f1d0104c508",
            "application_number": "BLA203314",
            "brand_name_base": "Tresiba",
            "pharm_class": [
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "64764-720",
            "generic_name": "vortioxetine",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "Trintellix",
            "active_ingredients": [
                {
                    "name": "VORTIOXETINE HYDROBROMIDE",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64764-720-07",
                    "description": "1 BOTTLE in 1 CARTON (64764-720-07)  / 7 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20131002",
                    "sample": false
                },
                {
                    "package_ndc": "64764-720-09",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-720-09)",
                    "marketing_start_date": "20131002",
                    "sample": false
                },
                {
                    "package_ndc": "64764-720-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-720-30)",
                    "marketing_start_date": "20131002",
                    "sample": false
                },
                {
                    "package_ndc": "64764-720-77",
                    "description": "500 TABLET, FILM COATED in 1 BOTTLE (64764-720-77)",
                    "marketing_start_date": "20131002",
                    "sample": false
                },
                {
                    "package_ndc": "64764-720-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (64764-720-90)",
                    "marketing_start_date": "20131002",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Takeda Pharmaceuticals America, Inc."
                ],
                "rxcui": [
                    "1439808",
                    "1439810",
                    "1439812",
                    "1790886",
                    "1790890",
                    "1790892"
                ],
                "spl_set_id": [
                    "1a5b68e2-14d0-419d-9ec6-1ca97145e838"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364764730307",
                    "0364764750305",
                    "0364764720308"
                ],
                "unii": [
                    "TKS641KOAY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "9a2e06ef-8cc7-4f2a-ae57-fb965b37550b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20131002",
            "product_id": "64764-720_9a2e06ef-8cc7-4f2a-ae57-fb965b37550b",
            "application_number": "NDA204447",
            "brand_name_base": "Trintellix"
        },
        {
            "product_ndc": "49702-258",
            "generic_name": "abacavir sulfate, dolutegravir sodium, lamivudine",
            "labeler_name": "ViiV Healthcare Company",
            "brand_name": "Triumeq PD",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49702-258-37",
                    "description": "1 KIT in 1 CARTON (49702-258-37)  *  90 TABLET, FILM COATED in 1 BOTTLE (49702-272-59)",
                    "marketing_start_date": "20220330",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "ViiV Healthcare Company"
                ],
                "rxcui": [
                    "1546888",
                    "1546894",
                    "2598348",
                    "2598352"
                ],
                "spl_set_id": [
                    "2997739a-aa91-42aa-a206-a70e2db7b84f"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0349702231139"
                ],
                "nui": [
                    "N0000175656",
                    "N0000175462",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "J220T4J9Q2",
                    "1Q1V9V5WYQ",
                    "2T8Q726O95"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "6e261498-84d5-45bd-868f-06a117c2d4e9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20220330",
            "product_id": "49702-258_6e261498-84d5-45bd-868f-06a117c2d4e9",
            "application_number": "NDA215413",
            "brand_name_base": "Triumeq PD"
        },
        {
            "product_ndc": "72789-408",
            "generic_name": "Tadalafil",
            "labeler_name": "PD-Rx Pharmaceuticals, Inc.",
            "brand_name": "Tadalafil",
            "active_ingredients": [
                {
                    "name": "TADALAFIL",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72789-408-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-408-30)",
                    "marketing_start_date": "20240611",
                    "sample": false
                },
                {
                    "package_ndc": "72789-408-90",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-408-90)",
                    "marketing_start_date": "20240611",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PD-Rx Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "484814"
                ],
                "spl_set_id": [
                    "828f0ee1-b9fc-4743-9394-fc086bcf5345"
                ],
                "upc": [
                    "0372789408309"
                ],
                "nui": [
                    "N0000175599",
                    "N0000020026"
                ],
                "pharm_class_epc": [
                    "Phosphodiesterase 5 Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Phosphodiesterase 5 Inhibitors [MoA]"
                ],
                "unii": [
                    "742SXX0ICT"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "1aa173bb-c5eb-5a52-e063-6294a90ae88c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201102",
            "product_id": "72789-408_1aa173bb-c5eb-5a52-e063-6294a90ae88c",
            "application_number": "ANDA211298",
            "brand_name_base": "Tadalafil",
            "pharm_class": [
                "Phosphodiesterase 5 Inhibitor [EPC]",
                "Phosphodiesterase 5 Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "77530-725",
            "generic_name": "Dihydroergotamine mesylate",
            "labeler_name": "Impel Pharmaceuticals Inc.",
            "brand_name": "Trudhesa",
            "active_ingredients": [
                {
                    "name": "DIHYDROERGOTAMINE MESYLATE",
                    "strength": "4 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "77530-725-00",
                    "description": "1 VIAL, GLASS in 1 CARTON (77530-725-00)  / 1 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20210924",
                    "sample": true
                },
                {
                    "package_ndc": "77530-725-04",
                    "description": "4 VIAL, GLASS in 1 CARTON (77530-725-04)  / 1 mL in 1 VIAL, GLASS",
                    "marketing_start_date": "20210924",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Impel Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2569836",
                    "2569842"
                ],
                "spl_set_id": [
                    "b81397b0-910d-4eb4-8fee-a9a3c9d94d63"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "81AXN7R2QT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY, METERED",
            "spl_id": "c4a41e43-8ce2-47d6-9ff6-241d50411b6a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "NASAL"
            ],
            "marketing_start_date": "20210924",
            "product_id": "77530-725_c4a41e43-8ce2-47d6-9ff6-241d50411b6a",
            "application_number": "NDA213436",
            "brand_name_base": "Trudhesa",
            "pharm_class": [
                "Ergotamine Derivative [EPC]",
                "Ergotamines [CS]"
            ]
        },
        {
            "product_ndc": "65649-003",
            "generic_name": "Plecanatide",
            "labeler_name": "Salix Pharmaceuticals Inc.",
            "brand_name": "Trulance Immediate release",
            "brand_name_suffix": "Immediate release",
            "active_ingredients": [
                {
                    "name": "PLECANATIDE",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65649-003-01",
                    "description": "1 BOTTLE in 1 CARTON (65649-003-01)  / 1 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20170221",
                    "sample": false
                },
                {
                    "package_ndc": "65649-003-03",
                    "description": "1 BOTTLE in 1 CARTON (65649-003-03)  / 3 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20170221",
                    "sample": false
                },
                {
                    "package_ndc": "65649-003-07",
                    "description": "1 BOTTLE in 1 CARTON (65649-003-07)  / 7 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20170221",
                    "sample": true
                },
                {
                    "package_ndc": "65649-003-30",
                    "description": "30 TABLET in 1 BOTTLE (65649-003-30)",
                    "marketing_start_date": "20170221",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Salix Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "1873757",
                    "1873765"
                ],
                "spl_set_id": [
                    "fe2895bf-71a6-493a-b0ca-e06b2dfefc82"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0365649003301"
                ],
                "nui": [
                    "N0000185500",
                    "N0000185499"
                ],
                "pharm_class_epc": [
                    "Guanylate Cyclase-C Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Guanylate Cyclase Activators [MoA]"
                ],
                "unii": [
                    "7IK8Z952OK"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "154842e6-a919-ba71-e063-6394a90aebd4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170221",
            "product_id": "65649-003_154842e6-a919-ba71-e063-6394a90aebd4",
            "application_number": "NDA208745",
            "brand_name_base": "Trulance",
            "pharm_class": [
                "Guanylate Cyclase Activators [MoA]",
                "Guanylate Cyclase-C Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "50090-5467",
            "generic_name": "Dulaglutide",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "Trulicity",
            "active_ingredients": [
                {
                    "name": "DULAGLUTIDE",
                    "strength": "3 mg/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-5467-0",
                    "description": "4 SYRINGE in 1 CARTON (50090-5467-0)  / .5 mL in 1 SYRINGE",
                    "marketing_start_date": "20210211",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "2395777",
                    "2395779"
                ],
                "spl_set_id": [
                    "6088c732-afa1-4fee-9206-22e52baf4731"
                ],
                "nui": [
                    "N0000178480",
                    "M0160181",
                    "N0000020058"
                ],
                "pharm_class_epc": [
                    "GLP-1 Receptor Agonist [EPC]"
                ],
                "pharm_class_cs": [
                    "Glucagon-Like Peptide 1 [CS]"
                ],
                "pharm_class_moa": [
                    "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
                ],
                "unii": [
                    "WTT295HSY5"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "68b8dd5a-c40a-4004-97c3-c989f85bba82",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20200903",
            "product_id": "50090-5467_68b8dd5a-c40a-4004-97c3-c989f85bba82",
            "application_number": "BLA125469",
            "brand_name_base": "Trulicity",
            "pharm_class": [
                "GLP-1 Receptor Agonist [EPC]",
                "Glucagon-Like Peptide 1 [CS]",
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "0005-0100",
            "generic_name": "meningococcal group B vaccine",
            "labeler_name": "Wyeth Pharmaceutical Division of Wyeth Holdings LLC",
            "brand_name": "Trumenba",
            "active_ingredients": [
                {
                    "name": "NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN",
                    "strength": "60 ug/.5mL"
                },
                {
                    "name": "NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN",
                    "strength": "60 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0005-0100-02",
                    "description": "1 SYRINGE in 1 CARTON (0005-0100-02)  / .5 mL in 1 SYRINGE (0005-0100-01)",
                    "marketing_start_date": "20141105",
                    "sample": false
                },
                {
                    "package_ndc": "0005-0100-05",
                    "description": "5 SYRINGE in 1 CARTON (0005-0100-05)  / .5 mL in 1 SYRINGE (0005-0100-01)",
                    "marketing_start_date": "20141105",
                    "sample": false
                },
                {
                    "package_ndc": "0005-0100-10",
                    "description": "10 SYRINGE in 1 CARTON (0005-0100-10)  / .5 mL in 1 SYRINGE (0005-0100-01)",
                    "marketing_start_date": "20141105",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "db82c2e0-645e-4d36-a27a-940b1dd8d32b",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20141105",
            "product_id": "0005-0100_db82c2e0-645e-4d36-a27a-940b1dd8d32b",
            "application_number": "BLA125549",
            "brand_name_base": "Trumenba"
        },
        {
            "product_ndc": "0310-9500",
            "generic_name": "capivasertib",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "TRUQAP",
            "active_ingredients": [
                {
                    "name": "CAPIVASERTIB",
                    "strength": "160 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-9500-01",
                    "description": "64 TABLET, FILM COATED in 1 BOTTLE (0310-9500-01)",
                    "marketing_start_date": "20231116",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2669972",
                    "2669978",
                    "2669980",
                    "2669982"
                ],
                "spl_set_id": [
                    "d698c106-2322-401e-b738-cbd83c843ecf"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0303109501011"
                ],
                "unii": [
                    "WFR23M21IE"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "51e5a19c-f33a-4c6f-ac59-b87059bcef3b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20231116",
            "product_id": "0310-9500_51e5a19c-f33a-4c6f-ac59-b87059bcef3b",
            "application_number": "NDA218197",
            "brand_name_base": "TRUQAP"
        },
        {
            "product_ndc": "61958-0704",
            "generic_name": "emtricitabine and tenofovir disoproxil fumarate",
            "labeler_name": "Gilead Sciences, Inc",
            "brand_name": "Truvada",
            "active_ingredients": [
                {
                    "name": "EMTRICITABINE",
                    "strength": "133 mg/1"
                },
                {
                    "name": "TENOFOVIR DISOPROXIL FUMARATE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-0704-1",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0704-1)",
                    "marketing_start_date": "20160310",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc"
                ],
                "rxcui": [
                    "476556",
                    "639888",
                    "1744001",
                    "1744003",
                    "1744005",
                    "1744007",
                    "1744009",
                    "1744011"
                ],
                "spl_set_id": [
                    "54e82b13-a037-49ed-b4b3-030b37c0ecdd"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175462",
                    "M0015066",
                    "N0000009947"
                ],
                "pharm_class_epc": [
                    "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Nucleosides [CS]"
                ],
                "pharm_class_moa": [
                    "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
                ],
                "unii": [
                    "G70B4ETF4S",
                    "OTT9J7900I"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "5991c53b-93e7-4a87-a010-5efb74f1229b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160310",
            "product_id": "61958-0704_5991c53b-93e7-4a87-a010-5efb74f1229b",
            "application_number": "NDA021752",
            "brand_name_base": "Truvada",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "63459-103",
            "generic_name": "rituximab-abbs",
            "labeler_name": "Cephalon, Inc.",
            "brand_name": "Truxima",
            "active_ingredients": [
                {
                    "name": "RITUXIMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "63459-103-10",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (63459-103-10)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20200504",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Cephalon, Inc."
                ],
                "rxcui": [
                    "2105826",
                    "2105831",
                    "2105834",
                    "2105835"
                ],
                "spl_set_id": [
                    "9af3ddc7-4217-417a-ac89-8704edc5bc44"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175078",
                    "N0000175657"
                ],
                "pharm_class_moa": [
                    "CD20-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_epc": [
                    "CD20-directed Cytolytic Antibody [EPC]"
                ],
                "unii": [
                    "4F4X42SYQ6"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "7b8afe53-a095-4dca-ae40-c4dc350be592",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200504",
            "product_id": "63459-103_7b8afe53-a095-4dca-ae40-c4dc350be592",
            "application_number": "BLA761088",
            "brand_name_base": "Truxima",
            "pharm_class": [
                "CD20-directed Antibody Interactions [MoA]",
                "CD20-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "51144-001",
            "generic_name": "tucatinib",
            "labeler_name": "SEAGEN INC.",
            "brand_name": "TUKYSA",
            "active_ingredients": [
                {
                    "name": "TUCATINIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51144-001-60",
                    "description": "60 TABLET in 1 BOTTLE (51144-001-60)",
                    "marketing_start_date": "20200417",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "SEAGEN INC."
                ],
                "rxcui": [
                    "2361290",
                    "2361296",
                    "2361298",
                    "2361300"
                ],
                "spl_set_id": [
                    "f27eb1b9-b7fc-424e-988f-84dd7bb195a3"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020001",
                    "N0000190114",
                    "N0000185503",
                    "N0000187062"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tyrosine Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]"
                ],
                "unii": [
                    "234248D0HH"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "20eeafc9-ef3a-48e9-a26d-d3c1d0369250",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200417",
            "product_id": "51144-001_20eeafc9-ef3a-48e9-a26d-d3c1d0369250",
            "application_number": "NDA213411",
            "brand_name_base": "TUKYSA",
            "pharm_class": [
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "75854-308",
            "generic_name": "ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, folic acid, pyridoxine hydrochloride, cyanocobalamin, biotin, calcium carbonate, ferrous fumarate, magnesium oxide, lactic acid and doconexent",
            "labeler_name": "Avion Pharmaceuticals, LLC",
            "brand_name": "PRENATE Restore",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
                    "strength": "10 [iU]/1"
                },
                {
                    "name": "ASCORBIC ACID",
                    "strength": "85 mg/1"
                },
                {
                    "name": "BIOTIN",
                    "strength": "500 ug/1"
                },
                {
                    "name": "CALCIUM CARBONATE",
                    "strength": "155 mg/1"
                },
                {
                    "name": "CHOLECALCIFEROL",
                    "strength": "1000 [iU]/1"
                },
                {
                    "name": "CYANOCOBALAMIN",
                    "strength": "12 ug/1"
                },
                {
                    "name": "DOCONEXENT",
                    "strength": "400 mg/1"
                },
                {
                    "name": "FERROUS FUMARATE",
                    "strength": "27 mg/1"
                },
                {
                    "name": "FOLIC ACID",
                    "strength": "1 mg/1"
                },
                {
                    "name": "LACTIC ACID",
                    "strength": "10 mg/1"
                },
                {
                    "name": "MAGNESIUM OXIDE",
                    "strength": "45 mg/1"
                },
                {
                    "name": "PYRIDOXINE HYDROCHLORIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75854-308-30",
                    "description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (75854-308-30)",
                    "marketing_start_date": "20130917",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Avion Pharmaceuticals, LLC"
                ],
                "spl_set_id": [
                    "1076ba9a-0168-492f-ba9b-99fa02186092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0375854308306"
                ],
                "nui": [
                    "N0000193618",
                    "M0001797",
                    "M0022797",
                    "N0000175952",
                    "M0022794",
                    "N0000175951"
                ],
                "pharm_class_epc": [
                    "Vitamin C [EPC]",
                    "Vitamin D [EPC]",
                    "Vitamin B12 [EPC]"
                ],
                "pharm_class_cs": [
                    "Ascorbic Acid [CS]",
                    "Vitamin D [CS]",
                    "Vitamin B 12 [CS]"
                ],
                "unii": [
                    "WR1WPI7EW8",
                    "PQ6CK8PD0R",
                    "6SO6U10H04",
                    "H0G9379FGK",
                    "1C6V77QF41",
                    "P6YC3EG204",
                    "ZAD9OKH9JC",
                    "R5L488RY0Q",
                    "935E97BOY8",
                    "33X04XA5AT",
                    "3A3U0GI71G",
                    "68Y4CF58BV"
                ]
            },
            "marketing_category": "UNAPPROVED DRUG OTHER",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20130917",
            "product_id": "75854-308_66e05fb4-63d1-469b-ad7f-3cef04c2cfa0",
            "brand_name_base": "PRENATE Restore",
            "pharm_class": [
                "Acidifying Activity [MoA]",
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Ascorbic Acid [CS]",
                "Blood Coagulation Factor [EPC]",
                "Calcium [CS]",
                "Calculi Dissolution Agent [EPC]",
                "Cations",
                "Divalent [CS]",
                "Increased Coagulation Factor Activity [PE]",
                "Increased Large Intestinal Motility [PE]",
                "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]",
                "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]",
                "Magnesium Ion Exchange Activity [MoA]",
                "Osmotic Activity [MoA]",
                "Osmotic Laxative [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]",
                "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
                "Vitamin B 12 [CS]",
                "Vitamin B 6 [Chemical/Ingredient]",
                "Vitamin B12 [EPC]",
                "Vitamin B6 Analog [EPC]",
                "Vitamin C [EPC]",
                "Vitamin D [CS]",
                "Vitamin D [EPC]"
            ]
        },
        {
            "product_ndc": "61958-1401",
            "generic_name": "COBICISTAT",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Tybost",
            "active_ingredients": [
                {
                    "name": "COBICISTAT",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-1401-1",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (61958-1401-1)",
                    "marketing_start_date": "20140924",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1551993",
                    "1551999"
                ],
                "spl_set_id": [
                    "3784c35c-e87f-410c-900b-8fd6313c6010"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190114",
                    "N0000191001",
                    "N0000185503",
                    "N0000182137",
                    "N0000190107",
                    "N0000190108",
                    "N0000190113",
                    "N0000191423"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Cytochrome P450 3A Inhibitor [EPC]"
                ],
                "unii": [
                    "LW2E03M5PG"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "4c7c1c0e-8107-4780-b8b9-cd0d443b74f6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20140924",
            "product_id": "61958-1401_4c7c1c0e-8107-4780-b8b9-cd0d443b74f6",
            "application_number": "NDA203094",
            "brand_name_base": "Tybost",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitor [EPC]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0671",
            "generic_name": "lapatinib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "TYKERB",
            "active_ingredients": [
                {
                    "name": "LAPATINIB DITOSYLATE",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0671-19",
                    "description": "150 TABLET in 1 BOTTLE (0078-0671-19)",
                    "marketing_start_date": "20160803",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "672149",
                    "672152"
                ],
                "spl_set_id": [
                    "eee37f88-ec6a-4c30-b8aa-e2c71f93088c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G873GX646R"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "c2612d2b-7cd4-48c2-88ab-8254882f7c82",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160803",
            "product_id": "0078-0671_c2612d2b-7cd4-48c2-88ab-8254882f7c82",
            "application_number": "NDA022059",
            "brand_name_base": "TYKERB",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70539-001",
            "generic_name": "abaloparatide",
            "labeler_name": "Radius Health, Inc.",
            "brand_name": "Tymlos",
            "active_ingredients": [
                {
                    "name": "ABALOPARATIDE",
                    "strength": "3.12 mg/1.56mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70539-001-02",
                    "description": "1 CARTRIDGE in 1 BOX, UNIT-DOSE (70539-001-02)  / 1.56 mL in 1 CARTRIDGE (70539-001-01)",
                    "marketing_start_date": "20170501",
                    "sample": false
                },
                {
                    "package_ndc": "70539-001-98",
                    "description": "1 CARTRIDGE in 1 BOX, UNIT-DOSE (70539-001-98)  / 1.56 mL in 1 CARTRIDGE (70539-001-99)",
                    "marketing_start_date": "20170501",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Radius Health, Inc."
                ],
                "rxcui": [
                    "1921075",
                    "1921081"
                ],
                "spl_set_id": [
                    "712143d9-e21e-4013-bb3b-3426a21060a8"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193453",
                    "M0150746"
                ],
                "pharm_class_epc": [
                    "Parathyroid Hormone-Related Peptide Analog [EPC]"
                ],
                "pharm_class_cs": [
                    "Parathyroid Hormone-Related Protein [CS]"
                ],
                "unii": [
                    "AVK0I6HY2U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "9ca7a022-6c6b-482e-8e13-338d6d257745",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20170501",
            "product_id": "70539-001_9ca7a022-6c6b-482e-8e13-338d6d257745",
            "application_number": "NDA208743",
            "brand_name_base": "Tymlos",
            "pharm_class": [
                "Parathyroid Hormone-Related Peptide Analog [EPC]",
                "Parathyroid Hormone-Related Protein [CS]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "83257-001",
            "generic_name": "trastuzumab-dkst",
            "labeler_name": "Biocon Biologics Inc.",
            "brand_name": "OGIVRI",
            "active_ingredients": [
                {
                    "name": "TRASTUZUMAB",
                    "strength": "150 mg/7.4mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83257-001-11",
                    "description": "1 VIAL in 1 CARTON (83257-001-11)  / 15 mL in 1 VIAL",
                    "marketing_start_date": "20231001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biocon Biologics Inc."
                ],
                "rxcui": [
                    "2179753",
                    "2179758",
                    "2179760",
                    "2179763"
                ],
                "spl_set_id": [
                    "b6465b44-a6dd-f99c-d009-6851cf05169c"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175661",
                    "N0000020008"
                ],
                "pharm_class_epc": [
                    "HER2/neu Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER2/Neu/cerbB2 Antagonists [MoA]"
                ],
                "unii": [
                    "P188ANX8CK"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20231001",
            "product_id": "83257-001_ede54dd8-7175-bb02-3d39-88cbf30c3ba2",
            "application_number": "BLA761074",
            "brand_name_base": "OGIVRI",
            "pharm_class": [
                "HER2/Neu/cerbB2 Antagonists [MoA]",
                "HER2/neu Receptor Antagonist [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "0023-6501",
            "generic_name": "ubrogepant",
            "labeler_name": "Allergan, Inc.",
            "brand_name": "UBRELVY",
            "active_ingredients": [
                {
                    "name": "UBROGEPANT",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0023-6501-01",
                    "description": "1 PACKET in 1 BOX (0023-6501-01)  / 1 TABLET in 1 PACKET",
                    "marketing_start_date": "20191223",
                    "sample": true
                },
                {
                    "package_ndc": "0023-6501-10",
                    "description": "10 PACKET in 1 BOX (0023-6501-10)  / 1 TABLET in 1 PACKET (0023-6501-02)",
                    "marketing_start_date": "20191223",
                    "sample": false
                },
                {
                    "package_ndc": "0023-6501-16",
                    "description": "16 PACKET in 1 BOX (0023-6501-16)  / 1 TABLET in 1 PACKET (0023-6501-02)",
                    "marketing_start_date": "20191223",
                    "sample": false
                },
                {
                    "package_ndc": "0023-6501-30",
                    "description": "30 PACKET in 1 BOX (0023-6501-30)  / 1 TABLET in 1 PACKET (0023-6501-02)",
                    "marketing_start_date": "20191223",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "2268221",
                    "2268227",
                    "2268229",
                    "2268231"
                ],
                "spl_set_id": [
                    "fd9f9458-fd96-4688-be3f-f77b3d1af6ab"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193917",
                    "N0000193918"
                ],
                "pharm_class_epc": [
                    "Calcitonin Gene-related Peptide Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"
                ],
                "unii": [
                    "AD0O8X2QJR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "5e093ad3-3dc4-4623-b6e0-2905b8a5325d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191223",
            "product_id": "0023-6501_5e093ad3-3dc4-4623-b6e0-2905b8a5325d",
            "application_number": "NDA211765",
            "brand_name_base": "UBRELVY",
            "pharm_class": [
                "Calcitonin Gene-related Peptide Receptor Antagonist [EPC]",
                "Calcitonin Gene-related Peptide Receptor Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "37000-995",
            "generic_name": "Sodium Fluoride and Potassium Nitrate",
            "labeler_name": "The Procter & Gamble Manufacturing Company",
            "brand_name": "Crest Premium Plus Sensitivity Active Foam",
            "brand_name_suffix": "Sensitivity Active Foam",
            "active_ingredients": [
                {
                    "name": "POTASSIUM NITRATE",
                    "strength": "50 mg/g"
                },
                {
                    "name": "SODIUM FLUORIDE",
                    "strength": "1.4 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "37000-995-52",
                    "description": "1 TUBE in 1 CARTON (37000-995-52)  / 147 g in 1 TUBE",
                    "marketing_start_date": "20210107",
                    "sample": false
                },
                {
                    "package_ndc": "37000-995-60",
                    "description": "1 TUBE in 1 CARTON (37000-995-60)  / 170 g in 1 TUBE",
                    "marketing_start_date": "20210107",
                    "sample": false
                },
                {
                    "package_ndc": "37000-995-70",
                    "description": "1 TUBE in 1 CARTON (37000-995-70)  / 198 g in 1 TUBE",
                    "marketing_start_date": "20210107",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "The Procter & Gamble Manufacturing Company"
                ],
                "rxcui": [
                    "1038800"
                ],
                "spl_set_id": [
                    "b8535d1c-cf15-f353-e053-2a95a90a7974"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "RU45X2JN0Z",
                    "8ZYQ1474W7"
                ]
            },
            "marketing_category": "OTC MONOGRAPH DRUG",
            "dosage_form": "PASTE, DENTIFRICE",
            "spl_id": "15d678b3-02d9-8d2d-e063-6394a90a737d",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "DENTAL"
            ],
            "marketing_start_date": "20210107",
            "product_id": "37000-995_15d678b3-02d9-8d2d-e063-6394a90a737d",
            "application_number": "M021",
            "brand_name_base": "Crest Premium Plus"
        },
        {
            "product_ndc": "70114-101",
            "generic_name": "pegfilgrastim-cbqv",
            "labeler_name": "Coherus BioSciences Inc",
            "brand_name": "UDENYCA",
            "active_ingredients": [
                {
                    "name": "PEGFILGRASTIM",
                    "strength": "6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70114-101-01",
                    "description": "1 SYRINGE in 1 CARTON (70114-101-01)  / .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20181102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Coherus BioSciences Inc"
                ],
                "rxcui": [
                    "2102703",
                    "2102705",
                    "2632544",
                    "2632547",
                    "2673598",
                    "2673602"
                ],
                "spl_set_id": [
                    "a8c290ee-b699-4395-a596-1453d4a4b4eb"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "dc3e9559-32df-41f3-a8fa-57ce4fb2ca6c",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20181102",
            "product_id": "70114-101_dc3e9559-32df-41f3-a8fa-57ce4fb2ca6c",
            "application_number": "BLA761039",
            "brand_name_base": "UDENYCA",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "25682-031",
            "generic_name": "RAVULIZUMAB",
            "labeler_name": "Alexion Pharmaceuticals Inc.",
            "brand_name": "ULTOMIRIS",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "25682-031-01",
                    "description": "1 KIT in 1 CARTON (25682-031-01)  *  1 CARTRIDGE in 1 TRAY / 3.5 mL in 1 CARTRIDGE",
                    "marketing_start_date": "20230401",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Alexion Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2107320",
                    "2107325",
                    "2461134",
                    "2461136",
                    "2461139",
                    "2461140",
                    "2632949",
                    "2632953"
                ],
                "spl_set_id": [
                    "a9a590d9-0217-43c7-908d-e62a71279791"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175575",
                    "N0000175974"
                ],
                "pharm_class_epc": [
                    "Complement Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Complement Inhibitors [MoA]"
                ],
                "unii": [
                    "C3VX249T6L"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "39c9b9f7-d48f-4cb6-988a-a5e6a0514f2f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20230401",
            "product_id": "25682-031_39c9b9f7-d48f-4cb6-988a-a5e6a0514f2f",
            "application_number": "BLA761108",
            "brand_name_base": "ULTOMIRIS"
        },
        {
            "product_ndc": "75987-150",
            "generic_name": "Inebilizumab",
            "labeler_name": "Horizon Therapeutics USA, Inc.",
            "brand_name": "UPLIZNA",
            "active_ingredients": [
                {
                    "name": "INEBILIZUMAB",
                    "strength": "10 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "75987-150-03",
                    "description": "3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03)  / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01)",
                    "marketing_start_date": "20200611",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Horizon Therapeutics USA, Inc."
                ],
                "rxcui": [
                    "2373955",
                    "2373960",
                    "2373966",
                    "2373967"
                ],
                "spl_set_id": [
                    "834db232-afb0-4dcf-93e0-009ce8245c20"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194013",
                    "N0000191422"
                ],
                "pharm_class_epc": [
                    "CD19-directed Cytolytic Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "CD19-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "74T7185BMM"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "9798b7eb-ddc0-4efb-8f92-bf6a82dbf269",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200611",
            "product_id": "75987-150_9798b7eb-ddc0-4efb-8f92-bf6a82dbf269",
            "application_number": "BLA761142",
            "brand_name_base": "UPLIZNA",
            "pharm_class": [
                "CD19-directed Antibody Interactions [MoA]",
                "CD19-directed Cytolytic Antibody [EPC]"
            ]
        },
        {
            "product_ndc": "66215-602",
            "generic_name": "Selexipag",
            "labeler_name": "Actelion Pharmaceuticals US, Inc.",
            "brand_name": "UPTRAVI",
            "active_ingredients": [
                {
                    "name": "SELEXIPAG",
                    "strength": "200 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66215-602-06",
                    "description": "1 BOTTLE in 1 CARTON (66215-602-06)  / 60 TABLET, COATED in 1 BOTTLE",
                    "marketing_start_date": "20151221",
                    "sample": false
                },
                {
                    "package_ndc": "66215-602-14",
                    "description": "1 BOTTLE in 1 CARTON (66215-602-14)  / 140 TABLET, COATED in 1 BOTTLE",
                    "marketing_start_date": "20151221",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Actelion Pharmaceuticals US, Inc."
                ],
                "rxcui": [
                    "1729007",
                    "1729013",
                    "1729027",
                    "1729029",
                    "1729031",
                    "1729033",
                    "1729045",
                    "1729047",
                    "1729051",
                    "1729053",
                    "1729055",
                    "1729057",
                    "1729059",
                    "1729061",
                    "1729063",
                    "1729065",
                    "1729075",
                    "1729076",
                    "2565271",
                    "2565275"
                ],
                "spl_set_id": [
                    "a7a23b87-f892-4e2c-8e2e-ebf841220f90"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192339",
                    "N0000020068"
                ],
                "pharm_class_epc": [
                    "Prostacyclin Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Prostacyclin Receptor Agonists [MoA]"
                ],
                "unii": [
                    "5EXC0E384L"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, COATED",
            "spl_id": "f9b62ce2-37c1-2e5c-e053-6394a90a657b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151221",
            "product_id": "66215-602_f9b62ce2-37c1-2e5c-e053-6394a90a657b",
            "application_number": "NDA207947",
            "brand_name_base": "UPTRAVI",
            "pharm_class": [
                "Prostacyclin Receptor Agonist [EPC]",
                "Prostacyclin Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "51759-305",
            "generic_name": "risperidone",
            "labeler_name": "Teva Pharmaceuticals USA, Inc.",
            "brand_name": "UZEDY",
            "active_ingredients": [
                {
                    "name": "RISPERIDONE",
                    "strength": "50 mg/.14mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51759-305-10",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (51759-305-10)  / .14 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20230501",
                    "sample": false
                },
                {
                    "package_ndc": "51759-305-11",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (51759-305-11)  / .14 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20230501",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Teva Pharmaceuticals USA, Inc."
                ],
                "rxcui": [
                    "2636033",
                    "2636039",
                    "2636041",
                    "2636042",
                    "2636043",
                    "2636044",
                    "2636045",
                    "2636046",
                    "2636047",
                    "2636048",
                    "2636049",
                    "2636050",
                    "2636051",
                    "2636052"
                ],
                "spl_set_id": [
                    "734eb776-4be0-4808-834b-0d8b0f9e021e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "L6UH7ZF8HC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE",
            "spl_id": "4da13042-134d-492b-a4d3-9a9146596b2d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20230501",
            "product_id": "51759-305_4da13042-134d-492b-a4d3-9a9146596b2d",
            "application_number": "NDA213586",
            "brand_name_base": "UZEDY",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "50242-096",
            "generic_name": "Faricimab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "VABYSMO",
            "active_ingredients": [
                {
                    "name": "FARICIMAB",
                    "strength": "6 mg/.05mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-096-01",
                    "description": "1 VIAL in 1 CARTON (50242-096-01)  / .05 mL in 1 VIAL (50242-096-03)",
                    "marketing_start_date": "20220128",
                    "sample": false
                },
                {
                    "package_ndc": "50242-096-86",
                    "description": "1 VIAL in 1 CARTON (50242-096-86)  / .05 mL in 1 VIAL (50242-096-77)",
                    "marketing_start_date": "20220128",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "2591588",
                    "2591594"
                ],
                "spl_set_id": [
                    "04cc9ef7-c02a-4e92-a655-0062674e8487"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "QC4F7FKK7I"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "6815251d-7f8d-4b04-8fc5-b1ec85a617ca",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVITREAL"
            ],
            "marketing_start_date": "20220128",
            "product_id": "50242-096_6815251d-7f8d-4b04-8fc5-b1ec85a617ca",
            "application_number": "BLA761235",
            "brand_name_base": "VABYSMO"
        },
        {
            "product_ndc": "0169-5176",
            "generic_name": "estradiol",
            "labeler_name": "Novo Nordisk",
            "brand_name": "Vagifem",
            "active_ingredients": [
                {
                    "name": "ESTRADIOL",
                    "strength": "10 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-5176-03",
                    "description": "8 APPLICATOR in 1 CARTON (0169-5176-03)  / 1 INSERT in 1 APPLICATOR",
                    "marketing_start_date": "20100111",
                    "sample": false
                },
                {
                    "package_ndc": "0169-5176-04",
                    "description": "18 APPLICATOR in 1 CARTON (0169-5176-04)  / 1 INSERT in 1 APPLICATOR",
                    "marketing_start_date": "20100111",
                    "sample": false
                },
                {
                    "package_ndc": "0169-5176-99",
                    "description": "6 APPLICATOR in 1 CARTON (0169-5176-99)  / 1 INSERT in 1 APPLICATOR",
                    "marketing_start_date": "20100111",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "884707",
                    "884709"
                ],
                "spl_set_id": [
                    "e5ad3cf6-dd96-4e64-af21-c1eee38d0b88"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0447348",
                    "N0000175825",
                    "N0000000100"
                ],
                "pharm_class_cs": [
                    "Estradiol Congeners [CS]"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "unii": [
                    "4TI98Z838E"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INSERT",
            "spl_id": "3f3eb506-32e2-497b-a6ea-71ff839b49f5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "VAGINAL"
            ],
            "marketing_start_date": "20100111",
            "product_id": "0169-5176_3f3eb506-32e2-497b-a6ea-71ff839b49f5",
            "application_number": "NDA020908",
            "brand_name_base": "Vagifem",
            "pharm_class": [
                "Estradiol Congeners [CS]",
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]"
            ]
        },
        {
            "product_ndc": "69639-120",
            "generic_name": "mechlorethamine hydrochloride",
            "labeler_name": "Helsinn Therapeutics (U.S.), Inc.",
            "brand_name": "VALCHLOR",
            "active_ingredients": [
                {
                    "name": "MECHLORETHAMINE",
                    "strength": ".012 g/60g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69639-120-01",
                    "description": "1 TUBE in 1 CARTON (69639-120-01)  / 60 g in 1 TUBE",
                    "marketing_start_date": "20181108",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Helsinn Therapeutics (U.S.), Inc."
                ],
                "rxcui": [
                    "1437711",
                    "1437713"
                ],
                "spl_set_id": [
                    "6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0369639120016"
                ],
                "nui": [
                    "N0000000236",
                    "N0000175558"
                ],
                "pharm_class_moa": [
                    "Alkylating Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Alkylating Drug [EPC]"
                ],
                "unii": [
                    "50D9XSG0VR"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GEL",
            "spl_id": "30452fee-68cf-4513-a339-4bfe5a623365",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20181108",
            "product_id": "69639-120_30452fee-68cf-4513-a339-4bfe5a623365",
            "application_number": "NDA202317",
            "brand_name_base": "VALCHLOR",
            "pharm_class": [
                "Alkylating Activity [MoA]",
                "Alkylating Drug [EPC]"
            ]
        },
        {
            "product_ndc": "72252-505",
            "generic_name": "diazepam",
            "labeler_name": "Neurelis, Inc",
            "dea_schedule": "CIV",
            "brand_name": "Valtoco",
            "active_ingredients": [
                {
                    "name": "DIAZEPAM",
                    "strength": "5 mg/.1mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72252-505-02",
                    "description": "2 BLISTER PACK in 1 CARTON (72252-505-02)  / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / .1 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200110",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Neurelis, Inc"
                ],
                "rxcui": [
                    "2272613",
                    "2272619",
                    "2272621",
                    "2272622",
                    "2272623",
                    "2272624",
                    "2272626",
                    "2272627",
                    "2272629",
                    "2272630",
                    "2272632",
                    "2272633",
                    "2272635",
                    "2272636"
                ],
                "spl_set_id": [
                    "1a8bcc90-68fa-474d-832c-0df01e825f39"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "Q3JTX2Q7TU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SPRAY",
            "spl_id": "d4304577-0d16-4b10-bce1-c72f81ab2cbc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "NASAL"
            ],
            "marketing_start_date": "20200110",
            "product_id": "72252-505_d4304577-0d16-4b10-bce1-c72f81ab2cbc",
            "application_number": "NDA211635",
            "brand_name_base": "Valtoco",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "65597-504",
            "generic_name": "QUIZARTINIB",
            "labeler_name": "Daiichi Sankyo Inc.",
            "brand_name": "VANFLYTA",
            "active_ingredients": [
                {
                    "name": "QUIZARTINIB DIHYDROCHLORIDE",
                    "strength": "17.7 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65597-504-04",
                    "description": "1 BOTTLE in 1 CARTON (65597-504-04)  / 14 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20230720",
                    "sample": false
                },
                {
                    "package_ndc": "65597-504-28",
                    "description": "1 BOTTLE in 1 CARTON (65597-504-28)  / 28 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20230720",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Daiichi Sankyo Inc."
                ],
                "rxcui": [
                    "2643054",
                    "2643060",
                    "2643062",
                    "2643064"
                ],
                "spl_set_id": [
                    "29cdbcfe-497d-4e78-bb7b-2d4acafe8e86"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "WK7Q6ZIZ10"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "a041742b-01c5-46c1-9990-1007981e36ef",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230720",
            "product_id": "65597-504_a041742b-01c5-46c1-9990-1007981e36ef",
            "application_number": "NDA216993",
            "brand_name_base": "VANFLYTA"
        },
        {
            "product_ndc": "0006-4831",
            "generic_name": "hepatitis A vaccine, inactivated",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "VAQTA",
            "active_ingredients": [
                {
                    "name": "HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)",
                    "strength": "25 [iU]/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-4831-41",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4831-41)  / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4831-01)",
                    "marketing_start_date": "19960329",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "261399ed-0541-4663-84c7-fef1bcd0bcf4",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "19960329",
            "product_id": "0006-4831_261399ed-0541-4663-84c7-fef1bcd0bcf4",
            "application_number": "BLA103606",
            "brand_name_base": "VAQTA",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Hepatitis A Vaccines [CS]",
                "Inactivated Hepatitis A Virus Vaccine [EPC]",
                "Vaccines",
                "Inactivated [CS]"
            ]
        },
        {
            "product_ndc": "0006-4827",
            "generic_name": "Varicella Virus Vaccine Live",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "VARIVAX",
            "active_ingredients": [
                {
                    "name": "VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN",
                    "strength": "1350 [PFU]/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-4827-00",
                    "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4827-00)  / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4827-01)",
                    "marketing_start_date": "19950317",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",
            "spl_id": "458c359d-8661-4b7e-8bef-e5a446a0cab6",
            "product_type": "VACCINE",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19950317",
            "product_id": "0006-4827_458c359d-8661-4b7e-8bef-e5a446a0cab6",
            "application_number": "BLA103552",
            "brand_name_base": "VARIVAX",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Chickenpox Vaccine [CS]",
                "Herpes Zoster Vaccine [CS]",
                "Live Attenuated Herpes Zoster Virus Vaccine [EPC]",
                "Live Attenuated Varicella Zoster Virus Vaccine [EPC]",
                "Vaccines",
                "Attenuated [CS]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0006-4329",
            "generic_name": "Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "VAXNEUVANCE",
            "active_ingredients": [
                {
                    "name": "CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN",
                    "strength": "30 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "4 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                },
                {
                    "name": "STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN",
                    "strength": "2 ug/.5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-4329-02",
                    "description": "1 SYRINGE, GLASS in 1 CARTON (0006-4329-02)  / .5 mL in 1 SYRINGE, GLASS (0006-4329-01)",
                    "marketing_start_date": "20210716",
                    "sample": false
                },
                {
                    "package_ndc": "0006-4329-03",
                    "description": "10 SYRINGE, GLASS in 1 CARTON (0006-4329-03)  / .5 mL in 1 SYRINGE, GLASS (0006-4329-01)",
                    "marketing_start_date": "20210716",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "128a60cb-4d53-4629-933e-29438ec98061",
            "product_type": "VACCINE",
            "route": [
                "INTRAMUSCULAR"
            ],
            "marketing_start_date": "20210716",
            "product_id": "0006-4329_128a60cb-4d53-4629-933e-29438ec98061",
            "application_number": "BLA125741",
            "brand_name_base": "VAXNEUVANCE",
            "pharm_class": [
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Actively Acquired Immunity [PE]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Inactivated Pneumococcal Vaccine [EPC]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Pneumococcal Vaccines [CS]",
                "Vaccines",
                "Conjugate [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]",
                "Vaccines",
                "Inactivated [CS]"
            ]
        },
        {
            "product_ndc": "55513-956",
            "generic_name": "panitumumab",
            "labeler_name": "Amgen Inc",
            "brand_name": "Vectibix",
            "active_ingredients": [
                {
                    "name": "PANITUMUMAB",
                    "strength": "400 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-956-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55513-956-01)  / 20 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20061010",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1657703",
                    "1657705",
                    "1657722",
                    "1657723"
                ],
                "spl_set_id": [
                    "e0fa4bca-f245-4d92-ae29-b0c630a315c2"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175664",
                    "N0000020010",
                    "M0001357"
                ],
                "pharm_class_epc": [
                    "Epidermal Growth Factor Receptor Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "HER1 Antagonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Antibodies, Monoclonal [CS]"
                ],
                "unii": [
                    "6A901E312A"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "59928d12-bde9-4433-8316-a142514ef952",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20061010",
            "product_id": "55513-956_59928d12-bde9-4433-8316-a142514ef952",
            "application_number": "BLA125147",
            "brand_name_base": "Vectibix",
            "pharm_class": [
                "Antibodies",
                "Monoclonal [CS]",
                "Epidermal Growth Factor Receptor Antagonist [EPC]",
                "HER1 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "61958-2901",
            "generic_name": "remdesivir",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Veklury",
            "active_ingredients": [
                {
                    "name": "REMDESIVIR",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-2901-2",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2901-2)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20201101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "2284960",
                    "2367758",
                    "2395502",
                    "2395504"
                ],
                "spl_set_id": [
                    "c0978fa8-53ff-4ca2-82a7-567fd3e958ca"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193948"
                ],
                "pharm_class_epc": [
                    "SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]"
                ],
                "unii": [
                    "3QKI37EEHE"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "0f3a7c5f-4b1f-4e0b-9b92-2f3addbf5cf9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20201101",
            "product_id": "61958-2901_0f3a7c5f-4b1f-4e0b-9b92-2f3addbf5cf9",
            "application_number": "NDA214787",
            "brand_name_base": "Veklury",
            "pharm_class": [
                "SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "13668-271",
            "generic_name": "CARBAMAZEPINE",
            "labeler_name": "Torrent Pharmaceuticals Limited",
            "brand_name": "CARBAMAZEPINE",
            "active_ingredients": [
                {
                    "name": "CARBAMAZEPINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "13668-271-01",
                    "description": "100 TABLET, CHEWABLE in 1 BOTTLE (13668-271-01)",
                    "marketing_start_date": "20090826",
                    "sample": false
                },
                {
                    "package_ndc": "13668-271-05",
                    "description": "500 TABLET, CHEWABLE in 1 BOTTLE (13668-271-05)",
                    "marketing_start_date": "20090826",
                    "sample": false
                },
                {
                    "package_ndc": "13668-271-10",
                    "description": "1000 TABLET, CHEWABLE in 1 BOTTLE (13668-271-10)",
                    "marketing_start_date": "20090826",
                    "sample": false
                },
                {
                    "package_ndc": "13668-271-49",
                    "description": "750 TABLET, CHEWABLE in 1 BOTTLE (13668-271-49)",
                    "marketing_start_date": "20090826",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Torrent Pharmaceuticals Limited"
                ],
                "rxcui": [
                    "308973",
                    "308979"
                ],
                "spl_set_id": [
                    "97e6e175-75e8-437b-b457-ddb1ae4e857d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0313668271010",
                    "0313668268300"
                ],
                "nui": [
                    "N0000008486",
                    "N0000175751",
                    "N0000185506",
                    "N0000191266",
                    "N0000187064",
                    "N0000185507",
                    "N0000185607"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_epc": [
                    "Mood Stabilizer [EPC]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 1A2 Inducers [MoA]",
                    "Cytochrome P450 2B6 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]"
                ],
                "unii": [
                    "33CM23913M"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET, CHEWABLE",
            "spl_id": "9b02cba5-6e06-4fd6-aefe-c9acfb817b15",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20090826",
            "product_id": "13668-271_9b02cba5-6e06-4fd6-aefe-c9acfb817b15",
            "application_number": "ANDA075712",
            "brand_name_base": "CARBAMAZEPINE",
            "pharm_class": [
                "Cytochrome P450 1A2 Inducers [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "Mood Stabilizer [EPC]"
            ]
        },
        {
            "product_ndc": "53436-084",
            "generic_name": "patiromer",
            "labeler_name": "Vifor Pharma, Inc.",
            "brand_name": "VELTASSA",
            "active_ingredients": [
                {
                    "name": "PATIROMER",
                    "strength": "8.4 g/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "53436-084-04",
                    "description": "4 PACKET in 1 CARTON (53436-084-04)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (53436-084-01)",
                    "marketing_start_date": "20151023",
                    "sample": false
                },
                {
                    "package_ndc": "53436-084-30",
                    "description": "30 PACKET in 1 CARTON (53436-084-30)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (53436-084-01)",
                    "marketing_start_date": "20151023",
                    "sample": false
                },
                {
                    "package_ndc": "53436-084-92",
                    "description": "4 PACKET in 1 CARTON (53436-084-92)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (53436-084-91)",
                    "marketing_start_date": "20160501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Vifor Pharma, Inc."
                ],
                "rxcui": [
                    "1716209",
                    "1716215",
                    "1716217",
                    "1716219",
                    "1716221",
                    "1716223"
                ],
                "spl_set_id": [
                    "bf002984-d6c9-46df-aecb-a07733f763c1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000178378",
                    "N0000178377"
                ],
                "pharm_class_epc": [
                    "Potassium Binder [EPC]"
                ],
                "pharm_class_moa": [
                    "Potassium Ion Binding Activity [MoA]"
                ],
                "unii": [
                    "1FQ2RY5YHH"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "POWDER, FOR SUSPENSION",
            "spl_id": "2be9a0fe-27cd-453c-98c3-162c98f66784",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151023",
            "product_id": "53436-084_2be9a0fe-27cd-453c-98c3-162c98f66784",
            "application_number": "NDA205739",
            "brand_name_base": "VELTASSA",
            "pharm_class": [
                "Potassium Binder [EPC]",
                "Potassium Ion Binding Activity [MoA]"
            ]
        },
        {
            "product_ndc": "61958-2301",
            "generic_name": "tenofovir alafenamide",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "VEMLIDY",
            "active_ingredients": [
                {
                    "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-2301-1",
                    "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2301-1)",
                    "marketing_start_date": "20161110",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1858261",
                    "1858267"
                ],
                "spl_set_id": [
                    "72e6b33c-0351-4070-9172-eeaa186c01d2"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "FWF6Q91TZO"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "fbf17731-3e68-4c45-8672-619e12c691ac",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20161110",
            "product_id": "61958-2301_fbf17731-3e68-4c45-8672-619e12c691ac",
            "application_number": "NDA208464",
            "brand_name_base": "VEMLIDY",
            "pharm_class": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
                "Nucleosides [CS]"
            ]
        },
        {
            "product_ndc": "0074-0576",
            "generic_name": "Venetoclax",
            "labeler_name": "AbbVie Inc.",
            "brand_name": "Venclexta",
            "active_ingredients": [
                {
                    "name": "VENETOCLAX",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0074-0576-11",
                    "description": "1 BLISTER PACK in 1 CARTON (0074-0576-11)  / 1 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20160411",
                    "sample": false
                },
                {
                    "package_ndc": "0074-0576-22",
                    "description": "120 TABLET, FILM COATED in 1 BOTTLE (0074-0576-22)",
                    "marketing_start_date": "20160411",
                    "sample": false
                },
                {
                    "package_ndc": "0074-0576-30",
                    "description": "1 BOTTLE in 1 CARTON (0074-0576-30)  / 28 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20220615",
                    "sample": false
                },
                {
                    "package_ndc": "0074-0576-34",
                    "description": "1 BOTTLE in 1 CARTON (0074-0576-34)  / 180 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20181121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "AbbVie Inc."
                ],
                "rxcui": [
                    "1747561",
                    "1747567",
                    "1747572",
                    "1747574",
                    "1747575",
                    "1747577",
                    "1747579",
                    "1747580"
                ],
                "spl_set_id": [
                    "b118a40d-6b56-cee3-10f6-ded821a97018"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192515",
                    "N0000009176",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "BCL-2 Inhibitor [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Cellular Death [PE]"
                ],
                "pharm_class_moa": [
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "N54AIC43PW"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "843d380a-6566-4045-bc90-1c3b633867ec",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160411",
            "product_id": "0074-0576_843d380a-6566-4045-bc90-1c3b633867ec",
            "application_number": "NDA208573",
            "brand_name_base": "Venclexta",
            "pharm_class": [
                "BCL-2 Inhibitor [EPC]",
                "Increased Cellular Death [PE]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "51662-1568",
            "generic_name": "VENOFER (IRON SUCROSE)",
            "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst",
            "brand_name": "VENOFER (IRON SUCROSE)",
            "active_ingredients": [
                {
                    "name": "IRON SUCROSE",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "51662-1568-3",
                    "description": "10 POUCH in 1 CASE (51662-1568-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1568-2)  / 5 mL in 1 VIAL, SINGLE-DOSE (51662-1568-1)",
                    "marketing_start_date": "20210625",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "HF Acquisition Co LLC, DBA HealthFirst"
                ],
                "rxcui": [
                    "1741267"
                ],
                "spl_set_id": [
                    "c59cb54c-bee5-96d6-e053-2995a90a767c"
                ],
                "nui": [
                    "M0011718",
                    "N0000177913"
                ],
                "pharm_class_cs": [
                    "Iron [CS]"
                ],
                "pharm_class_epc": [
                    "Parenteral Iron Replacement [EPC]"
                ],
                "unii": [
                    "FZ7NYF5N8L"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "1677c959-a5e5-8d41-e063-6294a90a4ebe",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210625",
            "product_id": "51662-1568_1677c959-a5e5-8d41-e063-6294a90a4ebe",
            "application_number": "NDA021135",
            "brand_name_base": "VENOFER (IRON SUCROSE)",
            "pharm_class": [
                "Iron [CS]",
                "Parenteral Iron Replacement [EPC]",
                "Phosphate Binder [EPC]",
                "Phosphate Chelating Activity [MoA]"
            ]
        },
        {
            "product_ndc": "66215-302",
            "generic_name": "iloprost",
            "labeler_name": "Actelion Pharmaceuticals US, Inc.",
            "brand_name": "VENTAVIS",
            "active_ingredients": [
                {
                    "name": "ILOPROST",
                    "strength": "10 ug/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "66215-302-30",
                    "description": "30 AMPULE in 1 CARTON (66215-302-30)  / 1 mL in 1 AMPULE (66215-302-00)",
                    "marketing_start_date": "20050507",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Actelion Pharmaceuticals US, Inc."
                ],
                "rxcui": [
                    "487056",
                    "582595",
                    "861964",
                    "861966"
                ],
                "spl_set_id": [
                    "d3bebc1c-f032-402a-bbc9-aff024276ed1"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175603",
                    "M0017817"
                ],
                "pharm_class_epc": [
                    "Prostacycline [EPC]"
                ],
                "pharm_class_cs": [
                    "Prostaglandins I [CS]"
                ],
                "unii": [
                    "JED5K35YGL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "431e95f6-7248-48e7-a836-3e43c7295229",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20050507",
            "product_id": "66215-302_431e95f6-7248-48e7-a836-3e43c7295229",
            "application_number": "NDA021779",
            "brand_name_base": "VENTAVIS",
            "pharm_class": [
                "Prostacycline [EPC]",
                "Prostaglandins I [CS]"
            ]
        },
        {
            "product_ndc": "0006-5029",
            "generic_name": "vericiguat",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "VERQUVO",
            "active_ingredients": [
                {
                    "name": "VERICIGUAT",
                    "strength": "5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-5029-01",
                    "description": "14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-01)",
                    "marketing_start_date": "20210201",
                    "sample": false
                },
                {
                    "package_ndc": "0006-5029-02",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0006-5029-02)",
                    "marketing_start_date": "20210201",
                    "sample": false
                },
                {
                    "package_ndc": "0006-5029-04",
                    "description": "10 BLISTER PACK in 1 CARTON (0006-5029-04)  / 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-5029-03)",
                    "marketing_start_date": "20210201",
                    "sample": false
                },
                {
                    "package_ndc": "0006-5029-06",
                    "description": "1 BOTTLE in 1 CARTON (0006-5029-06)  / 14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-05)",
                    "marketing_start_date": "20210201",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "2475846",
                    "2475852",
                    "2475854",
                    "2475856",
                    "2475858",
                    "2475860"
                ],
                "spl_set_id": [
                    "17056d73-1b1b-4bf2-9c07-b7a9367f0d6d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300065029023",
                    "0300065030012",
                    "0300065028026"
                ],
                "nui": [
                    "N0000190484",
                    "N0000190485"
                ],
                "pharm_class_moa": [
                    "Guanylate Cyclase Stimulators [MoA]"
                ],
                "pharm_class_epc": [
                    "Soluble Guanylate Cyclase Stimulator [EPC]"
                ],
                "unii": [
                    "LV66ADM269"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "9bdc3dc1-e1f4-435b-923a-86ab6d16cf15",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210201",
            "product_id": "0006-5029_9bdc3dc1-e1f4-435b-923a-86ab6d16cf15",
            "application_number": "NDA214377",
            "brand_name_base": "VERQUVO",
            "pharm_class": [
                "Guanylate Cyclase Stimulators [MoA]",
                "Soluble Guanylate Cyclase Stimulator [EPC]"
            ]
        },
        {
            "product_ndc": "0002-4483",
            "generic_name": "abemaciclib",
            "labeler_name": "Eli Lilly and Company",
            "brand_name": "Verzenio",
            "active_ingredients": [
                {
                    "name": "ABEMACICLIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0002-4483-54",
                    "description": "1 BLISTER PACK in 1 CARTON (0002-4483-54)  / 14 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20171006",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eli Lilly and Company"
                ],
                "rxcui": [
                    "1946830",
                    "1946836",
                    "1946838",
                    "1946840",
                    "1946842",
                    "1946844",
                    "1946846",
                    "1946848"
                ],
                "spl_set_id": [
                    "be4bc0de-0fdc-4d46-8d25-be43c79e6a06"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175082"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Kinase Inhibitors [MoA]"
                ],
                "unii": [
                    "60UAB198HK"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "1bfe414d-380c-400b-8ae2-7caa0877dcad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170928",
            "product_id": "0002-4483_1bfe414d-380c-400b-8ae2-7caa0877dcad",
            "application_number": "NDA208716",
            "brand_name_base": "Verzenio",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "61874-075",
            "generic_name": "Eluxadoline",
            "labeler_name": "Allergan, Inc.",
            "dea_schedule": "CIV",
            "brand_name": "Viberzi",
            "active_ingredients": [
                {
                    "name": "ELUXADOLINE",
                    "strength": "75 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61874-075-60",
                    "description": "60 CARTON in 1 BOTTLE (61874-075-60)  / 1 BLISTER PACK in 1 CARTON (61874-075-08)  / 8 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20151001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Allergan, Inc."
                ],
                "rxcui": [
                    "1653786",
                    "1653792",
                    "1719764",
                    "1719766"
                ],
                "spl_set_id": [
                    "7821bd40-4c84-4984-951b-6436ae20421a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191867",
                    "N0000191866"
                ],
                "pharm_class_epc": [
                    "mu-Opioid Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Opioid mu-Receptor Agonists [MoA]"
                ],
                "unii": [
                    "45TPJ4MBQ1"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "22af8fe9-6dca-4a72-bb3d-941379ab6b21",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20151001",
            "product_id": "61874-075_22af8fe9-6dca-4a72-bb3d-941379ab6b21",
            "application_number": "NDA206940",
            "brand_name_base": "Viberzi",
            "pharm_class": [
                "Opioid mu-Receptor Agonists [MoA]",
                "mu-Opioid Receptor Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "59572-102",
            "generic_name": "azacitidine",
            "labeler_name": "Celgene Corporation",
            "brand_name": "VIDAZA",
            "active_ingredients": [
                {
                    "name": "AZACITIDINE",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-102-01",
                    "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (59572-102-01)",
                    "marketing_start_date": "20040705",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "485246",
                    "545206"
                ],
                "spl_set_id": [
                    "3495a71a-cc04-4776-851f-f185956f32af"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000233",
                    "N0000175595"
                ],
                "pharm_class_moa": [
                    "Nucleic Acid Synthesis Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Nucleoside Metabolic Inhibitor [EPC]"
                ],
                "unii": [
                    "M801H13NRU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "8cba79e2-11fa-4eb9-87e7-827ca781fbf3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20040705",
            "product_id": "59572-102_8cba79e2-11fa-4eb9-87e7-827ca781fbf3",
            "application_number": "NDA050794",
            "brand_name_base": "VIDAZA",
            "pharm_class": [
                "Nucleic Acid Synthesis Inhibitors [MoA]",
                "Nucleoside Metabolic Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "0078-1175",
            "generic_name": "alpelisib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "VIJOICE",
            "active_ingredients": [
                {
                    "name": "ALPELISIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-1175-51",
                    "description": "28 PACKET in 1 CARTON (0078-1175-51)  / 1 GRANULE in 1 PACKET (0078-1175-19)",
                    "marketing_start_date": "20240424",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2169310",
                    "2169316",
                    "2169319",
                    "2598459",
                    "2598461",
                    "2598463",
                    "2598464",
                    "2598465",
                    "2598466",
                    "2598467",
                    "2598469",
                    "2598470",
                    "2680135",
                    "2680138",
                    "2680139",
                    "2680140"
                ],
                "spl_set_id": [
                    "638069a4-aee0-46c9-9e21-54ad449c163c"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "08W5N2C97Q"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GRANULE",
            "spl_id": "50112a95-4b1a-4134-879c-3fc912782810",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20240424",
            "product_id": "0078-1175_50112a95-4b1a-4134-879c-3fc912782810",
            "application_number": "NDA218466",
            "brand_name_base": "VIJOICE"
        },
        {
            "product_ndc": "73292-011",
            "generic_name": "viltolarsen",
            "labeler_name": "NS Pharma, Inc.",
            "brand_name": "Viltepso",
            "active_ingredients": [
                {
                    "name": "VILTOLARSEN",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73292-011-01",
                    "description": "1 VIAL, GLASS in 1 CARTON (73292-011-01)  / 1 INJECTION, SOLUTION in 1 VIAL, GLASS",
                    "marketing_start_date": "20200813",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NS Pharma, Inc."
                ],
                "rxcui": [
                    "2389844",
                    "2389849"
                ],
                "spl_set_id": [
                    "1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "SXA7YP6EKX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "660fd183-2dc3-4e7c-9695-6105573165c9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200813",
            "product_id": "73292-011_660fd183-2dc3-4e7c-9695-6105573165c9",
            "application_number": "NDA212154",
            "brand_name_base": "Viltepso"
        },
        {
            "product_ndc": "68135-100",
            "generic_name": "elosulfase alfa",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "VIMIZIM",
            "active_ingredients": [
                {
                    "name": "ELOSULFASE ALFA",
                    "strength": "5 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-100-01",
                    "description": "1 VIAL in 1 CARTON (68135-100-01)  / 5 mL in 1 VIAL",
                    "marketing_start_date": "20140214",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "1490047",
                    "1490052"
                ],
                "spl_set_id": [
                    "0caa2565-12b2-0ad0-1f9a-273e81c3d4cc"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0000794",
                    "N0000175823"
                ],
                "pharm_class_cs": [
                    "alpha-Glucosidases [CS]"
                ],
                "pharm_class_epc": [
                    "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]"
                ],
                "unii": [
                    "ODJ69JZG85"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
            "spl_id": "8c7a8949-b407-41ab-b2e3-88c83b6a9213",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20140214",
            "product_id": "68135-100_8c7a8949-b407-41ab-b2e3-88c83b6a9213",
            "application_number": "BLA125460",
            "brand_name_base": "VIMIZIM",
            "pharm_class": [
                "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]",
                "alpha-Glucosidases [CS]"
            ]
        },
        {
            "product_ndc": "68071-2263",
            "generic_name": "Lisinopril and Hydrochlorothiazide Tablets",
            "labeler_name": "NuCare Pharmaceuticals,Inc.",
            "brand_name": "Lisinopril and Hydrochlorothiazide",
            "active_ingredients": [
                {
                    "name": "HYDROCHLOROTHIAZIDE",
                    "strength": "12.5 mg/1"
                },
                {
                    "name": "LISINOPRIL",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68071-2263-9",
                    "description": "90 TABLET in 1 BOTTLE (68071-2263-9)",
                    "marketing_start_date": "20200916",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "NuCare Pharmaceuticals,Inc."
                ],
                "rxcui": [
                    "197886"
                ],
                "spl_set_id": [
                    "af74c331-7402-408c-e053-2a95a90a1043"
                ],
                "upc": [
                    "0368071226393"
                ],
                "nui": [
                    "N0000175359",
                    "N0000175419",
                    "M0471776"
                ],
                "pharm_class_pe": [
                    "Increased Diuresis [PE]"
                ],
                "pharm_class_epc": [
                    "Thiazide Diuretic [EPC]"
                ],
                "pharm_class_cs": [
                    "Thiazides [CS]"
                ],
                "unii": [
                    "0J48LPH2TH",
                    "E7199S1YWR"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191226",
            "product_id": "68071-2263_d606a1a1-73b5-6ab9-e053-2995a90adde9",
            "application_number": "ANDA204058",
            "brand_name_base": "Lisinopril and Hydrochlorothiazide",
            "pharm_class": [
                "Angiotensin Converting Enzyme Inhibitor [EPC]",
                "Angiotensin-converting Enzyme Inhibitors [MoA]",
                "Increased Diuresis [PE]",
                "Thiazide Diuretic [EPC]",
                "Thiazides [CS]"
            ]
        },
        {
            "product_ndc": "69468-151",
            "generic_name": "uridine triacetate",
            "labeler_name": "Wellstat Therapeutics Corporation",
            "brand_name": "VISTOGARD",
            "active_ingredients": [
                {
                    "name": "URIDINE TRIACETATE",
                    "strength": "951 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "69468-151-04",
                    "description": "4 PACKET in 1 CARTON (69468-151-04)  / 10 g in 1 PACKET (69468-151-10)",
                    "marketing_start_date": "20160301",
                    "sample": false
                },
                {
                    "package_ndc": "69468-151-10",
                    "description": "10 g in 1 PACKET (69468-151-10)",
                    "marketing_start_date": "20160301",
                    "sample": false
                },
                {
                    "package_ndc": "69468-151-20",
                    "description": "20 PACKET in 1 CARTON (69468-151-20)  / 10 g in 1 PACKET (69468-151-10)",
                    "marketing_start_date": "20160301",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Wellstat Therapeutics Corporation"
                ],
                "rxcui": [
                    "1739794",
                    "1739800"
                ],
                "spl_set_id": [
                    "5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "2WP61F175M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GRANULE",
            "spl_id": "8e64b577-1ecb-46f2-a7c8-3577a16f8837",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160301",
            "product_id": "69468-151_8e64b577-1ecb-46f2-a7c8-3577a16f8837",
            "application_number": "NDA208159",
            "brand_name_base": "VISTOGARD",
            "pharm_class": [
                "Analogs/Derivatives [Chemical/Ingredient]",
                "Pyrimidine Analog [EPC]",
                "Pyrimidines [Chemical/Ingredient]"
            ]
        },
        {
            "product_ndc": "24208-560",
            "generic_name": "verteporfin for injection",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Visudyne",
            "active_ingredients": [
                {
                    "name": "VERTEPORFIN",
                    "strength": "15 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-560-15",
                    "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (24208-560-15)",
                    "marketing_start_date": "20230227",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "313595",
                    "351914"
                ],
                "spl_set_id": [
                    "2f0a34ce-3c57-4ac8-b28e-512be807272f"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000010217",
                    "N0000175540",
                    "N0000009801"
                ],
                "pharm_class_moa": [
                    "Photoabsorption [MoA]"
                ],
                "pharm_class_epc": [
                    "Photoenhancer [EPC]"
                ],
                "pharm_class_pe": [
                    "Photosensitizing Activity [PE]"
                ],
                "unii": [
                    "0X9PA28K43"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "f48ec619-2eda-4360-9c67-bb79bdd00353",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20000412",
            "product_id": "24208-560_f48ec619-2eda-4360-9c67-bb79bdd00353",
            "application_number": "NDA021119",
            "brand_name_base": "Visudyne",
            "pharm_class": [
                "Photoabsorption [MoA]",
                "Photoenhancer [EPC]",
                "Photosensitizing Activity [PE]"
            ]
        },
        {
            "product_ndc": "83021-187",
            "marketing_end_date": "20261020",
            "generic_name": "Hydrolyzed Elastin, Hydrolysed Collagen, Cocoglycerides",
            "labeler_name": "ANUBIS COSMETICS SL",
            "brand_name": "Anubis Barcelona Vital Line",
            "active_ingredients": [
                {
                    "name": ".ALPHA.-HEXYLCINNAMALDEHYDE",
                    "strength": ".16 g/200mL"
                },
                {
                    "name": ".BETA.-CITRONELLOL, (R)-",
                    "strength": ".0056 g/200mL"
                },
                {
                    "name": "AVOBENZONE",
                    "strength": "2 g/200mL"
                },
                {
                    "name": "BENZOIC ACID",
                    "strength": ".24 g/200mL"
                },
                {
                    "name": "BUTYLATED HYDROXYTOLUENE",
                    "strength": ".005 g/200mL"
                },
                {
                    "name": "CENTAUREA CYANUS FLOWER",
                    "strength": ".05 g/200mL"
                },
                {
                    "name": "CETOSTEARYL ALCOHOL",
                    "strength": "12.58 g/200mL"
                },
                {
                    "name": "CETYL ALCOHOL",
                    "strength": "4 g/200mL"
                },
                {
                    "name": "COCO-GLYCERIDES",
                    "strength": "8 g/200mL"
                },
                {
                    "name": "DEHYDROACETIC ACID",
                    "strength": ".14 g/200mL"
                },
                {
                    "name": "FRAGRANCE 13576",
                    "strength": ".98 g/200mL"
                },
                {
                    "name": "GLYCERIN",
                    "strength": "6.94 g/200mL"
                },
                {
                    "name": "HYDROLYSED MARINE COLLAGEN (ENZYMATIC",
                    "strength": ".6 g/200mL"
                },
                {
                    "name": "2000 MW)",
                    "strength": ".03 g/200mL"
                },
                {
                    "name": "HYDROLYZED BOVINE ELASTIN (BASE",
                    "strength": ".0054 g/200mL"
                },
                {
                    "name": "1000 MW)",
                    "strength": ".038 g/200mL"
                },
                {
                    "name": "ISOMETHYL-.ALPHA.-IONONE",
                    "strength": "12 g/200mL"
                },
                {
                    "name": "LIMONENE, (+)-",
                    "strength": "5 g/200mL"
                },
                {
                    "name": "MEDIUM-CHAIN TRIGLYCERIDES",
                    "strength": "1.62 g/200mL"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": ".006 g/200mL"
                },
                {
                    "name": "PHENOXYETHANOL",
                    "strength": ".05 g/200mL"
                },
                {
                    "name": "POTASSIUM PHOSPHATE, UNSPECIFIED FORM",
                    "strength": "140 mL/200mL"
                },
                {
                    "name": "VIOLA ODORATA"
                },
                {
                    "name": "WATER"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "83021-187-01",
                    "description": "200 mL in 1 TUBE (83021-187-01)",
                    "marketing_start_date": "20221025",
                    "marketing_end_date": "20261020",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "ANUBIS COSMETICS SL"
                ],
                "spl_set_id": [
                    "ebe024f7-7c45-ad60-e053-2995a90a45d6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "8436019951187"
                ],
                "nui": [
                    "N0000175806",
                    "N0000175807",
                    "N0000185370",
                    "N0000175629",
                    "N0000184306",
                    "N0000185001",
                    "M0000728",
                    "M0009417"
                ],
                "pharm_class_moa": [
                    "Ammonium Ion Binding Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Nitrogen Binding Agent [EPC]",
                    "Non-Standardized Chemical Allergen [EPC]"
                ],
                "pharm_class_pe": [
                    "Increased Histamine Release [PE]",
                    "Cell-mediated Immunity [PE]",
                    "Increased IgG Production [PE]"
                ],
                "pharm_class_cs": [
                    "Allergens [CS]",
                    "Glycerol [CS]"
                ],
                "unii": [
                    "7X6O37OK2I",
                    "P01OUT964K",
                    "G63QQF2NOX",
                    "8SKN0B0MIM",
                    "1P9D0Z171K",
                    "QZ239038YC",
                    "2DMT128M1S",
                    "936JST6JCN",
                    "ISE9I7DNUG",
                    "2KAG279R6R",
                    "5EM498GW35",
                    "PDC6A3C0OX",
                    "9XP4LC555B",
                    "GFD7C86Q1W",
                    "C9H2L21V7U",
                    "4Y5P7MUD51",
                    "HIE492ZZ3T",
                    "B7862WZ632",
                    "AET12U8B74",
                    "059QF0KO0R"
                ]
            },
            "marketing_category": "OTC MONOGRAPH FINAL",
            "dosage_form": "CREAM",
            "spl_id": "045289e2-7a72-8d91-e063-6394a90ab123",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20221025",
            "product_id": "83021-187_045289e2-7a72-8d91-e063-6394a90ab123",
            "application_number": "M016",
            "brand_name_base": "Anubis Barcelona Vital Line",
            "pharm_class": [
                "Allergens [CS]",
                "Ammonium Ion Binding Activity [MoA]",
                "Cell-mediated Immunity [PE]",
                "Glycerol [CS]",
                "Increased Histamine Release [PE]",
                "Increased IgG Production [PE]",
                "Nitrogen Binding Agent [EPC]",
                "Non-Standardized Chemical Allergen [EPC]"
            ]
        },
        {
            "product_ndc": "55550-102",
            "generic_name": "Homosalate, Octinoxate, Octisalate, Oxybenzone",
            "labeler_name": "Total Resources International",
            "brand_name": "Sunscreen",
            "active_ingredients": [
                {
                    "name": "HOMOSALATE",
                    "strength": "6 mg/g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.5 mg/g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5 mg/g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55550-102-01",
                    "description": "1.5 g in 1 PACKET (55550-102-01)",
                    "marketing_start_date": "20230120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Total Resources International"
                ],
                "spl_set_id": [
                    "7d4f820d-e154-428e-89c2-2e26e088ceef"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "LOTION",
            "spl_id": "f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20230120",
            "product_id": "55550-102_f2b4ed5f-347d-9ee4-e053-2995a90a25f0",
            "application_number": "part352",
            "brand_name_base": "Sunscreen"
        },
        {
            "product_ndc": "65044-9971",
            "generic_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "labeler_name": "Jubilant HollisterStier LLC",
            "brand_name": "White Faced Hornet Hymenoptera Venom Venomil Maintenance",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65044-9971-1",
                    "description": "1 KIT in 1 TRAY (65044-9971-1)  *  1.2 mL in 1 VIAL (65044-9981-2)",
                    "marketing_start_date": "19820222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "b9289dcf-445f-4a93-89f7-f513569254fd",
            "product_type": "STANDARDIZED ALLERGENIC",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "19820222",
            "product_id": "65044-9971_b9289dcf-445f-4a93-89f7-f513569254fd",
            "application_number": "BLA103885",
            "brand_name_base": "White Faced Hornet Hymenoptera Venom Venomil Maintenance"
        },
        {
            "product_ndc": "0078-0620",
            "generic_name": "everolimus",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "Afinitor",
            "active_ingredients": [
                {
                    "name": "EVEROLIMUS",
                    "strength": "7.5 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0620-51",
                    "description": "28 BLISTER PACK in 1 CARTON (0078-0620-51)  / 1 TABLET in 1 BLISTER PACK (0078-0620-61)",
                    "marketing_start_date": "20110729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "845507",
                    "845512",
                    "845515",
                    "845518",
                    "998189",
                    "998191",
                    "1119400",
                    "1119402",
                    "1308428",
                    "1308430",
                    "1308432",
                    "1310138",
                    "1310144",
                    "1310147"
                ],
                "spl_set_id": [
                    "2150f73a-179b-4afc-b8ce-67c85cc72f04"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076",
                    "N0000182141",
                    "N0000182137",
                    "N0000175625",
                    "N0000175624",
                    "N0000175550"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]",
                    "mTOR Inhibitor Immunosuppressant [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "Cytochrome P450 2D6 Inhibitors [MoA]",
                    "mTOR Inhibitors [MoA]"
                ],
                "pharm_class_pe": [
                    "Decreased Immunologic Activity [PE]"
                ],
                "unii": [
                    "9HW64Q8G6G"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110729",
            "product_id": "0078-0620_fb94cd17-b6ab-4fdf-9280-1fcce4122cc2",
            "application_number": "NDA022334",
            "brand_name_base": "Afinitor",
            "pharm_class": [
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Decreased Immunologic Activity [PE]",
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]",
                "mTOR Inhibitor Immunosuppressant [EPC]",
                "mTOR Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "71052-914",
            "generic_name": "Melanotan I Acetate",
            "labeler_name": "DARMERICA, LLC",
            "active_ingredients": [
                {
                    "name": "PEPTIDE B27PD",
                    "strength": "1 g/g"
                }
            ],
            "finished": false,
            "packaging": [
                {
                    "package_ndc": "71052-914-01",
                    "description": "1 g in 1 CONTAINER (71052-914-01)",
                    "marketing_start_date": "26-AUG-20"
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BULK INGREDIENT",
            "dosage_form": "POWDER",
            "spl_id": "f2b51e84-d062-d2af-e053-2a95a90ac4a9",
            "product_type": "BULK INGREDIENT",
            "marketing_start_date": "20200826",
            "product_id": "71052-914_f2b51e84-d062-d2af-e053-2a95a90ac4a9",
            "brand_name_base": null
        },
        {
            "product_ndc": "50419-390",
            "generic_name": "LAROTRECTINIB",
            "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.",
            "brand_name": "VITRAKVI",
            "active_ingredients": [
                {
                    "name": "LAROTRECTINIB",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50419-390-01",
                    "description": "60 CAPSULE in 1 BOTTLE (50419-390-01)",
                    "marketing_start_date": "20190726",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bayer HealthCare Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2105633",
                    "2105645",
                    "2105649",
                    "2105653",
                    "2105655",
                    "2105657"
                ],
                "spl_set_id": [
                    "0c8ca614-58b2-4aa4-83d3-0387a8f782fd"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000193859"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tropomyosin Receptor Kinases Inhibitors [MoA]"
                ],
                "unii": [
                    "PF9462I9HX"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "3e340753-c526-4748-9e8a-d99e3511d7ef",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190726",
            "product_id": "50419-390_3e340753-c526-4748-9e8a-d99e3511d7ef",
            "application_number": "NDA210861",
            "brand_name_base": "VITRAKVI",
            "pharm_class": [
                "Kinase Inhibitor [EPC]",
                "Tropomyosin Receptor Kinases Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "65757-300",
            "generic_name": "naltrexone",
            "labeler_name": "Alkermes, Inc.",
            "brand_name": "VIVITROL",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65757-300-01",
                    "description": "1 KIT in 1 CARTON (65757-300-01)  *  4 mL in 1 VIAL, GLASS (65757-302-02)  *  4 mL in 1 VIAL, GLASS (65757-304-03)",
                    "marketing_start_date": "20060613",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Alkermes, Inc."
                ],
                "rxcui": [
                    "637213",
                    "637216"
                ],
                "spl_set_id": [
                    "cd11c435-b0f0-4bb9-ae78-60f101f3703f"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "908a42b5-e168-42ca-9421-0f5f2288b7e2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20060613",
            "product_id": "65757-300_908a42b5-e168-42ca-9421-0f5f2288b7e2",
            "application_number": "NDA021897",
            "brand_name_base": "VIVITROL"
        },
        {
            "product_ndc": "0069-1198",
            "generic_name": "dacomitinib",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Vizimpro",
            "active_ingredients": [
                {
                    "name": "DACOMITINIB",
                    "strength": "30 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-1198-30",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0069-1198-30)",
                    "marketing_start_date": "20181004",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2058915",
                    "2058922",
                    "2058924",
                    "2058926",
                    "2058930",
                    "2058932"
                ],
                "spl_set_id": [
                    "4ab27d2f-e385-4e9c-b324-fa69c10b855a"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300691198308",
                    "0300692299301",
                    "0300690197302"
                ],
                "unii": [
                    "5092U85G58"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7a7e890e-6637-4aff-b4fd-96815d2f1f3f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181004",
            "product_id": "0069-1198_7a7e890e-6637-4aff-b4fd-96815d2f1f3f",
            "application_number": "NDA211288",
            "brand_name_base": "Vizimpro"
        },
        {
            "product_ndc": "72482-100",
            "generic_name": "Pacritinib",
            "labeler_name": "CTI BioPharma Corp.",
            "brand_name": "Vonjo",
            "active_ingredients": [
                {
                    "name": "PACRITINIB",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72482-100-12",
                    "description": "40 CARTON in 1 BOX (72482-100-12)  / 1 BOTTLE in 1 CARTON / 120 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20220228",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "CTI BioPharma Corp."
                ],
                "rxcui": [
                    "2595248",
                    "2595254"
                ],
                "spl_set_id": [
                    "4b5ab444-0e1a-4984-99db-76ad11a298ee"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372482100128"
                ],
                "nui": [
                    "N0000175605",
                    "N0000020001",
                    "N0000190857",
                    "N0000182138",
                    "N0000182141",
                    "N0000185503",
                    "N0000190113",
                    "N0000191265"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tyrosine Kinase Inhibitors [MoA]",
                    "Janus Kinase Inhibitors [MoA]",
                    "Cytochrome P450 1A2 Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "Organic Cation Transporter 1 Inhibitors [MoA]"
                ],
                "unii": [
                    "G22N65IL3O"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "ece208e4-cc91-4c8f-913c-0aa8d8270c71",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220228",
            "product_id": "72482-100_ece208e4-cc91-4c8f-913c-0aa8d8270c71",
            "application_number": "NDA208712",
            "brand_name_base": "Vonjo",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Janus Kinase Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Organic Cation Transporter 1 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0944-7551",
            "generic_name": "von Willebrand Factor (Recombinant)",
            "labeler_name": "Takeda Pharmaceuticals America, Inc.",
            "brand_name": "VONVENDI",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0944-7551-02",
                    "description": "1 KIT in 1 CARTON (0944-7551-02)  *  5 mL in 1 VIAL, SINGLE-DOSE (0944-7550-01)  *  5 mL in 1 VIAL, GLASS (64764-515-50)",
                    "marketing_start_date": "20151208",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "26db2aa3-9f54-4299-b6bf-e9168a55c5d0",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20151208",
            "product_id": "0944-7551_26db2aa3-9f54-4299-b6bf-e9168a55c5d0",
            "application_number": "BLA125577",
            "brand_name_base": "VONVENDI"
        },
        {
            "product_ndc": "61958-2401",
            "generic_name": "SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR",
            "labeler_name": "Gilead Sciences, Inc.",
            "brand_name": "Vosevi",
            "active_ingredients": [
                {
                    "name": "SOFOSBUVIR",
                    "strength": "400 mg/1"
                },
                {
                    "name": "VELPATASVIR",
                    "strength": "100 mg/1"
                },
                {
                    "name": "VOXILAPREVIR",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61958-2401-1",
                    "description": "28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2401-1)",
                    "marketing_start_date": "20170718",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Gilead Sciences, Inc."
                ],
                "rxcui": [
                    "1939329",
                    "1939335"
                ],
                "spl_set_id": [
                    "17ffc094-8ca7-45d2-80d8-fd043bc9a221"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191493",
                    "N0000191258",
                    "N0000191256",
                    "N0000190113",
                    "N0000185503",
                    "N0000190107",
                    "N0000190108",
                    "N0000190109",
                    "N0000182639",
                    "N0000182638"
                ],
                "pharm_class_epc": [
                    "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
                    "Hepatitis C Virus NS5A Inhibitor [EPC]",
                    "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "RNA Replicase Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]",
                    "HCV NS3/4A Protease Inhibitors [MoA]"
                ],
                "unii": [
                    "WJ6CA3ZU8B",
                    "KCU0C7RS7Z",
                    "0570F37359"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "965dff7b-aaeb-4025-bce1-75c541beeb0a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170718",
            "product_id": "61958-2401_965dff7b-aaeb-4025-bce1-75c541beeb0a",
            "application_number": "NDA209195",
            "brand_name_base": "Vosevi",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "HCV NS3/4A Protease Inhibitors [MoA]",
                "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]",
                "Hepatitis C Virus NS5A Inhibitor [EPC]",
                "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "RNA Replicase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0078-0670",
            "marketing_end_date": "20241031",
            "generic_name": "pazopanib hydrochloride",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "VOTRIENT",
            "active_ingredients": [
                {
                    "name": "PAZOPANIB HYDROCHLORIDE",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0670-66",
                    "description": "120 TABLET, FILM COATED in 1 BOTTLE (0078-0670-66)",
                    "marketing_start_date": "20160712",
                    "marketing_end_date": "20241031",
                    "sample": false
                }
            ],
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "867502",
                    "867506"
                ],
                "spl_set_id": [
                    "eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "33Y9ANM545"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "ea6ebe8a-c7a9-4fdf-9a88-00767a8bbf69",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160712",
            "product_id": "0078-0670_ea6ebe8a-c7a9-4fdf-9a88-00767a8bbf69",
            "application_number": "NDA022465",
            "brand_name_base": "VOTRIENT",
            "pharm_class": [
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2D6 Inhibitors [MoA]",
                "Cytochrome P450 3A4 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "71881-400",
            "generic_name": "fecal microbiota spores, live-brpk",
            "labeler_name": "Aimmune Therapeutics, Inc.",
            "brand_name": "VOWST",
            "active_ingredients": [
                {
                    "name": "DONOR HUMAN STOOL SPORES (ETHANOL TREATED)",
                    "strength": "30000000 [CFU]/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71881-400-12",
                    "description": "1 BOTTLE in 1 CARTON (71881-400-12)  / 12 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20230426",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Aimmune Therapeutics, Inc."
                ],
                "rxcui": [
                    "2636542",
                    "2636548"
                ],
                "spl_set_id": [
                    "99e5a37a-930c-4641-bcdd-7013ec1c15fe"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "9K7X6R5BMW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "CAPSULE",
            "spl_id": "14249e84-64b4-4b03-9dc4-f3eaa1ca6afc",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230426",
            "product_id": "71881-400_14249e84-64b4-4b03-9dc4-f3eaa1ca6afc",
            "application_number": "BLA125757",
            "brand_name_base": "VOWST"
        },
        {
            "product_ndc": "68135-082",
            "generic_name": "vosoritide",
            "labeler_name": "BioMarin Pharmaceutical Inc.",
            "brand_name": "VOXZOGO 0.4mg",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68135-082-36",
                    "description": "1 KIT in 1 CARTON (68135-082-36)  *  10 VIAL, SINGLE-DOSE in 1 CARTON (68135-061-00)  / .5 mL in 1 VIAL, SINGLE-DOSE *  10 INJECTION, SOLUTION in 1 CARTON (68135-070-12)",
                    "marketing_start_date": "20211119",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "BioMarin Pharmaceutical Inc."
                ],
                "rxcui": [
                    "2586364",
                    "2586369",
                    "2586371",
                    "2586373",
                    "2586375",
                    "2586377"
                ],
                "spl_set_id": [
                    "228e8560-04a4-4bb1-a81f-29531a9e4d27"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "78a4280e-9611-4031-a7f1-be9d0dc75c63",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20211119",
            "product_id": "68135-082_78a4280e-9611-4031-a7f1-be9d0dc75c63",
            "application_number": "NDA214938",
            "brand_name_base": "VOXZOGO 0.4mg"
        },
        {
            "product_ndc": "25682-049",
            "generic_name": "Danicopan",
            "labeler_name": "Alexion Pharmaceuticals Inc.",
            "brand_name": "Voydeya",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "25682-049-04",
                    "description": "4 BLISTER PACK in 1 CARTON (25682-049-04)  / 1 KIT in 1 BLISTER PACK (25682-049-42)  *  21 TABLET, FILM COATED in 1 BLISTER PACK (25682-040-21)  *  21 TABLET, FILM COATED in 1 BLISTER PACK (25682-043-21)",
                    "marketing_start_date": "20240329",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Alexion Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "2678957",
                    "2678963",
                    "2678965",
                    "2678967",
                    "2678968",
                    "2678969",
                    "2678970",
                    "2678971",
                    "2678972",
                    "2678973",
                    "2678974",
                    "2678975"
                ],
                "spl_set_id": [
                    "ab8d1cbd-a28b-4d49-82ab-5c7460719ac7"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "JM8C1SFX0U"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "f9818aeb-5559-40de-a5de-fca756111274",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20240329",
            "product_id": "25682-049_f9818aeb-5559-40de-a5de-fca756111274",
            "application_number": "NDA218037",
            "brand_name_base": "Voydeya"
        },
        {
            "product_ndc": "70518-3157",
            "generic_name": "cariprazine",
            "labeler_name": "REMEDYREPACK INC.",
            "brand_name": "Vraylar",
            "active_ingredients": [
                {
                    "name": "CARIPRAZINE",
                    "strength": "6 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70518-3157-0",
                    "description": "30 POUCH in 1 BOX (70518-3157-0)  / 1 CAPSULE, GELATIN COATED in 1 POUCH (70518-3157-1)",
                    "marketing_start_date": "20210715",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "REMEDYREPACK INC."
                ],
                "rxcui": [
                    "1667676",
                    "1667678"
                ],
                "spl_set_id": [
                    "3435ec73-86ed-46d1-bd1f-ee6c30209123"
                ],
                "nui": [
                    "N0000175430"
                ],
                "pharm_class_epc": [
                    "Atypical Antipsychotic [EPC]"
                ],
                "unii": [
                    "F6RJL8B278"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, GELATIN COATED",
            "spl_id": "138c7c3c-eb42-44c8-e063-6394a90a13be",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210715",
            "product_id": "70518-3157_138c7c3c-eb42-44c8-e063-6394a90a13be",
            "application_number": "NDA204370",
            "brand_name_base": "Vraylar",
            "pharm_class": [
                "Atypical Antipsychotic [EPC]"
            ]
        },
        {
            "product_ndc": "81672-5051",
            "generic_name": "tapinarof",
            "labeler_name": "Dermavant Sciences, Inc.",
            "brand_name": "VTAMA",
            "active_ingredients": [
                {
                    "name": "TAPINAROF",
                    "strength": "10 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "81672-5051-1",
                    "description": "1 TUBE in 1 PACKAGE (81672-5051-1)  / 60 g in 1 TUBE",
                    "marketing_start_date": "20220526",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Dermavant Sciences, Inc."
                ],
                "rxcui": [
                    "2602301",
                    "2602306"
                ],
                "spl_set_id": [
                    "9309d20f-8cd4-4c96-93fa-7f730e83c7ab"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194018",
                    "N0000194019"
                ],
                "pharm_class_epc": [
                    "Aryl Hydrocarbon Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Aryl Hydrocarbon Receptor Agonists [MoA]"
                ],
                "unii": [
                    "84HW7D0V04"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "00ef33c1-86d8-2846-e063-6394a90ad76d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20220526",
            "product_id": "81672-5051_00ef33c1-86d8-2846-e063-6394a90ad76d",
            "application_number": "NDA215272",
            "brand_name_base": "VTAMA",
            "pharm_class": [
                "Aryl Hydrocarbon Receptor Agonist [EPC]",
                "Aryl Hydrocarbon Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "64406-020",
            "generic_name": "diroximel fumarate",
            "labeler_name": "Biogen Inc.",
            "brand_name": "Vumerity",
            "active_ingredients": [
                {
                    "name": "DIROXIMEL FUMARATE",
                    "strength": "231 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "64406-020-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (64406-020-01)  / 106 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20191029",
                    "sample": false
                },
                {
                    "package_ndc": "64406-020-03",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (64406-020-03)  / 120 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20191029",
                    "sample": false
                },
                {
                    "package_ndc": "64406-020-05",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (64406-020-05)  / 106 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20191029",
                    "sample": true
                },
                {
                    "package_ndc": "64406-020-07",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (64406-020-07)  / 14 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20220901",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Biogen Inc."
                ],
                "rxcui": [
                    "2261788",
                    "2261794"
                ],
                "spl_set_id": [
                    "2d74414f-6b83-4ea2-9a95-3cecabbce774"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0364406020018",
                    "0364406020056",
                    "0364406020032"
                ],
                "unii": [
                    "K0N0Z40J3W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "d0f169df-2480-4e9a-82e1-224ac82adbee",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20191029",
            "product_id": "64406-020_d0f169df-2480-4e9a-82e1-224ac82adbee",
            "application_number": "NDA211855",
            "brand_name_base": "Vumerity"
        },
        {
            "product_ndc": "67386-130",
            "generic_name": "eptinezumab-jjmr",
            "labeler_name": "Lundbeck Pharmaceuticals LLC",
            "brand_name": "Vyepti",
            "active_ingredients": [
                {
                    "name": "EPTINEZUMAB",
                    "strength": "100 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "67386-130-51",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-51)  / 1 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20200221",
                    "sample": false
                },
                {
                    "package_ndc": "67386-130-91",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91)  / 1 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20230401",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Lundbeck Pharmaceuticals LLC"
                ],
                "rxcui": [
                    "2283049",
                    "2283054"
                ],
                "spl_set_id": [
                    "79065861-6aa5-4d1f-829f-3a6471286b36"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193952",
                    "N0000193953"
                ],
                "pharm_class_epc": [
                    "Calcitonin Gene-related Peptide Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Calcitonin Gene-related Peptide Antagonists [MoA]"
                ],
                "unii": [
                    "8202AY8I7H"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "51eec92f-302d-4c04-9fb5-8bbea8ae190b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200221",
            "product_id": "67386-130_51eec92f-302d-4c04-9fb5-8bbea8ae190b",
            "application_number": "BLA761119",
            "brand_name_base": "Vyepti",
            "pharm_class": [
                "Calcitonin Gene-related Peptide Antagonist [EPC]",
                "Calcitonin Gene-related Peptide Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "0069-8730",
            "generic_name": "tafamidis",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Vyndamax",
            "active_ingredients": [
                {
                    "name": "TAFAMIDIS",
                    "strength": "61 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-8730-30",
                    "description": "30 BLISTER PACK in 1 CARTON (0069-8730-30)  / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-8730-01)",
                    "marketing_start_date": "20190827",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2168534",
                    "2168540",
                    "2168542",
                    "2168548"
                ],
                "spl_set_id": [
                    "1b4121ee-a733-4456-a917-be2603477839"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8FG9H9D31J",
                    "ZU7CF08A1A"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, LIQUID FILLED",
            "spl_id": "c9d88433-ff16-418a-a127-6c045ce77c5d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190827",
            "product_id": "0069-8730_c9d88433-ff16-418a-a127-6c045ce77c5d",
            "application_number": "NDA212161",
            "brand_name_base": "Vyndamax"
        },
        {
            "product_ndc": "0069-1975",
            "generic_name": "tafamidis meglumine",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Vyndaqel",
            "active_ingredients": [
                {
                    "name": "TAFAMIDIS MEGLUMINE",
                    "strength": "20 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-1975-40",
                    "description": "4 CARTON in 1 CARTON (0069-1975-40)  / 30 BLISTER PACK in 1 CARTON / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0069-1975-12)",
                    "marketing_start_date": "20190516",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "2168534",
                    "2168540",
                    "2168542",
                    "2168548"
                ],
                "spl_set_id": [
                    "1b4121ee-a733-4456-a917-be2603477839"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8FG9H9D31J",
                    "ZU7CF08A1A"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE, LIQUID FILLED",
            "spl_id": "c9d88433-ff16-418a-a127-6c045ce77c5d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190516",
            "product_id": "0069-1975_c9d88433-ff16-418a-a127-6c045ce77c5d",
            "application_number": "NDA211996",
            "brand_name_base": "Vyndaqel"
        },
        {
            "product_ndc": "16571-754",
            "generic_name": "Neomycin and Polymyxin B Sulfates and Bacitracin Zinc",
            "labeler_name": "Rising Pharma Holdings, Inc.",
            "brand_name": "Neomycin and Polymyxin B Sulfates and Bacitracin Zinc",
            "active_ingredients": [
                {
                    "name": "BACITRACIN ZINC",
                    "strength": "400 [USP'U]/g"
                },
                {
                    "name": "NEOMYCIN SULFATE",
                    "strength": "3.5 mg/g"
                },
                {
                    "name": "POLYMYXIN B SULFATE",
                    "strength": "10000 [USP'U]/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "16571-754-53",
                    "description": "1 TUBE in 1 CARTON (16571-754-53)  / 3.5 g in 1 TUBE",
                    "marketing_start_date": "20211101",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Rising Pharma Holdings, Inc."
                ],
                "rxcui": [
                    "308493"
                ],
                "spl_set_id": [
                    "48173c90-79ed-459d-b259-947bc7952c13"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0316571754533"
                ],
                "unii": [
                    "89Y4M234ES",
                    "057Y626693",
                    "19371312D4"
                ]
            },
            "marketing_category": "NDA AUTHORIZED GENERIC",
            "dosage_form": "OINTMENT",
            "spl_id": "48173c90-79ed-459d-b259-947bc7952c13",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20170407",
            "product_id": "16571-754_48173c90-79ed-459d-b259-947bc7952c13",
            "application_number": "NDA050417",
            "brand_name_base": "Neomycin and Polymyxin B Sulfates and Bacitracin Zinc",
            "pharm_class": [
                "Aminoglycoside Antibacterial [EPC]",
                "Aminoglycosides [CS]",
                "Decreased Cell Wall Synthesis & Repair [PE]",
                "Polymyxin-class Antibacterial [EPC]",
                "Polymyxins [CS]"
            ]
        },
        {
            "product_ndc": "73475-3041",
            "generic_name": "EFGARTIGIMOD ALFA",
            "labeler_name": "argenx US",
            "brand_name": "VYVGART",
            "active_ingredients": [
                {
                    "name": "EFGARTIGIMOD ALFA",
                    "strength": "20 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73475-3041-5",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3041-5)  / 20 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20211217",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "argenx US"
                ],
                "rxcui": [
                    "2587723",
                    "2587729"
                ],
                "spl_set_id": [
                    "8aefc8e3-26d6-4ff6-aab9-a7542927e084"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194004",
                    "N0000194005"
                ],
                "pharm_class_epc": [
                    "Neonatal Fc Receptor Blocker [EPC]"
                ],
                "pharm_class_moa": [
                    "Neonatal Fc Receptor Blockers [MoA]"
                ],
                "unii": [
                    "961YV2O515"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "580e546c-abd9-4af3-ab36-328f49877c3a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20211217",
            "product_id": "73475-3041_580e546c-abd9-4af3-ab36-328f49877c3a",
            "application_number": "BLA761195",
            "brand_name_base": "VYVGART",
            "pharm_class": [
                "Neonatal Fc Receptor Blocker [EPC]",
                "Neonatal Fc Receptor Blockers [MoA]"
            ]
        },
        {
            "product_ndc": "68727-745",
            "generic_name": "(daunorubicin and cytarabine) liposome",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "brand_name": "VYXEOS",
            "active_ingredients": [
                {
                    "name": "CYTARABINE",
                    "strength": "100 mg/20mL"
                },
                {
                    "name": "DAUNORUBICIN",
                    "strength": "44 mg/20mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68727-745-01",
                    "description": "20 mL in 1 VIAL (68727-745-01)",
                    "marketing_start_date": "20170803",
                    "sample": false
                },
                {
                    "package_ndc": "68727-745-02",
                    "description": "40 mL in 1 CARTON (68727-745-02)",
                    "marketing_start_date": "20170803",
                    "sample": false
                },
                {
                    "package_ndc": "68727-745-05",
                    "description": "100 mL in 1 CARTON (68727-745-05)",
                    "marketing_start_date": "20170803",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1942743",
                    "1942748"
                ],
                "spl_set_id": [
                    "7ea701ce-e7d3-4349-a9c2-642a501d45c8"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000233",
                    "N0000175595",
                    "N0000175414",
                    "M0028312",
                    "N0000000176"
                ],
                "pharm_class_moa": [
                    "Nucleic Acid Synthesis Inhibitors [MoA]",
                    "Topoisomerase Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Nucleoside Metabolic Inhibitor [EPC]",
                    "Anthracycline Topoisomerase Inhibitor [EPC]"
                ],
                "pharm_class_cs": [
                    "Anthracyclines [CS]"
                ],
                "unii": [
                    "04079A1RDZ",
                    "ZS7284E0ZP"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",
            "spl_id": "83857dc4-2e28-4030-ac34-87408d28e337",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20170803",
            "product_id": "68727-745_83857dc4-2e28-4030-ac34-87408d28e337",
            "application_number": "NDA209401",
            "brand_name_base": "VYXEOS",
            "pharm_class": [
                "Anthracycline Topoisomerase Inhibitor [EPC]",
                "Anthracyclines [CS]",
                "Nucleic Acid Synthesis Inhibitors [MoA]",
                "Nucleoside Metabolic Inhibitor [EPC]",
                "Topoisomerase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "24208-504",
            "generic_name": "latanoprostene bunod",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Vyzulta",
            "active_ingredients": [
                {
                    "name": "LATANOPROSTENE BUNOD",
                    "strength": ".24 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-504-01",
                    "description": "1 BOTTLE in 1 CARTON (24208-504-01)  / 2.5 mL in 1 BOTTLE",
                    "marketing_start_date": "20180611",
                    "sample": true
                },
                {
                    "package_ndc": "24208-504-02",
                    "description": "1 BOTTLE in 1 CARTON (24208-504-02)  / 2.5 mL in 1 BOTTLE",
                    "marketing_start_date": "20180611",
                    "sample": false
                },
                {
                    "package_ndc": "24208-504-05",
                    "description": "1 BOTTLE in 1 CARTON (24208-504-05)  / 5 mL in 1 BOTTLE",
                    "marketing_start_date": "20171102",
                    "sample": false
                },
                {
                    "package_ndc": "24208-504-06",
                    "description": "1 BOTTLE in 1 CARTON (24208-504-06)  / 5 mL in 1 BOTTLE",
                    "marketing_start_date": "20171102",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "1988394",
                    "1988399"
                ],
                "spl_set_id": [
                    "60ce7900-a677-4fc2-88d0-1603baa9dbd4"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "I6393O0922"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION/ DROPS",
            "spl_id": "12648511-1ae2-aaf8-e063-6394a90a2297",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20171102",
            "product_id": "24208-504_12648511-1ae2-aaf8-e063-6394a90a2297",
            "application_number": "NDA207795",
            "brand_name_base": "Vyzulta"
        },
        {
            "product_ndc": "0310-9400",
            "generic_name": "EPLONTERSEN",
            "labeler_name": "AstraZeneca Pharmaceuticals LP",
            "brand_name": "WAINUA",
            "active_ingredients": [
                {
                    "name": "EPLONTERSEN",
                    "strength": "45 mg/45mg"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0310-9400-01",
                    "description": "45 mg in 1 SYRINGE, GLASS (0310-9400-01)",
                    "marketing_start_date": "20231221",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "AstraZeneca Pharmaceuticals LP"
                ],
                "rxcui": [
                    "2671944",
                    "2671950"
                ],
                "spl_set_id": [
                    "d7dcb847-71dd-4fff-82d0-d43a465fc096"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "0GRZ0F5XJ6"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "78620b95-6d89-4d5e-95be-e3395b24a207",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20231221",
            "product_id": "0310-9400_78620b95-6d89-4d5e-95be-e3395b24a207",
            "application_number": "NDA217388",
            "brand_name_base": "WAINUA"
        },
        {
            "product_ndc": "72028-045",
            "generic_name": "PITOLISANT HYDROCHLORIDE",
            "labeler_name": "Harmony Biosciences, LLC",
            "brand_name": "Wakix",
            "active_ingredients": [
                {
                    "name": "PITOLISANT HYDROCHLORIDE",
                    "strength": "4.45 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72028-045-03",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (72028-045-03)  / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20190814",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Harmony Biosciences, LLC"
                ],
                "rxcui": [
                    "2197884",
                    "2197890",
                    "2197892",
                    "2197894"
                ],
                "spl_set_id": [
                    "8daa5562-824e-476c-9652-26ceef3d4b0e"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "YV33CH63HI"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "b4401c40-d27c-4a82-9c17-dac9c771a6ec",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190814",
            "product_id": "72028-045_b4401c40-d27c-4a82-9c17-dac9c771a6ec",
            "application_number": "NDA211150",
            "brand_name_base": "Wakix"
        },
        {
            "product_ndc": "0006-5331",
            "generic_name": "belzutifan",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "WELIREG",
            "active_ingredients": [
                {
                    "name": "BELZUTIFAN",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-5331-01",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (0006-5331-01)",
                    "marketing_start_date": "20210813",
                    "sample": false
                },
                {
                    "package_ndc": "0006-5331-58",
                    "description": "1 BOTTLE in 1 CARTON (0006-5331-58)  / 90 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20230621",
                    "sample": true
                },
                {
                    "package_ndc": "0006-5331-59",
                    "description": "1 BOTTLE in 1 CARTON (0006-5331-59)  / 90 TABLET, FILM COATED in 1 BOTTLE",
                    "marketing_start_date": "20230621",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "2567231",
                    "2567237"
                ],
                "spl_set_id": [
                    "13e15ee0-d679-4fa9-9430-e2e2170474da"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300065331010"
                ],
                "nui": [
                    "N0000193999",
                    "N0000193998",
                    "N0000185506"
                ],
                "pharm_class_epc": [
                    "Hypoxia-inducible Factor Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]"
                ],
                "unii": [
                    "7K28NB895L"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "7813ec9d-ead4-4834-a056-63f02e489e66",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210813",
            "product_id": "0006-5331_7813ec9d-ead4-4834-a056-63f02e489e66",
            "application_number": "NDA215383",
            "brand_name_base": "WELIREG",
            "pharm_class": [
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]",
                "Hypoxia-inducible Factor Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "70518-2501",
            "generic_name": "fluticasone propionate and salmeterol",
            "labeler_name": "REMEDYREPACK INC.",
            "brand_name": "Wixela Inhub",
            "active_ingredients": [
                {
                    "name": "FLUTICASONE PROPIONATE",
                    "strength": "250 ug/1"
                },
                {
                    "name": "SALMETEROL XINAFOATE",
                    "strength": "50 ug/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70518-2501-0",
                    "description": "1 INHALER in 1 CARTON (70518-2501-0)  / 60 POWDER in 1 INHALER",
                    "marketing_start_date": "20191219",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "REMEDYREPACK INC."
                ],
                "rxcui": [
                    "896209",
                    "2110513"
                ],
                "spl_set_id": [
                    "8eb3083e-11c2-4272-8adc-4b7fbbfc0483"
                ],
                "unii": [
                    "O2GMZ0LF5W",
                    "6EW8Q962A5"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "POWDER",
            "spl_id": "129a7d63-5fd7-980c-e063-6394a90a1339",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20191219",
            "product_id": "70518-2501_129a7d63-5fd7-980c-e063-6394a90a1339",
            "application_number": "ANDA208891",
            "brand_name_base": "Wixela Inhub",
            "pharm_class": [
                "Adrenergic beta2-Agonists [MoA]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]",
                "beta2-Adrenergic Agonist [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0069-8141",
            "generic_name": "CRIZOTINIB",
            "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
            "brand_name": "Xalkori",
            "active_ingredients": [
                {
                    "name": "CRIZOTINIB",
                    "strength": "200 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0069-8141-20",
                    "description": "60 CAPSULE in 1 BOTTLE (0069-8141-20)",
                    "marketing_start_date": "20110826",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pfizer Laboratories Div Pfizer Inc"
                ],
                "rxcui": [
                    "1148498",
                    "1148502",
                    "1148504",
                    "1148506",
                    "2670166",
                    "2670170",
                    "2670172",
                    "2670174",
                    "2670176",
                    "2670178"
                ],
                "spl_set_id": [
                    "2a51b0de-47d6-455e-a94c-d2c737b04ff7"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300698140201",
                    "0300690507606",
                    "0300690251608",
                    "0300691500606",
                    "0300698141208"
                ],
                "nui": [
                    "N0000175605",
                    "N0000190114",
                    "N0000020000",
                    "N0000182139",
                    "N0000185503",
                    "N0000191265",
                    "N0000187061"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "Receptor Tyrosine Kinase Inhibitors [MoA]",
                    "Cytochrome P450 2B6 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Organic Cation Transporter 1 Inhibitors [MoA]",
                    "Organic Cation Transporter 2 Inhibitors [MoA]"
                ],
                "unii": [
                    "53AH36668S"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "e4384d2f-d204-468c-a2d4-23666e3a493f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110826",
            "product_id": "0069-8141_e4384d2f-d204-468c-a2d4-23666e3a493f",
            "application_number": "NDA202570",
            "brand_name_base": "Xalkori",
            "pharm_class": [
                "Cytochrome P450 2B6 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Organic Cation Transporter 1 Inhibitors [MoA]",
                "Organic Cation Transporter 2 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Receptor Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50090-3625",
            "generic_name": "rivaroxaban",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "Xarelto",
            "active_ingredients": [
                {
                    "name": "RIVAROXABAN",
                    "strength": "10 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-3625-0",
                    "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-3625-0)",
                    "marketing_start_date": "20181006",
                    "sample": false
                },
                {
                    "package_ndc": "50090-3625-1",
                    "description": "12 TABLET, FILM COATED in 1 BOTTLE (50090-3625-1)",
                    "marketing_start_date": "20240515",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "1114198",
                    "1114202"
                ],
                "spl_set_id": [
                    "7e9ab975-db2f-423c-a089-bc5a73313609"
                ],
                "nui": [
                    "N0000175635",
                    "N0000175637"
                ],
                "pharm_class_moa": [
                    "Factor Xa Inhibitors [MoA]"
                ],
                "pharm_class_epc": [
                    "Factor Xa Inhibitor [EPC]"
                ],
                "unii": [
                    "9NDF7JZ4M3"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "555f1ee6-225c-4834-b936-cdad8f836f81",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110701",
            "product_id": "50090-3625_555f1ee6-225c-4834-b936-cdad8f836f81",
            "application_number": "NDA022406",
            "brand_name_base": "Xarelto",
            "pharm_class": [
                "Factor Xa Inhibitor [EPC]",
                "Factor Xa Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "52652-2001",
            "generic_name": "Methotrexate",
            "labeler_name": "Azurity Pharmaceuticals, Inc.",
            "brand_name": "Xatmep",
            "active_ingredients": [
                {
                    "name": "METHOTREXATE",
                    "strength": "2.5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52652-2001-1",
                    "description": "120 mL in 1 BOTTLE (52652-2001-1)",
                    "marketing_start_date": "20170501",
                    "sample": false
                },
                {
                    "package_ndc": "52652-2001-6",
                    "description": "60 mL in 1 BOTTLE (52652-2001-6)",
                    "marketing_start_date": "20180813",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Azurity Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1921592",
                    "1921598"
                ],
                "spl_set_id": [
                    "aec9984e-34c5-481b-b6bf-9bb5caf1daf8"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175584",
                    "N0000000111"
                ],
                "pharm_class_epc": [
                    "Folate Analog Metabolic Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Folic Acid Metabolism Inhibitors [MoA]"
                ],
                "unii": [
                    "YL5FZ2Y5U1"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "3b7dce90-1119-49cf-80bf-38e07e4d8dc4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20170501",
            "product_id": "52652-2001_3b7dce90-1119-49cf-80bf-38e07e4d8dc4",
            "application_number": "NDA208400",
            "brand_name_base": "Xatmep",
            "pharm_class": [
                "Folate Analog Metabolic Inhibitor [EPC]",
                "Folic Acid Metabolism Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "71699-203",
            "generic_name": "cenobamate",
            "labeler_name": "SK Life Science, Inc.",
            "brand_name": "Xcopri Titration Pack",
            "brand_name_suffix": "Titration Pack",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71699-203-28",
                    "description": "1 KIT in 1 CARTON (71699-203-28)  *  1 TABLET, FILM COATED in 1 BLISTER PACK *  1 TABLET, FILM COATED in 1 BLISTER PACK",
                    "marketing_start_date": "20200312",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "4a418423-f7fc-46f7-93bb-12347232a3ec",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20200312",
            "product_id": "71699-203_4a418423-f7fc-46f7-93bb-12347232a3ec",
            "application_number": "NDA212839",
            "brand_name_base": "Xcopri"
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "13533-810",
            "generic_name": "immune globulin subcutaneous, human-klhw",
            "labeler_name": "GRIFOLS USA, LLC",
            "brand_name": "XEMBIFY",
            "active_ingredients": [
                {
                    "name": "HUMAN IMMUNOGLOBULIN G",
                    "strength": "200 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "13533-810-05",
                    "description": "1 VIAL in 1 CARTON (13533-810-05)  / 5 mL in 1 VIAL (13533-810-06)",
                    "marketing_start_date": "20190703",
                    "sample": false
                },
                {
                    "package_ndc": "13533-810-10",
                    "description": "1 VIAL in 1 CARTON (13533-810-10)  / 10 mL in 1 VIAL (13533-810-11)",
                    "marketing_start_date": "20190703",
                    "sample": false
                },
                {
                    "package_ndc": "13533-810-20",
                    "description": "1 VIAL in 1 CARTON (13533-810-20)  / 20 mL in 1 VIAL (13533-810-21)",
                    "marketing_start_date": "20190703",
                    "sample": false
                },
                {
                    "package_ndc": "13533-810-50",
                    "description": "1 VIAL in 1 CARTON (13533-810-50)  / 50 mL in 1 VIAL (13533-810-51)",
                    "marketing_start_date": "20190703",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "SOLUTION",
            "spl_id": "74d8dcfc-4a65-4920-9974-fee811e297e9",
            "product_type": "PLASMA DERIVATIVE",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20190703",
            "product_id": "13533-810_74d8dcfc-4a65-4920-9974-fee811e297e9",
            "application_number": "BLA125683",
            "brand_name_base": "XEMBIFY",
            "pharm_class": [
                "Antigen Neutralization [MoA]",
                "Human Immunoglobulin G [EPC]",
                "Immunoglobulins [CS]",
                "Passively Acquired Immunity [PE]"
            ]
        },
        {
            "product_ndc": "43858-502",
            "generic_name": "Sterile Penicillin G Procaine",
            "labeler_name": "Sandoz GmbH",
            "active_ingredients": [
                {
                    "name": "PENICILLIN G PROCAINE",
                    "strength": "10 kg/10kg"
                }
            ],
            "finished": false,
            "packaging": [
                {
                    "package_ndc": "43858-502-00",
                    "description": "20 kg in 1 DRUM (43858-502-00)",
                    "marketing_start_date": "01-FEB-10"
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {},
            "marketing_category": "BULK INGREDIENT",
            "dosage_form": "POWDER",
            "spl_id": "a23c19b6-ce37-41a8-b7e2-d215e4a03774",
            "product_type": "BULK INGREDIENT",
            "marketing_start_date": "20100201",
            "product_id": "43858-502_a23c19b6-ce37-41a8-b7e2-d215e4a03774",
            "brand_name_base": null
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "70720-125",
            "generic_name": "telotristat ethyl",
            "labeler_name": "TerSera Therapeutics LLC",
            "brand_name": "Xermelo",
            "active_ingredients": [
                {
                    "name": "TELOTRISTAT ETHYL",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70720-125-85",
                    "description": "4 BOX in 1 CASE (70720-125-85)  / 1 BLISTER PACK in 1 BOX (70720-125-22)  / 21 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20211001",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TerSera Therapeutics LLC"
                ],
                "rxcui": [
                    "1872453",
                    "1872458"
                ],
                "spl_set_id": [
                    "a4ac9d62-887c-4c8f-b04d-a5f31cec7c86"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8G388563M7"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "ba59d050-c350-492f-a421-f4b64f6fc60e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201005",
            "product_id": "70720-125_ba59d050-c350-492f-a421-f4b64f6fc60e",
            "application_number": "NDA208794",
            "brand_name_base": "Xermelo",
            "pharm_class": [
                "Tryptophan Hydroxylase Inhibitor [EPC]",
                "Tryptophan Hydroxylase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "55513-730",
            "generic_name": "denosumab",
            "labeler_name": "Amgen Inc",
            "brand_name": "XGEVA",
            "active_ingredients": [
                {
                    "name": "DENOSUMAB",
                    "strength": "120 mg/1.7mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "55513-730-01",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01)  / 1.7 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20101118",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Amgen Inc"
                ],
                "rxcui": [
                    "1046398",
                    "1046402"
                ],
                "spl_set_id": [
                    "628f0998-1206-4001-aeee-18133aa9f3bf"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0355513730013"
                ],
                "nui": [
                    "N0000187055",
                    "N0000187054"
                ],
                "pharm_class_epc": [
                    "RANK Ligand Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "RANK Ligand Blocking Activity [MoA]"
                ],
                "unii": [
                    "4EQZ6YO2HI"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "45458fe3-43a4-40e9-b030-b3a44880ccd9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20101118",
            "product_id": "55513-730_45458fe3-43a4-40e9-b030-b3a44880ccd9",
            "application_number": "BLA125320",
            "brand_name_base": "XGEVA",
            "pharm_class": [
                "RANK Ligand Blocking Activity [MoA]",
                "RANK Ligand Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "65649-303",
            "generic_name": "rifaximin",
            "labeler_name": "Salix Pharmaceuticals, Inc.",
            "brand_name": "XIFAXAN",
            "active_ingredients": [
                {
                    "name": "RIFAXIMIN",
                    "strength": "550 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65649-303-01",
                    "description": "3 CARTON in 1 TRAY (65649-303-01)  / 1 BLISTER PACK in 1 CARTON / 2 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20100501",
                    "sample": false
                },
                {
                    "package_ndc": "65649-303-02",
                    "description": "60 TABLET in 1 BOTTLE (65649-303-02)",
                    "marketing_start_date": "20100501",
                    "sample": false
                },
                {
                    "package_ndc": "65649-303-03",
                    "description": "6 BLISTER PACK in 1 CARTON (65649-303-03)  / 10 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20100501",
                    "sample": false
                },
                {
                    "package_ndc": "65649-303-05",
                    "description": "3 CARTON in 1 TRAY (65649-303-05)  / 1 BLISTER PACK in 1 CARTON / 3 TABLET in 1 BLISTER PACK",
                    "marketing_start_date": "20100501",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Salix Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "429662",
                    "539789",
                    "856664",
                    "856666"
                ],
                "spl_set_id": [
                    "c5e8e2fd-7087-4b78-9181-cc259c0be2f1"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0365649303029",
                    "0365649301032"
                ],
                "nui": [
                    "N0000175500",
                    "M0019113"
                ],
                "pharm_class_epc": [
                    "Rifamycin Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Rifamycins [CS]"
                ],
                "unii": [
                    "L36O5T016N"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "0a33f9a9-1faa-7cdf-e063-6294a90adca1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20100501",
            "product_id": "65649-303_0a33f9a9-1faa-7cdf-e063-6294a90adca1",
            "application_number": "NDA021361",
            "brand_name_base": "XIFAXAN",
            "pharm_class": [
                "Rifamycin Antibacterial [EPC]",
                "Rifamycins [CS]"
            ]
        },
        {
            "product_ndc": "0009-0068",
            "generic_name": "alprazolam",
            "labeler_name": "PHARMACIA & UPJOHN COMPANY LLC",
            "dea_schedule": "CIV",
            "brand_name": "Xanax XR",
            "brand_name_suffix": "XR",
            "active_ingredients": [
                {
                    "name": "ALPRAZOLAM",
                    "strength": "3 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0009-0068-07",
                    "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0009-0068-07)",
                    "marketing_start_date": "20030117",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "PHARMACIA & UPJOHN COMPANY LLC"
                ],
                "spl_set_id": [
                    "aa58fff3-c297-49be-838b-599c32ad9835"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175694",
                    "M0002356"
                ],
                "pharm_class_epc": [
                    "Benzodiazepine [EPC]"
                ],
                "pharm_class_cs": [
                    "Benzodiazepines [CS]"
                ],
                "unii": [
                    "YU55MQ3IZY"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, EXTENDED RELEASE",
            "spl_id": "d2328712-99ff-46d4-a2e8-5969509700ad",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20030117",
            "product_id": "0009-0068_d2328712-99ff-46d4-a2e8-5969509700ad",
            "application_number": "NDA021434",
            "brand_name_base": "Xanax",
            "pharm_class": [
                "Benzodiazepine [EPC]",
                "Benzodiazepines [CS]"
            ]
        },
        {
            "product_ndc": "24208-911",
            "generic_name": "Lifitegrast",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Xiidra",
            "active_ingredients": [
                {
                    "name": "LIFITEGRAST",
                    "strength": "50 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-911-12",
                    "description": "12 POUCH in 1 CARTON (24208-911-12)  / 5 AMPULE in 1 POUCH (24208-911-05)  / .2 mL in 1 AMPULE",
                    "marketing_start_date": "20240102",
                    "sample": false
                },
                {
                    "package_ndc": "24208-911-94",
                    "description": "4 POUCH in 1 CARTON (24208-911-94)  / 5 AMPULE in 1 POUCH (24208-911-95)  / .2 mL in 1 AMPULE",
                    "marketing_start_date": "20240102",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "1801835",
                    "1801840"
                ],
                "spl_set_id": [
                    "1a914080-a3c0-44be-b601-0ae3160e77eb"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000192701",
                    "N0000192700"
                ],
                "pharm_class_epc": [
                    "Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"
                ],
                "unii": [
                    "038E5L962W"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION/ DROPS",
            "spl_id": "16dec2db-7f68-af1e-e063-6294a90a5dee",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20240102",
            "product_id": "24208-911_16dec2db-7f68-af1e-e063-6294a90a5dee",
            "application_number": "NDA208073",
            "brand_name_base": "Xiidra",
            "pharm_class": [
                "Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]",
                "Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "24208-040",
            "generic_name": "triamcinolone acetonide",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Xipere",
            "active_ingredients": [
                {
                    "name": "TRIAMCINOLONE ACETONIDE",
                    "strength": "40 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-040-01",
                    "description": "1 TRAY in 1 CARTON (24208-040-01)  / 1 VIAL in 1 TRAY / .9 mL in 1 VIAL (24208-040-02)",
                    "marketing_start_date": "20211217",
                    "sample": true
                },
                {
                    "package_ndc": "24208-040-40",
                    "description": "1 TRAY in 1 CARTON (24208-040-40)  / 1 VIAL in 1 TRAY / .9 mL in 1 VIAL (24208-040-41)",
                    "marketing_start_date": "20211217",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "2585221",
                    "2585226"
                ],
                "spl_set_id": [
                    "ea6ad429-967f-4f75-a33d-e06f849bee80"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "F446C597KA"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SUSPENSION",
            "spl_id": "6a81389a-79a4-4a3c-81d4-621c3b4add6f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20211217",
            "product_id": "24208-040_6a81389a-79a4-4a3c-81d4-621c3b4add6f",
            "application_number": "NDA211950",
            "brand_name_base": "Xipere",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "50242-040",
            "generic_name": "omalizumab",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "XOLAIR",
            "active_ingredients": [
                {
                    "name": "OMALIZUMAB",
                    "strength": "150 mg/1.2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-040-62",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62)  / 1.2 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20030620",
                    "sample": false
                },
                {
                    "package_ndc": "50242-040-86",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86)  / 1.2 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20131220",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1657209",
                    "1657212",
                    "2058943",
                    "2058946",
                    "2058949",
                    "2058950",
                    "2663917",
                    "2663918",
                    "2663920",
                    "2663923",
                    "2673760",
                    "2673761",
                    "2673762",
                    "2673763"
                ],
                "spl_set_id": [
                    "7f6a2191-adfb-48b9-9bfa-0d9920479f0d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175794",
                    "N0000175793",
                    "N0000175792"
                ],
                "pharm_class_epc": [
                    "Anti-IgE [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased IgE Activity [PE]"
                ],
                "pharm_class_moa": [
                    "IgE-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "2P471X1Z11"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "a7cc3af0-74f0-42dd-9059-6f8e420ebfcb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20030620",
            "product_id": "50242-040_a7cc3af0-74f0-42dd-9059-6f8e420ebfcb",
            "application_number": "BLA103976",
            "brand_name_base": "XOLAIR",
            "pharm_class": [
                "Anti-IgE [EPC]",
                "Decreased IgE Activity [PE]",
                "IgE-directed Antibody Interactions [MoA]"
            ]
        },
        {
            "product_ndc": "0469-1425",
            "generic_name": "gilteritinib",
            "labeler_name": "Astellas Pharma US, Inc.",
            "brand_name": "Xospata",
            "active_ingredients": [
                {
                    "name": "GILTERITINIB FUMARATE",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0469-1425-21",
                    "description": "1 BOTTLE in 1 CARTON (0469-1425-21)  / 21 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20220430",
                    "sample": true
                },
                {
                    "package_ndc": "0469-1425-90",
                    "description": "1 BOTTLE in 1 CARTON (0469-1425-90)  / 90 TABLET in 1 BOTTLE",
                    "marketing_start_date": "20181129",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Astellas Pharma US, Inc."
                ],
                "rxcui": [
                    "2105811",
                    "2105817"
                ],
                "spl_set_id": [
                    "b5ff59aa-9c0d-49a8-9053-1f179b482383"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "5RZZ0Z1GJT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET",
            "spl_id": "92b78198-99b0-4895-aa24-ce776f9c5842",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20181129",
            "product_id": "0469-1425_92b78198-99b0-4895-aa24-ce776f9c5842",
            "application_number": "NDA211349",
            "brand_name_base": "Xospata"
        },
        {
            "product_ndc": "72237-104",
            "generic_name": "selinexor",
            "labeler_name": "Karyopharm Therapeutics Inc.",
            "brand_name": "XPOVIO",
            "active_ingredients": [
                {
                    "name": "SELINEXOR",
                    "strength": "60 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72237-104-01",
                    "description": "4 BLISTER PACK in 1 CARTON (72237-104-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (72237-104-11)",
                    "marketing_start_date": "20210519",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Karyopharm Therapeutics Inc."
                ],
                "rxcui": [
                    "2178395",
                    "2178396",
                    "2178402",
                    "2178403",
                    "2178404",
                    "2178405",
                    "2178406",
                    "2178407",
                    "2178408",
                    "2178409",
                    "2382989",
                    "2382990",
                    "2382991",
                    "2382992",
                    "2382993",
                    "2548732",
                    "2548733",
                    "2548735",
                    "2548736",
                    "2548738",
                    "2548739",
                    "2548741",
                    "2548742",
                    "2548762",
                    "2548763",
                    "2548765",
                    "2548766",
                    "2548767",
                    "2548768",
                    "2548769"
                ],
                "spl_set_id": [
                    "f6dd2682-75a6-4863-90a8-a3197f6f78a8"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372237101127",
                    "0372237101110",
                    "0372237101141",
                    "0372237101158",
                    "0372237101165",
                    "0372237101172",
                    "0372237102162",
                    "0372237104111",
                    "0372237102179",
                    "0372237103152",
                    "0372237102124"
                ],
                "nui": [
                    "N0000194021",
                    "N0000194022"
                ],
                "pharm_class_epc": [
                    "Nuclear Export Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Nuclear Export Inhibitors [MoA]"
                ],
                "unii": [
                    "31TZ62FO8F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0aa4ad93-ecc2-41b6-9668-ad45f3f32c61",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210519",
            "product_id": "72237-104_0aa4ad93-ecc2-41b6-9668-ad45f3f32c61",
            "application_number": "NDA212306",
            "brand_name_base": "XPOVIO"
        },
        {
            "product_ndc": "0469-0125",
            "generic_name": "enzalutamide",
            "labeler_name": "Astellas Pharma US, Inc.",
            "brand_name": "Xtandi",
            "active_ingredients": [
                {
                    "name": "ENZALUTAMIDE",
                    "strength": "40 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0469-0125-99",
                    "description": "1 BOTTLE in 1 CARTON (0469-0125-99)  / 120 CAPSULE in 1 BOTTLE",
                    "marketing_start_date": "20120831",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Astellas Pharma US, Inc."
                ],
                "rxcui": [
                    "1307303",
                    "1307309",
                    "2390644",
                    "2390646",
                    "2390648",
                    "2390650"
                ],
                "spl_set_id": [
                    "b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0304690125990"
                ],
                "nui": [
                    "N0000175560",
                    "N0000000243",
                    "N0000185506",
                    "N0000185507",
                    "N0000185607"
                ],
                "pharm_class_epc": [
                    "Androgen Receptor Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Androgen Receptor Antagonists [MoA]",
                    "Cytochrome P450 3A4 Inducers [MoA]",
                    "Cytochrome P450 2C9 Inducers [MoA]",
                    "Cytochrome P450 2C19 Inducers [MoA]"
                ],
                "unii": [
                    "93T0T9GKNU"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20120831",
            "product_id": "0469-0125_bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb",
            "application_number": "NDA203415",
            "brand_name_base": "Xtandi",
            "pharm_class": [
                "Androgen Receptor Antagonists [MoA]",
                "Androgen Receptor Inhibitor [EPC]",
                "Cytochrome P450 2C19 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]"
            ]
        },
        {
            "product_ndc": "50090-1683",
            "generic_name": "norelgestromin and ethinyl estradiol",
            "labeler_name": "A-S Medication Solutions",
            "brand_name": "XULANE",
            "active_ingredients": [
                {
                    "name": "ETHINYL ESTRADIOL",
                    "strength": "35 ug/d"
                },
                {
                    "name": "NORELGESTROMIN",
                    "strength": "150 ug/d"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50090-1683-0",
                    "description": "3 POUCH in 1 CARTON (50090-1683-0)  / 1 d in 1 POUCH",
                    "marketing_start_date": "20150206",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "A-S Medication Solutions"
                ],
                "rxcui": [
                    "1534809",
                    "1536586"
                ],
                "spl_set_id": [
                    "adcf17ef-e60b-48a4-9478-3998dab2bbbd"
                ],
                "nui": [
                    "N0000175825",
                    "N0000000100",
                    "M0447349",
                    "N0000175602"
                ],
                "pharm_class_epc": [
                    "Estrogen [EPC]",
                    "Progestin [EPC]"
                ],
                "pharm_class_moa": [
                    "Estrogen Receptor Agonists [MoA]"
                ],
                "pharm_class_cs": [
                    "Progesterone Congeners [CS]"
                ],
                "unii": [
                    "423D2T571U",
                    "R0TAY3X631"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "PATCH",
            "spl_id": "ebc72113-be27-4819-9f7d-3ba574452d8e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TRANSDERMAL"
            ],
            "marketing_start_date": "20140416",
            "product_id": "50090-1683_ebc72113-be27-4819-9f7d-3ba574452d8e",
            "application_number": "ANDA200910",
            "brand_name_base": "XULANE",
            "pharm_class": [
                "Estrogen Receptor Agonists [MoA]",
                "Estrogen [EPC]",
                "Progesterone Congeners [CS]",
                "Progestin [EPC]"
            ]
        },
        {
            "product_ndc": "0169-2911",
            "generic_name": "insulin degludec and liraglutide",
            "labeler_name": "Novo Nordisk",
            "brand_name": "Xultophy 100/3.6",
            "active_ingredients": [
                {
                    "name": "INSULIN DEGLUDEC",
                    "strength": "100 [iU]/mL"
                },
                {
                    "name": "LIRAGLUTIDE",
                    "strength": "3.6 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0169-2911-15",
                    "description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15)  / 3 mL in 1 SYRINGE, PLASTIC",
                    "marketing_start_date": "20161121",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novo Nordisk"
                ],
                "rxcui": [
                    "1860167",
                    "1860172"
                ],
                "spl_set_id": [
                    "21335fe4-d395-4501-ac2a-2f20d7520da9"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0011417",
                    "N0000175453",
                    "N0000178480",
                    "M0160181",
                    "N0000020058"
                ],
                "pharm_class_cs": [
                    "Insulin [CS]",
                    "Glucagon-Like Peptide 1 [CS]"
                ],
                "pharm_class_epc": [
                    "Insulin Analog [EPC]",
                    "GLP-1 Receptor Agonist [EPC]"
                ],
                "pharm_class_moa": [
                    "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
                ],
                "unii": [
                    "54Q18076QB",
                    "839I73S42A"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "835dcfd2-6752-4201-9723-78d0c28a9ee1",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20161121",
            "product_id": "0169-2911_835dcfd2-6752-4201-9723-78d0c28a9ee1",
            "application_number": "BLA208583",
            "brand_name_base": "Xultophy 100/3.6",
            "pharm_class": [
                "GLP-1 Receptor Agonist [EPC]",
                "Glucagon-Like Peptide 1 [CS]",
                "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
                "Insulin Analog [EPC]",
                "Insulin [CS]"
            ]
        },
        {
            "product_ndc": "58394-014",
            "generic_name": "antihemophilic factor (recombinant)",
            "labeler_name": "Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC",
            "brand_name": "Xyntha",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "58394-014-01",
                    "description": "1 KIT in 1 CARTON (58394-014-01)  *  4 mL in 1 SYRINGE (58394-018-01)  *  1 mL in 1 PACKET *  4 mL in 1 VIAL, SINGLE-USE (58394-114-01)",
                    "marketing_start_date": "20080801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "9cd2da48-5ef1-4a5d-a293-561bd86b51fe",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20080801",
            "product_id": "58394-014_9cd2da48-5ef1-4a5d-a293-561bd86b51fe",
            "application_number": "BLA125264",
            "brand_name_base": "Xyntha"
        },
        {
            "product_ndc": "68727-100",
            "generic_name": "sodium oxybate",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "dea_schedule": "CIII",
            "brand_name": "Xyrem",
            "active_ingredients": [
                {
                    "name": "SODIUM OXYBATE",
                    "strength": ".5 g/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68727-100-01",
                    "description": "180 mL in 1 BOTTLE, PLASTIC (68727-100-01)",
                    "marketing_start_date": "20020717",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "349482",
                    "352257"
                ],
                "spl_set_id": [
                    "926eb076-a4a8-45e4-91ef-411f0aa4f3ca"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "7G33012534"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "c0195565-56b4-426a-8b1a-868519d6dfaa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20020717",
            "product_id": "68727-100_c0195565-56b4-426a-8b1a-868519d6dfaa",
            "application_number": "NDA021196",
            "brand_name_base": "Xyrem",
            "pharm_class": [
                "Central Nervous System Depressant [EPC]",
                "Central Nervous System Depression [PE]",
                "Decreased Central Nervous System Organized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "68727-150",
            "generic_name": "(calcium, magnesium, potassium, and sodium oxybates)",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "dea_schedule": "CIII",
            "brand_name": "XYWAV",
            "active_ingredients": [
                {
                    "name": "CALCIUM OXYBATE",
                    "strength": ".5 g/mL"
                },
                {
                    "name": "MAGNESIUM OXYBATE",
                    "strength": ".5 g/mL"
                },
                {
                    "name": "POTASSIUM OXYBATE",
                    "strength": ".5 g/mL"
                },
                {
                    "name": "SODIUM OXYBATE",
                    "strength": ".5 g/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68727-150-01",
                    "description": "180 mL in 1 BOTTLE, PLASTIC (68727-150-01)",
                    "marketing_start_date": "20201102",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2393794",
                    "2393795"
                ],
                "spl_set_id": [
                    "1e0ae43a-037f-42af-8e23-a0e51d75abe8"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "8W24SYD6ZI",
                    "G983HLV265",
                    "S8NKF3H3KT",
                    "7G33012534"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "86a47492-82fd-4903-a8a2-2356393074f4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201102",
            "product_id": "68727-150_86a47492-82fd-4903-a8a2-2356393074f4",
            "application_number": "NDA212690",
            "brand_name_base": "XYWAV",
            "pharm_class": [
                "Central Nervous System Depressant [EPC]",
                "Central Nervous System Depressant [EPC]",
                "Central Nervous System Depressant [EPC]",
                "Central Nervous System Depressant [EPC]",
                "Central Nervous System Depression [PE]",
                "Central Nervous System Depression [PE]",
                "Central Nervous System Depression [PE]",
                "Central Nervous System Depression [PE]",
                "Decreased Central Nervous System Organized Electrical Activity [PE]",
                "Decreased Central Nervous System Organized Electrical Activity [PE]",
                "Decreased Central Nervous System Organized Electrical Activity [PE]",
                "Decreased Central Nervous System Organized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "0003-2327",
            "generic_name": "ipilimumab",
            "labeler_name": "E.R. Squibb & Sons, L.L.C.",
            "brand_name": "YERVOY",
            "active_ingredients": [
                {
                    "name": "IPILIMUMAB",
                    "strength": "5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0003-2327-11",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11)  / 10 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20110325",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "E.R. Squibb & Sons, L.L.C."
                ],
                "rxcui": [
                    "1657005",
                    "1657007",
                    "1657012",
                    "1657013"
                ],
                "spl_set_id": [
                    "2265ef30-253e-11df-8a39-0800200c9a66"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000182635",
                    "N0000182634",
                    "N0000182157"
                ],
                "pharm_class_epc": [
                    "CTLA-4-directed Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "CTLA-4-directed Antibody Interactions [MoA]"
                ],
                "pharm_class_pe": [
                    "Increased T Lymphocyte Activation [PE]"
                ],
                "unii": [
                    "6T8C155666"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "839bc9a8-9583-41fa-beb6-728ef542fa72",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20110325",
            "product_id": "0003-2327_839bc9a8-9583-41fa-beb6-728ef542fa72",
            "application_number": "BLA125377",
            "brand_name_base": "YERVOY",
            "pharm_class": [
                "CTLA-4-directed Antibody Interactions [MoA]",
                "CTLA-4-directed Blocking Antibody [EPC]",
                "Increased T Lymphocyte Activation [PE]"
            ]
        },
        {
            "product_ndc": "71287-119",
            "generic_name": "axicabtagene ciloleucel",
            "labeler_name": "Kite Pharma, Inc.",
            "brand_name": "YESCARTA",
            "active_ingredients": [
                {
                    "name": "AXICABTAGENE CILOLEUCEL",
                    "strength": "2000000 1/68mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71287-119-02",
                    "description": "1 BAG in 1 PACKAGE (71287-119-02)  / 68 mL in 1 BAG (71287-119-01)",
                    "marketing_start_date": "20171018",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Kite Pharma, Inc."
                ],
                "spl_set_id": [
                    "9b70606e-b99c-4272-a0f1-b5523cce0c59"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000193546",
                    "N0000193549",
                    "N0000193544",
                    "N0000193548",
                    "M000615883",
                    "N0000182157"
                ],
                "pharm_class_epc": [
                    "CD19-directed Chimeric Antigen Receptor [EPC]",
                    "Genetically-modified Autologous T Cells [EPC]"
                ],
                "pharm_class_moa": [
                    "CD19 Receptor Interactions [MoA]"
                ],
                "pharm_class_cs": [
                    "CD19-specific Chimeric Antigen Receptor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased T Lymphocyte Activation [PE]"
                ],
                "unii": [
                    "U2I8T43Y7R"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SUSPENSION",
            "spl_id": "49d30336-4c2f-457f-9dc9-6dd309ffcf44",
            "product_type": "CELLULAR THERAPY",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20171018",
            "product_id": "71287-119_49d30336-4c2f-457f-9dc9-6dd309ffcf44",
            "application_number": "BLA125643",
            "brand_name_base": "YESCARTA",
            "pharm_class": [
                "CD19 Receptor Interactions [MoA]",
                "CD19-directed Chimeric Antigen Receptor [EPC]",
                "CD19-specific Chimeric Antigen Receptor [CS]",
                "Genetically-modified Autologous T Cells [EPC]",
                "Increased T Lymphocyte Activation [PE]",
                "T Lymphocytes",
                "Cultured",
                "Autologous",
                "Genetically-modified [EXT]"
            ]
        },
        {
            "product_ndc": "59676-610",
            "generic_name": "Trabectedin",
            "labeler_name": "Janssen Products, LP",
            "brand_name": "YONDELIS",
            "active_ingredients": [
                {
                    "name": "TRABECTEDIN",
                    "strength": ".05 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59676-610-01",
                    "description": "20 mL in 1 VIAL, SINGLE-USE (59676-610-01)",
                    "marketing_start_date": "20151023",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Janssen Products, LP"
                ],
                "rxcui": [
                    "1718589",
                    "1718594"
                ],
                "spl_set_id": [
                    "472bd78e-be17-4b9d-90f4-9482c3aec9ff"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000236",
                    "N0000175558"
                ],
                "pharm_class_moa": [
                    "Alkylating Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Alkylating Drug [EPC]"
                ],
                "unii": [
                    "ID0YZQ2TCP"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "8218989c-639a-11ea-bb8e-0434fc2ca371",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20151023",
            "product_id": "59676-610_8218989c-639a-11ea-bb8e-0434fc2ca371",
            "application_number": "NDA207953",
            "brand_name_base": "YONDELIS",
            "pharm_class": [
                "Alkylating Activity [MoA]",
                "Alkylating Drug [EPC]"
            ]
        },
        {
            "product_ndc": "49502-806",
            "generic_name": "revefenacin",
            "labeler_name": "Mylan Specialty L.P.",
            "brand_name": "YUPELRI",
            "active_ingredients": [
                {
                    "name": "REVEFENACIN",
                    "strength": "175 ug/3mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "49502-806-87",
                    "description": "7 POUCH in 1 CARTON (49502-806-87)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-33)  / 3 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190101",
                    "sample": true
                },
                {
                    "package_ndc": "49502-806-93",
                    "description": "30 POUCH in 1 CARTON (49502-806-93)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-32)  / 3 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20181203",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Mylan Specialty L.P."
                ],
                "rxcui": [
                    "2102779",
                    "2102784"
                ],
                "spl_set_id": [
                    "6dfebf04-7c90-436a-9b16-750d3c1ee0a6"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175574",
                    "N0000175370"
                ],
                "pharm_class_epc": [
                    "Anticholinergic [EPC]"
                ],
                "pharm_class_moa": [
                    "Cholinergic Antagonists [MoA]"
                ],
                "unii": [
                    "G2AE2VE07O"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "10a82af1-5439-42be-b133-7ac409784ea9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "RESPIRATORY (INHALATION)"
            ],
            "marketing_start_date": "20181203",
            "product_id": "49502-806_10a82af1-5439-42be-b133-7ac409784ea9",
            "application_number": "NDA210598",
            "brand_name_base": "YUPELRI",
            "pharm_class": [
                "Anticholinergic [EPC]",
                "Cholinergic Antagonists [MoA]"
            ]
        },
        {
            "product_ndc": "71879-136",
            "generic_name": "fluocinolone acetonide",
            "labeler_name": "EyePoint Pharmaceuticals, Inc",
            "brand_name": "YUTIQ",
            "active_ingredients": [
                {
                    "name": "FLUOCINOLONE ACETONIDE",
                    "strength": ".18 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "71879-136-01",
                    "description": "1 POUCH in 1 BOX, UNIT-DOSE (71879-136-01)  / 1 APPLICATOR in 1 POUCH / 1 IMPLANT in 1 APPLICATOR",
                    "marketing_start_date": "20181012",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "EyePoint Pharmaceuticals, Inc"
                ],
                "rxcui": [
                    "2099361",
                    "2099366"
                ],
                "spl_set_id": [
                    "43ba66d9-653d-48b9-9914-b0a50b68b79a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175576",
                    "N0000175450"
                ],
                "pharm_class_epc": [
                    "Corticosteroid [EPC]"
                ],
                "pharm_class_moa": [
                    "Corticosteroid Hormone Receptor Agonists [MoA]"
                ],
                "unii": [
                    "0CD5FD6S2M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "IMPLANT",
            "spl_id": "0c69de0f-072c-8de5-e063-6294a90a35fe",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAOCULAR"
            ],
            "marketing_start_date": "20181012",
            "product_id": "71879-136_0c69de0f-072c-8de5-e063-6294a90a35fe",
            "application_number": "NDA210331",
            "brand_name_base": "YUTIQ",
            "pharm_class": [
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "0071-0237",
            "generic_name": "Ethosuximide",
            "labeler_name": "Parke-Davis Div of Pfizer Inc",
            "brand_name": "Zarontin",
            "active_ingredients": [
                {
                    "name": "ETHOSUXIMIDE",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0071-0237-24",
                    "description": "100 CAPSULE in 1 BOTTLE (0071-0237-24)",
                    "marketing_start_date": "20000922",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Parke-Davis Div of Pfizer Inc"
                ],
                "rxcui": [
                    "197682",
                    "201737"
                ],
                "spl_set_id": [
                    "0e008f33-70a1-4bc6-b3a0-d45214418ab6"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "unii": [
                    "5SEH9X1D1D"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "edbd0e03-32f6-4f34-9686-f63912bbe623",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20000922",
            "product_id": "0071-0237_edbd0e03-32f6-4f34-9686-f63912bbe623",
            "application_number": "NDA012380",
            "brand_name_base": "Zarontin",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
            ]
        },
        {
            "product_ndc": "61314-326",
            "generic_name": "filgrastim-sndz",
            "labeler_name": "Sandoz Inc.",
            "brand_name": "ZARXIO",
            "active_ingredients": [
                {
                    "name": "FILGRASTIM",
                    "strength": "480 ug/.8mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61314-326-01",
                    "description": "1 BLISTER PACK in 1 CARTON (61314-326-01)  / 1 SYRINGE in 1 BLISTER PACK / .8 mL in 1 SYRINGE",
                    "marketing_start_date": "20180222",
                    "sample": false
                },
                {
                    "package_ndc": "61314-326-10",
                    "description": "2 BLISTER PACK in 1 CARTON (61314-326-10)  / 5 SYRINGE in 1 BLISTER PACK (61314-326-05)  / .8 mL in 1 SYRINGE",
                    "marketing_start_date": "20180222",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Sandoz Inc."
                ],
                "rxcui": [
                    "1605066",
                    "1605071",
                    "1605074",
                    "1605075"
                ],
                "spl_set_id": [
                    "c0d1c22b-566b-4776-bdbf-00f96dad0cae"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "PVI5M0M1GW"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "c286da0e-23e9-4d80-a1b1-92619c116f6d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20150306",
            "product_id": "61314-326_c286da0e-23e9-4d80-a1b1-92619c116f6d",
            "application_number": "BLA125553",
            "brand_name_base": "ZARXIO",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "80644-0012",
            "generic_name": "dasiglucagon",
            "labeler_name": "Zealand Pharma US, Inc",
            "brand_name": "Zegalogue",
            "active_ingredients": [
                {
                    "name": "DASIGLUCAGON",
                    "strength": ".6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "80644-0012-1",
                    "description": "1 CONTAINER in 1 PACKAGE (80644-0012-1)  / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20210405",
                    "sample": false
                },
                {
                    "package_ndc": "80644-0012-2",
                    "description": "2 PACKAGE in 1 CARTON (80644-0012-2)  / 1 CONTAINER in 1 PACKAGE / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20210405",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Zealand Pharma US, Inc"
                ],
                "rxcui": [
                    "2535238",
                    "2535243",
                    "2535247",
                    "2535249"
                ],
                "spl_set_id": [
                    "c6c32b47-c47c-4a7f-8d4d-23578f663217"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000190852",
                    "N0000193923",
                    "N0000009345"
                ],
                "pharm_class_epc": [
                    "Antihypoglycemic Agent [EPC]"
                ],
                "pharm_class_moa": [
                    "Glucagon Receptor Agonists [MoA]"
                ],
                "pharm_class_pe": [
                    "Increased Glycogenolysis [PE]"
                ],
                "unii": [
                    "AD4J2O47FQ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "06e3f110-a8d1-d5cc-e063-6394a90ab33d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20210405",
            "product_id": "80644-0012_06e3f110-a8d1-d5cc-e063-6394a90ab33d",
            "application_number": "NDA214231",
            "brand_name_base": "Zegalogue",
            "pharm_class": [
                "Antihypoglycemic Agent [EPC]",
                "Glucagon Receptor Agonists [MoA]",
                "Increased Glycogenolysis [PE]"
            ]
        },
        {
            "product_ndc": "0173-0915",
            "generic_name": "niraparib",
            "labeler_name": "GlaxoSmithKline LLC",
            "brand_name": "ZEJULA",
            "active_ingredients": [
                {
                    "name": "NIRAPARIB TOSYLATE MONOHYDRATE",
                    "strength": "300 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0173-0915-13",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0173-0915-13)",
                    "marketing_start_date": "20230627",
                    "sample": false
                },
                {
                    "package_ndc": "0173-0915-61",
                    "description": "30 TABLET, FILM COATED in 1 BOTTLE (0173-0915-61)",
                    "marketing_start_date": "20230627",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "GlaxoSmithKline LLC"
                ],
                "rxcui": [
                    "2637449",
                    "2637452",
                    "2637465",
                    "2640210",
                    "2640212",
                    "2640214"
                ],
                "spl_set_id": [
                    "b7f675e2-159c-490c-b6f4-3f16d9492b7d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0301730912138",
                    "0301730915139",
                    "0301730909138"
                ],
                "unii": [
                    "195Q483UZD"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "23c684fe-9cd2-405f-9a4e-60c9564b44e6",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20230627",
            "product_id": "0173-0915_23c684fe-9cd2-405f-9a4e-60c9564b44e6",
            "application_number": "NDA214876",
            "brand_name_base": "ZEJULA",
            "pharm_class": [
                "Poly(ADP-Ribose) Polymerase Inhibitor [EPC]",
                "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0187-0453",
            "generic_name": "SELEGILINE HYDROCHLORIDE",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "ZELAPAR",
            "active_ingredients": [
                {
                    "name": "SELEGILINE HYDROCHLORIDE",
                    "strength": "1.25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0187-0453-02",
                    "description": "6 POUCH in 1 CARTON (0187-0453-02)  / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH",
                    "marketing_start_date": "20060614",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "859190",
                    "859192"
                ],
                "spl_set_id": [
                    "380d7717-2a79-42f3-a712-efe5e7696ba0"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "6W731X367Q"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, ORALLY DISINTEGRATING",
            "spl_id": "f8d8f532-d8a6-4eff-baab-325fed820cdb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20060614",
            "product_id": "0187-0453_f8d8f532-d8a6-4eff-baab-325fed820cdb",
            "application_number": "NDA021479",
            "brand_name_base": "ZELAPAR",
            "pharm_class": [
                "Monoamine Oxidase Inhibitor [EPC]",
                "Monoamine Oxidase Inhibitors [MoA]",
                "Monoamine Oxidase Type B Inhibitor [EPC]",
                "Monoamine Oxidase-B Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "50242-090",
            "generic_name": "Vemurafenib",
            "labeler_name": "Genentech, Inc.",
            "brand_name": "ZELBORAF",
            "active_ingredients": [
                {
                    "name": "VEMURAFENIB",
                    "strength": "240 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50242-090-02",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (50242-090-02)  / 112 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20150908",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Genentech, Inc."
                ],
                "rxcui": [
                    "1147223",
                    "1147228"
                ],
                "spl_set_id": [
                    "38eea320-7e0c-485a-bc30-98c3c45e2763"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000175076",
                    "N0000182138",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Protein Kinase Inhibitors [MoA]",
                    "Cytochrome P450 1A2 Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "207SMY3FQT"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "12c533cf-cb4e-4c17-986c-100fcd1056eb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20110817",
            "product_id": "50242-090_12c533cf-cb4e-4c17-986c-100fcd1056eb",
            "application_number": "NDA202429",
            "brand_name_base": "ZELBORAF",
            "pharm_class": [
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Protein Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "0053-7202",
            "generic_name": ".ALPHA.1-PROTEINASE INHIBITOR HUMAN",
            "labeler_name": "CSL Behring LLC",
            "brand_name": "ZEMAIRA",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0053-7202-02",
                    "description": "1 KIT in 1 CARTON (0053-7202-02)  *  76 mL in 1 VIAL, SINGLE-USE (0053-7212-01)  *  76 mL in 1 VIAL, SINGLE-USE (0053-7653-80)",
                    "marketing_start_date": "20190424",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {},
            "marketing_category": "BLA",
            "dosage_form": "KIT",
            "spl_id": "7eb65947-7ddd-4986-9e22-104c72907808",
            "product_type": "PLASMA DERIVATIVE",
            "marketing_start_date": "20190424",
            "product_id": "0053-7202_7eb65947-7ddd-4986-9e22-104c72907808",
            "application_number": "BLA125078",
            "brand_name_base": "ZEMAIRA"
        },
        {
            "product_ndc": "73562-114",
            "generic_name": "pancrelipase lipase, pancrelipase protease, pancrelipase amylase",
            "labeler_name": "Aimmune Therapeutics, Inc.",
            "brand_name": "Zenpep",
            "active_ingredients": [
                {
                    "name": "PANCRELIPASE AMYLASE",
                    "strength": "168000 [USP'U]/1"
                },
                {
                    "name": "PANCRELIPASE LIPASE",
                    "strength": "40000 [USP'U]/1"
                },
                {
                    "name": "PANCRELIPASE PROTEASE",
                    "strength": "126000 [USP'U]/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73562-114-01",
                    "description": "100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-114-01)",
                    "marketing_start_date": "20201101",
                    "sample": false
                },
                {
                    "package_ndc": "73562-114-12",
                    "description": "12 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-114-12)",
                    "marketing_start_date": "20201101",
                    "sample": true
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Aimmune Therapeutics, Inc."
                ],
                "rxcui": [
                    "1594671",
                    "1594673",
                    "1595290",
                    "1595292",
                    "1595455",
                    "1595457",
                    "1595460",
                    "1595462",
                    "1595471",
                    "1595473",
                    "1595476",
                    "1595478",
                    "1995477",
                    "1995479",
                    "2669470",
                    "2669472"
                ],
                "spl_set_id": [
                    "7f16f2d4-8df6-4bd7-ac10-56994fa257b0"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0373562112017",
                    "0373562116015",
                    "0373562115018",
                    "0373562117012",
                    "0373562114011",
                    "0373562113014",
                    "0373562110013"
                ],
                "unii": [
                    "YOJ58O116E",
                    "3560D81V50",
                    "8MYC33932O"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "CAPSULE, DELAYED RELEASE",
            "spl_id": "06e56fa7-2bfe-4a3d-87c4-d9aa52fea5c7",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201101",
            "product_id": "73562-114_06e56fa7-2bfe-4a3d-87c4-d9aa52fea5c7",
            "application_number": "BLA022210",
            "brand_name_base": "Zenpep"
        },
        {
            "product_ndc": "0006-3074",
            "generic_name": "elbasvir and grazoprevir",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "ZEPATIER",
            "active_ingredients": [
                {
                    "name": "ELBASVIR",
                    "strength": "50 mg/1"
                },
                {
                    "name": "GRAZOPREVIR ANHYDROUS",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-3074-02",
                    "description": "2 DOSE PACK in 1 CARTON (0006-3074-02)  / 14 TABLET, FILM COATED in 1 DOSE PACK (0006-3074-01)",
                    "marketing_start_date": "20160128",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "1734636",
                    "1734642"
                ],
                "spl_set_id": [
                    "164dc02a-9180-426a-b8b5-04ab39d2bbd4"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191256",
                    "N0000190113",
                    "N0000182638",
                    "N0000182639",
                    "N0000190114"
                ],
                "pharm_class_epc": [
                    "Hepatitis C Virus NS5A Inhibitor [EPC]",
                    "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Breast Cancer Resistance Protein Inhibitors [MoA]",
                    "HCV NS3/4A Protease Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]"
                ],
                "unii": [
                    "632L571YDK",
                    "8YE81R1X1J"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "194bbac3-2955-4d3f-ae5e-9da852e428fa",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20160128",
            "product_id": "0006-3074_194bbac3-2955-4d3f-ae5e-9da852e428fa",
            "application_number": "NDA208261",
            "brand_name_base": "ZEPATIER",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "HCV NS3/4A Protease Inhibitors [MoA]",
                "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]",
                "Hepatitis C Virus NS5A Inhibitor [EPC]"
            ]
        },
        {
            "product_ndc": "59572-810",
            "generic_name": "ozanimod hydrochloride",
            "labeler_name": "Celgene Corporation",
            "brand_name": "ZEPOSIA 7-Day Starter Pack",
            "brand_name_suffix": "7-Day Starter Pack",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59572-810-07",
                    "description": "1 KIT in 1 BLISTER PACK (59572-810-07)  *  1 CAPSULE in 1 BLISTER PACK *  1 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20200327",
                    "sample": false
                },
                {
                    "package_ndc": "59572-810-97",
                    "description": "1 KIT in 1 BLISTER PACK (59572-810-97)  *  1 CAPSULE in 1 BLISTER PACK *  1 CAPSULE in 1 BLISTER PACK",
                    "marketing_start_date": "20200327",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Celgene Corporation"
                ],
                "rxcui": [
                    "2288406",
                    "2288412",
                    "2288414",
                    "2288416",
                    "2288418",
                    "2288420",
                    "2288430",
                    "2288431",
                    "2288432",
                    "2288433",
                    "2642213",
                    "2642214"
                ],
                "spl_set_id": [
                    "93ce2fab-edfb-4804-8074-963071de51e4"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "3UPR33JAAM"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "0836b6ca-508f-4680-a585-34e3c0ba565e",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "marketing_start_date": "20200327",
            "product_id": "59572-810_0836b6ca-508f-4680-a585-34e3c0ba565e",
            "application_number": "NDA209899",
            "brand_name_base": "ZEPOSIA"
        },
        {
            "product_ndc": "68727-712",
            "generic_name": "Lurbinectedin",
            "labeler_name": "Jazz Pharmaceuticals, Inc.",
            "brand_name": "ZEPZELCA",
            "active_ingredients": [
                {
                    "name": "LURBINECTEDIN",
                    "strength": ".5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "68727-712-01",
                    "description": "8 mL in 1 VIAL, SINGLE-DOSE (68727-712-01)",
                    "marketing_start_date": "20200615",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Jazz Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2374733",
                    "2374738"
                ],
                "spl_set_id": [
                    "632bb50c-3bcb-4c85-9056-fc33410550ae"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000000236",
                    "N0000175558"
                ],
                "pharm_class_moa": [
                    "Alkylating Activity [MoA]"
                ],
                "pharm_class_epc": [
                    "Alkylating Drug [EPC]"
                ],
                "unii": [
                    "2CN60TN6ZS"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "3d667d47-35e9-4eeb-a5a6-2a879f52eac5",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20200615",
            "product_id": "68727-712_3d667d47-35e9-4eeb-a5a6-2a879f52eac5",
            "application_number": "NDA213702",
            "brand_name_base": "ZEPZELCA",
            "pharm_class": [
                "Alkylating Activity [MoA]",
                "Alkylating Drug [EPC]"
            ]
        },
        {
            "product_ndc": "72485-114",
            "generic_name": "Lincomycin",
            "labeler_name": "Armas Pharmaceuticals Inc.",
            "brand_name": "Lincomycin",
            "active_ingredients": [
                {
                    "name": "LINCOMYCIN HYDROCHLORIDE",
                    "strength": "600 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72485-114-01",
                    "description": "1 VIAL, MULTI-DOSE in 1 CARTON (72485-114-01)  / 2 mL in 1 VIAL, MULTI-DOSE",
                    "marketing_start_date": "20230505",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Armas Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "239212"
                ],
                "spl_set_id": [
                    "fd2838b7-f8c9-4049-a306-ea620a9c0fe2"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372485114016"
                ],
                "unii": [
                    "M6T05Z2B68"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAMUSCULAR",
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230505",
            "product_id": "72485-114_f455d6a8-9e3c-433b-9a30-4bbf1de99af0",
            "application_number": "ANDA215082",
            "brand_name_base": "Lincomycin"
        },
        {
            "product_ndc": "73027-216",
            "generic_name": "Alcohol",
            "labeler_name": "JIANGSU HANHE DAILY CHEMICALS CO., LTD.",
            "brand_name": "Rilakkuma Aloe Vera Scented",
            "active_ingredients": [
                {
                    "name": "ALCOHOL",
                    "strength": "75 mL/100mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73027-216-01",
                    "description": "30 mL in 1 BOTTLE (73027-216-01)",
                    "marketing_start_date": "20210524",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "JIANGSU HANHE DAILY CHEMICALS CO., LTD."
                ],
                "rxcui": [
                    "1305100"
                ],
                "spl_set_id": [
                    "91eca6d8-3500-4400-9c51-695f33aeed65"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0843074194370"
                ],
                "unii": [
                    "3K9958V90M"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "GEL",
            "spl_id": "f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20210524",
            "product_id": "73027-216_f6f15373-e2ab-412a-e053-6394a90a8ad0",
            "application_number": "part333A",
            "brand_name_base": "Rilakkuma Aloe Vera Scented"
        },
        {
            "product_ndc": "61314-866",
            "generic_name": "pegfilgrastim-bmez",
            "labeler_name": "Sandoz Inc",
            "brand_name": "ZIEXTENZO",
            "active_ingredients": [
                {
                    "name": "PEGFILGRASTIM",
                    "strength": "6 mg/.6mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "61314-866-01",
                    "description": "1 BLISTER PACK in 1 CARTON (61314-866-01)  / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE",
                    "marketing_start_date": "20191104",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sandoz Inc"
                ],
                "rxcui": [
                    "2260704",
                    "2260709"
                ],
                "spl_set_id": [
                    "7dada041-6528-4acf-809c-62d271538c9a"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "M0024696",
                    "N0000009451",
                    "N0000175666"
                ],
                "pharm_class_cs": [
                    "Granulocyte Colony-Stimulating Factor [CS]"
                ],
                "pharm_class_pe": [
                    "Increased Myeloid Cell Production [PE]"
                ],
                "pharm_class_epc": [
                    "Leukocyte Growth Factor [EPC]"
                ],
                "unii": [
                    "3A58010674"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "287d94a9-83b1-4a7c-8186-0018f7c4415f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20191104",
            "product_id": "61314-866_287d94a9-83b1-4a7c-8186-0018f7c4415f",
            "application_number": "BLA761045",
            "brand_name_base": "ZIEXTENZO",
            "pharm_class": [
                "Granulocyte Colony-Stimulating Factor [CS]",
                "Granulocyte-Macrophage Colony-Stimulating Factor [CS]",
                "Increased Myeloid Cell Production [PE]",
                "Leukocyte Growth Factor [EPC]"
            ]
        },
        {
            "product_ndc": "50474-990",
            "generic_name": "zilucoplan",
            "labeler_name": "UCB, Inc.",
            "brand_name": "ZILBRYSQ",
            "active_ingredients": [
                {
                    "name": "ZILUCOPLAN",
                    "strength": "40 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50474-990-80",
                    "description": "4 CARTON in 1 BOX (50474-990-80)  / 7 SYRINGE, GLASS in 1 CARTON / .416 mL in 1 SYRINGE, GLASS",
                    "marketing_start_date": "20240315",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "UCB, Inc."
                ],
                "rxcui": [
                    "2672496",
                    "2672502",
                    "2672504",
                    "2672505",
                    "2672506",
                    "2672507"
                ],
                "spl_set_id": [
                    "9f1d53d6-e495-4a3a-8bb9-680a15d25034"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175575",
                    "N0000175974"
                ],
                "pharm_class_epc": [
                    "Complement Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Complement Inhibitors [MoA]"
                ],
                "unii": [
                    "YG391PK0CC"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "64f76ecc-80d3-4ccd-8962-c1f1d5fe55fb",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20240103",
            "product_id": "50474-990_64f76ecc-80d3-4ccd-8962-c1f1d5fe55fb",
            "application_number": "NDA216834",
            "brand_name_base": "ZILBRYSQ",
            "pharm_class": [
                "Complement Inhibitor [EPC]",
                "Complement Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "65250-003",
            "generic_name": "triamcinolone acetonide extended-release injectable suspension",
            "labeler_name": "Pacira Pharmaceuticals, Inc.",
            "brand_name": "Zilretta",
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "65250-003-01",
                    "description": "1 KIT in 1 CARTON (65250-003-01)  *  1 INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE in 1 VIAL, SINGLE-DOSE (65250-001-01)  *  1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE (65250-002-01)",
                    "marketing_start_date": "20171006",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Pacira Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "1947131",
                    "1947133"
                ],
                "spl_set_id": [
                    "cd5c4673-21f2-4126-9556-da847b3a228b"
                ],
                "is_original_packager": [
                    true
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "KIT",
            "spl_id": "61b0ba20-8899-406a-99be-daef39df8f89",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRA-ARTICULAR"
            ],
            "marketing_start_date": "20171006",
            "product_id": "65250-003_61b0ba20-8899-406a-99be-daef39df8f89",
            "application_number": "NDA208845",
            "brand_name_base": "Zilretta"
        },
        {
            "product_ndc": "0006-3025",
            "generic_name": "bezlotoxumab",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "ZINPLAVA",
            "active_ingredients": [
                {
                    "name": "BEZLOTOXUMAB",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-3025-00",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3025-00)  / 40 mL in 1 VIAL, SINGLE-DOSE (0006-3025-01)",
                    "marketing_start_date": "20161021",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "1855052",
                    "1855057"
                ],
                "spl_set_id": [
                    "8f479bfe-2bfa-4cc5-9aee-1357364480b0"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "4H5YMK1H2E"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "10a116c7-454f-42f0-8519-05ae60cc8791",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20161021",
            "product_id": "0006-3025_10a116c7-454f-42f0-8519-05ae60cc8791",
            "application_number": "BLA761046",
            "brand_name_base": "ZINPLAVA"
        },
        {
            "product_ndc": "24208-535",
            "generic_name": "ganciclovir",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "ZIRGAN",
            "active_ingredients": [
                {
                    "name": "GANCICLOVIR",
                    "strength": "1.5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-535-15",
                    "description": "1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-15)  / 1.5 g in 1 TUBE, WITH APPLICATOR",
                    "marketing_start_date": "20100430",
                    "sample": false
                },
                {
                    "package_ndc": "24208-535-35",
                    "description": "1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-35)  / 5 g in 1 TUBE, WITH APPLICATOR",
                    "marketing_start_date": "20100430",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "388052",
                    "864650"
                ],
                "spl_set_id": [
                    "ea25e7ac-7a93-4ec8-975b-2cec197e1c27"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175461",
                    "N0000020060",
                    "N0000175459",
                    "N0000175466"
                ],
                "pharm_class_epc": [
                    "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
                    "Nucleoside Analog Antiviral [EPC]"
                ],
                "pharm_class_moa": [
                    "DNA Polymerase Inhibitors [MoA]"
                ],
                "unii": [
                    "P9G3CKZ4P5"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "GEL",
            "spl_id": "125fcc15-69c3-3cd0-e063-6394a90a598d",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20100430",
            "product_id": "24208-535_125fcc15-69c3-3cd0-e063-6394a90a598d",
            "application_number": "NDA022211",
            "brand_name_base": "ZIRGAN",
            "pharm_class": [
                "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
                "DNA Polymerase Inhibitors [MoA]",
                "Nucleoside Analog Antiviral [EPC]",
                "Nucleoside Analog [EXT]"
            ]
        },
        {
            "product_ndc": "73079-050",
            "generic_name": "lonafarnib",
            "labeler_name": "Eiger BioPharmaceuticals, Inc.",
            "brand_name": "Zokinvy",
            "active_ingredients": [
                {
                    "name": "LONAFARNIB",
                    "strength": "50 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73079-050-30",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (73079-050-30)  / 30 CAPSULE in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20201120",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Eiger BioPharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2467582",
                    "2467588",
                    "2467590",
                    "2467592"
                ],
                "spl_set_id": [
                    "956a142f-35d6-4fe3-8aef-7e4878d275ed"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0373079050307",
                    "0373079075300"
                ],
                "nui": [
                    "N0000193938",
                    "N0000193939",
                    "N0000187062",
                    "N0000190114",
                    "N0000185503",
                    "N0000182140",
                    "N0000190107",
                    "N0000190108",
                    "N0000190113"
                ],
                "pharm_class_epc": [
                    "Farnesyltransferase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Farnesyltransferase Inhibitors [MoA]",
                    "Cytochrome P450 2C8 Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]",
                    "Cytochrome P450 2C19 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                    "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                    "Breast Cancer Resistance Protein Inhibitors [MoA]"
                ],
                "unii": [
                    "IOW153004F"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "c395d7f5-cc38-407a-85fd-7dc4b3fd32f3",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20201120",
            "product_id": "73079-050_c395d7f5-cc38-407a-85fd-7dc4b3fd32f3",
            "application_number": "NDA213969",
            "brand_name_base": "Zokinvy",
            "pharm_class": [
                "Breast Cancer Resistance Protein Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Farnesyltransferase Inhibitor [EPC]",
                "Farnesyltransferase Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
                "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
                "P-Glycoprotein Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "70720-951",
            "generic_name": "goserelin",
            "labeler_name": "TerSera Therapeutics LLC",
            "brand_name": "ZOLADEX",
            "active_ingredients": [
                {
                    "name": "GOSERELIN ACETATE",
                    "strength": "10.8 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "70720-951-30",
                    "description": "1 POUCH in 1 CARTON (70720-951-30)  / 1 SYRINGE in 1 POUCH / 1 IMPLANT in 1 SYRINGE",
                    "marketing_start_date": "20180126",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "TerSera Therapeutics LLC"
                ],
                "rxcui": [
                    "211544",
                    "314008"
                ],
                "spl_set_id": [
                    "e4cb3c20-2738-400a-b522-3f36f71fe6c5"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "6YUU2PV0U8"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "IMPLANT",
            "spl_id": "2cec27f6-1a75-488e-b8fc-3b368818f97b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "SUBCUTANEOUS"
            ],
            "marketing_start_date": "20180126",
            "product_id": "70720-951_2cec27f6-1a75-488e-b8fc-3b368818f97b",
            "application_number": "NDA020578",
            "brand_name_base": "ZOLADEX",
            "pharm_class": [
                "Gonadotropin Releasing Hormone Receptor Agonist [EPC]",
                "Gonadotropin Releasing Hormone Receptor Agonists [MoA]"
            ]
        },
        {
            "product_ndc": "0006-0568",
            "generic_name": "vorinostat",
            "labeler_name": "Merck Sharp & Dohme LLC",
            "brand_name": "ZOLINZA",
            "active_ingredients": [
                {
                    "name": "VORINOSTAT",
                    "strength": "100 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0006-0568-40",
                    "description": "120 CAPSULE in 1 BOTTLE (0006-0568-40)",
                    "marketing_start_date": "20061006",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Merck Sharp & Dohme LLC"
                ],
                "rxcui": [
                    "668579",
                    "668606"
                ],
                "spl_set_id": [
                    "cd86ee78-2781-468b-930c-3c4677bcc092"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0300060568404"
                ],
                "nui": [
                    "N0000175588",
                    "N0000175071"
                ],
                "pharm_class_epc": [
                    "Histone Deacetylase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Histone Deacetylase Inhibitors [MoA]"
                ],
                "unii": [
                    "58IFB293JI"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "255c6d3a-625e-43a7-ae67-ba5053f6e03f",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20061006",
            "product_id": "0006-0568_255c6d3a-625e-43a7-ae67-ba5053f6e03f",
            "application_number": "NDA021991",
            "brand_name_base": "ZOLINZA",
            "pharm_class": [
                "Histone Deacetylase Inhibitor [EPC]",
                "Histone Deacetylase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "59212-681",
            "generic_name": "Zonisamide",
            "labeler_name": "Concordia Pharmaceuticals Inc.",
            "brand_name": "Zonegran",
            "active_ingredients": [
                {
                    "name": "ZONISAMIDE",
                    "strength": "25 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "59212-681-10",
                    "description": "100 CAPSULE in 1 BOTTLE (59212-681-10)",
                    "marketing_start_date": "20000327",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Concordia Pharmaceuticals Inc."
                ],
                "rxcui": [
                    "284408",
                    "314285",
                    "403966",
                    "404725"
                ],
                "spl_set_id": [
                    "d12de43e-3ac3-4335-bc85-70d7366a91eb"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486",
                    "M0020790",
                    "N0000000235",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_cs": [
                    "Sulfonamides [CS]"
                ],
                "pharm_class_moa": [
                    "Carbonic Anhydrase Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "459384H98V"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CAPSULE",
            "spl_id": "93089228-c3a5-4e71-baac-58a930480f2b",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20000327",
            "product_id": "59212-681_93089228-c3a5-4e71-baac-58a930480f2b",
            "application_number": "NDA020789",
            "brand_name_base": "Zonegran",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Carbonic Anhydrase Inhibitors [MoA]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Sulfonamides [CS]"
            ]
        },
        {
            "product_ndc": "52652-8001",
            "generic_name": "ZONISAMIDE",
            "labeler_name": "Azurity Phramaceuticals, Inc.",
            "brand_name": "ZONISADE",
            "active_ingredients": [
                {
                    "name": "ZONISAMIDE",
                    "strength": "100 mg/5mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "52652-8001-1",
                    "description": "1 BOTTLE in 1 CARTON (52652-8001-1)  / 150 mL in 1 BOTTLE",
                    "marketing_start_date": "20220715",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Azurity Phramaceuticals, Inc."
                ],
                "rxcui": [
                    "2606782",
                    "2606788"
                ],
                "spl_set_id": [
                    "ac16fa15-32e9-4f92-8bc6-d8d41ae002c6"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0352652800119"
                ],
                "nui": [
                    "N0000175753",
                    "N0000008486",
                    "M0020790",
                    "N0000000235",
                    "N0000185503"
                ],
                "pharm_class_epc": [
                    "Anti-epileptic Agent [EPC]"
                ],
                "pharm_class_pe": [
                    "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
                ],
                "pharm_class_cs": [
                    "Sulfonamides [CS]"
                ],
                "pharm_class_moa": [
                    "Carbonic Anhydrase Inhibitors [MoA]",
                    "P-Glycoprotein Inhibitors [MoA]"
                ],
                "unii": [
                    "459384H98V"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "df27963d-6762-4aee-9d48-f5d33ae5ff66",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220715",
            "product_id": "52652-8001_df27963d-6762-4aee-9d48-f5d33ae5ff66",
            "application_number": "NDA214273",
            "brand_name_base": "ZONISADE",
            "pharm_class": [
                "Anti-epileptic Agent [EPC]",
                "Carbonic Anhydrase Inhibitors [MoA]",
                "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
                "P-Glycoprotein Inhibitors [MoA]",
                "Sulfonamides [CS]"
            ]
        },
        {
            "product_ndc": "73191-325",
            "generic_name": "Octinoxate, Homosalate, Octisilate, Oxybenzone and Avobenzone",
            "labeler_name": "Florida Private Labeling LLC",
            "brand_name": "Lavelier Divine Day Defense Broad Spectrum SPF 30",
            "active_ingredients": [
                {
                    "name": "AVOBENZONE",
                    "strength": "1.5 g/100g"
                },
                {
                    "name": "HOMOSALATE",
                    "strength": "6.2 g/100g"
                },
                {
                    "name": "OCTINOXATE",
                    "strength": "7.4 g/100g"
                },
                {
                    "name": "OCTISALATE",
                    "strength": "5.2 g/100g"
                },
                {
                    "name": "OXYBENZONE",
                    "strength": "3.1 g/100g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73191-325-19",
                    "description": "1 JAR in 1 CARTON (73191-325-19)  / 60 g in 1 JAR",
                    "marketing_start_date": "20190801",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Florida Private Labeling LLC"
                ],
                "spl_set_id": [
                    "094ef88d-9b1a-4489-87f8-0f11278dcfc6"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "G63QQF2NOX",
                    "V06SV4M95S",
                    "4Y5P7MUD51",
                    "4X49Y0596W",
                    "95OOS7VE0Y"
                ]
            },
            "marketing_category": "OTC MONOGRAPH NOT FINAL",
            "dosage_form": "CREAM",
            "spl_id": "635b4131-cc91-47d2-af60-fb4c071d0e85",
            "product_type": "HUMAN OTC DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20190801",
            "product_id": "73191-325_635b4131-cc91-47d2-af60-fb4c071d0e85",
            "application_number": "part352",
            "brand_name_base": "Lavelier Divine Day Defense Broad Spectrum SPF 30"
        },
        {
            "product_ndc": "81583-100",
            "generic_name": "ganaxolone",
            "labeler_name": "Marinus Pharmaceuticals, Inc.",
            "dea_schedule": "CV",
            "brand_name": "ZTALMY",
            "active_ingredients": [
                {
                    "name": "GANAXOLONE",
                    "strength": "50 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "81583-100-01",
                    "description": "1 BOTTLE, PLASTIC in 1 CARTON (81583-100-01)  / 110 mL in 1 BOTTLE, PLASTIC",
                    "marketing_start_date": "20220606",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Marinus Pharmaceuticals, Inc."
                ],
                "rxcui": [
                    "2604694",
                    "2604700"
                ],
                "spl_set_id": [
                    "d91612c4-b03a-4be4-a1ee-6a13e3b83d4e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000194006",
                    "N0000193997"
                ],
                "pharm_class_epc": [
                    "Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"
                ],
                "pharm_class_moa": [
                    "GABA A Receptor Positive Modulators [MoA]"
                ],
                "unii": [
                    "98WI44OHIQ"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION",
            "spl_id": "04aae8de-0bd2-497b-8ba9-e82e8fa12f7a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20220606",
            "product_id": "81583-100_04aae8de-0bd2-497b-8ba9-e82e8fa12f7a",
            "application_number": "NDA215904",
            "brand_name_base": "ZTALMY",
            "pharm_class": [
                "GABA A Receptor Positive Modulators [MoA]",
                "Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"
            ]
        },
        {
            "product_ndc": "72152-547",
            "generic_name": "brexanolone",
            "labeler_name": "Sage Therapeutics, Inc.",
            "dea_schedule": "CIV",
            "brand_name": "Zulresso",
            "active_ingredients": [
                {
                    "name": "BREXANOLONE",
                    "strength": "5 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72152-547-20",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72152-547-20)  / 20 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20190617",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Sage Therapeutics, Inc."
                ],
                "rxcui": [
                    "2121781",
                    "2121786"
                ],
                "spl_set_id": [
                    "b40f3b2a-1859-4ed6-8551-444300806d13"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372152547208"
                ],
                "nui": [
                    "N0000194006",
                    "N0000193997"
                ],
                "pharm_class_epc": [
                    "Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]"
                ],
                "pharm_class_moa": [
                    "GABA A Receptor Positive Modulators [MoA]"
                ],
                "unii": [
                    "S39XZ5QV8Y"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "INJECTION, SOLUTION",
            "spl_id": "8115acb4-4050-4778-b516-e21ef742d451",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20190617",
            "product_id": "72152-547_8115acb4-4050-4778-b516-e21ef742d451",
            "application_number": "NDA211371",
            "brand_name_base": "Zulresso"
        },
        {
            "product_ndc": "99207-276",
            "generic_name": "imiquimod",
            "labeler_name": "Bausch Health US, LLC",
            "brand_name": "Zyclara",
            "active_ingredients": [
                {
                    "name": "IMIQUIMOD",
                    "strength": "2.5 mg/g"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "99207-276-01",
                    "description": "1 BOTTLE, PUMP in 1 CARTON (99207-276-01)  / 7.5 g in 1 BOTTLE, PUMP",
                    "marketing_start_date": "20120229",
                    "sample": false
                },
                {
                    "package_ndc": "99207-276-75",
                    "description": "1 BOTTLE, PUMP in 1 CARTON (99207-276-75)  / 7.5 g in 1 BOTTLE, PUMP",
                    "marketing_start_date": "20120229",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch Health US, LLC"
                ],
                "rxcui": [
                    "967017",
                    "967021"
                ],
                "spl_set_id": [
                    "28cd9b5b-680b-480f-b33d-9c5b52bbf03d"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000009267",
                    "N0000009269",
                    "N0000000157"
                ],
                "pharm_class_pe": [
                    "Increased Cytokine Activity [PE]",
                    "Increased Cytokine Production [PE]"
                ],
                "pharm_class_moa": [
                    "Interferon Inducers [MoA]"
                ],
                "unii": [
                    "P1QW714R7M"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "CREAM",
            "spl_id": "0e7a6f8f-fba5-afe1-e063-6294a90ae551",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "TOPICAL"
            ],
            "marketing_start_date": "20120229",
            "product_id": "99207-276_0e7a6f8f-fba5-afe1-e063-6294a90ae551",
            "application_number": "NDA022483",
            "brand_name_base": "Zyclara",
            "pharm_class": [
                "Increased Cytokine Activity [PE]",
                "Increased Cytokine Production [PE]",
                "Interferon Inducers [MoA]"
            ]
        },
        {
            "product_ndc": "72888-108",
            "generic_name": "carbidopa and levodopa",
            "labeler_name": "Advagen Pharma Ltd.,",
            "brand_name": "Carbidopa-levodopa",
            "active_ingredients": [
                {
                    "name": "CARBIDOPA",
                    "strength": "25 mg/1"
                },
                {
                    "name": "LEVODOPA",
                    "strength": "250 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "72888-108-00",
                    "description": "1000 TABLET in 1 BOTTLE (72888-108-00)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-01",
                    "description": "100 TABLET in 1 BOTTLE (72888-108-01)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-05",
                    "description": "500 TABLET in 1 BOTTLE (72888-108-05)",
                    "marketing_start_date": "20210729",
                    "sample": false
                },
                {
                    "package_ndc": "72888-108-30",
                    "description": "30 TABLET in 1 BOTTLE (72888-108-30)",
                    "marketing_start_date": "20210729",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Advagen Pharma Ltd.,"
                ],
                "rxcui": [
                    "197443",
                    "197444",
                    "197445"
                ],
                "spl_set_id": [
                    "9e3c796b-2e68-4bcc-b927-18a58bea4703"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0372888106304",
                    "0372888106007",
                    "0372888108056",
                    "0372888107004",
                    "0372888107011",
                    "0372888106014",
                    "0372888108308",
                    "0372888107301",
                    "0372888106052",
                    "0372888108018",
                    "0372888108001"
                ],
                "nui": [
                    "N0000175754",
                    "N0000175755",
                    "N0000193220",
                    "M0370111"
                ],
                "pharm_class_epc": [
                    "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
                    "Aromatic Amino Acid [EPC]"
                ],
                "pharm_class_moa": [
                    "DOPA Decarboxylase Inhibitors [MoA]"
                ],
                "pharm_class_cs": [
                    "Amino Acids, Aromatic [CS]"
                ],
                "unii": [
                    "MNX7R8C5VO",
                    "46627O600J"
                ]
            },
            "marketing_category": "ANDA",
            "dosage_form": "TABLET",
            "spl_id": "f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20210729",
            "product_id": "72888-108_f225fba2-3ed1-1cc8-e053-2995a90a9733",
            "application_number": "ANDA216505",
            "brand_name_base": "Carbidopa-levodopa",
            "pharm_class": [
                "Amino Acids",
                "Aromatic [CS]",
                "Aromatic Amino Acid [EPC]"
            ]
        },
        {
            "product_ndc": "0078-0694",
            "generic_name": "ceritinib",
            "labeler_name": "Novartis Pharmaceuticals Corporation",
            "brand_name": "ZYKADIA",
            "active_ingredients": [
                {
                    "name": "CERITINIB",
                    "strength": "150 mg/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "0078-0694-48",
                    "description": "21 TABLET, FILM COATED in 1 BOTTLE (0078-0694-48)",
                    "marketing_start_date": "20190318",
                    "sample": true
                },
                {
                    "package_ndc": "0078-0694-84",
                    "description": "84 TABLET, FILM COATED in 1 BOTTLE (0078-0694-84)",
                    "marketing_start_date": "20190318",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Novartis Pharmaceuticals Corporation"
                ],
                "rxcui": [
                    "2121059",
                    "2121061"
                ],
                "spl_set_id": [
                    "fff5d805-4ffd-4e8e-8e63-6f129697563e"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175605",
                    "N0000020001",
                    "N0000190114",
                    "N0000185504"
                ],
                "pharm_class_epc": [
                    "Kinase Inhibitor [EPC]"
                ],
                "pharm_class_moa": [
                    "Tyrosine Kinase Inhibitors [MoA]",
                    "Cytochrome P450 3A Inhibitors [MoA]",
                    "Cytochrome P450 2C9 Inhibitors [MoA]"
                ],
                "unii": [
                    "K418KG2GET"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "TABLET, FILM COATED",
            "spl_id": "0e388aac-e284-48b6-a0bd-17e5514c167a",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "ORAL"
            ],
            "marketing_start_date": "20190318",
            "product_id": "0078-0694_0e388aac-e284-48b6-a0bd-17e5514c167a",
            "application_number": "NDA211225",
            "brand_name_base": "ZYKADIA",
            "pharm_class": [
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 3A Inhibitors [MoA]",
                "Kinase Inhibitor [EPC]",
                "Tyrosine Kinase Inhibitors [MoA]"
            ]
        },
        {
            "product_ndc": "24208-358",
            "generic_name": "loteprednol etabonate and tobramycin",
            "labeler_name": "Bausch & Lomb Incorporated",
            "brand_name": "Zylet",
            "active_ingredients": [
                {
                    "name": "LOTEPREDNOL ETABONATE",
                    "strength": "5 mg/mL"
                },
                {
                    "name": "TOBRAMYCIN",
                    "strength": "3 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "24208-358-01",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-358-01)  / 1 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20041214",
                    "sample": true
                },
                {
                    "package_ndc": "24208-358-05",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-358-05)  / 5 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20041214",
                    "sample": false
                },
                {
                    "package_ndc": "24208-358-10",
                    "description": "1 BOTTLE, DROPPER in 1 CARTON (24208-358-10)  / 10 mL in 1 BOTTLE, DROPPER",
                    "marketing_start_date": "20041214",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "Bausch & Lomb Incorporated"
                ],
                "rxcui": [
                    "545255",
                    "545259"
                ],
                "spl_set_id": [
                    "3dd9b060-5355-404d-bdf1-09ee8b52a9f5"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175477",
                    "M0000946"
                ],
                "pharm_class_epc": [
                    "Aminoglycoside Antibacterial [EPC]"
                ],
                "pharm_class_cs": [
                    "Aminoglycosides [CS]"
                ],
                "unii": [
                    "YEH1EZ96K6",
                    "VZ8RRZ51VK"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SUSPENSION/ DROPS",
            "spl_id": "4e532599-a607-4047-a600-d3e32fd515a4",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "OPHTHALMIC"
            ],
            "marketing_start_date": "20041214",
            "product_id": "24208-358_4e532599-a607-4047-a600-d3e32fd515a4",
            "application_number": "NDA050804",
            "brand_name_base": "Zylet",
            "pharm_class": [
                "Aminoglycoside Antibacterial [EPC]",
                "Aminoglycosides [CS]",
                "Corticosteroid Hormone Receptor Agonists [MoA]",
                "Corticosteroid [EPC]"
            ]
        },
        {
            "product_ndc": "79952-110",
            "generic_name": "loncastuximab tesirine",
            "labeler_name": "ADC Therapeutics America, Inc.",
            "brand_name": "ZYNLONTA",
            "active_ingredients": [
                {
                    "name": "LONCASTUXIMAB TESIRINE",
                    "strength": "10 mg/2mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "79952-110-01",
                    "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01)  / 2 mL in 1 VIAL, SINGLE-DOSE",
                    "marketing_start_date": "20210430",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "ADC Therapeutics America, Inc."
                ],
                "rxcui": [
                    "2540969",
                    "2540974"
                ],
                "spl_set_id": [
                    "af54af12-3edf-4301-8bc5-0446bc813c1d"
                ],
                "is_original_packager": [
                    true
                ],
                "upc": [
                    "0379952110014"
                ],
                "unii": [
                    "7K5O7P6QIU"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
            "spl_id": "42218472-2cc4-4e9c-837a-ff6598db59a9",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20210430",
            "product_id": "79952-110_42218472-2cc4-4e9c-837a-ff6598db59a9",
            "application_number": "BLA761196",
            "brand_name_base": "ZYNLONTA"
        },
        {
            "product_ndc": "47426-301",
            "generic_name": "BUPIVACAINE and MELOXICAM",
            "labeler_name": "Heron Therapeutics, Inc.",
            "brand_name": "ZYNRELEF",
            "active_ingredients": [
                {
                    "name": "BUPIVACAINE",
                    "strength": "400 mg/14mL"
                },
                {
                    "name": "MELOXICAM",
                    "strength": "12 mg/14mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "47426-301-02",
                    "description": "1 CARTON in 1 KIT (47426-301-02)  / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-301-04)  / 14 mL in 1 VIAL, SINGLE-DOSE (47426-301-06)",
                    "marketing_start_date": "20210701",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Heron Therapeutics, Inc."
                ],
                "rxcui": [
                    "2560306",
                    "2560308",
                    "2560309",
                    "2560311",
                    "2560312",
                    "2560315",
                    "2560319",
                    "2560321"
                ],
                "spl_set_id": [
                    "dab484a7-9353-43ba-9e74-7fab910c712b"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000175682",
                    "M0000897",
                    "N0000175976",
                    "N0000000160",
                    "M0001335",
                    "N0000175722"
                ],
                "pharm_class_epc": [
                    "Amide Local Anesthetic [EPC]",
                    "Nonsteroidal Anti-inflammatory Drug [EPC]"
                ],
                "pharm_class_cs": [
                    "Amides [CS]",
                    "Anti-Inflammatory Agents, Non-Steroidal [CS]"
                ],
                "pharm_class_pe": [
                    "Local Anesthesia [PE]"
                ],
                "pharm_class_moa": [
                    "Cyclooxygenase Inhibitors [MoA]"
                ],
                "unii": [
                    "Y8335394RO",
                    "VG2QF83CGL"
                ]
            },
            "marketing_category": "NDA",
            "dosage_form": "SOLUTION",
            "spl_id": "b012c506-f781-45ef-8de2-f61d38f28177",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INFILTRATION"
            ],
            "marketing_start_date": "20210701",
            "product_id": "47426-301_b012c506-f781-45ef-8de2-f61d38f28177",
            "application_number": "NDA211988",
            "brand_name_base": "ZYNRELEF",
            "pharm_class": [
                "Amide Local Anesthetic [EPC]",
                "Amides [CS]",
                "Anti-Inflammatory Agents",
                "Non-Steroidal [CS]",
                "Cyclooxygenase Inhibitors [MoA]",
                "Local Anesthesia [PE]",
                "Nonsteroidal Anti-inflammatory Drug [EPC]"
            ]
        },
        {
            "product_ndc": "73554-3111",
            "generic_name": "betibeglogene autotemcel",
            "labeler_name": "bluebird bio, Inc.",
            "brand_name": "Zynteglo",
            "active_ingredients": [
                {
                    "name": "BETIBEGLOGENE AUTOTEMCEL",
                    "strength": "20000000 1/1"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "73554-3111-1",
                    "description": "1 SUSPENSION in 1 BAG (73554-3111-1)",
                    "marketing_start_date": "20220817",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20241231",
            "openfda": {
                "manufacturer_name": [
                    "bluebird bio, Inc."
                ],
                "rxcui": [
                    "2610435",
                    "2610436"
                ],
                "spl_set_id": [
                    "86931613-c262-47f5-8202-bc31fa69ad3d"
                ],
                "is_original_packager": [
                    true
                ],
                "unii": [
                    "MEE8487RTP"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "SUSPENSION",
            "spl_id": "1f4166d5-1256-4c4d-b974-6afbab410b31",
            "product_type": "CELLULAR THERAPY",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20220817",
            "product_id": "73554-3111_1f4166d5-1256-4c4d-b974-6afbab410b31",
            "application_number": "BLA125717",
            "brand_name_base": "Zynteglo"
        },
        {
            "product_ndc": "50881-006",
            "generic_name": "retifanlimab-dlwr",
            "labeler_name": "Incyte Corporation",
            "brand_name": "ZYNYZ",
            "active_ingredients": [
                {
                    "name": "RETIFANLIMAB",
                    "strength": "25 mg/mL"
                }
            ],
            "finished": true,
            "packaging": [
                {
                    "package_ndc": "50881-006-03",
                    "description": "1 VIAL, SINGLE-USE in 1 CARTON (50881-006-03)  / 20 mL in 1 VIAL, SINGLE-USE",
                    "marketing_start_date": "20230322",
                    "sample": false
                }
            ],
            "listing_expiration_date": "20251231",
            "openfda": {
                "manufacturer_name": [
                    "Incyte Corporation"
                ],
                "rxcui": [
                    "2632985",
                    "2632991"
                ],
                "spl_set_id": [
                    "109648d0-d30a-42fc-8273-39cb1540a751"
                ],
                "is_original_packager": [
                    true
                ],
                "nui": [
                    "N0000191260",
                    "N0000191259"
                ],
                "pharm_class_epc": [
                    "Programmed Death Receptor-1 Blocking Antibody [EPC]"
                ],
                "pharm_class_moa": [
                    "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
                ],
                "unii": [
                    "2Y3T5IF01Z"
                ]
            },
            "marketing_category": "BLA",
            "dosage_form": "INJECTION",
            "spl_id": "584c49ff-644e-49e0-a1bd-3573d00656c2",
            "product_type": "HUMAN PRESCRIPTION DRUG",
            "route": [
                "INTRAVENOUS"
            ],
            "marketing_start_date": "20230322",
            "product_id": "50881-006_584c49ff-644e-49e0-a1bd-3573d00656c2",
            "application_number": "BLA761334",
            "brand_name_base": "ZYNYZ",
            "pharm_class": [
                "Programmed Death Receptor-1 Blocking Antibody [EPC]",
                "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
            ]
        }
    ]
}